Citrus Sinensis ID: 025933
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | 2.2.26 [Sep-21-2011] | |||||||
| P0C5D6 | 334 | Serine/threonine-protein | yes | no | 0.890 | 0.655 | 0.730 | 1e-89 | |
| A2ZAB5 | 334 | Serine/threonine-protein | N/A | no | 0.890 | 0.655 | 0.730 | 1e-89 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.833 | 0.599 | 0.723 | 3e-86 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.829 | 0.601 | 0.717 | 4e-84 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.934 | 0.678 | 0.653 | 5e-84 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.869 | 0.591 | 0.669 | 4e-82 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.890 | 0.610 | 0.657 | 2e-81 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.910 | 0.674 | 0.653 | 9e-81 | |
| Q6ZI44 | 365 | Serine/threonine-protein | no | no | 0.890 | 0.6 | 0.644 | 2e-80 | |
| Q9C958 | 361 | Serine/threonine-protein | no | no | 0.849 | 0.578 | 0.666 | 9e-80 |
| >sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 329 bits (844), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 163/223 (73%), Positives = 184/223 (82%), Gaps = 4/223 (1%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C L EICHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAY
Sbjct: 108 LISGVSYCHSL-EICHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAY 166
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGK++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI VQY +PD
Sbjct: 167 IAPEVLSRKEYDGKVADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPD 226
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS+DCR LLSQIFVADPSKRI IPEIKKH WFLKNLPKEI E EK +YK+ PT
Sbjct: 227 YVRVSSDCRRLLSQIFVADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPT 286
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESE 234
Q+VEEIMRIIQEAK+PG+ +A A ++ +++ D E E
Sbjct: 287 QAVEEIMRIIQEAKVPGD---MAAADPALLAELAELKSDDEEE 326
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2ZAB5|SAPK3_ORYSI Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. indica GN=SAPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 163/223 (73%), Positives = 184/223 (82%), Gaps = 4/223 (1%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C L EICHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAY
Sbjct: 108 LISGVSYCHSL-EICHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAY 166
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGK++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI VQY +PD
Sbjct: 167 IAPEVLSRKEYDGKVADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPD 226
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS+DCR LLSQIFVADPSKRI IPEIKKH WFLKNLPKEI E EK +YK+ PT
Sbjct: 227 YVRVSSDCRRLLSQIFVADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPT 286
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESE 234
Q+VEEIMRIIQEAK+PG+ +A A ++ +++ D E E
Sbjct: 287 QAVEEIMRIIQEAKVPGD---MAAADPALLAELAELKSDDEEE 326
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 149/206 (72%), Positives = 175/206 (84%), Gaps = 1/206 (0%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q +CHRDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAY
Sbjct: 107 LISGVSYCHSMQ-VCHRDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAY 165
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGK++DVWSCGVTLYVMLVGAYPFEDP+DPRNFRKTI RI +VQY +PD
Sbjct: 166 IAPEVLSRKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPD 225
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVSADCRHLLS+IFV +P +RI IPEIK HPWFLKNLP E+ + + + + A + P+
Sbjct: 226 YVRVSADCRHLLSRIFVGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPS 285
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQG 217
QS+EE+M IIQEA+ PG+A K+AG G
Sbjct: 286 QSLEEVMAIIQEARKPGDAMKLAGAG 311
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 147/205 (71%), Positives = 172/205 (83%), Gaps = 1/205 (0%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q ICHRDLKLENTLLDGS PRLKICDFGYSKS LLHSQPKSTVGTPAY
Sbjct: 107 LISGVSYCHSMQ-ICHRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAY 165
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVLARKEYDGK++DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PD
Sbjct: 166 IAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPD 225
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS +CRHLLS+IFVA+P +RI IPEIK HPWFLKNLP E+ + + + + + P+
Sbjct: 226 YVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPS 285
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQ 216
Q +EEIM IIQEA+ PG+ +K +GQ
Sbjct: 286 QGLEEIMAIIQEARKPGDGSKFSGQ 310
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 151/231 (65%), Positives = 183/231 (79%), Gaps = 1/231 (0%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q ICHRDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAY
Sbjct: 107 LISGVSYCHSMQ-ICHRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 165
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVLARKEYDGK++DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PD
Sbjct: 166 IAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPD 225
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS +CRHLLS+IFVA+P +RI IPEIK HPWFLKNLP E+ + + + + + P+
Sbjct: 226 YVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPS 285
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 242
Q +EEIM IIQEA+ PG+ +K +GQ S D + +++ SGD++
Sbjct: 286 QGLEEIMAIIQEARKPGDGSKFSGQIPGLGSMELDDIDTDDIDVEDSGDFV 336
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 144/215 (66%), Positives = 170/215 (79%), Gaps = 1/215 (0%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q +CHRDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAY
Sbjct: 124 LISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 182
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL +KEYDGK++DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PD
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YV +S +CRHL+S+IFVADP+KRI IPEI+ H WFLKNLP +++ + DQP
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG 302
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDD 226
QS+EEIM+II EA +P T+ G+ D DD
Sbjct: 303 QSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDD 337
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 148/225 (65%), Positives = 178/225 (79%), Gaps = 6/225 (2%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 65
YF ++ S+ C ++Q ICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHS+PKST
Sbjct: 102 YFFQQLICGVSY-CHFMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKST 159
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
VGTPAYIAPEVL+R+EYDGK +DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RI ++
Sbjct: 160 VGTPAYIAPEVLSRREYDGKTADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSI 219
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEA 185
QY +P+YV VS DCR LLS+IFVA+P+KRI I EI+ HPWFLKNLP+E+ E + Y +
Sbjct: 220 QYKIPEYVHVSQDCRQLLSRIFVANPAKRITIREIRNHPWFLKNLPRELTEAAQAMYYKK 279
Query: 186 GRDQPT---QSVEEIMRIIQEAKM-PGEATKVAGQGAAGASDPDD 226
PT QSVEEIM+I++EA+ P +T VAG G + +D
Sbjct: 280 DNSAPTYSVQSVEEIMKIVEEARTPPRSSTPVAGFGWQEEDEQED 324
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (767), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 149/228 (65%), Positives = 181/228 (79%), Gaps = 4/228 (1%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+C +Q +CHRDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL
Sbjct: 103 YCHSMQ-VCHRDLKLENTLLDGSVAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+R+EYDGK++DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PDYVRVS
Sbjct: 162 SRREYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYSVPDYVRVSM 221
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEI 197
DC HLLS+IFV +P +RI IPEIK HPWFLK LP E+ + + + + A + P+QS+EE
Sbjct: 222 DCIHLLSRIFVGNPQQRITIPEIKNHPWFLKRLPVEMTDEYQRSMQLADMNTPSQSLEEA 281
Query: 198 MRIIQEAKMPGE-ATKVAGQGAAGAS--DPDDMEGDIESEIDASGDYM 242
M IIQEA+ PG+ A VAGQ A S D + ++++SGD++
Sbjct: 282 MAIIQEAQKPGDNALGVAGQVACLGSMDLDDIDFDIDDIDVESSGDFV 329
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 145/225 (64%), Positives = 178/225 (79%), Gaps = 6/225 (2%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 65
YF ++ S+ C ++Q ICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHS+PKST
Sbjct: 102 YFFQQLICGVSY-CHFMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKST 159
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
VGTPAYIAPEVL+R+EYDGK++DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RI ++
Sbjct: 160 VGTPAYIAPEVLSRREYDGKMADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIVSI 219
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNY--- 182
QY +P+YV +S DCR LLS+IFVA+P+KRI I EI+ HPWF+KNLP+E+ E + Y
Sbjct: 220 QYKIPEYVHISQDCRQLLSRIFVANPAKRITIREIRNHPWFMKNLPRELTEAAQAKYYKK 279
Query: 183 KEAGRDQPTQSVEEIMRIIQEAKM-PGEATKVAGQGAAGASDPDD 226
+ R Q+V+EIM+I+QEAK P +T VAG G + +D
Sbjct: 280 DNSARTFSDQTVDEIMKIVQEAKTPPPSSTPVAGFGWTEEEEQED 324
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 9e-80, Method: Compositional matrix adjust.
Identities = 144/216 (66%), Positives = 170/216 (78%), Gaps = 7/216 (3%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q ICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHS PKSTVGTPAY
Sbjct: 107 LISGVSYCHAMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAY 165
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+R EYDGK++DVWSCGVTLYVMLVGAYPFED EDP+NF+KTI RI V+Y +PD
Sbjct: 166 IAPEVLSRGEYDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPD 225
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YV +S DC+HLLS+IFV + +KRI I +IKKHPWFLKNLP+E+ EI + Y ++ PT
Sbjct: 226 YVHISQDCKHLLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFR--KENPT 283
Query: 192 ---QSVEEIMRIIQEAKMPGEATKVAGQ-GAAGASD 223
QSVEEIM+I++EAK P ++ G G G D
Sbjct: 284 FSLQSVEEIMKIVEEAKTPARVSRSIGAFGWGGGED 319
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| 255552916 | 336 | Serine/threonine-protein kinase SAPK3, p | 0.882 | 0.645 | 0.803 | 1e-100 | |
| 225427681 | 340 | PREDICTED: serine/threonine-protein kina | 0.894 | 0.647 | 0.795 | 1e-100 | |
| 449459014 | 340 | PREDICTED: serine/threonine-protein kina | 0.939 | 0.679 | 0.75 | 2e-99 | |
| 3811293 | 339 | putative serine/threonine protein kinase | 0.894 | 0.648 | 0.769 | 1e-97 | |
| 224126431 | 338 | predicted protein [Populus trichocarpa] | 0.882 | 0.642 | 0.812 | 3e-97 | |
| 147783296 | 367 | hypothetical protein VITISV_005083 [Viti | 0.865 | 0.580 | 0.807 | 5e-97 | |
| 356563403 | 336 | PREDICTED: serine/threonine-protein kina | 0.918 | 0.672 | 0.734 | 1e-94 | |
| 329025156 | 339 | serine/threonine protein kinase [Solanum | 0.894 | 0.648 | 0.737 | 1e-94 | |
| 356511001 | 336 | PREDICTED: serine/threonine-protein kina | 0.910 | 0.666 | 0.737 | 2e-94 | |
| 404435145 | 339 | sucrose non-fermenting 1-related protein | 0.894 | 0.648 | 0.733 | 6e-94 |
| >gi|255552916|ref|XP_002517501.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis] gi|223543512|gb|EEF45043.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 176/219 (80%), Positives = 195/219 (89%), Gaps = 2/219 (0%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
EICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYD
Sbjct: 119 EICHRDLKLENTLLDGSPTPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYD 178
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
GKI+DVWSCGVTLYVMLVGAYPFEDPED RNFRKTI RI +VQY +PDYVRVSADC+HLL
Sbjct: 179 GKIADVWSCGVTLYVMLVGAYPFEDPEDSRNFRKTIGRIMSVQYSIPDYVRVSADCKHLL 238
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
S+IFVA+P+KRI IPEIK+HPWFLKNLPKE+IEIEKT Y E+ RDQP+QSVEEIMRIIQE
Sbjct: 239 SRIFVANPAKRITIPEIKQHPWFLKNLPKELIEIEKTTYAESERDQPSQSVEEIMRIIQE 298
Query: 204 AKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 242
AK PGE K + G S DD++ D+ESEID SG+++
Sbjct: 299 AKTPGEGAKFSELAVPGTS--DDLDADLESEIDISGEFV 335
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225427681|ref|XP_002262726.1| PREDICTED: serine/threonine-protein kinase SAPK3 [Vitis vinifera] gi|296083436|emb|CBI23389.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 175/220 (79%), Positives = 192/220 (87%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
EICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKS VGTPAYIAPEVL+RKEYD
Sbjct: 119 EICHRDLKLENTLLDGSPMPRLKICDFGYSKSALLHSQPKSAVGTPAYIAPEVLSRKEYD 178
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
GKI+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYV VSA+CR LL
Sbjct: 179 GKIADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVHVSAECRQLL 238
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
S+IFVA+P+KRI IPEIK+HPWFLKN PKE+IE EKTNY E DQ QSVEEIMRIIQE
Sbjct: 239 SRIFVANPAKRITIPEIKQHPWFLKNFPKELIEGEKTNYGELHHDQLVQSVEEIMRIIQE 298
Query: 204 AKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMS 243
A+ PGE +KV G GA D DD+E D+ESEID SG++M+
Sbjct: 299 ARTPGEGSKVDGHSLDGALDSDDLEADLESEIDVSGEFMA 338
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459014|ref|XP_004147241.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus] gi|449515157|ref|XP_004164616.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 367 bits (942), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 174/232 (75%), Positives = 201/232 (86%), Gaps = 1/232 (0%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C +Q ICHRDLKLENTLLDGSP P+LKICDFGYSKS LLHSQPKSTVGTPAY
Sbjct: 108 LISGVSYCHSMQ-ICHRDLKLENTLLDGSPTPQLKICDFGYSKSALLHSQPKSTVGTPAY 166
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGKI+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PD
Sbjct: 167 IAPEVLSRKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIARILSVQYSIPD 226
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS +CR+LLS+IFVA+P+KRI I EIK+ PWF KNLPKE+IEIEKTN+K+ +Q +
Sbjct: 227 YVRVSVECRNLLSRIFVANPAKRITIQEIKQLPWFFKNLPKELIEIEKTNFKQQEHNQLS 286
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMS 243
QSVEEIM+I+QEA PGEA+KV Q AG S DD+EGDI+SE+D SGDY++
Sbjct: 287 QSVEEIMQIVQEAMTPGEASKVGDQALAGGSGLDDLEGDIDSEVDVSGDYVT 338
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3811293|gb|AAC69450.1| putative serine/threonine protein kinase [Nicotiana tabacum] gi|4098172|gb|AAD00239.1| PK11-C1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 361 bits (927), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 170/221 (76%), Positives = 196/221 (88%), Gaps = 1/221 (0%)
Query: 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ EICHRDLKLENTLLDGS PR+KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RK
Sbjct: 116 HAMEICHRDLKLENTLLDGSASPRVKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRK 175
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
EYDGKI+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + QY +PDYVR+SADC+
Sbjct: 176 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQYSIPDYVRISADCK 235
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 200
+LLS+IFVA+PSKRI IPEIKKHPWFLKNLPK++++ E + Y+EA +Q QSVEEIMRI
Sbjct: 236 NLLSRIFVANPSKRITIPEIKKHPWFLKNLPKDLMDGEHSKYEEAS-EQLQQSVEEIMRI 294
Query: 201 IQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 241
IQEAK+PGE +K GQ AG ++PDD E D+ESEID+S D+
Sbjct: 295 IQEAKIPGEVSKPEGQATAGTAEPDDTEDDLESEIDSSNDF 335
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126431|ref|XP_002329552.1| predicted protein [Populus trichocarpa] gi|222870261|gb|EEF07392.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 360 bits (924), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 178/219 (81%), Positives = 195/219 (89%), Gaps = 2/219 (0%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
EICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYD
Sbjct: 119 EICHRDLKLENTLLDGSPAPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYD 178
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYVRVSADC+HLL
Sbjct: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVRVSADCKHLL 238
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
S+IFVA+P+KRI IPEIK+HPWFLKNLPKE++EIEKTN+ ++ RDQP QSVEEIM IIQE
Sbjct: 239 SRIFVANPAKRITIPEIKQHPWFLKNLPKELVEIEKTNFTKSERDQPAQSVEEIMSIIQE 298
Query: 204 AKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 242
AK PGE KVA AG SD D+ D++SE+D SGD M
Sbjct: 299 AKTPGEGGKVAEHAFAGTSDDLDV--DLDSEVDVSGDIM 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147783296|emb|CAN62023.1| hypothetical protein VITISV_005083 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 359 bits (922), Expect = 5e-97, Method: Compositional matrix adjust.
Identities = 172/213 (80%), Positives = 185/213 (86%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
EICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKS VGTPAYIAPEVL+RKEYD
Sbjct: 119 EICHRDLKLENTLLDGSPMPRLKICDFGYSKSALLHSQPKSAVGTPAYIAPEVLSRKEYD 178
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
GKI+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYV VSA CR LL
Sbjct: 179 GKIADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVHVSAXCRQLL 238
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
S+IFVA+P+KRI IPEIK+HPWFLKN PKE+IE EKTNY E DQ QSVEEIMRIIQE
Sbjct: 239 SRIFVANPAKRITIPEIKQHPWFLKNFPKELIEGEKTNYGELHHDQLVQSVEEIMRIIQE 298
Query: 204 AKMPGEATKVAGQGAAGASDPDDMEGDIESEID 236
A+ PGE +KV G GA D DD+E D+ESEID
Sbjct: 299 ARTPGEGSKVDGHSLDGALDSDDLEADLESEID 331
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563403|ref|XP_003549953.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 351 bits (901), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 169/230 (73%), Positives = 194/230 (84%), Gaps = 4/230 (1%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C + EICHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAY
Sbjct: 108 LISGVSYCHSM-EICHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAY 166
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +QY +PD
Sbjct: 167 IAPEVLSRKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGIQYSIPD 226
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS+DCR+LLS+IFVADP+KRI IPEIK++PWFLKN+PKEIIE E+ ++E +DQP
Sbjct: 227 YVRVSSDCRNLLSRIFVADPAKRITIPEIKQYPWFLKNMPKEIIEAERKGFEETTKDQPN 286
Query: 192 QSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 241
Q VEEIMRIIQ A++PG+ +K AG+G + D+E D EID SGDY
Sbjct: 287 QKVEEIMRIIQAARIPGQGSK-AGEGGQAGTGSLDIEDD--EEIDVSGDY 333
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|329025156|gb|AEB71561.1| serine/threonine protein kinase [Solanum chacoense] | Back alignment and taxonomy information |
|---|
Score = 351 bits (901), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 163/221 (73%), Positives = 195/221 (88%), Gaps = 1/221 (0%)
Query: 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ EICHRDLKLENTLLDGSP PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RK
Sbjct: 116 HTMEICHRDLKLENTLLDGSPSPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRK 175
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
EYDGKI+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + Q+ +PDYVR++ DC+
Sbjct: 176 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQHSIPDYVRITPDCK 235
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 200
+LLS+IFVA+PSKRI IPEIKKHPWFLKNLPKE++++E ++E+ +Q QSVEEIM++
Sbjct: 236 NLLSRIFVANPSKRITIPEIKKHPWFLKNLPKELMDVEHAKFEESS-EQLQQSVEEIMKM 294
Query: 201 IQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 241
IQEAK+PG +K G+ AG ++ DD+E D+ESEID+S D+
Sbjct: 295 IQEAKIPGVVSKSEGKDPAGTAEQDDLEEDLESEIDSSNDF 335
|
Source: Solanum chacoense Species: Solanum chacoense Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511001|ref|XP_003524220.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 351 bits (901), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 171/232 (73%), Positives = 195/232 (84%), Gaps = 8/232 (3%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
+I +C + EICHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAY
Sbjct: 108 LISGVSYCHSM-EICHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAY 166
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPEVL+RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI VQY +PD
Sbjct: 167 IAPEVLSRKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGVQYSIPD 226
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 191
YVRVS+DCR+LLS+IFVADP+KRI IPEIK++PWFLKN+PKEIIE E+ ++E +DQP+
Sbjct: 227 YVRVSSDCRNLLSRIFVADPAKRITIPEIKQYPWFLKNMPKEIIEAERKGFEETTKDQPS 286
Query: 192 QSVEEIMRIIQEAKMPGEATKVA--GQGAAGASDPDDMEGDIESEIDASGDY 241
Q VEEIMRIIQEA++PG+ +K GQ G+ D +D E EID SGDY
Sbjct: 287 QKVEEIMRIIQEARIPGQGSKAGEVGQVGTGSLDIEDDE-----EIDVSGDY 333
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435145|gb|AFR68939.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 349 bits (896), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 162/221 (73%), Positives = 194/221 (87%), Gaps = 1/221 (0%)
Query: 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ EICHRDLKLENTLLDGSP PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RK
Sbjct: 116 HTMEICHRDLKLENTLLDGSPSPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRK 175
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
EYDGKI+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + Q+ +PDYVR++ DC+
Sbjct: 176 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQHSIPDYVRITPDCK 235
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 200
+LLS+IFVA+PSKRI IPE KKHPWFLKNLPKE++++E ++E+ +Q QSVEEIM++
Sbjct: 236 NLLSRIFVANPSKRITIPETKKHPWFLKNLPKELMDVEHAKFEESS-EQLQQSVEEIMKM 294
Query: 201 IQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 241
IQEAK+PG +K G+ AG ++ DD+E D+ESEID+S D+
Sbjct: 295 IQEAKIPGVVSKSEGKDPAGTAEQDDLEEDLESEIDSSNDF 335
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 246 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.878 | 0.596 | 0.680 | 2e-79 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.922 | 0.628 | 0.638 | 2.4e-76 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.918 | 0.640 | 0.624 | 3.9e-76 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.857 | 0.586 | 0.659 | 1.7e-73 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.902 | 0.614 | 0.638 | 2.8e-73 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.890 | 0.638 | 0.642 | 4.1e-72 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.951 | 0.668 | 0.596 | 8.6e-72 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.882 | 0.640 | 0.597 | 1.2e-65 | |
| DICTYBASE|DDB_G0277165 | 833 | DDB_G0277165 "BRSK subfamily p | 0.589 | 0.174 | 0.432 | 4.4e-29 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.695 | 0.350 | 0.391 | 5.6e-28 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 151/222 (68%), Positives = 180/222 (81%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+C +Q +CHRDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL
Sbjct: 130 YCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 188
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+KEYDGK++DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK--TNYKEAGRDQPTQSVE 195
+CRHL+S+IFVADP+KRI IPEI+ H WFLKNLP +++ T + E+ DQP QS+E
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES--DQPGQSIE 306
Query: 196 EIMRIIQEAKMPGEATKVAGQGAAGASD-PDDMEGDIESEID 236
EIM+II EA +P T+ G+ D DDME D+ES++D
Sbjct: 307 EIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLD 348
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 150/235 (63%), Positives = 180/235 (76%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 65
YF ++ S+ C +Q ICHRDLKLENTLLDGSP PRLKICDFGYSKS LLHS PKST
Sbjct: 102 YFFQQLISGVSY-CHAMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKST 159
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
VGTPAYIAPEVL+R EYDGK++DVWSCGVTLYVMLVGAYPFED EDP+NF+KTI RI V
Sbjct: 160 VGTPAYIAPEVLSRGEYDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAV 219
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEA 185
+Y +PDYV +S DC+HLLS+IFV + +KRI I +IKKHPWFLKNLP+E+ EI + Y
Sbjct: 220 KYKIPDYVHISQDCKHLLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFR- 278
Query: 186 GRDQPT---QSVEEIMRIIQEAKMPGEATKVAGQ-GAAGASDPDDMEGDIESEID 236
++ PT QSVEEIM+I++EAK P ++ G G G D + E D E E++
Sbjct: 279 -KENPTFSLQSVEEIMKIVEEAKTPARVSRSIGAFGWGGGEDAEGKEEDAEEEVE 332
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 143/229 (62%), Positives = 175/229 (76%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+C LQ ICHRDLKLENTLLDGSP P LKICDFGYSKS +LHS+PKSTVGTPAYIAPEVL
Sbjct: 113 YCHSLQ-ICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVL 171
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+R+EYDGK +DVWSCGVTLYVMLVGAYPFEDP DP+NFRKTI RI VQY +PDYV +S
Sbjct: 172 SRREYDGKHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQ 231
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEI 197
+C+HLLS+IFV + +KRI + EIK HPW+LKNLPKE++E + Y + QSVE+I
Sbjct: 232 ECKHLLSRIFVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDI 291
Query: 198 MRIIQEAKMPGEATKVAGQGAAGASDPD--DMEGDIESEIDASGDYMSH 244
M+I+ EA+ P +T +GA + + D+E ++E E D +Y H
Sbjct: 292 MKIVGEARNPAPSTSAVKSSGSGADEEEEEDVEAEVEEEEDDEDEYEKH 340
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
Identities = 145/220 (65%), Positives = 175/220 (79%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+C LQ ICHRDLKLENTLLDGSP P LKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL
Sbjct: 113 YCHSLQ-ICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+R+EYDGK +DVWSCGVTLYVMLVG YPFEDP+DPRNFRKTI RI VQY +PDYV +S
Sbjct: 172 SRREYDGKHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQ 231
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT---QSV 194
+CRHLLS+IFV + +KRI + EIKKHPW+LKNLPKE+ E + Y + R+ P+ QSV
Sbjct: 232 ECRHLLSRIFVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYK--RETPSFSLQSV 289
Query: 195 EEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESE 234
E+IM+I+ EA+ P ++ A +G D +D+E ++E E
Sbjct: 290 EDIMKIVGEARNPAPSSN-AVKGFD--DDEEDVEDEVEEE 326
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.8e-73, P = 2.8e-73
Identities = 145/227 (63%), Positives = 175/227 (77%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+C +Q ICHRDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL
Sbjct: 131 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
R+EYDGKI+DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEI 197
+C HL+S+IFVADP+ RI IPEIK H WFLKNLP +++ T + +QP QS++ I
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTI 309
Query: 198 MRIIQEAKMPGEATKVAGQGAAGASD-PDDMEG-DIESEID--ASGD 240
M+II EA +P + D DDM+ D ESEID +SG+
Sbjct: 310 MQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGE 356
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 4.1e-72, P = 4.1e-72
Identities = 153/238 (64%), Positives = 180/238 (75%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
++C LQ ICHRDLKLENTLLDGS PR+KICDFGYSKSG+LHSQPK+TVGTPAYIAPEV
Sbjct: 112 NYCHSLQ-ICHRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEV 170
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
L+ KEYDGKI+DVWSCGVTLYVMLVGAYPFEDP DP++FRKTI RI QY +PDYVRVS
Sbjct: 171 LSTKEYDGKIADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVS 230
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEE 196
+CRHLLS+IFVA+P KRI I EIK H WFLKNLP E+ E + G TQ+VEE
Sbjct: 231 DECRHLLSRIFVANPEKRITIEEIKNHSWFLKNLPVEMYE---GSLMMNGPS--TQTVEE 285
Query: 197 IMRIIQEAKMP-GEATKVAGQGAAGAS----------DPDDMEGDIESEIDASGDYMS 243
I+ II+EA+ P AT +AG G +G S D DD++ D + +ID + D +S
Sbjct: 286 IVWIIEEARKPITVATGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFD-DIDTA-DLLS 341
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
Identities = 148/248 (59%), Positives = 183/248 (73%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 65
YF +I +C +Q ICHRDLKLENTLLDGSP LKICDFGYSKS +LHSQPKST
Sbjct: 103 YFKQ--LISGVSYCHAMQ-ICHRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKST 159
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
VGTPAY+APEVL+RKEY+GKI+DVWSCGVTLYVMLVGAYPFEDPEDPRN R TI RI +V
Sbjct: 160 VGTPAYVAPEVLSRKEYNGKIADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSV 219
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN---LPKEIIEIEK-TN 181
Y +PDYVR+S++C+HLLS+IFVADP KRI +PEI+KHPWFLK +P E + +
Sbjct: 220 HYTIPDYVRISSECKHLLSRIFVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVE 279
Query: 182 YKEAGRDQPTQSVEEIMRIIQEAKMPGEAT-KVAGQGAA-GASDPDDME-GDIESEID-- 236
+E ++ QSVEEI++II+EA+ T G G G+ D DD++ DI ++D
Sbjct: 280 EEEEEEEKCRQSVEEIVKIIEEARKGVNGTDNNGGLGLIDGSIDLDDIDDADIYDDVDDD 339
Query: 237 --ASGDYM 242
+GD++
Sbjct: 340 EERNGDFV 347
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 132/221 (59%), Positives = 156/221 (70%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
H + +ICHRDLKLENTLLDGSP PRLKICDFGYSKS +LHS PKSTVGTPAYIAPEV
Sbjct: 112 HYLHALQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVF 171
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
R EYDGK DVWSCGV LYVMLVGAYPFEDP+DPRNFRKT+ +I V Y +P YV +S
Sbjct: 172 CRSEYDGKSVDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISE 231
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQ---PTQSV 194
DCR LLS+IFVA+P R + EIK H WFLKNLP+E+ E + Y + + Q V
Sbjct: 232 DCRKLLSRIFVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRV 291
Query: 195 EEIMRIIQEAK-MPGEATKVAGQGAAGASDPDDMEGDIESE 234
EEIM+I+ EA+ +P + V G+ D ++ D E
Sbjct: 292 EEIMKIVGEARTIPNLSRPVESLGSDKKDDDEEEYLDANDE 332
|
|
| DICTYBASE|DDB_G0277165 DDB_G0277165 "BRSK subfamily protein kinase DDB_G0277165" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 4.4e-29, P = 4.4e-29
Identities = 70/162 (43%), Positives = 101/162 (62%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVG 67
+I +C + + ICHRDLK EN LL G R+KI DFG K LLH+ + G
Sbjct: 117 IIIGLEYC-HSRNICHRDLKPENLLLSGDK--RIKIADFGMGSIVRKDMLLHT----SCG 169
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
+P Y +PEV++ +YDG+ +DVWSCGV LY +L G PF+D N R+ +++++N +
Sbjct: 170 SPHYASPEVVSGIDYDGQKADVWSCGVILYALLTGKLPFDD----ENIRRLLNKVKNGAF 225
Query: 128 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
+P Y+ D + LL+++ DPSKRI I EIK+HPWF+ N
Sbjct: 226 SMPPYIH--KDAQDLLTKMLTVDPSKRISIKEIKEHPWFVSN 265
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 315 (115.9 bits), Expect = 5.6e-28, P = 5.6e-28
Identities = 76/194 (39%), Positives = 108/194 (55%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLL 58
YF +I C + + + HRDLK EN L+D + LK+ DFG S + GLL
Sbjct: 145 YFQQ--LISAVDFC-HSRGVSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLL 199
Query: 59 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
H+Q GTPAY+APEVL +K YDG D+WSCG+ LYV+L G PF+D N K
Sbjct: 200 HTQ----CGTPAYVAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKM 251
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI-IEI 177
+I ++ P + S + + L+S++ V DP+KRI IP I + PWF KN+ I +I
Sbjct: 252 YRKIFKSEFEYPPWF--SPESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKI 309
Query: 178 EKTNYKEAGRDQPT 191
++ + + PT
Sbjct: 310 DELEIQNVEDETPT 323
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7309 | 0.8902 | 0.6556 | N/A | no |
| P0C5D6 | SAPK3_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7309 | 0.8902 | 0.6556 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 246 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-40 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-20 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-08 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.003 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-47
Identities = 54/149 (36%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL I HRDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVL
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSA 137
K Y + D+WS GV LY +L G PF + + +I + F P +S
Sbjct: 170 GKGYGKAV-DIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDISP 225
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ + L+ ++ V DP KR+ E +HP+F
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-40
Identities = 61/145 (42%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I HRDLK EN LLD + +KI DFG +K L S +T VGTP Y+APEVL
Sbjct: 119 IIHRDLKPENILLDENGV--VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYFLPDYVRVSADCRH 141
G DVWS GV LY +L G PF E+ + + I RI +++ P + S + +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWF 166
L+ + DPSKR EI +HPWF
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-36
Identities = 60/163 (36%), Positives = 81/163 (49%), Gaps = 25/163 (15%)
Query: 20 FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTV 66
FY EI +RDLK EN LLD +K+ DFG +K S+ +
Sbjct: 97 FYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFC 154
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
GTP Y+APEVL K Y GK D WS GV LY ML G PF + ++ ++I
Sbjct: 155 GTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAE----DRKEIYEKILKDP 209
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
P++ +S + R L+S + DP+KR+ EIK HP+F
Sbjct: 210 LRFPEF--LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-30
Identities = 63/154 (40%), Positives = 80/154 (51%), Gaps = 19/154 (12%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---------TVGTPAYIAPE 75
I HRDLK +N L+D + LK+ DFG SK GL+ Q VGTP YIAPE
Sbjct: 114 IIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
V+ + + K D WS G LY LVG PF E P + I N + P+ V V
Sbjct: 172 VILGQGH-SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEV 226
Query: 136 SADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
S + L+S++ V DP KR+ I EIK HP+F
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 54/158 (34%), Positives = 81/158 (51%), Gaps = 26/158 (16%)
Query: 17 HHCFYLQEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 74
H +I +RDLK EN LLD G +KI DFG++K + + + GTP Y+AP
Sbjct: 118 HSL----DIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAP 167
Query: 75 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYV 133
E++ K Y GK D W+ G+ +Y ML G PF D + + K + ++R +F
Sbjct: 168 EIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF----- 221
Query: 134 RVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
S D + L+ + D +KR+ + +IK HPWF
Sbjct: 222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-28
Identities = 51/147 (34%), Positives = 65/147 (44%), Gaps = 41/147 (27%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVL 77
YL I HRDLK EN LLD S ++K+ DFG SK S K+ VGTPAY+APEVL
Sbjct: 107 YLHSNGIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
K Y + SD+WS GV LY +
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------P 188
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHP 164
+ + L+ ++ DP KR EI +H
Sbjct: 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 21 YL--QEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
YL I HRD+K N LL DG +K+ DFG S + VGTP ++APEV
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRV 135
+ K YD K +D+WS G+T + G P+ + K + +I N L + +
Sbjct: 169 INGKPYDYK-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKW 223
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
S + + L + +P KR ++ KHP+
Sbjct: 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPE 75
YL I HRD+K N L+D +K+ DFG +K S GTP ++APE
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
V+ R E G+ +D+WS G T+ M G P+ + +P I +P+++
Sbjct: 174 VI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-IPEHL-- 229
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
S + + L + DP KR E+ +HP+
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 53/167 (31%), Positives = 73/167 (43%), Gaps = 34/167 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------------SGLLHSQPK 63
I HRDLK EN LLD +KI DFG +K +
Sbjct: 123 IIHRDLKPENILLDK--DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
S VGT Y++PE+L K GK SD+W+ G +Y ML G PF + T +I
Sbjct: 181 SFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTFQKIL 235
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRI----PIPEIKKHPWF 166
++Y P D + L+ ++ V DP R+ E+K HP+F
Sbjct: 236 KLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 61/200 (30%), Positives = 82/200 (41%), Gaps = 54/200 (27%)
Query: 13 IFTSHHC-FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSK----- 54
+F FY+ E+ HRD+K +N L+D +K+ DFG K
Sbjct: 97 VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKA 154
Query: 55 ---------------------SGLLHSQPK----STVGTPAYIAPEVLARKEYDGKISDV 89
H Q + STVGTP YIAPEVL Y + D
Sbjct: 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDW 213
Query: 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIF 147
WS GV LY ML G PF ++T ++I N + L P VS + L+ +
Sbjct: 214 WSLGVILYEMLYGFPPFYSD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-L 268
Query: 148 VADPSKRI-PIPEIKKHPWF 166
+ DP R+ EIK HP+F
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-24
Identities = 60/156 (38%), Positives = 80/156 (51%), Gaps = 19/156 (12%)
Query: 20 FYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
+L E I +RDLKL+N LLD + +KI DFG K G+L ST GTP YIAPE+
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
L+ + Y G D W+ GV LY ML G PFE D ED + I + P ++
Sbjct: 168 LSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDEVRYPRWLSK 221
Query: 136 SADCRHLLSQIFVADPSKRIPIP-----EIKKHPWF 166
A + +L +P KR+ +IK HP+F
Sbjct: 222 EA--KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-23
Identities = 49/140 (35%), Positives = 74/140 (52%), Gaps = 11/140 (7%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARK 80
++I HRD+K +N L +K+ DFG SK L + K+ VGTP Y++PE+ K
Sbjct: 122 RKILHRDIKPQNIFLT--SNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y+ K SD+WS G LY + +PFE N + +I QY P + S++ R
Sbjct: 179 PYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQY-PPIPSQYSSELR 232
Query: 141 HLLSQIFVADPSKRIPIPEI 160
+L+S + DP +R I +I
Sbjct: 233 NLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 56/155 (36%), Positives = 84/155 (54%), Gaps = 16/155 (10%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL + I +RDLK EN LLD +K+ DFG++K + + GTP Y+APE++
Sbjct: 108 YLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPF-EDPEDP-RNFRKTIDRIRNVQYFLPDYVRVS 136
K YD D WS G+ LY +L G PF ED EDP + + +++ P+Y+ +
Sbjct: 166 NKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKA 222
Query: 137 ADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
A + L+ Q+ +P +R+ I +IKKH WF
Sbjct: 223 A--KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-23
Identities = 57/144 (39%), Positives = 83/144 (57%), Gaps = 11/144 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I +RDLKL+N LLD +KI DFG K + ST GTP YIAPE+L ++Y+
Sbjct: 117 IIYRDLKLDNVLLD--KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ D WS GV LY ML+G PF ++ F D I N + P + +S + + L
Sbjct: 175 ESV-DWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFPRW--ISKEAKDCL 227
Query: 144 SQIFVADPSKRIPIP-EIKKHPWF 166
S++F DP+KR+ + +I++HP+F
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-23
Identities = 52/154 (33%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 76
YL I HRD+K +N LLD Q + I DF + + +T GTP Y+APEV
Sbjct: 115 YLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEV 170
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDY-VR 134
L R+ Y D WS GVT Y L G P+ + R D+IR Q Y
Sbjct: 171 LCRQGY-SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPAT 224
Query: 135 VSADCRHLLSQIFVADPSKRI--PIPEIKKHPWF 166
S + ++++ DP KR+ + ++K HP+F
Sbjct: 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-23
Identities = 55/147 (37%), Positives = 78/147 (53%), Gaps = 15/147 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRD+K EN L+D + LK+ DFG S++GL K VGTP Y+APE + D
Sbjct: 118 IIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VSADCRHL 142
K+SD WS G ++ L G PF E P I R + + P+ V+ S + L
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILS-RRINW--PEEVKEFCSPEAVDL 227
Query: 143 LSQIFVADPSKRIP---IPEIKKHPWF 166
++++ DP+KR+ EIK HP+F
Sbjct: 228 INRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 53/144 (36%), Positives = 82/144 (56%), Gaps = 11/144 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I +RDLKL+N LLD +KI DFG K +L T GTP YIAPE+L ++Y+
Sbjct: 117 IVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ D WS GV LY ML+G PF ++ F+ IR P + ++ + + +L
Sbjct: 175 TSV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPCYPRW--LTREAKDIL 227
Query: 144 SQIFVADPSKRIPIP-EIKKHPWF 166
++FV +P +R+ + +I++HP+F
Sbjct: 228 VKLFVREPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 54/146 (36%), Positives = 80/146 (54%), Gaps = 15/146 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I +RDLKL+N +LD +KI DFG K + ST GTP YIAPE+L +Y
Sbjct: 117 IIYRDLKLDNVMLDR--DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 84 GKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRH 141
+ D WS GV LY ML+G PF D ED + +++ P Y R ++ + +
Sbjct: 175 FSV-DWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPRWITKESKD 225
Query: 142 LLSQIFVADPSKRIPIP-EIKKHPWF 166
+L ++F DP++R+ + I+ HP+F
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 38/179 (21%)
Query: 20 FYLQE------------ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
FY+ E HRDLK EN L+D S +K+ DFG SK + + S VG
Sbjct: 105 FYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIV--TYANSVVG 160
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF------EDPEDPRNFRKTIDR 121
+P Y+APEVL K YD + D WS G LY L G PF E E+ + +++T+ R
Sbjct: 161 SPDYMAPEVLRGKGYDFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
Query: 122 IRNVQYFLPDYVR----VSADCRHLLSQIFVADPSKRI-PIPEIKKHPWFLKNLPKEII 175
P Y +S + L++++ + DPS+R + +IK HP+F K + +
Sbjct: 220 --------PVYDDPRFNLSDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-21
Identities = 55/156 (35%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 77
YL E I +RDLKL+N LLD + +KI DFG K G+ ST GTP ++APEVL
Sbjct: 116 YLHENKIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
Y + D W GV +Y MLVG PF +D E+ D I N + P + +
Sbjct: 174 TETSYTRAV-DWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEVRYPRF--L 224
Query: 136 SADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
S + ++ ++ +P +R+ ++KK P+F
Sbjct: 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 62/166 (37%), Positives = 83/166 (50%), Gaps = 27/166 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
CFYL EI +RDLK EN LLD Q +K+ DFG K + T
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLCKESIHEGTVTHTF 160
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GT Y+APE+L R + GK D WS G +Y ML GA PF N +KTID+I
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFT----AENRKKTIDKILKG 215
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ LP Y ++ + R LL ++ +PS R+ E++ HP+F
Sbjct: 216 KLNLPPY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-21
Identities = 62/154 (40%), Positives = 78/154 (50%), Gaps = 16/154 (10%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 77
YL I +RDLK EN LLD Q + + DFG K G+ HS+ ST GTP Y+APEVL
Sbjct: 111 YLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
++ YD + D W G LY ML G PF R+ + D I N L + VS
Sbjct: 169 RKQPYD-RTVDWWCLGAVLYEMLYGLPPFYS----RDTAEMYDNILNKPLRLKPNISVS- 222
Query: 138 DCRHLLSQIFVADPSKRI----PIPEIKKHPWFL 167
RHLL + D +KR+ EIK H +F
Sbjct: 223 -ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-20
Identities = 55/154 (35%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 11 VMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 70
V I + H + + I HRDLK +N LLD + +KI DFG SK S+ + VGTP
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLD-KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
YI+PE+ K Y+ K SD+W+ G LY + FE P K + +
Sbjct: 167 YISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKI---MSGTFAPIS 222
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
D R S D R L+ + DPSKR + +I P
Sbjct: 223 D--RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 40/207 (19%)
Query: 20 FYLQEI------------CHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKST 65
FYL E+ HRD+K EN L+D + +K+ DFG + + K
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLP 163
Query: 66 VGTPAYIAPEVLARKEYDGKIS-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 120
VGTP YIAPEVL DGK + D WS GV Y M+ G PF E KT +
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYN 219
Query: 121 RIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF-------LKNLP 171
I N Q FL P+ +VS+D L+ Q + +R+ + HP+F ++N
Sbjct: 220 NIMNFQRFLKFPEDPKVSSDFLDLI-QSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSL 278
Query: 172 KEII-----EIEKTNYKEAGRDQPTQS 193
+ + + +N+ E ++ +S
Sbjct: 279 PPFVPTLKSDDDTSNFDEPEKNSTRRS 305
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 55/205 (26%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFG-------------- 51
Y + T++ S H L I HRD+K +N LLD +K+ DFG
Sbjct: 106 YIAETILAIDSIH--KLGYI-HRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFY 160
Query: 52 ------------------YSKSGLLHSQPK-------STVGTPAYIAPEVLARKEYDGKI 86
S + + STVGTP YIAPEV + Y K
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKE 219
Query: 87 SDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144
D WS GV +Y MLVG PF ++P++ +RK I+ +Q+ PD V +S + + L+
Sbjct: 220 CDWWSLGVIMYEMLVGYPPFCSDNPQE--TYRKIINWKETLQF--PDEVPLSPEAKDLIK 275
Query: 145 QIFVADPSKRIPIP---EIKKHPWF 166
+ + +R+ EIK HP+F
Sbjct: 276 R-LCCEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 82
I +RD+KLEN LLD + + + DFG SK L + + S GT Y+APEV+
Sbjct: 126 IIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 83 D-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCR 140
K D WS GV + +L GA PF + +N + I RI + P +SA+ R
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMSAEAR 240
Query: 141 HLLSQIFVADPSKRI---PIPEIKKHPWF 166
+ ++ DP KR+ EIK HP+F
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-20
Identities = 55/155 (35%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 19 CFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 77
+ + +RDLK EN LLD Q + +CDFG K + +T GTP Y+APE+L
Sbjct: 108 NLHKFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL 165
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVS 136
Y K D W+ GV LY ML G PF D +RK + + +R PD
Sbjct: 166 LGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-----FPDGFD-- 217
Query: 137 ADCRHLLSQIFVADPSKRIPI---PEIKKHPWFLK 168
D + LL + DP++R+ EIK HP+F +
Sbjct: 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 87.9 bits (216), Expect = 4e-20
Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVL 77
I HRD+K EN LLD +K+ DFG +K + + + P ++VGTP Y+APEVL
Sbjct: 122 IIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 78 --ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------QYF 128
Y SD+WS G+TLY +L G PFE ++ +T+ I +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ +S LL ++ DP R+ H
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 56/178 (31%), Positives = 76/178 (42%), Gaps = 37/178 (20%)
Query: 21 YLQEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHSQP- 62
+L I +RDLK EN LL S P P K G +S +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 63 ----------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 112
S VGT YIAPEV++ + + D W+ G+ LY ML G PF+
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG---- 234
Query: 113 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI----PIPEIKKHPWF 166
N +T I + P VS+ R L+ ++ V DPSKR+ EIK+HP+F
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-20
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
HRD+K +N LLD S LK+ DFG +G++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVLKSQGG 220
Query: 83 D---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
D G+ D WS GV LY MLVG PF + K +D ++ + PD + +S
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIEISKQA 278
Query: 140 RHLLSQIFVADPSK--RIPIPEIKKHPWF 166
+ L+ + R + EIK HP+F
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-19
Identities = 57/170 (33%), Positives = 94/170 (55%), Gaps = 24/170 (14%)
Query: 5 CYFSST-VMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 61
C++++ V+IF YLQ I +RDLK EN LLD +K+ DFG++K ++ ++
Sbjct: 134 CFYAAQIVLIFE-----YLQSLNIVYRDLKPENLLLD--KDGFIKMTDFGFAK--VVDTR 184
Query: 62 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 121
+ GTP YIAPE+L + GK +D W+ G+ +Y +LVG PF E ++K ++
Sbjct: 185 TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243
Query: 122 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
I + P + + +C+HL+ ++ D +KR +K+HPWF
Sbjct: 244 I----IYFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-19
Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 81
++ +RDLKLEN +LD +KI DFG K G+ T GTP Y+APEVL +
Sbjct: 114 CDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 141
Y G+ D W GV +Y M+ G PF + ++ K + I + P +S + +
Sbjct: 172 Y-GRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEEIRFPR--TLSPEAKS 224
Query: 142 LLSQIFVADPSKRI-----PIPEIKKHPWFL 167
LL+ + DP +R+ EI +H +F
Sbjct: 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-19
Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 27/177 (15%)
Query: 8 SSTVMIFTSHHCFYLQE------------ICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55
S VM FYL E I +RDLK EN LLD +K+ DFG SK
Sbjct: 90 SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKE 147
Query: 56 GLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 114
+ H + S GT Y+APEV+ R+ + + +D WS GV ++ ML G+ PF+ ++
Sbjct: 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQG----KD 202
Query: 115 FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
++T+ I + +P + +S + + LL +F +P+ R+ + EIK+HP+F
Sbjct: 203 RKETMTMILKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 61/184 (33%), Positives = 90/184 (48%), Gaps = 34/184 (18%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----- 60
YF+ TV+ H + I HRDLK +N L+ + +K+ DFG SK GL+
Sbjct: 106 YFAETVLALEYLHNY---GIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLY 160
Query: 61 -----------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--E 107
K GTP YIAPEV+ R+ Y GK D W+ G+ LY LVG PF +
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 108 DPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQIFVADPSKRIPIP---EIKKH 163
PE+ F + I + P+ + AD + L+S++ +P +R+ E+K+H
Sbjct: 220 TPEEL--FGQVI----SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273
Query: 164 PWFL 167
+FL
Sbjct: 274 RFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIA 73
YL I HRD+K N LD + +K+ DFG + + + + +S GTPAY+A
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 74 PEVLARKEYDGKI--SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
PEV+ + G +D+WS G + M G P+ + ++ F+ + +PD
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPD 229
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+++S + + L + +DP KR E+ +HP+
Sbjct: 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-19
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 23 QEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLA 78
Q + HRD+K ++ LL DG R+K+ DFG+ + + P KS VGTP ++APEV++
Sbjct: 134 QGVIHRDIKSDSILLTSDG----RVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSA 137
R Y ++ D+WS G+ + M+ G P+ + E P + + RIR+ L + +VS
Sbjct: 189 RLPYGTEV-DIWSLGIMVIEMVDGEPPYFN-EPPL---QAMKRIRDNLPPKLKNLHKVSP 243
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
R L ++ V DP++R E+ HP+ K P I
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 51/152 (33%), Positives = 74/152 (48%), Gaps = 17/152 (11%)
Query: 21 YL--QEICHRDLKLENTLL--DGSPQPRLKICDFGYS-KSGLLHSQPKSTVGTPAYIAPE 75
YL Q + HRD+K N L DG +K+ DFG + K + S VGTP ++APE
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVR 134
V+ SD+WS G T+ +L G P+ D N + RI ++ LP+
Sbjct: 170 VIEMSGASTA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--G 222
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+S + + L Q F DP+ R ++ KHPW
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 52/153 (33%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL E I HRD+K N L++ Q +K+CDFG S L++S K+ VGT +Y+APE +
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERI 171
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQY-FLPDYVRV 135
+Y K SD+WS G++L + G +P+ D P + + I N LP +
Sbjct: 172 QGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KF 229
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
S D + ++ + DP +R E+ +HP+ K
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 17 HHCFYLQE----ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAY 71
+ C + + HRDLK N LD +K+ DFG +K S T VGTP Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
++PE L YD K SD+WS G +Y + + PF RN + +I+ + F
Sbjct: 177 MSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGK-FRRI 230
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
R S++ ++ + DP KR E+ + P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-19
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 17/155 (10%)
Query: 20 FYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
F+L + I +RDLKL+N +LD +KI DFG K + + T GTP YIAPE+
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
+A + Y GK D W+ GV LY ML G PF+ ++ F+ ++ NV Y
Sbjct: 173 IAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAV 229
Query: 137 ADCRHLLSQIFVADPSKRIPI-----PEIKKHPWF 166
+ C+ LL++ P+KR+ +I++H +F
Sbjct: 230 SICKGLLTK----HPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-19
Identities = 53/153 (34%), Positives = 81/153 (52%), Gaps = 18/153 (11%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL I +RDLK EN LLD + +K+ DFG++K + + + GTP Y+APEV+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDN--KGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQ 188
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 138
K + GK D W+ GV LY + G PF D + P FR ++I + P++ A
Sbjct: 189 SKGH-GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWFDGRA- 242
Query: 139 CRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
R L+ + D +KR+ + ++K HP+F
Sbjct: 243 -RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-18
Identities = 49/153 (32%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 19 CFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPE 75
+ Q+I HRDLK N LL + +KI D G SK + +Q +GTP Y+APE
Sbjct: 118 ALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKNMAKTQ----IGTPHYMAPE 171
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFE--DPEDPRN--FRKTIDRIRNVQYFLPD 131
V + Y K SD+WS G LY M A PFE +D R R I
Sbjct: 172 VWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP------- 223
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
S D ++ + + P R +I P
Sbjct: 224 --IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 20 FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
FY +I +RDLK EN LLD R I D G + + K G
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAG 156
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
TP Y+APEVL + YD + D ++ G TLY M+ G PF ++ + R +
Sbjct: 157 TPGYMAPEVLQGEVYDFSV-DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215
Query: 128 FLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
PD + S + + L + DP KR+ E+++HP F
Sbjct: 216 EYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 58/165 (35%), Positives = 84/165 (50%), Gaps = 14/165 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 82
I +RD+KLEN LLD + + + DFG SK L + + S GT Y+APE++ K
Sbjct: 126 IVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRH 141
GK D WS G+ ++ +L GA PF E RN + + RI P + + +
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPS--FIGPEAQD 240
Query: 142 LLSQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIEIEKTN 181
LL ++ DP KR+ EIK+HP+F K L E + + K N
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLDWEALALRKVN 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-18
Identities = 54/149 (36%), Positives = 83/149 (55%), Gaps = 15/149 (10%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 82
+I +RDLKLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +Y
Sbjct: 115 KIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
G+ D W GV +Y M+ G PF + + + F + + ++++ P +SAD + L
Sbjct: 173 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKF--PR--TLSADAKSL 225
Query: 143 LSQIFVADPSKRI-----PIPEIKKHPWF 166
LS + + DP+KR+ EI +H +F
Sbjct: 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 28/154 (18%)
Query: 27 HRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKE 81
HRD+K +N LL DGS +K+ DFG++ L S+ S VGTP ++APEV+ RK+
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192
Query: 82 YDGKISDVWSCGVTLYVMLVGAYP-FEDPEDPRNFRKTID-----RIRNVQYFLPDYVRV 135
Y K+ D+WS G+ M G P +P P I ++N + +
Sbjct: 193 YGPKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKGIPPLKNPE-------KW 242
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
S + + L++ V DP KR E+ +HP FLK
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
+ +RDLKL+N LLD + K+ DFG K G+L+ +T GTP YIAPE+L EY
Sbjct: 117 VIYRDLKLDNILLDA--EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 84 GKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
+ D W+ GV +Y M+ G PFE D ED + I + P V +S + +
Sbjct: 175 PSV-DWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSI 226
Query: 143 LSQIFVADPSKRIPI-------PEIKKHPWFLK 168
L +P+KR+ IK+HP+F +
Sbjct: 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-17
Identities = 63/173 (36%), Positives = 88/173 (50%), Gaps = 23/173 (13%)
Query: 20 FYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEV 76
F+L I +RDLKL+N +LD + +KI DFG K + K+ GTP YIAPE+
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
+A + Y GK D W+ GV LY ML G PFE ++ F+ ++ NV Y
Sbjct: 173 IAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 229
Query: 137 ADCRHLLSQIFVADPSKRIPI-PE----IKKHPWFLKNLPKEIIEIEKTNYKE 184
A C+ L+++ P KR+ PE IK+H +F I+ EK KE
Sbjct: 230 AICKGLMTK----HPGKRLGCGPEGERDIKEHAFF------RYIDWEKLERKE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 59/147 (40%), Positives = 74/147 (50%), Gaps = 14/147 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I +RDLK EN LLD Q + + DFG K + H+ ST GTP Y+APEVL ++ YD
Sbjct: 117 IVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ D W G LY ML G PF RN + D I N L + SA RHLL
Sbjct: 175 -RTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPNITNSA--RHLL 227
Query: 144 SQIFVADPSKRI----PIPEIKKHPWF 166
+ D +KR+ EIK H +F
Sbjct: 228 EGLLQKDRTKRLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 9e-17
Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 11/145 (7%)
Query: 25 ICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 81
I HRD+K N L+ G KI DFG SK +T VGT Y++PE + + E
Sbjct: 121 IIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCR 140
+D+WS G+TL +G +PF P P +F + + I + LP S + R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFR 233
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPW 165
+S DP KR E+ +HP+
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 56/155 (36%), Positives = 83/155 (53%), Gaps = 17/155 (10%)
Query: 20 FYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
F+L I +RDLKL+N +LD + +KI DFG K ++ T GTP YIAPE+
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
+A + Y GK D W+ GV LY ML G PF+ ++ F+ ++ NV Y
Sbjct: 173 IAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAV 229
Query: 137 ADCRHLLSQIFVADPSKRIPI-PE----IKKHPWF 166
+ C+ L+++ PSKR+ PE I++H +F
Sbjct: 230 SICKGLMTKH----PSKRLGCGPEGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 50/148 (33%), Positives = 79/148 (53%), Gaps = 16/148 (10%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
EI +RDLK EN LLD + +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLD--KEGHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K D W+ G+ +Y MLVG PF D N ++I + P ++ + A + L+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPRHLDLYA--KDLI 229
Query: 144 SQIFVADPSKRI-----PIPEIKKHPWF 166
++ V D ++R+ ++K H WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQ 61
Y + V+ + H L HRD+K +N LLD LK+ DFG ++G++
Sbjct: 147 YTAEVVLALDAIHSMGL---IHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD 201
Query: 62 PKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
+ VGTP YI+PEVL + Y G+ D WS GV L+ MLVG PF + K
Sbjct: 202 --TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
+D ++ + P+ V +S ++L+ F+ D R+ + EIK+HP+F
Sbjct: 260 MDHKNSLNF--PEDVEISKHAKNLICA-FLTDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 81
+ + +RDLKLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +
Sbjct: 115 KNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCR 140
Y G+ D W GV +Y M+ G PF + + + F + + IR + P + +
Sbjct: 173 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP-------EAK 224
Query: 141 HLLSQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 176
LLS + DP +R+ EI +H +F + +++ E
Sbjct: 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE 265
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 40/108 (37%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
S VGTP YIAPEVL R Y ++ D WS GV LY MLVG PF +T ++
Sbjct: 203 SLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPA----ETQLKVI 257
Query: 124 NVQYFL--PDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
N + L P ++S + L+ ++ R+ EIK HP+F
Sbjct: 258 NWETTLHIPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 17/150 (11%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARKE- 81
HRD+K +N LLD S LK+ DFG +K G++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKSQGG 220
Query: 82 --YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
Y G+ D WS GV LY MLVG PF + K ++ ++ + PD +S +
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDISKEA 278
Query: 140 RHLLSQIFVADPSKRI---PIPEIKKHPWF 166
++L+ F+ D R+ + EIK+H +F
Sbjct: 279 KNLICA-FLTDREVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 57/170 (33%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL I HRD+K N LL Q +K+CDFG S L++S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGE-LVNSLAGTFTGTSFYMAPERIQ 176
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNFRKTIDRIRNVQYFLPD--- 131
K Y SDVWS G+TL + +PF E P P I + N + L D
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE--LKDEPG 233
Query: 132 -YVRVSADCRHLLSQIFVADPSKRIPIP-EIKKHPWFLKNLPKEIIEIEK 179
++ S + + + Q DP++R P P ++ +HPW +K K+ + + K
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRR-PTPWDMLEHPW-IKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-16
Identities = 54/149 (36%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I +RDLKL+N LLD + K+ DFG K G+ + + ST GTP YIAPE+L Y
Sbjct: 117 IIYRDLKLDNVLLDH--EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY- 173
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
G D W+ GV LY ML G PFE + F + I N + P + +S D +L
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPTW--LSQDAVDIL 227
Query: 144 SQIFVADPSKRIPI------PEIKKHPWF 166
+P+ R+ I +HP+F
Sbjct: 228 KAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-16
Identities = 47/135 (34%), Positives = 73/135 (54%), Gaps = 12/135 (8%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 81
+++ +RD+KLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +
Sbjct: 114 RDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCR 140
Y G+ D W GV +Y M+ G PF + + R F + + IR P +S + +
Sbjct: 172 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----FPR--TLSPEAK 223
Query: 141 HLLSQIFVADPSKRI 155
LL+ + DP +R+
Sbjct: 224 SLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-16
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 17 HHCFYLQ--EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQ---PKSTVGTPA 70
YL I HRD+K N L D + +K+ DFG SK + S KS GTP
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYF 128
+++PEV++ + Y G+ +DVWS G T+ ML P+ + E I +I +
Sbjct: 173 WMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQ 227
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP + VS D R+ L + FV + KR E+ +H +
Sbjct: 228 LPSH--VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-16
Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR-KEY 82
+ HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ K Y
Sbjct: 122 VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
D K +D+WS G+T+Y M G P+ D D FR + ++ L D S R
Sbjct: 180 DTK-ADIWSLGITIYEMATGNPPYSD-VDA--FRAMMLIPKSKPPRLEDN-GYSKLLREF 234
Query: 143 LSQIFVADPSKRIPIPEIKKHPW 165
++ +P +R+ E+ K W
Sbjct: 235 VAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-15
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQ 61
C++++ ++ H + + I +RDLK EN LLD R I D G + K G S+
Sbjct: 100 CFYTAQIISGLEH--LHQRRIIYRDLKPENVLLDNDGNVR--ISDLGLAVELKDG--QSK 153
Query: 62 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 121
K GTP ++APE+L +EYD + D ++ GVTLY M+ PF + ++ R
Sbjct: 154 TKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 122 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PEIKKHPWF 166
I N PD + S + + DP KR+ ++ HP F
Sbjct: 213 ILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 20 FYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79
+ + I HRD+K N L++ Q +K+CDFG S L++S + VGT Y++PE +
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGE-LINSIADTFVGTSTYMSPERIQG 176
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-------DPRNFRKTIDRIRNVQY-FLPD 131
+Y K SDVWS G+++ + +G +PF DP + +I LP
Sbjct: 177 GKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPE--IKKHPW 165
D R + + DP++R P P+ P+
Sbjct: 236 S-DFPEDLRDFVDACLLKDPTER-PTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 49/192 (25%), Positives = 67/192 (34%), Gaps = 47/192 (24%)
Query: 16 SHHCFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLL 58
S YL ++ HRDLK EN L++ LK+ DFG S
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPY 155
Query: 59 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED----- 111
V T Y APE+L + D+WS G +L +P + D
Sbjct: 156 THY----VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
Query: 112 --------PRNFRKTIDRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKR 154
P + K RN ++ P + S LLSQ+ DP KR
Sbjct: 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271
Query: 155 IPIPEIKKHPWF 166
I + HP+F
Sbjct: 272 ITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-15
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL + HRD+K N L+D + +K+ DFG +K + S KS G+P ++APEV+A
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVS 136
++ G +D+WS G T+ M G P+ E + +I + +PD+ +S
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFKIGRSKELPPIPDH--LS 228
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHP 164
+ + + + DPS R E+ +HP
Sbjct: 229 DEAKDFILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 82
+I +RDLK EN LLD + + +CDFG SK+ L ++ +T GT Y+APEVL ++
Sbjct: 116 DIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-TIDRIRNVQYFLPDYVRVSADCRH 141
K D WS GV ++ M G PF + + +R ++R P V +S + R
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-----FPKNV-LSDEGRQ 227
Query: 142 LLSQIFVADPSKRI----PIPEIKKHPWF 166
+ + +P R+ E+K+HP+F
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 57/186 (30%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 17 HHCFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 64
H FY EI +RDLKL+N LLD + +K+ D+G K G+ S
Sbjct: 97 HARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGIRPGDTTS 154
Query: 65 T-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE---DPEDPRNFRKTID 120
T GTP YIAPE+L ++Y + D W+ GV ++ M+ G PF+ ++P + T D
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPD--QNTED 211
Query: 121 RIRNVQYFLPDYVRV----SADCRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNL 170
+ Q L +R+ S +L DP +R+ +IK HP+F +N+
Sbjct: 212 YL--FQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF-RNI 268
Query: 171 PKEIIE 176
+++E
Sbjct: 269 DWDLLE 274
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-15
Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 17/147 (11%)
Query: 23 QEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVL 77
++I HRD+K +N L DG+ +K+ DFG ++ +L+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+ Y+ K SD+W+ G LY M + FE N + + +I Y P S
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSY-PPVSSHYSY 227
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHP 164
D R+L+SQ+F +P R + I +
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-15
Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 13/160 (8%)
Query: 20 FYLQEICHRDLKLENTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEV 76
+ Q + HRD+K ++ LL DG R+K+ DFG+ ++ + KS VGTP ++APE+
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRV 135
++R Y ++ D+WS G+ + M+ G P+ + E P K + IR N+ L + +V
Sbjct: 188 ISRLPYGPEV-DIWSLGIMVIEMVDGEPPYFN-EPPL---KAMKMIRDNLPPKLKNLHKV 242
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
S + L ++ V DP++R E+ KHP+ K P I
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCI 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRD+K N L++G+ Q +K+CDFG S L+ S K+ +G +Y+APE + +
Sbjct: 124 IIHRDVKPTNVLVNGNGQ--VKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 85 KI-----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSAD 138
SDVWS G+++ M +G YP+ PE N + I LP S D
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS--GYSDD 237
Query: 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
+ +++ P++R ++ +HPW +K
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-14
Identities = 50/178 (28%), Positives = 71/178 (39%), Gaps = 35/178 (19%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYI 72
+C + I HRDLK +N L++ LK+ DFG +++ P T V T Y
Sbjct: 112 AYC-HSHRILHRDLKPQNILINRDGV--LKLADFGLARA---FGIPLRTYTHEVVTLWYR 165
Query: 73 APEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFE------------------DPEDPR 113
APE+L K Y + D+WS G M+ G F E
Sbjct: 166 APEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224
Query: 114 NFRKTIDRIRNVQYFLPDYV-----RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
K D F P + R+ + LLS++ +P+KRI E KHP+F
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 15/154 (9%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPE- 75
YL + HRD+K N L++ + Q +K+CDFG S L+ S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGY-LVDSVAKTIDAGCKPYMAPER 174
Query: 76 ---VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
L +K YD K SDVWS G+T+ + G +P++ + P F++ + LP
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPAE 231
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ S + + +++ + +R PE+ +HP+F
Sbjct: 232 -KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 54/151 (35%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 27 HRDLKLENTLL--DGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLA- 78
HRD+K N LL DGS +KI DFG S S K+ VGTP ++APEV+
Sbjct: 125 HRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DYVRV 135
YD K +D+WS G+T + GA P+ + T ++N L DY +
Sbjct: 181 VHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLT---LQNDPPSLETGADYKKY 236
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
S R ++S DPSKR E+ KH +F
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 60/200 (30%), Positives = 85/200 (42%), Gaps = 48/200 (24%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---------- 55
Y + TV+ + H HRD+K +N LLD + +K+ DFG
Sbjct: 106 YIAETVLAIDAIHQL---GFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 56 -GLLHSQPK-------------------------STVGTPAYIAPEVLARKEYDGKISDV 89
L H+ P STVGTP YIAPEV + Y+ K+ D
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDW 219
Query: 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149
WS GV +Y ML+G PF +RK ++ + + P V +S + L+ + F
Sbjct: 220 WSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCT 276
Query: 150 DPSKRI---PIPEIKKHPWF 166
D RI + EIK HP+F
Sbjct: 277 DSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 18/174 (10%)
Query: 10 TVMIFTSHHCFYLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-T 65
TV I + H YL+E + HRD+K N LLD S +K+CDFG S L+ S+ K+ +
Sbjct: 120 TVAIVKALH--YLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGR-LVDSKAKTRS 174
Query: 66 VGTPAYIAPEVL----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 121
G AY+APE + +YD + +DVWS G++L + G +P+ F + + +
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPY--KNCKTEF-EVLTK 230
Query: 122 IRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
I + LP S D + D KR E+ +HP+ + E+
Sbjct: 231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 52/156 (33%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKSTVGTPA 70
YL E I HRD+K N L+D + Q RL+I DFG + +G Q +GT A
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIA 173
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
++APEVL R E G+ DVWS G + M P+ + E N I +I +
Sbjct: 174 FMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPS 231
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+S R + + P R P E+ KHP F
Sbjct: 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 58/172 (33%), Positives = 78/172 (45%), Gaps = 27/172 (15%)
Query: 17 HHCFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 64
H FY EIC +RDLKL+N LLD +K+ D+G K GL S
Sbjct: 97 HARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTS 154
Query: 65 T-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE---DPEDPRNFRKTID 120
T GTP YIAPE+L +EY G D W+ GV ++ M+ G PF+ D D
Sbjct: 155 TFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 121 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI------PIPEIKKHPWF 166
I +P ++ V A H+L DP +R+ +IK H +F
Sbjct: 214 VILEKPIRIPRFLSVKAS--HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-14
Identities = 49/147 (33%), Positives = 83/147 (56%), Gaps = 8/147 (5%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKE 81
Q + HRD+K ++ LL + R+K+ DFG+ ++ + KS VGTP ++APEV++R
Sbjct: 137 QGVIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 141
Y ++ D+WS G+ + M+ G P+ + + R+ D N+ + D +VS+ R
Sbjct: 195 YGTEV-DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRG 250
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168
L + V +PS+R E+ +HP FLK
Sbjct: 251 FLDLMLVREPSQRATAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-14
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPE 75
+ I HRD+K N L+D + +KI DFG SK S + S G+ ++APE
Sbjct: 125 RGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVR 134
V+ + Y K +D+WS G + ML G +PF D + I +I N +P +
Sbjct: 183 VVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPD----CTQLQAIFKIGENASPEIPSNIS 237
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
A L + F D +KR E+ KHP+
Sbjct: 238 SEA--IDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-14
Identities = 55/149 (36%), Positives = 72/149 (48%), Gaps = 14/149 (9%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 81
I +RDLK EN LLD Q + + DFG K G+ + ST GTP Y+APEVL ++
Sbjct: 115 LNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 141
YD + D W G LY ML G PF R+ + D I + LP + A C
Sbjct: 173 YD-RTVDWWCLGAVLYEMLYGLPPFYS----RDVSQMYDNILHKPLQLPG-GKTVAAC-D 225
Query: 142 LLSQIFVADPSKRI----PIPEIKKHPWF 166
LL + D +R+ EIK H +F
Sbjct: 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDG 84
HRD+K N LL S + +K+ DFG S L + K + VGTP ++APEV+ + YD
Sbjct: 121 HRDIKAANILL--SEEGDVKLADFGVSGQ-LTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRVSA 137
K +D+WS G+T + G P D P+N +++ + S
Sbjct: 178 K-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NKFSK 225
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-----LPKEIIEIEK 179
+ +S DP +R E+ KH F+K +IE K
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKHK-FIKKAKKTSYLTLLIERIK 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-14
Identities = 51/153 (33%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKE- 81
I +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++ +
Sbjct: 126 IIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 82 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
+D K D WS GV +Y +L GA PF + + + RI + P +SA +
Sbjct: 184 GHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAK 240
Query: 141 HLLSQIFVADPSKRI-----PIPEIKKHPWFLK 168
++ ++ + DP KR+ EIKKHP+F K
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 47/135 (34%), Positives = 62/135 (45%), Gaps = 13/135 (9%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLAR 79
++I HRD+K N LD +KI D G +K LL + VGTP Y++PE+
Sbjct: 120 KKILHRDIKSLNLFLDAYDN--VKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCED 175
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
K Y+ K SDVW+ GV LY G +PF+ K IR V F P S
Sbjct: 176 KPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKI---IRGV--FPPVSQMYSQQL 229
Query: 140 RHLLSQIFVADPSKR 154
L+ Q D +R
Sbjct: 230 AQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-14
Identities = 35/83 (42%), Positives = 55/83 (66%), Gaps = 4/83 (4%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
+I HRD+K N L++ Q +K+CDFG S L++S K+ VGT AY+APE ++ ++Y
Sbjct: 115 KILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERISGEQY- 170
Query: 84 GKISDVWSCGVTLYVMLVGAYPF 106
G SDVWS G++ + +G +P+
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 49/146 (33%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARK 80
++I HRD+K +N L + K+ DFG ++ L S + VGTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y+ K +D+WS G LY + +PFE N + + +I YF P S D R
Sbjct: 178 PYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQ-GYFAPISPNFSRDLR 231
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166
L+SQ+F P R I I K P+
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 51/148 (34%), Positives = 74/148 (50%), Gaps = 14/148 (9%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 82
I +RDLK EN LLD Q + + DFG K G+ S +T GTP Y+APEV+ ++ Y
Sbjct: 116 NIVYRDLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
D + D W G LY ML G PF R+ + D I + L ++A +
Sbjct: 174 DNTV-DWWCLGAVLYEMLYGLPPFYC----RDVAEMYDNILHKPLVLRPGASLTA--WSI 226
Query: 143 LSQIFVADPSKRI----PIPEIKKHPWF 166
L ++ D +R+ EI++HP+F
Sbjct: 227 LEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 58/186 (31%), Positives = 80/186 (43%), Gaps = 45/186 (24%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEV 76
YL+E I HRD+K N L++ + +K+CDFG S G L S S VGT +Y++PE
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVS--GQLIDSMANSFVGTRSYMSPER 169
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR----------IRNVQ 126
L Y + SD+WS G++L M +G YP P D + R R V
Sbjct: 170 LQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIP-PPDAKELEAMFGRPVSEGEAKESHRPVS 227
Query: 127 YFLPDYVRVSADCRHLLSQI-------------------FVA-----DPSKRIPIPEIKK 162
PD R A LL I FV +P +R + E+ K
Sbjct: 228 GHPPDSPRPMA-IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286
Query: 163 HPWFLK 168
HP+ +
Sbjct: 287 HPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 57/170 (33%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 77
YL E I +RDLKL+N LLD + +K+ D+G K GL ST GTP YIAPE+L
Sbjct: 111 YLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDY 132
++Y G D W+ GV ++ M+ G PF+ D D I Q +P
Sbjct: 169 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227
Query: 133 VRVSADCRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 176
+ V A +L DP +R+ +I+ HP+F +N+ +++E
Sbjct: 228 LSVKA--ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLME 274
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-13
Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV--GTPAYIAPE 75
H + + I HRDLK +N L + LKI DFG S+ L+ S +T GTP Y++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPE 175
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVR 134
L + YD K SD+WS G LY M A+ FE +NF + RI LP+
Sbjct: 176 ALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--T 228
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
S ++ + DPS R EI ++P+
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 30/170 (17%)
Query: 23 QEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 78
++ HRDLK N LL DG +K+ DFG S Q + T +GTP ++APEV+A
Sbjct: 122 HKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 79 ----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-------TIDRIRNVQY 127
YD K +D+WS G+TL + P + R K T+D+
Sbjct: 178 ETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS---- 232
Query: 128 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
+ S+ L V DP R E+ KHP+ + I+
Sbjct: 233 ------KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 24 EICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 80
++ HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ RK
Sbjct: 135 QVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y K+ D+WS G+ M+ G P+ + E+P R N L + ++SA R
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFR 246
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168
L++ D KR E+ +HP FLK
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 26/159 (16%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAY 71
YL E + HRD+K +N LL + +K+ DFG S +Q ST +GTP +
Sbjct: 128 YLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVS------AQLDSTLGRRNTFIGTPYW 179
Query: 72 IAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
+APEV+A E YD + SDVWS G+T + G P D R K RN
Sbjct: 180 MAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKI---PRNPP 235
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
L S +S+ + + +R + E+ +HP+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 19 CFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL 77
+ I HRD+K N L + +K+ DFG SK G +S ++ VGTP Y++PE+
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+Y+ K SD+W+ G LY +L F D N + +I Y P S+
Sbjct: 174 QGVKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNY-TPVVSVYSS 227
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHP 164
+ L+ + DP KR E+ P
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-13
Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ I +RDLK EN LLD R I D G + + VGT Y+APEV+ + Y
Sbjct: 121 ERIVYRDLKPENILLDDYGHIR--ISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
D W G +Y M+ G PF ++ + R++ Q + + S R +
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235
Query: 143 LSQIFVADPSKRI-----PIPEIKKHPWF 166
Q+ DP R+ E+K HP+F
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-13
Identities = 53/148 (35%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 24 EICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 80
++ HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ RK
Sbjct: 135 QVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y K+ D+WS G+ M+ G P+ + E+P R N L + R+SA R
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPERLSAVFR 246
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168
L++ D +R E+ +HP FLK
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-13
Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 14/149 (9%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
YL ++ HRDL N L+ +KI DFG S+ + G I APE
Sbjct: 120 YLASKKFVHRDLAARNCLVGE--DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 134
L + K SDVWS GV L+ + +GA P+ + + ++ +R Y LP
Sbjct: 178 SLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GYRLPKPEY 231
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKH 163
+ L+ + DP R E+ +
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 51/171 (29%), Positives = 89/171 (52%), Gaps = 16/171 (9%)
Query: 23 QEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLA 78
Q + HRD+K ++ LL DG R+K+ DFG+ + + PK S VGTP ++APEV++
Sbjct: 136 QGVIHRDIKSDSILLTLDG----RVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVIS 190
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSA 137
R Y ++ D+WS G+ + M+ G P+ + P K R+R+ L + ++S
Sbjct: 191 RTPYGTEV-DIWSLGIMVIEMVDGEPPYFS-DSPVQAMK---RLRDSPPPKLKNAHKISP 245
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYKEAGR 187
R L ++ +P +R E+ HP+ L+ LP+ ++ + + K
Sbjct: 246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKRTST 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 52/165 (31%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 20 FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
FY EIC +RDLK EN LLD ++I D G + K VG
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
T Y+APEV+ + Y D W+ G LY M+ G PF+ + R+ ++R+ V+
Sbjct: 164 TVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL--VKE 219
Query: 128 FLPDY-VRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+Y + S D R L + DP +R+ E+K+HP F
Sbjct: 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-13
Identities = 57/171 (33%), Positives = 79/171 (46%), Gaps = 31/171 (18%)
Query: 20 FYLQEI------------CHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPK 63
FYL E+ HRD+K +N LLD + RL DFG G + S
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRL--ADFGSCLRLLADGTVQSN-- 161
Query: 64 STVGTPAYIAPEVLARKEYDGKIS-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
VGTP YI+PE+L E DGK D WS GV +Y ML G PF + K
Sbjct: 162 VAVGTPDYISPEILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
++ + Q F PD VS + + L+ ++ + P R+ + + K HP+F
Sbjct: 221 MNHKEHFQ-FPPDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 61/185 (32%), Positives = 89/185 (48%), Gaps = 23/185 (12%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTPAYIAPEVLARKEYD 83
HRDLK N L P +K+ DFG+SK + S GTP Y+APE+ RK Y
Sbjct: 192 HRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K +D+WS GV LY +L PF+ P R+ + ++ +Y P VS+ + LL
Sbjct: 250 KK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALL 303
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLK---NLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 200
+ +P+ R P + H FLK NL ++I+ +T EEI+R
Sbjct: 304 DPLLSKNPALR-PTTQQLLHTEFLKYVANLFQDIVRHSETISP--------HDREEILRQ 354
Query: 201 IQEAK 205
+QE+
Sbjct: 355 LQESG 359
|
Length = 478 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 56/155 (36%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 20 FYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPA 70
YL I HRD+K N L D + +K+ DFG SK SG + KS GTP
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSG---TGIKSVTGTPY 174
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
+++PEV++ + Y G+ +DVWS T+ ML P+ + E K + LP
Sbjct: 175 WMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LP 231
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPE-IKKHP 164
D VS CR L QIFV + KR P E + +HP
Sbjct: 232 D--GVSDACRDFLKQIFVEE--KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
S VGTP YIAPEVL RK Y ++ D WS GV L+ MLVG PF P K I+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIPEIKKHPWF 166
+ +P V++S + L++++ + + R +IK HP+F
Sbjct: 266 TLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 52/171 (30%), Positives = 70/171 (40%), Gaps = 34/171 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVL--ARK 80
I HRDLK N L+ LKI DFG ++ S V T Y APE+L ARK
Sbjct: 120 IMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------LPDY 132
YD + D+W+ G +L G+ P E+ + R LPDY
Sbjct: 178 -YDPGV-DLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 133 VRVS-------------ADCR----HLLSQIFVADPSKRIPIPEIKKHPWF 166
+++ D LL + V DPSKR+ E +HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 23/161 (14%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
YL+E I HRD+K N LLD + +K+CDFG S L+ S K+ G Y+APE
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPER 178
Query: 77 LA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-----F 128
+ R YD + SDVWS G+TLY + G +P+ + D++ V
Sbjct: 179 IDPSARDGYDVR-SDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPIL 231
Query: 129 LPDYVR-VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
R S + ++ + D SKR E+ +HP+
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIA 73
H + HRD+K +N LLD + RL DFG ++ G + Q VGTP YI+
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTV--QSSVAVGTPDYIS 171
Query: 74 PEVLARKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
PE+L E G D WS GV +Y ML G PF + K ++ Q+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF-- 229
Query: 130 PDYVR-VSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
P ++ VS + + L+ Q + +R+ I + KKH +F
Sbjct: 230 PSHITDVSEEAKDLI-QRLICSRERRLGQNGIEDFKKHAFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-12
Identities = 38/132 (28%), Positives = 55/132 (41%), Gaps = 13/132 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEVLARKEYDG 84
HRDL N L+ +KI DFG S+ + G P ++APE L ++
Sbjct: 125 HRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRHL 142
K SDVWS GV L+ + F E P + + ++ Y LP + L
Sbjct: 183 K-SDVWSFGVLLWEI------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235
Query: 143 LSQIFVADPSKR 154
+ Q + DP R
Sbjct: 236 MLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 21/155 (13%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEVLAR 79
I HRD+K N + + +K+ D G SK+ HS VGTP Y++PE +
Sbjct: 127 IMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPERIHE 180
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
Y+ K SD+WS G LY M PF D N +I Y S +
Sbjct: 181 NGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
R L+S+ DP KR P+I ++ + KE+
Sbjct: 238 RDLVSRCINPDPEKR---PDI----SYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 38/141 (26%), Positives = 59/141 (41%), Gaps = 17/141 (12%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-----LHSQPKSTVGTPAYIA 73
YL + HRDL N L+ +KI DFG S+ K + ++A
Sbjct: 118 YLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMA 172
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
PE L ++ K SDVWS GV L+ + E+P + + ++ ++ Y LP
Sbjct: 173 PESLKEGKFTSK-SDVWSFGVLLWEIFTLG---EEPYPGMSNAEVLEYLKK-GYRLPKPP 227
Query: 134 RVSADCRHLLSQIFVADPSKR 154
+ L+ Q + DP R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 8e-12
Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 37/209 (17%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV-LAR 79
+ HRDLK N L++ + LKICDFG ++ K V T Y APE+ L+
Sbjct: 124 VIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181
Query: 80 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI--DRIR 123
Y I D+WS G +L +P D D K I ++ R
Sbjct: 182 SRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 124 NVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF--LKNLPK 172
N LP + S + LL ++ V DP KRI E HP+ L +
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300
Query: 173 EIIEIEKTNYKEAGRDQPTQSVEEIMRII 201
E + ++ D+ T EE+ +I
Sbjct: 301 EPVAKPPFDFDFFDDDELT--EEELKELI 327
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 47/178 (26%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV- 76
YL + I HRD+K N L++ + +KI DFG S+ P S+VGT AY++PE
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI 240
Query: 77 ---LARKEYDGKISDVWSCGVTLYVMLVGAYPF------------------EDPEDPRNF 115
L YDG D+WS GV++ +G +PF + PE P
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT- 299
Query: 116 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
S + RH +S +P+KR ++ +HP+ L+ P +
Sbjct: 300 -------------------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 48/153 (31%), Positives = 68/153 (44%), Gaps = 12/153 (7%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG---LLHSQPKSTVGTPAYIAPE 75
YL + I HRDLK +N L+D KI DFG SK + Q S G+ ++APE
Sbjct: 123 YLHSKGILHRDLKADNLLVDA--DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 76 V--LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
V + Y K+ D+WS G + M G P+ D E K + R+ PD
Sbjct: 181 VIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKRSAPPIPPDVS 238
Query: 134 -RVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+S L+ F +P R E+ +HP+
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 20 FYLQEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
+ ++ HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
+ RK Y K+ D+WS G+ M+ G P+ + E+P R N L + ++S
Sbjct: 187 VTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLS 242
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
R L++ D KR E+ +HP FLK
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 63/200 (31%), Positives = 86/200 (43%), Gaps = 48/200 (24%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---------- 55
Y + TV+ S H HRD+K +N LLD + +K+ DFG
Sbjct: 106 YIAETVLAIDSIHQL---GFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 56 -GLLHSQPK-------------------------STVGTPAYIAPEVLARKEYDGKISDV 89
L HS P STVGTP YIAPEV + Y+ K+ D
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDW 219
Query: 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149
WS GV +Y ML+G PF E P+ K + + F P+ V +S + L+ + F
Sbjct: 220 WSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLIFPPE-VPISEKAKDLILR-FCC 276
Query: 150 DPSKRIPIP---EIKKHPWF 166
+ RI P EIK +P+F
Sbjct: 277 EWEHRIGAPGVEEIKTNPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 25 ICHRDLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ +RDLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 81 -EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-IRNVQYFLPDYVRVSAD 138
YD +D +S G L+ +L G PF + + IDR + LPD S +
Sbjct: 171 VAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPD--SFSPE 225
Query: 139 CRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
R LL + D ++R+ E+K+HP+F
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDR 121
STVGTP YIAPE+ ++ Y G+ D WS G ++ L+G PF E+ + +RK I+
Sbjct: 207 STVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHE--TYRKIINW 263
Query: 122 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
+ + PD + +S + L+ ++ + + R+ EIK HP+F
Sbjct: 264 RETLYF--PDDIHLSVEAEDLIRRL-ITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 33/171 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV-LAR 79
+ HRDLK N LL+ + LKICDFG ++ V T Y APE+ L
Sbjct: 127 VLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS 184
Query: 80 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNF---------RKTIDRIRNVQ-- 126
K Y I D+WS G L ML +P +D N ++ ++ I +++
Sbjct: 185 KGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243
Query: 127 -YF--LPDYVRVS-------ADCR--HLLSQIFVADPSKRIPIPEIKKHPW 165
Y LP +V AD + LL ++ +P KRI + E HP+
Sbjct: 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 38/93 (40%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL+E I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERL 174
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 110
Y + SD+WS G++L M +G YP P+
Sbjct: 175 QGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL+E I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERL 174
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 110
Y + SD+WS G++L + +G YP P+
Sbjct: 175 QGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 20 FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
FY E+C +RDLK EN LLD + ++I D G + + VG
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQ 126
T Y+APEV+ ++Y D W G +Y M+ G PF ++ R R+ +D R++ Q
Sbjct: 164 TVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEVDRRVKEDQ 221
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PEIKKHPWF 166
+ + S D + + + +P +R+ +K+HP F
Sbjct: 222 EEYSE--KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 4e-11
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 24 EICHRDLKLENTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARK 80
++ HRD+K +N LL DGS +K+ DFG+ ++ S+ + VGTP ++APEV+ RK
Sbjct: 136 QVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y K+ D+WS G+ M+ G P+ + E+P R N L + ++SA R
Sbjct: 192 AYGPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFR 247
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168
L++ D KR E+ +H FLK
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-11
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QP 62
Y + V+ S H + HRD+K +N L+D + RL DFG S L+ Q
Sbjct: 107 YLAEMVIAIDSVHQLHY---VHRDIKPDNILMDMNGHIRL--ADFG-SCLKLMEDGTVQS 160
Query: 63 KSTVGTPAYIAPEVLARKEYDGK-----ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 117
VGTP YI+PE+L E DGK D WS GV +Y ML G PF + K
Sbjct: 161 SVAVGTPDYISPEILQAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 118 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIPEIKKHPWF 166
++ Q F VS D + L+ ++ + + + I + K+HP+F
Sbjct: 220 IMNHKERFQ-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 6e-11
Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 42/173 (24%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
I HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE L Y
Sbjct: 121 IFHRDIKPENILIK---DDILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDGY 175
Query: 83 DGKISDVWSCGVTLYVM--LVGAYPFEDPEDPRNFRKTIDRIRNV--------------- 125
G D+W+ G + + L +P + D I +I +V
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELD------QIAKIHDVLGTPDAEVLKKFRKS 229
Query: 126 ---QYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
Y P SA+ LL ++ DP +RI + +HP+F
Sbjct: 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
YL + HRD+K N LL+ Q K+ DFG S L + K + +GTP ++APEV
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFED 108
+ Y+ K D+WS G+T M G P+ D
Sbjct: 171 IQEIGYNNKA-DIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 7e-11
Identities = 54/186 (29%), Positives = 74/186 (39%), Gaps = 44/186 (23%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYI 72
H + L HRDLK N L+ LK+ DFG ++S P V T Y
Sbjct: 119 HSNWIL----HRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYR 169
Query: 73 APEVL--ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRK----TIDR 121
APE+L AR Y + D+WS G +L+ PF + + F T +
Sbjct: 170 APELLFGARH-YGVGV-DMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 122 IRNVQYFLPDYVRV---------------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
V LPDYV S D LL ++ +P+KRI + +HP+F
Sbjct: 227 WPGVTS-LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 167 LKNLPK 172
N P
Sbjct: 286 -SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 53/194 (27%), Positives = 76/194 (39%), Gaps = 56/194 (28%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVL 77
YL E I HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+L
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180
Query: 78 -ARKEYDGKISDVWSCG---------------------VTLYVMLVGA-----YP----- 105
Y I D+W+ G + L + L+G +P
Sbjct: 181 LGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 106 -----FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160
F P+ P N K + +S LL+ + + DP KR E
Sbjct: 240 PLVGKFTLPKQPYNNLK------------HKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287
Query: 161 KKHPWFLKN-LPKE 173
+ +F + LP E
Sbjct: 288 LESSYFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
Q I HRD+K EN ++ Q + I D G ++ ++ GT APEVLAR +Y
Sbjct: 176 QRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233
Query: 83 DGKISDVWSCGVTLYVMLVGAYP---FEDP 109
+ K D+WS G+ L+ ML AYP FEDP
Sbjct: 234 NSKA-DIWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 25/169 (14%)
Query: 20 FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
FY EI +RDLK EN LLD ++I D G + + VG
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVG 163
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
T Y+APEVL + Y D W G +Y M+ G PF ++ + R+ +D R V
Sbjct: 164 TVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKE-KVKREEVD--RRVLE 219
Query: 128 FLPDY-VRVSADCRHLLSQIFVADPSKRIPIP-----EIKKHPWFLKNL 170
Y + S + + + + DP +R+ E+K+HP F +N+
Sbjct: 220 TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP-FFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 29/201 (14%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIA 73
HH + + + HRD+K N LL +K+ DFG+SK + + ++ GTP Y+A
Sbjct: 157 HHV-HSKHMIHRDIKSANILL--CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDY 132
PE+ RK Y K +D++S GV LY +L PF D N + + + +Y LP
Sbjct: 214 PEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP- 267
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP------KEIIEIEKTNYKEAG 186
+S + + +++ + +DP +R P K L N+P ++EI +T +G
Sbjct: 268 -SISPEMQEIVTALLSSDPKRR---PSSSK----LLNMPICKLFISGLLEIVQTQPGFSG 319
Query: 187 --RDQPTQSVEEIMRIIQEAK 205
RD ++ +++ +++Q +
Sbjct: 320 PLRDTISRQIQQTKQLLQVER 340
|
Length = 496 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 40/171 (23%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR-KEYD 83
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+L R Y
Sbjct: 122 HRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 84 GKISDVWSCG---VTLYVM------------------LVGAYPFED--PEDPR-----NF 115
+ D+W+ G LY + ++G P + PE + F
Sbjct: 178 SPV-DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT-PTKQDWPEGYKLASKLGF 235
Query: 116 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
R ++ +P+ S + L+ + DP KR + +HP+F
Sbjct: 236 RFPQFAPTSLHQLIPN---ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 52/184 (28%), Positives = 75/184 (40%), Gaps = 37/184 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIAPEVL- 77
+ HRDLK N L++ + L+I DFG ++ GL S + V T Y APE+L
Sbjct: 128 VIHRDLKPSNLLVNEDCE--LRIGDFGMAR-GLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI--DR 121
+ EY I D+WS G ML +P ++ I DR
Sbjct: 185 SLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 122 IRNVQYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+R LP + + S + LLSQ+ DP +RI + + +HP FL
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-FLAQYHD 302
Query: 173 EIIE 176
E
Sbjct: 303 PDDE 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 51/158 (32%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKST 65
T I + I HRD+K N L D +K+ DFG SK L + KS
Sbjct: 112 TRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSV 169
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GTP +++PEV++ + Y G+ +D+WS G T+ ML P+ + E K + N
Sbjct: 170 TGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
LP + VS CR L +IFV + R E+ +H
Sbjct: 229 V--LPPH--VSDHCRDFLKRIFV-EAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 34/168 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK +N L+ + ++KI DFG ++ S V T Y APEVL + Y
Sbjct: 128 IVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYAT 185
Query: 85 KISDVWSCGVTLYVM---------------------LVGAYPFED-PED----PRNFRKT 118
+ D+WS G + ++G E+ P + +F
Sbjct: 186 PV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY 244
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
R+ + F+P+ + + LL ++ +P KRI E +HP+F
Sbjct: 245 --TPRSFKSFVPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 35/203 (17%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKEYD 83
+ HRDLK N L++ + LKICDFG ++ + Q V T Y APE+ L ++YD
Sbjct: 129 VVHRDLKPSNILINENCD--LKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 84 GKISDVWSCGVTLYVMLVGA--YPFEDP------------------------EDPRNFRK 117
++ D+WS G ML G +P +D E+ F +
Sbjct: 185 VEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 118 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF--LKNLPKEII 175
++ + R F + LL ++ V DP KRI E HP+ + E +
Sbjct: 244 SLPK-REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302
Query: 176 EIEKTNYKEAGRDQPTQSVEEIM 198
EK ++ D P + + +M
Sbjct: 303 AEEKFDWSFNDADLPVDTWKVMM 325
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 49/154 (31%), Positives = 70/154 (45%), Gaps = 23/154 (14%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDG 84
HRD+K N LL S Q +K+ DFG + L +Q K + VGTP ++APEV+ + YD
Sbjct: 124 HRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV------RVSAD 138
K +D+WS G+T + G P D R V + +P S
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSDMHPMR-----------VLFLIPKNNPPTLTGEFSKP 228
Query: 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+ + DPS R E+ KH + +KN K
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 49/170 (28%), Positives = 70/170 (41%), Gaps = 32/170 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 82
+ HRDLK N LL+ + LKICDFG +++ + V T Y APE+ L EY
Sbjct: 129 VLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186
Query: 83 DGKISDVWSCG---------------------VTLYVMLVGA-----YPFEDPEDPRNFR 116
I DVWS G + L L+G+ F E R +
Sbjct: 187 TTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245
Query: 117 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+++ F + + LL ++ V DPSKRI + E HP+
Sbjct: 246 RSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-10
Identities = 40/118 (33%), Positives = 56/118 (47%), Gaps = 21/118 (17%)
Query: 23 QEICHRDLKLENTLLDG---------------SPQPRLKICDFGYSKSGLLHSQPKSTVG 67
+ + HRDLK +N L + +P KI DFG SK+ + S S VG
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG 203
Query: 68 TPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
TP Y +PE+L K YD K SD+W+ G +Y + G PF NF + I ++
Sbjct: 204 TPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKAN---NFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 7e-10
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 29/156 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I H D+KLEN L D + + R+ +CD+G K P GT Y +PE + YD
Sbjct: 130 IIHNDIKLENVLYDRA-KDRIYLCDYGLCKI---IGTPSCYDGTLDYFSPEKIKGHNYD- 184
Query: 85 KIS-DVWSCGVTLYVMLVGAYPFEDPED---------PRNFRKTIDRIRNVQYFLPDYVR 134
+S D W+ GV Y +L G +PF++ ED R +K + I+NV D+V+
Sbjct: 185 -VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQ 242
Query: 135 VSADCRHLLSQIFVADPSKR-IPIPEIKKHPWFLKN 169
+ + + R EI KHP FLK
Sbjct: 243 ----------SMLKYNINYRLTNYNEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-10
Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAY 71
YL C HRD+K N +L P +K+ DFG ++ G + KS GTP +
Sbjct: 117 YLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
+APEV+ Y G+ SD+WS G T++ M G P D I R + LPD
Sbjct: 175 MAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLAS-MDRLAAMFYIGAHRGLMPRLPD 232
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
SA ++ D +R ++ +H +
Sbjct: 233 --SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-10
Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARK 80
I HRD+K N L D + +K+ DFG SK + + +S GTP +++PEV++ +
Sbjct: 127 IVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y G+ +DVWS G T+ ML P+ + E K + N Q LP + +S R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--LPSH--ISEHAR 239
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPW 165
L IFV + R E+ +HP+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 25 ICHRDLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ +RDLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADC 139
+D +S G L+ +L G PF + + IDR+ V LPD S +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTVNVELPD--SFSPEL 226
Query: 140 RHLLSQIFVADPSKRIPI-----PEIKKHPWF 166
+ LL + D SKR+ E+K+H +F
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS----TVGTPAYIAPEVLA 78
+ + HRD+K +N L + ++K+ DFG S L + P + VGTP Y+ PE+
Sbjct: 119 KRVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 138
Y+ K SD+WS G LY + +PF+ +++ I ++ Y P S +
Sbjct: 174 NMPYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSY-KPLPSHYSYE 227
Query: 139 CRHLLSQIFVADPSKR 154
R L+ Q+F +P R
Sbjct: 228 LRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-09
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 63
+ Y ++ SH + ++ HRD+K +N LL + +K+ DFG S +
Sbjct: 113 IAYICREILRGLSH--LHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRR 168
Query: 64 ST-VGTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-- 115
+T +GTP ++APEV+A E YD K SD+WS G+T M GA P D R
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227
Query: 116 --RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
R R+++ ++ S + + V + S+R ++ KHP+
Sbjct: 228 IPRNPAPRLKSKKW--------SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 38/80 (47%), Positives = 46/80 (57%), Gaps = 11/80 (13%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-L 77
YL HRD+K N LL + +K+ DFG S L S S VGTP ++APEV L
Sbjct: 130 YLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVIL 184
Query: 78 ARKE--YDGKISDVWSCGVT 95
A E YDGK+ DVWS G+T
Sbjct: 185 AMDEGQYDGKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARKEY 82
+ HRDLK +N L++ + LK+ DFG +++ G+ + + V T Y AP+VL + Y
Sbjct: 121 VLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN--FR-------KTIDRI--------- 122
I D+WS G + M+ G +P + ED FR T I
Sbjct: 179 STSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 123 ------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+++Q P + D LL ++ +P RI + +HPWF
Sbjct: 238 FPRYPPQDLQQLFPHADPLGID---LLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 11/111 (9%)
Query: 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 63
+ Y ++ +H + ++ HRD+K +N LL + +K+ DFG S +
Sbjct: 123 IAYICREILRGLAH--LHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRR 178
Query: 64 ST-VGTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFED 108
+T +GTP ++APEV+A E YD + SD+WS G+T M GA P D
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEV 76
C + + HRDLK +N L++ + + LK+ DFG +++ G+ + V T Y P+V
Sbjct: 114 FC-HSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 77 L-ARKEYDGKISDVWSCGVTLYVMLVGA---YPFEDPEDP--RNFR----KTIDRIRNVQ 126
L K Y I D+WS G + +P D +D R FR T + V
Sbjct: 171 LFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 127 YFLPDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LPDY ++++ R LL + V +P +RI E +HP+F
Sbjct: 230 K-LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 49/184 (26%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAP 74
+L + I HRDLK N LL + + LKICDFG ++ + P V T Y AP
Sbjct: 121 HLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAR---EYGSPLKPYTQLVVTLWYRAP 175
Query: 75 EVL-ARKEYDGKISDVWSCG------VTLYVMLVGA--------------YPFED--PED 111
E+L KEY I D+WS G +T + G P E P
Sbjct: 176 ELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG- 233
Query: 112 PRNFRKTIDRIRNVQYFLPDYVRVSADCRH---------LLSQIFVADPSKRIPIPEIKK 162
F + + + + Y ++ LL+++ DP+KRI + K
Sbjct: 234 ---FSE-LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289
Query: 163 HPWF 166
HP+F
Sbjct: 290 HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 20/141 (14%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR-- 79
+I HRD+K +N L++ + +KI DFG SK ++ ++ GT Y+APEV+ +
Sbjct: 127 NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------NFRKTIDRIRNVQYFLPDYV 133
+ Y G +D+WS G T+ M G PF + +P+ K I P+
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-------PE-- 235
Query: 134 RVSADCRHLLSQIFVADPSKR 154
+SA+ ++ + + F DP KR
Sbjct: 236 SLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-09
Identities = 35/84 (41%), Positives = 49/84 (58%), Gaps = 6/84 (7%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDG 84
HRD+K N LL S Q +K+ DFG + L +Q K + VGTP ++APEV+ + YD
Sbjct: 124 HRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 85 KISDVWSCGVTLYVMLVGAYPFED 108
K +D+WS G+T + G P D
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-09
Identities = 34/83 (40%), Positives = 46/83 (55%), Gaps = 11/83 (13%)
Query: 21 YLQEI--CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
YL E HRD+K N LL +K+ DFG S + L + K S +GTP ++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGD--VKLADFGVS-AQLTATIAKRKSFIGTPYWMAPEV 172
Query: 77 LA---RKEYDGKISDVWSCGVTL 96
A + YDGK D+W+ G+T
Sbjct: 173 AAVERKGGYDGKC-DIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 39/177 (22%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK N ++ LKI DFG +++ + V T Y APEV+ Y
Sbjct: 144 IIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR---------------IRNV---- 125
+ D+WS G + ++ G+ F+ + + K I++ +RN
Sbjct: 202 NV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR 260
Query: 126 -QY-------FLPDYVRVS---------ADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
QY PD++ S + R LLS++ V DP KRI + E +HP+
Sbjct: 261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 36/171 (21%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKST--VGTPAYIAPEV-LARK 80
HRDLK N L++ + LKICDFG ++ + T V T Y APE+ L+ +
Sbjct: 128 HRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNF---------RKTIDRI--RNVQ 126
Y I DVWS G L L+G P +D D N +T+ RI Q
Sbjct: 186 SYTKAI-DVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243
Query: 127 YF---LPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+ LP+ + + LL ++ DP+KRI + E +HP+
Sbjct: 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 41/139 (29%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ I HRDL N +L ++ I DFG +K S+ S VGT Y PE++ + Y
Sbjct: 133 KRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY 190
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVRVSADCRH 141
G+ +DVW+ G LY M PF N +I Y LP+ + S D
Sbjct: 191 -GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLPEGM-YSEDVTD 244
Query: 142 LLSQIFVADPSKRIPIPEI 160
+++ D R I ++
Sbjct: 245 VITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 40/106 (37%), Positives = 54/106 (50%), Gaps = 7/106 (6%)
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
S VGTP YIAPEVL R Y ++ D WS GV LY MLVG PF K I+
Sbjct: 207 SLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
++ +P ++S + L+ ++ P R+ EIK HP+F
Sbjct: 266 SLH--IPPQAKLSPEASDLIIKL-CRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 1e-08
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYD 83
HRDL N L+ + +KI DFG S+ + G ++APE L ++
Sbjct: 125 HRDLAARNCLVTENLV--VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SDVWS GV L+ + +G P+
Sbjct: 183 SK-SDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 25/155 (16%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 84
HRD+K N LL S +K+ DFG + L +Q K VGTP ++APEV+ + YD
Sbjct: 124 HRDIKAANVLL--SEHGEVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRVSA 137
K +D+WS G+T + G P + P+N T++ N L ++V
Sbjct: 181 K-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE--GNYSKPLKEFVEACL 237
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+ +PS R E+ KH + ++ K
Sbjct: 238 N----------KEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 56/198 (28%)
Query: 21 YLQE--ICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS------TVGTPA 70
YL + HRDLK N L+ +G + +KI D G ++ L ++ K V T
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVTIW 180
Query: 71 YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRN-FRKT-IDRIR 123
Y APE+ L + Y I D+W+ G ++ L+ P E N F++ ++RI
Sbjct: 181 YRAPELLLGARHYTKAI-DIWAIGC-IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 124 NVQYF-----------LPDY------------------------VRVSADCRHLLSQIFV 148
V +P+Y + + LL ++
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298
Query: 149 ADPSKRIPIPEIKKHPWF 166
DP+KRI E +HP+F
Sbjct: 299 YDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLA-RK 80
I HRD+K N LL + + +K+ DFG S + L ++ + ++VGTP ++APEV+A +
Sbjct: 148 RIIHRDVKGNNILL--TTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 81 EYDGKIS---DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVS 136
+YD DVWS G+T + G P D KT+ +I RN P +
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTLFKIPRNPP---PTLLHPE 257
Query: 137 ADCR---HLLSQIFVADPSKRIPIPEIKKHPWFLK 168
CR H +SQ + D R + + +HP F+K
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 1 MISVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGL 57
M V ++S+ + H + +I +RD+K EN LLD RL D G + K G
Sbjct: 94 MERVIHYSAQITCGILH--LHSMDIVYRDMKPENVLLDDQGNCRLS--DLGLAVELKDGK 149
Query: 58 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 117
+Q GT Y+APE+L + Y + D ++ G ++Y M+ G PF ++ ++
Sbjct: 150 TITQ---RAGTNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMVAGRTPF------KDHKE 199
Query: 118 TIDRIRNVQYFLPDYVR 134
+ + + L D V+
Sbjct: 200 KVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 77
YL E I HRDLK +N L + +K+ D G ++ ST +GTP Y++PE+
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VS 136
+ K Y+ K SDVW+ G +Y M + F + ++ + RI ++ LP + S
Sbjct: 175 SNKPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDYS 227
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+ L++ + P KR + I + P+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 47/147 (31%), Positives = 70/147 (47%), Gaps = 23/147 (15%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTP-AYIAPEVLARKE 81
HRDL N LL S +KICDFG ++ ++ P K P ++APE + +
Sbjct: 202 HRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
Y + SDVWS GV L+ + +GA P+ D E R ++ R+R Y P+ +
Sbjct: 258 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRAPDYTTPEMYQTM 315
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKH 163
DC H +PS+R E+ +H
Sbjct: 316 LDCWH-------GEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 33/82 (40%), Positives = 46/82 (56%), Gaps = 8/82 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLARK 80
I HRD+K EN L+ S LK+CDFG++++ L ++P S V T Y APE+L
Sbjct: 121 IIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLVGD 176
Query: 81 EYDGKISDVWSCGVTLYVMLVG 102
GK DVW+ G + +L G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 38/80 (47%), Positives = 45/80 (56%), Gaps = 11/80 (13%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-L 77
YL HRD+K N LL Q +K+ DFG S S S VGTP ++APEV L
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQ--VKLADFG---SASKSSPANSFVGTPYWMAPEVIL 190
Query: 78 ARKE--YDGKISDVWSCGVT 95
A E YDGK+ DVWS G+T
Sbjct: 191 AMDEGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIA 73
YL+E + HRDL N L+ +PQ +KI DFG +K LL K ++A
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMA 179
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E + + Y K SDVWS GVT++ +M GA P+E
Sbjct: 180 LESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 34/170 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEV-LARKEY 82
+ HRDLK +N L+D + LK+ DFG +++ G+ V T Y APE+ L ++Y
Sbjct: 120 VLHRDLKPQNLLID--REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRI---------RNVQYFLPDY 132
+ D+WS G M+ F D E + FR I R V LPDY
Sbjct: 178 STPV-DIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTS-LPDY 233
Query: 133 V----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ D LLS++ V DP+KRI +HP+F
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 32/150 (21%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTP-AYIAPEVLARKE 81
HRDL N LL S +KICDFG ++ ++ P K P ++APE + K
Sbjct: 196 HRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
Y + SDVWS GV L+ + +GA P+ D E R ++ R+R +Y P+ +
Sbjct: 252 YTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-RMRAPEYATPEIYSIM 309
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
DC H +P R P F
Sbjct: 310 LDCWH-------NNPEDR---------PTF 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 21 YLQE--ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPE 75
YL E I HRDLK N L LDG +K+ DFG S Q + S +GTP ++APE
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 76 VL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFL 129
V+ + YD K +DVWS G+TL M E P N + + +I ++ L
Sbjct: 174 VVMCETSKDRPYDYK-ADVWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSEPPTL 228
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
R S++ + L + + R ++ +HP+ N K I E+
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIREL 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 44/173 (25%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLA 78
+ I HRD+K EN L+ S +K+CDFG++++ L T V T Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFART-LAAPGEVYTDYVATRWYRAPELLV 173
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQY---- 127
G+ D+W+ G + ML G F D + I R + +
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 128 ----FLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP+ + ++S L Q DP R ++ H +F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 35/85 (41%), Positives = 48/85 (56%), Gaps = 10/85 (11%)
Query: 25 ICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARK 80
ICHRDLK +N L+D P LK+CDFG +K+ L + S + + Y APE+ L
Sbjct: 191 ICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYP 105
Y I D+WS G + M++G YP
Sbjct: 247 NYTTHI-DLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
+GTP Y+APE+L K + + D W+ GV L+ L G PF D E P ++ I N
Sbjct: 541 LGTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFND-ETP---QQVFQNILNR 595
Query: 126 QYFLPD-YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
P+ ++S + ++ + + DP+KR + E+K+HP F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-08
Identities = 36/74 (48%), Positives = 45/74 (60%), Gaps = 9/74 (12%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE-- 81
+ HRD+K N LL Q +K+ DFG S + S S VGTP ++APEV LA E
Sbjct: 146 MIHRDIKAGNILLTEPGQ--VKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 82 YDGKISDVWSCGVT 95
YDGK+ DVWS G+T
Sbjct: 201 YDGKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-08
Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 17/143 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEVL 77
+ + HRD+K N + + +K+ D G SK+ HS VGTP Y++PE +
Sbjct: 125 RRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERI 178
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
Y+ K SD+WS G LY M PF D N +I Y S
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 138 DCRHLLSQIFVADPSKRIPIPEI 160
R L+S DP +R P+I
Sbjct: 236 KLRELVSMCIYPDPDQR---PDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 21/143 (14%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTP-AYIAPEVLARKE 81
HRDL N LL S +KICDFG ++ ++ P K + P ++APE + K
Sbjct: 197 HRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSARLPLKWMAPESIFDKV 252
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTID---RIRNVQYFLPDYVRVSA 137
Y + SDVWS GV L+ + +GA P+ + F + + R+R + P+ R+
Sbjct: 253 YTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIML 311
Query: 138 DCRHLLSQIFVADPSKRIPIPEI 160
C DP +R +
Sbjct: 312 ACWQ-------GDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 50/179 (27%), Positives = 71/179 (39%), Gaps = 41/179 (22%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIAPEV 76
+ HRDLK N LL+ R+K+ DFG ++S + V T Y APE+
Sbjct: 126 GNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 77 L-ARKEYDGKISDVWSCGVTLYVMLVGAYPF---------------------EDPEDPR- 113
L Y K D+WS G L ML+G F ED E +
Sbjct: 184 LLGSTRYT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242
Query: 114 NFRKTI------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
F T+ + + LP S D LL ++ V +P+KR+ E +HP+
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKA---SDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 42/189 (22%), Positives = 65/189 (34%), Gaps = 49/189 (25%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGY------------SKSGLLHSQPKST 65
H I HRD+K N L+D LKI DFG G + +
Sbjct: 132 HE---NHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 66 VGTPAYIAPE-VLARKEYDGKISDVWSCGVTLYVM------LVGAYPFE----------- 107
V T Y PE +L + Y + D+W G M L G +
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 108 -DPEDPRNFRK---------TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157
E +R + R ++ + ++ + LLS++ DP KR+
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLE---ERFGKLGPEGLDLLSKLLSLDPYKRLTA 302
Query: 158 PEIKKHPWF 166
+ +HP+F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 35/90 (38%), Positives = 48/90 (53%), Gaps = 13/90 (14%)
Query: 18 HCFYLQEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAP 74
+ +I HRDLK N LL DG +K+ DFG S + Q + S +GTP ++AP
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 75 EV-----LARKEYDGKISDVWSCGVTLYVM 99
EV + YD K +D+WS G+TL M
Sbjct: 180 EVVMCETMKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-07
Identities = 39/170 (22%), Positives = 67/170 (39%), Gaps = 31/170 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL-ARKE 81
I HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 121 ILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-----------RIRNVQYF-- 128
Y ++ D+WS G L + +G F+ + K + + + +F
Sbjct: 179 YGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237
Query: 129 ----------LPDYVR--VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
L ++ + + LL ++ DP KRI + +H +F
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 35/174 (20%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 80
+++ HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P++L
Sbjct: 123 RKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 81 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRI-------------RNV 125
+Y +I D+W G Y M G +P E+ +F I RI N
Sbjct: 181 DYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNE 236
Query: 126 QYFLPDYVRVSADCRH------------LLSQIFVADPSKRIPIPEIKKHPWFL 167
++ +Y + ADC H LLS++ + KRI E KHP+F
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 49/188 (26%), Positives = 78/188 (41%), Gaps = 38/188 (20%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIA 73
YL HRDL N L++ + +KI DFG +K L + V P + A
Sbjct: 124 YLGSQRYIHRDLAARNILVES--EDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWYA 180
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
PE L ++ SDVWS GVTLY + P + P P F + I + Q + +
Sbjct: 181 PECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMIGIAQG-QMIVTRLL 236
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQS 193
LL +R+P P + P E+ ++ K ++ +D+P S
Sbjct: 237 E-------LLK------EGERLPRPP---------SCPDEVYDLMKLCWEAEPQDRP--S 272
Query: 194 VEEIMRII 201
+++ I+
Sbjct: 273 FADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 42/137 (30%), Positives = 59/137 (43%), Gaps = 14/137 (10%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEVL 77
+ + HRD+K N + + +K+ D G SK+ HS VGTP Y++PE +
Sbjct: 125 RRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERI 178
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
Y+ K SD+WS G LY M PF D N +I Y S
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 138 DCRHLLSQIFVADPSKR 154
+ R L++ DP KR
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-07
Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 8/143 (5%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLA--RKEYD 83
HRD+K N LL + +K+ DFG S ++ KS +GTP ++APEV A RK
Sbjct: 129 HRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHL 142
++ D+W+ G+T + P D R F T + + L D ++ S H
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK--LKDKMKWSNSFHHF 244
Query: 143 LSQIFVADPSKRIPIPEIKKHPW 165
+ +P KR ++ +HP+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-07
Identities = 33/72 (45%), Positives = 42/72 (58%), Gaps = 9/72 (12%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE--YD 83
HRD+K N LL +K+ DFG S + + VGTP ++APEV LA E YD
Sbjct: 138 HRDVKAGNILLSEPGL--VKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 84 GKISDVWSCGVT 95
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 46/172 (26%), Positives = 65/172 (37%), Gaps = 36/172 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL-ARKE 81
I HRD+K N L++ + LKICDFG ++ T V T Y APE+L +
Sbjct: 124 ILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFE----------------DP---------EDPRNF- 115
Y + D+WS G +L F+ P E R
Sbjct: 182 YTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240
Query: 116 --RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
V Y L + + + HLL ++ V DP KRI + HP+
Sbjct: 241 LRGPHKPPSLPVLYTLSS--QATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 30/169 (17%)
Query: 9 STVMIFTSHHC-----FYLQEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLH 59
+ +++F C + Q HRDL N LLD RL KI DFG +K+ G +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEY 163
Query: 60 SQPKSTVGTPAY-IAPEVLARKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 117
+ + +P + A E L KE SDVWS GVTLY +L + P P+ F +
Sbjct: 164 YRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEE 219
Query: 118 TID-------RIRNVQYF-----LPDYVRVSADCRHLLSQIFVADPSKR 154
I +R ++ LP + L+ + + R
Sbjct: 220 MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 51/173 (29%), Positives = 69/173 (39%), Gaps = 34/173 (19%)
Query: 20 FYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79
+ I HRDLK EN L+ Q +K+ DFG ++ V T Y APEVL +
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 80 KEYDGKISDVWSCGVTLYVM---------------------LVGAYPFED-PED---PR- 113
Y + D+WS G M L+G P +D P D PR
Sbjct: 182 STYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240
Query: 114 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
F R VQ +P+ A LL ++ +P KRI +HP+F
Sbjct: 241 AFSPRGP--RPVQSVVPEIEESGAQ---LLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-07
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 1 MISVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 60
++ +C M + F HRDL N L+D Q +K+ DFG S+ +L
Sbjct: 102 LLEMCKDVCEGMAYLESKQFI-----HRDLAARNCLVDD--QGCVKVSDFGLSRY-VLDD 153
Query: 61 QPKSTVGTP---AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 107
+ S+VG+ + PEVL ++ K SDVW+ GV ++ V +G P+E
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 46/169 (27%), Positives = 67/169 (39%), Gaps = 33/169 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
I HRDLK N ++ + LKI DFG ++ H+ + T V T Y APE++ +
Sbjct: 139 IIHRDLKPSNIAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 192
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTID--RIRNVQ 126
+ D+WS G + +L G +P D D + I RN
Sbjct: 193 YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI 252
Query: 127 YFLPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP + + LL ++ V DP KRI E HP+
Sbjct: 253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 38/179 (21%)
Query: 16 SHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYI 72
H+C HRD+K EN L+ + Q ++K+CDFG+++ +L V T Y
Sbjct: 118 KHNCI------HRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYR 167
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDP-----RNFRKTIDRIRNV 125
APE+L G DVW+ G +L G +P + D + I R + +
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 126 ----QYF----LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
Q+F +P+ + +S+ L DP++R+ E+ +HP+F
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 5/76 (6%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 84
HRD+KLEN L+ + L DFG + + VGT A +PE+LA Y
Sbjct: 290 HRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-C 346
Query: 85 KISDVWSCGVTLYVML 100
+I+D+WSCG+ L ML
Sbjct: 347 EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-07
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 39/208 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK N L + LKI DFG ++ S+ V T Y APEV+ +
Sbjct: 139 IIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVILNWMHYT 194
Query: 85 KISDVWSCGVTLYVMLVGAYPFE--------------------------DPEDPRNFRKT 118
+ D+WS G + ML G F+ ED +N+ K
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254
Query: 119 IDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEII 175
+ R R + LP+ + ++L ++ V D RI E HP+F + + P++
Sbjct: 255 LPRFRKKDFRSLLPN---ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET 311
Query: 176 EIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
E + D+ QS+EE R+
Sbjct: 312 EAPPYDDS---FDEVDQSLEEWKRLTFT 336
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 46/173 (26%), Positives = 64/173 (36%), Gaps = 44/173 (25%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIAPEVLARKEY 82
HRD+K N LL+ Q +K+ DFG ++ L +S+ + V T Y PE+L +E
Sbjct: 139 HRDIKCSNILLNNKGQ--IKLADFGLAR--LYNSEESRPYTNKVITLWYRPPELLLGEER 194
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPE---------------DPRNFRKTID------- 120
G DVWSCG L + F+ + P + I
Sbjct: 195 YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 254
Query: 121 --------RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
R+R F+P LL + DPSKR E PW
Sbjct: 255 KPKKQYRRRLREEFSFIP------TPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-07
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 21 YLQE--ICHRDLKLENTLL-DGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAY 71
YL E + HRDL N L+ +G ++KI DFG S+ S + S+ + V +
Sbjct: 142 YLAEMKLVHRDLAARNVLVAEGR---KMKISDFGLSRDVYEEDSYVKRSKGRIPV---KW 195
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF 128
+A E L Y + SDVWS GV L+ ++ +G YP PE N KT R+
Sbjct: 196 MAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER---- 250
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162
P+ S + +L+ + +P KR +I K
Sbjct: 251 -PE--NCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-07
Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTP 69
+I H C + +I HRD+K EN L+ S LK+CDFG++++ S T V T
Sbjct: 109 LIKAIHWC-HKNDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTL 96
Y +PE+L Y GK D+WS G L
Sbjct: 166 WYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPE 75
YL+ HRDL N L+ +K+ DFG ++ +L Q S+ GT + +PE
Sbjct: 115 YLESSNVIHRDLAARNCLV--GENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPE 171
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
V + +Y K SDVWS GV ++ V G P+E+
Sbjct: 172 VFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 10/93 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
YL+ HRDL N L+ +K+ DFG ++ +L Q S+ GT + PE
Sbjct: 115 YLESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPE 171
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 107
V + K SDVWS GV ++ V G P+E
Sbjct: 172 VFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 56/218 (25%), Positives = 84/218 (38%), Gaps = 39/218 (17%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK N ++ LKI DFG +++ V T Y APEV+ Y
Sbjct: 140 IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 85 KISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQYFL 129
+ D+WS G + M+ +P D D P +K +RN
Sbjct: 198 NV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 130 PDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPWFLK 168
P Y ++ AD H LLS++ V DP+KRI + E +HP+
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316
Query: 169 NLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKM 206
+E + D+ ++EE +I + M
Sbjct: 317 WYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 26/166 (15%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 83
+ HRDLK +N L++ + +K+ DFG +++ G+ V T Y APE+L +Y
Sbjct: 121 VLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 84 GKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV--- 133
D+WS G M+ F D E + FR +T+ V + LPDY
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 134 -------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ D R LLSQ+ DP+KRI HP+F
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 19/149 (12%)
Query: 21 YLQEI--CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YI 72
YL ++ HRDL N L++ K+ DFG S+ +L P+ T T +
Sbjct: 122 YLSDMNYVHRDLAARNILVNS--NLECKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWT 177
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
APE +A +++ SDVWS G+ ++ VM G P+ D + K I N + LP
Sbjct: 178 APEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI----NDGFRLPA 231
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEI 160
+ + L+ Q + D ++R +I
Sbjct: 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDI 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 48/178 (26%), Positives = 70/178 (39%), Gaps = 41/178 (23%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK N ++ LKI DFG +++ V T Y APEV+ Y
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---------------------- 122
+ D+WS G + M+ G F + + K I+++
Sbjct: 205 NV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 123 -----RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 165
+ + PD V AD H LLS++ V D SKRI + E +HP+
Sbjct: 264 PKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 39/186 (20%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 80
+++ HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P+VL
Sbjct: 123 RKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 81 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN--FR-------------KTIDRIR 123
EY +I D+W G + M G +P ED + FR + D +
Sbjct: 181 EYSTQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 124 NVQYFLPDYV---------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LK 168
N Y P Y R+ + LL++ + KRI E KH +F +
Sbjct: 240 N--YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIH 297
Query: 169 NLPKEI 174
+LP+ I
Sbjct: 298 SLPESI 303
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 26/116 (22%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----------------YSKSGLLHSQ---PKST 65
+ HRDLK +N LL + + I D+G + + +S P
Sbjct: 134 VLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 121
VGTP Y+APE L +D+++ GV LY ML ++P+ + RK R
Sbjct: 192 VGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR----KKGRKISYR 242
|
Length = 932 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 49/185 (26%), Positives = 73/185 (39%), Gaps = 48/185 (25%)
Query: 25 ICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I HRDLK N ++ D + LKI DFG +++ V T Y APEV+ Y
Sbjct: 139 IIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 194
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFED--------------PED--------------- 111
+ D+WS G + M+ G +P D P D
Sbjct: 195 KENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253
Query: 112 --PRNFRKTIDRIRNVQYFLPDYVRVS----ADCRHLLSQIFVADPSKRIPIPEIKKHP- 164
P+ + + + F PD + + R LLS++ V DP KRI + + +HP
Sbjct: 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313
Query: 165 ---WF 166
W+
Sbjct: 314 INVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 14/144 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKE--- 81
HRD+K N LL + + +K+ DFG S + L ++ + ++VGTP ++APEV+A ++
Sbjct: 147 HRDVKGNNILL--TTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD 203
Query: 82 --YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
YD + DVWS G+T + G P D R K RN L S +
Sbjct: 204 STYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKI---PRNPPPTLHQPELWSNEF 259
Query: 140 RHLLSQIFVADPSKRIPIPEIKKH 163
+ + D KR + ++ +H
Sbjct: 260 NDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 51/198 (25%)
Query: 18 HCFYLQEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS------TVGTP 69
H + + HRDLK N L+ +G + R+KI D G+++ L +S K V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 124
Y APE+L + K D+W+ G +L F ED + + +DRI N
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 125 VQYF-----------LPDYVRVSADCR-------------------------HLLSQIFV 148
V F +P++ + D R HLL ++
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299
Query: 149 ADPSKRIPIPEIKKHPWF 166
DP KRI + + P+F
Sbjct: 300 MDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-06
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 16/140 (11%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPE 75
YL+E HRDL N L+ K+ DFG ++ L+ + + APE
Sbjct: 119 YLEEQNSIHRDLAARNILVG--EDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPE 174
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 134
+ + K SDVWS G+ LY + G P+ N + D+I Y +P +
Sbjct: 175 AASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQI-TAGYRMPCPAK 228
Query: 135 VSADCRHLLSQIFVADPSKR 154
+ ++ + + A+P R
Sbjct: 229 CPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 11/81 (13%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA-YIAPEV 76
YL + HRDL N L+ S K+ DFG +K + G P + APE
Sbjct: 117 YLEEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAKE----ASQGQDSGKLPVKWTAPEA 170
Query: 77 LARKEYDGKISDVWSCGVTLY 97
L K++ K SDVWS G+ L+
Sbjct: 171 LREKKFSTK-SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 32/91 (35%), Positives = 41/91 (45%), Gaps = 8/91 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYS-KSGLLHSQPKST--VGTPAYIAPE 75
YL I HRD+K EN LD L DFG + K P+ GT +PE
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPF 106
+LA Y K +D+WS G+ L+ M V
Sbjct: 258 LLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 46/184 (25%), Positives = 65/184 (35%), Gaps = 54/184 (29%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 80
+ + HRDLK +N L+ S + LK+ DFG +++ + S+ S V T Y P+VL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPF---EDPED-------------------------- 111
EY + D+W G Y M G F D ED
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238
Query: 112 ---------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162
PR R+ + L + +P KRI E K
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRI-----------PHGEELALKFLQYEPKKRISAAEAMK 287
Query: 163 HPWF 166
HP+F
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 27/72 (37%), Positives = 44/72 (61%), Gaps = 5/72 (6%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYS-KSGLLHSQPKSTVGTPAYIAPEVLARKEYDG- 84
HRD+K N LL + +K+ DFG + K ++ KS +GTP ++APEV A ++ G
Sbjct: 129 HRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 85 -KISDVWSCGVT 95
++ D+W+ G+T
Sbjct: 187 NQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-----PA-YI 72
YL E+ HRDL N L+ + K+ DFG S+ ++T T P +
Sbjct: 121 YLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSR---RLEDSEATYTTKGGKIPIRWT 175
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
APE +A +++ SDVWS G+ ++ VM G P+ D
Sbjct: 176 APEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-05
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 51/198 (25%)
Query: 18 HCFYLQEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS------TVGTP 69
H + + HRDLK N L+ +G + R+KI D G+++ L +S K V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 124
Y APE+L + K D+W+ G +L F ED + F +DRI +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 125 VQYF-----------LPDYVRVSADCRH-------------------------LLSQIFV 148
V F +P+Y + D R LL ++
Sbjct: 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299
Query: 149 ADPSKRIPIPEIKKHPWF 166
DP+KRI + + P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 50/169 (29%), Positives = 72/169 (42%), Gaps = 32/169 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARKEY 82
+ HRDLK +N L+D +K+ DFG +++ G+ V T Y APEVL Y
Sbjct: 122 VLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 83 DGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFR-------KTIDRIRNVQYFLPDYV 133
+ D+WS G T++ + P D E + FR T D V LPDY
Sbjct: 180 STPV-DIWSIG-TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS-LPDYK 236
Query: 134 R----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ D LL ++ + DP+KRI + HP+F
Sbjct: 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 35/173 (20%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARK 80
++I HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P+V L
Sbjct: 122 RKILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 81 EYDGKISDVWSCGVTLYVMLVG--------------------AYPFEDP-------EDPR 113
EY I D+W G LY M G P E+ E+ R
Sbjct: 180 EYSTPI-DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238
Query: 114 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
++ R + + P R+ D LLS + + + RI +H +F
Sbjct: 239 SYLFPQYRAQPLINHAP---RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 49/190 (25%), Positives = 75/190 (39%), Gaps = 55/190 (28%)
Query: 20 FYLQ--EICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPA 70
+Y+ +I HRD+K N L+ DG LK+ DFG +++ L K V T
Sbjct: 133 YYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 71 YIAPEVLARKEYDGKISDVWSCG---------------------VTLYVMLVGA-----Y 104
Y PE+L + G D+W G +TL L G+ +
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248
Query: 105 P-------FEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156
P F+ E P+ RK +R++ YV+ L+ ++ V DP+KRI
Sbjct: 249 PGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPHALDLIDKLLVLDPAKRID 300
Query: 157 IPEIKKHPWF 166
H +F
Sbjct: 301 ADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 13/87 (14%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTP-AYI 72
YL + HRDL N LL + ++KI DFG ++ + + V P A+
Sbjct: 112 YLESKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWC 167
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVM 99
APE L + + SDVW GVTL+ M
Sbjct: 168 APESLRTRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 47/180 (26%), Positives = 68/180 (37%), Gaps = 41/180 (22%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KST--VGTPAYIA 73
HC + + HRDLK +N L+D + LKI D G ++ S P T + T Y A
Sbjct: 125 HC-HKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLGRA---FSIPVKSYTHEIVTLWYRA 179
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-------------------- 113
PEVL + D+WS G M F P D
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 114 ---NFRK----TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
R + +++ +PD +S + LL ++ DP+KRI HP+F
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 42/148 (28%), Positives = 63/148 (42%), Gaps = 14/148 (9%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTP-AYIAPE 75
YL+ HRDL N L+ + LKI DFG S+ G +++ P + APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 134
L Y + SDVWS G+ L+ +G P+ + + R+ I+ Y +P
Sbjct: 166 ALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQT-RERIES----GYRMPAPQL 219
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKK 162
+ L+ Q + DP R EI
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 35/95 (36%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGT--P-AYIAP 74
YL+ HRDL N LL Q KI DFG S++ G ++T P + AP
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 75 EVLARKEYDGKISDVWSCGVTLYVML-VGAYPFED 108
E + ++ K SDVWS GVTL+ GA P+ +
Sbjct: 168 ECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 35/171 (20%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKE 81
+I HRDLK N ++ + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 140 DIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFED------------------------PEDPRNF 115
+ + D+WS G + +L G +P D E RN+
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 116 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+++ ++ + F ++ + LL ++ V D KRI + H +F
Sbjct: 254 IQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 43/175 (24%), Positives = 62/175 (35%), Gaps = 43/175 (24%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKSTVGTPAYIAPEVLA 78
HRDLK N ++ + LKI DFG YS G L + T Y +P +L
Sbjct: 137 HRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEGLVTKWYRSPRLLL 191
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRNVQY 127
K D+W+ G ML G F + P + + + NV
Sbjct: 192 SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNV-- 249
Query: 128 FLPDYVR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+P +VR V+ + L QI +P R+ E HP+
Sbjct: 250 -IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 80
Q I HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VL
Sbjct: 122 QHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPF 106
+Y + D+W G ML G F
Sbjct: 180 DYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
I HRDLK N ++ + LKI DFG ++ H+ + T V T Y APEV+ +
Sbjct: 138 IIHRDLKPGNLAVNEDCE--LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 83 DGKISDVWSCGVTLYVMLVGAYPF--EDPEDP------------RNFRKTIDRIRNVQYF 128
+ D+WS G + ML G F +D D F + ++ Y
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251
Query: 129 --LPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
LP Y R S LL ++ D KR+ E +HP+F + E
Sbjct: 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF-DSFRDADEET 310
Query: 178 EKTNYKEAGRDQPTQSVEEIMRIIQE 203
E+ Y ++ + SV+E + I +
Sbjct: 311 EQQPYDDS-LENEKLSVDEWKKHIYK 335
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ HRDLK +N L+ S Q +K+ DFG ++ S V T Y APEVL + Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 186
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 122
+ D+WS G M F D K +D I
Sbjct: 187 ATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 18/103 (17%)
Query: 7 FSSTVMIFTSHHCF---YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 61
++++ S C YL HRDL N L++ + R+KI DFG +K + Q
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIGDFGLTK---VLPQ 160
Query: 62 PKS--TVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY 97
K V P + APE L ++ SDVWS GV LY
Sbjct: 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-05
Identities = 31/86 (36%), Positives = 43/86 (50%), Gaps = 11/86 (12%)
Query: 27 HRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE 81
HRDL N +L + +C DFG SK SG + Q + +IA E LA +
Sbjct: 136 HRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 191
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPF 106
Y K SDVW+ GVT++ + G P+
Sbjct: 192 YTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYD 83
HRDL N L+ S +K+ DFG ++ +L + S+ G + PEV +Y
Sbjct: 123 HRDLAARNCLV--SSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFE 107
K SDVWS GV ++ V G PFE
Sbjct: 180 SK-SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 33/102 (32%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFG----------YSKSG--LLHSQPKSTV 66
YL HRDL N ++ + +KI DFG Y K G LL
Sbjct: 134 YLAAKKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-------- 183
Query: 67 GTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPF 106
P ++APE L + K SDVWS GV L+ M + P+
Sbjct: 184 --PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 48/169 (28%), Positives = 68/169 (40%), Gaps = 31/169 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 83
+ HRDLK +N L+D LK+ DFG +++ G+ V T Y APE+L +
Sbjct: 123 VLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 84 GKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQY--------FLPDYV 133
D+WS G ++ +V P D E F+ I RI LPDY
Sbjct: 182 STPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLPDYK 238
Query: 134 R----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ LLS++ DPSKRI +H +F
Sbjct: 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIA 73
YL+E + HRDL N L+ PQ +KI DFG +K LL + K ++A
Sbjct: 124 YLEERRLVHRDLAARNVLVKT-PQ-HVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMA 179
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 107
E + + Y + SDVWS GVT++ +M G+ P++
Sbjct: 180 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 17/143 (11%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAY-IAPEVLARKEY 82
HRDL N L++ + ++KI DFG +K+ + K + +P + APE L + ++
Sbjct: 132 HRDLAARNVLVES--EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNV---QYFLPDY 132
SDVWS GVTLY +L P P + + T+ R+ V LP
Sbjct: 190 -YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 133 VRVSADCRHLLSQIFVADPSKRI 155
+ L+ + + PSKR
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRT 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 26/146 (17%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTP 69
YL+ HRDL N L+ + + LKI DFG Y+ +G + P
Sbjct: 109 YLESKHCIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK----- 161
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
+ APE L Y + SDVWS G+ L+ +GA P+ + + + R+ I+ + V+
Sbjct: 162 -WTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIE--QGVRLP 216
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKR 154
P+ L+ + + DP +R
Sbjct: 217 CPE--LCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTPAYIAPEVLARK 80
+ H+D+ N ++D Q +KI D S+ H + ++A E L K
Sbjct: 137 GVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194
Query: 81 EYDGKISDVWSCGVTLY-VMLVGAYPFE--DPEDPRNFRKTIDRI 122
EY SDVWS GV L+ +M +G P+ DP + + K R+
Sbjct: 195 EYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 28/72 (38%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGK 85
HRDL N L+ S K+ DFG +K S + T P + APE L K++ K
Sbjct: 125 HRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 86 ISDVWSCGVTLY 97
SDVWS G+ L+
Sbjct: 180 -SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 31/83 (37%), Positives = 42/83 (50%), Gaps = 9/83 (10%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPA-YIAP 74
YL+E HRDL N LL Q KI DFG SK + + + K+ P + AP
Sbjct: 110 YLEETNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 75 EVLARKEYDGKISDVWSCGVTLY 97
E + ++ K SDVWS GV ++
Sbjct: 168 ECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKE 81
+++ HRDL N L+ S K+ DFG ++ G S P + APE L K+
Sbjct: 119 KKLVHRDLAARNILV--SEDGVAKVSDFGLARVG---SMGVDNSKLPVKWTAPEALKHKK 173
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
+ K SDVWS GV L+ V G P+ P+ K + Y + AD
Sbjct: 174 FSSK-SDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 141 HLLSQIFVADPSKRIPIPEIKK 162
L++ + +P KR ++++
Sbjct: 228 VLMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 20 FYLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTP-AYI 72
+YL+E HR+L N LL ++I DFG + LL+ K S TP ++
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVAD--LLYPDDKKYFYSEHKTPIKWM 178
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPF 106
A E + Y + SDVWS GVT++ M+ GA P+
Sbjct: 179 ALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 27 HRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82
HRDL N L+ +G +KICDFG ++ + S ST ++APE + Y
Sbjct: 262 HRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318
Query: 83 DGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRN--FRKTIDR 121
+SDVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 319 T-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 33/88 (37%), Positives = 44/88 (50%), Gaps = 11/88 (12%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKIC--DFGYSKSGLLHSQPK--STVGTPAYIAP 74
YL E I HRD+K EN ++ P +C DFG + + + K GT A AP
Sbjct: 197 YLHENRIIHRDIKAENIFIN---HPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252
Query: 75 EVLARKEYDGKISDVWSCGVTLYVMLVG 102
E+LAR Y G D+WS G+ L+ M
Sbjct: 253 ELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKSTVGTPAYIAPEVL 77
+ HRDL N +L+ + + +C DFG SK SG + Q ++ ++A E L
Sbjct: 132 KNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187
Query: 78 ARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
A Y SDVW+ GVT++ +M G P+ E+ + I R Q PD +
Sbjct: 188 ADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ--PPDCL--- 241
Query: 137 ADCRHLLSQIFVADPSKR 154
D L+ Q + +P R
Sbjct: 242 EDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 50/196 (25%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----------SGLLHSQPK-- 63
H +++ HRDL N ++ + KI DFG ++ S Q +
Sbjct: 136 HKWYFM----HRDLSPANIFINS--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 64 --STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFED----------- 108
S V T Y APE+L E D+WS G +L G +P E+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249
Query: 109 ---PED---------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156
P + P T + ++++ P+ S D LL + +P +RI
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN---ASDDAIDLLQSLLKLNPLERIS 306
Query: 157 IPEIKKHPWFLKNLPK 172
E KH +F K+ P
Sbjct: 307 AKEALKHEYF-KSDPL 321
|
Length = 335 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTP---AYIAP 74
YL+ HRDL N LL Q KI DFG SK+ G S K+ + AP
Sbjct: 110 YLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 75 EVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDP 112
E + +++ + SDVWS G+T++ G P++ + P
Sbjct: 168 ECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGP 205
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 19 CFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSG-----LLHSQPKST---VGTP 69
C + Q I HRDLK +N ++ + +P K+ DFG + T +GTP
Sbjct: 94 CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTP 153
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 102
Y APE L R E SD+++ G+ L G
Sbjct: 154 TYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 12/89 (13%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLARK 80
HRDL N L++ + K+ DFG S+ +L P++ T + APE +A +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 81 EYDGKISDVWSCGVTLY-VMLVGAYPFED 108
++ SDVWS G+ ++ VM G P+ +
Sbjct: 185 KFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 52/206 (25%), Positives = 74/206 (35%), Gaps = 61/206 (29%)
Query: 17 HHCFYLQE------------ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK- 63
HH F+L + + HRDLK +N L + +LKICDFG ++ +
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPTAI 161
Query: 64 ---STVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGA--YPFED-------- 108
V T Y APE+ +Y I D+WS G +L G +P ++
Sbjct: 162 FWTDYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
Query: 109 --------PEDPRNFRKTIDRIRNVQY--------------FLPDYVRVSADCRHLLSQI 146
PE TI R+RN + F + LL ++
Sbjct: 221 TDLLGTPSPE-------TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL 273
Query: 147 FVADPSKRIPIPEIKKHPWFLKNLPK 172
DP R E P+F K L K
Sbjct: 274 LAFDPKDRPTAEEALADPYF-KGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 11/90 (12%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGT-PA-YIAPEVL 77
++ HRDL N L+ + +KI DFG ++ +H K+T G P ++APE L
Sbjct: 151 KKCIHRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYYRKTTNGRLPVKWMAPEAL 206
Query: 78 ARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
+ Y + SDVWS GV L+ + +G P+
Sbjct: 207 FDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
HRDL N +L+ + + + DFG SK +G + Q + +IA E LA + Y
Sbjct: 135 HRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT 192
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFEDPED 111
K SDVWS GVT++ + G P+ E+
Sbjct: 193 TK-SDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 39/111 (35%), Positives = 50/111 (45%), Gaps = 19/111 (17%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKIC--DFGY------SKSGLLHSQPKSTVGTPAYIAP 74
+ I HRD+K EN L++G P+ IC DFG S S H TV T AP
Sbjct: 279 EGIIHRDIKTENVLVNG-PE---DICLGDFGAACFARGSWSTPFHYGIAGTVDTN---AP 331
Query: 75 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP--RNFRKTIDRI 122
EVLA Y + D+WS G+ ++ V A F R + I RI
Sbjct: 332 EVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 42/143 (29%), Positives = 61/143 (42%), Gaps = 14/143 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG--TPAYI---APEVLARKE 81
HRDL N L+ + +KI DFG S++ L+S V P I A E + +
Sbjct: 153 HRDLATRNCLVGKNYT--IKIADFGMSRN--LYSSDYYRVQGRAPLPIRWMAWESVLLGK 208
Query: 82 YDGKISDVWSCGVTLY--VMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSA 137
+ K SDVW+ GVTL+ + L P+E D + R+ Q +LP
Sbjct: 209 FTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPK 267
Query: 138 DCRHLLSQIFVADPSKRIPIPEI 160
D L+ + + D R EI
Sbjct: 268 DIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 39/168 (23%), Positives = 71/168 (42%), Gaps = 19/168 (11%)
Query: 1 MISVCYFSSTVMIF-TSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SG 56
+ + + M + +SHH HRDL N L+ +KI DFG S+ S
Sbjct: 126 FLHIAIQIAAGMEYLSSHH------FVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSA 177
Query: 57 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 115
+ ++ ++ PE + ++ + SD+WS GV L+ + G P+ +
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYG----FSN 232
Query: 116 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
++ I+ IR+ Q LP A L+ + + P++R +I
Sbjct: 233 QEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 41/120 (34%), Positives = 57/120 (47%), Gaps = 18/120 (15%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFG-----YSK---SGLLHSQPKSTVGTPAYIAP 74
++ HRDL N +LD S +K+ DFG Y K S H+ K V ++A
Sbjct: 117 KKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMAL 171
Query: 75 EVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
E L +++ K SDVWS GV L+ +M GA YP D D + R+ +Y PD
Sbjct: 172 ESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPD 229
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP----AYIAPEVLARKEY 82
HRDL N LL + +KICDFG ++ ++H + G+ ++APE + Y
Sbjct: 260 HRDLAARNVLL--AQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPESIFDNLY 316
Query: 83 DGKISDVWSCGVTLY-VMLVGAYPF 106
+SDVWS G+ L+ + +G P+
Sbjct: 317 T-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 21 YLQEI--CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEV 76
YL+ HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE
Sbjct: 122 YLESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 77 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
+ + + SDVW GV ++ ++++G PF+ ++ I RI N + LP
Sbjct: 180 INFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIENGER-LPMPPNC 233
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIK 161
L+++ + DPSKR E+K
Sbjct: 234 PPTLYSLMTKCWAYDPSKRPRFTELK 259
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 21 YLQEI--CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPE 75
YL+E+ HRDL N L+ SP +KI DFG ++ + G ++A E
Sbjct: 124 YLEEVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 107
+ + + + SDVWS GVT++ +M GA P++
Sbjct: 182 SILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
HC + +L E ++DG +P L++ S GLL + K + + AY+APE
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETR 850
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 110
K+ K SD++ G+ L +L G P D E
Sbjct: 851 ETKDITEK-SDIYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 39/157 (24%)
Query: 19 CFYLQEI--CHRDLKLENTLL---DGSPQPRLKICDFG----------YSKSGLLHSQPK 63
C YL+++ HRDL N L+ +KI DFG Y K G +
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG----EGL 174
Query: 64 STVGTPAYIAPEVLARKEYDGKI---SDVWSCGVTLY-VMLVG--AYPFEDPEDPRNFRK 117
V ++APE L DGK SDVWS GV ++ ++ +G YP + ++
Sbjct: 175 LPV---RWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 118 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 154
R++ + PD L++ + DPS+R
Sbjct: 228 AGGRLQKPEN-CPD------KIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 39/149 (26%), Positives = 61/149 (40%), Gaps = 20/149 (13%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ I RDL N LLD +L +S+ + Y APEV E
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE- 158
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
+ + D WS G L+ +L G E N + +P++ VS + R L
Sbjct: 159 ETEACDWWSLGAILFELLTGKTLVECHPSGIN--------THTTLNIPEW--VSEEARSL 208
Query: 143 LSQIFVADPSKRI-----PIPEIKKHPWF 166
L Q+ +P++R+ + +IK HP+F
Sbjct: 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 16/99 (16%)
Query: 21 YLQEI--CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-------- 70
YL E+ HRDL N L++ + K+ DFG S+ L T +
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIR 176
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ APE +A +++ SDVWS G+ ++ VM G P+ D
Sbjct: 177 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (87), Expect = 0.003
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I HRDLK +N L+ + + LK+ DFG +++ + S S V T Y P+VL
Sbjct: 124 ILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPED 111
D+W G M+ G F +D
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 11/138 (7%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPA-YIAPEVLARKEYD 83
HRDL N LL + +KICDFG ++ + S K P ++APE + Y
Sbjct: 164 HRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT 221
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
+ SDVWS G+ L+ + +G+ P+ F K I Y + A+ +
Sbjct: 222 FE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHAPAEIYDI 276
Query: 143 LSQIFVADPSKRIPIPEI 160
+ + ADP KR +I
Sbjct: 277 MKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.87 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.51 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.5 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.49 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.46 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.21 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.19 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.0 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.97 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.71 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.37 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.11 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.79 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.69 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 96.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.58 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 95.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.49 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.24 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.12 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.9 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.86 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.54 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 93.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.02 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 92.94 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 92.62 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.42 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.23 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.21 | |
| PLN02236 | 344 | choline kinase | 92.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.81 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.56 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.83 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.66 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 90.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 88.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 88.42 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 87.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 84.11 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=296.66 Aligned_cols=155 Identities=36% Similarity=0.559 Sum_probs=130.0
Q ss_pred HHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc--cCCcch
Q 025933 11 VMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE--YDGKIS 87 (246)
Q Consensus 11 ~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~ 87 (246)
.|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+.......+++.||||.|.|||++.+.. +++.++
T Consensus 283 ~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kV 362 (475)
T KOG0615|consen 283 KQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKV 362 (475)
T ss_pred HHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchh
Confidence 456699999999999999999999999876 33459999999999766677788999999999999997654 345458
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
|+||+||+||.+++|.+||.+......+.+ ++....+. .+.+..++.++++||.+||..||++|||+.|+|+|||
T Consensus 363 DiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 363 DIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred eeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 999999999999999999987665543333 33444443 3567889999999999999999999999999999999
Q ss_pred ccc
Q 025933 166 FLK 168 (246)
Q Consensus 166 ~~~ 168 (246)
|+.
T Consensus 440 ~~~ 442 (475)
T KOG0615|consen 440 FKD 442 (475)
T ss_pred hhc
Confidence 964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=268.93 Aligned_cols=155 Identities=34% Similarity=0.616 Sum_probs=130.1
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchh
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 88 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 88 (246)
+-|||+||.|||.++|||||+||+|+|+.+. ...-|||+|||++...........++|||.|||||++...+|... +|
T Consensus 116 ~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kp-vD 194 (355)
T KOG0033|consen 116 IQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKP-VD 194 (355)
T ss_pred HHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCc-ch
Confidence 4578999999999999999999999999543 234599999999986554444456789999999999999898655 99
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 89 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 89 iwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
||+.|||||.|+.|++||.+.+..+.+ +++....+ ..|.++++++++++|+++||..||.+|+|+.|+|+|||+
T Consensus 195 iW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 195 IWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred hhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 999999999999999999985554444 44444444 445788999999999999999999999999999999999
Q ss_pred ccC
Q 025933 167 LKN 169 (246)
Q Consensus 167 ~~~ 169 (246)
.+.
T Consensus 271 ~~r 273 (355)
T KOG0033|consen 271 CNR 273 (355)
T ss_pred cch
Confidence 753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=282.57 Aligned_cols=160 Identities=29% Similarity=0.464 Sum_probs=136.1
Q ss_pred HHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
-.+..+++.||.|||+ ++||||||||+|||++..+. |||||||.++.... ....+++||..|||||.+.+..|+.+
T Consensus 181 ~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvn-S~a~tfvGT~~YMsPERi~g~~Ys~~ 257 (364)
T KOG0581|consen 181 GKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVN-SIANTFVGTSAYMSPERISGESYSVK 257 (364)
T ss_pred HHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhh-hhcccccccccccChhhhcCCcCCcc
Confidence 3567789999999996 99999999999999999887 99999999986543 36688999999999999999999877
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhcc-ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+||||||+.++|+++|++||... .......+.+..+... ...+|.. .+|+++++||..||++||.+|+|+.++++|
T Consensus 258 -sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 258 -SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 89999999999999999999775 2334556667776653 3334442 499999999999999999999999999999
Q ss_pred cccccCCC
Q 025933 164 PWFLKNLP 171 (246)
Q Consensus 164 p~~~~~~~ 171 (246)
||+++...
T Consensus 336 pfi~~~~~ 343 (364)
T KOG0581|consen 336 PFIKKFED 343 (364)
T ss_pred HHHhhccc
Confidence 99976543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.93 Aligned_cols=154 Identities=33% Similarity=0.584 Sum_probs=136.6
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
+.+.||+.||.|||+++|||||||..|+|++.+.+ |||+|||||...... ....+.||||.|.|||++....++ ..
T Consensus 122 y~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHs-fE 198 (592)
T KOG0575|consen 122 YFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHS-FE 198 (592)
T ss_pred HHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccceecCCCcccChhHhccCCCC-Cc
Confidence 34677889999999999999999999999999887 999999999866544 566788999999999999877765 44
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||||+||++|.||.|++||.. ..+.++..++....+.+|. .+|.++++||.+||..||.+|||++++|.|+||
T Consensus 199 vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 199 VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999999999975 5567777888888998888 799999999999999999999999999999999
Q ss_pred ccCC
Q 025933 167 LKNL 170 (246)
Q Consensus 167 ~~~~ 170 (246)
....
T Consensus 273 ~~g~ 276 (592)
T KOG0575|consen 273 KSGF 276 (592)
T ss_pred hCCC
Confidence 5544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=286.52 Aligned_cols=155 Identities=35% Similarity=0.562 Sum_probs=132.2
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC--------------CCCCCCCCCCCCCCcch
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--------------HSQPKSTVGTPAYIAPE 75 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~--------------~~~~~~~~gt~~y~aPE 75 (246)
++||+.||.|||++|||||||||+|||++.++. +||+|||.|+.... .....+++||..|.+||
T Consensus 180 AAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 180 AAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred HHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 567889999999999999999999999999887 99999999874321 11125579999999999
Q ss_pred hccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC
Q 025933 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 76 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
++..+..+ +.+|+|+||||+|+|+.|.+||.+.++ ..+++++....+.+|. .+++.+++||+++|.+||.+|+
T Consensus 258 lL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFqkI~~l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rl 330 (604)
T KOG0592|consen 258 LLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANE----YLIFQKIQALDYEFPE--GFPEDARDLIKKLLVRDPSDRL 330 (604)
T ss_pred HhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccH----HHHHHHHHHhcccCCC--CCCHHHHHHHHHHHccCccccc
Confidence 99877765 449999999999999999999998666 4556667778887777 7899999999999999999999
Q ss_pred CHHHHhcCcccccCCChH
Q 025933 156 PIPEIKKHPWFLKNLPKE 173 (246)
Q Consensus 156 t~~e~l~hp~~~~~~~~~ 173 (246)
|+++|.+||||....-..
T Consensus 331 t~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 331 TSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cHHHHhhCcccccCChhh
Confidence 999999999997654433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.97 Aligned_cols=156 Identities=44% Similarity=0.764 Sum_probs=136.5
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCC-CCCCCCCCCCCCCCCCcchhcccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSG-LLHSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
++.||+|++ .|+.|||++||+||||||+|||++.+ ++ +||+|||++... .......+.+||+.|+|||++.+.
T Consensus 122 ar~~F~Qli---sav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 122 ARKYFRQLI---SAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred HHHHHHHHH---HHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCCCCCcccCCCCCcccCCHHHhCCC
Confidence 456776665 88899999999999999999999988 55 999999999876 355677889999999999999998
Q ss_pred c-cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 E-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
. |+++++||||+||+||.|++|+.||...+.. ....++....+.+|.+.. |+++++|+++||..||.+|+|+.+
T Consensus 197 ~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 197 GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHH
Confidence 8 9999999999999999999999999874443 344446777888887533 999999999999999999999999
Q ss_pred HhcCccccc
Q 025933 160 IKKHPWFLK 168 (246)
Q Consensus 160 ~l~hp~~~~ 168 (246)
++.||||+.
T Consensus 272 i~~h~w~~~ 280 (370)
T KOG0583|consen 272 ILEHPWFQK 280 (370)
T ss_pred HhhChhhcc
Confidence 999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.02 Aligned_cols=156 Identities=37% Similarity=0.694 Sum_probs=142.7
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..||. ||+.|+.|||..+|+||||||+|+|++..++ +||+|||+|.....+....+.||+|+|.|||++.|.+|+
T Consensus 115 a~ff~---QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 115 AHFFR---QILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred HHHHH---HHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccccCCCcccCCchhhcCCCCC
Confidence 34555 4568899999999999999999999998887 999999999977778888899999999999999999999
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+.++||||+|||||.||+|+.||.+ ++++.++.++..+.|.+|. ++|.++++||++||..||.+|+|.+++++|
T Consensus 190 G~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 190 GRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 9999999999999999999999974 5678888899999999996 799999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
||+.+..
T Consensus 264 P~l~g~~ 270 (786)
T KOG0588|consen 264 PFLSGYT 270 (786)
T ss_pred chhhcCC
Confidence 9997653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=267.83 Aligned_cols=160 Identities=26% Similarity=0.403 Sum_probs=134.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
-..+.|++.|++|||+++||||||||+||||+.++. +||||||+|+... .....+.++.|+||.|||.+.+...+++
T Consensus 104 k~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~ 181 (396)
T KOG0593|consen 104 KKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGK 181 (396)
T ss_pred HHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCC
Confidence 345778889999999999999999999999998887 9999999999655 3444456789999999999999666677
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------CCCC----------CCcCCHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------FLPD----------YVRVSADCR 140 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~----------~~~~~~~~~ 140 (246)
.+||||+||++.||++|.+-|.+.++.+++..+...+.+... .+|. +++++.-+.
T Consensus 182 pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~l 261 (396)
T KOG0593|consen 182 PVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLL 261 (396)
T ss_pred cccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHH
Confidence 799999999999999999999999999888777655422111 1121 345778899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
||+++||..||.+|++.++++.|+||..
T Consensus 262 d~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 262 DLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHhcCCccccccHHHHhcChHHHH
Confidence 9999999999999999999999999943
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=272.60 Aligned_cols=193 Identities=25% Similarity=0.319 Sum_probs=144.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhccccccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
-+.++|+|.||+|+|+.+|+||||||.|+|++.++. +||||||+|+.... ...++..+.|.||.|||++....-+
T Consensus 128 q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Y 205 (359)
T KOG0660|consen 128 QYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEY 205 (359)
T ss_pred HHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccc
Confidence 345889999999999999999999999999998887 99999999996542 3344667899999999998765444
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------hccccC-----CCCCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------------RNVQYF-----LPDYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~--------------------~~~~~~-----~~~~~~~~~~ 138 (246)
++++||||+|||+.||++|++-|.|.+...++..++.-+ .+.... ...+++.++.
T Consensus 206 t~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~ 285 (359)
T KOG0660|consen 206 TKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPL 285 (359)
T ss_pred cchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHH
Confidence 566999999999999999999998876655554444221 111100 1124678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
+.+|+.+||.+||.+|+|++|+|+|||+.................. .+...+.+++.+++.+.
T Consensus 286 AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~~~~~~~~~r~~i~~e 348 (359)
T KOG0660|consen 286 AIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FEHELTEEELRELIYKE 348 (359)
T ss_pred HHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---ccccccHHHHHHHHHHH
Confidence 9999999999999999999999999999876654433322221111 22236677777776654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=265.29 Aligned_cols=156 Identities=33% Similarity=0.579 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-----ccc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-----KEY 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~ 82 (246)
+++-|+++++.|+|.++||||||||+|||++++.+ +||+|||++.....+...+..||||+|+|||.+.. .+.
T Consensus 127 ~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pG 204 (411)
T KOG0599|consen 127 RIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPG 204 (411)
T ss_pred HHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCC
Confidence 46788999999999999999999999999999887 99999999998888888888999999999999864 233
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+++.+|+||+|||+|.|+.|.+||......-.++.+++ .+.++..|.|.++|...++||.+||+.||.+|+|++|+|.
T Consensus 205 Ys~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 205 YSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 35669999999999999999999986433333333322 2345566889999999999999999999999999999999
Q ss_pred Ccccc
Q 025933 163 HPWFL 167 (246)
Q Consensus 163 hp~~~ 167 (246)
||||.
T Consensus 283 Hpff~ 287 (411)
T KOG0599|consen 283 HPFFI 287 (411)
T ss_pred ChHHH
Confidence 99993
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=271.06 Aligned_cols=161 Identities=35% Similarity=0.571 Sum_probs=130.4
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
|++|+. .|+.||.|||++|||||||||+|||++..|+ |+|+|||+|+..... ....+.|||+.|||||++.+.+
T Consensus 127 arfYla---Ei~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 127 ARFYLA---EIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred HHHHHH---HHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCccccccCCccccChHHHhcCC
Confidence 455554 4568999999999999999999999999888 999999999954433 3455679999999999999999
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCc-CCHHHHHHHHHhcccCCCCCC----C
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQIFVADPSKRI----P 156 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~----t 156 (246)
|+.. +|+||||+++|+|++|.+||.+.+..+.+ +++...+. +..+. ++.++++||+++|.+||.+|. +
T Consensus 202 y~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~----~~I~~~k~--~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d 274 (357)
T KOG0598|consen 202 YDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMY----DKILKGKL--PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGD 274 (357)
T ss_pred CCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHH----HHHhcCcC--CCCCccCCHHHHHHHHHHhccCHHHhcCCCCC
Confidence 8755 99999999999999999999986654444 44444432 22223 899999999999999999996 6
Q ss_pred HHHHhcCcccccCCChHHH
Q 025933 157 IPEIKKHPWFLKNLPKEII 175 (246)
Q Consensus 157 ~~e~l~hp~~~~~~~~~~~ 175 (246)
+.++.+||||..-.-+...
T Consensus 275 ~~~ik~HpfF~~inW~~l~ 293 (357)
T KOG0598|consen 275 AEEIKRHPFFKGINWEKLL 293 (357)
T ss_pred hHHhhcCcccccCCHHHHH
Confidence 8899999999875544433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=260.57 Aligned_cols=161 Identities=33% Similarity=0.546 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
.++-||..|+.|||+.+|.||||||+|+|...+. +..+||+|||+|+.........+.|-||+|.|||++-...|+ +.
T Consensus 165 eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKyd-ks 243 (400)
T KOG0604|consen 165 EIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYD-KS 243 (400)
T ss_pred HHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcC-CC
Confidence 4677889999999999999999999999996543 356999999999987767778889999999999999888876 44
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+|+||+||++|.|++|.+||++......-.....+++..+|.+| +|..+|+.++++|+++|..+|.+|+|+++++.||
T Consensus 244 cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 99999999999999999999876653333334456677777765 5788999999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
|+.+.
T Consensus 324 wi~~~ 328 (400)
T KOG0604|consen 324 WINQY 328 (400)
T ss_pred hhccc
Confidence 99764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.82 Aligned_cols=164 Identities=24% Similarity=0.363 Sum_probs=140.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.||++||+++|++|+.|||+||+|||+.++.. |||+|||+|+........+.++.|+||+|||++....++.
T Consensus 111 ~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys 188 (538)
T KOG0661|consen 111 DIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYS 188 (538)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCCcchhhhcccccchHHhhhccccC
Confidence 35678899999999999999999999999999987665 9999999999877666777889999999999998877777
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------------cccCCCC---------CCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQYFLPD---------YVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~---------~~~~~~~~~ 140 (246)
..+||||+|||++|+.+-++-|.|.++.+++.++.+-+.. ..+.+|. .++.+.++.
T Consensus 189 ~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~ 268 (538)
T KOG0661|consen 189 SPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAA 268 (538)
T ss_pred CchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHH
Confidence 7799999999999999999999999998888887765421 1122232 234789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+||.+||..||.+||||.++|+||||....
T Consensus 269 ~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 269 SLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 999999999999999999999999997644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.52 Aligned_cols=165 Identities=36% Similarity=0.567 Sum_probs=135.3
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC------------------------
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL------------------------ 58 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~------------------------ 58 (246)
+++|+..++ .|+..+|+.|+|||||||+|+||+..|+ +||+|||||.....
T Consensus 243 arfYiaE~v---lAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (550)
T KOG0605|consen 243 ARFYIAETV---LAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD 317 (550)
T ss_pred HHHHHHHHH---HHHHHHHHcCcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence 566766554 7888999999999999999999999988 99999999851100
Q ss_pred -CC---CC--------------------CCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHH
Q 025933 59 -HS---QP--------------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 114 (246)
Q Consensus 59 -~~---~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 114 (246)
.. .. .+++|||.|||||++.+.+|. ..+|+||||||+||||.|.+||.+.+..++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00 00 145899999999999999986 449999999999999999999999888888
Q ss_pred HHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccCCChHHHH
Q 025933 115 FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKNLPKEIIE 176 (246)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~ 176 (246)
+++++.+..... +|....++++++|||.+||. ||.+|.. ++||.+||||....-..+-+
T Consensus 397 ~rkI~nwr~~l~--fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 397 YRKIVNWRETLK--FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLRE 458 (550)
T ss_pred HHHHHHHhhhcc--CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhc
Confidence 888887654443 46666789999999999999 9999985 89999999998755444433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=254.02 Aligned_cols=154 Identities=35% Similarity=0.585 Sum_probs=131.4
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
|++|. +||+.||.|||+++|++|||||+|||++.+|. +||+|||+|+.. .....+.||||.|+|||++...+|
T Consensus 146 arFYA---AeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v--~~rT~TlCGTPeYLAPEii~sk~y 218 (355)
T KOG0616|consen 146 ARFYA---AEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRV--SGRTWTLCGTPEYLAPEIIQSKGY 218 (355)
T ss_pred HHHHH---HHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEe--cCcEEEecCCccccChHHhhcCCC
Confidence 45554 55668999999999999999999999999988 999999999854 333567899999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PI 157 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~ 157 (246)
. +++|+|||||++|||+.|.+||.+.+.. ++.+++...+..+|. .+++++++||+++|+.|-.+|. ..
T Consensus 219 n-kavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~KI~~~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~ 291 (355)
T KOG0616|consen 219 N-KAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEKILEGKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGV 291 (355)
T ss_pred C-cchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHHHHhCcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCc
Confidence 5 5599999999999999999999987764 445556666777776 5899999999999999999995 56
Q ss_pred HHHhcCcccccCC
Q 025933 158 PEIKKHPWFLKNL 170 (246)
Q Consensus 158 ~e~l~hp~~~~~~ 170 (246)
.++..||||....
T Consensus 292 ~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 292 EDIKNHPWFKGVD 304 (355)
T ss_pred cccccCccccccc
Confidence 8999999997543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=269.31 Aligned_cols=158 Identities=27% Similarity=0.427 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
.+++..++.||+|||.+||+|||||.+|||+..++. |||+|||+|....... ...+.+|||+|||||++....|..+
T Consensus 372 A~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~K 449 (550)
T KOG0578|consen 372 AAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPK 449 (550)
T ss_pred HHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCcc
Confidence 345667789999999999999999999999998887 9999999998665444 4556789999999999999998766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+||||||+++.||+-|.+||......+.+..+. .++...+.....+|+.+++||.+||+.|+.+|++|.|+|+|||
T Consensus 450 -VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa---~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 450 -VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred -ccchhhhhHHHHHhcCCCCccCCChHHHHHHHh---hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 899999999999999999998755544433332 2344455566689999999999999999999999999999999
Q ss_pred cccCC
Q 025933 166 FLKNL 170 (246)
Q Consensus 166 ~~~~~ 170 (246)
|....
T Consensus 526 l~~a~ 530 (550)
T KOG0578|consen 526 LKMAK 530 (550)
T ss_pred hhhcC
Confidence 95443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=266.78 Aligned_cols=159 Identities=35% Similarity=0.594 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC------CCCCCCCCCCCCCCCcchh
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEV 76 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~------~~~~~~~~~gt~~y~aPE~ 76 (246)
|+.||+= ++.||.|||.+|||||||||.|+|++.++. |||+|||.+-... ........+|||.|+|||.
T Consensus 212 Ar~ylrD---vv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 212 ARKYLRD---VVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred HHHHHHH---HHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 4455544 458999999999999999999999998876 9999999987431 1222344789999999999
Q ss_pred ccc---cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC
Q 025933 77 LAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 153 (246)
Q Consensus 77 ~~~---~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 153 (246)
+.+ ..+.+.+.||||+||+||+|+.|+.||.+. ...++..+|.+....+|..+.+.+.++|||++||.+||.+
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhh
Confidence 987 557788899999999999999999999874 4456667777777788888889999999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 025933 154 RIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 154 R~t~~e~l~hp~~~~~~ 170 (246)
|+++.++..|||.....
T Consensus 363 Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 363 RITLPDIKLHPWVTRDG 379 (576)
T ss_pred eeehhhheecceeccCC
Confidence 99999999999997653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=246.26 Aligned_cols=162 Identities=28% Similarity=0.353 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC-CCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ 84 (246)
+=+++.|++.|++|||++.|+||||||.|+||++++. +||+|||+++.+....... ..+.|.||.|||.+.|...++
T Consensus 103 iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg 180 (318)
T KOG0659|consen 103 IKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYG 180 (318)
T ss_pred HHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcccccceeeeeccChHHhccchhcC
Confidence 3356888999999999999999999999999998887 9999999999665443333 347899999999999877667
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C---------------CC------CCCcCCHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F---------------LP------DYVRVSADCRHL 142 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~---------------~~------~~~~~~~~~~~l 142 (246)
..+||||.|||+.||+.|.+-|.|.++.+++..++........ . .| .++..+.++.||
T Consensus 181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldL 260 (318)
T KOG0659|consen 181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDL 260 (318)
T ss_pred CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHH
Confidence 7799999999999999999999999999998888876532111 0 11 134467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 143 LSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+.+||..||.+|+|+.|+++|+||...
T Consensus 261 l~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 261 LSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHhhhccCchhcccHHHHhcchhhhcC
Confidence 999999999999999999999999763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=260.31 Aligned_cols=155 Identities=32% Similarity=0.457 Sum_probs=121.5
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCC----CCCCCCCCCCCCCCcchhccccccCC
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLL----HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
+.|+++||.|||++|||||||||+|||++. ++. +||+|||+++.... ........||+.|||||++.+.....
T Consensus 123 tr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~ 200 (313)
T KOG0198|consen 123 TRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR 200 (313)
T ss_pred HHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCCCcCC
Confidence 567889999999999999999999999998 466 99999999885442 12234568999999999998643333
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhcc-ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+||||+||++.||++|+.||... ..... .+...... .+.+| ..+|+++++||.+||.+||.+||||+++|.
T Consensus 201 ~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~---~~~ig~~~~~P~ip--~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 201 RESDIWSLGCTVVEMLTGKPPWSEFFEEAEA---LLLIGREDSLPEIP--DSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred ccchhhhcCCEEEeccCCCCcchhhcchHHH---HHHHhccCCCCCCC--cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4599999999999999999999763 22222 22222121 22233 369999999999999999999999999999
Q ss_pred CcccccCCC
Q 025933 163 HPWFLKNLP 171 (246)
Q Consensus 163 hp~~~~~~~ 171 (246)
|||......
T Consensus 276 hpf~~~~~~ 284 (313)
T KOG0198|consen 276 HPFLKQNSI 284 (313)
T ss_pred Chhhhcccc
Confidence 999876544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=253.75 Aligned_cols=164 Identities=26% Similarity=0.321 Sum_probs=133.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.-..+.||+.||.|||+++|+||||||+||||+.++. +||+|||+|+..... ......++|.+|.|||++.+...++
T Consensus 122 ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys 199 (323)
T KOG0594|consen 122 IKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYS 199 (323)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCC
Confidence 3456788899999999999999999999999999776 999999999855433 3345568999999999999885444
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------cCCCC----------CCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------YFLPD----------YVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------~~~~~----------~~~~~~~~~ 140 (246)
..+||||+|||++||+++++-|.+..+.+++..+++.+.... ..++. .+..+++..
T Consensus 200 ~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~ 279 (323)
T KOG0594|consen 200 TSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGI 279 (323)
T ss_pred CCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHH
Confidence 559999999999999999999999998888888877652211 01111 122346899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+|+.+||+.+|.+|.|++.++.||||.....
T Consensus 280 dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 280 ELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 9999999999999999999999999976533
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=268.78 Aligned_cols=153 Identities=34% Similarity=0.569 Sum_probs=132.9
Q ss_pred HHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 11 VMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 11 ~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
+.++.||+|||++||||||||.+|||++..|+ +||+|||+++... ......+.||||.|||||++.+..|+.. +|+
T Consensus 475 Aev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDW 551 (694)
T KOG0694|consen 475 AEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDW 551 (694)
T ss_pred HHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCccccccCChhhcChhhhccCcccch-hhH
Confidence 34778999999999999999999999999988 9999999999766 3445567899999999999999999766 999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHP 164 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp 164 (246)
|||||+||+||.|..||.+.+.. +++..+.+..+..|. .+|.++.++++++|.+||++|.. ++++.+||
T Consensus 552 W~lGVLlyeML~Gq~PF~gddEe----e~FdsI~~d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 552 WGLGVLLYEMLVGESPFPGDDEE----EVFDSIVNDEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 99999999999999999986653 455666777777777 58999999999999999999996 57899999
Q ss_pred ccccCCCh
Q 025933 165 WFLKNLPK 172 (246)
Q Consensus 165 ~~~~~~~~ 172 (246)
||+.-.-.
T Consensus 626 FFr~i~w~ 633 (694)
T KOG0694|consen 626 FFRSIDWD 633 (694)
T ss_pred ccccCCHH
Confidence 99875533
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=251.24 Aligned_cols=159 Identities=29% Similarity=0.439 Sum_probs=133.6
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
+.||+.||.|||+.||+||||||+|+|+|.+. +.+||||||.|+....+....+...|+.|+|||.+.+...++.+.||
T Consensus 131 t~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDi 209 (364)
T KOG0658|consen 131 TYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDI 209 (364)
T ss_pred HHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEE
Confidence 56788999999999999999999999999763 35999999999987777777788899999999999886655555999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------cc---cCCC----------CCCcCCHHHHHHHHHh
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------VQ---YFLP----------DYVRVSADCRHLLSQI 146 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~----------~~---~~~~----------~~~~~~~~~~~li~~~ 146 (246)
||.|||+.||+.|++-|.|.+...++..+++-... .. ..+| .....++++.+|+.++
T Consensus 210 WSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~ 289 (364)
T KOG0658|consen 210 WSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKL 289 (364)
T ss_pred hhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHH
Confidence 99999999999999999998888888877754311 11 0111 1245789999999999
Q ss_pred cccCCCCCCCHHHHhcCcccccC
Q 025933 147 FVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 147 L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
|..+|.+|.++.|++.||||...
T Consensus 290 L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 290 LQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hccChhhcCCHHHHhcchhhHHh
Confidence 99999999999999999999653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=259.51 Aligned_cols=163 Identities=27% Similarity=0.375 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 128 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 205 (364)
T cd07875 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205 (364)
T ss_pred HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCch
Confidence 3456788999999999999999999999999988776 99999999985433333345679999999999988888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------------cccC--------------CC---
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------------VQYF--------------LP--- 130 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------------~~~~--------------~~--- 130 (246)
+|||||||++|+|++|+.||.+.+....+.+++..... .... .+
T Consensus 206 -~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (364)
T cd07875 206 -VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS 284 (364)
T ss_pred -hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccc
Confidence 89999999999999999999876655544444332110 0000 00
Q ss_pred -CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 131 -DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 131 -~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.....+..+++||.+||+.||.+|||+.++|+||||.....
T Consensus 285 ~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 285 EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred cccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 01123568899999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=244.45 Aligned_cols=158 Identities=25% Similarity=0.305 Sum_probs=131.9
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCcch
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
.++|+|.|++|||.+.|+|||||++|+|++..|. +||+|||+|+.+... ...+..+.|.||.|||++.+..-++.++
T Consensus 182 L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~i 259 (419)
T KOG0663|consen 182 LMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAV 259 (419)
T ss_pred HHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcch
Confidence 5789999999999999999999999999998887 999999999965433 3345568999999999999876555669
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------CCC---------CCC--cCCHHHHH
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------FLP---------DYV--RVSADCRH 141 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~~---------~~~--~~~~~~~~ 141 (246)
|+||+|||+.+|+.+++-|.|.+..+++.++++-...... .++ .+. .++....+
T Consensus 260 DMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~ 339 (419)
T KOG0663|consen 260 DMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFD 339 (419)
T ss_pred hhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHH
Confidence 9999999999999999999999998888888865421110 000 011 15588999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
|+..+|.+||.+|.||+++|+|.||..
T Consensus 340 Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 340 LLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred HHHHHhccCccccccHHHhhccccccc
Confidence 999999999999999999999999976
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=257.38 Aligned_cols=160 Identities=30% Similarity=0.522 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC--CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...+.|++.+++|||+.||+||||||+|+|+..... .++|++|||++............+||+.|+|||++.+..|..
T Consensus 138 ~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~ 217 (382)
T KOG0032|consen 138 AGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGD 217 (382)
T ss_pred HHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCc
Confidence 456788999999999999999999999999976532 469999999998766555667789999999999999888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
. +||||+||++|.|++|.+||.+......+.++... ...+..+.|..++..+++||++||..||.+|+|+.++|+||
T Consensus 218 ~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 218 E-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred c-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 5 89999999999999999999987776665543322 23445577888999999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
|+...
T Consensus 295 Wi~~~ 299 (382)
T KOG0032|consen 295 WIKSI 299 (382)
T ss_pred cccCC
Confidence 99764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=263.25 Aligned_cols=159 Identities=27% Similarity=0.419 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-ccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 86 (246)
.++.|++.||+|||+++|+||||||+|||++.++. .+||+|||+++.........+.+||+.|+|||++.+. .++ .+
T Consensus 174 ~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~ 251 (440)
T PTZ00036 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYT-TH 251 (440)
T ss_pred HHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCC-cH
Confidence 45668999999999999999999999999986542 4999999999865444444556799999999998765 455 44
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------ccCCCC----------CCcCCHHHHHHH
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------QYFLPD----------YVRVSADCRHLL 143 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~li 143 (246)
+||||+||++|+|++|.+||.+......+.+++...... ...+|. ....+.++++||
T Consensus 252 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li 331 (440)
T PTZ00036 252 IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFI 331 (440)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHH
Confidence 999999999999999999998877666655554322110 000111 124678999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccc
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
.+||.+||.+|+|+.++++||||..
T Consensus 332 ~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 332 SQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHCCCChhHCcCHHHHhCChhHHh
Confidence 9999999999999999999999964
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=254.57 Aligned_cols=162 Identities=27% Similarity=0.399 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
...+.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 126 ~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~- 202 (359)
T cd07876 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN- 202 (359)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc-
Confidence 346789999999999999999999999999988776 99999999975433333445679999999999998888766
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh------------------ccccCC--------------C----
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR------------------NVQYFL--------------P---- 130 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~------------------~~~~~~--------------~---- 130 (246)
+|||||||++|+|++|..||.+.+....+........ ...... +
T Consensus 203 ~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
T cd07876 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESE 282 (359)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccc
Confidence 8999999999999999999987655433332222110 000000 0
Q ss_pred CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 131 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.....+..+++||.+||..||.+|||+.|+++||||.....
T Consensus 283 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 283 RDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred cccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 01124678999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=253.67 Aligned_cols=163 Identities=26% Similarity=0.361 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.+
T Consensus 121 ~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 198 (355)
T cd07874 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198 (355)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCch
Confidence 3456788999999999999999999999999988776 99999999985443333445679999999999988888766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------------ccc-----C---------CC---
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------------VQY-----F---------LP--- 130 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------------~~~-----~---------~~--- 130 (246)
+|||||||++|+|++|+.||.+......+...+..... ... . .+
T Consensus 199 -~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (355)
T cd07874 199 -VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 277 (355)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccc
Confidence 89999999999999999999876544433333222100 000 0 00
Q ss_pred -CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 131 -DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 131 -~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.....+..+++||.+||..||.+|||+.|+++||||.....
T Consensus 278 ~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 278 EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred ccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 01124578899999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.82 Aligned_cols=160 Identities=25% Similarity=0.394 Sum_probs=128.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||++.............||+.|+|||++.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05631 104 AIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcc
Confidence 3456778999999999999999999999999987776 99999999975433333345679999999999998888766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
+||||+||++|+|++|+.||.+.............+..... .....++.++.+||++||..||.+|++ ++++
T Consensus 182 -~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 258 (285)
T cd05631 182 -PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258 (285)
T ss_pred -cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 89999999999999999999876543333333333333222 223368999999999999999999997 8999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 259 ~~h~~~~~~~ 268 (285)
T cd05631 259 KQHPIFKNIN 268 (285)
T ss_pred hcCHhhcCCC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=248.06 Aligned_cols=159 Identities=27% Similarity=0.359 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.
T Consensus 111 ~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 188 (290)
T cd07862 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 188 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCCcccccccccccccChHHHhCCCCCC
Confidence 34567889999999999999999999999999988776 9999999997544333334557999999999998877766
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCC--------------------CCCcCCHHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP--------------------DYVRVSADCRHLL 143 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~li 143 (246)
+ +||||+||++|+|++|.+||.+..+...+.+++........ .++ ..+.++..+++|+
T Consensus 189 ~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 267 (290)
T cd07862 189 P-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267 (290)
T ss_pred c-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHH
Confidence 5 89999999999999999999987766665555443210000 000 0134788899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+||+.||++|||+.++++||||
T Consensus 268 ~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 268 LKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHhccCchhcCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=254.74 Aligned_cols=157 Identities=32% Similarity=0.604 Sum_probs=139.3
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
+..||.||+ .|+.|||+..+|||||||+||.+-... +-|||.|||++..+.......+.||+..|.|||++.+..|
T Consensus 120 a~kYF~QI~---~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsY 195 (864)
T KOG4717|consen 120 AKKYFAQIV---HAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSY 195 (864)
T ss_pred HHHHHHHHH---HHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCcchhhcccchhhccCchhhhcCcc
Confidence 567886665 788899999999999999999775432 3499999999998888888899999999999999999999
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+..++||||||||||-|+||++||...++.+++ ..+...+|..|. .++.+|++||..||+.||++|.+.++|..
T Consensus 196 DAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----TmImDCKYtvPs--hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 196 DAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----TMIMDCKYTVPS--HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CCcchhhhHHHHHHHHHHhCCCccccccchhhh----hhhhcccccCch--hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 999999999999999999999999988886554 445677888887 79999999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
|+|++..
T Consensus 270 ~~Wlq~~ 276 (864)
T KOG4717|consen 270 TSWLQAG 276 (864)
T ss_pred cccccCC
Confidence 9999653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.10 Aligned_cols=154 Identities=29% Similarity=0.554 Sum_probs=131.7
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC-CCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
.+..|++.||+|||+++|+|||+||.|||+..++. +|+||||+++....+... ++.-|||.|||||++.++.|+..
T Consensus 104 ~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~- 180 (808)
T KOG0597|consen 104 AIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHT- 180 (808)
T ss_pred HHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccch-
Confidence 45778899999999999999999999999998877 999999999965544433 33469999999999999999877
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+|+||+|||+||+..|++||.. +.+.+.++.|.......|. ..+..++.||..+|.+||.+|+|+.+++.|||+
T Consensus 181 sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 181 SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 8999999999999999999975 4455666666655544444 799999999999999999999999999999998
Q ss_pred ccCC
Q 025933 167 LKNL 170 (246)
Q Consensus 167 ~~~~ 170 (246)
.+..
T Consensus 255 k~~~ 258 (808)
T KOG0597|consen 255 KGKI 258 (808)
T ss_pred hhhh
Confidence 7643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=253.96 Aligned_cols=159 Identities=25% Similarity=0.370 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 81 (246)
.||+ .||+.||.|||.+||+|||||..||||+.++. +||+|||||+.+.... ..++.+.|.||.|||++.|..
T Consensus 221 Kc~m---kQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t 295 (560)
T KOG0600|consen 221 KCYM---KQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT 295 (560)
T ss_pred HHHH---HHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCCcccccceEEeeccChHHhcCCc
Confidence 4555 45669999999999999999999999999887 9999999999544333 466778999999999999987
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc------CCCC-----------------CCcCCHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------FLPD-----------------YVRVSAD 138 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~-----------------~~~~~~~ 138 (246)
-++.++|+||.||||.||+.|++.|.+..+.+++.+++.-...... .+|. +..++..
T Consensus 296 ~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~ 375 (560)
T KOG0600|consen 296 SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPAS 375 (560)
T ss_pred ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHH
Confidence 6677799999999999999999999999999998888865422110 1111 2347889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
+.+|+..||..||.+|.||.++|.|+||.
T Consensus 376 ~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 376 ALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHHHHHHHhccCccccccHHHHhcCcccc
Confidence 99999999999999999999999999993
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=245.10 Aligned_cols=159 Identities=24% Similarity=0.366 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+....+
T Consensus 105 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccccCceecccccChHHhcCCcccC
Confidence 3456778999999999999999999999999988776 999999998743222 1223457899999999987644334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCCCC---------CCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFLPD---------YVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~ 140 (246)
.++||||+||++|+|++|+.||.+....+.+..+....... ....|. ...++.+++
T Consensus 183 ~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (288)
T cd07871 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGI 262 (288)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHH
Confidence 45999999999999999999998766544443333221100 000111 134688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||++||+.||.+|||++|+++||||
T Consensus 263 dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 263 DLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=250.38 Aligned_cols=155 Identities=32% Similarity=0.536 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 98 ~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (323)
T cd05571 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175 (323)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCcc
Confidence 345678999999999999999999999999988776 99999999875322 222344579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+||||+||++|+|++|..||.+..... ....+......+| ..++.++++||++||..||.+|| ++.++
T Consensus 176 -~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 176 -VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred -ccCcccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 899999999999999999997654322 2233333333333 36899999999999999999999 89999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 249 l~h~~f~~~~ 258 (323)
T cd05571 249 MEHRFFASIN 258 (323)
T ss_pred HcCCCcCCCC
Confidence 9999997754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=246.83 Aligned_cols=164 Identities=30% Similarity=0.423 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----C-CCCCCCCCCCCcchhcc-c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----Q-PKSTVGTPAYIAPEVLA-R 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~-~~~~~gt~~y~aPE~~~-~ 79 (246)
+..++.++|+||.|||.+|-||||||+.||||+.+|. |||+|||++....... . .++.+||++|||||++. +
T Consensus 128 Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~ 205 (516)
T KOG0582|consen 128 IATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ 205 (516)
T ss_pred HHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhc
Confidence 4456778899999999999999999999999999988 9999999875332221 1 15568999999999953 3
Q ss_pred -cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------CCCCCCcCCHHHHHHHHHhcccCC
Q 025933 80 -KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------FLPDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 80 -~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp 151 (246)
.+|+.+ +||||||++..||.+|..||......+.+...++ +..+ .......++..++.+|..||++||
T Consensus 206 ~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq---n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 206 LHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ---NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred ccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 456655 8999999999999999999988776555443332 2221 111234577899999999999999
Q ss_pred CCCCCHHHHhcCcccccCCChHHH
Q 025933 152 SKRIPIPEIKKHPWFLKNLPKEII 175 (246)
Q Consensus 152 ~~R~t~~e~l~hp~~~~~~~~~~~ 175 (246)
.+|||++++|+|+||.+....+..
T Consensus 282 ~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 282 SKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred ccCCCHHHHhccHHHhhccchhhc
Confidence 999999999999999876655433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=242.30 Aligned_cols=159 Identities=30% Similarity=0.501 Sum_probs=130.7
Q ss_pred cHHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC------------------------
Q 025933 2 ISVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL------------------------ 57 (246)
Q Consensus 2 i~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~------------------------ 57 (246)
+|++|... ++.||.|||..|||+|||||+||||..+|+ |-|+||.|+....
T Consensus 180 ~aRFYaAE---vl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~ 254 (459)
T KOG0610|consen 180 AARFYAAE---VLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQ 254 (459)
T ss_pred hHHHHHHH---HHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCccccccc
Confidence 35666644 558899999999999999999999999888 9999999853110
Q ss_pred ----------C-C----------------------CCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCC
Q 025933 58 ----------L-H----------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY 104 (246)
Q Consensus 58 ----------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 104 (246)
. . ....+++||-.|+|||++.|.+.. .++|+|+|||++|||+.|..
T Consensus 255 ~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-sAVDWWtfGIflYEmLyG~T 333 (459)
T KOG0610|consen 255 PSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-SAVDWWTFGIFLYEMLYGTT 333 (459)
T ss_pred ccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-chhhHHHHHHHHHHHHhCCC
Confidence 0 0 011245799999999999988875 55999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccccCC
Q 025933 105 PFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP----IPEIKKHPWFLKNL 170 (246)
Q Consensus 105 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~hp~~~~~~ 170 (246)
||.+.+..+++.++ ......+|..+.++..++|||+++|.+||++|+. |.||.+||||.+..
T Consensus 334 PFKG~~~~~Tl~NI----v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 334 PFKGSNNKETLRNI----VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred CcCCCCchhhHHHH----hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 99998886666554 4555667777789999999999999999999998 99999999997643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=242.94 Aligned_cols=161 Identities=21% Similarity=0.306 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+......
T Consensus 106 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (303)
T cd07869 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183 (303)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCc
Confidence 456779999999999999999999999999988776 99999999874322 122234578999999999876543345
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHHhccc-----------cC--------CCC-------CCcCCHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-RKTIDRIRNVQ-----------YF--------LPD-------YVRVSAD 138 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~~~~~~~~~~~-----------~~--------~~~-------~~~~~~~ 138 (246)
++||||+||++|+|++|..||.+..+.... ..+........ .. .+. ....+..
T Consensus 184 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (303)
T cd07869 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH 263 (303)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChH
Confidence 589999999999999999999876553322 22211110000 00 000 0124578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+++||.+||+.||.+|||+.++++||||...
T Consensus 264 ~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 264 AEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.11 Aligned_cols=158 Identities=26% Similarity=0.333 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||..|+|||++.+..++.+
T Consensus 110 ~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (288)
T cd07863 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP 187 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcccCCCccccccccCchHhhCCCCCCc
Confidence 4556788999999999999999999999999988776 99999999975443333345578999999999988877665
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---c----cC-----C---------CCCCcCCHHHHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---Q----YF-----L---------PDYVRVSADCRHLLS 144 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---~----~~-----~---------~~~~~~~~~~~~li~ 144 (246)
+||||+||++|+|++|.+||.+......+.++....... . .. . ...+.++..+++||.
T Consensus 188 -~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (288)
T cd07863 188 -VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLL 266 (288)
T ss_pred -chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHH
Confidence 899999999999999999998766655555544322100 0 00 0 011346788999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 025933 145 QIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 145 ~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||++||.+|||+.+++.||||
T Consensus 267 ~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 267 EMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=259.76 Aligned_cols=163 Identities=23% Similarity=0.353 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCC--------------CcEEEeccCCccCCCCCCCCCCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQ--------------PRLKICDFGYSKSGLLHSQPKSTVGTPA 70 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~--------------~~vkl~Dfg~s~~~~~~~~~~~~~gt~~ 70 (246)
...++.|++.||.|||. .|||||||||+|||++.++. ..+||+|||++... .......+||+.
T Consensus 233 ~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~ 310 (467)
T PTZ00284 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRH 310 (467)
T ss_pred HHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCcc
Confidence 34567899999999998 59999999999999976542 24999999988632 223345689999
Q ss_pred CCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------------ccCCC
Q 025933 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------------QYFLP 130 (246)
Q Consensus 71 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------~~~~~ 130 (246)
|+|||++.+..|+.+ +|||||||++|+|++|++||.+....+.+..+....... ....+
T Consensus 311 Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 389 (467)
T PTZ00284 311 YRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389 (467)
T ss_pred ccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccc
Confidence 999999998888755 899999999999999999998766543332221110000 00000
Q ss_pred C----------------CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 131 D----------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 131 ~----------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
. ....++.+.+||.+||++||.+|||++|+|+||||.+...
T Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 390 CTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred cCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0 0012456789999999999999999999999999976443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=247.61 Aligned_cols=153 Identities=25% Similarity=0.349 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCcch
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
++..++.|+.|+|.++.+|||||+.|||+...+. |||+|||++....... ...+++|||.|||||++.+..|+.+ +
T Consensus 116 ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-A 192 (467)
T KOG0201|consen 116 ILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTK-A 192 (467)
T ss_pred ehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccccccccccccchhhhccccccch-h
Confidence 4667889999999999999999999999988866 9999999987543332 3367899999999999998899887 8
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
||||||++.+||++|.+||......+.+.- +.+..+ ......+|+.+++|+..||.+||+.||+|.++|+|+|++
T Consensus 193 DIWSLGITaiEla~GePP~s~~hPmrvlfl----Ipk~~P-P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk 267 (467)
T KOG0201|consen 193 DIWSLGITAIELAKGEPPHSKLHPMRVLFL----IPKSAP-PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIK 267 (467)
T ss_pred hhhhhhHHHHHHhcCCCCCcccCcceEEEe----ccCCCC-CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence 999999999999999999987655322111 111111 111236899999999999999999999999999999997
Q ss_pred cC
Q 025933 168 KN 169 (246)
Q Consensus 168 ~~ 169 (246)
..
T Consensus 268 ~a 269 (467)
T KOG0201|consen 268 RA 269 (467)
T ss_pred hc
Confidence 63
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=248.19 Aligned_cols=160 Identities=32% Similarity=0.463 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+....
T Consensus 107 ~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 184 (332)
T cd05614 107 VRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184 (332)
T ss_pred HHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCC
Confidence 3455678999999999999999999999999988776 9999999987532222 22345799999999999875533
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIP 158 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ 158 (246)
+.++|||||||++|+|++|..||...........+...+.......+ ..++..+++||.+||..||++|+ +++
T Consensus 185 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 262 (332)
T cd05614 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262 (332)
T ss_pred CCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHH
Confidence 44589999999999999999999754433233333333333333333 36899999999999999999999 788
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 263 ~~l~h~~~~~~ 273 (332)
T cd05614 263 EIKEHPFFKGL 273 (332)
T ss_pred HHHcCCCcCCC
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=242.42 Aligned_cols=151 Identities=31% Similarity=0.540 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++... ......+||+.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~- 178 (291)
T cd05612 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKA- 178 (291)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhcc--CCcccccCChhhcCHHHHcCCCCCch-
Confidence 456788999999999999999999999999987766 9999999987532 22334579999999999988877655
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHh
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIK 161 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l 161 (246)
+|||||||++|+|++|..||.+......+ ..+......+|. .++..+++||++||+.||.+|++ +++++
T Consensus 179 ~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 179 VDWWALGILIYEMLVGYPPFFDDNPFGIY----EKILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 89999999999999999999875543332 333333333333 57899999999999999999995 99999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 253 ~h~~~~~ 259 (291)
T cd05612 253 NHRWFKS 259 (291)
T ss_pred cCccccC
Confidence 9999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=244.92 Aligned_cols=156 Identities=31% Similarity=0.534 Sum_probs=130.0
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CC---CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQ---PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~---~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
+.||+.||++||+++||||||||+||||+.. .. ..+||+|||+|+.........+.||+|.|||||++....|+.+
T Consensus 115 m~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAK 194 (429)
T KOG0595|consen 115 MQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAK 194 (429)
T ss_pred HHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccch
Confidence 6788999999999999999999999999765 22 5699999999998776666678899999999999999999988
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+|+||+|+|+|++++|+.||...+..+. +..+.......|. ...++..+.+|+..+|.++|..|.++.+.+.|+
T Consensus 195 -ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL----~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 195 -ADLWSIGTILYQCLTGKPPFDAETPKEL----LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred -hhHHHHHHHHHHHHhCCCCccccCHHHH----HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 8999999999999999999987554333 3334433333332 224678889999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
+...+.
T Consensus 270 ~l~~~p 275 (429)
T KOG0595|consen 270 FLAANP 275 (429)
T ss_pred hcccCc
Confidence 986654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=227.94 Aligned_cols=149 Identities=34% Similarity=0.616 Sum_probs=130.4
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
+.|++.|+.|||.++||||||||+|+|++..+. +||+|||.+.... .....+.|||..|.+||...+..++.+ +|+
T Consensus 130 i~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~ 205 (281)
T KOG0580|consen 130 IKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDL 205 (281)
T ss_pred HHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccch-hhH
Confidence 445668889999999999999999999988877 9999999998644 555678899999999999999998866 899
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
|++|++.|+++.|.+||.+... .+..+++.+....+|. .++.+++|||.+||.++|.+|++..+++.|||+..
T Consensus 206 w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p~--~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFPS--TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCCc--ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999987554 4455566677777774 79999999999999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=244.20 Aligned_cols=154 Identities=32% Similarity=0.527 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 96 ~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 173 (312)
T cd05585 96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173 (312)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCc
Confidence 446778999999999999999999999999988776 999999998743222 22334579999999999988888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC---CHHHHhc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKK 162 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~ 162 (246)
+||||+||++|+|++|..||.+..... ....+......+| ..+++.+++||.+||..||.+|| ++.+++.
T Consensus 174 -~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 174 -VDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEPLRFP--DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -cceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCCCC--CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 899999999999999999998754433 2333333333333 36899999999999999999997 5799999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 247 hp~~~~~ 253 (312)
T cd05585 247 HPFFSQL 253 (312)
T ss_pred CCCcCCC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=245.77 Aligned_cols=155 Identities=35% Similarity=0.577 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 97 ~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (328)
T cd05593 97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174 (328)
T ss_pred HHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCc
Confidence 3456788999999999999999999999999988776 99999999875322 22233457999999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|||||||++|+|++|..||.+..... ....+......+| ..++.++.+||++||.+||.+|+ ++.+
T Consensus 175 ~-~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 175 A-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFP--RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred c-CCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 5 899999999999999999997654332 2223333333333 36899999999999999999997 8999
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 248 il~h~~~~~~ 257 (328)
T cd05593 248 IMRHSFFTGV 257 (328)
T ss_pred HhcCCCcCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=237.58 Aligned_cols=158 Identities=25% Similarity=0.340 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......||+.|+|||++.+..++
T Consensus 102 ~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccccccccccccCCcHHHcCCCCC
Confidence 3456788999999999999999999999999987776 9999999997543221 22345699999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------c---ccCCCC-----------CCcCCH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------V---QYFLPD-----------YVRVSA 137 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------~---~~~~~~-----------~~~~~~ 137 (246)
.+ +|+||+||++|+|++|++||.+.........+...... . ....+. ...+|.
T Consensus 180 ~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 258 (287)
T cd07848 180 KA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSG 258 (287)
T ss_pred Cc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCH
Confidence 55 89999999999999999999876544333222111000 0 000011 123688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+++||++||++||.+|||++++++||||
T Consensus 259 ~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 259 VLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.92 Aligned_cols=151 Identities=30% Similarity=0.516 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcch
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++... ....+.+||+.|+|||++.+..++.+ +
T Consensus 122 ~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~ 196 (329)
T PTZ00263 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGKA-V 196 (329)
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcC--CCcceecCChhhcCHHHHcCCCCCCc-c
Confidence 34678899999999999999999999999988776 9999999997432 22344679999999999988877655 8
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKK 162 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~ 162 (246)
|||||||++|+|++|..||.+....+. ...+......+|. .++..+++||++||..||.+|++ +++++.
T Consensus 197 DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 197 DWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred eeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999999999999987554333 3333344433343 58899999999999999999997 799999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 271 hp~f~~~ 277 (329)
T PTZ00263 271 HPYFHGA 277 (329)
T ss_pred CCccCCC
Confidence 9999764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=244.45 Aligned_cols=154 Identities=33% Similarity=0.535 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (320)
T cd05590 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176 (320)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCc
Confidence 345778999999999999999999999999988776 999999998743222 22334579999999999988777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH------HH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI------PE 159 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e 159 (246)
+||||+||++|+|++|+.||.+...... ...+.......|. .++.++++||++||++||.+|+++ ++
T Consensus 177 -~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 249 (320)
T cd05590 177 -VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249 (320)
T ss_pred -cchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHH
Confidence 8999999999999999999987554332 3333333333333 589999999999999999999998 99
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 250 ~~~h~~f~~~ 259 (320)
T cd05590 250 ILRHPFFKEL 259 (320)
T ss_pred HHcCCCcCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=233.24 Aligned_cols=199 Identities=24% Similarity=0.349 Sum_probs=151.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
=++.+|.+-|++++|+.||+||||||+||++..++. +||+|||+++.....-..+..+.|..|.|||++.+..|...
T Consensus 121 s~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~- 197 (369)
T KOG0665|consen 121 SYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN- 197 (369)
T ss_pred HHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCcccccCchhheeeccCchheeccCCccc-
Confidence 356788889999999999999999999999988776 99999999986544445566789999999999998888766
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------------------CCCC--------
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------------------FLPD-------- 131 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~-------- 131 (246)
+||||+||++.+|++|+.-|.|....+++.++.+....... .+|+
T Consensus 198 vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e 277 (369)
T KOG0665|consen 198 VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLE 277 (369)
T ss_pred chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccccc
Confidence 89999999999999999999887766666666554311110 0111
Q ss_pred -CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHhcCCC
Q 025933 132 -YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPG 208 (246)
Q Consensus 132 -~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (246)
.+.-+..+++|+.+||..||++|.+++++|+|||++-++.....+...........+....+.+|+.+.+.+.-+.-
T Consensus 278 ~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f 355 (369)
T KOG0665|consen 278 GSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRF 355 (369)
T ss_pred CCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhh
Confidence 01124568999999999999999999999999999855554444433333333444555666888888877654443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=251.02 Aligned_cols=148 Identities=34% Similarity=0.494 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEec-CCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~-~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
-.|++||+.|+.|||.+|||||||||+|||++ +.++ ++|+|||.++.... ...+.+-|..|.|||++....|+..
T Consensus 418 ~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~--~~~tp~~t~~y~APEvl~~~~yt~a 493 (612)
T KOG0603|consen 418 SQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELER--SCDTPALTLQYVAPEVLAIQEYTEA 493 (612)
T ss_pred HHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCch--hhcccchhhcccChhhhccCCCCcc
Confidence 35888999999999999999999999999995 5555 99999999985332 2445577899999999998888766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+||||||++||+||+|+.||...... .++..++....+. ..+|..+++||.+||+.||.+|+++.+++.|||
T Consensus 494 -cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 494 -CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 99999999999999999999877665 3344444433332 479999999999999999999999999999999
Q ss_pred c
Q 025933 166 F 166 (246)
Q Consensus 166 ~ 166 (246)
|
T Consensus 566 ~ 566 (612)
T KOG0603|consen 566 F 566 (612)
T ss_pred h
Confidence 9
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=243.73 Aligned_cols=161 Identities=25% Similarity=0.358 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhccc--
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLAR-- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~-- 79 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+
T Consensus 105 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 182 (338)
T cd07859 105 HQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182 (338)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc
Confidence 3456789999999999999999999999999988776 9999999987432211 1134579999999999865
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-----------------------HHhcccc--CCCCCCc
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-----------------------RIRNVQY--FLPDYVR 134 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~-----------------------~~~~~~~--~~~~~~~ 134 (246)
..++.+ +|||||||++|+|++|++||.+......+..+.. .+..... ....++.
T Consensus 183 ~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
T cd07859 183 SKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPN 261 (338)
T ss_pred cccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCC
Confidence 455544 8999999999999999999976554322211110 0000000 0012335
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 135 ~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+++.+.+||.+||..||.+|||++++++||||...
T Consensus 262 ~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 262 ADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 78899999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=244.33 Aligned_cols=161 Identities=23% Similarity=0.338 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++... ......+||+.|+|||++.+....+.
T Consensus 120 ~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~ 195 (343)
T cd07878 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC--CCcCCccccccccCchHhcCCccCCc
Confidence 3456789999999999999999999999999988776 9999999998532 23345679999999999977433344
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------------ccCCC------CCCcCCHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------------QYFLP------DYVRVSADCR 140 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~------~~~~~~~~~~ 140 (246)
++|||||||++|+|++|..||.+......+..+....... ....+ .+...++.+.
T Consensus 196 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07878 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAI 275 (343)
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHH
Confidence 5999999999999999999998755444333332211000 00001 0123567889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+||.+||..||.+|||+.+++.||||....
T Consensus 276 ~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 276 DLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=242.45 Aligned_cols=160 Identities=26% Similarity=0.358 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC--CCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhcccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 80 (246)
..++.|++.||.|||+++|+||||||+|||+... ..+.+||+|||+++..... ......+||+.|+|||++.+.
T Consensus 111 ~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred HHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 4567889999999999999999999999999432 2235999999999753221 122345789999999999875
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHh------------------------cccc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIR------------------------NVQY 127 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------~~~~~~~~~~~------------------------~~~~ 127 (246)
...+.++||||+||++|+|++|.+||.+.... ..+..++.... ....
T Consensus 191 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (317)
T cd07868 191 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 270 (317)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhcccc
Confidence 54345599999999999999999999654321 11111111000 0000
Q ss_pred CC--------CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 128 FL--------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 128 ~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.. ......+..+.+||++||+.||.+|||++|+++||||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 271 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=243.63 Aligned_cols=160 Identities=31% Similarity=0.460 Sum_probs=119.0
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccccC---
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--- 83 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~--- 83 (246)
..|+|.|++++|.+||||.||||.|.|+-. +++||+|||+|....... ...+.+||+.||+||.+....++
T Consensus 466 wkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~ 542 (677)
T KOG0596|consen 466 WKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN 542 (677)
T ss_pred HHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccC
Confidence 445668889999999999999999999854 349999999998543222 23456899999999998643332
Q ss_pred -------CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 84 -------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 84 -------~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
+.++||||||||||+|+.|+.||.. ..+....+..+..... .+|..+. ..++.++++.||..||++|
T Consensus 543 ~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR 618 (677)
T KOG0596|consen 543 GKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---IINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKR 618 (677)
T ss_pred CCcceeecCccchhhhhhHHHHHHhcCCchHH---HHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccC
Confidence 2348999999999999999999964 3333444444444333 3343322 2349999999999999999
Q ss_pred CCHHHHhcCccccc-CCChHHHH
Q 025933 155 IPIPEIKKHPWFLK-NLPKEIIE 176 (246)
Q Consensus 155 ~t~~e~l~hp~~~~-~~~~~~~~ 176 (246)
||+.++|+|||+.- ..+.+...
T Consensus 619 ~si~eLLqhpFl~~~~i~~~~m~ 641 (677)
T KOG0596|consen 619 WSIPELLQHPFLQIQPIPVEQMA 641 (677)
T ss_pred CCcHHHhcCcccccccccchHHH
Confidence 99999999999876 44444443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=250.79 Aligned_cols=162 Identities=25% Similarity=0.319 Sum_probs=129.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.+-..+.||+.+|.+||+.+|||+|||||||||..-....|||+|||.|... .....+.+-++.|+|||++.|.+|+.
T Consensus 290 ~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~--~q~vytYiQSRfYRAPEVILGlpY~~ 367 (586)
T KOG0667|consen 290 LVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE--SQRVYTYIQSRFYRAPEVILGLPYDT 367 (586)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc--CCcceeeeeccccccchhhccCCCCC
Confidence 3445678899999999999999999999999998776678999999998743 23334778999999999999999987
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh------------------c----------------------
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR------------------N---------------------- 124 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~------------------~---------------------- 124 (246)
+ .||||||||++||.+|.+-|.|.+..+++..+++-.. .
T Consensus 368 ~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~ 446 (586)
T KOG0667|consen 368 A-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEV 446 (586)
T ss_pred c-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhh
Confidence 7 8999999999999999999999888777766664330 0
Q ss_pred --------cccCCC-CC-------C-cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 125 --------VQYFLP-DY-------V-RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 125 --------~~~~~~-~~-------~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.....| .. . .....+.+||++||..||.+|+|+.++|+||||...
T Consensus 447 ~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 447 RKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred hhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 000011 00 0 112467999999999999999999999999999743
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=246.06 Aligned_cols=152 Identities=32% Similarity=0.541 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++... ....+.+||+.|+|||++.+..++.+
T Consensus 134 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~- 208 (340)
T PTZ00426 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGKA- 208 (340)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC--CCcceecCChhhcCHHHHhCCCCCcc-
Confidence 456778899999999999999999999999987776 9999999997432 22345679999999999988777655
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHHh
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIK 161 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l 161 (246)
+|+||+||++|+|++|..||.+......+. .+.......|. .++..++++|++||..||.+|+ ++++++
T Consensus 209 ~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQ----KILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred ccccchhhHHHHHhcCCCCCCCCCHHHHHH----HHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 899999999999999999998755433332 33333333343 5789999999999999999996 899999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 283 ~hp~f~~~ 290 (340)
T PTZ00426 283 EHPWFGNI 290 (340)
T ss_pred cCCCcCCC
Confidence 99999753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=226.78 Aligned_cols=154 Identities=29% Similarity=0.501 Sum_probs=124.7
Q ss_pred HHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---cccCCc
Q 025933 10 TVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---KEYDGK 85 (246)
Q Consensus 10 ~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~ 85 (246)
++-++.||.||.+ ++|||||+||+|||++..|+ +||||||++.+.......+...|-+.|||||.+.- ..|+-.
T Consensus 197 tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiR 274 (391)
T KOG0983|consen 197 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIR 274 (391)
T ss_pred HHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccccccCCccccCccccCCCCCCccchh
Confidence 3456789999976 57999999999999999988 99999999987655555455579999999999853 356655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+||||||+.++||.||+.||.+... .+.+.++++ .....+|....+|+.+++|+..||.+|+.+||...++|+||
T Consensus 275 -aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 275 -ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred -hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 8999999999999999999987543 333333332 22344565566999999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
|+...
T Consensus 351 Fi~~y 355 (391)
T KOG0983|consen 351 FIKRY 355 (391)
T ss_pred ceeec
Confidence 98754
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=242.96 Aligned_cols=154 Identities=31% Similarity=0.551 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 181 (324)
T cd05587 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181 (324)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcc
Confidence 445778999999999999999999999999988776 99999999874322 222334579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-----HHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~ 160 (246)
+|+||+||++|+|++|+.||.+......+ ..+.......|. .++.++++|+++||.+||.+|+++ +++
T Consensus 182 -~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (324)
T cd05587 182 -VDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDI 254 (324)
T ss_pred -cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 89999999999999999999875543333 333333333333 689999999999999999999986 899
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 255 ~~hp~~~~~ 263 (324)
T cd05587 255 REHAFFRRI 263 (324)
T ss_pred hcCCCcCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=242.26 Aligned_cols=154 Identities=32% Similarity=0.592 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 100 ~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~- 176 (316)
T cd05620 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS- 176 (316)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcc-
Confidence 45678999999999999999999999999988776 99999999874322 222344579999999999988888755
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-HHHhcCcc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-PEIKKHPW 165 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp~ 165 (246)
+||||+||++|+|++|..||.+..... ....+.......|. .++.++++||++||..||.+|+++ +++++|||
T Consensus 177 ~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 177 VDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 899999999999999999998655432 22333333333333 479999999999999999999998 58999999
Q ss_pred cccCC
Q 025933 166 FLKNL 170 (246)
Q Consensus 166 ~~~~~ 170 (246)
|....
T Consensus 251 f~~~~ 255 (316)
T cd05620 251 FKTIN 255 (316)
T ss_pred cCCCC
Confidence 97653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.29 Aligned_cols=160 Identities=22% Similarity=0.299 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
.+.++.|++.||.|||+++||||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++
T Consensus 184 ~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC
Confidence 4567789999999999999999999999999988776 999999998642211 222345799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHH----------------------hccccC----CC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRI----------------------RNVQYF----LP 130 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~~~~~~----------------------~~~~~~----~~ 130 (246)
.+ +||||+||++|+|++|..||..... ...+..++... ...... .+
T Consensus 262 ~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (391)
T PHA03212 262 PA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340 (391)
T ss_pred cH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCC
Confidence 55 8999999999999999988754321 11111111111 000000 01
Q ss_pred C---CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 131 D---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 131 ~---~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
. ...++.++.+||.+||.+||.+|||++|+|+||||..
T Consensus 341 ~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 341 LWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 1 1135678999999999999999999999999999975
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=242.37 Aligned_cols=156 Identities=32% Similarity=0.568 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.
T Consensus 97 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05595 97 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCc
Confidence 3456678999999999999999999999999988776 999999998753222 2223457999999999998888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|||||||++|+|++|..||.+.+..... ..+......+|. .+++++++||.+||..||.+|+ ++.+
T Consensus 175 ~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 175 A-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred h-hchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 5 89999999999999999999865543332 222233333343 6899999999999999999998 8999
Q ss_pred HhcCcccccCC
Q 025933 160 IKKHPWFLKNL 170 (246)
Q Consensus 160 ~l~hp~~~~~~ 170 (246)
+++||||.+..
T Consensus 248 ~l~h~~~~~~~ 258 (323)
T cd05595 248 VMEHRFFLSIN 258 (323)
T ss_pred HHcCCCcCCCC
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.10 Aligned_cols=159 Identities=29% Similarity=0.412 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..++.
T Consensus 99 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 176 (280)
T cd05608 99 ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCc
Confidence 3456788999999999999999999999999987766 9999999987432221 223457999999999999888875
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|+||+||++|+|++|+.||...............+..... .....++..+.+|+.+||+.||.+|+ ++++
T Consensus 177 ~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (280)
T cd05608 177 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG 253 (280)
T ss_pred c-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 5 89999999999999999999765433222233333322222 22336899999999999999999999 8899
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 254 ~l~h~~~~~~ 263 (280)
T cd05608 254 LRTHPLFRDL 263 (280)
T ss_pred HhcChhhhcC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=228.83 Aligned_cols=142 Identities=31% Similarity=0.455 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHhHh--CC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhcccccc
Q 025933 8 SSTVMIFTSHHCFYL--QE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~--~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...+|++.||..||+ .. |+||||||.||+++.+|. |||+|||+++....... ..+.+|||+||+||++...+|
T Consensus 128 k~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y 205 (375)
T KOG0591|consen 128 KYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGY 205 (375)
T ss_pred HHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCC
Confidence 346788899999999 44 999999999999999887 99999999986544332 245689999999999999999
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-CCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
+.+ +||||+||++|||+.-++||.+. ++..+-.++.+..+. .|. ..+|.++..||..|+..||..||+.
T Consensus 206 ~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 206 NFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred Ccc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-HHhhhHHHHHHHHHccCCcccCCCc
Confidence 877 99999999999999999999984 666677777777653 331 3689999999999999999999983
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.04 Aligned_cols=154 Identities=31% Similarity=0.422 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHHhHhCC-cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcc--
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQE-ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLA-- 78 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~-ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~-- 78 (246)
+...+.+++||+.|+.|||+++ ||||||||+|||++.+. ..+||+|||+++..... ...+...||+.|||||++.
T Consensus 141 ~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~ 219 (362)
T KOG0192|consen 141 LKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE 219 (362)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccccccCCCCCccccChhhhcCC
Confidence 3456889999999999999999 99999999999999876 23999999999854333 3344468999999999999
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
...|+.+ +||||||+++|||++|+.||.+........ .+.......+.+..+++.+..|+.+||..||.+||++.
T Consensus 220 ~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~----~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 220 KSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVAS----AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred CCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence 5688777 899999999999999999998866532222 22222222222335899999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
+++.
T Consensus 295 ei~~ 298 (362)
T KOG0192|consen 295 EIVS 298 (362)
T ss_pred HHHH
Confidence 9865
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=241.58 Aligned_cols=155 Identities=32% Similarity=0.540 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05591 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCccccccccCccccCHHHHcCCCCCCc
Confidence 446778999999999999999999999999988776 999999998743222 22334579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-------CHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-------PIP 158 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------t~~ 158 (246)
+||||+||++|+|++|+.||.+......+ ..+.......|. .++.++.+||++||.+||.+|+ +++
T Consensus 177 -~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~ 249 (321)
T cd05591 177 -VDWWALGVLMYEMMAGQPPFEADNEDDLF----ESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGED 249 (321)
T ss_pred -cceechhHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHH
Confidence 89999999999999999999876543333 333333333343 5789999999999999999999 899
Q ss_pred HHhcCcccccCC
Q 025933 159 EIKKHPWFLKNL 170 (246)
Q Consensus 159 e~l~hp~~~~~~ 170 (246)
++++||||....
T Consensus 250 ~~~~hp~~~~~~ 261 (321)
T cd05591 250 AIKQHPFFKEID 261 (321)
T ss_pred HHhcCCccCCCC
Confidence 999999996643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=244.39 Aligned_cols=158 Identities=29% Similarity=0.438 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------------------------
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------------------- 60 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------------------- 60 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 104 ~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (363)
T cd05628 104 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181 (363)
T ss_pred HHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccccccccccccccccccc
Confidence 445678889999999999999999999999988776 9999999986421100
Q ss_pred ----------CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 025933 61 ----------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130 (246)
Q Consensus 61 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 130 (246)
...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+.++... .....+|
T Consensus 182 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p 258 (363)
T cd05628 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW--KETLIFP 258 (363)
T ss_pred cchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--cCcccCC
Confidence 0123579999999999988888765 89999999999999999999876554444333321 1122334
Q ss_pred CCCcCCHHHHHHHHHhcccCCC---CCCCHHHHhcCcccccCC
Q 025933 131 DYVRVSADCRHLLSQIFVADPS---KRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 131 ~~~~~~~~~~~li~~~L~~dp~---~R~t~~e~l~hp~~~~~~ 170 (246)
....+++++++||.+|+. +|. .||+++++++||||....
T Consensus 259 ~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 259 PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 444689999999999876 444 458999999999997653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.63 Aligned_cols=156 Identities=31% Similarity=0.543 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.
T Consensus 103 ~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 180 (324)
T cd05589 103 AVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180 (324)
T ss_pred HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCc
Confidence 3456788999999999999999999999999988776 99999999874322 22234567999999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|+|||||++|+|++|..||.+......+ ..+.......|. .++..+.+||.+||..||.+|| ++.+
T Consensus 181 ~-~DiwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 181 A-VDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred c-cchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 5 89999999999999999999875543332 333333333343 5899999999999999999999 6999
Q ss_pred HhcCcccccCC
Q 025933 160 IKKHPWFLKNL 170 (246)
Q Consensus 160 ~l~hp~~~~~~ 170 (246)
+++||||....
T Consensus 254 l~~~~~f~~~~ 264 (324)
T cd05589 254 VKKQPFFRDIN 264 (324)
T ss_pred HhhCCCcCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=241.84 Aligned_cols=155 Identities=32% Similarity=0.527 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 103 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 180 (323)
T cd05616 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCC
Confidence 3456788999999999999999999999999988876 99999999874322 22234557999999999999888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-----HH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e 159 (246)
+ +|||||||++|+|++|+.||.+......+ ..+.......|. .++.++++|+.+||++||.+|+++ .+
T Consensus 181 ~-~DiwSlGvil~elltg~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05616 181 S-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERD 253 (323)
T ss_pred c-cchhchhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHH
Confidence 5 89999999999999999999875543333 333333333343 689999999999999999999984 89
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 254 i~~h~~~~~~ 263 (323)
T cd05616 254 IKEHAFFRYI 263 (323)
T ss_pred HhcCCCcCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=240.36 Aligned_cols=155 Identities=33% Similarity=0.510 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 103 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 180 (323)
T cd05584 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180 (323)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCc
Confidence 345678999999999999999999999999988776 999999998743222 22234579999999999988777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|||||||++|+|++|..||.+...... ...+.......| ..+++.+.+||++||.+||.+|+ +++++
T Consensus 181 -~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 181 -VDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred -ceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 8999999999999999999987554332 333333333333 36899999999999999999999 89999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
+.||||....
T Consensus 254 ~~h~~~~~~~ 263 (323)
T cd05584 254 QSHPFFRHVN 263 (323)
T ss_pred hcCCCcCCCC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=238.22 Aligned_cols=153 Identities=31% Similarity=0.588 Sum_probs=133.9
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
+-+|+| |..|++|||+++++|||||.+|||++.+++ +||+|||++..+....-..++||+|.|.+||++.+.+|.
T Consensus 156 RhfFRQ---IvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~ 230 (668)
T KOG0611|consen 156 RHFFRQ---IVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYK 230 (668)
T ss_pred HHHHHH---HHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCC
Confidence 445555 559999999999999999999999999988 999999999876666677889999999999999999999
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+..+|.|||||+||.|+.|..||.+.+. ...+.++....|.-|. -+.++.-||+.||..||.+|.|++++-.|
T Consensus 231 GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 231 GPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 9999999999999999999999988554 4455666677776665 57789999999999999999999999999
Q ss_pred ccccc
Q 025933 164 PWFLK 168 (246)
Q Consensus 164 p~~~~ 168 (246)
-|+.=
T Consensus 304 WWvNw 308 (668)
T KOG0611|consen 304 WWVNW 308 (668)
T ss_pred heeec
Confidence 88743
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=242.16 Aligned_cols=161 Identities=27% Similarity=0.452 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccc----c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLAR----K 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~----~ 80 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||..|+|||++.. .
T Consensus 170 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 247 (353)
T PLN00034 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247 (353)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccccccCccccCccccccccccC
Confidence 3457789999999999999999999999999988776 999999998753222 12244579999999999853 2
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.+.+.++|||||||++|+|++|+.||..... ..+......+... ........++.++++||.+||..||++|||+.|+
T Consensus 248 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el 325 (353)
T PLN00034 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQL 325 (353)
T ss_pred cCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3344458999999999999999999974332 1222222222211 1122234688999999999999999999999999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||.+..
T Consensus 326 l~hp~~~~~~ 335 (353)
T PLN00034 326 LQHPFILRAQ 335 (353)
T ss_pred hcCcccccCC
Confidence 9999998753
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=242.87 Aligned_cols=161 Identities=29% Similarity=0.418 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++||||||||+|||++..+. +||+|||+++............||+.|+|||++.+..++.
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 235 (357)
T PHA03209 158 QALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNS 235 (357)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccccccccccCCeecCCCCCCc
Confidence 44667889999999999999999999999999988776 9999999987433333334557999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCC-CCCCCh---------HHHHHHHHHHhccccCCC------------------------
Q 025933 85 KISDVWSCGVTLYVMLVGAYPF-EDPEDP---------RNFRKTIDRIRNVQYFLP------------------------ 130 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf-~~~~~~---------~~~~~~~~~~~~~~~~~~------------------------ 130 (246)
+ +|||||||++|+|+++..|+ ...... ..+.+++.........++
T Consensus 236 ~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (357)
T PHA03209 236 K-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314 (357)
T ss_pred h-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccc
Confidence 6 89999999999999855444 332111 111111111110000001
Q ss_pred ----CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 131 ----DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 131 ----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
....++.++.+||.+||+.||.+|||+.|+|+||||.+
T Consensus 315 ~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 01246778889999999999999999999999999964
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=244.06 Aligned_cols=155 Identities=32% Similarity=0.556 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 7 FSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 98 ~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05594 98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175 (325)
T ss_pred HHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCC
Confidence 4457889999999997 79999999999999988776 99999999874322 22233457999999999998888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|||||||++|+|++|..||.+...... ...+......+|. .+++++.+||++||+.||.+|+ ++.+
T Consensus 176 ~-~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 248 (325)
T cd05594 176 A-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248 (325)
T ss_pred c-cccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHH
Confidence 5 8999999999999999999976544322 2233333333343 6899999999999999999997 8999
Q ss_pred HhcCcccccCC
Q 025933 160 IKKHPWFLKNL 170 (246)
Q Consensus 160 ~l~hp~~~~~~ 170 (246)
+++||||....
T Consensus 249 il~h~~~~~~~ 259 (325)
T cd05594 249 IMQHKFFAGIV 259 (325)
T ss_pred HhcCCCcCCCC
Confidence 99999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.70 Aligned_cols=162 Identities=25% Similarity=0.323 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......+|+.|+|||++.+....
T Consensus 105 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 182 (372)
T cd07853 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY 182 (372)
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCC
Confidence 4456788999999999999999999999999988776 999999998743222 122334689999999999875533
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-------------------hccccCC-------CCCCcCCH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-------------------RNVQYFL-------PDYVRVSA 137 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~~~-------~~~~~~~~ 137 (246)
..++||||+||++|+|++|+.||.+......+..+.... ....... ......++
T Consensus 183 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (372)
T cd07853 183 TSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262 (372)
T ss_pred CcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCH
Confidence 445899999999999999999998766544433332210 0001111 11234688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
++.+||.+||+.||.+|||+.++++||||...
T Consensus 263 ~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 263 EAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.86 Aligned_cols=158 Identities=30% Similarity=0.493 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 99 ~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (329)
T cd05618 99 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCc
Confidence 456778999999999999999999999999988776 99999999874322 222334579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC----
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPED-----PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---- 156 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---- 156 (246)
+|+|||||++|+|++|..||..... ..........+.......|. .++..+.+||++||..||.+|++
T Consensus 177 -~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~ 253 (329)
T cd05618 177 -VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQ 253 (329)
T ss_pred -cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCC
Confidence 8999999999999999999953111 11111222333333333443 68999999999999999999998
Q ss_pred --HHHHhcCcccccC
Q 025933 157 --IPEIKKHPWFLKN 169 (246)
Q Consensus 157 --~~e~l~hp~~~~~ 169 (246)
+.++++||||...
T Consensus 254 ~~~~~i~~hp~f~~~ 268 (329)
T cd05618 254 TGFADIQGHPFFRNV 268 (329)
T ss_pred CCHHHHhcCCCCCCC
Confidence 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=243.97 Aligned_cols=157 Identities=34% Similarity=0.503 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------------------------
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------------------- 60 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------------------- 60 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 104 ~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (350)
T cd05573 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181 (350)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccc
Confidence 456789999999999999999999999999988776 9999999987433222
Q ss_pred ----CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCC
Q 025933 61 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136 (246)
Q Consensus 61 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (246)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........++.... .....|....++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~ 258 (350)
T cd05573 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK--ESLRFPPDPPVS 258 (350)
T ss_pred cccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccC--CcccCCCCCCCC
Confidence 1234569999999999988887665 899999999999999999998766544433333211 223345545579
Q ss_pred HHHHHHHHHhcccCCCCCCC-HHHHhcCcccccC
Q 025933 137 ADCRHLLSQIFVADPSKRIP-IPEIKKHPWFLKN 169 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t-~~e~l~hp~~~~~ 169 (246)
+++++||.+||. ||.+|++ ++++++||||...
T Consensus 259 ~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 259 PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=239.66 Aligned_cols=154 Identities=31% Similarity=0.454 Sum_probs=132.0
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
.++|+-||..||+.+||+|||||+|||+|+.|+ |.|+|+|+|............+||.+|||||++.+..|+.. +|+
T Consensus 293 AAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dw 369 (591)
T KOG0986|consen 293 AAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFS-PDW 369 (591)
T ss_pred HHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCC-ccH
Confidence 346778999999999999999999999999888 99999999997777777777899999999999999998766 899
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHP 164 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp 164 (246)
|||||++|+|+.|+.||..........++-+.+.......++ ++|+++++|.+.+|.+||.+|.. +.++.+||
T Consensus 370 f~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 370 FSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred HHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 999999999999999998766544444555555554444453 79999999999999999999984 67999999
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
||+.
T Consensus 448 fFk~ 451 (591)
T KOG0986|consen 448 FFKD 451 (591)
T ss_pred cccc
Confidence 9976
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.25 Aligned_cols=158 Identities=30% Similarity=0.484 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (329)
T cd05588 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCc
Confidence 456778899999999999999999999999988776 99999999874322 222344579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC----
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---- 156 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---- 156 (246)
+|+||+||++|+|++|+.||...... .......+.+.......|. .++..+.+||++||+.||.+|+|
T Consensus 177 -~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~ 253 (329)
T cd05588 177 -VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQ 253 (329)
T ss_pred -cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 89999999999999999999632111 1111122333333333443 68999999999999999999997
Q ss_pred --HHHHhcCcccccC
Q 025933 157 --IPEIKKHPWFLKN 169 (246)
Q Consensus 157 --~~e~l~hp~~~~~ 169 (246)
++++++||||...
T Consensus 254 ~~~~~i~~hp~~~~~ 268 (329)
T cd05588 254 TGFRDIKSHPFFRNI 268 (329)
T ss_pred CCHHHHhcCCCCCCC
Confidence 7899999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=239.04 Aligned_cols=154 Identities=36% Similarity=0.629 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05592 99 RFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176 (316)
T ss_pred HHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCc
Confidence 345778999999999999999999999999988776 999999999743222 22334579999999999988887755
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-HHHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-PEIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp 164 (246)
+||||+||++|+|++|..||.+......+ ..+.......|. .++.++.+||.+||..||.+|+++ .+++.||
T Consensus 177 -~DvwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05592 177 -VDWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRLGVDGDIRQHP 249 (316)
T ss_pred -ccchhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence 89999999999999999999875543322 233333333333 588999999999999999999986 5888999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
||...
T Consensus 250 ~~~~~ 254 (316)
T cd05592 250 FFRGI 254 (316)
T ss_pred ccCCC
Confidence 99764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=244.13 Aligned_cols=157 Identities=29% Similarity=0.455 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+......
T Consensus 99 ~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (330)
T cd05586 99 KFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176 (330)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCC
Confidence 446778999999999999999999999999988776 99999999874322 222345679999999999876543344
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC----CHHHHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI----PIPEIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l 161 (246)
++||||+||++|+|++|..||.+..... ....+......++. ..++.++++||++||..||.+|| ++.+++
T Consensus 177 ~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll 251 (330)
T cd05586 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK 251 (330)
T ss_pred ccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHh
Confidence 5899999999999999999998754432 23333333333343 24789999999999999999998 789999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||....
T Consensus 252 ~h~~~~~~~ 260 (330)
T cd05586 252 EHPFFADID 260 (330)
T ss_pred cCccccCCC
Confidence 999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=245.11 Aligned_cols=157 Identities=34% Similarity=0.538 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc---c
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE---Y 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~ 82 (246)
.++.|++.||+|||+++|+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+.. .
T Consensus 146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 223 (370)
T cd05596 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223 (370)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCC
Confidence 35678999999999999999999999999988776 9999999987533221 223457999999999986532 2
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC--CCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~ 160 (246)
.+.++|+|||||++|+|++|..||.+......+.++... ......|....+|.++++||++||..+|.+ |+|++++
T Consensus 224 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 234489999999999999999999876654444333321 112334555568999999999999999988 9999999
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
++||||..
T Consensus 302 l~h~~~~~ 309 (370)
T cd05596 302 KSHPFFKN 309 (370)
T ss_pred hcCcccCC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=239.24 Aligned_cols=155 Identities=34% Similarity=0.566 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.
T Consensus 98 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 175 (318)
T cd05570 98 ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175 (318)
T ss_pred HHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCc
Confidence 3456788999999999999999999999999988776 999999998743222 2223457999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-----HH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e 159 (246)
+ +|+||+||++|+|++|..||.+...... ...+.......|. .++..+++||++||..||.+|||+ .+
T Consensus 176 ~-~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ 248 (318)
T cd05570 176 A-VDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248 (318)
T ss_pred c-hhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 5 8999999999999999999976554322 2233333333343 589999999999999999999999 99
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
++.||||...
T Consensus 249 ll~~~~~~~~ 258 (318)
T cd05570 249 IKGHPFFREI 258 (318)
T ss_pred HhcCCCcCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=236.77 Aligned_cols=161 Identities=22% Similarity=0.316 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+......
T Consensus 107 ~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 184 (309)
T cd07872 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184 (309)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccccccccccccccCCHHHhCCCCCCc
Confidence 445678999999999999999999999999988776 9999999987432221 2234468999999999876443344
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCC---------CCCCcCCHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFL---------PDYVRVSADCRH 141 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~~~~~~~~ 141 (246)
++||||+||++|+|++|+.||.+.+..+....+....... .... .....++.++++
T Consensus 185 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T cd07872 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIE 264 (309)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHH
Confidence 5999999999999999999998765544433333211000 0000 112357889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
||.+||..||.+|||+.++++||||...
T Consensus 265 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 265 LLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=243.89 Aligned_cols=162 Identities=25% Similarity=0.329 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||++|||||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..
T Consensus 186 ~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 263 (392)
T PHA03207 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263 (392)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccccccccccccCccCHhHhcCCC
Confidence 45677889999999999999999999999999988776 9999999987433221 122457999999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccc-------------------------cCCCC--
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQ-------------------------YFLPD-- 131 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~-------------------------~~~~~-- 131 (246)
++.+ +|||||||++|+|++|+.||.+.... ..+..++....... +..+.
T Consensus 264 ~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (392)
T PHA03207 264 YCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVI 342 (392)
T ss_pred CCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchh
Confidence 8766 89999999999999999999765432 22222222211100 00111
Q ss_pred -CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 132 -YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 132 -~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
...++.++++||++||..||.+|||+.++|.||||.+.
T Consensus 343 ~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 343 RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 01356789999999999999999999999999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=233.35 Aligned_cols=159 Identities=28% Similarity=0.413 Sum_probs=128.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++............+|++.|+|||++.+..++.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05605 104 AVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCcc
Confidence 3456789999999999999999999999999987766 99999999875433333344579999999999988777665
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|+||+||++|+|++|..||.+.........+...+.......+ ..++..+.+||.+||..||.+|| +++++
T Consensus 182 -~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05605 182 -PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV 258 (285)
T ss_pred -ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH
Confidence 89999999999999999999876554333333333333222222 35899999999999999999999 89999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 259 ~~~~~~~~~ 267 (285)
T cd05605 259 KAHPFFRTA 267 (285)
T ss_pred hcCcCccCC
Confidence 999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.41 Aligned_cols=190 Identities=25% Similarity=0.322 Sum_probs=147.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---ccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~ 81 (246)
.+..++-+.|.||+|||+++.||||||..|||++..+. |||+|||.+.. .....+++|||+|||||++. .+.
T Consensus 127 EIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PAnsFvGTPywMAPEVILAMDEGq 201 (948)
T KOG0577|consen 127 EIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPANSFVGTPYWMAPEVILAMDEGQ 201 (948)
T ss_pred HHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCchhcccCCccccchhHheeccccc
Confidence 45567788999999999999999999999999998877 99999998864 33457899999999999985 478
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
|+++ +||||||++..+|.-+++|+...+....+..+- .+..+.++ .+.+|..++.|+..||++-|..|||.++++
T Consensus 202 Ydgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 202 YDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred cCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHH---hcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 8888 899999999999999999987755443333322 22233333 346899999999999999999999999999
Q ss_pred cCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 162 KHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 162 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
+|+|+....+...........+.+-++..........+++...
T Consensus 277 ~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~e 319 (948)
T KOG0577|consen 277 KHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 319 (948)
T ss_pred hcchhccCCCchHHHHHHHHHHHHHHHhhhhhHHHHHHHHhhc
Confidence 9999998888776655554444444444444444455554443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=232.21 Aligned_cols=160 Identities=21% Similarity=0.328 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
....+.|++.||.|||+++|+||||||+||+++.++. ++|+|||++.............||+.|+|||++.+..++.+
T Consensus 97 ~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 174 (277)
T cd05607 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCc
Confidence 3456778999999999999999999999999988776 99999999875433333334579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----HHHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l 161 (246)
+|+||+||++|+|++|..||.......................+ ...++.++++||.+||++||.+||++ ++++
T Consensus 175 -~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 175 -VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 89999999999999999999764432222333333322222221 23589999999999999999999999 6788
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 253 ~h~~f~~~ 260 (277)
T cd05607 253 KHEFFKTI 260 (277)
T ss_pred cChhhcCC
Confidence 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=238.79 Aligned_cols=155 Identities=34% Similarity=0.611 Sum_probs=124.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05619 99 TFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176 (316)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCch
Confidence 345778999999999999999999999999988776 999999998743221 22334579999999999988887665
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH-HHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP-EIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp 164 (246)
+|+||+||++|+|++|..||.+..... ....+.......|. .++.++++||.+||..||.+|+++. +++.||
T Consensus 177 -~DvwslG~il~el~~G~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05619 177 -VDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLGVKGDIRQHP 249 (316)
T ss_pred -hhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence 899999999999999999998754432 22333333333333 4789999999999999999999996 899999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||....
T Consensus 250 ~~~~~~ 255 (316)
T cd05619 250 FFREID 255 (316)
T ss_pred ccCCCC
Confidence 997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.06 Aligned_cols=155 Identities=35% Similarity=0.511 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (323)
T cd05575 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176 (323)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcc
Confidence 345788999999999999999999999999988776 999999998753222 22234579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----HHHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l 161 (246)
+|||||||++|+|++|..||.+.+..+. ...+....... ...++..+.+||++||++||.+||++ .+++
T Consensus 177 -~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 177 -VDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRL--KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred -ccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 8999999999999999999987544332 23333333222 23579999999999999999999987 6999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
.||||....
T Consensus 250 ~~~~~~~~~ 258 (323)
T cd05575 250 NHVFFSSIN 258 (323)
T ss_pred cCCCcCCCC
Confidence 999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.48 Aligned_cols=156 Identities=31% Similarity=0.478 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .....+||+.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~- 178 (333)
T cd05600 104 RFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFT- 178 (333)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCc-
Confidence 345778999999999999999999999999988776 99999999975332 3345679999999999988877655
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC----CcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY----VRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+|||||||++|+|++|..||.+....+.+..+..... ....|.. ..++.++.+||.+||..+|.+|++++++++
T Consensus 179 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 8999999999999999999987655443333322111 1111221 256899999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 257 h~~~~~~ 263 (333)
T cd05600 257 HPFFKEV 263 (333)
T ss_pred CcccCCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=238.88 Aligned_cols=159 Identities=31% Similarity=0.476 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (327)
T cd05617 99 RFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176 (327)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCch
Confidence 456788999999999999999999999999988776 99999999874322 223345679999999999988888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC------
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP------ 156 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------ 156 (246)
+|||||||++|+|++|..||...... .........+.......|. .++..+.++|++||.+||.+|++
T Consensus 177 -~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 253 (327)
T cd05617 177 -VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTG 253 (327)
T ss_pred -heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence 89999999999999999999642211 1111222233333333343 58999999999999999999998
Q ss_pred HHHHhcCcccccCC
Q 025933 157 IPEIKKHPWFLKNL 170 (246)
Q Consensus 157 ~~e~l~hp~~~~~~ 170 (246)
+++++.||||....
T Consensus 254 ~~~i~~h~~f~~~~ 267 (327)
T cd05617 254 FSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHcCCCCCCCC
Confidence 57999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=237.16 Aligned_cols=156 Identities=30% Similarity=0.465 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.
T Consensus 98 ~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05604 98 ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175 (325)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCC
Confidence 3456778999999999999999999999999988776 999999998753222 2233457999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEI 160 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~ 160 (246)
+ +|||||||++|+|++|..||.+.+..+.+. .+....... .+..+..+.++|++||.+||.+||++ .++
T Consensus 176 ~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 176 T-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred c-CccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 5 899999999999999999998755433333 333222222 23589999999999999999999976 589
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 249 ~~h~~f~~~~ 258 (325)
T cd05604 249 QEHPFFESLS 258 (325)
T ss_pred hcCCCcCCCC
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=238.82 Aligned_cols=154 Identities=32% Similarity=0.488 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05602 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176 (325)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCc
Confidence 345789999999999999999999999999988776 99999999874322 222344579999999999988887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH----HHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP----EIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----e~l 161 (246)
+||||+||++|+|++|..||.+......+.. +..... .....++..+.++|.+||++||.+|+++. +++
T Consensus 177 -~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 177 -VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred -cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 8999999999999999999987554333332 222222 22336899999999999999999999875 899
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+|+||...
T Consensus 250 ~~~~~~~~ 257 (325)
T cd05602 250 NHIFFSPI 257 (325)
T ss_pred cCcccCCC
Confidence 99999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=242.01 Aligned_cols=157 Identities=33% Similarity=0.533 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------------------------
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------------------- 60 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------------------- 60 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++......
T Consensus 104 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (364)
T cd05599 104 RFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181 (364)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccccccccccccccccccc
Confidence 446778999999999999999999999999988776 9999999986321110
Q ss_pred -------------CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 025933 61 -------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127 (246)
Q Consensus 61 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 127 (246)
...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~--~~~~ 258 (364)
T cd05599 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW--KETL 258 (364)
T ss_pred cccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCcc
Confidence 0113469999999999988888655 89999999999999999999876544333333221 1122
Q ss_pred CCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 025933 128 FLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKN 169 (246)
Q Consensus 128 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~ 169 (246)
..|....+++.+++||++||. +|.+|++ +.+++.||||...
T Consensus 259 ~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 259 QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 334444679999999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.13 Aligned_cols=159 Identities=25% Similarity=0.470 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++... ........||+.|+|||++.+..++.+
T Consensus 106 ~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~ 182 (331)
T cd06649 106 GKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ 182 (331)
T ss_pred HHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccc-ccccccCCCCcCcCCHhHhcCCCCCch
Confidence 45677899999999986 6999999999999988776 9999999987532 223344579999999999988887765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH-------------------------------------------HHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-------------------------------------------DRI 122 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~-------------------------------------------~~~ 122 (246)
+|||||||++|+|++|+.||...... .+...+ ..+
T Consensus 183 -~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T cd06649 183 -SDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260 (331)
T ss_pred -HhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH
Confidence 89999999999999999999654321 111111 111
Q ss_pred hccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 123 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
............+++++++||.+||++||++|||+.++++||||....
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 261 VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 111000001124788999999999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=242.79 Aligned_cols=159 Identities=32% Similarity=0.514 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc---
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE--- 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--- 81 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++....... ...+.+||+.|+|||++.+..
T Consensus 145 ~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 222 (370)
T cd05621 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222 (370)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCC
Confidence 345678999999999999999999999999988776 9999999997532222 123567999999999997543
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC--CCCHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIPE 159 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e 159 (246)
+.+.++|+||+||++|+|++|..||.+......+.++... ......|....++..+++|+.+||..++.+ |+|+.+
T Consensus 223 ~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred CCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 2234589999999999999999999876654444433321 122334555568999999999999865544 899999
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 301 ~l~hp~~~~~ 310 (370)
T cd05621 301 IKQHPFFKND 310 (370)
T ss_pred HhcCcccCCC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=241.93 Aligned_cols=157 Identities=29% Similarity=0.463 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccc-----
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~----- 79 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++........ .....||+.|+|||++..
T Consensus 105 ~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (330)
T cd05601 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182 (330)
T ss_pred HHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccc
Confidence 345678999999999999999999999999988776 99999999975332221 123469999999999863
Q ss_pred -cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 -KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 -~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++. ++|||||||++|+|++|..||........+.++.... .....|....++..+++||.+||. +|.+|||++
T Consensus 183 ~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~ 258 (330)
T cd05601 183 KGTYGV-ECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYE 258 (330)
T ss_pred cCCCCC-cceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHH
Confidence 34444 4899999999999999999998766544444333221 112234555689999999999998 999999999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
+++.||||...
T Consensus 259 ~l~~h~~~~~~ 269 (330)
T cd05601 259 GLCCHPFFSKI 269 (330)
T ss_pred HHhCCCCcCCC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=243.69 Aligned_cols=156 Identities=33% Similarity=0.506 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----------------------------
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---------------------------- 59 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---------------------------- 59 (246)
.++.|++.||.|||+++|+||||||+|||++.++. +||+|||++......
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (382)
T cd05625 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182 (382)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccccccccccccccccccccccccccc
Confidence 34678889999999999999999999999988776 999999997421100
Q ss_pred --------------------CCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 025933 60 --------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 119 (246)
Q Consensus 60 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~ 119 (246)
....+.+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+........++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred ccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00123469999999999988888765 899999999999999999998765544333332
Q ss_pred HHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 025933 120 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKN 169 (246)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~ 169 (246)
.. ......|....+++++++||.+|+ .+|.+|++ ++++++||||...
T Consensus 262 ~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 262 NW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred cc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 21 122334445578999999999986 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=240.53 Aligned_cols=159 Identities=28% Similarity=0.412 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhcc-----cc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLA-----RK 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~-----~~ 80 (246)
-++..|++.||.|||+++|||||||..|||+.-+|. |+|+|||++..... .....+++|||+|||||++. ..
T Consensus 133 qvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~ 210 (1187)
T KOG0579|consen 133 QVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQ 210 (1187)
T ss_pred HHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhccccCCcccccchheeeccccCC
Confidence 456788999999999999999999999999998887 99999999763322 22345789999999999974 46
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+|+.+ +||||||++|.+|.-+.+|-...+..+.+.++- ....+.+-.+..++..+.||+++||.+||..||++.++
T Consensus 211 PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 211 PYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred Cchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 77656 899999999999999999987766654444332 22333344456789999999999999999999999999
Q ss_pred hcCcccccCCC
Q 025933 161 KKHPWFLKNLP 171 (246)
Q Consensus 161 l~hp~~~~~~~ 171 (246)
++||||.....
T Consensus 287 l~Hpfv~~~~S 297 (1187)
T KOG0579|consen 287 LKHPFVQNAPS 297 (1187)
T ss_pred hhCcccccCCc
Confidence 99999985443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=242.09 Aligned_cols=156 Identities=33% Similarity=0.502 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-----------------------------
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----------------------------- 59 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----------------------------- 59 (246)
++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.....
T Consensus 106 ~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (381)
T cd05626 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183 (381)
T ss_pred HHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCccccccccccc
Confidence 4568889999999999999999999999987765 999999997521100
Q ss_pred -------------------CCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 025933 60 -------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 120 (246)
Q Consensus 60 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~ 120 (246)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........++..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred ccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 00123479999999999988887755 8999999999999999999987655433333322
Q ss_pred HHhccccCCCCCCcCCHHHHHHHHHhccc--CCCCCCCHHHHhcCcccccC
Q 025933 121 RIRNVQYFLPDYVRVSADCRHLLSQIFVA--DPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~R~t~~e~l~hp~~~~~ 169 (246)
. ......|....+++++++||.+||.. +|..|+++.++++||||...
T Consensus 263 ~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 263 W--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred c--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 1 12233455556899999999996654 55569999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=227.35 Aligned_cols=155 Identities=34% Similarity=0.561 Sum_probs=129.3
Q ss_pred HHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCcchhHH
Q 025933 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 90 (246)
Q Consensus 12 qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 90 (246)
.|+.||.|||+++||+||||.+|+|++.+|+ +||+|||+++... .....+++||||.|+|||++....|.. ++|+|
T Consensus 276 EIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgr-aVDWW 352 (516)
T KOG0690|consen 276 EIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGR-AVDWW 352 (516)
T ss_pred HHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccceeccccCChhhcCchhhccccccc-eeehh
Confidence 3668999999999999999999999999988 9999999998654 344567889999999999999888864 49999
Q ss_pred hHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 025933 91 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPW 165 (246)
Q Consensus 91 slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~ 165 (246)
.+||++|+|+||+.||...+....+. -+.-....+|. .++++++.|+..+|.+||.+|.. +.|+.+|+|
T Consensus 353 G~GVVMYEMmCGRLPFyn~dh~kLFe----LIl~ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 353 GVGVVMYEMMCGRLPFYNKDHEKLFE----LILMEDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred hhhHHHHHHHhccCcccccchhHHHH----HHHhhhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 99999999999999999866644333 33333344555 79999999999999999999984 789999999
Q ss_pred cccCCChHHH
Q 025933 166 FLKNLPKEII 175 (246)
Q Consensus 166 ~~~~~~~~~~ 175 (246)
|....-....
T Consensus 427 F~~v~W~~~~ 436 (516)
T KOG0690|consen 427 FASVDWEATY 436 (516)
T ss_pred hccCCHHHHH
Confidence 9875544433
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=236.40 Aligned_cols=161 Identities=25% Similarity=0.348 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC--CCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~ 79 (246)
...++.|++.||.|||+++|+||||||+|||+... ..+++||+|||+++...... ......||+.|+|||++.+
T Consensus 110 ~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred HHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC
Confidence 34667899999999999999999999999999432 22359999999997432211 1234568999999999976
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHH-----------h-------------ccc
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRI-----------R-------------NVQ 126 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------~~~~~~~~~~-----------~-------------~~~ 126 (246)
....+.++||||+||++|+|++|.+||...... ..+....... . ...
T Consensus 190 ~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (317)
T cd07867 190 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTT 269 (317)
T ss_pred CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccc
Confidence 543345599999999999999999999653321 1111111100 0 000
Q ss_pred cC--------CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 127 YF--------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 127 ~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.. .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 270 YANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00011245678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=246.81 Aligned_cols=162 Identities=25% Similarity=0.331 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..++.|++.||.|||+++||||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++.+..++.
T Consensus 270 ~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 347 (501)
T PHA03210 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE 347 (501)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc
Confidence 356789999999999999999999999999988776 99999999975432221 22457999999999998888865
Q ss_pred cchhHHhHHHHHHHHHhCCCC-CCCCC--ChHHHHHHHHHHhccccCCC--------------------------CCCcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYP-FEDPE--DPRNFRKTIDRIRNVQYFLP--------------------------DYVRV 135 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~P-f~~~~--~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~ 135 (246)
+ +|||||||++|+|++|..+ |.... ....+.+++..+......+| ....+
T Consensus 348 ~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 426 (501)
T PHA03210 348 I-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGL 426 (501)
T ss_pred H-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCC
Confidence 5 8999999999999998754 43222 12233333221110000000 01135
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 136 ~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+.++.++|.+||..||.+|||+.|+|.||||.....
T Consensus 427 ~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 427 PADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred ChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 678889999999999999999999999999976543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=235.34 Aligned_cols=155 Identities=31% Similarity=0.534 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.
T Consensus 103 ~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 180 (323)
T cd05615 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCC
Confidence 3456778999999999999999999999999998776 999999998743222 2233457999999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e 159 (246)
+ +|+||+||++|+|++|..||.+....... ..+.......| ..++.++++|+.+||.+||.+|++ .++
T Consensus 181 ~-~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05615 181 S-VDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYP--KSLSKEAVSICKGLMTKHPSKRLGCGPEGERD 253 (323)
T ss_pred c-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHH
Confidence 5 89999999999999999999875543332 33333333333 368999999999999999999997 478
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 254 i~~h~~f~~~ 263 (323)
T cd05615 254 IREHAFFRRI 263 (323)
T ss_pred HhcCcccCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=231.72 Aligned_cols=157 Identities=30% Similarity=0.446 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++.............||..|+|||++.+..++.+
T Consensus 105 ~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~- 181 (285)
T cd05630 105 VFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181 (285)
T ss_pred HHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCc-
Confidence 445678999999999999999999999999988766 99999999875433333344579999999999988887655
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHh
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIK 161 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l 161 (246)
+|+||+||++|+|++|..||....................... ...+++++++|+.+||+.||.+|+| +++++
T Consensus 182 ~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY--SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc--CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH
Confidence 8999999999999999999986543222111111111111112 2357899999999999999999999 89999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 260 ~h~~~~~ 266 (285)
T cd05630 260 EHPLFKQ 266 (285)
T ss_pred cChhhhc
Confidence 9999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=243.16 Aligned_cols=162 Identities=22% Similarity=0.317 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 80 (246)
...+.++.|++.||.|||++|||||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+.
T Consensus 260 ~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~ 337 (461)
T PHA03211 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD 337 (461)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccccccCCCcCCcCHHHHcCC
Confidence 345678899999999999999999999999999987766 9999999987432211 11234699999999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhccc--------------------------c
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQ--------------------------Y 127 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~~~~~~~~~~--------------------------~ 127 (246)
.++.+ +|||||||++|+|++|..|+..... ...+.+++....... +
T Consensus 338 ~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 416 (461)
T PHA03211 338 PYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY 416 (461)
T ss_pred CCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence 88755 8999999999999998766533221 122223322211000 0
Q ss_pred C---CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 128 F---LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 128 ~---~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
. +..+..++.++.+||.+||..||.+|||+.|+|+||||..
T Consensus 417 ~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 417 TRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0111245678999999999999999999999999999964
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=237.70 Aligned_cols=163 Identities=26% Similarity=0.391 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
...+.|++.||.|||++||+||||||+||+++.++. +||+|||+++............|++.|+|||.+.+..++.+
T Consensus 121 ~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 197 (353)
T cd07850 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN- 197 (353)
T ss_pred HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCc-
Confidence 346788999999999999999999999999988776 99999999985433333344568999999999988888765
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------------cc---------C-----CCC---
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------------QY---------F-----LPD--- 131 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------------------~~---------~-----~~~--- 131 (246)
+||||+||++|+|++|+.||...+....+.++....... .. . .+.
T Consensus 198 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T cd07850 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE 277 (353)
T ss_pred hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc
Confidence 899999999999999999998765444333332211000 00 0 000
Q ss_pred --CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 132 --YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 132 --~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
....+..+++||.+||+.||.+|||+.++|.||||..+...
T Consensus 278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 11346678999999999999999999999999999866553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=242.04 Aligned_cols=156 Identities=29% Similarity=0.504 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---------------------------
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------------------------- 60 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------------------------- 60 (246)
.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 105 ~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (377)
T cd05629 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182 (377)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccc
Confidence 35678899999999999999999999999987766 9999999985211000
Q ss_pred ---------------------CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 025933 61 ---------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 119 (246)
Q Consensus 61 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~ 119 (246)
...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 0012469999999999988888655 899999999999999999998765544433332
Q ss_pred HHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccccC
Q 025933 120 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR---IPIPEIKKHPWFLKN 169 (246)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~hp~~~~~ 169 (246)
.. .....+|....++.++++||.+||. +|.+| +++.+++.||||...
T Consensus 262 ~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 262 NW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred cc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 21 1122345545689999999999998 77765 599999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=241.31 Aligned_cols=157 Identities=32% Similarity=0.511 Sum_probs=122.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------------------------
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------------------- 60 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------------------- 60 (246)
..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 104 ~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (360)
T cd05627 104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181 (360)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccc
Confidence 446778899999999999999999999999988776 9999999986321100
Q ss_pred ----------CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 025933 61 ----------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130 (246)
Q Consensus 61 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 130 (246)
...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+.++... .....+|
T Consensus 182 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~--~~~~~~p 258 (360)
T cd05627 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW--KETLVFP 258 (360)
T ss_pred cccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCCCCCHHHHHHHHHcC--CCceecC
Confidence 0123579999999999998888765 89999999999999999999876654443333221 1122234
Q ss_pred CCCcCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccC
Q 025933 131 DYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKN 169 (246)
Q Consensus 131 ~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~ 169 (246)
....++.++++||.+|+ .||.+|+ +++++++||||...
T Consensus 259 ~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 259 PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 44458999999999987 4999998 47999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=244.48 Aligned_cols=155 Identities=31% Similarity=0.399 Sum_probs=132.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..++.|..+|+.|++|||.+.|||||||.-||||..+.. |||+|||-++.........+++||..|||||++.+.+.+
T Consensus 212 ~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcs 289 (904)
T KOG4721|consen 212 SLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCS 289 (904)
T ss_pred HHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcc
Confidence 356788999999999999999999999999999988776 999999999865555555678999999999999999998
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||||||||||..||.+.+.. .++-.+......+|-+..++..++-||+.||...|..||++.++|.|
T Consensus 290 EK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 290 EK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred cc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 87 89999999999999999999765442 23333444455567777899999999999999999999999999999
Q ss_pred cc
Q 025933 164 PW 165 (246)
Q Consensus 164 p~ 165 (246)
--
T Consensus 365 ld 366 (904)
T KOG4721|consen 365 LD 366 (904)
T ss_pred Hh
Confidence 43
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=238.66 Aligned_cols=158 Identities=28% Similarity=0.408 Sum_probs=134.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..+.|++|++.|+.|||++.|+|||||+.||+++.++. |||+|||+|+...... ...+.+||+.||+||++.+.+|.
T Consensus 107 ~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn 184 (426)
T KOG0589|consen 107 RILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYN 184 (426)
T ss_pred HHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCC
Confidence 45778999999999999999999999999999998887 8999999999765555 55677899999999999999998
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++-+++|.+.+......++.+ .. ..|....++.+++.||+.||.++|..||++.++|.+
T Consensus 185 ~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 185 EK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----GL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc-CcchhhcchHHHHHhcccccCccchHHHHHHHhh----cc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 77 8999999999999999999987665444444333 22 345556899999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|......
T Consensus 259 P~l~~~~ 265 (426)
T KOG0589|consen 259 PHLLRYL 265 (426)
T ss_pred hhhhhHH
Confidence 8876433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=246.56 Aligned_cols=155 Identities=26% Similarity=0.414 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhccccccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++
T Consensus 146 ~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 223 (496)
T PTZ00283 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223 (496)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC
Confidence 456789999999999999999999999999988776 99999999874322 1223446799999999999988887
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|+.||.+.... ..+..+..... .+....+++++.+|+.+||..||.+||++.++++|
T Consensus 224 ~k-~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 224 KK-ADMFSLGVLLYELLTLKRPFDGENME----EVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cH-HHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 55 89999999999999999999765432 23333332222 23344689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
||+...
T Consensus 298 p~~~~~ 303 (496)
T PTZ00283 298 PICKLF 303 (496)
T ss_pred HHHHHh
Confidence 998643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=234.80 Aligned_cols=155 Identities=32% Similarity=0.456 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05603 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCc
Confidence 345778999999999999999999999999988776 99999999875322 222334579999999999988887766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----HHHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l 161 (246)
+|||||||++|+|++|..||.+.+... ....+.......| ...+..+.++|.+||++||.+|+++ .+++
T Consensus 177 -~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 177 -VDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred -CcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 899999999999999999998754322 2333333333333 3678999999999999999999975 5999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+|+||....
T Consensus 250 ~~~~~~~~~ 258 (321)
T cd05603 250 NHVFFSPIN 258 (321)
T ss_pred CCCCcCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=237.18 Aligned_cols=155 Identities=32% Similarity=0.523 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.
T Consensus 100 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 177 (318)
T cd05582 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177 (318)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCC
Confidence 4556789999999999999999999999999988776 999999998754332 2233457999999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e 159 (246)
+ +|||||||++|+|++|+.||.+....... ..+.......|. .++..+++||++||+.||.+||+ +.+
T Consensus 178 ~-~DiwslG~il~el~tg~~p~~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 178 S-ADWWSFGVLMFEMLTGSLPFQGKDRKETM----TMILKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred c-cceeccceEeeeeccCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 5 89999999999999999999865543332 333333333343 58999999999999999999999 778
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
++.||||...
T Consensus 251 ~~~~~~~~~~ 260 (318)
T cd05582 251 IKRHPFFSTI 260 (318)
T ss_pred HhCCCCcCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=239.27 Aligned_cols=158 Identities=32% Similarity=0.504 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc---c
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE---Y 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~ 82 (246)
..+.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ...+.+||+.|+|||++.+.. .
T Consensus 146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 223 (371)
T cd05622 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223 (371)
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCcc
Confidence 45678999999999999999999999999988776 9999999987533221 223557999999999987543 1
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC--CCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~ 160 (246)
.+.++|||||||++|+|++|..||.+.+....+.++.... ....+|....++..+++||.+||..++.+ |++++++
T Consensus 224 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei 301 (371)
T cd05622 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI 301 (371)
T ss_pred CCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHH
Confidence 2344899999999999999999998765443433332211 12334555578999999999999844443 7899999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++|+||...
T Consensus 302 ~~h~~~~~~ 310 (371)
T cd05622 302 KRHLFFKND 310 (371)
T ss_pred hcCcccCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=241.83 Aligned_cols=156 Identities=32% Similarity=0.493 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----------------------------
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---------------------------- 59 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---------------------------- 59 (246)
.++.||+.||.|||+++|+||||||+|||++.++. +||+|||++......
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (376)
T cd05598 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182 (376)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence 35678899999999999999999999999988776 999999997421000
Q ss_pred ----------------CCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 025933 60 ----------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123 (246)
Q Consensus 60 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 123 (246)
....+.+||+.|||||++.+..++.+ +|||||||++|+|++|..||.+.........+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-- 259 (376)
T cd05598 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW-- 259 (376)
T ss_pred ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeehhhCCCCCCCCCHHHHHHHHhcc--
Confidence 00113479999999999988888655 89999999999999999999876654433322211
Q ss_pred ccccCCCCCCcCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccC
Q 025933 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKN 169 (246)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~ 169 (246)
......+....++..+.+||.+|+ .+|.+|+ ++.++++||||...
T Consensus 260 ~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 260 ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 112233444568999999999976 5999999 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=227.12 Aligned_cols=160 Identities=26% Similarity=0.424 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++.............|+..|+|||++.+..++.
T Consensus 103 ~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~ 180 (285)
T cd05632 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCc
Confidence 34567789999999999999999999999999987765 9999999987543333334557999999999998877766
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e 159 (246)
+ +|+||+||++|+|++|..||.+.............+....... ...++.++.+|+.+||..||.+||+ +.+
T Consensus 181 ~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05632 181 S-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257 (285)
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence 5 8999999999999999999987554433333333333322222 2358899999999999999999999 889
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
++.|+||...
T Consensus 258 l~~~~~~~~~ 267 (285)
T cd05632 258 VKRHPFFRNM 267 (285)
T ss_pred HHcChhhhcC
Confidence 9999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=225.84 Aligned_cols=159 Identities=23% Similarity=0.357 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++..... .......+++.|+|||++.+....+
T Consensus 101 ~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 178 (284)
T cd07839 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccC
Confidence 4567889999999999999999999999999988766 999999998743222 1223346789999999987755434
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcc------------cc-CC----------CCCCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV------------QY-FL----------PDYVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~------------~~-~~----------~~~~~~~~~~~ 140 (246)
.++|+||+||++|+|++|..||....+. ..+..+....... .+ .. +..+.++.+++
T Consensus 179 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07839 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR 258 (284)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHH
Confidence 4599999999999999998886543332 2222222111000 00 00 11234789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||.+||..||.+|||++++++||||
T Consensus 259 ~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 259 DLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=226.31 Aligned_cols=160 Identities=24% Similarity=0.306 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+....
T Consensus 102 ~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd07861 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCcccccCCcccccccChHHhcCCCCc
Confidence 34567889999999999999999999999999988776 9999999987432221 12234678999999998765433
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------ccC---------CCCCCcCCHHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYF---------LPDYVRVSADCR 140 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~---------~~~~~~~~~~~~ 140 (246)
..++|+|||||++|+|++|+.||.+................. ... ......++.+++
T Consensus 180 ~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (285)
T cd07861 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGL 259 (285)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHH
Confidence 344899999999999999999998755433332222211000 000 011234789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||++||..||.+|||+.+++.||||
T Consensus 260 ~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 260 DLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=234.33 Aligned_cols=151 Identities=30% Similarity=0.586 Sum_probs=135.2
Q ss_pred HHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhHHh
Q 025933 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 91 (246)
Q Consensus 12 qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 91 (246)
-+++|+.|||.+|||+|||||+|++++.+|. +||.|||+|+.........++||||.|.|||++.+++.+.. +|.||
T Consensus 528 cv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWa 604 (732)
T KOG0614|consen 528 CVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWA 604 (732)
T ss_pred HHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchh-hHHHH
Confidence 3678899999999999999999999999988 99999999997777777788999999999999999888765 89999
Q ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccc
Q 025933 92 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 166 (246)
Q Consensus 92 lG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~ 166 (246)
||+++|||++|.+||.+.+...++..++..+....+ |. .++..+.+||+++...+|.+|.. +.++.+|.||
T Consensus 605 LGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~--Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF--PR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc--cc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 999999999999999999988888888877665443 43 78999999999999999999986 7899999999
Q ss_pred ccC
Q 025933 167 LKN 169 (246)
Q Consensus 167 ~~~ 169 (246)
..-
T Consensus 681 ~gf 683 (732)
T KOG0614|consen 681 EGF 683 (732)
T ss_pred hcC
Confidence 653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=241.79 Aligned_cols=154 Identities=29% Similarity=0.422 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ...+.+||+.|+|||++.+..++
T Consensus 172 ~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 345678999999999999999999999999988776 9999999997543221 13345799999999999888776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||.+..... ++..+..... .+....++.++++||.+||..||++||++.+++.|
T Consensus 250 ~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 250 KK-ADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred cH-HhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 55 899999999999999999997654432 2333322222 12334688999999999999999999999999999
Q ss_pred ccccc
Q 025933 164 PWFLK 168 (246)
Q Consensus 164 p~~~~ 168 (246)
+|+..
T Consensus 324 ~~~~~ 328 (478)
T PTZ00267 324 EFLKY 328 (478)
T ss_pred HHHHH
Confidence 99853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=232.07 Aligned_cols=164 Identities=25% Similarity=0.348 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......||+.|+|||.+.+...
T Consensus 109 ~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (336)
T cd07849 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186 (336)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCC
Confidence 456778999999999999999999999999988776 9999999987432211 1123468999999998765432
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------------cc--ccCCC---CCCcCCH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--------------------NV--QYFLP---DYVRVSA 137 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~--------------------~~--~~~~~---~~~~~~~ 137 (246)
.+.++|+||+||++|+|++|+.||.+............... .. ....+ ..+..+.
T Consensus 187 ~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T cd07849 187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADP 266 (336)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCc
Confidence 33458999999999999999999976443222211111000 00 00000 1134688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
.+.+||.+||..||.+|||+.++++||||......
T Consensus 267 ~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 267 KALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 89999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=227.15 Aligned_cols=161 Identities=24% Similarity=0.359 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||++....... ......+++.|+|||++.+.....
T Consensus 106 ~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 183 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183 (301)
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCc
Confidence 3446678999999999999999999999999988776 9999999987432222 223346789999999987654334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------------cccCCCC---------CCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQYFLPD---------YVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~---------~~~~~~~~~ 140 (246)
.++|||||||++|+|++|++||.+.+..+....+...... .....+. ...++..++
T Consensus 184 ~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (301)
T cd07873 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA 263 (301)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHH
Confidence 4589999999999999999999876543333222221100 0001111 124788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
+||.+||..||.+|||++++++||||..
T Consensus 264 ~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 264 ELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=223.72 Aligned_cols=159 Identities=27% Similarity=0.416 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.....+.|++.||+|||+++|+||||||+||+++. +. +||+|||+++............++..|+|||.+......+
T Consensus 101 ~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 177 (282)
T cd07831 101 RVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCC
Confidence 34556788999999999999999999999999988 44 9999999997544333334456899999999876544434
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc--------------cccCCCC---------CCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------------VQYFLPD---------YVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~---------~~~~~~~~~~ 141 (246)
.++|+||+||++|+|++|..||.+.+..+.+......... ..+..+. ...++..+++
T Consensus 178 ~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (282)
T cd07831 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLD 257 (282)
T ss_pred cchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHH
Confidence 5599999999999999999999876544333322221100 0011111 1246899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
||.+||.+||.+|||++++++||||
T Consensus 258 li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 258 LLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHhccCcccccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=218.96 Aligned_cols=163 Identities=31% Similarity=0.558 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCC--------CCCCCCCCCCCCCCcchhcc-
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLL--------HSQPKSTVGTPAYIAPEVLA- 78 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~--------~~~~~~~~gt~~y~aPE~~~- 78 (246)
.+-.|+.||.|||.+||.||||||+|||-... ....||||||.+...... .....+.+|+..|||||+..
T Consensus 181 vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 181 VVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred HHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhh
Confidence 34558899999999999999999999998543 334589999998653211 12234568999999999863
Q ss_pred ---ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhccccCCCC--CCcCCHHHHHH
Q 025933 79 ---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 142 (246)
Q Consensus 79 ---~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 142 (246)
...++.+.+|.||||||+|.||+|++||.+.-. ..=..+++..|....|.+|+ |..+|.++++|
T Consensus 261 fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdl 340 (463)
T KOG0607|consen 261 FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL 340 (463)
T ss_pred hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHH
Confidence 344556779999999999999999999976322 11235567778888888875 77899999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 143 LSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+..+|.+|+.+|.++.++++|||+....+
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCccccccch
Confidence 99999999999999999999999977544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=240.84 Aligned_cols=152 Identities=36% Similarity=0.689 Sum_probs=130.6
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchh
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 88 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 88 (246)
+.|||.||+|||-++|||+||||+|||+.+. ...++||||||+|+......-.++.+|||.|+|||++.+++|... .|
T Consensus 670 vtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrS-LD 748 (888)
T KOG4236|consen 670 VTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRS-LD 748 (888)
T ss_pred HHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcccccc-cc
Confidence 6788999999999999999999999999654 346899999999997666666678899999999999999999766 89
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 89 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 89 iwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||.|||+|.-++|.+||....+. -+++.+..+.. ..|..+++++.|||..+|+..-.+|.|++..+.|||+
T Consensus 749 MWSVGVIiYVsLSGTFPFNEdEdI------ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 749 MWSVGVIIYVSLSGTFPFNEDEDI------NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred ceeeeEEEEEEecccccCCCccch------hHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 999999999999999999765442 23344444433 3577899999999999999999999999999999998
Q ss_pred cc
Q 025933 167 LK 168 (246)
Q Consensus 167 ~~ 168 (246)
+.
T Consensus 823 q~ 824 (888)
T KOG4236|consen 823 QD 824 (888)
T ss_pred hc
Confidence 65
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=242.89 Aligned_cols=156 Identities=29% Similarity=0.451 Sum_probs=125.8
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccc-cccCCcch
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLAR-KEYDGKIS 87 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~ 87 (246)
.-||++||+|||++.|||||||-+|||++.- .+.+||+|||-+++... +....++.||..|||||++.. ...+++++
T Consensus 681 tkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aA 759 (1226)
T KOG4279|consen 681 TKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAA 759 (1226)
T ss_pred HHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchh
Confidence 5688899999999999999999999999753 34599999999986433 333456789999999999964 34457889
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
|||||||++.||.||++||.....+.. .+-++.-.+...|.+..++.+++.||.+|+..||.+||+|.++|..||+.
T Consensus 760 DIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq 836 (1226)
T KOG4279|consen 760 DIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ 836 (1226)
T ss_pred hhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence 999999999999999999987665533 12222223333444557899999999999999999999999999999997
Q ss_pred cC
Q 025933 168 KN 169 (246)
Q Consensus 168 ~~ 169 (246)
.+
T Consensus 837 ~~ 838 (1226)
T KOG4279|consen 837 HN 838 (1226)
T ss_pred cC
Confidence 65
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=228.20 Aligned_cols=158 Identities=26% Similarity=0.477 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++.... ........||..|+|||++.+..++.+
T Consensus 106 ~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (333)
T cd06650 106 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ 182 (333)
T ss_pred HHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhh-hhccccCCCCccccCHHHhcCCCCCcH
Confidence 45667899999999985 7999999999999987776 9999999987432 222234579999999999988777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH-----------------------------------------HHHhc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-----------------------------------------DRIRN 124 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~-----------------------------------------~~~~~ 124 (246)
+|+|||||++|+|++|+.||...... .....+ ..+..
T Consensus 183 -~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (333)
T cd06650 183 -SDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN 260 (333)
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhc
Confidence 89999999999999999999754321 111111 11111
Q ss_pred cccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 125 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 125 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
..........++.++++||.+||++||.+|||+.+++.||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 261 EPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000012367899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=221.27 Aligned_cols=153 Identities=28% Similarity=0.373 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccc-----c
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLAR-----K 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~ 80 (246)
..++.|++.|++|||+++|+||||||+||+++.++. +||+|||+++..... .......|++.|+|||++.+ .
T Consensus 114 ~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 191 (272)
T cd06637 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191 (272)
T ss_pred HHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecccccccCCcccccccccCHhHhccccCcCC
Confidence 456779999999999999999999999999988776 999999998743221 22334578999999999863 3
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|+||+||++|+|++|..||............ ............++..+.+|+.+||..||.+|||+.++
T Consensus 192 ~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 192 TYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred CCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 45444 89999999999999999999754432222111 11111112223578999999999999999999999999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
++||||
T Consensus 267 l~~~~~ 272 (272)
T cd06637 267 MKHPFI 272 (272)
T ss_pred hhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=226.60 Aligned_cols=194 Identities=24% Similarity=0.307 Sum_probs=134.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||.|||.+||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+
T Consensus 106 ~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhC
Confidence 34567889999999999999999999999999988776 9999999987432211 1223468999999998865
Q ss_pred c-ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------------cc-c---cC-CCCCC
Q 025933 80 K-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--------------------NV-Q---YF-LPDYV 133 (246)
Q Consensus 80 ~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~--------------------~~-~---~~-~~~~~ 133 (246)
. .++ .++|+||+||++|+|++|.+||.+......+...+.... .. . .. .....
T Consensus 184 ~~~~~-~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (332)
T cd07857 184 FQSYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFP 262 (332)
T ss_pred CCCCC-cHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCC
Confidence 3 444 448999999999999999999976553332222221100 00 0 00 01123
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHH
Q 025933 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203 (246)
Q Consensus 134 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (246)
..+..+++|+.+||+.||.+|||+.+++.|||+.++..+...... ............+.+++...+++
T Consensus 263 ~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 330 (332)
T cd07857 263 NANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC--QKPFDFSFESEDSMEELRDMIIE 330 (332)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc--cccccCCccccccHHHHHHHHhh
Confidence 468899999999999999999999999999999766433222111 11111222345566676665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=224.84 Aligned_cols=159 Identities=27% Similarity=0.432 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc---c
Q 025933 6 YFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK---E 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~---~ 81 (246)
...++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++............|++.|+|||++.+. .
T Consensus 109 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (288)
T cd06616 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186 (288)
T ss_pred HHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhccCCccccccCccCccCHHHhccccccC
Confidence 345678899999999975 9999999999999988766 999999998754333333344689999999999766 4
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
++.+ +|+||+||++|+|++|..||..... . ...+...... ....+ ....++.++.+||.+||..||.+|||++
T Consensus 187 ~~~~-~Di~slG~il~el~~g~~p~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 262 (288)
T cd06616 187 YDVR-SDVWSLGITLYEVATGKFPYPKWNS--V-FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK 262 (288)
T ss_pred Ccch-hhhhHHHHHHHHHHhCCCCchhcch--H-HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 5544 8999999999999999999975431 1 1222222111 11111 1235789999999999999999999999
Q ss_pred HHhcCcccccCC
Q 025933 159 EIKKHPWFLKNL 170 (246)
Q Consensus 159 e~l~hp~~~~~~ 170 (246)
++++||||....
T Consensus 263 ~i~~~~~~~~~~ 274 (288)
T cd06616 263 ELLEHPFIKDYE 274 (288)
T ss_pred HHhcChhhhchh
Confidence 999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=221.39 Aligned_cols=158 Identities=35% Similarity=0.573 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCC-CCCCCCCCCCCCCCCCcchhcc-cccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKSTVGTPAYIAPEVLA-RKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~ 82 (246)
....++.|++.||.+||+++|+||||||+||+++.++. ++|+|||.+... ..........++..|+|||++. +..+
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 176 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKY 176 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSB
T ss_pred cccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc
Confidence 34667889999999999999999999999999997766 999999998742 2233344567899999999998 5555
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+ +|+||+|+++|+|++|..||........ ...+........ ........+..+.++|.+||..||++|||+.++
T Consensus 177 ~~~-~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 177 TRK-SDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp STH-HHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccc-ccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 544 9999999999999999999987622222 222222221111 111111234899999999999999999999999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
++||||
T Consensus 255 ~~~~~~ 260 (260)
T PF00069_consen 255 LKHPWF 260 (260)
T ss_dssp HTSGGG
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=219.45 Aligned_cols=153 Identities=32% Similarity=0.415 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----CCCCCCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~ 82 (246)
..++.|++.|+.|||+++|+||||||+||+++.++. ++|+|||+++........ ....|+..|+|||.+.+..+
T Consensus 107 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCC
Confidence 345678899999999999999999999999987766 999999998743221111 23468889999999988777
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|+||+||++|+|++|+.||........... ........+....++..+.++|.+||..+|.+|||+.++++
T Consensus 185 ~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 185 GRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred Cch-hhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 655 8999999999999999999976544333222 22222222223368999999999999999999999999999
Q ss_pred Cccc
Q 025933 163 HPWF 166 (246)
Q Consensus 163 hp~~ 166 (246)
||||
T Consensus 260 ~~~~ 263 (263)
T cd06625 260 HFFV 263 (263)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=226.65 Aligned_cols=161 Identities=25% Similarity=0.320 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||+++|+||||||+||+++.++. +||+|||++....... ......+++.|+|||++.+.....
T Consensus 110 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (309)
T cd07845 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187 (309)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccCCCCcccccccccChhhhcCCCCcC
Confidence 4567889999999999999999999999999988776 9999999987543221 222335688899999987644334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCCCC---------CCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFLPD---------YVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~ 140 (246)
.++|+||+||++|+|++|.+||.+.+....+..+....... .+..+. ....++.+.
T Consensus 188 ~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T cd07845 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL 267 (309)
T ss_pred chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHH
Confidence 45999999999999999999998766655544443321100 000010 123588999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
+||.+||+.||++|||++++++||||.+
T Consensus 268 ~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 268 RLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=220.80 Aligned_cols=161 Identities=27% Similarity=0.368 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcc-----c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLA-----R 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~-----~ 79 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++...... .......|+..|+|||++. +
T Consensus 105 ~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (282)
T cd06643 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccccccccccCHhhccccCCCC
Confidence 4456778999999999999999999999999988766 999999998743222 1223456899999999984 2
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++. ++|+||+||++|+|++|.+||............. .......+....++.++++||.+||..||.+||++.+
T Consensus 183 ~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 183 RPYDY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCc-cchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 33443 4899999999999999999997654433322221 1111122333468899999999999999999999999
Q ss_pred HhcCcccccCCCh
Q 025933 160 IKKHPWFLKNLPK 172 (246)
Q Consensus 160 ~l~hp~~~~~~~~ 172 (246)
+++||||......
T Consensus 259 il~~~~~~~~~~~ 271 (282)
T cd06643 259 LLQHPFVTVNSNK 271 (282)
T ss_pred HhcCCCEeccCCC
Confidence 9999999865443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=222.13 Aligned_cols=157 Identities=29% Similarity=0.390 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||++...... ......||..|+|||.+.+ ..++.
T Consensus 99 ~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 175 (279)
T cd05633 99 MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDS 175 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCc
Confidence 4456788999999999999999999999999987776 999999998643222 2233469999999999864 44554
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|+||+||++|+|++|..||........ .............. ...++.+++++|++||..||.+|+ |+++
T Consensus 176 ~-~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 251 (279)
T cd05633 176 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVEL--PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQE 251 (279)
T ss_pred h-hhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCC--ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 4 8999999999999999999976443221 11111111122222 236899999999999999999999 6999
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 252 ~~~h~~~~~~ 261 (279)
T cd05633 252 VKEHVFFKGI 261 (279)
T ss_pred HHhCccccCC
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=226.79 Aligned_cols=151 Identities=23% Similarity=0.382 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ...+..+++.|+|||++.+..
T Consensus 175 ~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 252 (338)
T cd05102 175 DLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252 (338)
T ss_pred HHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCC
Confidence 34567789999999999999999999999999987765 9999999997432211 112334678899999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+...+ .... .......+++.+.+|+.+||..||.+|||+.++
T Consensus 253 ~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 253 YTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL---KDGT-RMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred CCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---hcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8766 899999999999997 999998755433332222 2211 122234678999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 328 ~~ 329 (338)
T cd05102 328 VE 329 (338)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=231.06 Aligned_cols=158 Identities=27% Similarity=0.472 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccc-----
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~----- 79 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +||+|||++........ ....+||+.|+|||++.+
T Consensus 105 ~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (332)
T cd05623 105 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182 (332)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcceecccccCccccCHHHHhccccCC
Confidence 345678899999999999999999999999987766 99999999874322221 123479999999999862
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC-CCCcCCHHHHHHHHHhcccCCCC--CCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRVSADCRHLLSQIFVADPSK--RIP 156 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~--R~t 156 (246)
..++. ++|||||||++|+|++|+.||........+.++.... .....| ....++.++++||++||..++.+ |++
T Consensus 183 ~~~~~-~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~ 259 (332)
T cd05623 183 GKYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG 259 (332)
T ss_pred CCCCC-cCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCccccCCHHHHHHHHHHccChhhhcCCCC
Confidence 33444 4899999999999999999998765544443332211 111122 23457999999999999765554 689
Q ss_pred HHHHhcCcccccC
Q 025933 157 IPEIKKHPWFLKN 169 (246)
Q Consensus 157 ~~e~l~hp~~~~~ 169 (246)
++++++||||...
T Consensus 260 ~~~~~~h~~f~~~ 272 (332)
T cd05623 260 IEDFKQHPFFTGI 272 (332)
T ss_pred HHHHhCCCCcCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=247.63 Aligned_cols=167 Identities=31% Similarity=0.465 Sum_probs=131.2
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccc-
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLAR- 79 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~- 79 (246)
|+||+.-+ +.||.-+|+.|.|||||||+||||+..|+ |||+|||.|-.....+ ...+.+|||.|.+||++..
T Consensus 177 ArFY~aEi---VlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 177 ARFYTAEI---VLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred HHHHHHHH---HHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 56676554 47888999999999999999999999888 9999999986443222 2345689999999999952
Q ss_pred --c-ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 80 --K-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 80 --~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
. +.++..+|+||+||++|+|+.|..||+...-..++.+++..- ..+.+|....+|+++++||.+++. +|..|.+
T Consensus 252 ~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 252 GDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--ESLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred cCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh--hhcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 1 344666999999999999999999999866666666665442 244556556799999999999766 7889998
Q ss_pred ---HHHHhcCcccccCCChHHHHH
Q 025933 157 ---IPEIKKHPWFLKNLPKEIIEI 177 (246)
Q Consensus 157 ---~~e~l~hp~~~~~~~~~~~~~ 177 (246)
++++..||||.+.....+.+.
T Consensus 329 rngiedik~HpFF~g~~W~~iR~~ 352 (1317)
T KOG0612|consen 329 RNGIEDIKNHPFFEGIDWDNIRES 352 (1317)
T ss_pred cccHHHHHhCccccCCChhhhhhc
Confidence 999999999987655444433
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=222.03 Aligned_cols=161 Identities=24% Similarity=0.299 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+||+++. ++. +||+|||+++..... .......+++.|+|||++.+...
T Consensus 111 ~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 188 (295)
T cd07837 111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH 188 (295)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeecccceecCCCccccCCcccccCCCChHHhhCCCC
Confidence 44567889999999999999999999999999987 444 999999998753222 12223467889999999865443
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C------------CC---------CCCcCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F------------LP---------DYVRVSADCR 140 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~------------~~---------~~~~~~~~~~ 140 (246)
...++|+||+||++|+|++|..||.+........++......... . .+ ..+.++..+.
T Consensus 189 ~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (295)
T cd07837 189 YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGL 268 (295)
T ss_pred CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHH
Confidence 334499999999999999999999877665555544433211000 0 00 0134789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
+||.+||..||.+||++.+++.||||.
T Consensus 269 ~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 269 DLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=220.76 Aligned_cols=160 Identities=26% Similarity=0.446 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
...+.|++.||.|||+++|+||||||+|||++.++. +||+|||++.... .......+||..|+|||++.+..++.+
T Consensus 98 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~- 173 (279)
T cd06619 98 GRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIH- 173 (279)
T ss_pred HHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecc-cccccCCCCChhhcCceeecCCCCCCc-
Confidence 456788999999999999999999999999988776 9999999987432 222344579999999999988777655
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRN---FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|+||+||++|+|++|..||........ .......+.............++++++++.+||+.||.+||++++++.|
T Consensus 174 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 8999999999999999999965322111 1111222111111111123478899999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|||....
T Consensus 254 ~~~~~~~ 260 (279)
T cd06619 254 PFIVQYN 260 (279)
T ss_pred ccccccc
Confidence 9997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=220.27 Aligned_cols=165 Identities=25% Similarity=0.316 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC--CCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~ 79 (246)
.=+++.||+.|++|||++-|+||||||.|||+..++ .++|||+|||+++.+...- .....+.|.+|.|||.+.|
T Consensus 134 vKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 134 VKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred HHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 346788999999999999999999999999997663 2569999999998543221 1223468999999999999
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCC---------hHHHHHHHHHHhcc-ccC------CCC------------
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------PRNFRKTIDRIRNV-QYF------LPD------------ 131 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---------~~~~~~~~~~~~~~-~~~------~~~------------ 131 (246)
...++++.|+||+|||+.||++-.+-|.+... .+++.+++.-+... ... .|+
T Consensus 214 a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~ 293 (438)
T KOG0666|consen 214 ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHY 293 (438)
T ss_pred cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhh
Confidence 88777889999999999999998887765321 12233333221100 000 011
Q ss_pred ------------CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 132 ------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 132 ------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
...-++.+.+|+.+||..||.+|+|++++|+|+||+...
T Consensus 294 ~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 294 YDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred cCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 111345689999999999999999999999999998763
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=221.12 Aligned_cols=160 Identities=26% Similarity=0.350 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||+|||.++|+||||+|+||+++.++. +||+|||++...... .......+++.|+|||++.+....
T Consensus 101 ~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 178 (284)
T cd07860 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCccccccccccccccCCeEEecCCCC
Confidence 34567888999999999999999999999999998776 999999998743222 122234578899999998765543
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------cCCC---------CCCcCCHHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------YFLP---------DYVRVSADCR 140 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~~~~~ 140 (246)
..++|+|||||++|+|++|+.||.+........+......... ..++ ....++.+++
T Consensus 179 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07860 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGR 258 (284)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHH
Confidence 4558999999999999999999987665544444333211100 0000 0124788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
++|.+||..||.+|||++++++||||
T Consensus 259 ~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 259 DLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=218.95 Aligned_cols=156 Identities=28% Similarity=0.432 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.|+.|||+++|+||||||+||+++.++. .++|+|||+++... ......|+..|+|||++.+..++.
T Consensus 110 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 185 (267)
T PHA03390 110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPSCYDGTLDYFSPEKIKGHNYDV 185 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCccCCCCCcccChhhhcCCCCCc
Confidence 44567889999999999999999999999999988761 49999999987432 123346899999999998888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-HHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-IPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~h 163 (246)
+ +|+||+||++|+|++|..||............+.... ....+....+++.+++||.+||+.||.+|++ ++++++|
T Consensus 186 ~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 186 S-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred h-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 5 8999999999999999999975443221111111111 2222333468999999999999999999996 6999999
Q ss_pred cccc
Q 025933 164 PWFL 167 (246)
Q Consensus 164 p~~~ 167 (246)
|||.
T Consensus 263 ~~~~ 266 (267)
T PHA03390 263 PFLK 266 (267)
T ss_pred Cccc
Confidence 9995
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=223.44 Aligned_cols=160 Identities=32% Similarity=0.582 Sum_probs=131.3
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 81 (246)
|++|. +.|+-||-|||++|||+||||.+|||+++.++ |||+|||+++...... ..++.||||.|+|||++..++
T Consensus 452 AvFYA---aEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP 526 (683)
T KOG0696|consen 452 AVFYA---AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP 526 (683)
T ss_pred hhhhh---HHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcceeeecCCCcccccceEEecc
Confidence 44444 34668899999999999999999999999887 9999999998654333 446779999999999999999
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI---- 157 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---- 157 (246)
|. +.+|+||+||+||||+.|++||.+.+..+.+..+.+. ....|. .+|.++.++.+.+|.+.|.+|...
T Consensus 527 Yg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----nvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~g 599 (683)
T KOG0696|consen 527 YG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----NVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEG 599 (683)
T ss_pred cc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----cCcCcc--cccHHHHHHHHHHhhcCCccccCCCCcc
Confidence 85 5599999999999999999999987776555555443 333444 789999999999999999999865
Q ss_pred -HHHhcCcccccCCChHH
Q 025933 158 -PEIKKHPWFLKNLPKEI 174 (246)
Q Consensus 158 -~e~l~hp~~~~~~~~~~ 174 (246)
.++..||||+......+
T Consensus 600 e~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 600 ERDIREHPFFRRIDWEKL 617 (683)
T ss_pred ccchhhCcchhhccHHHH
Confidence 57999999986544333
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=227.65 Aligned_cols=161 Identities=29% Similarity=0.410 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcccc-ccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARK-EYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~ 83 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++..... .......++..|+|||.+.+. .++
T Consensus 110 ~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (337)
T cd07858 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYT 187 (337)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCcccccccccccCccChHHHhcCCCCC
Confidence 3556789999999999999999999999999988766 999999998754322 222345688999999998653 444
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------hcccc-----CCCCCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------------RNVQY-----FLPDYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~--------------------~~~~~-----~~~~~~~~~~~ 138 (246)
.++|+|||||++|+|++|+.||.+.+....+..+.... ..... .....+.++..
T Consensus 188 -~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (337)
T cd07858 188 -TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL 266 (337)
T ss_pred -CcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHH
Confidence 44899999999999999999997654322221111100 00000 00112357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+++||++||+.||.+|||++++++||||...
T Consensus 267 ~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 267 AIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=219.85 Aligned_cols=154 Identities=32% Similarity=0.453 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC-----CCCCCCCCCCcchhcccc-
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-----KSTVGTPAYIAPEVLARK- 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~~~~~- 80 (246)
..++.|++.||.|||+++|+||||||+||+++.++. +||+|||++......... ....|+..|+|||++...
T Consensus 105 ~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 182 (267)
T cd06610 105 ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182 (267)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHcccc
Confidence 456788899999999999999999999999998766 999999998744332221 334689999999998766
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC---CCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD---YVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
.++.+ +|+|||||++|+|++|..||........+.+.... .....+. ...++..+++++.+||..||.+|||+
T Consensus 183 ~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (267)
T cd06610 183 GYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTA 258 (267)
T ss_pred CcCcc-cchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCH
Confidence 45444 89999999999999999999766554433333222 1111111 23678999999999999999999999
Q ss_pred HHHhcCccc
Q 025933 158 PEIKKHPWF 166 (246)
Q Consensus 158 ~e~l~hp~~ 166 (246)
.++++||||
T Consensus 259 ~~ll~~p~~ 267 (267)
T cd06610 259 EELLKHKFF 267 (267)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=219.61 Aligned_cols=159 Identities=25% Similarity=0.412 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.+|.|||+++|+||||||+||+++.++. +||+|||++....... ......++..|+|||++.+....+
T Consensus 102 ~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (286)
T cd07847 102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCcccccCcccccccCCHHHHhCCCCcC
Confidence 4567888999999999999999999999999987765 9999999987543322 223346888999999987644323
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------cc----CCCC----------CCcCCHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------QY----FLPD----------YVRVSADC 139 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-----------~~----~~~~----------~~~~~~~~ 139 (246)
.++|+||+||++|+|++|..||.+....+....+....... .+ ..+. ...++..+
T Consensus 180 ~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07847 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPA 259 (286)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHH
Confidence 44899999999999999999998766544433322211100 00 0011 23568899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+||.+||..||++|||+.+++.||||
T Consensus 260 ~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 260 LSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=227.37 Aligned_cols=158 Identities=28% Similarity=0.485 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhccc-----
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~----- 79 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++......... ...+||+.|+|||++.+
T Consensus 105 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05597 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182 (331)
T ss_pred HHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCccccceeccccccCHHHHhhccccc
Confidence 446778999999999999999999999999987776 999999998643322221 22469999999999863
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC-CCCCcCCHHHHHHHHHhcccCCCC--CCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDYVRVSADCRHLLSQIFVADPSK--RIP 156 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~--R~t 156 (246)
..++ .++||||+||++|+|++|+.||.+....+.+..+.... ..... +....++..+++||++||..++.+ |++
T Consensus 183 ~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~ 259 (331)
T cd05597 183 GRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG 259 (331)
T ss_pred cCCC-CcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CcccCCCccCCCCHHHHHHHHHHccCcccccCCCC
Confidence 2333 44899999999999999999998755444433332211 11112 223357999999999999765444 789
Q ss_pred HHHHhcCcccccC
Q 025933 157 IPEIKKHPWFLKN 169 (246)
Q Consensus 157 ~~e~l~hp~~~~~ 169 (246)
++++++||||...
T Consensus 260 ~~~~l~hp~~~~~ 272 (331)
T cd05597 260 LQDFKDHPFFEGI 272 (331)
T ss_pred HHHHhcCCCCCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=216.13 Aligned_cols=153 Identities=25% Similarity=0.399 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.++.+||++||+||||||+||+++.++. ++|+|||++....... ......|++.|+|||++.+..++.
T Consensus 104 ~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (257)
T cd08223 104 VVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181 (257)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCccccccCCcCccChhHhcCCCCCc
Confidence 3567788999999999999999999999999987766 9999999987432221 223446899999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||...+....... +..... .+....++..+.+++.+||..||.+|||+.++++||
T Consensus 182 ~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 182 K-SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred h-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 5 8999999999999999999976443222222 222111 122246889999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
||
T Consensus 256 ~~ 257 (257)
T cd08223 256 YI 257 (257)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=221.10 Aligned_cols=151 Identities=17% Similarity=0.158 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchhc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVL 77 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~~ 77 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+...... ......||+.|+|||++
T Consensus 128 ~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence 3567889999999999999999999999999987765 9999999987432111 11234699999999999
Q ss_pred cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH-----HHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 78 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
.+..++.+ +||||+||++|+|++|..||.+......... .+.++..... .....+..+.++++.||..+|.
T Consensus 206 ~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 281 (294)
T PHA02882 206 NGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYE 281 (294)
T ss_pred CCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCC
Confidence 88888655 8999999999999999999987643222211 1222222222 2235689999999999999999
Q ss_pred CCCCHHHHhc
Q 025933 153 KRIPIPEIKK 162 (246)
Q Consensus 153 ~R~t~~e~l~ 162 (246)
+||+++++++
T Consensus 282 ~rp~~~~l~~ 291 (294)
T PHA02882 282 EKPDYDALIK 291 (294)
T ss_pred CCCCHHHHHH
Confidence 9999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=228.05 Aligned_cols=161 Identities=24% Similarity=0.306 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++... .......|++.|+|||.+.+....+.+
T Consensus 120 ~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (342)
T cd07879 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD--AEMTGYVVTRWYRAPEVILNWMHYNQT 195 (342)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC--CCCCCceeeecccChhhhcCccccCch
Confidence 346788999999999999999999999999988766 9999999987532 223345688999999998764323344
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------ccccCCC------CCCcCCHHHHH
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------------NVQYFLP------DYVRVSADCRH 141 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~------~~~~~~~~~~~ 141 (246)
+|+|||||++|+|++|+.||.+......+..++.... ......+ .++..+..+.+
T Consensus 196 ~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (342)
T cd07879 196 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVD 275 (342)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHH
Confidence 8999999999999999999987554333333222100 0000000 12346788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
||.+||+.||.+||++.+++.||||.....
T Consensus 276 li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 276 LLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=226.34 Aligned_cols=162 Identities=25% Similarity=0.337 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc-
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK- 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~- 80 (246)
...++.|++.||.|||++||+||||||.|||++.++. ++|+|||++....... ......++..|+|||.+.+.
T Consensus 105 ~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (330)
T cd07834 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS 182 (330)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccccccccccccccccCcCCceeeeccc
Confidence 3457888999999999999999999999999988765 9999999987543322 23345689999999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------------cC-----CCCCCcC
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------------YF-----LPDYVRV 135 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------~~-----~~~~~~~ 135 (246)
.++. ++|+||+||++|+|++|.+||.+......+..+........ .. ......+
T Consensus 183 ~~~~-~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (330)
T cd07834 183 RYTK-AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA 261 (330)
T ss_pred CCCc-chhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccC
Confidence 5544 48999999999999999999987665444443333211000 00 0012346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 136 ~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+..+.+||.+||.++|.+|||+++++.||||.+..
T Consensus 262 ~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 262 SPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 88999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=222.97 Aligned_cols=155 Identities=34% Similarity=0.544 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------------------------
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------------------- 60 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------------------- 60 (246)
..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++.......
T Consensus 106 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (316)
T cd05574 106 RFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183 (316)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcc
Confidence 345678999999999999999999999999988766 9999999976322111
Q ss_pred ----CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCC
Q 025933 61 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136 (246)
Q Consensus 61 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (246)
......||..|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++. ......+....++
T Consensus 184 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~ 258 (316)
T cd05574 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL----KKEVTFPGSPPVS 258 (316)
T ss_pred cccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHh----cCCccCCCccccC
Confidence 0112368899999999988777655 899999999999999999998766554443332 2233344444479
Q ss_pred HHHHHHHHHhcccCCCCCCC----HHHHhcCccccc
Q 025933 137 ADCRHLLSQIFVADPSKRIP----IPEIKKHPWFLK 168 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t----~~e~l~hp~~~~ 168 (246)
..++++|++||..||++||| +++++.||||..
T Consensus 259 ~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 99999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=219.81 Aligned_cols=158 Identities=29% Similarity=0.434 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++.............++..|+|||++.+..++.+
T Consensus 97 ~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 174 (277)
T cd05577 97 AIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCch
Confidence 4556789999999999999999999999999988776 99999999875433333344568889999999987776655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|+||+||++|+|++|+.||...........+......... .....+++.+.++|++||+.||.+|| ++.++
T Consensus 175 -~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 175 -VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred -hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 89999999999999999999765542222222222222222 22235799999999999999999999 88889
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
+.||||..
T Consensus 252 l~h~~~~~ 259 (277)
T cd05577 252 REHPLFKD 259 (277)
T ss_pred HhChhhhc
Confidence 99999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=219.74 Aligned_cols=153 Identities=27% Similarity=0.354 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccc-----c
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLAR-----K 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~-----~ 80 (246)
..++.|++.|+.|||+++|+||||||+||+++.++. ++|+|||++..... ........|++.|+|||.+.. .
T Consensus 124 ~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~ 201 (282)
T cd06636 124 AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201 (282)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCc
Confidence 445678999999999999999999999999988776 99999999874322 122334578999999999863 3
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|+|||||++|+|++|..||........... +............++.++.+||.+||..||.+|||+.++
T Consensus 202 ~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 202 TYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred CCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 45444 8999999999999999999976543322221 111111111223578999999999999999999999999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
++||||
T Consensus 277 l~~~~~ 282 (282)
T cd06636 277 LKHPFI 282 (282)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=221.42 Aligned_cols=159 Identities=26% Similarity=0.377 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......|++.|+|||.+.+..++
T Consensus 117 ~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 194 (296)
T cd06654 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCcccCCccccCHHHHcCCCCC
Confidence 34567788999999999999999999999999987765 9999999987432221 12334789999999999877776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|+|||||++|+|++|+.||........... .........+....++..+.+|+.+||..||++|||+.++++|
T Consensus 195 ~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 55 8999999999999999999976554322221 1122222223344688999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 271 ~~~~~~ 276 (296)
T cd06654 271 QFLKIA 276 (296)
T ss_pred hhhhcc
Confidence 999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=219.70 Aligned_cols=160 Identities=27% Similarity=0.350 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.+|.|||+++|+|+||||+||+++.++. ++|+|||++....... ......|+..|+|||.+.+....
T Consensus 101 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 178 (286)
T cd07832 101 VKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCccccccCcccccCceeeeccccC
Confidence 3456778999999999999999999999999988766 9999999987543322 12345689999999998765543
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------CC---------CCCCcCCHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------FL---------PDYVRVSADC 139 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~---------~~~~~~~~~~ 139 (246)
..++||||+||++|+|++|.+||.+..+...+..+......... .. ...+..+..+
T Consensus 179 ~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (286)
T cd07832 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEA 258 (286)
T ss_pred CchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHH
Confidence 45599999999999999999888776655544444332211000 00 0113467899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
.+||.+||..||.+|||++++++||||.
T Consensus 259 ~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 259 LDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 9999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=219.66 Aligned_cols=160 Identities=26% Similarity=0.360 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++...... .......+++.|+|||.+.+....
T Consensus 107 ~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 184 (293)
T cd07843 107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184 (293)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCccccccccccccccCchhhcCCccc
Confidence 34567889999999999999999999999999998776 999999998754332 222334688999999998765433
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------cc-------CCCCCCc--CCH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------------QY-------FLPDYVR--VSA 137 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-----------------~~-------~~~~~~~--~~~ 137 (246)
..++|+||+||++|+|++|.+||........+.++....... .. ....+.. ++.
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (293)
T cd07843 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSD 264 (293)
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCCh
Confidence 344899999999999999999998766655444443321100 00 0011112 488
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+.+||++||+.||++|||+.|++.||||
T Consensus 265 ~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 265 NGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=226.55 Aligned_cols=164 Identities=24% Similarity=0.340 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
....+.|++.||.|||++||+||||||+||+++.++. +||+|||++.... .......++..|+|||.+.+....+.
T Consensus 120 ~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (343)
T cd07851 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccc--ccccCCcccccccCHHHHhCCCCCCc
Confidence 3456788999999999999999999999999988766 9999999987532 22344578899999999865433334
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------------ccC-----CCCCCcCCHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------------QYF-----LPDYVRVSADCR 140 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------~~~-----~~~~~~~~~~~~ 140 (246)
++|+||+||++|+|++|+.||.+......+..+....... ... ...+...+..+.
T Consensus 196 ~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 275 (343)
T cd07851 196 TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI 275 (343)
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHH
Confidence 4899999999999999999998765544443333221000 000 001124689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCCChH
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 173 (246)
+||.+||..||.+|||+.++++||||.+...+.
T Consensus 276 dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 276 DLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=220.13 Aligned_cols=159 Identities=26% Similarity=0.393 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
..+..+.|++.|+.|||+++|+||||||+||+++.++. +||+|||++........ .....|+..|+|||.+.+..++
T Consensus 116 ~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 193 (296)
T cd06655 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCcCCCccccCcchhcCCCCC
Confidence 34566788999999999999999999999999987766 99999999875332221 2234688999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|+|||||++|+|++|..||.+........... ............++..+++||++||..||.+|||+.+++.|
T Consensus 194 ~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 194 PK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 55 899999999999999999998765433322221 11122223344688999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 270 ~~~~~~ 275 (296)
T cd06655 270 PFLKLA 275 (296)
T ss_pred hHhhhc
Confidence 999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=236.34 Aligned_cols=159 Identities=36% Similarity=0.600 Sum_probs=138.5
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
+..+|.+ ++.|++|||.++|||||||++|||++.+.+ +||+|||++..+.......+.||++.|.|||++.+..|
T Consensus 157 ar~~F~q---~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y 231 (596)
T KOG0586|consen 157 ARAKFRQ---IVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKY 231 (596)
T ss_pred hhhhhHH---HHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccccCCCCCccChHhhcCccc
Confidence 3456665 558999999999999999999999998887 99999999998777777889999999999999999999
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+..+|+||+|+++|.|++|..||.+.. +.....++...++..|. -++.+|.+||+++|.++|.+|++.+++++
T Consensus 232 ~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 232 DGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred CCcceehhhhhhhheeeeecccccCCcc----cccccchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 9999999999999999999999998744 33444455666777777 48999999999999999999999999999
Q ss_pred CcccccCCCh
Q 025933 163 HPWFLKNLPK 172 (246)
Q Consensus 163 hp~~~~~~~~ 172 (246)
|.|.......
T Consensus 306 ~~W~n~~~~~ 315 (596)
T KOG0586|consen 306 DRWRNDLLEA 315 (596)
T ss_pred hcccchhhhh
Confidence 9998655443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=215.40 Aligned_cols=158 Identities=30% Similarity=0.467 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|+|+++++|+||||.||+++.++. ++|+|||+++............|++.|++||.+.+..++.+
T Consensus 95 ~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 172 (262)
T cd05572 95 ARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172 (262)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCCh
Confidence 3456778999999999999999999999999988776 99999999885443323334578999999999887777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
+|+||+|+++|+|++|..||...... ..+....+.............+.+++++|.+||..||.+|++ ++|+
T Consensus 173 -~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l 249 (262)
T cd05572 173 -VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI 249 (262)
T ss_pred -hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHH
Confidence 89999999999999999999765521 122222333211122222345899999999999999999999 9999
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
++||||..
T Consensus 250 ~~~~~~~~ 257 (262)
T cd05572 250 KKHKWFNG 257 (262)
T ss_pred hcChhhhC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.38 Aligned_cols=159 Identities=28% Similarity=0.368 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|||+++|+||||+|+||+++.++. ++|+|||+++..... .......|++.|+|||.+.+..++.
T Consensus 100 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 177 (274)
T cd06609 100 IAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177 (274)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeecccccccccccCCccccChhhhccCCCCc
Confidence 3556788999999999999999999999999998776 999999998754332 2233457889999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+|||||++|+|++|..||......... ..+... ....+. ..++..+.+++.+||..+|.+|||++++++|
T Consensus 178 ~-sDv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 178 K-ADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred h-hhHHHHHHHHHHHHhCCCCcccCchHHHH----HHhhhcCCCCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 5 89999999999999999999765432222 122221 111222 1278999999999999999999999999999
Q ss_pred cccccCCCh
Q 025933 164 PWFLKNLPK 172 (246)
Q Consensus 164 p~~~~~~~~ 172 (246)
|||.+....
T Consensus 252 ~~~~~~~~~ 260 (274)
T cd06609 252 KFIKKAKKT 260 (274)
T ss_pred hhhcCCCcc
Confidence 999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=252.90 Aligned_cols=152 Identities=26% Similarity=0.433 Sum_probs=122.9
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccccc--c
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLARKE--Y 82 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~ 82 (246)
+.|++.|+.|||++|||||||||+||+++.+|. +|++|||.|+....+. .....+||+.|||||++.+.. .
T Consensus 1340 t~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG 1417 (1509)
T KOG4645|consen 1340 TKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKG 1417 (1509)
T ss_pred HHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCC
Confidence 567889999999999999999999999998886 9999999987443332 223568999999999997644 2
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-cccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+.++||||||||+.||+||+.||...+.. ..++..+.. ..+.+|. ++|.+.++||.+||+.||++|.++.|++
T Consensus 1418 ~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1418 HGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred CCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 344589999999999999999999765443 445554433 2333444 6999999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
.|.|-..
T Consensus 1493 e~~f~~~ 1499 (1509)
T KOG4645|consen 1493 EHAFGKS 1499 (1509)
T ss_pred Hhhcccc
Confidence 9998543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=214.42 Aligned_cols=155 Identities=26% Similarity=0.402 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|||.++|+||||+|.||+++.++. +||+|||++....... ......|+..|+|||++.+..++.
T Consensus 101 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 178 (256)
T cd06612 101 IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccccCCccccCHHHHhcCCCCc
Confidence 3456788999999999999999999999999988776 9999999987543322 223345889999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +||||+||++|+|++|+.||............ .............++..+.++|.+||+.||.+|||+.+++.||
T Consensus 179 ~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 179 K-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---ccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 5 89999999999999999999764432221111 1111111222335788999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
||
T Consensus 255 ~~ 256 (256)
T cd06612 255 FI 256 (256)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.76 Aligned_cols=158 Identities=29% Similarity=0.431 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-ccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 84 (246)
...++.|++.|++|||+++|+||||||+||+++.++. +||+|||++..... .......|+..|+|||++.+. .++.
T Consensus 99 ~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 175 (278)
T cd05606 99 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDS 175 (278)
T ss_pred HHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCc-cCCcCcCCCcCCcCcHHhcCCCCCCc
Confidence 3456788899999999999999999999999987765 99999999874322 223345799999999999754 4554
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|+||+||++|+|++|..||.+...... ..............|. .++..+.+++.+||..+|.+|+ ++.+
T Consensus 176 ~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ 251 (278)
T cd05606 176 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251 (278)
T ss_pred c-cchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHH
Confidence 4 8999999999999999999976533211 1122222222222333 5799999999999999999999 9999
Q ss_pred HhcCcccccCC
Q 025933 160 IKKHPWFLKNL 170 (246)
Q Consensus 160 ~l~hp~~~~~~ 170 (246)
+++||||....
T Consensus 252 ll~~~~~~~~~ 262 (278)
T cd05606 252 VKEHPFFRSLD 262 (278)
T ss_pred HHhCccccCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=200.87 Aligned_cols=160 Identities=23% Similarity=0.361 Sum_probs=129.3
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
+-++|++.+|.|||++++.||||||+|+||+.++. +||+|||+++.+... ......+.|.+|.+|.++.+...+...
T Consensus 105 sfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~ts 182 (292)
T KOG0662|consen 105 SFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182 (292)
T ss_pred HHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccc
Confidence 45789999999999999999999999999999887 999999999854332 344455789999999999987765555
Q ss_pred hhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc-------CCCC----------------CCcCCHHHHHH
Q 025933 87 SDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY-------FLPD----------------YVRVSADCRHL 142 (246)
Q Consensus 87 ~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~----------------~~~~~~~~~~l 142 (246)
.|+||.|||+.|+.. |++-|.+.+-.+++.+++........ .+|. .++++...++|
T Consensus 183 idmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdl 262 (292)
T KOG0662|consen 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDL 262 (292)
T ss_pred hHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHH
Confidence 899999999999986 88888888777788777765422111 0111 12345678999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 143 LSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+.++|.-+|.+|++++++++||||...
T Consensus 263 lqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 263 LQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHHhccCcccccCHHHHhcCcccccc
Confidence 999999999999999999999999754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=224.44 Aligned_cols=161 Identities=27% Similarity=0.345 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC------CCCCCCCCCCCCcchhcccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS------QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 80 (246)
..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... ......||..|+|||.+.+.
T Consensus 110 ~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence 456789999999999999999999999999988876 9999999987433221 11234689999999988664
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------------------cccc--CCCCCCcC
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-----------------------NVQY--FLPDYVRV 135 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~-----------------------~~~~--~~~~~~~~ 135 (246)
.....++|+||+||++|+|++|+.||.+........+...... .... .....+.+
T Consensus 188 ~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (337)
T cd07852 188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA 267 (337)
T ss_pred ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCC
Confidence 4334559999999999999999999976555443333222110 0000 00112347
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 136 ~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+.++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 268 ~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 268 SDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 8999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=219.52 Aligned_cols=159 Identities=28% Similarity=0.472 Sum_probs=124.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|||+++|+||||||+||+++.++. +||+|||++...... .......|+..|+|||.+.+..++.
T Consensus 120 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 197 (292)
T cd06658 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197 (292)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCceeecCccccCHHHHccCCCCc
Confidence 4566788999999999999999999999999988766 999999998643221 1223456899999999998777765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|+.||........+..+. . ......+....++..+.+++.+||..||.+|||++++++||
T Consensus 198 ~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 198 E-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-D--NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h--cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 5 899999999999999999998655433322211 1 11222233335788999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||....
T Consensus 274 ~~~~~~ 279 (292)
T cd06658 274 FLKLAG 279 (292)
T ss_pred hhhccC
Confidence 997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=214.62 Aligned_cols=152 Identities=31% Similarity=0.420 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-------CCCCCCCCCCCCcchhccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 79 (246)
..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......|+..|+|||.+.+
T Consensus 109 ~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred HHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCCccccccccCCCcCccChhHhcc
Confidence 456788999999999999999999999999987766 9999999987543111 1122358899999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|+||+||++|+|++|..||.+........+ +... ........++..+.++|++||+.||.+||++.+
T Consensus 187 ~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 187 TSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IGEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hhcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 777655 8999999999999999999986544332222 1111 111222357899999999999999999999999
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
+++||||
T Consensus 261 il~~~~~ 267 (267)
T cd06628 261 LLKHPFL 267 (267)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=221.68 Aligned_cols=159 Identities=26% Similarity=0.324 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC----CCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG----SPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVL 77 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~----~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~ 77 (246)
...++.|++.||+|||+++|+||||||+||+++. ++. +||+|||++........ .....+++.|+|||++
T Consensus 110 ~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (316)
T cd07842 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187 (316)
T ss_pred HHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCccccccCCCcccccccCCccccccccCHHHH
Confidence 4567789999999999999999999999999987 554 99999999875322211 2234688999999998
Q ss_pred cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH---------HHHHHHHHHhcc-------------------ccCC
Q 025933 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---------NFRKTIDRIRNV-------------------QYFL 129 (246)
Q Consensus 78 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------~~~~~~~~~~~~-------------------~~~~ 129 (246)
.+......++|+|||||++|+|++|++||.+..... .+.+++..+... ....
T Consensus 188 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (316)
T cd07842 188 LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKT 267 (316)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccC
Confidence 765433445999999999999999999997654321 111111110000 0000
Q ss_pred CCC------------CcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 130 PDY------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 130 ~~~------------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
... ...+..+.++|.+||..||++|||+.+++.||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 268 KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 111 1467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=217.54 Aligned_cols=156 Identities=28% Similarity=0.379 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccc---
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKE--- 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--- 81 (246)
...++.|++.||+|||+++|+||||||+||+++.++. +||+|||++....... ......|+..|+|||++....
T Consensus 130 ~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 207 (291)
T cd06639 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD 207 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccccccCccCCccccChhhhcCCCCcc
Confidence 4557888999999999999999999999999988766 9999999987533222 123346899999999986432
Q ss_pred --cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 --YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 --~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|+||+||++|+|++|+.||..........++. .............+..+.+||.+||+.+|.+||++.+
T Consensus 208 ~~~~~~-~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 208 YSYDAR-CDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred cccCCc-cchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 3444 899999999999999999997654433332211 1111122223357789999999999999999999999
Q ss_pred HhcCcccc
Q 025933 160 IKKHPWFL 167 (246)
Q Consensus 160 ~l~hp~~~ 167 (246)
++.||||+
T Consensus 284 il~~~~~~ 291 (291)
T cd06639 284 LLEHPFIK 291 (291)
T ss_pred HhcCcccC
Confidence 99999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=216.83 Aligned_cols=159 Identities=30% Similarity=0.529 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|||+++|+||||||+||+++.++. ++|+|||++....... ......|++.|+|||.+.+..++.
T Consensus 117 ~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (285)
T cd06648 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCC
Confidence 3567888999999999999999999999999988766 9999999876432211 223346899999999998877766
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+||++|+|++|..||.......... .+... .........++..+.+|+.+||..+|++|||+.++++|
T Consensus 195 ~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 195 E-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 5 899999999999999999997654433322 22222 11222233478999999999999999999999999999
Q ss_pred cccccCCC
Q 025933 164 PWFLKNLP 171 (246)
Q Consensus 164 p~~~~~~~ 171 (246)
|||.+...
T Consensus 270 ~~~~~~~~ 277 (285)
T cd06648 270 PFLAKAGP 277 (285)
T ss_pred cccccCCC
Confidence 99987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=217.40 Aligned_cols=157 Identities=28% Similarity=0.511 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc----cc
Q 025933 7 FSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR----KE 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~----~~ 81 (246)
..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++.............|+..|+|||.+.+ ..
T Consensus 106 ~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (283)
T cd06617 106 GKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183 (283)
T ss_pred HHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccccccccccCCccccChhhcCCcccccc
Confidence 46678899999999998 9999999999999988776 99999999875432222233568999999999864 33
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+||+||++|+|++|..||...... +.+... ........+. ..++.++++||.+||..+|.+||++.++
T Consensus 184 ~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~i 258 (283)
T cd06617 184 YDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPEL 258 (283)
T ss_pred cCcc-ccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4444 89999999999999999999653322 222221 1111222222 2478999999999999999999999999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
+.||||.+..
T Consensus 259 l~~~~~~~~~ 268 (283)
T cd06617 259 LQHPFFELHL 268 (283)
T ss_pred hcCchhhhcc
Confidence 9999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=221.84 Aligned_cols=160 Identities=21% Similarity=0.310 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchhc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVL 77 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~~ 77 (246)
...++.|++.||.|||+++|+||||||+|||++.++. ++++|||.+....... ......++..|+|||++
T Consensus 103 ~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 103 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHh
Confidence 4567888999999999999999999999999988776 9999998654221111 11223567889999999
Q ss_pred ccc--ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------------------------
Q 025933 78 ARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------------------------- 126 (246)
Q Consensus 78 ~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------- 126 (246)
.+. .++.+ +||||+||++|+|++|..||....................
T Consensus 181 ~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T cd08227 181 QQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTT 259 (327)
T ss_pred hcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccc
Confidence 753 45544 8999999999999999999976543332222111000000
Q ss_pred -----------cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 127 -----------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 127 -----------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
...+....+++.+++||.+||+.||.+|||+.++++||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 260 VSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000111235778999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=226.16 Aligned_cols=157 Identities=27% Similarity=0.469 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhccc-----c
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLAR-----K 80 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~-----~ 80 (246)
.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++........ ...+||+.|+|||++.+ .
T Consensus 106 ~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (331)
T cd05624 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183 (331)
T ss_pred HHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCC
Confidence 45678899999999999999999999999987776 999999998743322211 23469999999999865 3
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC-CCCcCCHHHHHHHHHhcccCCCC--CCCH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRVSADCRHLLSQIFVADPSK--RIPI 157 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~--R~t~ 157 (246)
.++ .++|+||+||++|+|++|+.||.+......+.++.... ....+| ....++..+++||.+||..++.+ |+++
T Consensus 184 ~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~ 260 (331)
T cd05624 184 KYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGI 260 (331)
T ss_pred CCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC--CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCH
Confidence 344 44899999999999999999998755444333332211 111122 23457899999999999976654 5689
Q ss_pred HHHhcCcccccC
Q 025933 158 PEIKKHPWFLKN 169 (246)
Q Consensus 158 ~e~l~hp~~~~~ 169 (246)
+++++||||...
T Consensus 261 ~~~~~h~~f~~~ 272 (331)
T cd05624 261 EDFKKHAFFEGI 272 (331)
T ss_pred HHHhcCCCcCCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=217.42 Aligned_cols=148 Identities=23% Similarity=0.251 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc--ccc
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 82 (246)
-+.++.|++.|+.|||. .+++||||||+|||++.++. +||+|||+++... .......||..|+|||++.+ ..+
T Consensus 124 ~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 199 (283)
T PHA02988 124 KLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILS--SPPFKNVNFMVYFSYKMLNDIFSEY 199 (283)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhc--cccccccCcccccCHHHhhhccccc
Confidence 35678899999999998 48999999999999998776 9999999987432 22234578999999999976 566
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|..||.+......+. .+.......+.....+..+++|+.+||+.||.+|||+.++++
T Consensus 200 ~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 200 TIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred cch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 655 899999999999999999998765433332 222222222333368999999999999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=215.51 Aligned_cols=159 Identities=27% Similarity=0.371 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+|+||||+||+++.++. +||+|||++.............++..|+|||++.+..++.
T Consensus 108 ~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 185 (287)
T cd07838 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYAT 185 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCcccccccccccccChHHhccCCCCC
Confidence 34567788999999999999999999999999998865 9999999987544333334456888999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cC-----------CC---------CCCcCCHHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YF-----------LP---------DYVRVSADCRHLL 143 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~-----------~~---------~~~~~~~~~~~li 143 (246)
+ +|+||+||++|+|++|.+||.+....+.+.++++...... .. .+ ....++..+.++|
T Consensus 186 ~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 264 (287)
T cd07838 186 P-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLL 264 (287)
T ss_pred c-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHH
Confidence 5 8999999999999999999988776666655554321100 00 00 0123568889999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+||..||.+||++.+++.||||
T Consensus 265 ~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 265 KKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHhccCCccCCCHHHHhcCcCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=232.77 Aligned_cols=160 Identities=19% Similarity=0.236 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC--CCCCCCCCCCCCCCcchhccccccC--
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--HSQPKSTVGTPAYIAPEVLARKEYD-- 83 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-- 83 (246)
.++.|++.||+|||+++|+||||||+|||++... ..+||+|||+++.... .......+||+.|||||.+......
T Consensus 259 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~ 337 (566)
T PLN03225 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 337 (566)
T ss_pred HHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCC
Confidence 4678899999999999999999999999998532 2499999999974322 1223456799999999976432221
Q ss_pred -------------------CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh----------ccccC------
Q 025933 84 -------------------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR----------NVQYF------ 128 (246)
Q Consensus 84 -------------------~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~----------~~~~~------ 128 (246)
..++||||+||++|+|+++..|+.. ....+.+.+.... .....
T Consensus 338 ~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (566)
T PLN03225 338 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRG 415 (566)
T ss_pred CccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhh
Confidence 1225999999999999997766532 2222222221110 00000
Q ss_pred CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 129 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+.........+.+||.+||++||.+|||+.++|+||||....
T Consensus 416 ~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 416 FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 000111234566999999999999999999999999997643
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=223.99 Aligned_cols=167 Identities=23% Similarity=0.317 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-----CCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||.|||.++|+||||||+||+++.++. +||+|||++........ .....|+..|+|||.+.+
T Consensus 108 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 108 HIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcC
Confidence 34556788999999999999999999999999998776 99999999874322211 123468999999999866
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------------ccccC--CC---CCCc
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--------------------NVQYF--LP---DYVR 134 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~--------------------~~~~~--~~---~~~~ 134 (246)
......++|+||+||++|+|++|+.||.+.+....+..+..... ..... .+ ....
T Consensus 186 ~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (334)
T cd07855 186 LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPK 265 (334)
T ss_pred CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHccc
Confidence 43334459999999999999999999976554332222111100 00000 00 0134
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChH
Q 025933 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173 (246)
Q Consensus 135 ~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 173 (246)
.+.+++++|++||+.+|.+|||+.+++.||||.+.....
T Consensus 266 ~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 266 ASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 689999999999999999999999999999997654443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=211.26 Aligned_cols=153 Identities=28% Similarity=0.405 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++....... .....|++.|+|||++.+..++.
T Consensus 103 ~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (256)
T cd08529 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchhhccccCccccCHHHhcCCCCCC
Confidence 4566789999999999999999999999999988766 99999999875433222 23346889999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+|||||++|+|++|+.||......... ..+..... .+....++.++.+++.+||+.+|++||++.++++||
T Consensus 181 ~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 181 K-SDVWALGVVLYECCTGKHPFDANNQGALI----LKIIRGVF-PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred c-cchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCC-CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 5 89999999999999999999765532222 22222211 122226789999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
|+
T Consensus 255 ~~ 256 (256)
T cd08529 255 SL 256 (256)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=215.25 Aligned_cols=160 Identities=25% Similarity=0.323 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++++||||+|+||+++.++. ++|+|||++....... ......++..|+|||++.+....
T Consensus 100 ~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 177 (283)
T cd07835 100 LIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccCccccccCCCCCceeecCccc
Confidence 34567889999999999999999999999999988665 9999999987432221 12234578899999988765432
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------------ccC----CCCCCcCCHHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------------QYF----LPDYVRVSADCR 140 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------~~~----~~~~~~~~~~~~ 140 (246)
..++|+||+||++|+|++|+.||..........++.+..... ... ......++..+.
T Consensus 178 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (283)
T cd07835 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGL 257 (283)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHH
Confidence 344899999999999999999998766544444433321000 000 011235778999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
++|.+||+.||.+|||+++++.||||
T Consensus 258 ~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 258 DLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=217.97 Aligned_cols=159 Identities=23% Similarity=0.328 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-----CCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||+|||+++|+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+
T Consensus 120 ~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC
Confidence 34567889999999999999999999999999987776 99999999874322211 123467889999999876
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-c---------------cCCCC-----------C
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-Q---------------YFLPD-----------Y 132 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~---------------~~~~~-----------~ 132 (246)
......++|+||+|+++|+|++|+.||.+....... ..+..+... . ...+. .
T Consensus 198 ~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (310)
T cd07865 198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP 276 (310)
T ss_pred CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc
Confidence 543334589999999999999999999765543222 222221100 0 00000 0
Q ss_pred CcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 133 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
...+..+++||.+||..||.+|||++++++||||
T Consensus 277 ~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 277 YVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1135778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=215.41 Aligned_cols=159 Identities=27% Similarity=0.382 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccc-----
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~----- 79 (246)
...++.|++.++.|||+++|+||||||+||+++.++. +||+|||++...... .......+++.|+|||++.+
T Consensus 112 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (292)
T cd06644 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189 (292)
T ss_pred HHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccceecCCccccCceeeccccccC
Confidence 4567888999999999999999999999999987765 999999998643221 12233468899999999853
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|+|||||++|+|++|..||..........+. ........+....++.++.++|++||..||.+||++++
T Consensus 190 ~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 190 TPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred CCCCch-hhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 334434 89999999999999999999765432222221 11111122233467899999999999999999999999
Q ss_pred HhcCcccccCC
Q 025933 160 IKKHPWFLKNL 170 (246)
Q Consensus 160 ~l~hp~~~~~~ 170 (246)
+++||||....
T Consensus 266 il~~~~~~~~~ 276 (292)
T cd06644 266 LLEHPFVSSVT 276 (292)
T ss_pred HhcCccccccc
Confidence 99999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=218.61 Aligned_cols=158 Identities=27% Similarity=0.478 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......|+..|+|||++.+..++.
T Consensus 119 ~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (297)
T cd06659 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196 (297)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceecCccccCHHHHccCCCCc
Confidence 4567788999999999999999999999999988776 9999999986432221 223456899999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+||++|+|++|..||.......... .+.... ........++..+.++|.+||+.+|.+||+++++++|
T Consensus 197 ~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 197 E-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 5 899999999999999999997654433322 221111 1122234578999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|||.+..
T Consensus 272 ~~~~~~~ 278 (297)
T cd06659 272 PFLLQTG 278 (297)
T ss_pred hhhccCC
Confidence 9998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=218.36 Aligned_cols=163 Identities=22% Similarity=0.323 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
.++-..|+||+|||...-||||||..|||++..+. .||+|||++....... ..++.+|||.|||||++..-+|+..
T Consensus 133 ~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~- 209 (502)
T KOG0574|consen 133 AVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTK- 209 (502)
T ss_pred HHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchh-
Confidence 34555779999999999999999999999998887 8999999997644332 3456789999999999998899877
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||||||++..+|..|++||.+--..+. ++---.+....+..+...|.++.||+++||.++|++|-|+.++++|||+
T Consensus 210 ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi 286 (502)
T KOG0574|consen 210 ADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI 286 (502)
T ss_pred hhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence 8999999999999999999976443222 2111112222233334578999999999999999999999999999999
Q ss_pred ccCCChHHHH
Q 025933 167 LKNLPKEIIE 176 (246)
Q Consensus 167 ~~~~~~~~~~ 176 (246)
+......+..
T Consensus 287 knA~g~~I~~ 296 (502)
T KOG0574|consen 287 KNAPGCDIMQ 296 (502)
T ss_pred cCCCcccHHH
Confidence 8766555443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=217.05 Aligned_cols=164 Identities=26% Similarity=0.324 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++..... .......+++.|+|||.+.+....
T Consensus 103 ~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (298)
T cd07841 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180 (298)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCC
Confidence 35667889999999999999999999999999998776 999999998754322 122334578899999998654433
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------cC--------C---CCCCcCCHHHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----------YF--------L---PDYVRVSADCRH 141 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~--------~---~~~~~~~~~~~~ 141 (246)
..++|+||+||++|+|++|.+||.+..+...+.++........ .. . ......+..+.+
T Consensus 181 ~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T cd07841 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALD 260 (298)
T ss_pred CcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHH
Confidence 4459999999999999999888877666554444433211000 00 0 011345789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
||.+||..||.+|||+.+++.|+||.+..
T Consensus 261 li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 261 LLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred HHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=214.51 Aligned_cols=161 Identities=27% Similarity=0.445 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc-
Q 025933 5 CYFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY- 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~- 82 (246)
....++.|++.||.|||. ++|+||||||+||+++.++. +||+|||++.... ........|++.|+|||.+.+...
T Consensus 103 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (286)
T cd06622 103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLV-ASLAKTNIGCQSYMAPERIKSGGPN 179 (286)
T ss_pred HHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCccccc-CCccccCCCccCccCcchhcCCCCC
Confidence 345667788999999997 59999999999999988665 9999999987432 222344568899999999865432
Q ss_pred ----CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 83 ----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 83 ----~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
...++|+||+||++|+|++|..||........+ ..+..+..... ......++.++.+||.+||+.+|.+||++.
T Consensus 180 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (286)
T cd06622 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257 (286)
T ss_pred ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHH
Confidence 133489999999999999999999764432222 22222222211 122335899999999999999999999999
Q ss_pred HHhcCcccccCC
Q 025933 159 EIKKHPWFLKNL 170 (246)
Q Consensus 159 e~l~hp~~~~~~ 170 (246)
+++.||||....
T Consensus 258 ~l~~~~~~~~~~ 269 (286)
T cd06622 258 QLLEHPWLVKYK 269 (286)
T ss_pred HHhcChhhhhcc
Confidence 999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=243.03 Aligned_cols=158 Identities=27% Similarity=0.373 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHhHhC-------CcccCCCCCCCEEecCC---------------CCCcEEEeccCCccCCCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQ-------EICHRDLKLENTLLDGS---------------PQPRLKICDFGYSKSGLLHSQPK 63 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~-------~ivHrDlkp~Nill~~~---------------~~~~vkl~Dfg~s~~~~~~~~~~ 63 (246)
.+.++.||+.||.|||.. +||||||||+||||+.. +...+||+|||++..........
T Consensus 120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~ 199 (1021)
T PTZ00266 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199 (1021)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccccc
Confidence 456788999999999994 49999999999999642 22348999999998543333334
Q ss_pred CCCCCCCCCcchhcccc--ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHH
Q 025933 64 STVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 141 (246)
Q Consensus 64 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (246)
..+||+.|+|||++.+. .++.+ +||||||||+|+|++|..||........+... +... ..++ ....+.++.+
T Consensus 200 s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELLTGk~PF~~~~~~~qli~~---lk~~-p~lp-i~~~S~eL~d 273 (1021)
T PTZ00266 200 SCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKANNFSQLISE---LKRG-PDLP-IKGKSKELNI 273 (1021)
T ss_pred ccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH---HhcC-CCCC-cCCCCHHHHH
Confidence 56799999999998643 35444 89999999999999999999765544333222 2221 1222 2357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
||.+||..+|.+||++.++|.|+|+...
T Consensus 274 LI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 274 LIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9999999999999999999999999644
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=214.04 Aligned_cols=155 Identities=32% Similarity=0.507 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||+++|+||||+|.||+++.++. +||+|||+++.... .....|+..|+|||.+.+..++.+
T Consensus 100 ~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~- 173 (260)
T cd05611 100 KQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKM- 173 (260)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCCcCccChhhhcCCCCcch-
Confidence 456778999999999999999999999999988766 99999999874322 234568899999999987776555
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHHHhcC
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKH 163 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h 163 (246)
+|+||+|+++|+|++|..||........+...... ...+.......++..+.++|.+||..||.+||+ ++|++.|
T Consensus 174 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR--RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 89999999999999999999765543332222111 111111222357899999999999999999995 5799999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||.+.
T Consensus 252 ~~~~~~ 257 (260)
T cd05611 252 PFFKSI 257 (260)
T ss_pred hHhhcC
Confidence 999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=221.34 Aligned_cols=157 Identities=27% Similarity=0.405 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCC------------------CCCcEEEeccCCccCCCCCCCCCCCCCCCC
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGS------------------PQPRLKICDFGYSKSGLLHSQPKSTVGTPA 70 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~------------------~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~ 70 (246)
...|++++++|||+.+++|-||||+|||+.++ .+..|||+|||.|+. ......+.+.|.+
T Consensus 197 m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf--~~e~hs~iVsTRH 274 (415)
T KOG0671|consen 197 MGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATF--DHEHHSTIVSTRH 274 (415)
T ss_pred HHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcce--eccCcceeeeccc
Confidence 45689999999999999999999999998321 123489999999973 3334466789999
Q ss_pred CCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------------ccCCCC-
Q 025933 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------------QYFLPD- 131 (246)
Q Consensus 71 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------------------~~~~~~- 131 (246)
|.|||++.+-+++.+ +||||+||||+|+.+|...|...++.+.+ ..++++... ...+|+
T Consensus 275 YRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~ 352 (415)
T KOG0671|consen 275 YRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEV 352 (415)
T ss_pred cCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccc
Confidence 999999999999866 99999999999999999999988866543 333333110 000000
Q ss_pred ----------------------CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 132 ----------------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 132 ----------------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
....-.++.|||++||.+||.+|+|+.|+|.||||...
T Consensus 353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 00112468899999999999999999999999999754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=224.14 Aligned_cols=190 Identities=25% Similarity=0.261 Sum_probs=134.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.... .......+++.|+|||.+.+....+.+
T Consensus 121 ~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 196 (343)
T cd07880 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTD--SEMTGYVVTRWYRAPEVILNWMHYTQT 196 (343)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccccc--cCccccccCCcccCHHHHhCCCCCCcH
Confidence 456789999999999999999999999999987766 9999999987532 222345688999999998764323345
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------------ccCCC---------CCCcCCHHHHH
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------------QYFLP---------DYVRVSADCRH 141 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~----------------~~~~~---------~~~~~~~~~~~ 141 (246)
+|+||+||++|++++|..||.+......+.+++...... ....+ ....++..+.+
T Consensus 197 ~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (343)
T cd07880 197 VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVN 276 (343)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHH
Confidence 899999999999999999998765443333332211000 00000 11357889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHH
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQ 202 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (246)
+|.+||..||.+|||+.+++.||||............. ......+...++.+|+.++..
T Consensus 277 li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 335 (343)
T cd07880 277 VLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP--PYDDSFDEVDQSLEEWKRLTF 335 (343)
T ss_pred HHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC--CccccHHhhccchHHHHHHHH
Confidence 99999999999999999999999998654432221111 111223344566777776654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=215.58 Aligned_cols=161 Identities=29% Similarity=0.460 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc---
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE--- 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~--- 81 (246)
...++.|++.|++|||+ ++|+||||+|+||+++.++. +||+|||++.............++..|+|||.+.+..
T Consensus 116 ~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 193 (296)
T cd06618 116 LGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193 (296)
T ss_pred HHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCcccCCCCCccccCHhhcCCCCCcc
Confidence 34678899999999997 59999999999999987765 9999999987543222223345788999999987543
Q ss_pred -cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-ccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 -~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|+||||+++|+|++|+.||...... .+....+. ......+....++.++.+|+.+||..||.+||++++
T Consensus 194 ~~~~~-~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 194 KYDIR-ADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred ccccc-hhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 4444 89999999999999999999653221 11222222 222223333357899999999999999999999999
Q ss_pred HhcCcccccCCCh
Q 025933 160 IKKHPWFLKNLPK 172 (246)
Q Consensus 160 ~l~hp~~~~~~~~ 172 (246)
+++||||......
T Consensus 270 il~~~~~~~~~~~ 282 (296)
T cd06618 270 LLQHPFIRRYETA 282 (296)
T ss_pred HhcChhhhccchh
Confidence 9999999765443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=215.54 Aligned_cols=153 Identities=32% Similarity=0.524 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||+|.|||++.++. +||+|||+++..... .....|++.|+|||.+.+...+.+
T Consensus 103 ~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 178 (290)
T cd05580 103 ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKA 178 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCcc
Confidence 3456788999999999999999999999999988766 999999998754322 344578999999999987766555
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|+||||+++|+|++|..||........ ...+.......|. .++..++++|.+||..||.+|+ +++++
T Consensus 179 -~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l 251 (290)
T cd05580 179 -VDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI 251 (290)
T ss_pred -ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHH
Confidence 8999999999999999999976553222 2223333333333 5789999999999999999999 89999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 252 ~~~~~~~~~ 260 (290)
T cd05580 252 KNHPWFAGI 260 (290)
T ss_pred HcCcccccC
Confidence 999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=214.77 Aligned_cols=158 Identities=27% Similarity=0.331 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---ccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~ 81 (246)
....++.|++.||.|||+++|+||||+|.||+++.++. +||+|||++.... ......|++.|+|||++. ...
T Consensus 116 ~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 190 (307)
T cd06607 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS---PANSFVGTPYWMAPEVILAMDEGQ 190 (307)
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---CCCCccCCccccCceeeeccCCCC
Confidence 44567789999999999999999999999999988776 9999999987432 223456889999999874 234
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +||||||+++|+|++|..||.+......... +............++..++++|.+||..||.+||++.+++
T Consensus 191 ~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 191 YDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred CCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 5544 8999999999999999999976543322221 1111111111224688999999999999999999999999
Q ss_pred cCcccccCCCh
Q 025933 162 KHPWFLKNLPK 172 (246)
Q Consensus 162 ~hp~~~~~~~~ 172 (246)
.||||......
T Consensus 266 ~~~~~~~~~~~ 276 (307)
T cd06607 266 KHRFVLRERPP 276 (307)
T ss_pred cChhhcccCCc
Confidence 99999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=214.60 Aligned_cols=159 Identities=30% Similarity=0.525 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|+|+ .+++||||||+||+++.++. +||+|||++....... .....|+..|+|||.+.+..++.
T Consensus 102 ~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~ 178 (265)
T cd06605 102 LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSL-AKTFVGTSSYMAPERIQGNDYSV 178 (265)
T ss_pred HHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHH-hhcccCChhccCHHHHcCCCCCc
Confidence 34678899999999999 99999999999999998765 9999999986432211 12267889999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhccc-cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|+||+||++|+|++|..||..... .......++.+.... ...+. ..++.+++++|.+||..||.+|||+.+++.
T Consensus 179 ~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 179 K-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 5 8999999999999999999975421 122223333332221 11122 127899999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||++.
T Consensus 257 ~~~~~~~ 263 (265)
T cd06605 257 HPFIKKY 263 (265)
T ss_pred Cchhhcc
Confidence 9999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=213.04 Aligned_cols=152 Identities=30% Similarity=0.414 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...+.|++.||.|||+++|+||||||+||+++.++. +||+|||+++..... .......++..|+|||.+.+..+
T Consensus 109 ~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC
Confidence 456788999999999999999999999999987766 999999998743211 11123458899999999988777
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.. +|+||+||++|+|++|+.||........... ..... ..+. ...+++.++++| +||..+|++||++++++
T Consensus 187 ~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 187 GRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred Cch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 655 8999999999999999999976543332222 11111 1121 224688899999 57778999999999999
Q ss_pred cCcccc
Q 025933 162 KHPWFL 167 (246)
Q Consensus 162 ~hp~~~ 167 (246)
+||||.
T Consensus 260 ~hp~~~ 265 (266)
T cd06651 260 RHPFAQ 265 (266)
T ss_pred cCcccc
Confidence 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=217.69 Aligned_cols=160 Identities=22% Similarity=0.305 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC------------CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ------------PKSTVGTPAYI 72 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~------------~~~~~gt~~y~ 72 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++....... .....|++.|+
T Consensus 116 ~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 193 (311)
T cd07866 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193 (311)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcC
Confidence 34556788999999999999999999999999988776 99999999874321111 12235788999
Q ss_pred cchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------cC---C----
Q 025933 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------------YF---L---- 129 (246)
Q Consensus 73 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------~~---~---- 129 (246)
|||.+.+......++||||+||++|+|++|++||.+.........+........ .. .
T Consensus 194 aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (311)
T cd07866 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL 273 (311)
T ss_pred ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH
Confidence 999986644333448999999999999999999987666544444333211000 00 0
Q ss_pred -CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 130 -PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 130 -~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
..+...+..+.+||.+||..||.+|||+.+++.||||
T Consensus 274 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 274 EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0012355789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=213.89 Aligned_cols=156 Identities=25% Similarity=0.344 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcc---ccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLA---RKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~ 81 (246)
....+.|++.|+.|||++||+||||||+||+++.++. +||+|||++...... .......|+..|+|||++. ...
T Consensus 108 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (267)
T cd06645 108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccccCcccccChhhhccccCCC
Confidence 3556788999999999999999999999999987766 999999998643221 1223457999999999974 334
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|+||+||++|+|++|..||............... ............++..+.++|.+||..+|++|||+++++
T Consensus 186 ~~~~-~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 186 YNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred CCch-hhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 5544 89999999999999999999754432222111110 000111112224788999999999999999999999999
Q ss_pred cCcc
Q 025933 162 KHPW 165 (246)
Q Consensus 162 ~hp~ 165 (246)
+|||
T Consensus 264 ~~~~ 267 (267)
T cd06645 264 QHPF 267 (267)
T ss_pred cCCC
Confidence 9998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.73 Aligned_cols=158 Identities=27% Similarity=0.410 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.+|.|||+++|+||||||+|||++.++. +||+|||++....... ......|++.|+|||.+.+..++.
T Consensus 117 ~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (297)
T cd06656 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194 (297)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCc
Confidence 4456778999999999999999999999999987766 9999999987432222 122346899999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||.+.......... .............++..+++|+.+||..||.+||++.++++||
T Consensus 195 ~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 195 K-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred H-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 5 89999999999999999999765432221111 1111112222345788999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
||...
T Consensus 271 ~~~~~ 275 (297)
T cd06656 271 FLKLA 275 (297)
T ss_pred hhccc
Confidence 99754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=214.90 Aligned_cols=159 Identities=28% Similarity=0.347 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcccc-cc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARK-EY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~ 82 (246)
....++.|++.||.|||+++|+|+||||+||+++.++. +||+|||.+....... ......++..|+|||.+.+. .+
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 176 (283)
T cd05118 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCC
Confidence 34567788999999999999999999999999988766 9999999987543322 22334688899999998776 44
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------CCC---------CCCcCCHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------FLP---------DYVRVSAD 138 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~~---------~~~~~~~~ 138 (246)
+ .++|+||+|+++|+|++|+.||.+.+..+.+.++......... ..+ ....++.+
T Consensus 177 ~-~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (283)
T cd05118 177 S-TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQ 255 (283)
T ss_pred C-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHH
Confidence 4 4499999999999999999999876655544444332211000 000 11246889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+++||.+||..||.+||++.+++.||||
T Consensus 256 ~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 256 ALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=215.41 Aligned_cols=160 Identities=25% Similarity=0.309 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..+.|++.||+|||+++|+||||||+||+++..+ ..+||+|||++...... .......+++.|+|||++.+......+
T Consensus 106 ~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 184 (294)
T PLN00009 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184 (294)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcH
Confidence 4567899999999999999999999999998543 24899999998743222 222344678999999998764433344
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------ccCCC---------CCCcCCHHHHHHH
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYFLP---------DYVRVSADCRHLL 143 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~~~---------~~~~~~~~~~~li 143 (246)
+|+||+||++|+|++|..||..........+.+...... ....+ ..+.++..+.+++
T Consensus 185 ~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 264 (294)
T PLN00009 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLL 264 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHH
Confidence 999999999999999999998765544444433221100 00000 1235788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccc
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
.+||..+|.+||++.++++||||..
T Consensus 265 ~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 265 SKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred HHHccCChhhCcCHHHHhcCchHhH
Confidence 9999999999999999999999964
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=215.35 Aligned_cols=158 Identities=26% Similarity=0.404 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccc-cC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKE-YD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~ 83 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......++..|+|||++.+.. ++
T Consensus 105 ~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 182 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccccccccccccCCcHHhhcCcccC
Confidence 3456779999999999999999999999999988776 9999999987432211 122335788999999987644 44
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhcc---------------ccCC---------CCCCcCC--
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNV---------------QYFL---------PDYVRVS-- 136 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~---------------~~~~---------~~~~~~~-- 136 (246)
.++||||+||++|+|++|..||.+...... ...+....... .... .....++
T Consensus 183 -~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (291)
T cd07844 183 -TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRI 261 (291)
T ss_pred -cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCc
Confidence 448999999999999999999976553222 21111110000 0000 0011234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.++.+++.+||..+|.+|||+.+++.||||
T Consensus 262 ~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 262 PHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=220.91 Aligned_cols=162 Identities=23% Similarity=0.358 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-ccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 84 (246)
...++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++... .......|+..|+|||++.+. .++.
T Consensus 122 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (345)
T cd07877 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQ 197 (345)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc--ccccccccCCCccCHHHHhCccCCCc
Confidence 3456789999999999999999999999999988776 9999999987432 223345789999999998763 4444
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------ccccCCC------CCCcCCHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------------NVQYFLP------DYVRVSADC 139 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~------~~~~~~~~~ 139 (246)
++|+||+||++|+|++|+.||........+..+..... ......+ .....++.+
T Consensus 198 -~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (345)
T cd07877 198 -TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 276 (345)
T ss_pred -hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHH
Confidence 48999999999999999999976554433333222110 0000001 112468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
++||.+||+.||.+|+++.+++.||||.+...+
T Consensus 277 ~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 277 VDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=223.23 Aligned_cols=149 Identities=24% Similarity=0.412 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCC---CCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG---TPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~g---t~~y~aPE~~~~~ 80 (246)
...+...+||++|++||+++++|||||.+.|||++.+.. +||+|||+|+. ..........| ...|.|||.+...
T Consensus 303 ~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 303 PQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARL-IGDDEYTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccc-cCCCceeecCCCCCCceecCHHHHhhC
Confidence 346778899999999999999999999999999998876 99999999993 22222222333 3569999999999
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||+||||+| |+.||.+....+.+ +.+ ...+.+|.+..+|+++.+++..||..+|++|||++.
T Consensus 380 ~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~----~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 380 KFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVL----ELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred Ccccc-cceeehhhhHHHHhccCCCCCCCCCHHHHH----HHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 99877 899999999999998 99999887664443 332 334567888899999999999999999999999986
Q ss_pred Hh
Q 025933 160 IK 161 (246)
Q Consensus 160 ~l 161 (246)
+.
T Consensus 454 L~ 455 (468)
T KOG0197|consen 454 LR 455 (468)
T ss_pred HH
Confidence 54
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=213.14 Aligned_cols=157 Identities=27% Similarity=0.391 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccc-cCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKE-YDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~ 84 (246)
..++.|++.||.|||.++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||.+.+.. ++.
T Consensus 106 ~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (291)
T cd07870 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183 (291)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCc
Confidence 346779999999999999999999999999987766 9999999987432211 223346789999999987644 444
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHH-----------hccc----cCC----C-------CCCcCCH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRI-----------RNVQ----YFL----P-------DYVRVSA 137 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~~~~~~-----------~~~~----~~~----~-------~~~~~~~ 137 (246)
.+|+||+||++|+|++|..||.+..... .+.+..... .... ... + .....+.
T Consensus 184 -~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (291)
T cd07870 184 -ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP 262 (291)
T ss_pred -HHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCCh
Confidence 4899999999999999999997654321 111111100 0000 000 0 0011367
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+.+++.+||..||.+|||+.+++.||||
T Consensus 263 ~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 263 KAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=213.17 Aligned_cols=157 Identities=28% Similarity=0.410 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccc-----
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~----- 79 (246)
...++.|++.+|.|||+++|+||||||+||+++.++. ++|+|||++....... ......|++.|+|||.+..
T Consensus 105 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 182 (280)
T cd06611 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccceeecchhhcCHHHHhhcccCC
Confidence 3456788999999999999999999999999988766 9999999886432221 2233468999999999853
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|+||+||++|+|++|..||.......... .+.... ........++.++.+||.+||..+|.+||+++
T Consensus 183 ~~~~~~-sDi~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 257 (280)
T cd06611 183 NPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLL----KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA 257 (280)
T ss_pred CCCCcc-ccHHHHHHHHHHHHhCCCCcccCCHHHHHH----HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHH
Confidence 234434 899999999999999999997654433222 222221 12222335789999999999999999999999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 258 ~il~~~~~~~~ 268 (280)
T cd06611 258 ELLKHPFVSDQ 268 (280)
T ss_pred HHhcChhhccc
Confidence 99999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=214.15 Aligned_cols=160 Identities=25% Similarity=0.365 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---cccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~ 82 (246)
...++.|++.++.|||++||+||||||+||+++.++. +||+|||++... .......|+..|+|||++. ...+
T Consensus 123 ~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (313)
T cd06633 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEGQY 197 (313)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCCCCccccccccChhhccccCCCCC
Confidence 4456788999999999999999999999999987766 999999998642 2233457899999999984 2445
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|+||+||++|+|++|..||............. ...........++..+++|+.+||+.+|.+||++.++++
T Consensus 198 ~~~-sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 198 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 444 899999999999999999997755433332221 111111112346788999999999999999999999999
Q ss_pred CcccccCCChHHH
Q 025933 163 HPWFLKNLPKEII 175 (246)
Q Consensus 163 hp~~~~~~~~~~~ 175 (246)
||||.........
T Consensus 273 ~~~~~~~~~~~~~ 285 (313)
T cd06633 273 HDFVRRDRPARVL 285 (313)
T ss_pred CcccCCCchhHHH
Confidence 9999876544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=209.67 Aligned_cols=154 Identities=36% Similarity=0.483 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.+++|||+++|+||||||+||+++.++. .+||+|||++.............|+..|+|||.+.+..++.+
T Consensus 103 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd08220 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcc
Confidence 3556788999999999999999999999999975543 479999999985544333344578999999999987776655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|+||+|+++|+|++|..||.+.......... .... ..+....++.++++++.+||..||.+|||+.++++|||
T Consensus 182 -~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 182 -SDIWALGCVLYELASLKRAFEAANLPALVLKI----MSGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred -cchHHHHHHHHHHHhCCCCcccCchHHHHHHH----HhcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 89999999999999999999775543332222 1111 11223358999999999999999999999999999999
Q ss_pred c
Q 025933 166 F 166 (246)
Q Consensus 166 ~ 166 (246)
|
T Consensus 256 ~ 256 (256)
T cd08220 256 C 256 (256)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=215.08 Aligned_cols=160 Identities=24% Similarity=0.336 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||+|||+++|+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+...
T Consensus 117 ~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 194 (302)
T cd07864 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEER 194 (302)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcccccccceeccCccChHHhcCCCC
Confidence 45677889999999999999999999999999988776 99999999875432221 122356788999998865443
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C-----------------------CCCCCcCCHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F-----------------------LPDYVRVSAD 138 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~ 138 (246)
...++||||+||++|+|++|++||........+..+......... . ...+..++..
T Consensus 195 ~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (302)
T cd07864 195 YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTP 274 (302)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHH
Confidence 334589999999999999999999876655444443332111000 0 0112347899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+.++|.+||..||.+|||+.+++.||||
T Consensus 275 ~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 275 ALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=217.11 Aligned_cols=162 Identities=22% Similarity=0.343 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--------CCCCCCCCCCCcchhc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--------PKSTVGTPAYIAPEVL 77 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~~ 77 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||.+........ .....++..|+|||++
T Consensus 103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 3456778999999999999999999999999987766 99999998864322111 1233577889999998
Q ss_pred ccc--ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------------------------ccc
Q 025933 78 ARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------------------------VQY 127 (246)
Q Consensus 78 ~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~----------------------------~~~ 127 (246)
.+. .++.+ +|+||+||++|+|++|..||..........+....... ...
T Consensus 181 ~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 181 QQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred cCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhh
Confidence 653 45544 89999999999999999999865543332221110000 000
Q ss_pred CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 128 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 128 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
..+....++.++.+|+.+||..||++|||++++++||||....
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0001112456889999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=211.08 Aligned_cols=156 Identities=27% Similarity=0.331 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcccc---c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARK---E 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~ 81 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......++..|+|||.+.+. .
T Consensus 103 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~ 180 (262)
T cd06613 103 IAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180 (262)
T ss_pred HHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccccccCCccccCchhhcccccCC
Confidence 4567888999999999999999999999999998776 9999999987533221 22345689999999998766 6
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|+||+||++|+|++|..||................. ..........++.++.+|+++||..+|.+|||+.+++
T Consensus 181 ~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 181 YDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred cCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 6655 8999999999999999999976554333222111100 0111112234678899999999999999999999999
Q ss_pred cCcc
Q 025933 162 KHPW 165 (246)
Q Consensus 162 ~hp~ 165 (246)
.|+|
T Consensus 259 ~~~~ 262 (262)
T cd06613 259 QHPF 262 (262)
T ss_pred cCCC
Confidence 9998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=221.36 Aligned_cols=161 Identities=22% Similarity=0.289 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..++.|++.||.|||++||+||||||+||+++..+. .+||+|||+++...... ......|+..|+|||.+.+...
T Consensus 117 ~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 195 (342)
T cd07854 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195 (342)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCccccccccccccccccccCHHHHhCccc
Confidence 456788999999999999999999999999975432 48999999987432111 1122357889999998765443
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------------ccccCCC---CCCcCCHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR---------------------NVQYFLP---DYVRVSAD 138 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~---------------------~~~~~~~---~~~~~~~~ 138 (246)
...++|+|||||++|+|++|+.||.+............... ......+ ....++.+
T Consensus 196 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (342)
T cd07854 196 YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275 (342)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHH
Confidence 34459999999999999999999976654433333222110 0000000 12357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
+++||.+||..||.+|||+.+++.||||..
T Consensus 276 ~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 276 ALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=213.33 Aligned_cols=160 Identities=27% Similarity=0.396 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||+|+||+++.++. ++|+|||++...... .......++..|+|||++.+....
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 178 (286)
T cd07846 101 RVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccCcccceeeccCcHHhcccccc
Confidence 34567789999999999999999999999999988776 999999998753222 222334688999999998764433
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCCC----------CCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFLP----------DYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~~----------~~~~~~~~ 138 (246)
+.++||||+||++|+|++|.+||.+.........+....... ....+ ..+.++..
T Consensus 179 ~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (286)
T cd07846 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGL 258 (286)
T ss_pred CchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHH
Confidence 345999999999999999999997655433333332211100 00001 12357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+.+|+.+||..+|.+||++.++++||||
T Consensus 259 ~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 259 VLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=211.57 Aligned_cols=154 Identities=24% Similarity=0.330 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-------CCCCCCCCCCCCCCcchhccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-------HSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 79 (246)
...+.|++.+|.|||+++|+|+||||+||+++.++. +||+|||++..... ........|+..|+|||++.+
T Consensus 105 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcC
Confidence 345678899999999999999999999999987766 99999999864211 111233468999999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|+|||||++|+|++|..||............. .......+....++..+.++|++||..+|.+||++.+
T Consensus 183 ~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 183 SGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 777655 899999999999999999997654332221111 1111111223358899999999999999999999999
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
++.||||
T Consensus 259 ~l~~~~~ 265 (265)
T cd06631 259 LLRHDFL 265 (265)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=218.67 Aligned_cols=163 Identities=24% Similarity=0.303 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---------------CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---------------HSQPKSTVGTP 69 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---------------~~~~~~~~gt~ 69 (246)
..+.++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++.... ........+++
T Consensus 120 ~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (335)
T PTZ00024 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTL 197 (335)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeeccccccccccccccccccccccccccccc
Confidence 34667889999999999999999999999999988776 99999999864320 11112235788
Q ss_pred CCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-C----------------C--
Q 025933 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-L----------------P-- 130 (246)
Q Consensus 70 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~----------------~-- 130 (246)
.|+|||.+.+....+.++|+|||||++|+|++|..||.+....+.+..+.......... + +
T Consensus 198 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
T PTZ00024 198 WYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD 277 (335)
T ss_pred CCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCccc
Confidence 99999998765443455999999999999999999998777655554444322111000 0 0
Q ss_pred ---CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 131 ---DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 131 ---~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.....+..+.++|.+||..+|.+|||+++++.||||...
T Consensus 278 ~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 278 LKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 012457889999999999999999999999999999765
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=213.18 Aligned_cols=158 Identities=28% Similarity=0.423 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccc-cc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARK-EY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~ 82 (246)
....+.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......++..|+|||++.+. .+
T Consensus 102 ~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 179 (288)
T cd07833 102 VRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCc
Confidence 3456788999999999999999999999999988766 9999999987543332 22345688999999999877 55
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------c---CCC-----------CCCcCC
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------Y---FLP-----------DYVRVS 136 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~------------~---~~~-----------~~~~~~ 136 (246)
+ .++|+||+|+++|+|++|..||.+.................. + ..+ ....++
T Consensus 180 ~-~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (288)
T cd07833 180 G-KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS 258 (288)
T ss_pred C-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccc
Confidence 4 448999999999999999999986554433333221110000 0 000 011248
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.++++||++||..+|.+|||++++++||||
T Consensus 259 ~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 259 SPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=212.11 Aligned_cols=155 Identities=28% Similarity=0.386 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcccc----
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARK---- 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~---- 80 (246)
...++.|++.||.|||+++|+||||+|+||+++.++. +||+|||++...... .......|+..|+|||++...
T Consensus 115 ~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 192 (275)
T cd06608 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD 192 (275)
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccchhhhcCccccccccCHhHhccccccc
Confidence 3456788999999999999999999999999988766 999999998643221 222345689999999998542
Q ss_pred -ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 -EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 -~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++|..||..........++. ............++..+++||.+||..||++|||+.+
T Consensus 193 ~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 193 ASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred CCcccc-ccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 23434 899999999999999999997654433332221 1111122222347889999999999999999999999
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
+++|||+
T Consensus 269 ll~~~~~ 275 (275)
T cd06608 269 LLEHPFI 275 (275)
T ss_pred HhcCCCC
Confidence 9999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=212.88 Aligned_cols=150 Identities=23% Similarity=0.399 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++...... ......+++.|+|||.+.+..+
T Consensus 126 ~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--EEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence 4567889999999999999999999999999988766 9999999987432211 1223457889999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+....+. ...+.... ..+....++.++.+|+++||..||.+||++.+++
T Consensus 204 ~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~----~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~ 277 (283)
T cd05048 204 TTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEV----IEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIH 277 (283)
T ss_pred chh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 655 899999999999998 9999987554332 22222222 1223346899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 278 ~~ 279 (283)
T cd05048 278 TR 279 (283)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=244.54 Aligned_cols=156 Identities=16% Similarity=0.180 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-----------------CCCcEEEeccCCccCCCCCC--------
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS-------- 60 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-----------------~~~~vkl~Dfg~s~~~~~~~-------- 60 (246)
.+.++.||+.||.|||++|||||||||+||||+.. ....+|++|||+++......
T Consensus 82 ~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~ 161 (793)
T PLN00181 82 CFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLE 161 (793)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhh
Confidence 45567888999999999999999999999999542 22347778888775321000
Q ss_pred ---------CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 025933 61 ---------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131 (246)
Q Consensus 61 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (246)
.....+||++|||||++.+..|+.+ +|||||||++|||++|.+|+.... ..+....... ..+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-----~~~~ 233 (793)
T PLN00181 162 EVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-----LPPQ 233 (793)
T ss_pred ccccCCCcccccccCCCcceEChhhhccCCCCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-----cChh
Confidence 0012368999999999998888655 999999999999999988875321 1111111111 1111
Q ss_pred CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 132 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.....+...+++.+||.+||.+||++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 11235667899999999999999999999999999753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=208.39 Aligned_cols=155 Identities=26% Similarity=0.447 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC-----CCCCCCCCCCcchhccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-----KSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 81 (246)
..++.|++.|+.|||+++|+||||||+||+++.++. +||+|||++......... ....+++.|+|||++.+..
T Consensus 102 ~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC
Confidence 456788999999999999999999999999988766 999999998754322221 1246788999999997655
Q ss_pred ---cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 82 ---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 82 ---~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
++.+ +|+||+|+++|++++|..||.......... ...........|....++..+.+||.+||+.+|.+|||+.
T Consensus 180 ~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 180 GKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHH
Confidence 5444 899999999999999999997654322211 1111122333455445689999999999999999999999
Q ss_pred HHhcCccc
Q 025933 159 EIKKHPWF 166 (246)
Q Consensus 159 e~l~hp~~ 166 (246)
+++.|||+
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=210.56 Aligned_cols=155 Identities=29% Similarity=0.424 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.+|.|||.++|+|+||||+||+++.++. ++|+|||++.............|+..|+|||.+.+..++.+
T Consensus 102 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 179 (258)
T cd05578 102 VKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179 (258)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCc
Confidence 4567788999999999999999999999999988776 99999999875443333344568899999999987776655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH--HHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI--PEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~e~l~h 163 (246)
+|+||+|+++|+|++|..||...... .............. ......+..+.++|.+||..||.+||++ .++++|
T Consensus 180 -~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 180 -VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADV--LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccc--cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 89999999999999999999865542 11122222221222 2233678999999999999999999999 999999
Q ss_pred ccc
Q 025933 164 PWF 166 (246)
Q Consensus 164 p~~ 166 (246)
|||
T Consensus 256 ~~~ 258 (258)
T cd05578 256 PYF 258 (258)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=226.26 Aligned_cols=157 Identities=26% Similarity=0.481 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
+..-.|..|||+||+|||++. |||||||-+||+|+++. +.|||+|+|||... .....++.+|||.|||||++. ..
T Consensus 143 kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~-r~s~aksvIGTPEFMAPEmYE-E~ 219 (632)
T KOG0584|consen 143 KAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLL-RKSHAKSVIGTPEFMAPEMYE-EN 219 (632)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHh-hccccceeccCccccChHHHh-hh
Confidence 456678889999999999997 99999999999998754 46999999999842 333445678999999999997 78
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.. +||||||+++.||+|+..||..-....+ +.++...+....+ ..--.+++++||.+||.. ...|+|+.|+
T Consensus 220 YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl----~kV~dPevr~fIekCl~~-~~~R~sa~eL 293 (632)
T KOG0584|consen 220 YNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL----SKVKDPEVREFIEKCLAT-KSERLSAKEL 293 (632)
T ss_pred cchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh----hccCCHHHHHHHHHHhcC-chhccCHHHH
Confidence 8777 8999999999999999999987665544 3333333222111 112368999999999999 9999999999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
|.||||...
T Consensus 294 L~d~Ff~~d 302 (632)
T KOG0584|consen 294 LKDPFFDED 302 (632)
T ss_pred hhChhhccc
Confidence 999999875
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=214.62 Aligned_cols=158 Identities=29% Similarity=0.548 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++.... .......+|++.|+|||++.+..++.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ 177 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYTV 177 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccc-ccccccCCCCcCccChhHhcCCCCCc
Confidence 44677889999999997 58999999999999988776 9999999987432 22234567899999999998777765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHH---------------------------------Hhc-cccCCC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR---------------------------------IRN-VQYFLP 130 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~---------------------------------~~~-~~~~~~ 130 (246)
+ +|+|||||++|+|++|..||..... ......+.. +.. .....|
T Consensus 178 ~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (308)
T cd06615 178 Q-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP 255 (308)
T ss_pred c-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc
Confidence 5 8999999999999999999965432 121111110 000 000111
Q ss_pred CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 131 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
. ..++.++++|+.+||..||++|||+.++++||||.+.
T Consensus 256 ~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 256 S-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred C-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1 1367899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=208.51 Aligned_cols=154 Identities=28% Similarity=0.430 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHHhH-----hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFY-----LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH-----~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~ 78 (246)
....++.|++.||.|+| +.+|+||||||+||+++.++. +||+|||++........ .....|++.|+|||++.
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 183 (265)
T cd08217 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183 (265)
T ss_pred HHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcccccccccCCCccChhhhc
Confidence 34567889999999999 999999999999999988766 99999999885433332 33457899999999998
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+..++.+ +|+||||+++|+|++|..||..... .. ....+..... .+....++..+.+++.+||..+|.+||++.
T Consensus 184 ~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~-~~---~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 257 (265)
T cd08217 184 HMSYDEK-SDIWSLGCLIYELCALSPPFTARNQ-LQ---LASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTE 257 (265)
T ss_pred CCCCCch-hHHHHHHHHHHHHHHCCCcccCcCH-HH---HHHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHH
Confidence 8776655 8999999999999999999987542 22 2222322222 122336889999999999999999999999
Q ss_pred HHhcCccc
Q 025933 159 EIKKHPWF 166 (246)
Q Consensus 159 e~l~hp~~ 166 (246)
++++|||+
T Consensus 258 ~il~~~~~ 265 (265)
T cd08217 258 ELLQLPLI 265 (265)
T ss_pred HHhhCCCC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=213.13 Aligned_cols=154 Identities=27% Similarity=0.371 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccc-----c
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLAR-----K 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~ 80 (246)
..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......|++.|+|||++.. .
T Consensus 127 ~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (286)
T cd06638 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS 204 (286)
T ss_pred HHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccc
Confidence 346778899999999999999999999999988776 9999999987533222 2233469999999999853 3
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|+||+||++|+|++|..||........+.... ............++..+.+||.+||..||.+|||+.++
T Consensus 205 ~~~~~-~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 205 TYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred cccch-hhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 34444 899999999999999999997654433222111 11111112223467899999999999999999999999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
++|+||
T Consensus 281 l~~~~~ 286 (286)
T cd06638 281 LQHVFI 286 (286)
T ss_pred hhcccC
Confidence 999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=217.74 Aligned_cols=152 Identities=22% Similarity=0.362 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||++.+..
T Consensus 174 ~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 174 DLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC
Confidence 45567789999999999999999999999999987765 9999999997532211 112334677899999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+....+.+...+... . ........++++.+++.+||+.+|.+||+++++
T Consensus 252 ~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 252 YTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG---T-RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred CCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc---C-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8776 899999999999998 999997654433333332221 1 111223578999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 327 l~~ 329 (337)
T cd05054 327 VEI 329 (337)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=212.16 Aligned_cols=159 Identities=25% Similarity=0.364 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||++++++. +||+|||+++...... ......++..|++||++.+.....
T Consensus 102 ~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 179 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCccccccccccccccChHHhcCCCCCC
Confidence 3567889999999999999999999999999988776 9999999987432221 123346789999999987654434
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------ccCCCC---------CCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYFLPD---------YVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~---------~~~~~~~~~~ 141 (246)
.++|+||+||++|+|++|..||.+....+...+++...... ....+. .+..+..+++
T Consensus 180 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (284)
T cd07836 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID 259 (284)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHH
Confidence 45999999999999999999998776655544443321100 000010 1245788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+|.+||+.||.+||++.++++||||
T Consensus 260 ~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 260 LLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=210.22 Aligned_cols=159 Identities=28% Similarity=0.397 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhcccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~~ 80 (246)
...++.|++.||.|||++||+||||||.||+++.++. .+||+|||++....... ......|+..|+|||.+.+.
T Consensus 105 ~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccC
Confidence 3556789999999999999999999999999976542 48999999987433221 11234688999999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|+||+||++|+|++|..||........... ................++.++.+++.+||..+|.+||++.++
T Consensus 184 ~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 184 QYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 77655 8999999999999999999975443222222 222222122222233578999999999999999999999999
Q ss_pred hcCcccc
Q 025933 161 KKHPWFL 167 (246)
Q Consensus 161 l~hp~~~ 167 (246)
++||||.
T Consensus 262 l~~~~~~ 268 (268)
T cd06630 262 LKHPVFR 268 (268)
T ss_pred hcCcccC
Confidence 9999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=208.86 Aligned_cols=146 Identities=26% Similarity=0.353 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++..... ......++..|+|||.+.+..++.+
T Consensus 87 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 162 (237)
T cd05576 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGGISEETEA 162 (237)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccCCCCCCch
Confidence 4567788999999999999999999999999988776 99999998764322 2234456788999999977777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-----HHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~ 160 (246)
+|+||+||++|+|++|..||...... .. .......| ..+++.+++||.+||+.||.+|+++ +++
T Consensus 163 -~DvwslG~il~el~~g~~~~~~~~~~------~~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 163 -CDWWSLGAILFELLTGKTLVECHPSG------IN--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred -hhHHHHHHHHHHHHHCcchhhcCchh------cc--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 89999999999999999887542211 00 01111223 3578999999999999999999986 999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
++||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=206.33 Aligned_cols=155 Identities=28% Similarity=0.406 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.++.+||.++++||||+|+||+++.++. ++|+|||++.............|+..|+|||.+.+..++.
T Consensus 99 ~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 176 (253)
T cd05122 99 QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176 (253)
T ss_pred HHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeeccccccccccccccceecCCcccCHHHHcCCCCCc
Confidence 34567889999999999999999999999999988766 9999999987543332234457899999999998777655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+|+++|+|++|..||............. .......+....++..+.++|.+||..||++|||+.++++||
T Consensus 177 ~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 177 K-ADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred c-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 5 899999999999999999997654332222111 122222233333589999999999999999999999999999
Q ss_pred c
Q 025933 165 W 165 (246)
Q Consensus 165 ~ 165 (246)
|
T Consensus 253 ~ 253 (253)
T cd05122 253 F 253 (253)
T ss_pred C
Confidence 8
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=210.00 Aligned_cols=155 Identities=29% Similarity=0.410 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc--
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE-- 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-- 81 (246)
..++.|++.||.|||+++++||||||+||+++.++. ++|+|||+++...... ......|+..|+|||++....
T Consensus 111 ~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (272)
T cd06629 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188 (272)
T ss_pred HHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeeccccccccccccccccccccCCccccCHHHhccccCC
Confidence 345678899999999999999999999999987766 9999999987432211 122346889999999987654
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|+||+|+++|++++|..||..........+.... ......+. ...++..++++|.+||..+|.+|||+++
T Consensus 189 ~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 189 YSAK-VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred CCcc-chhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 4444 89999999999999999999654332222221111 11111121 2356899999999999999999999999
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
+++||||
T Consensus 266 il~~~~~ 272 (272)
T cd06629 266 LLQHPFI 272 (272)
T ss_pred HhhCCCC
Confidence 9999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=209.53 Aligned_cols=155 Identities=27% Similarity=0.415 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccc--cC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE--YD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~ 83 (246)
..++.|++.|+.|||+++|+||||||+||+++... ..+||+|||++...... .......|++.|+|||++.+.. ++
T Consensus 111 ~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 189 (268)
T cd06624 111 IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189 (268)
T ss_pred HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccCCCCccccChhhhccccccCC
Confidence 45567899999999999999999999999997532 24999999998643221 1222345889999999986543 44
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.++|+||+|+++|+|++|..||............ .......... ...+++++++|+.+||..+|.+|||+.+++.|
T Consensus 190 -~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 190 -APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEI--PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -chhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCC--CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 4489999999999999999999754432211100 0111111112 23578999999999999999999999999999
Q ss_pred ccc
Q 025933 164 PWF 166 (246)
Q Consensus 164 p~~ 166 (246)
|||
T Consensus 266 ~~~ 268 (268)
T cd06624 266 PFL 268 (268)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=213.19 Aligned_cols=157 Identities=32% Similarity=0.498 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----------------CCCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----------------QPKSTVGTP 69 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----------------~~~~~~gt~ 69 (246)
...++.|++.|+.|||+++|+||||||.||+++.++. +||+|||+++...... ......|+.
T Consensus 103 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (305)
T cd05609 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180 (305)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCc
Confidence 3456778999999999999999999999999987766 9999999986321100 011235788
Q ss_pred CCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcc
Q 025933 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFV 148 (246)
Q Consensus 70 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~ 148 (246)
.|+|||.+.+..++.+ +|+|||||++|+|++|..||.+....+. ...........+. ...++.+++++|++||.
T Consensus 181 ~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (305)
T cd05609 181 EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEEL----FGQVISDDIEWPEGDEALPADAQDLISRLLR 255 (305)
T ss_pred cccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCCCCccccCCHHHHHHHHHHhc
Confidence 9999999988777655 8999999999999999999986543322 2222222212222 12578999999999999
Q ss_pred cCCCCCCC---HHHHhcCcccccC
Q 025933 149 ADPSKRIP---IPEIKKHPWFLKN 169 (246)
Q Consensus 149 ~dp~~R~t---~~e~l~hp~~~~~ 169 (246)
.||.+||+ +.++++||||...
T Consensus 256 ~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 256 QNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cChhhccCccCHHHHHhCccccCC
Confidence 99999998 7899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=209.07 Aligned_cols=156 Identities=38% Similarity=0.577 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---------CCCCCCCCCCCCcchh
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---------~~~~~~gt~~y~aPE~ 76 (246)
...++.|++.||.|||+++|+||||+|+||+++.++. +||+|||++....... ......++..|+|||.
T Consensus 95 ~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 172 (265)
T cd05579 95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172 (265)
T ss_pred HHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHH
Confidence 3456788999999999999999999999999998776 9999999987533221 1123468889999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
+....++.+ +|+||||+++|++++|..||........ ...+.......+....++..+.+++++||+.+|.+|||
T Consensus 173 ~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (265)
T cd05579 173 ILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG 247 (265)
T ss_pred hcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCC
Confidence 987776544 8999999999999999999976553322 23333333344443345999999999999999999999
Q ss_pred H---HHHhcCccccc
Q 025933 157 I---PEIKKHPWFLK 168 (246)
Q Consensus 157 ~---~e~l~hp~~~~ 168 (246)
+ .++++||||.+
T Consensus 248 ~~~~~~~l~~~~~~~ 262 (265)
T cd05579 248 AKSIEEIKNHPFFKG 262 (265)
T ss_pred CccHHHHhcCccccC
Confidence 9 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=210.42 Aligned_cols=159 Identities=25% Similarity=0.341 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.+|.|||+++|+|+||||.||+++.++. ++|+|||++.............|+..|+|||++.+......
T Consensus 101 ~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 178 (283)
T cd07830 101 IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCC
Confidence 4556788999999999999999999999999998776 99999999875443333344578999999998854432234
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------------cccCCC---------CCCcCCHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQYFLP---------DYVRVSADCRH 141 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~~~ 141 (246)
++|+||||+++++|++|.+||........+.+....... .....+ .....+..+++
T Consensus 179 ~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (283)
T cd07830 179 PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID 258 (283)
T ss_pred ccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHH
Confidence 489999999999999999999876655444433321100 000000 01234688999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
||++||..||.+|||++|++.||||
T Consensus 259 li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 259 LIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHhcccCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=209.70 Aligned_cols=159 Identities=28% Similarity=0.395 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcccc-cc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARK-EY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~ 82 (246)
....++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++...... ......++..|+|||.+.+. .+
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 176 (282)
T cd07829 99 LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHY 176 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCC
Confidence 34567789999999999999999999999999988766 9999999987543222 22234567889999998766 55
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-----------c---ccCCC---------CCCcCCHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-----------V---QYFLP---------DYVRVSADC 139 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-----------~---~~~~~---------~~~~~~~~~ 139 (246)
+. ++|+|||||++|+|++|..||.+......+.++...... . ....+ ..+..+..+
T Consensus 177 ~~-~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd07829 177 ST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255 (282)
T ss_pred Cc-cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHH
Confidence 44 489999999999999999999876554444333321110 0 00001 122357899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.++|++||..||.+||++.+++.||||
T Consensus 256 ~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 256 IDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=212.87 Aligned_cols=160 Identities=28% Similarity=0.510 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.+++|||++||+||||||+||+++.++. ++|+|||++....... ......|++.|+|||.+.+..++.
T Consensus 118 ~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 195 (292)
T cd06657 118 IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195 (292)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccccCccccCHHHhcCCCCCc
Confidence 4566788999999999999999999999999988766 9999999886433221 223356899999999998777665
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+|+++|+|++|..||.+......... +.. ......+....++..+.+++.+||..||.+||++.+++.||
T Consensus 196 ~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~ 271 (292)
T cd06657 196 E-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRD--NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 271 (292)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--hCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence 5 8999999999999999999986544333222 111 11222233346789999999999999999999999999999
Q ss_pred ccccCCC
Q 025933 165 WFLKNLP 171 (246)
Q Consensus 165 ~~~~~~~ 171 (246)
||.+...
T Consensus 272 ~~~~~~~ 278 (292)
T cd06657 272 FLAKAGP 278 (292)
T ss_pred HHhccCC
Confidence 9987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=206.67 Aligned_cols=154 Identities=29% Similarity=0.422 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc-cCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE-YDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ 84 (246)
....+.|++.|+.|||+++|+||||||+||+++.++. +||+|||++.............|+..|+|||.+.... ++.
T Consensus 104 ~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~ 181 (258)
T cd06632 104 IRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181 (258)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCc
Confidence 3445778999999999999999999999999988766 9999999987543333334557899999999987665 554
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||..........+ .............++..+++++++||..+|.+||++.+++.||
T Consensus 182 ~-~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 182 A-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred h-hhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 4 8999999999999999999976543222221 1111111112235789999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
|+
T Consensus 257 ~~ 258 (258)
T cd06632 257 FV 258 (258)
T ss_pred CC
Confidence 96
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=220.16 Aligned_cols=151 Identities=21% Similarity=0.348 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... ..+..++..|||||++.+..
T Consensus 213 ~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 290 (374)
T cd05106 213 DLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV 290 (374)
T ss_pred HHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC
Confidence 34677889999999999999999999999999987665 99999999875332211 11223566799999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||........+.+... .....+.....++++++++.+||+.||.+|||+.++
T Consensus 291 ~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 291 YTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred CCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7766 899999999999997 9999976544333333222 112222223468999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 366 ~~ 367 (374)
T cd05106 366 SQ 367 (374)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=197.78 Aligned_cols=158 Identities=22% Similarity=0.330 Sum_probs=124.2
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
+.|+|.||.|||++||+|||+||.|++|+... ..++|+|+|+|.........+..+.+..|--||.+..-+......|+
T Consensus 138 ~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 138 IYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred HHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence 45677999999999999999999999998654 36999999999977666666777899999999999876655555899
Q ss_pred HhHHHHHHHHHhCCCCC-CCCCChHHHHHHHHHHh---------ccc-------------c-------C-CCC-CCcCCH
Q 025933 90 WSCGVTLYVMLVGAYPF-EDPEDPRNFRKTIDRIR---------NVQ-------------Y-------F-LPD-YVRVSA 137 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf-~~~~~~~~~~~~~~~~~---------~~~-------------~-------~-~~~-~~~~~~ 137 (246)
|||||++..|++.+-|| .|.++.+++.++..-+. +.. . + .+. ..-+++
T Consensus 217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~p 296 (338)
T KOG0668|consen 217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSP 296 (338)
T ss_pred HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCCh
Confidence 99999999999988886 45556666655443220 000 0 0 001 112579
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
++.|||.++|..|.++|+||.|++.||||..
T Consensus 297 eaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 297 EAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 9999999999999999999999999999953
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=232.51 Aligned_cols=151 Identities=26% Similarity=0.451 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC----------CCCCCCCC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----------STVGTPAY 71 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~----------~~~gt~~y 71 (246)
.+.+.|+.|+.+|+.+||... |||||||.|||||+.++. .||||||.+.......... ...-|+.|
T Consensus 144 ~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~Y 221 (738)
T KOG1989|consen 144 DEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQY 221 (738)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccc
Confidence 357889999999999999999 999999999999998887 9999999886322211110 12468999
Q ss_pred Ccchhc---cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcc
Q 025933 72 IAPEVL---ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 148 (246)
Q Consensus 72 ~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 148 (246)
+|||.+ .+...+.+ +|||||||+||.|++...||.+... -.|.+..|.+|.+++++..+++||+.||+
T Consensus 222 RsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~--------laIlng~Y~~P~~p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 222 RSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGK--------LAILNGNYSFPPFPNYSDRLKDLIRTMLQ 292 (738)
T ss_pred cChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEeccccCCCCccHHHHHHHHHHHHhc
Confidence 999997 45566656 8999999999999999999987533 13567889999999999999999999999
Q ss_pred cCCCCCCCHHHHhcCcc
Q 025933 149 ADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 149 ~dp~~R~t~~e~l~hp~ 165 (246)
.||.+||++-+++.+-+
T Consensus 293 ~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 293 PNPDERPNIYQVLEEIF 309 (738)
T ss_pred cCcccCCCHHHHHHHHH
Confidence 99999999999877643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=212.30 Aligned_cols=155 Identities=23% Similarity=0.322 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||++.+..
T Consensus 139 ~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 35678899999999999999999999999999988766 9999999987432221 112234678899999998777
Q ss_pred cCCcchhHHhHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhcc--ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 82 YDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~--g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
++.+ +|||||||++|+|++ +..||.+................. .......+.++..+.+|+.+||..||.+|||+
T Consensus 217 ~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 217 FTTA-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCch-hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 7655 899999999999986 667887655433333222211111 11112234578999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.++.+
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 99853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=213.70 Aligned_cols=160 Identities=25% Similarity=0.329 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---ccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---KEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~ 82 (246)
....+.|++.++.|||+++|+||||||.||+++.++. +||+|||++.... ......|++.|+|||.+.+ ..+
T Consensus 117 ~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 191 (308)
T cd06634 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQY 191 (308)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeec---CcccccCCccccCHHHHhhcccCCC
Confidence 3456788999999999999999999999999987765 9999999986432 2234568999999999742 344
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|..||............ ............++..+++||++||..+|.+||+++++++
T Consensus 192 ~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 192 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred Ccc-cchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 444 89999999999999999999764432222221 1111111122357889999999999999999999999999
Q ss_pred CcccccCCChHHH
Q 025933 163 HPWFLKNLPKEII 175 (246)
Q Consensus 163 hp~~~~~~~~~~~ 175 (246)
|||+....+....
T Consensus 267 ~~~~~~~~~~~~~ 279 (308)
T cd06634 267 HRFVLRERPPTVI 279 (308)
T ss_pred CccccccCChhHH
Confidence 9999886654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=209.01 Aligned_cols=153 Identities=31% Similarity=0.414 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC----CCCCCCCCCCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL----HSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..++.|++.+|.|||+++|+||||||+||+++.++. +||+|||+++.... ........|+..|+|||++.+..+
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCC
Confidence 456788999999999999999999999999987776 99999999874321 112233468999999999987777
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|+|||||++|+|++|+.||.......... ..............++..+.++|.+||. +|++||+++++++
T Consensus 187 ~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 187 GRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred Ccc-hhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 655 899999999999999999997654332222 1111111111223578899999999995 9999999999999
Q ss_pred Ccccc
Q 025933 163 HPWFL 167 (246)
Q Consensus 163 hp~~~ 167 (246)
|||+.
T Consensus 261 ~~~~~ 265 (265)
T cd06652 261 HTFVH 265 (265)
T ss_pred CcccC
Confidence 99973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=211.81 Aligned_cols=153 Identities=24% Similarity=0.340 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccc---cc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLAR---KE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~ 81 (246)
...++.|++.|+.|||+++|+||||||+||+++.++. +||+|||+++...... ......|++.|+|||.+.. ..
T Consensus 108 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 185 (267)
T cd06646 108 IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCccccCccccCHhHcccccCCC
Confidence 4556788999999999999999999999999987776 9999999987542221 2234568999999999842 33
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC---CCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF---LPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
++ .++|+||+||++|+|++|..||........... +...... .+....++..+.+||++||..+|++|||++
T Consensus 186 ~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 260 (267)
T cd06646 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE 260 (267)
T ss_pred Cc-chhhHHHHHHHHHHHHhCCCCccccchhhhhee----eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHH
Confidence 44 348999999999999999999965432211111 1111111 112235789999999999999999999999
Q ss_pred HHhcCcc
Q 025933 159 EIKKHPW 165 (246)
Q Consensus 159 e~l~hp~ 165 (246)
++++|+|
T Consensus 261 ~il~~l~ 267 (267)
T cd06646 261 RLLTHLF 267 (267)
T ss_pred HHhcCCC
Confidence 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=210.32 Aligned_cols=160 Identities=23% Similarity=0.347 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||+|||.++++|+||||+||+++.++. +||+|||++....... ......++..|+|||.+.+...
T Consensus 101 ~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 178 (287)
T cd07840 101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCcccccccccccccCCceeeEcccc
Confidence 34677889999999999999999999999999998776 9999999987543322 1233467889999998765433
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCC-----------------------CCCc-CCH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP-----------------------DYVR-VSA 137 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~-----------------------~~~~-~~~ 137 (246)
.+.++||||||+++|+|++|..||...........+........ ...+ .... ++.
T Consensus 179 ~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T cd07840 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258 (287)
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCH
Confidence 33458999999999999999999987665444444333211000 0000 0112 388
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+.+++++||..+|.+||++.+++.||||
T Consensus 259 ~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 259 SALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=210.72 Aligned_cols=163 Identities=29% Similarity=0.453 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++++||||+|.||+++.++. ++|+|||++...... ......++..|+|||.+.+..++.+
T Consensus 107 ~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~ 183 (287)
T cd06621 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS-LAGTFTGTSFYMAPERIQGKPYSIT 183 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc-ccccccCCccccCHHHhcCCCCCch
Confidence 4467888999999999999999999999999988766 999999998743222 2223467889999999988887766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcc-ccCCCC----CCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV-QYFLPD----YVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
+|+||+||++|+|++|..||...... ....+....+... ....+. ....++.+.+||.+||..||.+|||+.|
T Consensus 184 -~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 262 (287)
T cd06621 184 -SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262 (287)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence 89999999999999999999765220 0111222222221 111111 1135678999999999999999999999
Q ss_pred HhcCcccccCCCh
Q 025933 160 IKKHPWFLKNLPK 172 (246)
Q Consensus 160 ~l~hp~~~~~~~~ 172 (246)
+++||||.+...+
T Consensus 263 il~~~~~~~~~~~ 275 (287)
T cd06621 263 MLEHPWIKAQMKK 275 (287)
T ss_pred HHhCccccccccc
Confidence 9999999765544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=212.14 Aligned_cols=150 Identities=23% Similarity=0.342 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
.+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||++..............+..|+|||++.+..++.+
T Consensus 121 ~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (297)
T cd05089 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK 198 (297)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCch
Confidence 4567889999999999999999999999999987765 99999999864221111111223557999999988777655
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|||||||++|+|++ |..||.+........ .+... ...+....++..+++|+.+||..+|.+|||++++++.
T Consensus 199 -~DvwSlG~il~el~t~g~~pf~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 199 -SDVWSFGVLLWEIVSLGGTPYCGMTCAELYE----KLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999997 999997655433222 22221 1222334688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=210.22 Aligned_cols=150 Identities=23% Similarity=0.339 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|+|+++|+||||||+|||++.++. +||+|||+++....... .....+++.|+|||.+.+..+
T Consensus 126 ~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred HHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--eEecccccccccccchheeeccCccCCccccCHHHHhcCCC
Confidence 4567889999999999999999999999999987766 99999999875322211 123346789999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+ ....+..... .+....++..+.+|+.+||+.+|.+||++.+++
T Consensus 204 ~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~ 277 (283)
T cd05091 204 SID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIH 277 (283)
T ss_pred Ccc-hhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 655 899999999999998 888987654432 2333333222 222346899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
..
T Consensus 278 ~~ 279 (283)
T cd05091 278 SR 279 (283)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=218.21 Aligned_cols=159 Identities=19% Similarity=0.307 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--------CCCCCCCCCCCcchhcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--------PKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~~~ 78 (246)
..++.|++.||.|||+++|+||||||+|||++.++. +|++||+.+........ .....++..|+|||++.
T Consensus 104 ~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (328)
T cd08226 104 GNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181 (328)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhc
Confidence 457789999999999999999999999999987765 99999986432111110 01123566799999997
Q ss_pred cc--ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------------------------
Q 025933 79 RK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--------------------------------- 123 (246)
Q Consensus 79 ~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~--------------------------------- 123 (246)
+. .++ .++||||+||++|+|++|..||.+..........+....
T Consensus 182 ~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (328)
T cd08226 182 QDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVA 260 (328)
T ss_pred CCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhc
Confidence 64 344 448999999999999999999976544333222111000
Q ss_pred --------ccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 124 --------NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 124 --------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
......+....++..+++||++||..||.+|||+.++++||||..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 261 AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000001112235678999999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=208.96 Aligned_cols=159 Identities=25% Similarity=0.407 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.+|.|||+++|+||||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+.+.....
T Consensus 103 ~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (277)
T cd06917 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccccccccCCcceeCHHHhccCCccc
Confidence 4556778999999999999999999999999998765 9999999987543322 223346899999999987544333
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
..+|+|||||++|+|++|..||.+....... ..+............++.++.+++.+||..||.+||++.++++|+
T Consensus 181 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 4489999999999999999999764432221 111111111111113788999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||++..
T Consensus 257 ~~~~~~ 262 (277)
T cd06917 257 WIKAHS 262 (277)
T ss_pred Hhhccc
Confidence 997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=209.89 Aligned_cols=161 Identities=26% Similarity=0.436 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.++.|||+ ++|+||||||+||+++.++. ++|+|||++.... ........|+..|+|||++.+..++
T Consensus 104 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~ 180 (284)
T cd06620 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQGGKYT 180 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchh-hhccCccccCcccCCHHHHccCCCC
Confidence 345667889999999997 68999999999999987765 9999999986432 2222345789999999999877776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDP-------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
.+ +|+||+||++|++++|..||...... .........+............++..+.+|+.+||..||.+|||
T Consensus 181 ~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 259 (284)
T cd06620 181 VK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259 (284)
T ss_pred cc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC
Confidence 55 89999999999999999999764432 11222233322221111111237889999999999999999999
Q ss_pred HHHHhcCcccccC
Q 025933 157 IPEIKKHPWFLKN 169 (246)
Q Consensus 157 ~~e~l~hp~~~~~ 169 (246)
+.++++|+||.+.
T Consensus 260 ~~e~~~~~~~~~~ 272 (284)
T cd06620 260 PQQLCAMPPFIQA 272 (284)
T ss_pred HHHHhcCcccccc
Confidence 9999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=211.52 Aligned_cols=158 Identities=27% Similarity=0.357 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---cccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~ 82 (246)
...++.|++.|+.|||+++|+||||+|+||+++.++. +||+|||++.... ......|++.|+|||.+. ...+
T Consensus 127 ~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (317)
T cd06635 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQY 201 (317)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---CcccccCCccccChhhhhcCCCCCC
Confidence 3456788999999999999999999999999987766 9999999986422 223456899999999974 3445
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|+||+||++|+|++|..||...........+ ............++..+++|+.+||+.+|.+||++.++++
T Consensus 202 ~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 202 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred Ccc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 545 89999999999999999999765433332222 2222222223357889999999999999999999999999
Q ss_pred CcccccCCChH
Q 025933 163 HPWFLKNLPKE 173 (246)
Q Consensus 163 hp~~~~~~~~~ 173 (246)
|+|+....+..
T Consensus 277 ~~~~~~~~~~~ 287 (317)
T cd06635 277 HMFVLRERPET 287 (317)
T ss_pred ChhhhccCccc
Confidence 99997655533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=207.63 Aligned_cols=153 Identities=28% Similarity=0.437 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.+.++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||++........ .....|++.|+|||++.+..++.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 180 (256)
T cd08218 103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCC
Confidence 3566789999999999999999999999999987766 99999999874322211 12345889999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||......... ..+..... .+....++.++.++|.+||..+|.+||++.++++||
T Consensus 181 ~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 181 K-SDIWALGCVLYEMCTLKHAFEAGNMKNLV----LKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred c-cchhHHHHHHHHHHcCCCCccCCCHHHHH----HHHhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 5 89999999999999999999764433222 22222221 122346789999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
||
T Consensus 255 ~~ 256 (256)
T cd08218 255 FI 256 (256)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=217.05 Aligned_cols=152 Identities=25% Similarity=0.353 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++|+||||||+|||++.+.. +||+|||+++....... .....++..|+|||++.+..
T Consensus 215 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 292 (375)
T cd05104 215 DLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV 292 (375)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCC
Confidence 45677889999999999999999999999999987665 99999999875332221 11223566799999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+.+.+.. ..........+.++++|+.+||..||++|||+.++
T Consensus 293 ~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 293 YTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred CCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 8765 899999999999998 89999775544443333322 11122223568899999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++.
T Consensus 368 l~~ 370 (375)
T cd05104 368 VQL 370 (375)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=206.18 Aligned_cols=153 Identities=28% Similarity=0.389 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.++.|||+++|+||||||+||+++.++. +||+|||++....... ......|++.|+|||.+.+..++.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~ 180 (256)
T cd08221 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCC
Confidence 3456788999999999999999999999999988776 9999999987543322 233457899999999998777665
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||......+.... +....+. +....++.++.+++.+||..+|.+||+++++++|+
T Consensus 181 ~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 181 K-SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred c-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 5 8999999999999999999976544333322 2222221 22246789999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
|+
T Consensus 255 ~l 256 (256)
T cd08221 255 LL 256 (256)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=213.10 Aligned_cols=150 Identities=22% Similarity=0.344 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC---CCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++........ ....++..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (316)
T cd05108 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188 (316)
T ss_pred HHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCCcceeccCCccceeecChHHhccCCC
Confidence 4567789999999999999999999999999988776 999999999854322221 12234668999999988887
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+... ..+...+ ......+....++.++.+++.+||..||.+||++.+++
T Consensus 189 ~~~-~Di~slGv~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 189 THQ-SDVWSYGVTVWELMTFGSKPYDGIPA-SEISSIL----EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262 (316)
T ss_pred Cch-hhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH----hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 755 899999999999997 9999976443 2222222 22223344456789999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
.+
T Consensus 263 ~~ 264 (316)
T cd05108 263 IE 264 (316)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=207.20 Aligned_cols=158 Identities=28% Similarity=0.434 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC-CCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.++.|||+ ++++||||+|+||+++.++. ++|+|||++.......... ...++..|+|||.+.+..++
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 178 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178 (264)
T ss_pred HHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCcccceeecccccCHhhhCCCCCC
Confidence 35678899999999999 99999999999999988776 9999999987543322222 34688999999999887766
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCc-CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||||+++|+|++|..||..... ....+....+.... ..+.... ++..+.++|.+||..+|++|||+.++++
T Consensus 179 ~~-~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 179 YA-ADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 55 8999999999999999999977642 11222233332211 1122223 7899999999999999999999999999
Q ss_pred Cccccc
Q 025933 163 HPWFLK 168 (246)
Q Consensus 163 hp~~~~ 168 (246)
||||..
T Consensus 256 ~~~~~~ 261 (264)
T cd06623 256 HPFIKK 261 (264)
T ss_pred CHHHHh
Confidence 999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=207.40 Aligned_cols=150 Identities=25% Similarity=0.341 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....+++.|+|||.+.+..+
T Consensus 114 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 191 (272)
T cd05075 114 LVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191 (272)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence 4566788999999999999999999999999987766 99999999885432211 122346778999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+..... ....+.... ..+....++..+.++|.+||..||.+|||+.+++
T Consensus 192 ~~~-~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 265 (272)
T cd05075 192 TTK-SDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265 (272)
T ss_pred ChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 655 899999999999999 899997654432 222222222 1233346889999999999999999999999997
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 266 ~~ 267 (272)
T cd05075 266 CE 267 (272)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=198.24 Aligned_cols=162 Identities=21% Similarity=0.298 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-----CCCCCCCCCCCCCcchhcccccc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+-+++.||.|+|.+.|+|||+|++|+||+.++. +||+|||+++.+... ...+..+.|.+|++||.+.+..-
T Consensus 128 k~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~ 205 (376)
T KOG0669|consen 128 KVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE 205 (376)
T ss_pred HHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc
Confidence 34556889999999999999999999999998876 999999999744322 12344577999999999998776
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCCCCC----------------------------
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYV---------------------------- 133 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~---------------------------- 133 (246)
+++..|||..|||+.+|++|.+-+.+.....++.-+..-..+. +..+|...
T Consensus 206 yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~ 285 (376)
T KOG0669|consen 206 YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPY 285 (376)
T ss_pred cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccc
Confidence 6677999999999999999999998877655543322211110 00011100
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 134 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.-.+++.+|+.+||..||.+|+++.+++.|.||.+...
T Consensus 286 ~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 286 VKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred cCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 12357889999999999999999999999999976543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=204.76 Aligned_cols=155 Identities=28% Similarity=0.419 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.+|.|||+++++|+||+|+||+++.++. +||+|||.+........ .....++..|+|||.+.+..+
T Consensus 103 ~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 180 (260)
T cd06606 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC
Confidence 4567889999999999999999999999999988665 99999999875443332 344568899999999987776
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|+||||+++|+|++|..||....... ...................+..++++|.+||..||.+||++.+++.
T Consensus 181 ~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 181 GRA-ADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 555 899999999999999999997655221 1222222111222223356899999999999999999999999999
Q ss_pred Cccc
Q 025933 163 HPWF 166 (246)
Q Consensus 163 hp~~ 166 (246)
||||
T Consensus 257 ~~~~ 260 (260)
T cd06606 257 HPFL 260 (260)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=212.07 Aligned_cols=158 Identities=27% Similarity=0.402 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.|+.|||+++|+||||||+||+++.++. +||+|||++....... ......|++.|+|||.+.+..++.+
T Consensus 118 ~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 195 (293)
T cd06647 118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195 (293)
T ss_pred HHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccccccCChhhcCchhhccCCCCch
Confidence 456778999999999999999999999999987765 9999999886433222 2233468899999999987777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|+||+||++|++++|..||............ ........+....++..++++|.+||..+|.+||++.+++.|+|
T Consensus 196 -~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 196 -VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 89999999999999999999765443221111 11112222333457889999999999999999999999999999
Q ss_pred cccCC
Q 025933 166 FLKNL 170 (246)
Q Consensus 166 ~~~~~ 170 (246)
|....
T Consensus 272 ~~~~~ 276 (293)
T cd06647 272 LKIAK 276 (293)
T ss_pred HhcCc
Confidence 97643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=207.60 Aligned_cols=150 Identities=22% Similarity=0.348 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC---CCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++........ ....+++.|+|||.+.+..
T Consensus 110 ~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (279)
T cd05109 110 DLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187 (279)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccccceeecCCCccchhhCCHHHhccCC
Confidence 45667889999999999999999999999999987665 999999998754322111 1223567899999998887
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||..... ......+ .. ....+.....+.++.+++.+||..||++||++.++
T Consensus 188 ~~~~-~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~---~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 188 FTHQ-SDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLL---EK-GERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred CCch-hHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH---HC-CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7765 899999999999998 8999975433 2222222 22 22233345689999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
+.
T Consensus 262 ~~ 263 (279)
T cd05109 262 VD 263 (279)
T ss_pred HH
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=207.53 Aligned_cols=158 Identities=27% Similarity=0.367 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||++.+..++.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 180 (277)
T cd06640 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccccccCcccccCHhHhccCCCcc
Confidence 3456788999999999999999999999999987766 9999999987533222 222346888999999998777765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+|||||++|+|++|..||.......... .+.... .......++..+.+++.+||..+|++||++.++++|+
T Consensus 181 ~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 181 K-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred H-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcCC-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 5 899999999999999999997654322221 111111 1111224788999999999999999999999999999
Q ss_pred ccccCCC
Q 025933 165 WFLKNLP 171 (246)
Q Consensus 165 ~~~~~~~ 171 (246)
||.....
T Consensus 255 ~~~~~~~ 261 (277)
T cd06640 255 FIVKNAK 261 (277)
T ss_pred Hhhhcch
Confidence 9965443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=204.61 Aligned_cols=155 Identities=32% Similarity=0.446 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+|+||||.||+++.++. .+||+|||.+........ .....|++.|+|||++.+..++
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~ 180 (257)
T cd08225 102 QILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCC
Confidence 34566778999999999999999999999999987653 379999999875432221 1234589999999999877776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|+||+||++|+|++|..||......+.... ..... ..+..+.++.+++++|.+||..+|.+|||+.++++|
T Consensus 181 ~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 181 NK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 55 8999999999999999999976543332222 22111 122334678999999999999999999999999999
Q ss_pred ccc
Q 025933 164 PWF 166 (246)
Q Consensus 164 p~~ 166 (246)
|||
T Consensus 255 ~~~ 257 (257)
T cd08225 255 PFL 257 (257)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=204.28 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||+|||+++|+||||||+||+++.++. +||+|||.+....... ......++..|+|||.+.+..
T Consensus 106 ~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (262)
T cd00192 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183 (262)
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccccccccccCCCcCccccCHHHhccCC
Confidence 45677889999999999999999999999999998766 9999999997543321 123345788999999998777
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+||+||++|+|++ |..||......... ..+.. ....+....++.++.+++.+||..||.+|||+.++
T Consensus 184 ~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 184 FTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVL----EYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred cchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence 7655 899999999999999 69999876443322 22222 22233344679999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 258 ~~~ 260 (262)
T cd00192 258 VER 260 (262)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=207.00 Aligned_cols=149 Identities=23% Similarity=0.375 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.|+.|+|+++|+||||||+||+++.++. +||+|||+++...... ......+++.|+|||++.+..+
T Consensus 124 ~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred HHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EEECCcccceecccCcceecCCCCcccceecChhhhccCCc
Confidence 4567889999999999999999999999999988766 9999999987432211 1123346788999999988888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....... ..+...... +....++..+++++.+||..||.+||++.|++
T Consensus 202 ~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 202 TTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVI----ECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred chh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 765 899999999999998 99999776543322 222222221 22236889999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 276 ~ 276 (280)
T cd05049 276 E 276 (280)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=209.45 Aligned_cols=159 Identities=32% Similarity=0.435 Sum_probs=122.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccc--cc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARK--EY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~ 82 (246)
..++.|++.||.|||+++++||||||+|||++.++. +||+|||+++...... ......|+..|+|||.+.+. .+
T Consensus 108 ~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (290)
T cd05613 108 QIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185 (290)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccccccccccCCcccCChhhccCCCCCC
Confidence 445568999999999999999999999999987765 9999999987532221 12234689999999998653 23
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PI 157 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~ 157 (246)
+ ..+|+||+|+++|+|++|..||...............+....... ...++..+.+++.+||..||.+|+ ++
T Consensus 186 ~-~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~ 262 (290)
T cd05613 186 D-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDA 262 (290)
T ss_pred C-ccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 3 348999999999999999999975443333334443333333222 335889999999999999999997 88
Q ss_pred HHHhcCcccccCC
Q 025933 158 PEIKKHPWFLKNL 170 (246)
Q Consensus 158 ~e~l~hp~~~~~~ 170 (246)
++++.||||.+..
T Consensus 263 ~~l~~~~~~~~~~ 275 (290)
T cd05613 263 DEIKKHPFFQKIN 275 (290)
T ss_pred HHHHcCcccccCC
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=204.63 Aligned_cols=149 Identities=21% Similarity=0.259 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.|++.||.|||+++|+||||||.||+++.++. +||+|||+++....... .....++..|+|||.+.+..
T Consensus 97 ~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC
Confidence 4567889999999999999999999999999988765 99999999874322211 11223467899999997777
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |..||....... +...+.... ..+....+++++.+||.+||+.||++||++.++
T Consensus 175 ~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~i~~~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 175 FSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMIESGE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred cCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 6655 899999999999997 999997654322 223333322 123334689999999999999999999999988
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
..
T Consensus 249 ~~ 250 (257)
T cd05116 249 EL 250 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=202.52 Aligned_cols=152 Identities=37% Similarity=0.541 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.|+.|+|+++++|+||||.||+++.++. ++|+|||++...... .......++..|+|||.+.+...+.
T Consensus 95 ~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 172 (250)
T cd05123 95 ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172 (250)
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCc
Confidence 4556788999999999999999999999999988776 999999998754332 1233456889999999998776655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH---HHHh
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI---PEIK 161 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l 161 (246)
+ +|+||||+++|++++|..||...... +....+.......+ ...+..+.+++++||..||.+||++ ++++
T Consensus 173 ~-~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 173 A-VDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred h-hhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 5 89999999999999999999765432 22233333333333 3568999999999999999999999 9999
Q ss_pred cCccc
Q 025933 162 KHPWF 166 (246)
Q Consensus 162 ~hp~~ 166 (246)
.||||
T Consensus 246 ~~~~f 250 (250)
T cd05123 246 AHPFF 250 (250)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=207.48 Aligned_cols=149 Identities=24% Similarity=0.359 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||++.+..+
T Consensus 122 ~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 4567889999999999999999999999999988776 9999999987432211 1123346778999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+...... ...+..... .+....++.++.+|+.+||..||.+|||+.+++
T Consensus 200 ~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~----~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 200 TTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 655 899999999999998 9999976554332 223333222 222335789999999999999999999999986
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
.
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=207.08 Aligned_cols=156 Identities=26% Similarity=0.332 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....+.|++.|+.|||+++|+|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+.+..++.
T Consensus 103 ~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (277)
T cd06642 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180 (277)
T ss_pred HHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhcccCcccccCHHHhCcCCCch
Confidence 3456788999999999999999999999999987766 9999999987533222 112346889999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+|||||++|+|++|..||.......... .+..... ......++.++.++|.+||..+|.+||++.++++||
T Consensus 181 ~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 181 K-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCCC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 5 899999999999999999997544322211 1111111 111224788999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
||.+.
T Consensus 255 ~~~~~ 259 (277)
T cd06642 255 FITRY 259 (277)
T ss_pred HHHHH
Confidence 98654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=206.65 Aligned_cols=150 Identities=27% Similarity=0.453 Sum_probs=117.8
Q ss_pred HHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc--cccCCcchhH
Q 025933 13 IFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDV 89 (246)
Q Consensus 13 il~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di 89 (246)
.+.||.||-. ..|||||+||+|||++..|. |||||||++......-..+.-.|-..|||||.+.. .+|+-. +|+
T Consensus 176 tV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDv 252 (361)
T KOG1006|consen 176 TVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDV 252 (361)
T ss_pred ehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchh-hhh
Confidence 4468888866 47999999999999999887 99999999975443333334478999999999853 456656 899
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC----CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL----PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
||||++|||+.+|.+||.+..+ ..+.+..+....+.. ....+++..++.+|..||.+|-..||...+++++||
T Consensus 253 WSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 253 WSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred hhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 9999999999999999986543 334444444433321 122358999999999999999999999999999999
Q ss_pred ccc
Q 025933 166 FLK 168 (246)
Q Consensus 166 ~~~ 168 (246)
++-
T Consensus 330 yr~ 332 (361)
T KOG1006|consen 330 YRM 332 (361)
T ss_pred hhh
Confidence 864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=221.13 Aligned_cols=158 Identities=32% Similarity=0.495 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-C-----------CC----------
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-L-----------HS---------- 60 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~-----------~~---------- 60 (246)
|++|+.. +.-|+.+.|+.|+|||||||+|||||.+|+ |||+|||||.-+. . .+
T Consensus 731 ARFYIAE---ltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~ 805 (1034)
T KOG0608|consen 731 ARFYIAE---LTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW 805 (1034)
T ss_pred HHHHHHH---HHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence 5566544 557888999999999999999999999988 9999999986210 0 00
Q ss_pred -----CC----------------CCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 025933 61 -----QP----------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 119 (246)
Q Consensus 61 -----~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~ 119 (246)
.. .+.+||+.|+|||++...+|+.. ||+||.|||||+|+.|++||......++..+++
T Consensus 806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhCCCCccCCCCCcceeeee
Confidence 00 13479999999999998888766 999999999999999999998877666655554
Q ss_pred HHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 025933 120 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKN 169 (246)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~ 169 (246)
.+-. ...++...++|.++.+||.++ .-++..|.. ++++..||||+.-
T Consensus 885 nw~~--~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 885 NWRN--FLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred ehhh--ccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcccccc
Confidence 4322 223466678999999999996 457888874 6789999999753
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=205.86 Aligned_cols=151 Identities=19% Similarity=0.253 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++++||||||+||+++.++. +||+|||+++...... ......+++.|+|||++.+..
T Consensus 120 ~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05062 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 197 (277)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC
Confidence 45567789999999999999999999999999998766 9999999987432211 112234678899999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |..||.+....... ..+..... .+.....+..+++++.+||+.||.+|||+.++
T Consensus 198 ~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 198 FTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVL----RFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred cCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 899999999999998 78999765443222 22222211 12233678899999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 272 l~~ 274 (277)
T cd05062 272 ISS 274 (277)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=204.13 Aligned_cols=154 Identities=31% Similarity=0.457 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++....... ......|++.|+|||.+.+..++
T Consensus 104 ~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 181 (258)
T cd08215 104 QILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181 (258)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcceecceeeeecccChhHhccCCCC
Confidence 34567889999999999999999999999999988766 9999999987543322 22345689999999998877776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|+||+|+++|+|++|..||....... ......... ..+....++..+.+++.+||..+|.+|||+.++++|
T Consensus 182 ~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 182 YK-SDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cc-ccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 55 899999999999999999997654322 222222211 112223688999999999999999999999999999
Q ss_pred ccc
Q 025933 164 PWF 166 (246)
Q Consensus 164 p~~ 166 (246)
|||
T Consensus 256 ~~~ 258 (258)
T cd08215 256 PFI 258 (258)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=209.96 Aligned_cols=150 Identities=22% Similarity=0.329 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
....+.|++.|+.|||++||+||||||+|||++.++. +||+|||+++............++..|+|||.+.+..++.+
T Consensus 126 ~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (303)
T cd05088 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 203 (303)
T ss_pred HHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc
Confidence 4556788999999999999999999999999987765 99999999864221111122234667999999977776655
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|||||||++|+|++ |..||.+....+.. ..+.. ....+.....+..+.+|+.+||..+|.+||++++++.+
T Consensus 204 -~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 204 -SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -ccchhhhhHHHHHHhcCCCCcccCChHHHH----HHHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999998 99999765443222 22211 12222333578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=203.87 Aligned_cols=150 Identities=23% Similarity=0.347 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.+|+|||+++|+||||||+||+++.++. +||+|||++......... ....++..|+|||.+.+..+
T Consensus 105 ~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred HHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccCCCCCccccCCHHHhccCCC
Confidence 34567889999999999999999999999999987766 999999998754322111 11234567999999988877
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+.. ..+.. .+..+....++..+.+++.+||..||++|||+.+++
T Consensus 183 ~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~ 256 (263)
T cd05052 183 SIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY----ELLEK-GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIH 256 (263)
T ss_pred Cch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 665 899999999999998 99999765433222 22222 112233346899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 257 ~ 257 (263)
T cd05052 257 Q 257 (263)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=205.64 Aligned_cols=150 Identities=21% Similarity=0.390 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..+
T Consensus 126 ~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05090 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203 (283)
T ss_pred HHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--EEeccccccccccCCcceecccCCCccceecChHHhccCCC
Confidence 4567889999999999999999999999999988766 9999999997532221 1223346778999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+.... .+...+... ...+....++..+++++.+||..||.+||++.+++
T Consensus 204 ~~~-~Dv~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 204 SSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVIEMVRKR-QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred Cch-hhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 655 899999999999998 99999765432 222222222 22334456899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 278 ~~ 279 (283)
T cd05090 278 TR 279 (283)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=203.07 Aligned_cols=157 Identities=26% Similarity=0.370 Sum_probs=121.1
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccccCCcch
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
++||+.||+|||+.+|.||||||.|+|++++.. +||||||+++...... .++..+.|.+|.|||++.|...++.++
T Consensus 162 lYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~Av 239 (449)
T KOG0664|consen 162 VYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAV 239 (449)
T ss_pred HHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCcc
Confidence 567889999999999999999999999998877 9999999998533222 223346789999999999877656669
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-------------------hccccCCCC---------CCcCCHHH
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-------------------RNVQYFLPD---------YVRVSADC 139 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~~---------~~~~~~~~ 139 (246)
||||.|||+.||+.++.-|...+..+++.-+.+-+ .......|. ...-..+.
T Consensus 240 DiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~hea 319 (449)
T KOG0664|consen 240 DIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEA 319 (449)
T ss_pred ceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHH
Confidence 99999999999999999998766665554433222 111111111 11234578
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
.+++.+||..||.+|++.++++.|+|..+
T Consensus 320 v~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 320 VDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHHHHHhCCCCcccccHhhhcccccccc
Confidence 89999999999999999999999999744
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=211.07 Aligned_cols=159 Identities=29% Similarity=0.467 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 86 (246)
.++.|++.||.|||+++|+||||||.||+++.++. +||+|||++... ........++..|+|||.+.+ ..++ .+
T Consensus 112 ~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~-~~ 186 (328)
T cd07856 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQ--DPQMTGYVSTRYYRAPEIMLTWQKYD-VE 186 (328)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCcccccccc--CCCcCCCcccccccCceeeeccCCcC-cH
Confidence 45778999999999999999999999999987765 999999998743 222344568889999999866 3444 45
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------hcc--ccCCC---CCCcCCHHHHH
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------------RNV--QYFLP---DYVRVSADCRH 141 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~--------------------~~~--~~~~~---~~~~~~~~~~~ 141 (246)
+|+||+||++|+|++|..||.+......+..+.+.. ... ....+ ..+.++..+++
T Consensus 187 ~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (328)
T cd07856 187 VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAID 266 (328)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHH
Confidence 999999999999999999997654322211111100 000 00011 12347889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+|.+||+.+|++|||+++++.||||.....
T Consensus 267 li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 267 LLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=206.23 Aligned_cols=158 Identities=28% Similarity=0.443 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....+.|++.+|.|||++||+|+||||+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.
T Consensus 118 ~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 195 (286)
T cd06614 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195 (286)
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCC
Confidence 4567889999999999999999999999999987776 9999999876432221 122345888999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+|||||++|+|++|..||...........+. .......+....++..++++|.+||..+|.+|||+.+++.|+
T Consensus 196 ~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 196 K-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred c-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 5 899999999999999999997654432222211 111122233334789999999999999999999999999999
Q ss_pred ccccC
Q 025933 165 WFLKN 169 (246)
Q Consensus 165 ~~~~~ 169 (246)
||.+.
T Consensus 272 ~~~~~ 276 (286)
T cd06614 272 FLKKA 276 (286)
T ss_pred Hhhcc
Confidence 99873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=204.51 Aligned_cols=150 Identities=25% Similarity=0.357 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..+
T Consensus 115 ~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCccceeeccccccccccccccCCccccCHhhcccCCC
Confidence 3556789999999999999999999999999987765 99999999875332211 112235678999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+.+ ..+.... ..+....++..+.+++.+||+.||.+|||+.+++
T Consensus 193 ~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~ 266 (273)
T cd05035 193 TSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLR 266 (273)
T ss_pred Ccc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 899999999999999 89999765543332 2222221 2223346899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 267 ~~ 268 (273)
T cd05035 267 EV 268 (273)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=205.93 Aligned_cols=160 Identities=33% Similarity=0.437 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccc--c
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKE--Y 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~ 82 (246)
..++.|++.+|.|||+.+++||||||.||+++.++. ++|+|||+++....... .....|+..|+|||.+.+.. .
T Consensus 108 ~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (288)
T cd05583 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185 (288)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccccccccccccCCccccCHHHhcCCCCCC
Confidence 445678999999999999999999999999987765 99999999875332221 12346899999999987654 4
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC---HHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPE 159 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e 159 (246)
+ .++|+||+|+++|+|++|..||...............+..... +....++..+.++|.+||+.||++||| +.+
T Consensus 186 ~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 186 D-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred c-chhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHH
Confidence 4 3489999999999999999999654332222333333333332 233357899999999999999999998 567
Q ss_pred HhcCcccccCCC
Q 025933 160 IKKHPWFLKNLP 171 (246)
Q Consensus 160 ~l~hp~~~~~~~ 171 (246)
+++||||.....
T Consensus 263 ~l~~~~~~~~~~ 274 (288)
T cd05583 263 IKNHPFFQGIDW 274 (288)
T ss_pred HhcCcccccCCH
Confidence 899999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=229.41 Aligned_cols=155 Identities=28% Similarity=0.376 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCC-------------------CCCCCCCC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-------------------LLHSQPKS 64 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~-------------------~~~~~~~~ 64 (246)
.++-....||++||.|+|++|||||||||.||+++..++ |||+|||++... ......++
T Consensus 697 d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 697 DEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred HHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 456667778999999999999999999999999998877 999999998741 01112345
Q ss_pred CCCCCCCCcchhccccc---cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHH
Q 025933 65 TVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADC 139 (246)
Q Consensus 65 ~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 139 (246)
.+||.-|+|||++.+.. |+.+ +|+||||+|++||+. ||... .....++.++++.....+ .+.+--+.-
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~y---PF~Ts---MERa~iL~~LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEMLY---PFGTS---MERASILTNLRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred ccceeeeecHHHhcccccccccch-hhhHHHHHHHHHHhc---cCCch---HHHHHHHHhcccCCCCCCcccccccchHH
Confidence 68999999999997655 7666 899999999999984 56431 223345555565444433 012233556
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
..+|+.||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999986
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=207.05 Aligned_cols=149 Identities=24% Similarity=0.366 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.|+.|||+++|+||||||+|||++.++. +||+|||++....... ......++..|+|||.+.+..+
T Consensus 125 ~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence 4567889999999999999999999999999988776 9999999987432211 1223457788999999988877
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||........ ...+..... .......+..+.+++.+||++||.+|||+.+++
T Consensus 203 ~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 203 TTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEV----IECITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 665 899999999999998 9999976554332 222222221 122335789999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 277 ~ 277 (291)
T cd05094 277 K 277 (291)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=203.60 Aligned_cols=150 Identities=21% Similarity=0.308 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..
T Consensus 110 ~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 187 (279)
T cd05111 110 RLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187 (279)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCC
Confidence 45667889999999999999999999999999987765 99999999974322211 12234677899999998878
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|++++ |..||.+.... ...+.+. ... ..+.....+.++.+++.+||..||.+|||+.++
T Consensus 188 ~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~~~---~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 188 YTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLLE---KGE-RLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred cCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH---CCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 7655 899999999999998 99999765432 2222222 221 222233467899999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 262 ~~ 263 (279)
T cd05111 262 AN 263 (279)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=204.39 Aligned_cols=153 Identities=35% Similarity=0.603 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---------------------CCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---------------------QPK 63 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---------------------~~~ 63 (246)
....++.|++.||.|||+++++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 103 ~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (280)
T cd05581 103 CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccc
Confidence 45667889999999999999999999999999987776 9999999987432211 112
Q ss_pred CCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHH
Q 025933 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143 (246)
Q Consensus 64 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 143 (246)
...|+..|+|||++.+..++.+ +|+||||++++++++|..||........+ ..+.......+ ..+++.+.+||
T Consensus 181 ~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li 253 (280)
T cd05581 181 SFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTF----QKILKLEYSFP--PNFPPDAKDLI 253 (280)
T ss_pred cccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhcCCCCC--CccCHHHHHHH
Confidence 3357889999999887766544 89999999999999999999876543332 23333333333 36799999999
Q ss_pred HHhcccCCCCCCCH----HHHhcCccc
Q 025933 144 SQIFVADPSKRIPI----PEIKKHPWF 166 (246)
Q Consensus 144 ~~~L~~dp~~R~t~----~e~l~hp~~ 166 (246)
.+||..||.+|||+ +++++||||
T Consensus 254 ~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=202.52 Aligned_cols=154 Identities=31% Similarity=0.408 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+||+++.++. ++|+|||+++..... .......|+..|+|||.+.+.
T Consensus 107 ~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCC
Confidence 34556788999999999999999999999999987765 999999998753211 112234689999999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|+|||||++|+|++|+.||......... .+ +.........+..+++.+.++|.+||. +|.+||++.++
T Consensus 185 ~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~-~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~ 258 (264)
T cd06653 185 GYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAI---FK-IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL 258 (264)
T ss_pred CCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHH---HH-HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence 76655 89999999999999999999765433322 22 221111111233688999999999999 57999999999
Q ss_pred hcCccc
Q 025933 161 KKHPWF 166 (246)
Q Consensus 161 l~hp~~ 166 (246)
+.|||.
T Consensus 259 ~~~~~~ 264 (264)
T cd06653 259 LRHPFV 264 (264)
T ss_pred hcCCCC
Confidence 999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=205.10 Aligned_cols=152 Identities=18% Similarity=0.276 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
.+.++.|++.|++|||+++++||||||+||+++.++. ..+||+|||+++...... ......++..|+|||++.+..
T Consensus 118 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05036 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI 197 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC
Confidence 4567889999999999999999999999999986542 348999999987532111 111223456799999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+....... . .+... ........++..+.+++.+||+.+|++|||+.++
T Consensus 198 ~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~-~---~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v 271 (277)
T cd05036 198 FTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-E---FVTGG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271 (277)
T ss_pred cCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 7765 899999999999997 99999865543322 2 22111 1122234678999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 272 l~~ 274 (277)
T cd05036 272 LER 274 (277)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=204.11 Aligned_cols=149 Identities=22% Similarity=0.331 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
.+.++.|++.|+.|||+++|+||||||+|||++.++. +||+|||++..............+..|+|||++.+..++.+
T Consensus 114 ~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 191 (270)
T cd05047 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCch
Confidence 3567888999999999999999999999999987765 99999999863221111112234567999999987777655
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 86 ISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 86 ~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+|+|||||++|+|++ |..||.+......+ ..+.. ....+....++.++.+|+.+||..||.+|||+.+++.
T Consensus 192 -~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 192 -SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -hhHHHHHHHHHHHHcCCCCCccccCHHHHH----HHHhC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 899999999999997 99999764433222 22222 1222333457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=204.64 Aligned_cols=155 Identities=21% Similarity=0.337 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..+
T Consensus 121 ~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 198 (288)
T cd05061 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECcCCccccccccccccccCCCcccccccCHHHhccCCC
Confidence 3456788999999999999999999999999988765 9999999987432211 1122345678999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+....+ ....+.... ..+.....+..+++++.+||+.||.+|||+.+++
T Consensus 199 ~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 199 TTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred ChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 899999999999998 788997654432 222222221 1122235689999999999999999999999987
Q ss_pred c------Cccccc
Q 025933 162 K------HPWFLK 168 (246)
Q Consensus 162 ~------hp~~~~ 168 (246)
+ ||||..
T Consensus 273 ~~l~~~~~~~~~~ 285 (288)
T cd05061 273 NLLKDDLHPSFPE 285 (288)
T ss_pred HHHHhhcCCCCCC
Confidence 6 888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=192.53 Aligned_cols=148 Identities=20% Similarity=0.223 Sum_probs=111.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||+|||+++ ||+|||++.++. +|+ ||+++.... ....||+.|||||++.+..++.
T Consensus 18 ~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~ 83 (176)
T smart00750 18 EIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRVDPYFMAPEVIQGQSYTE 83 (176)
T ss_pred HHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCCcccccChHHhcCCCCcc
Confidence 45677889999999999998 999999988776 888 999874322 2236899999999999888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHHhccccC-CCCCCcCCH--HHHHHHHHhcccCCCCCCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRIRNVQYF-LPDYVRVSA--DCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+ +||||+||++|+|++|..||....... .+............. .+....++. .++++|.+||..||.+||++.++
T Consensus 84 ~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~l 162 (176)
T smart00750 84 K-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHY 162 (176)
T ss_pred h-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHH
Confidence 5 899999999999999999997644322 222222222111100 011122333 69999999999999999999999
Q ss_pred hcCcccc
Q 025933 161 KKHPWFL 167 (246)
Q Consensus 161 l~hp~~~ 167 (246)
++|+|+.
T Consensus 163 l~~~~~~ 169 (176)
T smart00750 163 LAHCRAL 169 (176)
T ss_pred HHHHHHH
Confidence 9999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=203.54 Aligned_cols=150 Identities=22% Similarity=0.289 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..
T Consensus 120 ~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05032 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (277)
T ss_pred HHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC
Confidence 34567889999999999999999999999999988776 9999999987432221 122345678899999998777
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|++++ |..||.+...... .+ .+... ...+.....+..+.+++.+||..+|.+|||+.++
T Consensus 198 ~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~-~~---~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 198 FTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEV-LK---FVIDG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred CCcc-cchHHHHHHHHHhhccCCCCCccCCHHHH-HH---HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7655 899999999999998 9999976544322 22 22221 1222233578999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
+.
T Consensus 272 ~~ 273 (277)
T cd05032 272 VS 273 (277)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=199.70 Aligned_cols=153 Identities=28% Similarity=0.427 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.++.|||++||+||||||+||+++.++. ++|+|||++........ .....|+..|+|||.+.+..++.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~ 178 (254)
T cd06627 101 VAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178 (254)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCc
Confidence 3456788999999999999999999999999988665 99999999875433222 23346889999999987766654
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+|+++|+|++|..||............ ..... .+....++..+++++.+||..+|++|||+.+++.||
T Consensus 179 ~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 179 A-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---VQDDH--PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred c-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hccCC--CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 4 89999999999999999999765533222221 11111 222346789999999999999999999999999999
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
||
T Consensus 253 ~~ 254 (254)
T cd06627 253 WI 254 (254)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=201.40 Aligned_cols=148 Identities=22% Similarity=0.378 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..+.++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++..... .....++..|+|||++.+..++.
T Consensus 103 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 178 (256)
T cd05082 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFST 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--CCCCccceeecCHHHHccCCCCc
Confidence 34567789999999999999999999999999988776 999999998743221 22334567899999998877765
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++ |..||...... .....+... ........+++.+++++.+||..+|.+|||+.++++
T Consensus 179 ~-~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 179 K-SDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred h-hhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5 899999999999997 99999754332 222222221 122223468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=204.86 Aligned_cols=150 Identities=21% Similarity=0.334 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.|+.|||+++|+||||||+|||++.++. +||+|||++....... ......+++.|+|||.+.+..
T Consensus 123 ~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 34567789999999999999999999999999987665 9999999986432211 112234578899999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |.+||........... +.... .......+++.+.+||.+||..||.+||++.++
T Consensus 201 ~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 201 FTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----ITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred cCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----HHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 7766 899999999999998 9999976554333222 22211 122233688999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 275 ~~ 276 (280)
T cd05092 275 HS 276 (280)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=199.66 Aligned_cols=152 Identities=31% Similarity=0.415 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++|++||||+|.||+++.++. +||+|||++...... ......|++.|+|||.+.+..++.+
T Consensus 105 ~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~ 181 (256)
T cd08530 105 IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYK 181 (256)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCch
Confidence 3466778999999999999999999999999988665 999999998754332 3334568899999999988777655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|+||+|+++|+|++|+.||...+.... ...+....+ .+....++.++++++.+||..+|.+|||+.++++||+
T Consensus 182 -~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 182 -SDIWSLGCLLYEMATFAPPFEARSMQDL----RYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC-CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 8999999999999999999976543222 122222221 1222367899999999999999999999999999997
Q ss_pred c
Q 025933 166 F 166 (246)
Q Consensus 166 ~ 166 (246)
+
T Consensus 256 ~ 256 (256)
T cd08530 256 V 256 (256)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=200.06 Aligned_cols=152 Identities=24% Similarity=0.349 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~ 79 (246)
.....++.|++.||+|||+++++||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+
T Consensus 97 ~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 97 STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174 (257)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcc
Confidence 345667789999999999999999999999999988765 99999999875432111 112357788999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|+|||||++|+|++ |..||......+....+ .......+.....+..+.+++.+||..+|++|||+.
T Consensus 175 ~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 249 (257)
T cd05040 175 RTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFA 249 (257)
T ss_pred cCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 787765 899999999999998 99999765443332222 212222333345789999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
+++.
T Consensus 250 ~~~~ 253 (257)
T cd05040 250 ALRE 253 (257)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=202.85 Aligned_cols=150 Identities=27% Similarity=0.395 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+|+||||.||+++.++. ++|+|||++........ .....|++.|+|||++.+..++.
T Consensus 102 ~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179 (255)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccccccCCccccCHHHHccCCcCc
Confidence 3456788999999999999999999999999987766 99999999875432221 23356899999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+|+++|+|++|..||........ ...+..... .+....++..+++||.+||..||.+|||+.+++.-
T Consensus 180 ~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 180 K-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred h-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 5 8999999999999999999976443222 222222222 22334688999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=201.71 Aligned_cols=152 Identities=26% Similarity=0.379 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+|+||||+||+++.++. ++|+|||++........ .....|+..|+|||.+.+..++.
T Consensus 108 ~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~ 185 (267)
T cd08229 108 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccc
Confidence 4566788999999999999999999999999987766 99999999875432221 22346899999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|+||+|+++|+|++|..||.+.... .......+....+.......++..+++++.+||..||.+|||+.++++
T Consensus 186 ~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 186 K-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred h-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 5 89999999999999999999754321 122223333222221122357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=204.45 Aligned_cols=155 Identities=25% Similarity=0.326 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+||+++.++. ++|+|||+++...... ......+++.|+|||.+.+..
T Consensus 131 ~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred HHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence 34567889999999999999999999999999988765 9999999987432221 122345678899999998777
Q ss_pred cCCcchhHHhHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHh--ccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 82 YDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIR--NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~--g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
++.+ +|||||||++|+|++ |..||........+........ ......+....++.++.+|+.+||+.||.+|||+
T Consensus 209 ~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 209 FTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred CCcc-chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence 7655 899999999999998 7788876554443333222111 1111223334578999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.++++
T Consensus 288 ~el~~ 292 (296)
T cd05051 288 REIHL 292 (296)
T ss_pred HHHHH
Confidence 99965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=202.18 Aligned_cols=149 Identities=20% Similarity=0.274 Sum_probs=110.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-----CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-----PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-----~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~ 79 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. ..+|++|||++..... .....|+..|+|||++.+
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 106 WKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVED 182 (262)
T ss_pred HHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcC
Confidence 34567889999999999999999999999999975442 2389999999864321 233468889999999874
Q ss_pred cccCCcchhHHhHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
....+.++|||||||++|+|+ .|..||......+. .. ...... ......+.++.+||.+||..||.+||++.
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~ 255 (262)
T cd05077 183 SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFR 255 (262)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence 333344589999999999998 58888865432211 11 111111 11223568899999999999999999999
Q ss_pred HHhcC
Q 025933 159 EIKKH 163 (246)
Q Consensus 159 e~l~h 163 (246)
+++++
T Consensus 256 ~il~~ 260 (262)
T cd05077 256 AIMRD 260 (262)
T ss_pred HHHHh
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=201.17 Aligned_cols=151 Identities=31% Similarity=0.436 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.|+.|||+++|+|+||||+||+++.+ .+||+|||+++....... .....|++.|+|||.+.+..++.+
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 185 (260)
T cd08222 109 CEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185 (260)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCch
Confidence 4567889999999999999999999999999753 399999999875332221 223468899999999987777656
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|+||+|+++|+|++|..||....... .......... ......++.++.++|.+||..||.+||++.++++|||
T Consensus 186 -~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 186 -SDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIVEGPT-PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCCC-CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 899999999999999999997543322 2222222111 1112357899999999999999999999999999999
Q ss_pred c
Q 025933 166 F 166 (246)
Q Consensus 166 ~ 166 (246)
|
T Consensus 260 ~ 260 (260)
T cd08222 260 I 260 (260)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=205.46 Aligned_cols=150 Identities=21% Similarity=0.326 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... .....+++.|+|||++.+..+
T Consensus 139 ~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (304)
T cd05101 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCC
Confidence 4566789999999999999999999999999987765 99999999875432111 122345678999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+ ....+.... .......++..+++|+.+||..+|.+|||+.+++
T Consensus 217 ~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 217 THQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred Cch-hhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 665 899999999999998 788887654322 222222221 2223346889999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+.
T Consensus 291 ~~ 292 (304)
T cd05101 291 ED 292 (304)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=227.27 Aligned_cols=155 Identities=28% Similarity=0.397 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC---CCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~---~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~ 79 (246)
...+.|++.||+.||+.+||||||||+||||.. ++..+++|+|||+|+...... ...+..||-+|+|||++..
T Consensus 609 ~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 609 ISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred HHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc
Confidence 456788999999999999999999999999976 455679999999998543322 2344579999999999987
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC-cCCHHHHHHHHHhcccCCCCCCCH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-RVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
..-.. ++||+|+|||+|+.++ |.+||.+.-.. -.++....+.+-... ....++++||.+||..+|..||+|
T Consensus 689 ~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R------~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa 761 (903)
T KOG1027|consen 689 DRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLER------QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSA 761 (903)
T ss_pred cccCc-ccchhhcCceEEEEecCCccCCCchHHh------hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCH
Confidence 76554 5899999999998888 59999753321 112333333221110 111289999999999999999999
Q ss_pred HHHhcCccccc
Q 025933 158 PEIKKHPWFLK 168 (246)
Q Consensus 158 ~e~l~hp~~~~ 168 (246)
.++|.||+|-.
T Consensus 762 ~~VL~HPlFW~ 772 (903)
T KOG1027|consen 762 TDVLNHPLFWD 772 (903)
T ss_pred HHHhCCCccCC
Confidence 99999999954
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=201.63 Aligned_cols=149 Identities=20% Similarity=0.328 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
.+.++.|++.||+|||+++++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++
T Consensus 105 ~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 182 (261)
T cd05072 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182 (261)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccCCCccceecCCHHHhccCCCC
Confidence 4567789999999999999999999999999988766 99999999975332211 1223456789999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+|||||++|+|++ |..||.+....... ..+.. ....+....++.++.+++.+||..+|++||+++++.+
T Consensus 183 ~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 183 IK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVM----SALQR-GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred hh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 899999999999998 99999765443222 22222 2233444568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=200.57 Aligned_cols=151 Identities=21% Similarity=0.282 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhcc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~ 78 (246)
...+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.
T Consensus 98 ~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 98 KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence 345667789999999999999999999999999988765 9999999987432111 111234677899999998
Q ss_pred ccccCCcchhHHhHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
+..++.+ +|||||||++|+|++| .+||...... . ....+.... ..+....++..+.+++.+||..+|++||++
T Consensus 176 ~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~-~---~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 249 (262)
T cd05058 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSF-D---ITVYLLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPTF 249 (262)
T ss_pred cCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHH-H---HHHHHhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 7777655 8999999999999995 5666543332 2 222222221 122223568899999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.++++
T Consensus 250 ~~il~ 254 (262)
T cd05058 250 SELVS 254 (262)
T ss_pred HHHHH
Confidence 99976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=201.99 Aligned_cols=151 Identities=20% Similarity=0.337 Sum_probs=110.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccc----
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLAR---- 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~---- 79 (246)
..++.|++.|++|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||++..
T Consensus 103 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05042 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180 (269)
T ss_pred HHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc
Confidence 456788999999999999999999999999988776 9999999986432211 1123346778999999753
Q ss_pred ---cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCC-CCCcCCHHHHHHHHHhcccCCCCC
Q 025933 80 ---KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 80 ---~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
..+ ..++||||+||++|+|++ |..||....+...+........ .....+ ....++..+.+++..|+ .||.+|
T Consensus 181 ~~~~~~-~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 181 LLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred cccccc-chhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 233 345899999999999998 7889876554443333322111 111111 12357889999999998 599999
Q ss_pred CCHHHHhc
Q 025933 155 IPIPEIKK 162 (246)
Q Consensus 155 ~t~~e~l~ 162 (246)
||++++++
T Consensus 258 pt~~~v~~ 265 (269)
T cd05042 258 PTAEEVHE 265 (269)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=204.89 Aligned_cols=150 Identities=23% Similarity=0.365 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..+
T Consensus 134 ~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred HHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence 3457889999999999999999999999999987765 99999999875332111 112234567999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+.+. .+.. ....+.....+..+.+|+.+||..||++|||+.+++
T Consensus 212 ~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil 285 (293)
T cd05053 212 THQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK----LLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285 (293)
T ss_pred Ccc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHH----HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 655 899999999999997 999997654433222 2221 112223346789999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 286 ~~ 287 (293)
T cd05053 286 ED 287 (293)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=201.26 Aligned_cols=151 Identities=17% Similarity=0.249 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC--CCCCCCCCCcchhccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKE 81 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~~~~~~ 81 (246)
...+.++.|++.||.|||+++|+||||||+|||++.++. +|++|||.+.......... ...++..|+|||++.+..
T Consensus 107 ~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (266)
T cd05064 107 GQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184 (266)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccchhcccCCCCceeecCHHHHhhCC
Confidence 345677889999999999999999999999999988765 9999999876432221111 223567899999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +||||+||++|++++ |..||.+...... ...+... ...+....++..+.+++.+||..+|.+||+++++
T Consensus 185 ~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 185 FSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDV----IKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred ccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 7655 899999999999775 9999987554332 2222222 2234445789999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 259 ~~ 260 (266)
T cd05064 259 HS 260 (266)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=199.82 Aligned_cols=149 Identities=21% Similarity=0.298 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+||+++.++. ++|+|||+++....... .....++..|+|||.+.+..++
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 181 (260)
T cd05069 104 LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcC
Confidence 4566788999999999999999999999999988776 99999999874322211 1123466789999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+|||||++|+|++ |..||.+......... +.. .+..+.....+..+++++++||.+||.+||+++++++
T Consensus 182 ~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 182 IK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred hH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 899999999999999 9999987554333222 221 2222333468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=199.75 Aligned_cols=150 Identities=20% Similarity=0.334 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.|++|||+++|+||||||+||+++.++. +||+|||+++........ ....++..|+|||.+.+..++
T Consensus 102 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCCCCCCccccCHHHhccCCCC
Confidence 4567788999999999999999999999999988776 999999998743221111 111234579999999887776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+|||||++|+|++ |..||......+... .+.. ....+.....+..+.+++.+||..+|++|||+.++++
T Consensus 180 ~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 180 SK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVSA-GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred ch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHHc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 55 899999999999998 899997655433322 2221 1222333468999999999999999999999999986
Q ss_pred C
Q 025933 163 H 163 (246)
Q Consensus 163 h 163 (246)
.
T Consensus 254 ~ 254 (256)
T cd05059 254 Q 254 (256)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=199.54 Aligned_cols=149 Identities=21% Similarity=0.306 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||+|||+++|+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 181 (260)
T cd05070 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCc
Confidence 4567888999999999999999999999999988765 99999999874322211 1122356679999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||||+++|+|++ |..||.+....+.. ..+.. ....+.....+..+++|+.+||.++|.+|||+.++.+
T Consensus 182 ~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 182 IK-SDVWSFGILLTELVTKGRVPYPGMNNREVL----EQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 55 899999999999999 89999765443322 22222 1223334468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=215.85 Aligned_cols=161 Identities=21% Similarity=0.221 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCC--CCCCCCCCcchhcccccc-
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS--TVGTPAYIAPEVLARKEY- 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~- 82 (246)
...++.|++.+|.|||+++|+||||||+|||++.++. +||+|||+++.......... ..+|+.|+|||.+.....
T Consensus 311 ~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence 3456788999999999999999999999999988765 99999999874332222222 235889999999854321
Q ss_pred -------------------C-CcchhHHhHHHHHHHHHhCCC-CCCCCCChHHH-------HHHHHHHhccccCCCCCCc
Q 025933 83 -------------------D-GKISDVWSCGVTLYVMLVGAY-PFEDPEDPRNF-------RKTIDRIRNVQYFLPDYVR 134 (246)
Q Consensus 83 -------------------~-~~~~DiwslG~il~~ll~g~~-Pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 134 (246)
. ....|+||+||++|+|++|.. ||.+....... .+.+.......+.++.+..
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~ 468 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDR 468 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccc
Confidence 1 112699999999999999875 77532211110 1111222233444555667
Q ss_pred CCHHHHHHHHHhcccCC---CCCCCHHHHhcCccccc
Q 025933 135 VSADCRHLLSQIFVADP---SKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 135 ~~~~~~~li~~~L~~dp---~~R~t~~e~l~hp~~~~ 168 (246)
.++.+++|+.+||.++| .+|+|+.|+|+||||..
T Consensus 469 ~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 469 NKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 89999999999999876 68999999999999964
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=202.52 Aligned_cols=153 Identities=24% Similarity=0.288 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+.
T Consensus 108 ~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc
Confidence 34567889999999999999999999999999987765 99999999875332211 1122456679999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH------------HHHhccccCCCCCCcCCHHHHHHHHHhcc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI------------DRIRNVQYFLPDYVRVSADCRHLLSQIFV 148 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 148 (246)
.++.+ +|||||||++|+|++|..||...... +.... ..........+....++..+.+++.+||.
T Consensus 186 ~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 186 KFSYA-SDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred CCCcc-cccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 77655 89999999999999999998653321 11100 00011111222334578999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 025933 149 ADPSKRIPIPEIKK 162 (246)
Q Consensus 149 ~dp~~R~t~~e~l~ 162 (246)
.||++|||+.+++.
T Consensus 263 ~~p~~Rps~~~i~~ 276 (283)
T cd05080 263 TEAKFRPTFRSLIP 276 (283)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=201.93 Aligned_cols=153 Identities=25% Similarity=0.371 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++....... ......|++.|+|||.+.+..++.
T Consensus 108 ~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 185 (267)
T cd08228 108 VWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185 (267)
T ss_pred HHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccchhHHHhcCCCCccccChhhhccCCCCc
Confidence 3466778999999999999999999999999988766 9999999987533221 122346889999999998777765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+|+++|+|++|..||...... .......+....+.......++..+.+++.+||..+|.+||++.++++.
T Consensus 186 ~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 186 K-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred h-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 5 89999999999999999999654321 1222233322222111122577899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=204.72 Aligned_cols=149 Identities=20% Similarity=0.320 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..+
T Consensus 136 ~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence 4566889999999999999999999999999987765 99999999974322111 111234567999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+...... ...+.... .......++.++++|+.+||..||.+|||+.+++
T Consensus 214 ~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 214 THQ-SDVWSFGILMWEIFTLGGSPYPGIPVEEL----FKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred Ccc-chhhHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 655 899999999999998 8999976443222 22222221 1222346788999999999999999999999988
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 288 ~ 288 (314)
T cd05099 288 E 288 (314)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=199.35 Aligned_cols=150 Identities=20% Similarity=0.284 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|+|+++|+||||||+||+++.++. +||+|||+++....... .....++..|+|||++.+..+
T Consensus 103 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (262)
T cd05071 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180 (262)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccccCCcccceecCHhHhccCCC
Confidence 34567789999999999999999999999999988766 99999999874322221 112346678999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.+........ .+.. ....+....++..+.+++.+||++||.+||++.+++
T Consensus 181 ~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~ 254 (262)
T cd05071 181 TIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 254 (262)
T ss_pred Cch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 655 899999999999999 888997655433322 2222 112233446889999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
.
T Consensus 255 ~ 255 (262)
T cd05071 255 A 255 (262)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=198.57 Aligned_cols=149 Identities=23% Similarity=0.323 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++........ ....++..|+|||++.+..++
T Consensus 102 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd05114 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc
Confidence 4567788999999999999999999999999987765 999999998753222211 122355689999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||+|+++|+|++ |+.||......+... .+..... .......+..+.+++.+||..+|.+||++.++++
T Consensus 180 ~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~----~i~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 180 SK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE----MISRGFR-LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred hh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHCCCC-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55 899999999999999 999997655433332 2222211 1222346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=199.10 Aligned_cols=150 Identities=21% Similarity=0.303 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+.
T Consensus 96 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 96 NVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC
Confidence 44667889999999999999999999999999987765 99999999874322211 1112235789999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|+|||||++|++++ |..||.+....... ..+.... ..+.....++++.++|.+||..||++||++.+
T Consensus 174 ~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 174 KFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVM----SFIEQGK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred CCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 77655 899999999999996 99999875543322 2222211 12223467899999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+.+
T Consensus 248 i~~ 250 (257)
T cd05115 248 VEE 250 (257)
T ss_pred HHH
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=198.76 Aligned_cols=150 Identities=24% Similarity=0.317 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC-C---CCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-K---STVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~-~---~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.+|.|||.++|+||||||+|||++.++. +||+|||+++........ . ...++..|+|||.+.+.
T Consensus 96 ~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05060 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173 (257)
T ss_pred HHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCC
Confidence 45677889999999999999999999999999988776 999999998743222211 1 11234679999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|+|||||++|+|++ |..||......+ ..+. +... ...+....++..++++|.+||..+|.+||++.+
T Consensus 174 ~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~---~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~ 247 (257)
T cd05060 174 KFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAM---LESG-ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSE 247 (257)
T ss_pred CCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHH-HHHH---HHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 77655 899999999999997 999997654422 2222 2222 223344468899999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 248 l~~ 250 (257)
T cd05060 248 LES 250 (257)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=198.94 Aligned_cols=150 Identities=21% Similarity=0.359 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.|++|||+++|+||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++
T Consensus 105 ~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 182 (261)
T cd05148 105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182 (261)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccccCCCCceEecCHHHHccCCCC
Confidence 34567889999999999999999999999999988766 99999999875322211 1123456789999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||||+++|+|++ |..||.+....+.+..+ .. .+..+.....+..+.+++.+||..||.+|||+.++++
T Consensus 183 ~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 183 TK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----TA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----Hh-CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55 899999999999998 89999765543333322 21 2223444578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=191.98 Aligned_cols=154 Identities=27% Similarity=0.405 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC----------CCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----------STVGTPAYI 72 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~----------~~~gt~~y~ 72 (246)
..+.+..++..||.+||+.. .+||||||.|||+.+++. ++|.|||.+......-... ....|..|.
T Consensus 128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyR 205 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYR 205 (302)
T ss_pred HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCccc
Confidence 34566777889999999999 999999999999988666 8999999886422111111 123688999
Q ss_pred cchhcccc---ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 73 APEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 73 aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
|||.+.-+ ..+.+ +|||||||++|.|+.|..||......-. .+--.+.+.+..+|....+|+.+.+||+.||+.
T Consensus 206 APELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqv 282 (302)
T KOG2345|consen 206 APELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQNAQISIPNSSRYSEALHQLIKSMLQV 282 (302)
T ss_pred CchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeeeccccccCCCCCccHHHHHHHHHHhcC
Confidence 99998643 33445 8999999999999999999952110000 000013455667788888999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 025933 150 DPSKRIPIPEIKKH 163 (246)
Q Consensus 150 dp~~R~t~~e~l~h 163 (246)
||.+||++.+++.+
T Consensus 283 dP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 283 DPNQRPTIPELLSK 296 (302)
T ss_pred CcccCCCHHHHHHH
Confidence 99999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=201.89 Aligned_cols=149 Identities=24% Similarity=0.363 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..+
T Consensus 129 ~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 4567889999999999999999999999999987765 99999999874322111 122345678999999887777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+.... .+.+. ... ....+....++.++.+++.+||..+|.+||++.+++
T Consensus 207 ~~~-~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~---~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 207 TTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNL---LKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred chH-hHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH---HhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 655 899999999999998 99999765432 22222 221 122233446889999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 281 ~ 281 (290)
T cd05045 281 K 281 (290)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=203.23 Aligned_cols=151 Identities=26% Similarity=0.387 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..
T Consensus 142 ~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred HHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 44567788999999999999999999999999987665 99999999874332211 11234677899999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +||||+||++|+|++ |..||.+......+.+... .....+.....+..+.+|+.+||.++|++|||+.++
T Consensus 220 ~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 220 YTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred CCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 7655 899999999999998 9999987655444333322 112222333578999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 295 l~ 296 (302)
T cd05055 295 VQ 296 (302)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=201.72 Aligned_cols=157 Identities=24% Similarity=0.338 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.++.|||+++|+|+||||.||+++.++. ++|+|||++....... ......|+..|+|||.+.+..++.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 180 (277)
T cd06641 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180 (277)
T ss_pred HHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccccCCccccChhhhccCCCCc
Confidence 3456788999999999999999999999999987766 9999999986433221 123346889999999998777665
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|+||+||++|+|++|..||......... ..+..... ......++.++.+++.+||..+|.+||++.++++||
T Consensus 181 ~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 181 K-ADIWSLGITAIELAKGEPPHSELHPMKVL----FLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred h-hhHHHHHHHHHHHHcCCCCCCccchHHHH----HHHhcCCC-CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 5 89999999999999999999764432222 12221111 111235789999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||.+..
T Consensus 255 ~~~~~~ 260 (277)
T cd06641 255 FIVRFA 260 (277)
T ss_pred HHhhhh
Confidence 997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=204.17 Aligned_cols=151 Identities=21% Similarity=0.317 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++....... .....+++.|+|||.+.+..
T Consensus 141 ~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (307)
T cd05098 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218 (307)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence 34567889999999999999999999999999987765 99999999874322111 11123456899999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |..||.+... ....+. +... ...+....++.++++|+.+||..+|.+|||+.++
T Consensus 219 ~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~---~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 219 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKL---LKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred CCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHH---HHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 7655 899999999999998 8899865432 222222 2221 2223334678999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 293 l~~ 295 (307)
T cd05098 293 VED 295 (307)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=199.94 Aligned_cols=152 Identities=33% Similarity=0.542 Sum_probs=122.3
Q ss_pred HHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCCcchhHH
Q 025933 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVW 90 (246)
Q Consensus 12 qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 90 (246)
.|..||+|||++|||+||||..|+|++..++ +||+|+|+++...... ...++||||.|.|||++.+..|.-. +|+|
T Consensus 359 ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdww 435 (593)
T KOG0695|consen 359 EICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWW 435 (593)
T ss_pred HHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHH
Confidence 3568999999999999999999999999887 9999999999765444 3456799999999999999998544 8999
Q ss_pred hHHHHHHHHHhCCCCCCC--CC-ChHHH-HHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC------HHHH
Q 025933 91 SCGVTLYVMLVGAYPFED--PE-DPRNF-RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP------IPEI 160 (246)
Q Consensus 91 slG~il~~ll~g~~Pf~~--~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~ 160 (246)
+|||++++|+.|+.||.- .+ ...+. --+++-+...+...|. .+|-.+..+++..|.+||.+|.. +.++
T Consensus 436 algvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~di 513 (593)
T KOG0695|consen 436 ALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDI 513 (593)
T ss_pred HHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhh
Confidence 999999999999999942 11 11111 1123334445555565 67888999999999999999974 6899
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
..|+||+.
T Consensus 514 k~h~ffr~ 521 (593)
T KOG0695|consen 514 KSHAFFRS 521 (593)
T ss_pred hcchhhhh
Confidence 99999973
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=197.83 Aligned_cols=149 Identities=24% Similarity=0.353 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC---CCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||++.......... ...++..|+|||.+.+..+
T Consensus 96 ~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred HHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCCceeecCchhhcCCCC
Confidence 4567889999999999999999999999999987765 9999999987432211110 1123456999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||........ ... +.. ....+....++..+.+|+.+||+.+|++|||+.+++
T Consensus 174 ~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~---~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 174 SSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REA---IEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred ChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-HHH---HHc-CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 665 899999999999997 8899965443222 221 111 112233346789999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 248 ~ 248 (252)
T cd05084 248 Q 248 (252)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=199.11 Aligned_cols=152 Identities=23% Similarity=0.352 Sum_probs=110.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc-
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE- 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~- 81 (246)
...++.|++.|++|||+++|+||||||+||+++.++. +||+|||+++...... ......|+..|+|||++.+..
T Consensus 102 ~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (269)
T cd05087 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179 (269)
T ss_pred HHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeecCCCcCCcccccCHhHhccccc
Confidence 4456789999999999999999999999999988765 9999999986432211 112345788899999986432
Q ss_pred ------cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCC
Q 025933 82 ------YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSK 153 (246)
Q Consensus 82 ------~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~ 153 (246)
++ .++|+||+||++|+|++ |..||......+........ .......|. ....+..+.+++.+|+ .+|.+
T Consensus 180 ~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~ 256 (269)
T cd05087 180 NLLVVDQT-KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQ 256 (269)
T ss_pred cccccCCC-ccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHh-cCccc
Confidence 23 34899999999999996 99999765543332221111 111111121 1246788999999998 68999
Q ss_pred CCCHHHHhc
Q 025933 154 RIPIPEIKK 162 (246)
Q Consensus 154 R~t~~e~l~ 162 (246)
|||+++++.
T Consensus 257 Rpt~~~l~~ 265 (269)
T cd05087 257 RPSAEEVHL 265 (269)
T ss_pred CCCHHHHHH
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=199.09 Aligned_cols=151 Identities=21% Similarity=0.298 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++|+||||||.||+++.++. +||+|||+++........ ....++..|+|||.+.+..+
T Consensus 101 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 178 (256)
T cd05113 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcc
Confidence 34667889999999999999999999999999987765 999999998743222111 12235677999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||........... +..... .+.....+..+++++.+||..||.+||++.+++
T Consensus 179 ~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll 252 (256)
T cd05113 179 SSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252 (256)
T ss_pred cch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 655 899999999999998 9999976554332222 222211 122235789999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
.+
T Consensus 253 ~~ 254 (256)
T cd05113 253 SS 254 (256)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=199.15 Aligned_cols=152 Identities=22% Similarity=0.327 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCC--CCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKS--TVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~--~~gt~~y~aPE~~~~~ 80 (246)
.....++.|++.|+.|||+++|+||||||.|||++.++. +||+|||+++.... .....+ ..++..|+|||.+.+.
T Consensus 106 ~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 183 (266)
T cd05033 106 GQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183 (266)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccccceeccCCCCCccccChhhhccC
Confidence 345677889999999999999999999999999988766 99999999985431 111111 2345789999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|+||||+++|+|++ |..||......+. ...+.. ....+.....+..+.+|+.+||..+|.+||++.+
T Consensus 184 ~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 257 (266)
T cd05033 184 KFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQ 257 (266)
T ss_pred CCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 77655 899999999999997 9999976544322 222222 1223334468999999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
++++
T Consensus 258 i~~~ 261 (266)
T cd05033 258 IVST 261 (266)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=197.67 Aligned_cols=149 Identities=19% Similarity=0.305 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCC---CCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV---GTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~---gt~~y~aPE~~~~~~ 81 (246)
....++.|++.|+.+||+++|+||||||+||+++.++. +||+|||+++...... ..... ++..|+|||++.+..
T Consensus 104 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05068 104 QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNR 180 (261)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCc-ccccCCCcCceeccCccccccCC
Confidence 34567788999999999999999999999999998776 9999999987543211 11122 345799999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |+.||.+......+. .+.. ....+.....+..+.+++.+||..+|.+||++.++
T Consensus 181 ~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 181 FSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQ-GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred CCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7666 899999999999999 999997655433222 2222 22233444688999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 255 ~~ 256 (261)
T cd05068 255 QW 256 (261)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=201.11 Aligned_cols=154 Identities=23% Similarity=0.324 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....+.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||+..+..+
T Consensus 132 ~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 209 (296)
T cd05095 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence 4566888999999999999999999999999987665 99999999874322211 112334678999999887777
Q ss_pred CCcchhHHhHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhc--cccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 83 DGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~--g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+.+ +|+|||||++|+|++ |..||......+........... .....+....++..+.+|+.+||+.||.+||++.
T Consensus 210 ~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 210 TTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred cch-hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 655 899999999999998 77899765544333222111111 1122344456789999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++.+
T Consensus 289 ~i~~ 292 (296)
T cd05095 289 EIHA 292 (296)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=201.05 Aligned_cols=154 Identities=24% Similarity=0.315 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++++||||||+||+++.++. +||+|||++........ .....++..|+|||++.+..+
T Consensus 131 ~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 208 (295)
T cd05097 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208 (295)
T ss_pred HHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCc
Confidence 4567889999999999999999999999999987765 99999999874322211 122345678999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhc--cccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 83 DGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~--g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+.+ +|+|||||++|+|++ |..||.................. ...........+..+++|+.+||..||.+|||+.
T Consensus 209 ~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 209 TTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred Cch-hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 655 899999999999988 67788765543333322221111 1111223345789999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++++
T Consensus 288 ~i~~ 291 (295)
T cd05097 288 KIHH 291 (295)
T ss_pred HHHH
Confidence 9865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=200.14 Aligned_cols=150 Identities=21% Similarity=0.354 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++...... ......++..|+|||++.+..
T Consensus 118 ~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 195 (280)
T cd05043 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE 195 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC
Confidence 34567789999999999999999999999999987765 9999999997532211 112234667899999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|++++ |..||...... .+. ..+.. ....+....+++++.+++.+||..||++|||+.++
T Consensus 196 ~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~-~~~---~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 196 YSSA-SDVWSFGVLLWELMTLGQTPYVEIDPF-EMA---AYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred CCch-hhHHHhHHHHHHHhcCCCCCcCcCCHH-HHH---HHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7655 899999999999998 99999765332 222 22222 22333344678999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 270 ~~ 271 (280)
T cd05043 270 VQ 271 (280)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=197.64 Aligned_cols=153 Identities=27% Similarity=0.397 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.|+.|||++||+||||||+||+++.++. ++|+|||++....... ......|++.|+|||.+.+..++
T Consensus 107 ~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 184 (267)
T cd08224 107 TIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCCCcccceecCCccccCHHHhccCCCC
Confidence 34567889999999999999999999999999987776 9999999987533222 12334688999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||+||++|+|++|..||..... ........+............++..+.++|.+||..+|.+|||+.++++
T Consensus 185 ~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 185 FK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55 8999999999999999999965432 2222233322222211111257889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=197.48 Aligned_cols=152 Identities=22% Similarity=0.306 Sum_probs=110.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccc---
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARK--- 80 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~--- 80 (246)
..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++....... .....+|+..|+|||++...
T Consensus 102 ~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (268)
T cd05086 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179 (268)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence 456778999999999999999999999999987766 9999999986322111 12345688999999998532
Q ss_pred ----ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC
Q 025933 81 ----EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 81 ----~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
.++ .++|||||||++|+|++ |..||......+.+...................+++.+.+++..|| .+|.+||
T Consensus 180 ~~~~~~~-~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp 257 (268)
T cd05086 180 LITAEQT-KPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRA 257 (268)
T ss_pred cccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCC
Confidence 223 34899999999999997 5778876555444444332211111111112347889999999999 6899999
Q ss_pred CHHHHhc
Q 025933 156 PIPEIKK 162 (246)
Q Consensus 156 t~~e~l~ 162 (246)
++.++++
T Consensus 258 ~~~~i~~ 264 (268)
T cd05086 258 TAEEVHR 264 (268)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=205.36 Aligned_cols=151 Identities=21% Similarity=0.316 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..
T Consensus 135 ~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (334)
T cd05100 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212 (334)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCC
Confidence 34557889999999999999999999999999987765 99999999874322111 11123456799999998887
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... ...+.. ....+.....+..+.+|+.+||..+|.+|||+.++
T Consensus 213 ~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 213 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEEL----FKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred cCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 7665 899999999999998 8899976543222 222222 12223334678999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 287 l~~ 289 (334)
T cd05100 287 VED 289 (334)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=224.45 Aligned_cols=152 Identities=24% Similarity=0.348 Sum_probs=114.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-------------------CCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-------------------SQPKST 65 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-------------------~~~~~~ 65 (246)
..+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......
T Consensus 114 ~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~ 191 (932)
T PRK13184 114 AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191 (932)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCC
Confidence 45677889999999999999999999999999988776 999999998743110 011124
Q ss_pred CCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHH
Q 025933 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 145 (246)
Q Consensus 66 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 145 (246)
+||+.|+|||++.+..++.+ +||||+||++|+|++|..||........... ..............+++.+.+++.+
T Consensus 192 vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ki~~~---~~i~~P~~~~p~~~iP~~L~~LI~r 267 (932)
T PRK13184 192 VGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKISYR---DVILSPIEVAPYREIPPFLSQIAMK 267 (932)
T ss_pred CCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhhhhhh---hhccChhhccccccCCHHHHHHHHH
Confidence 69999999999988887655 8999999999999999999976443221111 1111111112234688999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 025933 146 IFVADPSKRIPIPEIKK 162 (246)
Q Consensus 146 ~L~~dp~~R~t~~e~l~ 162 (246)
||..||++|++..+.+.
T Consensus 268 cL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 268 ALAVDPAERYSSVQELK 284 (932)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999987655443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=196.96 Aligned_cols=148 Identities=18% Similarity=0.236 Sum_probs=110.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCC------cEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQP------RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~------~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~ 79 (246)
.+.++.|++.||.|||+++|+||||||+||+++.++.. .++++|||++..... .....++..|+|||++.+
T Consensus 102 ~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 102 KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIEN 178 (258)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccC
Confidence 34567899999999999999999999999999766532 379999999864321 233568899999999986
Q ss_pred cccCCcchhHHhHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
.......+|+|||||++|+|++|. .||...... ...... ......|. ..+.++.+|+.+||+.||++|||++
T Consensus 179 ~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~~~~----~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~ 251 (258)
T cd05078 179 PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKLQFY----EDRHQLPA--PKWTELANLINQCMDYEPDFRPSFR 251 (258)
T ss_pred CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHHHHH----HccccCCC--CCcHHHHHHHHHHhccChhhCCCHH
Confidence 443234489999999999999984 666543322 211111 11222232 4678999999999999999999999
Q ss_pred HHhcC
Q 025933 159 EIKKH 163 (246)
Q Consensus 159 e~l~h 163 (246)
++++.
T Consensus 252 ~il~~ 256 (258)
T cd05078 252 AIIRD 256 (258)
T ss_pred HHHHh
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=197.22 Aligned_cols=149 Identities=21% Similarity=0.329 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
.+.++.|++.||+|||+++++||||||+||+++.++. ++|+|||++........ .....++..|+|||++.+..++
T Consensus 104 ~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 181 (260)
T cd05067 104 LIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcC
Confidence 4567889999999999999999999999999988776 99999999875332111 1123456789999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||||+++|++++ |+.||.+......... +.. ....+.....+.++.+++.+||..+|++|||+++++.
T Consensus 182 ~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 182 IK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----LER-GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred cc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55 899999999999998 9999987654333222 111 2223334467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=201.28 Aligned_cols=150 Identities=21% Similarity=0.356 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (303)
T cd05110 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188 (303)
T ss_pred HHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCcccccccCCCccccccCCHHHhccCCC
Confidence 4566789999999999999999999999999987665 99999999975332211 112345778999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+... ......+. .....+.....+..+.+++.+||..+|++||++.+++
T Consensus 189 ~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~ 262 (303)
T cd05110 189 THQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLE----KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELA 262 (303)
T ss_pred ChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 899999999999997 8999976432 23333322 2222344446789999999999999999999999987
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+.
T Consensus 263 ~~ 264 (303)
T cd05110 263 AE 264 (303)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=205.33 Aligned_cols=152 Identities=22% Similarity=0.372 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||++........ .....++..|+|||.+.+..
T Consensus 180 ~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 180 DLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257 (343)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC
Confidence 34567889999999999999999999999999987765 99999999875322111 11223567899999998887
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |..||........+...+. ... ..+.....++.+.+++.+||+.||.+|||+.++
T Consensus 258 ~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 258 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---EGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred CCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---ccC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7766 899999999999997 9999976544333322221 111 112223468899999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 333 l~~ 335 (343)
T cd05103 333 VEH 335 (343)
T ss_pred HHH
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=214.61 Aligned_cols=156 Identities=27% Similarity=0.464 Sum_probs=119.0
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
..|++.||..|-..||+|.||||.|||++.+.. .+||||||.|.... ....+.+..+..|.|||++.|-+|+.. .|+
T Consensus 542 aqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~-eneitPYLVSRFYRaPEIiLG~~yd~~-iD~ 618 (752)
T KOG0670|consen 542 AQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS-ENEITPYLVSRFYRAPEIILGLPYDYP-IDT 618 (752)
T ss_pred HHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc-cccccHHHHHHhccCcceeecCcccCC-ccc
Confidence 456678888999999999999999999987654 58999999987432 233344567889999999999999866 899
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHH--------HhccccCCCC------------------------------
Q 025933 90 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR--------IRNVQYFLPD------------------------------ 131 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~------------------------------ 131 (246)
||.||+||||.+|+.-|.|..+...+.-.+.- +++.+|.-..
T Consensus 619 WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt 698 (752)
T KOG0670|consen 619 WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT 698 (752)
T ss_pred eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc
Confidence 99999999999999999987775544332221 1111110000
Q ss_pred ----------------CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 132 ----------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 132 ----------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
...+-..+++||.+||.+||++|+|..++|+||||..
T Consensus 699 kdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 699 KDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0012246899999999999999999999999999964
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=209.76 Aligned_cols=151 Identities=25% Similarity=0.403 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..
T Consensus 238 ~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 238 DLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC
Confidence 45677889999999999999999999999999988765 9999999987432221 112335778899999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||........+...+ .. ....+....++..+.+++.+||..||++|||+.++
T Consensus 316 ~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 316 YTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI---KS-GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred CCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH---hc-CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 7655 899999999999997 999997654333322222 11 22233344688999999999999999999999988
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
.+
T Consensus 391 ~~ 392 (400)
T cd05105 391 SD 392 (400)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=197.20 Aligned_cols=152 Identities=21% Similarity=0.334 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC---CCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP---QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~---~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~ 78 (246)
..+.++.|++.||+|||+++|+||||||+||+++.+. ...+||+|||+++...... ......++..|+|||++.
T Consensus 107 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 107 ELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 3456778999999999999999999999999998765 1249999999987432211 112234678899999998
Q ss_pred ccccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
+..++.+ +|||||||++|+|++ |..||......+. ...+... ........++..+.+||.+||..+|.+||++
T Consensus 187 ~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 260 (269)
T cd05044 187 DGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEV----LQHVTAG-GRLQKPENCPDKIYQLMTNCWAQDPSERPTF 260 (269)
T ss_pred cCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHH----HHHHhcC-CccCCcccchHHHHHHHHHHcCCCcccCCCH
Confidence 8777655 899999999999998 9999976544322 2222211 1222334678999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.++++
T Consensus 261 ~~i~~ 265 (269)
T cd05044 261 DRIQE 265 (269)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=195.53 Aligned_cols=147 Identities=23% Similarity=0.399 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
.+.++.|++.|+.|||+++++||||||+||+++.++. +||+|||+++.... .......+..|+|||.+.+..++.+
T Consensus 102 ~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~ 177 (254)
T cd05083 102 LLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFSSK 177 (254)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceeccc--cCCCCCCCceecCHHHhccCCcCch
Confidence 4556789999999999999999999999999987765 99999999874322 1222344678999999987777655
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 86 ISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 86 ~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+|+|||||++|+|++ |..||........ ...+... ...+....++..+.+++.+||..+|.+||++.+++.
T Consensus 178 -~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 178 -SDVWSYGVLLWEVFSYGRAPYPKMSLKEV----KECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -hhHHHHHHHHHHHHhCCCCCCccCCHHHH----HHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999997 9999976543222 2222221 222223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=195.10 Aligned_cols=149 Identities=26% Similarity=0.367 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC---CCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.++.|||+++|+||||||+||+++.++. +||+|||++......... ....++..|+|||.+.+..+
T Consensus 95 ~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 95 LLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred HHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcceeccCChHhhccCCC
Confidence 4567788999999999999999999999999988776 999999998743211111 11234567999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|+|++ |..||.......... .+.. ....+.....+..+.+++.+||..+|.+|||+.+++
T Consensus 173 ~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 173 TSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRE----RIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred Ccc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHH----HHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 655 899999999999998 889997655432222 1211 122233346789999999999999999999999998
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 247 ~ 247 (251)
T cd05041 247 N 247 (251)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=214.02 Aligned_cols=149 Identities=25% Similarity=0.394 Sum_probs=112.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhccc---
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLAR--- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~--- 79 (246)
.+-++-|+++|+.|||.++|||||||..||++..++. |||+|||++...... .......|...|||||++..
T Consensus 490 ~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~ 567 (678)
T KOG0193|consen 490 TIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD 567 (678)
T ss_pred HHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc
Confidence 3556778999999999999999999999999988765 999999998643222 12234468889999999864
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC----CCcCCHHHHHHHHHhcccCCCCCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD----YVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
.+|+. .+||||||||+|||++|..||........+.. + ...+..|+ ..+.+.++++|+..||.+++++||
T Consensus 568 nPfS~-qSDVYaFGiV~YELltg~lPysi~~~dqIifm----V-GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 568 NPFSF-QSDVYAFGIVWYELLTGELPYSIQNRDQIIFM----V-GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred CCCCc-ccchhhhhHHHHHHHhCcCCcCCCChhheEEE----e-cccccCccchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence 35554 49999999999999999999984332211111 1 11111222 235677999999999999999999
Q ss_pred CHHHHhc
Q 025933 156 PIPEIKK 162 (246)
Q Consensus 156 t~~e~l~ 162 (246)
.+.+||.
T Consensus 642 ~F~~il~ 648 (678)
T KOG0193|consen 642 LFPQLLS 648 (678)
T ss_pred cHHHHHH
Confidence 9999875
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=193.67 Aligned_cols=150 Identities=22% Similarity=0.329 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.+|.|+|+++++||||||+||+++.++. +||+|||++......... ....++..|+|||++.+..+
T Consensus 94 ~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 171 (250)
T cd05085 94 QLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171 (250)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCcccccCHHHhccCCC
Confidence 34566788999999999999999999999999987765 999999998743221111 11234567999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+||||+++|++++ |..||.+....... ..+.. .........++..+.+++.+||..+|++||++.+++
T Consensus 172 ~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 172 SSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred Cch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 655 899999999999998 99999765443222 22221 122223346889999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 246 ~ 246 (250)
T cd05085 246 K 246 (250)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=199.15 Aligned_cols=154 Identities=25% Similarity=0.345 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 81 (246)
.+.++.|++.||+|+|++||+||||||+||+++.++. +||+|||+++....... .....|+..|+|||++.+..
T Consensus 111 ~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 188 (284)
T cd05079 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence 4567789999999999999999999999999987765 99999999875432221 12345677899999998777
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
++.+ +|||||||++|+|++++.|+..... ..........+.. ....+....++..+.+|+.+||+.|
T Consensus 189 ~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 266 (284)
T cd05079 189 FYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQ 266 (284)
T ss_pred CCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc-CccCCCCCCCCHHHHHHHHHHccCC
Confidence 7655 8999999999999998776532111 0011111111111 1223334568999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 025933 151 PSKRIPIPEIKKH 163 (246)
Q Consensus 151 p~~R~t~~e~l~h 163 (246)
|.+|||+.+++++
T Consensus 267 p~~Rpt~~~il~~ 279 (284)
T cd05079 267 PSKRTTFQNLIEG 279 (284)
T ss_pred cccCcCHHHHHHH
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=193.86 Aligned_cols=148 Identities=22% Similarity=0.361 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||.++|+||||||+||+++.++. +||+|||+++..... .....++..|+|||.+.+..++.
T Consensus 103 ~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~ 178 (256)
T cd05039 103 QQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQG--QDSGKLPVKWTAPEALREKKFST 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccc--cccCCCcccccCchhhcCCcCCc
Confidence 34567789999999999999999999999999987766 999999999854221 12334566799999998777765
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|+||||+++|++++ |..||...... ... ..+.. .+.......+++.+.++|.+||..+|.+|||+.++++
T Consensus 179 ~-~Di~slG~il~~l~~~g~~p~~~~~~~-~~~---~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 179 K-SDVWSFGILLWEIYSFGRVPYPRIPLK-DVV---PHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred H-HHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH---HHHhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5 899999999999997 99999765432 222 22221 1122223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=194.57 Aligned_cols=149 Identities=22% Similarity=0.342 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
.+.++.|++.||.|+|+++++||||||+||+++..+. +||+|||++........ .....++..|+|||++.+..++
T Consensus 104 ~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 181 (260)
T cd05073 104 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181 (260)
T ss_pred HHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcC
Confidence 4567789999999999999999999999999987765 99999999874322211 1122456779999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+|||||++|++++ |..||.+........ .+. ..+..+.....+.++.+++.+||..+|.+||++.++++
T Consensus 182 ~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 182 IK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 55 899999999999998 999998655432222 221 22233444568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=206.52 Aligned_cols=152 Identities=22% Similarity=0.350 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ...+..++..|+|||.+.+..
T Consensus 240 ~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 317 (401)
T cd05107 240 DLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL 317 (401)
T ss_pred HHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC
Confidence 45667889999999999999999999999999987665 9999999987432211 122345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|+|++ |..||......+...+.+. .....+.+..++..+.+|+.+||..+|.+||++.++
T Consensus 318 ~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 318 YTTL-SDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred CCcH-hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7655 899999999999998 8999976554333322222 122223334678999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++.
T Consensus 393 l~~ 395 (401)
T cd05107 393 VHL 395 (401)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=191.04 Aligned_cols=156 Identities=34% Similarity=0.533 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.+++.++.+||+.+|+|+||+|.||+++.++. ++|+|||++.............++..|++||.+.+..++.
T Consensus 88 ~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~ 165 (244)
T smart00220 88 EARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGK 165 (244)
T ss_pred HHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHHccCCCCc
Confidence 34567888999999999999999999999999988765 9999999987544333445567899999999998777766
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCc-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+|++++++++|..||......... ................ ++..+.+++.+||..+|.+||++.++++|
T Consensus 166 ~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 166 A-VDVWSLGVILYELLTGKPPFPGDDQLLEL---FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 4 89999999999999999999764433332 2222222222222111 78999999999999999999999999999
Q ss_pred ccc
Q 025933 164 PWF 166 (246)
Q Consensus 164 p~~ 166 (246)
|||
T Consensus 242 ~~~ 244 (244)
T smart00220 242 PFF 244 (244)
T ss_pred CCC
Confidence 997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=195.17 Aligned_cols=150 Identities=22% Similarity=0.341 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CC--CCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KS--TVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~--~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.|++|||+++|+||||||+||+++.++. +||+|||++......... .. ...+..|+|||++.+.
T Consensus 108 ~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (268)
T cd05063 108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccCCCcCceecCHHHhhcC
Confidence 34567788999999999999999999999999987765 999999998743221111 11 1234579999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|+|||||++|+|++ |..||........ ...+... ...|.....+..+.+++.+||..+|.+||++.+
T Consensus 186 ~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~----~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 186 KFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEV----MKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred CcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 77655 899999999999997 9999976554332 2222221 233444467899999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 260 i~~ 262 (268)
T cd05063 260 IVN 262 (268)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=195.90 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......+++.|++||.+.+..+
T Consensus 115 ~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred HHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence 3567788999999999999999999999999987766 9999999987532221 1122345678999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |.+||.+...... ...+.... ........+..+.+++.+||..+|.+|||+.+++
T Consensus 193 ~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~ 266 (273)
T cd05074 193 TTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266 (273)
T ss_pred chh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 899999999999999 8899976443222 22222221 1222235789999999999999999999999987
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
.+
T Consensus 267 ~~ 268 (273)
T cd05074 267 DQ 268 (273)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=194.92 Aligned_cols=151 Identities=25% Similarity=0.368 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC--CCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~ 82 (246)
.....+.|++.||.|+|+++++||||||+||+++.++. +||+|||+++........ ....++..|+|||.+....+
T Consensus 108 ~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (270)
T cd05056 108 SLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185 (270)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccceecCCCCccccccChhhhccCCC
Confidence 34556789999999999999999999999999988766 999999998743322111 12234567999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|||||++|++++ |..||.+........ .+.... ..+....++..+.+++.+||..+|.+|||+.+++
T Consensus 186 ~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~ 259 (270)
T cd05056 186 TSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIG----RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259 (270)
T ss_pred Cch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 655 899999999999986 999997665433222 222221 2234457899999999999999999999999987
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
..
T Consensus 260 ~~ 261 (270)
T cd05056 260 AQ 261 (270)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=197.83 Aligned_cols=148 Identities=22% Similarity=0.336 Sum_probs=114.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
+.++.|++.||.|||.++++||||||.||+++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 133 ~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (288)
T cd05050 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210 (288)
T ss_pred HHHHHHHHHHHHHHHhCCeecccccHhheEecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence 567888999999999999999999999999987766 99999999874322111 1122356679999999888876
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+|||||++|+|++ |..||.+....+ ....+..... .+.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 211 ~~-~Dv~slG~il~el~~~~~~p~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 211 TE-SDVWAYGVVLWEIFSYGMQPYYGMAHEE----VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 65 899999999999997 888997654432 2233332221 2233467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=195.44 Aligned_cols=152 Identities=21% Similarity=0.355 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.....+.|++.||+|||+++|+||||||+||+++.++. ++|+|||+++...... ......++..|+|||.+.+..+
T Consensus 118 ~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred HHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 34556788999999999999999999999999988776 9999999987432211 1223356778999999887776
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
..+ +||||||+++|+|++ |..||....... ............+....++..+.+++.+||..+|.+|||+.+++
T Consensus 196 ~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l 270 (275)
T cd05046 196 STK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270 (275)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 544 899999999999998 888997654422 22333333333333446889999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
.+
T Consensus 271 ~~ 272 (275)
T cd05046 271 SA 272 (275)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=193.28 Aligned_cols=147 Identities=22% Similarity=0.271 Sum_probs=110.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCC-----cEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQP-----RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~-----~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~ 79 (246)
..+.++.|++.||.|||+++|+||||||+|||++..+.. .+||+|||++..... .....++..|+|||++.+
T Consensus 102 ~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN 178 (259)
T ss_pred HHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC
Confidence 346677899999999999999999999999999876521 499999999875322 233457788999999977
Q ss_pred c--ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 80 K--EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 80 ~--~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
. .++.+ +|+|||||++|+|++ |..||...... ....... .....+. .....+.+++.+||..+|.+|||
T Consensus 179 ~~~~~~~~-~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~----~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt 250 (259)
T cd05037 179 GQASLTIA-ADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ----DQHRLPM--PDCAELANLINQCWTYDPTKRPS 250 (259)
T ss_pred CCCCcchh-hHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh----cCCCCCC--CCchHHHHHHHHHhccChhhCCC
Confidence 6 45444 899999999999999 68888665422 2111111 1111222 23489999999999999999999
Q ss_pred HHHHhc
Q 025933 157 IPEIKK 162 (246)
Q Consensus 157 ~~e~l~ 162 (246)
+.++++
T Consensus 251 ~~~il~ 256 (259)
T cd05037 251 FRAILR 256 (259)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=192.39 Aligned_cols=150 Identities=25% Similarity=0.380 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC--CCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.|++|||+++|+||||||+||+++.++. ++|+|||+++......... ...+++.|+|||.+.+..+
T Consensus 104 ~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 181 (258)
T smart00219 104 DLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKF 181 (258)
T ss_pred HHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccccccccCCCcccccChHHhccCCC
Confidence 34567788999999999999999999999999988775 9999999987543221111 1236789999999976666
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+||+||++|+|++ |.+||......... ..+.... ..+....++..+.+++.+||..||.+|||+.+++
T Consensus 182 ~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 255 (258)
T smart00219 182 TSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVL----EYLKKGY-RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELV 255 (258)
T ss_pred Ccc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhcCC-CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence 655 899999999999998 88898764432222 2222222 2233345899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 256 ~ 256 (258)
T smart00219 256 E 256 (258)
T ss_pred h
Confidence 5
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=193.72 Aligned_cols=149 Identities=21% Similarity=0.307 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.|+.|||+++|+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++
T Consensus 105 ~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 182 (261)
T cd05034 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182 (261)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhhhccCCCccccCHHHhccCCcC
Confidence 3567788999999999999999999999999988766 99999999874322111 1122345689999999877776
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|+||+||++|++++ |+.||.+......+. .+.. .+..+.....+..+.+++.+||..+|.+||+++++..
T Consensus 183 ~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 183 IK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLE----QVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55 899999999999998 999997655433332 2221 2223444467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=195.35 Aligned_cols=151 Identities=26% Similarity=0.358 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.+|.|||. ++|+||||||.||+++.++. +||+|||++.............|+..|+|||.+.+..++.
T Consensus 115 ~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 192 (269)
T cd08528 115 IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE 192 (269)
T ss_pred HHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecccceeecccccccccccCcccCcChhhhcCCCCch
Confidence 34567789999999996 78999999999999988766 9999999997544333334456899999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||||+++|+|++|..||......... ..+............++..+.+++.+||..||.+||++.++..+
T Consensus 193 ~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 193 K-ADVWAFGCILYQMCTLQPPFYSTNMLSLA----TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred H-HHHHHHHHHHHHHHhCCCcccccCHHHHH----HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 5 89999999999999999999764432222 22222222222223578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=194.02 Aligned_cols=151 Identities=22% Similarity=0.338 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-C---CCCCCCCCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-P---KSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~---~~~~gt~~y~aPE~~~~ 79 (246)
...+.++.|++.|+.|||+++|+||||||+|||++.++. +||+|||+++....... . ....++..|+|||.+.+
T Consensus 106 ~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 106 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCCCccceeecCHhHhcc
Confidence 345677889999999999999999999999999987765 99999999875332211 1 11123567999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|+|||||++|++++ |..||......+.. ..+... ...+....++..+.+++.+||+++|.+||++.
T Consensus 184 ~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (267)
T cd05066 184 RKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVI----KAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFE 257 (267)
T ss_pred CccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHH----HHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHH
Confidence 777655 899999999999886 99999765543322 222222 23344456889999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++++
T Consensus 258 ~i~~ 261 (267)
T cd05066 258 QIVS 261 (267)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=195.91 Aligned_cols=153 Identities=24% Similarity=0.306 Sum_probs=112.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----CCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.|++.||.|||++||+||||||+||+++.++. +||+|||+++........ ....++..|+|||++.+..
T Consensus 110 ~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (284)
T cd05081 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC
Confidence 3456788999999999999999999999999987765 999999998753322111 1112445699999998777
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChH------------HHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------------NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
++.+ +|+|||||++|+|++|..|+....... ....... ........+....++..+.+|+.+||..
T Consensus 188 ~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05081 188 FSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNN 265 (284)
T ss_pred cChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-HHhcCCcCCCCCCCCHHHHHHHHHHccC
Confidence 7655 899999999999999887764322110 0001111 1122223344456889999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
+|++|||+.++++
T Consensus 266 ~p~~Rpt~~ei~~ 278 (284)
T cd05081 266 DPSQRPSFSELAL 278 (284)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=198.78 Aligned_cols=151 Identities=34% Similarity=0.473 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 80 (246)
...+.++.|++.||.|||+++|+|++|++.|||++.++. +||+|||+++...... ......+...|+|||.+.+.
T Consensus 103 ~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 180 (259)
T PF07714_consen 103 QQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG 180 (259)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS
T ss_pred ccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 346778999999999999999999999999999998775 9999999987541111 11233467789999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +||||||+++|++++ |+.||....... +...+.... ..+....++..+.++|.+||..||.+|||+.+
T Consensus 181 ~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 181 EYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKLKQGQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQE 254 (259)
T ss_dssp EESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHHHTTE-ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred ccccc-cccccccccccccccccccccccccccc----ccccccccc-cceeccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence 77655 999999999999999 789997664322 223332222 23334468999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 255 i~~ 257 (259)
T PF07714_consen 255 ILQ 257 (259)
T ss_dssp HHH
T ss_pred HHh
Confidence 874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=194.97 Aligned_cols=150 Identities=25% Similarity=0.356 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC---CCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++......... ...++..|+|||.+....
T Consensus 110 ~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (279)
T cd05057 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187 (279)
T ss_pred HHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCcccceecCCCcccccccCHHHhhcCC
Confidence 45677889999999999999999999999999987765 9999999997543222111 112356799999998777
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|+|||||++|++++ |..||.+....+ +. ..+... ...+.....+.++.+++.+||..||.+||++.++
T Consensus 188 ~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 188 YTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE-IP---DLLEKG-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred cCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH-HH---HHHhCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7655 899999999999998 999997654322 22 222222 1233334578999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 262 ~~ 263 (279)
T cd05057 262 IN 263 (279)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=193.53 Aligned_cols=150 Identities=23% Similarity=0.355 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC---CCCC---CCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTV---GTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~---~~~~---gt~~y~aPE~~~ 78 (246)
....++.|++.||.|||+++++||||||+||+++.++. +||+|||++......... .... ++..|+|||.+.
T Consensus 107 ~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCccccccccccCCCcceeecCHhHhc
Confidence 34567788999999999999999999999999987665 999999998643221111 1111 235799999998
Q ss_pred ccccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
+..++.+ +||||+||++|++++ |..||........ ...+.. ....+....++..+.+++.+||..+|.+||++
T Consensus 185 ~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (269)
T cd05065 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDV----INAIEQ-DYRLPPPMDCPTALHQLMLDCWQKDRNARPKF 258 (269)
T ss_pred cCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHH----HHHHHc-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 8787655 899999999999886 9999976544322 222222 22334445688999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.+++.
T Consensus 259 ~~i~~ 263 (269)
T cd05065 259 GQIVS 263 (269)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-27 Score=193.77 Aligned_cols=148 Identities=21% Similarity=0.315 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-----CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-----QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-----~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
.+.++.|++.||.|||+++|+||||||.|||++..+ ...+|++|||++..... .....++..|+|||.+.+.
T Consensus 119 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~ 195 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGG 195 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCC
Confidence 456788999999999999999999999999997543 12489999998764221 1234578889999998764
Q ss_pred ccCCcchhHHhHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.....++|+|||||++|+|+ +|..||........ ..... .....+. ..++.+.++|.+||..+|.+|||+.+
T Consensus 196 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~----~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~ 268 (274)
T cd05076 196 NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYE----KKHRLPE--PSCKELATLISQCLTYEPTQRPSFRT 268 (274)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHH----hccCCCC--CCChHHHHHHHHHcccChhhCcCHHH
Confidence 33334499999999999985 69999976544222 12211 1122222 35678999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
++++
T Consensus 269 il~~ 272 (274)
T cd05076 269 ILRD 272 (274)
T ss_pred HHHh
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=192.09 Aligned_cols=149 Identities=22% Similarity=0.350 Sum_probs=112.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccccCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..++.|++.++.|||+++++||||||+||+++.++. +||+|||++........ .....++..|+|||.+.+..++.
T Consensus 103 ~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~ 180 (256)
T cd05112 103 LGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180 (256)
T ss_pred HHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcCh
Confidence 456678899999999999999999999999987765 99999999874322111 11223567899999998777765
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|+||+||++|+|++ |..||........ ...+.... ........+..+.+|+.+||..+|++|||+.+++++
T Consensus 181 ~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 181 K-SDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINAGF-RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred H-HHHHHHHHHHHHHHcCCCCCCCcCCHHHH----HHHHhCCC-CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 5 899999999999998 9999976443222 22222211 111122468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=214.14 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC---CCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~ 80 (246)
.-.+.+..||+.|+.||-++.+|||||-..|+||..+.. |||+|||+++..-...-.+ ...-...|||||.+..+
T Consensus 603 ~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~ 680 (774)
T KOG1026|consen 603 SQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG 680 (774)
T ss_pred HHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence 346788999999999999999999999999999988776 9999999998432211111 12234679999999999
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.|++. +||||+||+|||+++ |..||.+..+.+. ++-++..+. ++.+.++|.++.+|+..||+.+|++||++.|
T Consensus 681 kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EV----Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 681 KFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEV----IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred cccch-hhhhhhhhhhhhhhccccCcccccchHHH----HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 99877 999999999999997 9999999887544 444444444 6666689999999999999999999999999
Q ss_pred Hh
Q 025933 160 IK 161 (246)
Q Consensus 160 ~l 161 (246)
|-
T Consensus 755 I~ 756 (774)
T KOG1026|consen 755 IH 756 (774)
T ss_pred HH
Confidence 74
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=193.73 Aligned_cols=154 Identities=23% Similarity=0.327 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----CCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||+|||+++|+||||||.||+++.++. +||+|||++......... ....++..|+|||.+.+.
T Consensus 110 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 187 (284)
T cd05038 110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187 (284)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccC
Confidence 34567889999999999999999999999999988765 999999998754322111 112345679999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.++.+ +|+|||||++|+|++|..||....... ........+. .....+....++..+.+|+.+||..
T Consensus 188 ~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05038 188 KFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEA 265 (284)
T ss_pred CCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhcc
Confidence 77655 899999999999999999986533211 1111222222 2222333446788999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
+|.+|||+.++++
T Consensus 266 ~p~~Rpt~~ei~~ 278 (284)
T cd05038 266 EPQDRPSFADLIL 278 (284)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=215.31 Aligned_cols=98 Identities=33% Similarity=0.606 Sum_probs=77.6
Q ss_pred CCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHH
Q 025933 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLS 144 (246)
Q Consensus 66 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 144 (246)
+||+.|+|||++.+..+..+ +|||||||++|+|++|..||.+......+..+ ......++. ...++..+.+++.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~-~DiwSlG~il~ElltG~~pf~~~~~~~~~~~i----l~~~~~~p~~~~~~~~~~~~~l~ 615 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNI----LNRDIPWPEGEEKLSVNAQNAIE 615 (669)
T ss_pred eeCccccCHHHcCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCcccccCCHHHHHHHH
Confidence 46889999999998887655 89999999999999999999875544333333 222222222 2357889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccc
Q 025933 145 QIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 145 ~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
+||..||.+||++.++++||||..
T Consensus 616 ~lL~~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred HHcccChhHCcCHHHHHhCHhhcC
Confidence 999999999999999999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=208.58 Aligned_cols=162 Identities=29% Similarity=0.365 Sum_probs=133.8
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccc--
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLAR-- 79 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 79 (246)
.-+|.|++..++.||..||.+.++|||||-.|||++.++. |||+|||++...... ....+.+|||.|||||++..
T Consensus 122 E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 122 EEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred hHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecccccccCcCCCcccccceeeeccc
Confidence 3467888999999999999999999999999999998877 999999999764433 34456789999999999964
Q ss_pred ---cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 80 ---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 80 ---~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
..|+.. +|+||||++..||.-|.+|+.+.-..+.+ +...++....+..+.+.+.++.+||..||.+|-.+||+
T Consensus 200 ~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 200 SPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred CCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 345444 89999999999999999999876554443 33344555555556678999999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 025933 157 IPEIKKHPWFLKNL 170 (246)
Q Consensus 157 ~~e~l~hp~~~~~~ 170 (246)
..++|+|||+....
T Consensus 276 ~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 276 TEELLKHPFITEQP 289 (953)
T ss_pred hhhhccCCcccccc
Confidence 99999999997544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=196.82 Aligned_cols=160 Identities=26% Similarity=0.387 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHhHhCC--cccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCC--------CCCCCCCCCCcchh
Q 025933 8 SSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP--------KSTVGTPAYIAPEV 76 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~--------~~~~gt~~y~aPE~ 76 (246)
++++||+.||.||.+.. |||-||||.|||+-+ +..+.+||+|||+++........ ....||.||++||.
T Consensus 572 SIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEc 651 (775)
T KOG1151|consen 572 SIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPEC 651 (775)
T ss_pred HHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcce
Confidence 68999999999999875 999999999999843 33356999999999864332211 23469999999999
Q ss_pred cccc----ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 77 LARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 77 ~~~~----~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
+.-. ..+.+ +||||+|||+|..+.|+.||........+.+--..+......+|.-+.++.++++||++||++--+
T Consensus 652 FvVgkePPKIsnK-VDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKe 730 (775)
T KOG1151|consen 652 FVVGKEPPKISNK-VDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKE 730 (775)
T ss_pred eecCCCCCccccc-eeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhh
Confidence 8533 23444 899999999999999999998655443333222223334455677678999999999999999999
Q ss_pred CCCCHHHHhcCccccc
Q 025933 153 KRIPIPEIKKHPWFLK 168 (246)
Q Consensus 153 ~R~t~~e~l~hp~~~~ 168 (246)
.|+...++-.||||..
T Consensus 731 DR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 731 DRIDVQQLACDPYLLP 746 (775)
T ss_pred hhhhHHHHccCccccc
Confidence 9999999999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=212.45 Aligned_cols=151 Identities=23% Similarity=0.333 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCC----CCCCCCCcchhcc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLA 78 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~----~gt~~y~aPE~~~ 78 (246)
.+.++...++++.|++||+++++|||||...|+|++.... |||+|||+|+... ....... .-...|||||.+.
T Consensus 801 ~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlArDiy-~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 801 MRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLARDIY-DKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred HHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhHhhh-hchheeccCccccceecCCHHHHh
Confidence 3567888999999999999999999999999999988754 9999999998321 1111111 1235799999999
Q ss_pred ccccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
...++.+ +|||||||++||+++ |..||.+..+.+.+.-.+. .. .++.+..++..+.+++..||..+|++||++
T Consensus 878 d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 878 DGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---GG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred hcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---CC--ccCCCCCCChHHHHHHHHHccCChhhCccH
Confidence 9999877 899999999999998 9999988776544432322 22 455666899999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
..+++
T Consensus 952 ~~i~~ 956 (1025)
T KOG1095|consen 952 RTIVE 956 (1025)
T ss_pred HHHHh
Confidence 99987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=193.29 Aligned_cols=158 Identities=23% Similarity=0.291 Sum_probs=114.8
Q ss_pred cHHHHHHHHHHHHHHHHHhHhCC---cccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCC-CCCCCCCcchh
Q 025933 2 ISVCYFSSTVMIFTSHHCFYLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKST-VGTPAYIAPEV 76 (246)
Q Consensus 2 i~~~~~~~~~qil~~l~~lH~~~---ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~-~gt~~y~aPE~ 76 (246)
-|...+.+++.++.||+|||... |||||||++|||+|.+.. .||+|||+|+.... .....+. .||.+|+|||+
T Consensus 172 ~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy 249 (361)
T KOG1187|consen 172 DWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEY 249 (361)
T ss_pred CHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccccceeeecCCCCccCChhh
Confidence 35667899999999999999965 999999999999998887 99999999986544 3333333 89999999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHH-Hhcc---ccCCCCC--CcCC-----HHHHHHH
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE--DPRNFRKTIDR-IRNV---QYFLPDY--VRVS-----ADCRHLL 143 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~~~~~-~~~~---~~~~~~~--~~~~-----~~~~~li 143 (246)
+..+..+.+ +|||||||++.||++|+.|..... ....+...... +... ...-|.. ...+ ..+..+.
T Consensus 250 ~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a 328 (361)
T KOG1187|consen 250 ASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELA 328 (361)
T ss_pred hccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHH
Confidence 988777766 899999999999999998876432 11112221111 1111 0011111 1223 2245677
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 025933 144 SQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~ 162 (246)
.+|++.+|..||++.++++
T Consensus 329 ~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 329 LRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHcCcCCCcCcCHHHHHH
Confidence 7999999999999999744
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=199.53 Aligned_cols=149 Identities=30% Similarity=0.409 Sum_probs=112.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC--CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-ccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 82 (246)
++..+..+..||+|||++|||||||||.||++-... ..-.||+|||.|+....+....+.+||+.|++||++.. +.|
T Consensus 122 ~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y 201 (732)
T KOG4250|consen 122 FLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKY 201 (732)
T ss_pred HHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCc
Confidence 455667788999999999999999999999985433 33369999999998888888889999999999999985 555
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------ccccCCCCCCcCCHHH----
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------------NVQYFLPDYVRVSADC---- 139 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~---- 139 (246)
+ ..+|.|||||++|+.+||..||......++..+++-.+. .....+|.+...+..+
T Consensus 202 ~-~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~ 280 (732)
T KOG4250|consen 202 T-ATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRL 280 (732)
T ss_pred C-ceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhh
Confidence 4 449999999999999999999976555543222222221 1122344444455443
Q ss_pred HHHHHHhcccCCCCCC
Q 025933 140 RHLLSQIFVADPSKRI 155 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~ 155 (246)
-.++..+|..+|.+|.
T Consensus 281 ~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 281 TKWLASMLEWNPRKRG 296 (732)
T ss_pred hHHHHHHHhhhHHHhC
Confidence 5677788999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-26 Score=196.85 Aligned_cols=145 Identities=28% Similarity=0.411 Sum_probs=117.3
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCC--CCCCCcchhccccccCCcch
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG--TPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~ 87 (246)
.+||-.||.|||+..+|||||...|||+.+... |||+|||+++......-.+...| ...|||||.+.-..++.. +
T Consensus 497 ~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtA-S 573 (974)
T KOG4257|consen 497 CYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTA-S 573 (974)
T ss_pred HHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhhccccccceeecCccccchhcccch-h
Confidence 456669999999999999999999999987765 99999999996554443333333 356999999998898766 9
Q ss_pred hHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 88 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 88 DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
|||-|||.+||++. |..||.+..+.+.+.. +.+ ...+|.++++++.+..|+.+||.++|.+||++.++..
T Consensus 574 DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~----iEn-GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 574 DVWMFGVCMWEILSLGVKPFQGVKNSDVIGH----IEN-GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHHHHHhcCCccccccccceEEE----ecC-CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999886 9999998766444322 222 2356777899999999999999999999999988754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=196.89 Aligned_cols=151 Identities=25% Similarity=0.350 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC-CCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~ 83 (246)
.-+..+++++.||.|||++++|||||-..|+|++.+.. +||+|||+++......... ..--...|+|||.+....|+
T Consensus 263 ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 263 EKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred HHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcceeeccccccCcceecChhhhccCccc
Confidence 34567889999999999999999999999999988775 8999999998654211111 11244679999999988887
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|||||||++||+.+ |..||.+.... .+..++....+..+.....+..+..++.+||..||++|+|+.++.+
T Consensus 341 ~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 341 FK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 77 899999999999998 88999886654 3444454555566666678999999999999999999999998865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=172.82 Aligned_cols=102 Identities=33% Similarity=0.535 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc----cccc
Q 025933 8 SSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA----RKEY 82 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~ 82 (246)
.+.+.++.||.|||++ .|||||+||.||||+..+. ||+||||++......-..+...|--.|||||.+. +..|
T Consensus 152 kIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY 229 (282)
T KOG0984|consen 152 KIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGY 229 (282)
T ss_pred HhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccc
Confidence 4566788999999997 6999999999999998876 9999999997543332222246888999999985 3467
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCCh
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP 112 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 112 (246)
+-+ +||||||+++.||.++++||.....+
T Consensus 230 ~vk-sDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 230 SVK-SDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eee-hhhhhhhhhhhhhhhccccccccCCH
Confidence 666 89999999999999999999775543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=185.48 Aligned_cols=161 Identities=28% Similarity=0.409 Sum_probs=111.1
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCC----------C----CCCC--------
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG----------L----LHSQ-------- 61 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~----------~----~~~~-------- 61 (246)
..|++- ++.||.++|.+|||||||||.|+|.+.... +-.|+|||++... . ....
T Consensus 135 ~~Yl~~---ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~ 210 (418)
T KOG1167|consen 135 RWYLRN---LLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC 210 (418)
T ss_pred HHHHHH---HHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence 344444 458889999999999999999999986543 4679999997510 0 0000
Q ss_pred -----------------------CCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHH
Q 025933 62 -----------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRK 117 (246)
Q Consensus 62 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~ 117 (246)
.....||++|.|||++..-+-.+.++||||.|||+..+++++.||....+ ...+.+
T Consensus 211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e 290 (418)
T KOG1167|consen 211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE 290 (418)
T ss_pred cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHH
Confidence 01236999999999987654444559999999999999999999864332 122211
Q ss_pred HHH--------HHh--ccc---------------------------cC--C------CCCCcCCHHHHHHHHHhcccCCC
Q 025933 118 TID--------RIR--NVQ---------------------------YF--L------PDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 118 ~~~--------~~~--~~~---------------------------~~--~------~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
+.. +.. ... +. . ......+..+.+|+.+||..||.
T Consensus 291 i~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~ 370 (418)
T KOG1167|consen 291 IATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ 370 (418)
T ss_pred HHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChh
Confidence 110 000 000 00 0 00112456899999999999999
Q ss_pred CCCCHHHHhcCccccc
Q 025933 153 KRIPIPEIKKHPWFLK 168 (246)
Q Consensus 153 ~R~t~~e~l~hp~~~~ 168 (246)
+|+|++++|+||||..
T Consensus 371 kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 371 KRITAEDALKHPFFDE 386 (418)
T ss_pred hcccHHHHhcCcCCcc
Confidence 9999999999999973
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=196.15 Aligned_cols=152 Identities=24% Similarity=0.397 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCC--CCCCC--CCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGT--PAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~--~~~gt--~~y~aPE~~~~ 79 (246)
..+++...||+.|+.||++..+|||||-..|||+..+.. +||+|||+++......... ...|+ ..|||||.+..
T Consensus 418 ~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 418 KDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred HHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 467889999999999999999999999999999998866 9999999998433322221 12232 34999999999
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..|+.+ +||||+||+|||+.+ |..||.+......+ ++.++. .+.+..+..++.++.++++.||..+|++||++.
T Consensus 496 ~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l---~~~l~~-G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 496 RVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEEL---LEFLKE-GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred Cccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHH---HHHHhc-CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 888877 899999999999998 89999874433333 233333 233444456899999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++..
T Consensus 571 ~~~~ 574 (609)
T KOG0200|consen 571 ECVE 574 (609)
T ss_pred HHHH
Confidence 9875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=190.15 Aligned_cols=149 Identities=25% Similarity=0.391 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCC----CCCCCCcchhcccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV----GTPAYIAPEVLARKEY 82 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~----gt~~y~aPE~~~~~~~ 82 (246)
..-++||+.|+.||.++++|||||-..|+|+.+... ||||||||.+....+....... -...|+|||.+....+
T Consensus 215 cdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 215 CDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred HHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc
Confidence 344789999999999999999999999999987554 9999999998655444443322 2356999999999999
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|+|++||++|||++ |..||.+......+ +++. ....++....++.++.++++.||..+|++|||+..|.
T Consensus 293 Sha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL----~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 293 SHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----KNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHH----Hhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 876 899999999999998 89999987764443 3333 3345666778999999999999999999999999886
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
..
T Consensus 367 ~~ 368 (1039)
T KOG0199|consen 367 ED 368 (1039)
T ss_pred Hh
Confidence 44
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=200.84 Aligned_cols=161 Identities=31% Similarity=0.513 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-----CCCCCCCCCCCcchhcc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----PKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~~~ 78 (246)
.|+|. |++.|++|+|++||.|||||++|+++..++. +||+|||.+..+..... ....+|+..|+|||++.
T Consensus 423 ~c~fK---qL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~ 497 (601)
T KOG0590|consen 423 DCFFK---QLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT 497 (601)
T ss_pred hHHHH---HHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc
Confidence 44544 5569999999999999999999999998876 99999999875433322 23457999999999999
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH---hccccCCCCCCcCCHHHHHHHHHhcccCCCCCC
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
+..|+...+||||.|++++.|++|+.||......++........ .......+....++...+.+|.+||+.||.+|.
T Consensus 498 ~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 498 GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred ccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 99999998999999999999999999997544332211000000 000000112234778899999999999999999
Q ss_pred CHHHHhcCcccccC
Q 025933 156 PIPEIKKHPWFLKN 169 (246)
Q Consensus 156 t~~e~l~hp~~~~~ 169 (246)
|+++|++.+||+..
T Consensus 578 ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 578 TIEQILNDEWIRSI 591 (601)
T ss_pred cHHHHhhChHhhhc
Confidence 99999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=178.49 Aligned_cols=123 Identities=27% Similarity=0.465 Sum_probs=81.1
Q ss_pred EEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCC------hHHHHHH
Q 025933 45 LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED------PRNFRKT 118 (246)
Q Consensus 45 vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~~ 118 (246)
|||+|||-|- ......+.-+-|..|+|||++.+..|... +||||++|++|||+||...|..... .+-+..+
T Consensus 393 vKIaDlGNAC--W~~khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNAC--WVHKHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchh--hhhhhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 4455555442 12222333456888999999999999877 8999999999999999988853221 1222222
Q ss_pred HHHH--------hccccC------------------CCCC----------CcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 119 IDRI--------RNVQYF------------------LPDY----------VRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 119 ~~~~--------~~~~~~------------------~~~~----------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
++-+ ...++. +|.. ..-..++.+||.-||+++|++|+||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 2211 111110 0100 012356789999999999999999999999
Q ss_pred CcccccCC
Q 025933 163 HPWFLKNL 170 (246)
Q Consensus 163 hp~~~~~~ 170 (246)
|||+....
T Consensus 550 hPwLn~~~ 557 (590)
T KOG1290|consen 550 HPWLNPVA 557 (590)
T ss_pred CccccCCC
Confidence 99997543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=181.65 Aligned_cols=151 Identities=24% Similarity=0.343 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCC---CCCCCcchhccc
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG---TPAYIAPEVLAR 79 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~g---t~~y~aPE~~~~ 79 (246)
++.+++-..||..|+.||..+++|||||...|+|+..+.. ||++|||+++... ....+...| ...|.|||.+..
T Consensus 364 avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMt-gDTYTAHAGAKFPIKWTAPEsLAy 440 (1157)
T KOG4278|consen 364 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 440 (1157)
T ss_pred hhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhc-CCceecccCccCcccccCcccccc
Confidence 4567778899999999999999999999999999988776 9999999998532 222222333 456999999999
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|||+|||+|||+.+ |-.||.+-+-. +...+ ....|.+..+..+++...+|++.||+..|..||++.
T Consensus 441 NtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-qVY~L----LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 441 NTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGL----LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred cccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHH----HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHH
Confidence 999877 899999999999987 88999875532 22333 334566666668999999999999999999999998
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
|+-+
T Consensus 515 eiHq 518 (1157)
T KOG4278|consen 515 EIHQ 518 (1157)
T ss_pred HHHH
Confidence 8743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=180.44 Aligned_cols=156 Identities=22% Similarity=0.284 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 80 (246)
..-+++..||+.|++||.+.++|||||.+.|+|++.+.. +||+|||+++......- ....+-...|||||.+..+
T Consensus 637 ~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg 714 (807)
T KOG1094|consen 637 APGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG 714 (807)
T ss_pred chhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence 345778999999999999999999999999999998877 99999999985322221 1122345789999999999
Q ss_pred ccCCcchhHHhHHHHHHHHH--hCCCCCCCCCChHHHHHHHHHHhc--cccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 81 EYDGKISDVWSCGVTLYVML--VGAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll--~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
.++.+ +|+|++|+++||++ +...||....+.+...+.-..... ....++.+.-++..+.+|+.+||..|-.+||+
T Consensus 715 kFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 715 KFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPS 793 (807)
T ss_pred cccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCC
Confidence 99876 89999999999975 588999877664433332221111 12223445578999999999999999999999
Q ss_pred HHHHhc
Q 025933 157 IPEIKK 162 (246)
Q Consensus 157 ~~e~l~ 162 (246)
++++..
T Consensus 794 Fe~lh~ 799 (807)
T KOG1094|consen 794 FEQLHL 799 (807)
T ss_pred HHHHHH
Confidence 999854
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-24 Score=168.61 Aligned_cols=156 Identities=21% Similarity=0.372 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---ccc-CC
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---KEY-DG 84 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~-~~ 84 (246)
+..|++.|+.|+|++++||||||.+||||-.....+|||||||+++.... .....--+..|.+||++.. ..+ ..
T Consensus 126 v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ 203 (378)
T KOG1345|consen 126 VFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVN 203 (378)
T ss_pred HHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--eehhhhhhcccCCcHHHhhccccceEec
Confidence 45788999999999999999999999999666666899999999874211 1111224556889998642 222 12
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhccccCCC-CCCcCCHHHHHHHHHhcccCCCCCCC---HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQYFLP-DYVRVSADCRHLLSQIFVADPSKRIP---IPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t---~~e 159 (246)
+..|+|.||+++|.+++|++||..... ...+.+..+.........| .+..+++.+..+.++-|..+|++|.. +..
T Consensus 204 ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 204 PSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 337999999999999999999974332 2345555555444433444 35668999999999999999999944 444
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
.....|.
T Consensus 284 ~rk~~w~ 290 (378)
T KOG1345|consen 284 MRKCLWK 290 (378)
T ss_pred HHHHHHH
Confidence 4444454
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=187.12 Aligned_cols=143 Identities=24% Similarity=0.384 Sum_probs=118.2
Q ss_pred HHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCC-CCC--CCCCCcchhccccccCCcchh
Q 025933 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS-TVG--TPAYIAPEVLARKEYDGKISD 88 (246)
Q Consensus 13 il~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~-~~g--t~~y~aPE~~~~~~~~~~~~D 88 (246)
|+.|++||-+++.|||||...|||++.+-. +|++|||+++...... ...+ ..| ...|.|||.+....++.. +|
T Consensus 740 IAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SD 816 (996)
T KOG0196|consen 740 IASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SD 816 (996)
T ss_pred HHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCccccccCCccceeecChhHhhhcccCch-hh
Confidence 678999999999999999999999998876 8999999998543333 2222 223 257999999999999766 99
Q ss_pred HHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 89 VWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 89 iwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
|||+|+++||.++ |..||....+.+.+..+ ...+.+|.+..++..+..|+..||++|-.+||.+.+|+.+
T Consensus 817 VWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-----e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 817 VWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-----EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ccccceEEEEecccCCCcccccchHHHHHHH-----HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999998775 99999987775544333 3456788888999999999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=194.65 Aligned_cols=152 Identities=16% Similarity=0.153 Sum_probs=105.5
Q ss_pred HHHHHHHHHHHHHHHhH---hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFY---LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH---~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.|++||| ..+|+||||||+||+++.+.. .++. ||...... ......||+.|+|||++.+..
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCccccccccCcccccCCC
Confidence 44567889999999999 669999999999999987766 4444 55543211 122346899999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcc-------ccCC----CCCCcCCHHHHHHHHHhccc
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV-------QYFL----PDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~~~li~~~L~~ 149 (246)
++.+ +||||+||++|||++|+.||...... ....+........ .... +.......++.+++.+||..
T Consensus 855 ~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 855 ITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred CCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence 8766 89999999999999999998532211 1111111110000 0000 00111233577899999999
Q ss_pred CCCCCCCHHHHhcC
Q 025933 150 DPSKRIPIPEIKKH 163 (246)
Q Consensus 150 dp~~R~t~~e~l~h 163 (246)
||.+|||+.++++.
T Consensus 934 ~P~~RPt~~evl~~ 947 (968)
T PLN00113 934 DPTARPCANDVLKT 947 (968)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=166.05 Aligned_cols=148 Identities=17% Similarity=0.266 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
+.-..|+..|+.+||+++|||.||...|++|++.-. |||+|=.+++...... ......-...||+||.+.+..|+
T Consensus 399 V~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys 476 (563)
T KOG1024|consen 399 VLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS 476 (563)
T ss_pred HHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc
Confidence 344568889999999999999999999999988755 9999999998533221 11122234579999999999998
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.. +|+|||||++|||++ |+.||..-++.+.. . ..+..+.+..+.++++++..++..||...|++||+++++..
T Consensus 477 sa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~-~----ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 477 SA-SDVWSFGVLLWELMTLGKLPYAEIDPFEME-H----YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ch-hhhHHHHHHHHHHHhcCCCCccccCHHHHH-H----HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 66 899999999999998 99999765543332 2 22334455555689999999999999999999999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=185.70 Aligned_cols=153 Identities=35% Similarity=0.558 Sum_probs=121.5
Q ss_pred HHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----------------CCCCCCCCCCCCcchh
Q 025933 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----------------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 13 il~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----------------~~~~~~gt~~y~aPE~ 76 (246)
.+.+++|+|+-+|+|||+||+|++|..-+. +|+.|||+++.+.... ..+..+|||.|.|||+
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 367899999999999999999999988777 9999999987432110 1134589999999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCCCC
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
+..++| ++.+|+|++|+|+|+.+.|+.||.+....+.+..++.- ...+|+ ....+++++++|.++|+.+|..|.
T Consensus 230 ilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 230 ILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 998888 56699999999999999999999987665444444332 222332 345889999999999999999996
Q ss_pred ---CHHHHhcCcccccCCCh
Q 025933 156 ---PIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 156 ---t~~e~l~hp~~~~~~~~ 172 (246)
.+-++.+|+||+..-.+
T Consensus 305 gt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 305 GTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccchhhhhhhccceeecccc
Confidence 46789999999764433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=177.16 Aligned_cols=150 Identities=23% Similarity=0.365 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCC-CC--CCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VG--TPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~-~g--t~~y~aPE~~~~~ 80 (246)
...+.|.+||++|+.|||++.+|||||-..|||+..-.. ||+.|||+++.........+. .| .+.|||-|.+...
T Consensus 798 q~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~ 875 (1177)
T KOG1025|consen 798 QDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR 875 (1177)
T ss_pred HHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccccccccccCcHHHHHHHhhcc
Confidence 457889999999999999999999999999999987766 999999999854433322222 22 4569999999988
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.|+.. +||||+||++||++| |..|+.+... +.+.+.++.. . .++.++..+-++.-++.+||..|+..||++++
T Consensus 876 ~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~g---e-RLsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 876 KYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKG---E-RLSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred CCCch-hhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhcc---c-cCCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 98766 899999999999997 9999987543 3334444332 2 35666689999999999999999999999987
Q ss_pred Hh
Q 025933 160 IK 161 (246)
Q Consensus 160 ~l 161 (246)
+-
T Consensus 950 l~ 951 (1177)
T KOG1025|consen 950 LA 951 (1177)
T ss_pred HH
Confidence 64
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-22 Score=167.68 Aligned_cols=153 Identities=23% Similarity=0.268 Sum_probs=105.6
Q ss_pred HHHHHHHHHHHHHHHhHhC---------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQ---------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYI 72 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~---------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~ 72 (246)
...+++..++.||+|||+. .|+|||||..|||+.++.. ..|+|||+|....... .....+||..||
T Consensus 308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYM 385 (534)
T KOG3653|consen 308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQGDTHGQVGTRRYM 385 (534)
T ss_pred HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCcchhhhhhhhhhc
Confidence 3456677788999999983 5999999999999998877 8999999997654332 223458999999
Q ss_pred cchhcccccc-----CCcchhHHhHHHHHHHHHhCCC------------CCCC----CCChHHHHHHHHHHhccccCCCC
Q 025933 73 APEVLARKEY-----DGKISDVWSCGVTLYVMLVGAY------------PFED----PEDPRNFRKTIDRIRNVQYFLPD 131 (246)
Q Consensus 73 aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~------------Pf~~----~~~~~~~~~~~~~~~~~~~~~~~ 131 (246)
|||++.+.-- .-++.||||+|.|+|||+++.. ||.. ....+.++..+-. .+..+.+|.
T Consensus 386 APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~-kK~RP~~p~ 464 (534)
T KOG3653|consen 386 APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR-KKQRPKIPD 464 (534)
T ss_pred CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh-hccCCCChh
Confidence 9999976421 1245899999999999998643 3321 1111222222211 112222222
Q ss_pred C---CcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 132 Y---VRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 132 ~---~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
. .....-+++.+..||..||+.|.|+.-+
T Consensus 465 ~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 465 AWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1 1234668999999999999999998644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-22 Score=172.92 Aligned_cols=158 Identities=25% Similarity=0.321 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhcc---ccccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLA---RKEYD 83 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~ 83 (246)
+.....+.+++|||++|-+|||||-.|||+++.+. |||+|||.+.... .-...+++.||++|||||+-. ...|.
T Consensus 116 yvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggyn 193 (829)
T KOG0576|consen 116 YVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 193 (829)
T ss_pred HHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccccc
Confidence 33455678999999999999999999999998888 9999999986432 233456789999999999863 34555
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.. +|+|++|+...++-.-++|-...-..+.+ ..+.+-......+.+....++.+.+|++.+|.++|++|||++.+|.|
T Consensus 194 ql-cdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 194 QL-CDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cc-ccccccccchhhhhhcCCcccccchHHHH-HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 44 99999999999998888886543332222 12221111122233445689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
||....
T Consensus 272 ~fvs~~ 277 (829)
T KOG0576|consen 272 PFVSQT 277 (829)
T ss_pred eeeccc
Confidence 998765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=163.03 Aligned_cols=156 Identities=23% Similarity=0.380 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHHHHhHhC--------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-----CCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQ--------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~--------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-----~~~~~~~gt~~y 71 (246)
.++..++.++.||+.||.. .|.|||||..|||+.+++. +.|+|+|||...... ...+..+||-.|
T Consensus 309 ~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY 386 (513)
T KOG2052|consen 309 GMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY 386 (513)
T ss_pred HHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeec
Confidence 4566778889999999983 4999999999999998887 899999999743322 233567899999
Q ss_pred Ccchhcccc----cc-CCcchhHHhHHHHHHHHHhC----------CCCCCCCCChHHHHHHHHHH---hccccCCCCCC
Q 025933 72 IAPEVLARK----EY-DGKISDVWSCGVTLYVMLVG----------AYPFEDPEDPRNFRKTIDRI---RNVQYFLPDYV 133 (246)
Q Consensus 72 ~aPE~~~~~----~~-~~~~~DiwslG~il~~ll~g----------~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 133 (246)
||||++... .+ +-+.+||||||.|+||++.+ ++||.+..+.+.-.+-+.++ .+..+..|..-
T Consensus 387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW 466 (513)
T KOG2052|consen 387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW 466 (513)
T ss_pred cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc
Confidence 999998532 11 12458999999999999853 57887655443333333332 22333333322
Q ss_pred cCCH---HHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 134 RVSA---DCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 134 ~~~~---~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.-.+ .+-.+++.||..||.-|.|+-.+.+
T Consensus 467 ~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 467 KSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2233 4467899999999999999876643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=147.32 Aligned_cols=119 Identities=40% Similarity=0.607 Sum_probs=99.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcccc-cc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARK-EY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~ 82 (246)
...++.+++.++++||+++++|+||+|.||+++. .+. ++|+|||.+....... ......+...|++||.+... .+
T Consensus 94 ~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 171 (215)
T cd00180 94 ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171 (215)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCC
Confidence 4556778899999999999999999999999987 554 9999999987432221 12335688899999999776 44
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ ...|+|++|++++++ ..+.+++.+|+..||.+||++.++++
T Consensus 172 ~-~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 172 S-EKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred C-chhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 4 448999999999998 67899999999999999999999998
Q ss_pred Cc
Q 025933 163 HP 164 (246)
Q Consensus 163 hp 164 (246)
|+
T Consensus 214 ~~ 215 (215)
T cd00180 214 HL 215 (215)
T ss_pred CC
Confidence 75
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-21 Score=168.26 Aligned_cols=142 Identities=33% Similarity=0.504 Sum_probs=117.0
Q ss_pred HHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhHHh
Q 025933 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 91 (246)
Q Consensus 12 qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 91 (246)
.++.++..+|+.+|+|||+|++||+++..|+ +|+.|||+++....... .|||..|||||++. ... .++|+||
T Consensus 105 elaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~---~cgt~eymApEI~~--gh~-~a~D~ws 176 (612)
T KOG0603|consen 105 ELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN--GHL-SAADWWS 176 (612)
T ss_pred HHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhh---cccchhhhhhHhhh--ccC-Ccccchh
Confidence 3567889999999999999999999998887 99999999986443322 29999999999997 222 3389999
Q ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccc
Q 025933 92 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 166 (246)
Q Consensus 92 lG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~ 166 (246)
+|++.++|++|..||.+ .++..+...+...|. ..+..+++++..++.++|.+|.. +.++++|+||
T Consensus 177 ~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~ 246 (612)
T KOG0603|consen 177 FGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF 246 (612)
T ss_pred hhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchh
Confidence 99999999999999986 344455555555555 68999999999999999999985 4799999999
Q ss_pred ccCCC
Q 025933 167 LKNLP 171 (246)
Q Consensus 167 ~~~~~ 171 (246)
.....
T Consensus 247 ~~i~~ 251 (612)
T KOG0603|consen 247 QSIDW 251 (612)
T ss_pred eeeeH
Confidence 76443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-21 Score=167.41 Aligned_cols=96 Identities=32% Similarity=0.513 Sum_probs=86.1
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhH
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 89 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 89 (246)
-.|+..|++.||++||||||||-+|+.++++|. +||+|||.+.. ........++||..|.|||++.|..|-++..||
T Consensus 676 FkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdi 752 (772)
T KOG1152|consen 676 FKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAY-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDI 752 (772)
T ss_pred HHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhh-hcCCCcceeeeeccccchhhhCCCccCCCcchh
Confidence 456779999999999999999999999999887 99999998863 344566778999999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCC
Q 025933 90 WSCGVTLYVMLVGAYPFED 108 (246)
Q Consensus 90 wslG~il~~ll~g~~Pf~~ 108 (246)
|++|++||.++....||+.
T Consensus 753 walgillytivykenpyyn 771 (772)
T KOG1152|consen 753 WALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhheeeEEEeccCCCcC
Confidence 9999999999999999863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=155.34 Aligned_cols=134 Identities=22% Similarity=0.316 Sum_probs=90.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-----
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK----- 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 80 (246)
-++.++|++..+++||..||||+||||+|++++.+|. ++|+||+........ ......+..|.+||.....
T Consensus 147 rl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~ 222 (288)
T PF14531_consen 147 RLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQ 222 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHH
T ss_pred HHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCc
Confidence 3566899999999999999999999999999999887 999999876532211 1113355779999987442
Q ss_pred ---ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 81 ---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 81 ---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
.++ .+.|.|+||+++|.|+||..||........ ....+....++++..+.||++||+.||.+|
T Consensus 223 ~~~~~t-~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 223 NNAPYT-FATDAWQLGITLYSLWCGRLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SEEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccceee-eccCHHHHHHHHHHHHHccCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 344 347999999999999999999975433111 011233344789999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=151.39 Aligned_cols=146 Identities=25% Similarity=0.329 Sum_probs=106.0
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEe--cCCCCCcEEEeccCCccCCCC-------CCCCCCCCCCCCCCcchhcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL-------HSQPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill--~~~~~~~vkl~Dfg~s~~~~~-------~~~~~~~~gt~~y~aPE~~~ 78 (246)
-+++|+++|+.+||++||.|||+|.+|||+ +++....+.|+|||-+-.... ....-...|+..-||||+..
T Consensus 345 ~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 468899999999999999999999999998 455556789999997642211 11112345888899999985
Q ss_pred cccc------CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 79 RKEY------DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 79 ~~~~------~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
..+. +++ +|.|+.|.+.||++....||++....-.-....+ ..... +....+++.+++|+..+|+.||+
T Consensus 425 a~PGp~avvny~k-AD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq--e~qLP--alp~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 425 AVPGPNAVVNYEK-ADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ--ESQLP--ALPSRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred cCCCCceeeccch-hhhhhhhhhHHHHhccCCcccccchheechhhhh--hhhCC--CCcccCChHHHHHHHHHhcCCcc
Confidence 4221 245 8999999999999999999987432111000111 11112 23347899999999999999999
Q ss_pred CCCCHH
Q 025933 153 KRIPIP 158 (246)
Q Consensus 153 ~R~t~~ 158 (246)
+|++..
T Consensus 500 kRvsp~ 505 (598)
T KOG4158|consen 500 KRVSPN 505 (598)
T ss_pred ccCCcc
Confidence 999854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=144.39 Aligned_cols=163 Identities=31% Similarity=0.450 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-------CCCCCCCCCCCCcchhc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------QPKSTVGTPAYIAPEVL 77 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------~~~~~~gt~~y~aPE~~ 77 (246)
.....+.|++.++.|+|.++++|||+||+||+++.... .++++|||+++...... ......||..|++||.+
T Consensus 102 ~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHh
Confidence 34566788889999999999999999999999987662 38999999987332221 23556899999999999
Q ss_pred ccc--ccCCcchhHHhHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhccccCCCCCCcC----CHHHHHHHHHhcc
Q 025933 78 ARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPED---PRNFRKTIDRIRNVQYFLPDYVRV----SADCRHLLSQIFV 148 (246)
Q Consensus 78 ~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~ 148 (246)
.+. .......|+||+|++++++++|..||..... .......+..........+..... ...+.+++.+++.
T Consensus 181 ~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLA 260 (384)
T ss_pred cCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHh
Confidence 873 3334458999999999999999999876553 222222222211110111111111 2578999999999
Q ss_pred cCCCCCCCHHHHhcCccccc
Q 025933 149 ADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 149 ~dp~~R~t~~e~l~hp~~~~ 168 (246)
.+|..|.+......+++...
T Consensus 261 ~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 261 KDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCchhcCCHHHHhhchHhhC
Confidence 99999999999888866543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=139.22 Aligned_cols=101 Identities=38% Similarity=0.498 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhc-cccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVL-ARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~ 81 (246)
.....+.|++.++.+||+++++|+||+|.||+++.++. ++|+|||++....... ......++..|++||.+ ....
T Consensus 99 ~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 176 (225)
T smart00221 99 EARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKG 176 (225)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCC
Confidence 34567788999999999999999999999999988755 9999999987543322 22445688899999998 5555
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFED 108 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~ 108 (246)
++. .+|+|++|+++++|++|+.||..
T Consensus 177 ~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 177 YGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 555 48999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=161.40 Aligned_cols=141 Identities=22% Similarity=0.338 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCC-------CCCCCCCCCcchhcccc
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK-------STVGTPAYIAPEVLARK 80 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~-------~~~gt~~y~aPE~~~~~ 80 (246)
++.|++.||..||..||+|+|||.+||||.+=+- +.|+||..-+...... ... +..--.+|+|||.+...
T Consensus 125 iaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 125 IAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred HHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence 4889999999999999999999999999987554 8999998665321111 111 11123469999998542
Q ss_pred c---------c-CCcchhHHhHHHHHHHHHh-CCCCCCCC-------CChHHHHHHHHHHhccccCCCCCCcCCHHHHHH
Q 025933 81 E---------Y-DGKISDVWSCGVTLYVMLV-GAYPFEDP-------EDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142 (246)
Q Consensus 81 ~---------~-~~~~~DiwslG~il~~ll~-g~~Pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 142 (246)
. . -.++.||||+||++.||++ |++||.-. .........++++ -+..++.|
T Consensus 203 ~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I------------ed~~~Rnl 270 (1431)
T KOG1240|consen 203 LGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI------------EDVSLRNL 270 (1431)
T ss_pred ccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC------------cCccHHHH
Confidence 2 0 1244799999999999988 78988420 0001111111111 24478999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 025933 143 LSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~h 163 (246)
|..|++.||.+|.+|++.|+.
T Consensus 271 il~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 271 ILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHccCchhccCHHHHHHh
Confidence 999999999999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-19 Score=150.96 Aligned_cols=146 Identities=27% Similarity=0.412 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-------CCCCCCCCCCCCcchhccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 79 (246)
+-|..|+..++.| ++.+|||+||.||+...+.. +||.|||+........ ..+..+||.+||+||.+.+
T Consensus 362 ~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 362 LDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred HHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 3456667788888 89999999999999987775 9999999976433222 2234579999999999999
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..|..+ +||||||+||++++. -..+|. -...+.-++...+. |.+..-.+.-.+|+..||...|.+||++.
T Consensus 437 ~~y~~k-vdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~ip-~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 437 QQYSEK-VDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGIIP-PEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhhh-cchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCCCC-hHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 999877 899999999999997 222221 12223333333321 12223345567999999999999999877
Q ss_pred HHhcCccc
Q 025933 159 EIKKHPWF 166 (246)
Q Consensus 159 e~l~hp~~ 166 (246)
+.-.|+|.
T Consensus 508 ~~~~~~~~ 515 (516)
T KOG1033|consen 508 EVALHEFL 515 (516)
T ss_pred HHhhhhhc
Confidence 77666663
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-16 Score=135.87 Aligned_cols=157 Identities=19% Similarity=0.121 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-C--CcEEEeccCCcc--CCCCCC-----C----CCCCCCCC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-Q--PRLKICDFGYSK--SGLLHS-----Q----PKSTVGTP 69 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~--~~vkl~Dfg~s~--~~~~~~-----~----~~~~~gt~ 69 (246)
-..+.+..|++.+|.++|+.|+|||||||.|+++.... . ..+.|.|||+++ ...... . .....||.
T Consensus 122 ~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ 201 (322)
T KOG1164|consen 122 KTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTL 201 (322)
T ss_pred hHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcc
Confidence 35678899999999999999999999999999997653 1 358999999998 321111 1 11235999
Q ss_pred CCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 70 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.|+++....+...... .|+||++.++.+++.|..||.+........+........... ......+..+..+...+-..
T Consensus 202 ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 279 (322)
T KOG1164|consen 202 RYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-RFGDLKPEEFAKILEYIDSL 279 (322)
T ss_pred ccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-cccCCChHHHHHHHHHhhcc
Confidence 9999999888777655 899999999999999999997766543333322222211111 12223456777777777778
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
+...+|....+..
T Consensus 280 ~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 280 DYEDKPDYEKLAE 292 (322)
T ss_pred CCcCCCCHHHHHH
Confidence 8888888776654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-17 Score=150.93 Aligned_cols=159 Identities=31% Similarity=0.513 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHHhH-hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCC---CCCCCC-CCCCCcchhc
Q 025933 4 VCYFSSTVMIFTSHHCFY-LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ---PKSTVG-TPAYIAPEVL 77 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH-~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~---~~~~~g-t~~y~aPE~~ 77 (246)
-+|+.+ +..++.|+| ..++.||||||+|.+++.++. .+|++|||+|..... ... ....+| ++.|+|||..
T Consensus 126 ~~~~~q---l~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 126 SRYLPQ---LNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred hhhhhh---hccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence 345544 458899999 999999999999999988872 389999999985443 222 223478 9999999999
Q ss_pred cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-cccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 78 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
.+..|.++..|+||+|+++..+++|..||............+ ... .......+..++....+++.++|..+|..|.+
T Consensus 202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW--KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred cchhhcCCCcccccccccccccccCCCCccccccccccceee--cccccccccCccccCChhhhhcccccccCCchhccc
Confidence 987787777999999999999999999997655433211111 111 12234456678999999999999999999999
Q ss_pred HHHHhcCccccc
Q 025933 157 IPEIKKHPWFLK 168 (246)
Q Consensus 157 ~~e~l~hp~~~~ 168 (246)
.+++..++|+..
T Consensus 280 ~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 280 IEELKLDNWLSS 291 (601)
T ss_pred cccccccccccc
Confidence 999999999976
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.1e-15 Score=129.74 Aligned_cols=157 Identities=22% Similarity=0.258 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCc-ccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEI-CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~i-vHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~ 79 (246)
.+-++-+..|+.||.|+|.-.| .|+.++..|++++..-. +||+|||+......... .....-...|.|||.+.+
T Consensus 48 ~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 48 FFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred HHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 4455667789999999999877 89999999999998776 99999999875432100 011123456999999976
Q ss_pred ccc------CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-cc-cCCCC---CCcCCHHHHHHHHHhcc
Q 025933 80 KEY------DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQ-YFLPD---YVRVSADCRHLLSQIFV 148 (246)
Q Consensus 80 ~~~------~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-~~-~~~~~---~~~~~~~~~~li~~~L~ 148 (246)
... -.+..|+||+|++++++++...||........-.+++..+.+ .. ...|. ....++.+..+++.||.
T Consensus 126 ~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~ 205 (484)
T KOG1023|consen 126 ALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWE 205 (484)
T ss_pred cccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcc
Confidence 421 134489999999999999999999764433222344444444 11 12232 12456689999999999
Q ss_pred cCCCCCCCHHHHhc
Q 025933 149 ADPSKRIPIPEIKK 162 (246)
Q Consensus 149 ~dp~~R~t~~e~l~ 162 (246)
.+|.+||+++.+..
T Consensus 206 e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 206 EIPEKRPSIEQIRS 219 (484)
T ss_pred cChhhCccHHHHHh
Confidence 99999999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-13 Score=112.22 Aligned_cols=107 Identities=21% Similarity=0.261 Sum_probs=87.0
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC---CcEEEeccCCccCCCCC--------CCCCCCCCCCCCC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLH--------SQPKSTVGTPAYI 72 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~---~~vkl~Dfg~s~~~~~~--------~~~~~~~gt~~y~ 72 (246)
...+-+..|++.-+.|+|++.+|+|||||+|.||...+. ..|.++|||+|+..... +..++..||..||
T Consensus 124 KTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYM 203 (449)
T KOG1165|consen 124 KTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYM 203 (449)
T ss_pred HhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeee
Confidence 345567889999999999999999999999999965332 34889999999854322 2235667999999
Q ss_pred cchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCC
Q 025933 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 111 (246)
Q Consensus 73 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 111 (246)
+--...+...+.. -|+=|||-++...|.|..||.+...
T Consensus 204 SINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 204 SINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred Eeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 9988887777655 7999999999999999999988654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=4e-14 Score=111.71 Aligned_cols=99 Identities=14% Similarity=0.045 Sum_probs=72.1
Q ss_pred HHHHHHHHHHHhHhCCcccCCC-CCCCEEecCCCCCcEEEeccCCccCCCCCCCC----C----------CCCCCCCCCc
Q 025933 9 STVMIFTSHHCFYLQEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----K----------STVGTPAYIA 73 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDl-kp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~----------~~~gt~~y~a 73 (246)
...|++.+|.++|.+||+|||| ||+|||++.++. ++|+|||++......... . -...++.|++
T Consensus 96 ~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~ 173 (218)
T PRK12274 96 YFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT 173 (218)
T ss_pred HHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 4567778899999999999999 799999987665 999999999843322210 0 0125778888
Q ss_pred chhcccc-ccCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 025933 74 PEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDP 109 (246)
Q Consensus 74 PE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 109 (246)
|+--.-- ..+-...++++.|+-+|.++|+..|+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 174 PVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 8754322 22223358889999999999999887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=108.57 Aligned_cols=147 Identities=18% Similarity=0.215 Sum_probs=102.6
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCC--------CCCCCCCCCCCCCcchhccc
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLH--------SQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 79 (246)
-+-|++.-+.|+|.+++|||||||+|.|+.-+.. .++.|+|||+|+..... +..+...||..|.+--...+
T Consensus 116 LaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 116 LADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred HHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh
Confidence 3557788899999999999999999999854322 35899999999854322 12234579999988776665
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC---CCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
...+.. -|+=|+|.++.....|..||.+...... .+..+++...+-..| ....+|.++.-.+..|-..--++-|.
T Consensus 196 ~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 196 IEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred hhhhhh-hhhhhhcceeeeeecCCCcccccchhhH-HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 555444 7999999999999999999988654322 122222222222222 24567888888888887766666665
Q ss_pred H
Q 025933 157 I 157 (246)
Q Consensus 157 ~ 157 (246)
.
T Consensus 274 y 274 (341)
T KOG1163|consen 274 Y 274 (341)
T ss_pred H
Confidence 4
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.9e-14 Score=120.42 Aligned_cols=71 Identities=17% Similarity=0.137 Sum_probs=56.0
Q ss_pred HHHHHHHHHHHHhHhCCcccCCC-CCCCEEecCCCCCcEEEeccCCccCCCCCCC---------CCCCCCCCCCCcchhc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---------PKSTVGTPAYIAPEVL 77 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDl-kp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---------~~~~~gt~~y~aPE~~ 77 (246)
.++.|++.+|.|||++||+|||| ||+|||++.++. +||+|||+|+....... ..+.++++.|+|||.+
T Consensus 115 ~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 115 AWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred HHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 44667889999999999999999 999999976655 99999999984332221 1344688899999998
Q ss_pred ccc
Q 025933 78 ARK 80 (246)
Q Consensus 78 ~~~ 80 (246)
...
T Consensus 193 ~~~ 195 (365)
T PRK09188 193 TPR 195 (365)
T ss_pred Chh
Confidence 643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.5e-13 Score=107.34 Aligned_cols=144 Identities=22% Similarity=0.283 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC--
Q 025933 8 SSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD-- 83 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-- 83 (246)
+-.+.++.+++|||+.. |.---|....++|+.+-..++-.+|-.++.. .....-.|.||+||.++.++-+
T Consensus 293 ~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n 366 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLN 366 (448)
T ss_pred HHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcc
Confidence 34677889999999976 3334588889999988776677777655432 1223457899999999766543
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
-.++|+|||++++|||.++..||......+--.++- +....... ++.++.....|+.-|+..||.+||.+..+.
T Consensus 367 ~raadmwsfaillwel~trevpfadlspmecgmkia--leglrv~i--ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 367 IRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--LEGLRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--hccccccC--CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 344899999999999999999998776643322221 12222333 347999999999999999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-12 Score=121.56 Aligned_cols=152 Identities=28% Similarity=0.461 Sum_probs=116.1
Q ss_pred HHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCcc-CCCC-----C--------------------------C
Q 025933 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK-SGLL-----H--------------------------S 60 (246)
Q Consensus 13 il~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~-~~~~-----~--------------------------~ 60 (246)
+..++.+||...++|||++|.|+|+..++. .++.+||... .+.. . .
T Consensus 913 ~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~ 990 (1205)
T KOG0606|consen 913 RVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEAR 990 (1205)
T ss_pred HHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccchhh
Confidence 446667999999999999999999988777 8899998322 1100 0 0
Q ss_pred CCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHH
Q 025933 61 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADC 139 (246)
Q Consensus 61 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 139 (246)
......||+.|.+||.+.+.... ..+|+|+.|+++++.++|.+||......+. ++.+.+....+|. ....+..+
T Consensus 991 ~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~tpq~~----f~ni~~~~~~~p~g~~~~s~~a 1065 (1205)
T KOG0606|consen 991 RKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAETPQQI----FENILNRDIPWPEGPEEGSYEA 1065 (1205)
T ss_pred ccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcchhhh----hhccccCCCCCCCCccccChhh
Confidence 01123689999999999887764 448999999999999999999987666444 4444444444443 23578999
Q ss_pred HHHHHHhcccCCCCCCCHH---HHhcCcccccCCC
Q 025933 140 RHLLSQIFVADPSKRIPIP---EIKKHPWFLKNLP 171 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~---e~l~hp~~~~~~~ 171 (246)
++++.++|..+|.+|..+. ++..|+||.....
T Consensus 1066 q~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1066 QDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 9999999999999999987 8999999976543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-12 Score=104.13 Aligned_cols=76 Identities=14% Similarity=0.163 Sum_probs=55.8
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchh
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 88 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 88 (246)
.+.+++.++..+|.+||+|||+||.||+++.++ ++|+|||.++....... ...++....|.-+ +|
T Consensus 140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a-----------~d~~vler~y~~~-~d 204 (232)
T PRK10359 140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKA-----------KDRIDLERHYGIK-NE 204 (232)
T ss_pred HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhh-----------HHHHHHHhHhccc-cc
Confidence 355788999999999999999999999998755 89999998764321110 0113334455544 89
Q ss_pred HHhHHHHHHHH
Q 025933 89 VWSCGVTLYVM 99 (246)
Q Consensus 89 iwslG~il~~l 99 (246)
+||||+++...
T Consensus 205 i~~lg~~~~~~ 215 (232)
T PRK10359 205 IKDLGYYLLIY 215 (232)
T ss_pred ccceeEeehHH
Confidence 99999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-12 Score=114.43 Aligned_cols=163 Identities=15% Similarity=0.202 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----C------CCCCCCCCCcch
Q 025933 7 FSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----K------STVGTPAYIAPE 75 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~------~~~gt~~y~aPE 75 (246)
|.-+.++..|+.|+|.. ++||+.|.|++|.++.++. .||+.|+++......... . ...-...|.|||
T Consensus 102 f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 34455666889999986 6999999999999998887 999999987633221110 0 112455799999
Q ss_pred hccccccCCcchhHHhHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 76 VLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 76 ~~~~~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
++.+.... .++|++|+||++|.+. .|+.-+...+....+........... +....+++.++++-|.++|..++..|
T Consensus 180 ~~~~~~~~-~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 180 YLLGTTNT-PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--FGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred hhcccccc-ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--ccccccCcHHHHHHHHHHhcCCcccC
Confidence 99875554 4489999999999988 45555544333222111111111111 12224789999999999999999999
Q ss_pred CCHHHHhcCcccccCCChHH
Q 025933 155 IPIPEIKKHPWFLKNLPKEI 174 (246)
Q Consensus 155 ~t~~e~l~hp~~~~~~~~~~ 174 (246)
|++.+++..|||....-+.+
T Consensus 257 p~~~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 257 PTLDLLLSIPFFSDPGLKAL 276 (700)
T ss_pred cchhhhhcccccCCchhhhh
Confidence 99999999999976544433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-11 Score=96.71 Aligned_cols=48 Identities=19% Similarity=0.087 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHHHHHh-HhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 5 CYFSSTVMIFTSHHCF-YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 5 ~~~~~~~qil~~l~~l-H~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.....+.|++.+|.++ |..||+||||||+|||++. + +++|+|||+|..
T Consensus 118 ~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~ 166 (190)
T cd05147 118 KARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVE 166 (190)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEcccccc
Confidence 3566778899999999 7999999999999999984 3 499999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-11 Score=95.33 Aligned_cols=48 Identities=17% Similarity=0.089 Sum_probs=42.2
Q ss_pred HHHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 5 CYFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
....++.|++.++.++|. +||+||||||+|||++ ++. ++|+|||+++.
T Consensus 118 ~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~--~~liDFG~a~~ 166 (190)
T cd05145 118 EAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK--PYIIDVSQAVE 166 (190)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--EEEEEccccee
Confidence 455677889999999999 9999999999999998 444 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5e-11 Score=111.95 Aligned_cols=97 Identities=23% Similarity=0.227 Sum_probs=77.0
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-----CCCcEEEeccCCccCC---CCCCCCCCCCCCCCCCcchhcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-----PQPRLKICDFGYSKSG---LLHSQPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-----~~~~vkl~Dfg~s~~~---~~~~~~~~~~gt~~y~aPE~~~ 78 (246)
+..++|++..+.-||.++|||+||||+|.||... ...-++|+|||-+... ......+..++|-.+-.+|...
T Consensus 797 ~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~ 876 (974)
T KOG1166|consen 797 MFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE 876 (974)
T ss_pred hHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc
Confidence 3446778888889999999999999999999421 2234899999988532 2233445567899999999999
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCC
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAY 104 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~ 104 (246)
|.+++-. +|.|.++.+++.||+|+.
T Consensus 877 grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 877 GRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 9888644 899999999999999964
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.2e-10 Score=91.72 Aligned_cols=155 Identities=14% Similarity=0.187 Sum_probs=101.1
Q ss_pred HHHHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCC-----CCCCCCCCCCCCCCCCcch
Q 025933 3 SVCYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-----LLHSQPKSTVGTPAYIAPE 75 (246)
Q Consensus 3 ~~~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~-----~~~~~~~~~~gt~~y~aPE 75 (246)
...|=.|+-||+.||.|||+.. |+|+.+....|++..++- +|+.---..... ..........|.++|.+||
T Consensus 175 ~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~ 252 (458)
T KOG1266|consen 175 QKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE 252 (458)
T ss_pred HHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCC
Confidence 4678889999999999999986 999999999999986664 554321111000 0000111224678899999
Q ss_pred hccccccCCcchhHHhHHHHHHHHHhCCCC-CCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYP-FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 76 ~~~~~~~~~~~~DiwslG~il~~ll~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
.=.....++. +|||++|....+|..+..- -.+...... ...+... -..+ -..--++++.+||+-.|..|
T Consensus 253 sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~-ee~ia~~---i~~l-----en~lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 253 SGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEV-EENIANV---IIGL-----ENGLQRGSITKCLEGEPNGR 322 (458)
T ss_pred cCcccccccc-hhhhhhhHHHHHHHHheeccCCCcceeeh-hhhhhhh---eeec-----cCccccCcCcccccCCCCCC
Confidence 7655555555 8999999999999877643 222221111 1111111 1111 11123578999999999999
Q ss_pred CCHHHHhcCcccccC
Q 025933 155 IPIPEIKKHPWFLKN 169 (246)
Q Consensus 155 ~t~~e~l~hp~~~~~ 169 (246)
|++.+++.||-....
T Consensus 323 p~ar~llfHpllfeV 337 (458)
T KOG1266|consen 323 PDARLLLFHPLLFEV 337 (458)
T ss_pred cchhhhhcCceeeec
Confidence 999999999976543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.2e-10 Score=91.26 Aligned_cols=44 Identities=25% Similarity=0.204 Sum_probs=39.5
Q ss_pred HHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 10 ~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
+.|++.++.+||.+||+||||||.|||++.++. ++|+|||.+..
T Consensus 148 ~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~ 191 (239)
T PRK01723 148 WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCccc
Confidence 567889999999999999999999999987664 99999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.5e-10 Score=88.72 Aligned_cols=45 Identities=16% Similarity=0.114 Sum_probs=36.6
Q ss_pred HHHHHHHHH-HHhHhCCcccCCCCCCCEEecCC--CCCcEEEeccCCc
Q 025933 9 STVMIFTSH-HCFYLQEICHRDLKLENTLLDGS--PQPRLKICDFGYS 53 (246)
Q Consensus 9 ~~~qil~~l-~~lH~~~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s 53 (246)
++.|++.++ +|||+++||||||||+|||++.. +..+++|+||+-+
T Consensus 109 ~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 109 QLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 467888788 89999999999999999999753 3346999995533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.9e-10 Score=90.37 Aligned_cols=46 Identities=24% Similarity=0.275 Sum_probs=40.6
Q ss_pred HHHHHHHHHHHHHhHhCC-cccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 7 FSSTVMIFTSHHCFYLQE-ICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~-ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++.|++.++++||.+| |+||||||+||+++ ++ +++|+|||.+..
T Consensus 151 ~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~~ 197 (237)
T smart00090 151 FELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSVE 197 (237)
T ss_pred HHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhhc
Confidence 456788999999999999 99999999999998 44 499999998863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-09 Score=96.88 Aligned_cols=148 Identities=20% Similarity=0.155 Sum_probs=106.7
Q ss_pred HHHHHH----HHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCC------CCCCCCCCCCcchhcc
Q 025933 10 TVMIFT----SHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQP------KSTVGTPAYIAPEVLA 78 (246)
Q Consensus 10 ~~qil~----~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~------~~~~gt~~y~aPE~~~ 78 (246)
+.+.+. ||..+|+.+|+|-|+||.||++..+ .. .+++|||+........-. ....|...|++||+..
T Consensus 224 ~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 224 LRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred HhhhhhcccccccccCCCcccccccchhheecccccce--eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 444455 9999999999999999999999877 44 899999987643222211 1225778899999986
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCC--CChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDP--EDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
+.. +...|++++|.++.+..++..++... ..+..++ +...........+..+...+..|+..+|..|++
T Consensus 302 ~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~ 372 (524)
T KOG0601|consen 302 GLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLT 372 (524)
T ss_pred ccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccc-------cccCchhhhcCcchhhhhHHHHhcCcchhhhhH
Confidence 543 34489999999999988887666443 2222211 111111123356777788999999999999999
Q ss_pred HHHHhcCccccc
Q 025933 157 IPEIKKHPWFLK 168 (246)
Q Consensus 157 ~~e~l~hp~~~~ 168 (246)
+..++.|+++..
T Consensus 373 ~q~~~~l~~i~s 384 (524)
T KOG0601|consen 373 AQILTALNVIHS 384 (524)
T ss_pred HHHHhccccccc
Confidence 999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-09 Score=85.18 Aligned_cols=46 Identities=26% Similarity=0.211 Sum_probs=40.4
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..+.+++.++.++|.++|+||||||.||+++.++. ++|+|||++..
T Consensus 129 ~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~ 174 (198)
T cd05144 129 EVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVS 174 (198)
T ss_pred HHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCcccc
Confidence 45667888999999999999999999999987665 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-09 Score=96.69 Aligned_cols=151 Identities=21% Similarity=0.173 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCC--cchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI--APEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~ 82 (246)
.+++.+.|++.++.++|+..++|+|+||.||++.+++ ...++.|||..... .... ....+..+++ ++.......+
T Consensus 367 ~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~-~~~~-~~~~~~~r~~p~~~~~~e~~~~ 443 (524)
T KOG0601|consen 367 PRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL-AFSS-GVFHHIDRLYPIAEILLEDYPH 443 (524)
T ss_pred hhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc-ceec-ccccccccccccchhhcccccc
Confidence 4678899999999999999999999999999998764 23789999987641 1111 1122333344 4544555555
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
..+ +|++|||..+.+.+++..--...... .. +... ..|..+.....+..+.+.+...++..|+.+.++..
T Consensus 444 ~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~---~~----i~~~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 444 LSK-ADIFSLGLSVDEAITGSPLSESGVQS---LT----IRSG--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ccc-cccccccccccccccCcccCcccccc---ee----eecc--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 444 89999999999999886432221111 11 1111 12333345588999999999999999999999988
Q ss_pred Cccccc
Q 025933 163 HPWFLK 168 (246)
Q Consensus 163 hp~~~~ 168 (246)
|+-|..
T Consensus 514 ~~~~~~ 519 (524)
T KOG0601|consen 514 HSEFYR 519 (524)
T ss_pred cchhhh
Confidence 876643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.3e-08 Score=84.03 Aligned_cols=153 Identities=13% Similarity=0.138 Sum_probs=103.4
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc-----
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA----- 78 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~----- 78 (246)
.+.++...-++.+-.-||.+|-+-+|++++|+|+++.+. |.|.|-..-..........+.+|.+.|.+||.-.
T Consensus 117 ~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~ 194 (637)
T COG4248 117 DFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFV 194 (637)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccCCceEecccCccccCCHHHhcccccc
Confidence 455666777888999999999999999999999988876 8888744322223334445678999999999854
Q ss_pred ccccCCcchhHHhHHHHHHHHHhC-CCCCCCCCC----hHHHHHHHHHH-----------hccccCCCCCCcCCHHHHHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPED----PRNFRKTIDRI-----------RNVQYFLPDYVRVSADCRHL 142 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g-~~Pf~~~~~----~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l 142 (246)
+..-+.. .|.|.||+++++++.| ++||.+-.. ...+...+... .......+.+.-+++++..|
T Consensus 195 g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAl 273 (637)
T COG4248 195 GFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQAL 273 (637)
T ss_pred ccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHH
Confidence 2233334 7999999999999986 999976321 11111111100 00001112234578899999
Q ss_pred HHHhccc--CCCCCCCHHH
Q 025933 143 LSQIFVA--DPSKRIPIPE 159 (246)
Q Consensus 143 i~~~L~~--dp~~R~t~~e 159 (246)
..+|+.. ++.-|||++.
T Consensus 274 F~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 274 FQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHhcccCCCCCCCCHHH
Confidence 9999876 4668999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.82 E-value=6e-09 Score=81.49 Aligned_cols=46 Identities=22% Similarity=0.177 Sum_probs=40.0
Q ss_pred HHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 7 FSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
...+.|++.++.++|. ++|+||||||+||+++ ++. ++|+|||.+..
T Consensus 117 ~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~--~~liDfg~a~~ 163 (187)
T cd05119 117 EELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK--VYIIDVPQAVE 163 (187)
T ss_pred HHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--EEEEECccccc
Confidence 4456778899999999 9999999999999998 444 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-08 Score=79.82 Aligned_cols=45 Identities=24% Similarity=0.225 Sum_probs=39.9
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.++.|++.+|.++|+.+++|||++|.||+++ ++ +++++|||+++.
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 4677889999999999999999999999998 44 499999998874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-08 Score=92.99 Aligned_cols=45 Identities=24% Similarity=0.242 Sum_probs=39.3
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.++.|++.+|.+||+++|+||||||+|||++ ++ .++|+|||+++.
T Consensus 432 ~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 432 ELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 4567888999999999999999999999994 33 399999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-08 Score=79.40 Aligned_cols=46 Identities=22% Similarity=0.228 Sum_probs=39.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++.++..+|.++|.++++|||++|.|||++ ++. ++|+|||.+..
T Consensus 98 ~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 98 LELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 35566788999999999999999999999998 443 99999998874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.8e-07 Score=71.27 Aligned_cols=45 Identities=16% Similarity=0.133 Sum_probs=37.5
Q ss_pred HHHHHHHHHHHHh-HhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCF-YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~l-H~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
....|++.++..+ |..||||+||++.|||+.. + .+.|+|||.+..
T Consensus 128 ~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~--~v~iIDF~qav~ 173 (197)
T cd05146 128 NAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G--KVWFIDVSQSVE 173 (197)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C--cEEEEECCCcee
Confidence 3456788888888 8999999999999999974 3 389999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.2e-07 Score=66.33 Aligned_cols=47 Identities=23% Similarity=0.260 Sum_probs=38.5
Q ss_pred HHHHHHHHHHHHHhHhC---CcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 7 FSSTVMIFTSHHCFYLQ---EICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~---~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.....+++.++.++|.. +++|+|++|.||+++..+. ++++|||.+..
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~~ 138 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEecccccC
Confidence 44566777888888884 6999999999999987544 99999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.4e-06 Score=73.37 Aligned_cols=91 Identities=14% Similarity=0.214 Sum_probs=66.3
Q ss_pred HHHHHHHHHHHHHhH-hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCC
Q 025933 7 FSSTVMIFTSHHCFY-LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH-~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.+.+.||+.||.||| ..+++|.+|.-..|+++..|. .||++|-++........ .....---.|..|+.+.....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~-- 182 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW-- 182 (690)
T ss_pred HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc--
Confidence 456889999999997 567999999999999999887 99999988753221111 111122223566765543332
Q ss_pred cchhHHhHHHHHHHHHhC
Q 025933 85 KISDVWSCGVTLYVMLVG 102 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g 102 (246)
. .|.|-|||++++++.|
T Consensus 183 s-~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 S-IDSWGLGCLIEELFNG 199 (690)
T ss_pred c-hhhhhHHHHHHHHhCc
Confidence 2 6999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-06 Score=67.08 Aligned_cols=43 Identities=30% Similarity=0.380 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHhHhCCc-----ccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 9 STVMIFTSHHCFYLQEI-----CHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~i-----vHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.+.+++.++..||..++ +|+|++|.||+++ ++ +++++|||.+.
T Consensus 88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 35577888999999985 9999999999998 33 38999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.6e-06 Score=69.07 Aligned_cols=46 Identities=20% Similarity=0.135 Sum_probs=38.5
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecC-----CCCCcEEEeccCCcc
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDG-----SPQPRLKICDFGYSK 54 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-----~~~~~vkl~Dfg~s~ 54 (246)
.+.++...+.-||.+||+|+|+++.|||++. ++...+.|+||+.+.
T Consensus 143 ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 143 LIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 4456788889999999999999999999975 234569999999775
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.9e-06 Score=65.50 Aligned_cols=38 Identities=26% Similarity=0.345 Sum_probs=33.0
Q ss_pred HHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 15 TSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 15 ~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..+.-||.+||||+||.++||++.+.. +.++|||++..
T Consensus 103 ~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 103 RLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence 456789999999999999999997654 89999999873
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.6e-06 Score=73.98 Aligned_cols=38 Identities=18% Similarity=0.176 Sum_probs=33.6
Q ss_pred HHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 16 SHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 16 ~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.+..+|..|++|+|+||.||+++.++. ++++|||++..
T Consensus 269 ~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~ 306 (437)
T TIGR01982 269 FLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGR 306 (437)
T ss_pred HHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeE
Confidence 467889999999999999999987765 99999999874
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.4e-06 Score=65.30 Aligned_cols=48 Identities=21% Similarity=0.131 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~ 55 (246)
..+.++...+.-||.+||+|+|+++.|||++.+. ..++.|+||+-++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 3455677888999999999999999999998775 34589999997663
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.79 E-value=3.7e-05 Score=60.30 Aligned_cols=43 Identities=28% Similarity=0.329 Sum_probs=30.8
Q ss_pred HHHHHHHH-HHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 10 TVMIFTSH-HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 10 ~~qil~~l-~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..+++..+ ..+|..||||+||.+.|||++.+ . +.++|||.+..
T Consensus 112 ~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~ 155 (188)
T PF01163_consen 112 LEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVD 155 (188)
T ss_dssp HHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEE
T ss_pred HHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCccee
Confidence 34455533 34689999999999999999876 3 99999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=5.4e-05 Score=58.54 Aligned_cols=43 Identities=28% Similarity=0.234 Sum_probs=34.9
Q ss_pred HHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccC
Q 025933 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKS 55 (246)
Q Consensus 13 il~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~ 55 (246)
+=+.+.-||.++|||+||..+||++.+.+. ..+.++|||++..
T Consensus 122 iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 122 IGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 335667899999999999999999977655 2348999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=5.3e-05 Score=68.56 Aligned_cols=37 Identities=27% Similarity=0.444 Sum_probs=30.4
Q ss_pred HhHhCCcccCCCCCCCEEecCCC--CCcEEEeccCCccC
Q 025933 19 CFYLQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKS 55 (246)
Q Consensus 19 ~lH~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~ 55 (246)
.+...|++|+|+||.||+++.++ .++++++|||++..
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 34568999999999999998765 23599999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=2.2e-05 Score=70.90 Aligned_cols=147 Identities=22% Similarity=0.169 Sum_probs=99.9
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchh
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 88 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 88 (246)
.+..-++.++++|+-.=+||| ||+..... +|+.+|+...........++..+|+.++|||+.....+... .|
T Consensus 341 ~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~ 412 (829)
T KOG0576|consen 341 PLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PD 412 (829)
T ss_pred hhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCCCCCCCCCchhhcccccccC-CC
Confidence 344456788999988778999 88876543 79999999876554445567789999999999999998877 79
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCcCCHHH-HHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 89 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADC-RHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 89 iwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|++|+-..++.-|.+|-..... ... .+.... +.+-.....+... +++...|+..-|..|+..-.++.|.+
T Consensus 413 ~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKv 486 (829)
T KOG0576|consen 413 SGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKV 486 (829)
T ss_pred ccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHH
Confidence 99999877777777766543111 000 000000 0000000111112 24778899999999999999999999
Q ss_pred cccC
Q 025933 166 FLKN 169 (246)
Q Consensus 166 ~~~~ 169 (246)
|...
T Consensus 487 fngC 490 (829)
T KOG0576|consen 487 FNGC 490 (829)
T ss_pred hccC
Confidence 8664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0002 Score=57.25 Aligned_cols=40 Identities=18% Similarity=0.164 Sum_probs=34.5
Q ss_pred HHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 12 qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
++.+++.-+|..|++|+|++|.|+++..++ ++++||+-.+
T Consensus 143 ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 143 KIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 466788999999999999999999998654 8999997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00025 Score=56.40 Aligned_cols=47 Identities=6% Similarity=-0.032 Sum_probs=40.0
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++.++...+.-||..|+.|+|+.+.||+++..+...|+++||--++
T Consensus 132 ~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 132 AMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 45667888999999999999999999999986555569999998665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00099 Score=64.29 Aligned_cols=144 Identities=18% Similarity=0.184 Sum_probs=92.0
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCC---CEEecCCCCCcEEEe--ccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLE---NTLLDGSPQPRLKIC--DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~---Nill~~~~~~~vkl~--Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++++||.|+|++...|.-|... +-..+..+ .+..+ ||+.++............-+..+-++|......+.
T Consensus 291 ~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~ 368 (1351)
T KOG1035|consen 291 LHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAK 368 (1351)
T ss_pred HHHHHhhhHHHHHHhccceeEEecccccccccCccc--eeecchhhhcccccCCCcccchhhcCccccccccccccccch
Confidence 3456889999999986555544433 22222222 24555 88887765544444444556667888887665553
Q ss_pred Cc-chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GK-ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~-~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.. ..|+|.+|.....+..|..+-.-. ..... .++. .......+++.+|+.-++++|+++.+++.
T Consensus 369 ~~r~~dL~~lgll~~~~~~~~~i~~~~-------~~~~~------~l~~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 369 KSRLTDLWCLGLLLLQLSQGEDISEKS-------AVPVS------LLDV--LSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hhhhhHHHHHHHHHhhhhhcCcccccc-------cchhh------hhcc--ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 22 259999999999988876542110 00000 1111 11126788999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
|+|.+..
T Consensus 434 ~~f~~~~ 440 (1351)
T KOG1035|consen 434 HPFLRFP 440 (1351)
T ss_pred chhcccc
Confidence 9997543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00018 Score=71.09 Aligned_cols=134 Identities=14% Similarity=0.098 Sum_probs=86.7
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCccC-CCCCCCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCC
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA 103 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 103 (246)
.+|+++|+.|.+|..+.. ||++++|+.+. ..........++++.|+.|++...-.++.+ +|+|..|+.+|....|.
T Consensus 1361 ~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred chhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhccc
Confidence 689999999999988776 99999999983 222223345578889999999877777655 89999999999998887
Q ss_pred CCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 104 YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 104 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
.+|. ......++.+...........-.|.++-.....+|-..-..||.-...+..+.|
T Consensus 1438 ~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1438 AYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 7763 233333333222111111111223344444444455555677776666665554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.019 Score=51.36 Aligned_cols=124 Identities=16% Similarity=0.195 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcch
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
+.+.|+..||.++|+.|+.=+-|.|.+||+.++. +++|+..|+........ + +.+.+. ++-
T Consensus 397 ~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~------~-------~~le~~----Qq~ 457 (655)
T KOG3741|consen 397 SYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP------T-------EPLESQ----QQN 457 (655)
T ss_pred HHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC------C-------cchhHH----hhh
Confidence 3467888999999999999899999999998665 48888887665322211 1 112111 226
Q ss_pred hHHhHHHHHHHHHhCCCC-CCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 88 DVWSCGVTLYVMLVGAYP-FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 88 DiwslG~il~~ll~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
|.-.||.++..|.+|..= +... ..... .+..+ ...++.+++++|.-+...++.. -++.+++.+
T Consensus 458 D~~~lG~ll~aLAt~~~ns~~~d-~~~~s--~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 458 DLRDLGLLLLALATGTENSNRTD-STQSS--HLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhhccccccccc-chHHH--HHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 888999999999998532 2111 11111 01111 1257899999999999999886 578888765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0039 Score=51.32 Aligned_cols=40 Identities=23% Similarity=0.272 Sum_probs=32.4
Q ss_pred HHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 13 il~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
|+.-+.-+...||||+|+++-||+++.++. +.++||--+.
T Consensus 211 il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 211 ILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred HHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 445555555899999999999999998877 9999996544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.009 Score=47.40 Aligned_cols=33 Identities=18% Similarity=0.330 Sum_probs=26.1
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++|+|+++.||+++.+....+.|+||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 568999999999999874222378999997763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.017 Score=47.08 Aligned_cols=40 Identities=20% Similarity=0.243 Sum_probs=31.3
Q ss_pred HHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 13 IFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 13 il~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
+++.+.-|.. .++||+||+.-|||+. .+. +.++|||-|..
T Consensus 175 ~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~ 215 (268)
T COG1718 175 VVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccc
Confidence 4455555555 8999999999999998 333 89999997763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.016 Score=49.10 Aligned_cols=30 Identities=27% Similarity=0.433 Sum_probs=24.7
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++||+|+.|.||+++.+.. .-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~--~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRL--SGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCce--EEEEeccccc
Confidence 47999999999999985532 4799999765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.028 Score=50.91 Aligned_cols=34 Identities=21% Similarity=0.258 Sum_probs=29.3
Q ss_pred HhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCC
Q 025933 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 56 (246)
Q Consensus 21 H~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~ 56 (246)
-..|++|.|.+|.||+++.++. +.+.|||+....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCc--EEEEcCcceecC
Confidence 3589999999999999998865 999999997643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.036 Score=46.83 Aligned_cols=30 Identities=30% Similarity=0.493 Sum_probs=25.6
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.+++|+|+++.||+++.++. +.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 57999999999999987653 6899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.089 Score=44.29 Aligned_cols=29 Identities=31% Similarity=0.684 Sum_probs=24.4
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.+++|+|+.+.||+++. +. +.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999986 33 7899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.038 Score=44.53 Aligned_cols=30 Identities=27% Similarity=0.525 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEecC-CCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDG-SPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+.+.|||++. ++. +.|+||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~--~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNS--VKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCC--EEEEEcccCC
Confidence 35899999999999986 343 8999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.031 Score=45.29 Aligned_cols=31 Identities=26% Similarity=0.279 Sum_probs=24.4
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.+++|+|+.+.|||++.... .-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i--~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRL--SAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCE--EEEEeCcccCc
Confidence 35899999999999975432 46999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.048 Score=45.65 Aligned_cols=30 Identities=30% Similarity=0.483 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.+++|+|+.|.|||++.++. +.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 46999999999999987543 5799998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.034 Score=46.75 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=24.7
Q ss_pred CcccCCCCCCCEEecCC----CCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGS----PQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~----~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.+.|||++.+ +. ++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKK--LVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCC
Confidence 58999999999999864 44 8999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.046 Score=46.52 Aligned_cols=18 Identities=39% Similarity=0.471 Sum_probs=15.0
Q ss_pred CCcccCCCCCCCEEecCC
Q 025933 23 QEICHRDLKLENTLLDGS 40 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~ 40 (246)
.+.+|-||||.|||+-++
T Consensus 302 ~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 302 DNFLHVDLKPDNILIFDS 319 (444)
T ss_pred ceeeeccCCCCcEEEecC
Confidence 358999999999999543
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.12 E-value=0.044 Score=43.20 Aligned_cols=32 Identities=22% Similarity=0.318 Sum_probs=25.5
Q ss_pred CCcccCCCCCCCEEecCCCCC---cEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQP---RLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~---~vkl~Dfg~s~ 54 (246)
..++|+|+.+.||++..++.+ .+.++||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 468999999999999754322 48899998776
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.06 Score=42.12 Aligned_cols=28 Identities=25% Similarity=0.400 Sum_probs=23.9
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.+|+|+.|.|+++..++ ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 58999999999997654 88999998764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.029 Score=44.71 Aligned_cols=31 Identities=35% Similarity=0.433 Sum_probs=19.6
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+.|.|||++..+ +++.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~-~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSD-GRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESST-TEEEE--GTT-E
T ss_pred cEEEEeccccccceeeecc-ceeEEEecccce
Confidence 5699999999999998322 236799998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.045 Score=46.74 Aligned_cols=33 Identities=33% Similarity=0.445 Sum_probs=23.8
Q ss_pred CCcccCCCCCCCEEecCCCC----------------CcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQ----------------PRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~----------------~~vkl~Dfg~s~~ 55 (246)
.+.+|-||||.|||+-++.. .+++|.||.+|..
T Consensus 298 ~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 298 TNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred ceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 35899999999999843322 1357788887763
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.59 E-value=0.063 Score=43.60 Aligned_cols=30 Identities=23% Similarity=0.240 Sum_probs=24.7
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+.|.|||++.+.. +.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~--~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKF--SGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcE--EEEEEccccc
Confidence 34899999999999987543 6899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.06 Score=44.14 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=24.6
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
.++|+|+.|.||+++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccCc
Confidence 589999999999998754 68999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.15 Score=39.99 Aligned_cols=49 Identities=10% Similarity=-0.028 Sum_probs=39.9
Q ss_pred HHHHHHHHHHHHHHHHhHh---CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 4 VCYFSSTVMIFTSHHCFYL---QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~---~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..-+.+++++++.+.+++. ..+.-.|++++|+-++.++. +|++|...+.
T Consensus 59 ~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 59 EQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 3456778888998888887 44777999999999997766 9999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.21 Score=39.55 Aligned_cols=32 Identities=25% Similarity=0.308 Sum_probs=26.3
Q ss_pred HHhHhCCcccCCCCCCCEEecCCCC--CcEEEec
Q 025933 18 HCFYLQEICHRDLKLENTLLDGSPQ--PRLKICD 49 (246)
Q Consensus 18 ~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~D 49 (246)
.||-.++|+.+||+|.||++..... .++.|+|
T Consensus 132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 7888999999999999999965443 2477888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.02 E-value=0.16 Score=46.20 Aligned_cols=34 Identities=18% Similarity=0.199 Sum_probs=28.4
Q ss_pred hCCcccCCCCCCCEEecCC--CCCcEEEeccCCccC
Q 025933 22 LQEICHRDLKLENTLLDGS--PQPRLKICDFGYSKS 55 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s~~ 55 (246)
..|++|+|-+|.||++..+ +..++.+.|||+...
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 4679999999999999853 345699999999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.052 Score=48.85 Aligned_cols=80 Identities=19% Similarity=0.210 Sum_probs=55.4
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-----------CCcCCHHHHHHHHHhcccCCCCC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-----------YVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R 154 (246)
++||||+|.++.++..|..-|......+....+. +. +..+. ...++....++.++|+-..|..|
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~-k~----~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILL-KY----YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHH-Hh----ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccc
Confidence 4899999999999999877665433332222211 11 11111 11356677889999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 025933 155 IPIPEIKKHPWFLKNL 170 (246)
Q Consensus 155 ~t~~e~l~hp~~~~~~ 170 (246)
|...++.+++-|...+
T Consensus 186 ~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEVY 201 (725)
T ss_pred cchhHHhcCccHHHHH
Confidence 9999999999886653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.90 E-value=0.067 Score=42.51 Aligned_cols=29 Identities=34% Similarity=0.694 Sum_probs=18.5
Q ss_pred CcccCCCCCCCEEe-cCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLL-DGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill-~~~~~~~vkl~Dfg~s~ 54 (246)
.++|.|+.+.|||+ ..++. ++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~--~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGE--VKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSC--EEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCe--EEEecHHHHh
Confidence 47899999999999 44444 9999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.14 Score=41.27 Aligned_cols=41 Identities=22% Similarity=0.092 Sum_probs=33.8
Q ss_pred HHHHHHHHHHhHh--CCcccCCCCCCCEEecCCCCCcEEEeccCC
Q 025933 10 TVMIFTSHHCFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGY 52 (246)
Q Consensus 10 ~~qil~~l~~lH~--~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~ 52 (246)
+...+.+|.-+|+ .+.+|+|..|+||+-+..|. +||.|-+-
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 4444788888995 35999999999999998887 99999763
|
The function of this family is unknown. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=92.62 E-value=0.1 Score=42.15 Aligned_cols=28 Identities=21% Similarity=0.268 Sum_probs=23.7
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 468999999999997654 7899998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.42 E-value=0.19 Score=42.51 Aligned_cols=29 Identities=21% Similarity=0.256 Sum_probs=25.4
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
+++|+|+.+.|+|++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999987765 8899998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.23 E-value=0.12 Score=50.92 Aligned_cols=33 Identities=27% Similarity=0.445 Sum_probs=26.4
Q ss_pred CCcccCCCCCCCEEecCCCCCcEE-EeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLK-ICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vk-l~Dfg~s~~ 55 (246)
+++||.|+.+.|||++.+...++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 579999999999999876532355 999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.21 E-value=0.26 Score=42.16 Aligned_cols=29 Identities=31% Similarity=0.431 Sum_probs=24.4
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
|||+|+.|.||+++.... -+.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999987653 26799999765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.27 Score=42.41 Aligned_cols=31 Identities=29% Similarity=0.654 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+++.|||++... ..+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 3589999999999997532 249999998775
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.81 E-value=0.14 Score=42.79 Aligned_cols=32 Identities=22% Similarity=0.322 Sum_probs=24.8
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++|+|++|.|||++.++. ..-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence 35899999999999986432 246999997764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.56 E-value=0.36 Score=40.14 Aligned_cols=29 Identities=34% Similarity=0.524 Sum_probs=25.0
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
-++|.|+.|.|+|.++.+. ++|+||-.|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~--l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGG--LFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCc--EEEEecccCC
Confidence 4899999999999987555 9999997665
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.13 Score=43.10 Aligned_cols=31 Identities=23% Similarity=0.442 Sum_probs=25.1
Q ss_pred CcccCCCCCCCEEecCCCCC---cEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQP---RLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~---~vkl~Dfg~s~ 54 (246)
-++|+|++..|||+..+..+ .+++.||.+++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 38999999999999665432 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.4 Score=41.58 Aligned_cols=28 Identities=36% Similarity=0.647 Sum_probs=25.0
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..=||++...||||+ .|+ |.|+||.+++
T Consensus 342 ~fehrnlt~~niLId-~Gn--vtLIDfklsR 369 (488)
T COG5072 342 PFEHRNLTLDNILID-EGN--VTLIDFKLSR 369 (488)
T ss_pred Ccccccccccceeee-cCc--eEEEEeeeee
Confidence 467999999999999 666 9999999998
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.66 E-value=0.23 Score=42.25 Aligned_cols=33 Identities=18% Similarity=0.294 Sum_probs=28.1
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 57 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~ 57 (246)
..++|+|+.+.|++++.... +-+.||+++..+.
T Consensus 198 ~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCe--eEEEeccccccCC
Confidence 35899999999999998776 8899999987543
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.60 E-value=0.33 Score=47.77 Aligned_cols=33 Identities=21% Similarity=0.216 Sum_probs=25.6
Q ss_pred hCCcccCCCCCCCEEecCCCCCc---EEEeccCCcc
Q 025933 22 LQEICHRDLKLENTLLDGSPQPR---LKICDFGYSK 54 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~~~~~---vkl~Dfg~s~ 54 (246)
..++||.|+++.|||++.+..+. .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 36799999999999998653211 3699999765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.50 E-value=0.44 Score=41.92 Aligned_cols=30 Identities=17% Similarity=0.267 Sum_probs=25.1
Q ss_pred hCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 22 LQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
...++|+|+.+.|||+..+. ++++||-++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~~---~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEEE---TKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCCC---cEEEeccccc
Confidence 35699999999999997653 8999998765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=90.30 E-value=0.57 Score=40.11 Aligned_cols=29 Identities=31% Similarity=0.510 Sum_probs=23.7
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
++|.|+.+.|||++.++ ..++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 78999999999997432 239999998775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.86 E-value=0.56 Score=40.05 Aligned_cols=28 Identities=18% Similarity=0.124 Sum_probs=23.2
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++||+|+.+.|||++ + . +.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~--~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G--PHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-C--cEEEeCCCCC
Confidence 4689999999999995 3 3 6799999765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=88.66 E-value=0.33 Score=42.03 Aligned_cols=32 Identities=16% Similarity=0.203 Sum_probs=25.8
Q ss_pred HhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 21 H~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
+...++|+|+.+.||+++.++ ++++|+.++..
T Consensus 190 ~~~~llHGDl~~gNi~~~~~~---~~~iD~e~~~~ 221 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEHE---TKVIDPEFAFY 221 (370)
T ss_pred CcceeeeccCCcccEEEcCCC---CEEEcCccccc
Confidence 345699999999999997654 68999987653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=88.42 E-value=0.97 Score=38.79 Aligned_cols=34 Identities=15% Similarity=0.201 Sum_probs=28.6
Q ss_pred HHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCc
Q 025933 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS 53 (246)
Q Consensus 18 ~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s 53 (246)
--|-.+|+||+|.+-=||++..++. ++++||--.
T Consensus 216 v~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQm 249 (465)
T KOG2268|consen 216 VRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQM 249 (465)
T ss_pred HHHHHcCceecccchheeEEecCCC--EEEeechHh
Confidence 4556899999999999999987665 999999644
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.04 E-value=1.2 Score=39.07 Aligned_cols=29 Identities=21% Similarity=0.346 Sum_probs=24.6
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
+..+|+||.|.|||++.++ +|++|.-++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~~---~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKNDS---TKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCCc---eEEEcccccc
Confidence 4589999999999998764 7999987765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=84.11 E-value=0.85 Score=44.12 Aligned_cols=33 Identities=24% Similarity=0.463 Sum_probs=25.5
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCccCC
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 56 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~ 56 (246)
.+||+|+++.|||++......+-|.||.++..+
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 599999999999998543222479999987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 246 | ||||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-84 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-83 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-82 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-82 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-78 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-77 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-28 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-18 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-15 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-15 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-15 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-15 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-15 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-15 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-15 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-15 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-15 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-15 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-15 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-04 |
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-103
Identities = 139/222 (62%), Positives = 170/222 (76%), Gaps = 4/222 (1%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
ICHRDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDG
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144
KI+DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256
Query: 145 QIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204
+IFVADP+ RI IPEIK H WFLKNLP +++ T + +QP QS++ IM+II EA
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEA 316
Query: 205 KMPGEATKVAGQGAAGASD----PDDMEGDIESEIDASGDYM 242
+P + D DD + + E +ID+SG+ +
Sbjct: 317 TIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEIV 358
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-75
Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 14/193 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKE 81
I HRD+K EN LLD + LKI DFG + +++ GT Y+APE+L R+E
Sbjct: 126 ITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCR 140
+ + DVWSCG+ L ML G P++ P D + + ++ + +L + ++ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI----IEIEKTNYKEAGRDQPTQSVEE 196
LL +I V +PS RI IP+IKK W+ K L K + + +G + QS +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299
Query: 197 IMRIIQEAKMPGE 209
+ ++ PG
Sbjct: 300 FSPVNSASRTPGS 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-70
Identities = 56/154 (36%), Positives = 84/154 (54%), Gaps = 10/154 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKE 81
I HRD+K EN LLD + LKI DFG + +++ GT Y+APE+L R+E
Sbjct: 126 ITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCR 140
+ + DVWSCG+ L ML G P++ P D + + ++ + +L + ++ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
LL +I V +PS RI IP+IKK W+ K L K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-56
Identities = 57/153 (37%), Positives = 81/153 (52%), Gaps = 17/153 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYS-----KSGLLHSQPKSTVGTPAYIAPEVL 77
Q+I HRD+K N L+ +KI DFG S LL + TVGTPA++APE L
Sbjct: 156 QKIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSN----TVGTPAFMAPESL 209
Query: 78 A--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
+ RK + GK DVW+ GVTLY + G PF D +I++ PD +
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE----RIMCLHSKIKSQALEFPDQPDI 265
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
+ D + L++++ +P RI +PEIK HPW +
Sbjct: 266 AEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 9e-56
Identities = 59/152 (38%), Positives = 82/152 (53%), Gaps = 16/152 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ HRDLK EN LLD KI DFG S L + + G+P Y APEV++ +
Sbjct: 132 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLRT----SCGSPNYAAPEVISGR 185
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y G D+WSCGV LY +L G PF+D P F+K IR +++P+Y ++
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVA 239
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
LL + DP KR I +I++H WF ++LP
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-55
Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144
DVWS GV LY ++ G+ PF+ + + +Y +P Y +S DC +LL
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLK 246
Query: 145 QIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIM 198
+ V +P KR + +I K W ++ ++ + E D Q +IM
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP----FVEPELDISDQKRIDIM 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 4e-55
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 83
I HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ R +
Sbjct: 133 ILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ SDVWS G Y +L+G PF+ + T++++ Y +P ++ S + + L+
Sbjct: 191 LE-SDVWSLGCMFYTLLIGRPPFDTD----TVKNTLNKVVLADYEMPSFL--SIEAKDLI 243
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176
Q+ +P+ R+ + + HP+ +N + +
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-55
Identities = 68/164 (41%), Positives = 92/164 (56%), Gaps = 16/164 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 80
I HRDLK EN LLD + +KI DFG S L + + G+P Y APEV+ K
Sbjct: 129 IVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLKT----SCGSPNYAAPEVINGK 182
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y G DVWSCG+ LYVMLVG PF+D P F+K + + Y +PD+ +S +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQ 236
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 184
L+ ++ VADP +RI I EI++ PWF NLP + +E+
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-55
Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 83
+ HRD+K EN LL LKI DFG+S S ++ + GT Y+ PE++ + +D
Sbjct: 130 VIHRDIKPENLLLGS--AGELKIADFGWSV--HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K+ D+WS GV Y LVG PFE +++T RI V++ PD+V + R L+
Sbjct: 186 EKV-DLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVEFTFPDFV--TEGARDLI 238
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN 181
S++ +PS+R + E+ +HPW N K K +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-55
Identities = 47/156 (30%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLLHSQPKSTVGTPAYIAPEVL 77
I H+D+K N LL LKI G + + + G+PA+ PE+
Sbjct: 130 IVHKDIKPGNLLLTT--GGTLKISALGVAEALHPFAADDTCRT----SQGSPAFQPPEIA 183
Query: 78 A-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
+ G D+WS GVTLY + G YPFE N K + I Y +P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD--CG 237
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
LL + +P+KR I +I++H WF K P
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-54
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 30/192 (15%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIA 73
+ + ICHRD+K N L+D R+K+ DFG S+ + + GT ++
Sbjct: 165 SYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGESEYMVDKKIKG----SRGTYEFMP 218
Query: 74 PEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
PE + + Y+G D+WS G+ LYVM PF + + + IR P
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK---ISLVELFNNIRTKNIEYPLD 275
Query: 133 VR-----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
+S + L +P++RI + KH W +++
Sbjct: 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLR 335
Query: 176 EIEKTNYKEAGR 187
E K YK+ +
Sbjct: 336 EFSKELYKKRKK 347
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-54
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 83
+ HRD+K EN L+ + LKI DFG+S S + T+ GT Y+ PE++ K +D
Sbjct: 135 VIHRDIKPENLLMGY--KGELKIADFGWSV--HAPSLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K+ D+W GV Y LVG PF+ P + +T RI NV P ++ S + L+
Sbjct: 191 EKV-DLWCAGVLCYEFLVGMPPFDSP----SHTETHRRIVNVDLKFPPFL--SDGSKDLI 243
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
S++ P +R+P+ + +HPW N +
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 62/183 (33%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 80
+ HRDLK EN LLD KI DFG S L + + G+P Y APEV++ +
Sbjct: 137 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLRT----SCGSPNYAAPEVISGR 190
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 140
Y G D+WS GV LY +L G PF+D P F+K I + ++ P Y ++
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVI 244
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 200
LL + DP KR I +I++H WF ++LPK + + + D+ + V E
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304
Query: 201 IQE 203
+E
Sbjct: 305 SEE 307
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-53
Identities = 55/166 (33%), Positives = 74/166 (44%), Gaps = 22/166 (13%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 73
HC + + HRD+K EN L+D + LK+ DFG K + GT Y
Sbjct: 163 RHC-HNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTD----FDGTRVYSP 216
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
PE + Y G+ + VWS G+ LY M+ G PFE + I Q F
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EEIIRGQVFFRQR- 265
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIE 178
VS++C+HL+ PS R EI+ HPW LP+E EI
Sbjct: 266 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-52
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 11/152 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 83
+ HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL++K +
Sbjct: 136 VIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ DVWS G +Y +LVG PFE ++T RI+ +Y +P ++ + L+
Sbjct: 194 FE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKHI--NPVAASLI 246
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKN-LPKEI 174
++ DP+ R I E+ +F +P +
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-52
Identities = 47/168 (27%), Positives = 65/168 (38%), Gaps = 21/168 (12%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 73
HC + + + HRD+K EN L+D K+ DFG GT Y
Sbjct: 153 QHC-HSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYTD----FDGTRVYSP 206
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
PE ++R +Y + VWS G+ LY M+ G PFE I + P +
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPAH- 255
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN 181
VS DC L+ + PS R + EI PW + K
Sbjct: 256 -VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-52
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 11/152 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 83
+ HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL++K +
Sbjct: 162 VIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
+ DVWS G +Y +LVG PFE ++T RI+ +Y +P ++ + L+
Sbjct: 220 FE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKHI--NPVAASLI 272
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKN-LPKEI 174
++ DP+ R I E+ +F +P +
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-50
Identities = 44/214 (20%), Positives = 79/214 (36%), Gaps = 30/214 (14%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYI 72
+ L++I HRD+K EN ++ +K+ DFG + + L ++ GT Y
Sbjct: 144 GYL-RLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLERGKLFYT----FCGTIEYC 196
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
APEVL Y G ++WS GVTLY ++ PF + ++ P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYL 246
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQ 192
VS + L+S + P +R + ++ PW + + +Y + +
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP-------VNLADYTWEEVFRVNK 297
Query: 193 SVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDD 226
++ + VA +
Sbjct: 298 PESGVLSAASLEMGNRSLSDVAQAQELCGGEGHH 331
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-43
Identities = 51/207 (24%), Positives = 74/207 (35%), Gaps = 25/207 (12%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE 81
I H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 129 IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 82 YD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
SDVWS G LY M G PF+ N + I + + +
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEIEF 242
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LKNLPKEIIEIEKTNYKEA 185
D + +L DP +RI IPE+ HP+ + + K E K +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 302
Query: 186 GRDQPTQSVEEIMRIIQEAKMPGEATK 212
S+ + + + E GE+
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-----KSTVGTPAYIAPEVL 77
Q ICHRD+K EN L + +K+ DFG SK + + GTP ++APEVL
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 78 --ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYV 133
+ Y K D WS GV L+++L+GA PF D + + N + P+Y
Sbjct: 247 NTTNESYGPKC-DAWSAGVLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYN 301
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+S R LLS + + +R +HPW + K
Sbjct: 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-42
Identities = 46/175 (26%), Positives = 65/175 (37%), Gaps = 20/175 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 79
I H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 146 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 80 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
SDVWS G LY M G PF+ N + I + + +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEI 259
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 184
D + +L DP +RI IPE+ HP+ + ++ K +E
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ-THPVNQMAKGTTEE 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 52/209 (24%), Positives = 74/209 (35%), Gaps = 25/209 (11%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 79
I H DLK N L+ LK+ DFG + S VG Y+ PE +
Sbjct: 174 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 80 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
SDVWS G LY M G PF+ + + I N +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEF 289
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LKNLPKEIIEIEKTNYK 183
PD D + +L DP +RI IPE+ HP+ + + K E K
Sbjct: 290 PDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 347
Query: 184 EAGRDQPTQSVEEIMRIIQEAKMPGEATK 212
+ S+ + + + E GE+
Sbjct: 348 QLVGLNSPNSILKAAKTLYEHYSGGESHN 376
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-41
Identities = 42/185 (22%), Positives = 70/185 (37%), Gaps = 36/185 (19%)
Query: 21 YLQE--ICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
+L+E I HR++K N + Q K+ DFG ++ Q S GT Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 77 LAR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
R K+Y + D+WS GVT Y G+ PF E PR ++ + +I +
Sbjct: 187 YERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 129 -------------------LPDYVRVSADCR----HLLSQIFVADPSKRIPIPEIKKHPW 165
+P +S + +L+ I AD K +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 166 FLKNL 170
+ +
Sbjct: 306 DILHR 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-40
Identities = 22/160 (13%), Positives = 47/160 (29%), Gaps = 26/160 (16%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA------ 78
+ H L+ + +LD + + + F + + + + PE+ A
Sbjct: 227 LVHTYLRPVDIVLD--QRGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRATIS 281
Query: 79 ----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 134
R+ D W+ G+ +Y + P +N
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN---------- 331
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
+ R LL R+ + + P + + L E+
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTEL 370
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-40
Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 17 HHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 75
+C + + HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+
Sbjct: 120 AYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-V 133
VL Y + D WS GV +YV+L G PF P D K IR + F +
Sbjct: 179 VL-EGLYGPEC-DEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWL 232
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
VS L+ ++ P +RI + +H WF K L +
Sbjct: 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-40
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 9/152 (5%)
Query: 17 HHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 75
+ + Q + H+DLK EN L SP +KI DFG ++ + GT Y+APE
Sbjct: 138 AYF-HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVR 134
V +++ K D+WS GV +Y +L G PF +K + + +
Sbjct: 197 VF-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRP 250
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
++ LL Q+ DP +R ++ H WF
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 25/171 (14%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---------------KSTVG 67
Q I HRDLK N +D S +KI DFG +K+ S +G
Sbjct: 135 QGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
T Y+A EVL + + D++S G+ + M+ YPF + ++R+V
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM---ERVNILKKLRSVSI 246
Query: 128 FLPDYV--RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176
P + ++ + DP+KR + W E+I+
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 50/169 (29%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FY EI HRDLK EN LL+ ++I DFG +K S+
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARAN 190
Query: 66 --VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
VGT Y++PE+L K K SD+W+ G +Y ++ G PF N +I
Sbjct: 191 SFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKII 245
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP------EIKKHPWF 166
++Y P+ R L+ ++ V D +KR+ +K HP+F
Sbjct: 246 KLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 57/164 (34%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 21 YL--QEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 78 A---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 132
Y+ + D WS GV L++ L G PF + + + D+I + +Y F+P+
Sbjct: 314 VSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVW 369
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176
VS L+ ++ V DP R E +HPW K +
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 57/191 (29%), Positives = 80/191 (41%), Gaps = 8/191 (4%)
Query: 25 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 84 --GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 139
+ D WS GV L++ L G PF + + D+I + +Y F+P+ VS
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 251
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMR 199
L+ ++ V DP R E +HPW K + + E+ + R
Sbjct: 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSR 311
Query: 200 IIQEAKMPGEA 210
A
Sbjct: 312 KRPREGEAEGA 322
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-38
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K D+W+CGV LY++LVG PF D + R + + I+ Y + V+ + +
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 240
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171
L+ + +P KRI + K PW
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 44/167 (26%), Positives = 61/167 (36%), Gaps = 22/167 (13%)
Query: 21 YL--QEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL I HRDLK EN +L G + KI D GY+K VGT Y+APE+L
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------- 128
+K+Y + D WS G + + G PF P + + N
Sbjct: 196 EQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 129 -----LPDYVRVS----ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP +S L + + +R P+ F
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-38
Identities = 51/149 (34%), Positives = 73/149 (48%), Gaps = 7/149 (4%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 82
I HRD+K EN L LK+ DFG++K ++ TP Y+APEVL ++Y
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKY 206
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
D D+WS GV +Y++L G PF RIR QY F VS D +
Sbjct: 207 DKSC-DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
L+ + DP++R+ I + HPW ++
Sbjct: 266 QLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-38
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 82
+ HRDLK EN L D + +KI DFG+++ +QP T T Y APE+L + Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI---DRIRNVQY-FLPDY-VRVSA 137
D D+WS GV LY ML G PF+ + + +I+ + F + VS
Sbjct: 187 DESC-DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
+ + L+ + DP+KR+ + ++ + W
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRD+K EN LL + + +KI DFG S + + +GT YIAPEVL +K+Y+
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKKYN 225
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K DVWSCGV +Y++L G PF +N + I ++ +Y F + +S + +
Sbjct: 226 EK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
L+ + D +KR E W K
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-37
Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD- 83
I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++ D
Sbjct: 145 IVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 84 ----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSA 137
GK D+WS GV +Y +L G+ PF + R I + Y F S
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYSD 258
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
+ L+S+ V P KR E HP+F + + +E+
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 26/160 (16%), Positives = 49/160 (30%), Gaps = 11/160 (6%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
LQ + H +N + P RL + D + ++ ++ Y E L
Sbjct: 209 NLQSKGLVHGHFTPDNLFIM--PDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREFLN 264
Query: 79 RKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF---RKTIDRIRNVQYFLPDYVR 134
+ W G+++Y + PF R ++
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
+ + L+ + D +R+ E + P F L EI
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF-LQLQNEI 363
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 41/218 (18%), Positives = 76/218 (34%), Gaps = 36/218 (16%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPR--LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
+L+E I HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 77 LAR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
R K+Y + D+WS GVT Y G+ PF E PR ++ + +I +
Sbjct: 187 YERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 129 -------------------LPDYVRVSADCR----HLLSQIFVADPSKRIPIPEIKKHPW 165
+P +S + +L+ I AD K +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 166 FLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
+ + + + + ++ +
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYK 343
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-37
Identities = 56/152 (36%), Positives = 77/152 (50%), Gaps = 9/152 (5%)
Query: 25 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL R YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K DVWS GV LY++L G PF + ++ + +Y F +S D +
Sbjct: 201 EKC-DVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKD 255
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
L+ ++ PS RI + +HPW K +E
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 57/160 (35%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 17 HHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 75
+ + I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPE
Sbjct: 135 TYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-V 133
VL R YD K DVWS GV LY++L G PF +N + R+ +Y F
Sbjct: 194 VL-RGTYDEKC-DVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWR 247
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
+S D + L+ ++ PS RI + +HPW K +
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 16/211 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I H D+K EN + + +KI DFG + K T T + APE++ R+ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 142
+D+W+ GV YV+L G PF +D +T+ ++ + F D VS + +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 143 LSQIFVADPSKRIPIPEIKKHPWF-------LKNLPKEIIEIEKTNYKEAGRDQPTQSVE 195
+ + +P KR+ + + +HPW +P + KE D P
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPA-PQP 343
Query: 196 EIMRIIQEAKMPGEATKVAGQGAAGASDPDD 226
I RI + + + Q D +
Sbjct: 344 AIGRIANFSSLR-KHRPQEYQIYDSYFDRKE 373
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-37
Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 4/148 (2%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRD+K EN L P LK+ DFG++K H+ + TP Y+APEVL ++YD
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVSADCRH 141
D+WS GV +Y++L G PF RIR QY P+ VS + +
Sbjct: 242 KSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169
L+ + +P++R+ I E HPW +++
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-37
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 25 ICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 80
+ HRDLK N L G+P+ ++ICDFG++K + T T ++APEVL R+
Sbjct: 137 VVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSAD 138
YD D+WS GV LY ML G PF + D + + RI + ++ Y VS
Sbjct: 196 GYDAAC-DIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 139 CRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ L+S++ DP +R+ + +HPW
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 57/158 (36%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRDLK EN LL +KI DFG S + K +GT YIAPEVL RK+YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K DVWS GV L+++L G PF + ++ + ++ +Y F VS +
Sbjct: 216 EKC-DVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 179
L+ Q+ D +RI + +HPW + K+ IE
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIEL 308
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-37
Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 27/166 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FYL E+ +RDLK EN LLD + +K+ DFG SK + H + +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 67 -GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GT Y+APEV+ R+ + + +D WS GV ++ ML G PF+ ++ ++T+ I
Sbjct: 187 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKA 241
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ +P + +S + + LL +F +P+ R+ + EIK+H +F
Sbjct: 242 KLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 54/153 (35%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 25 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL YD
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYD 205
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K DVWS GV LY++L G PF N + ++ +Y F +VS +
Sbjct: 206 EKC-DVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
L+ ++ PS RI + H W ++I
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-37
Identities = 51/153 (33%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 82
I HRDLK EN L ++ I DFG SK + + + GTP Y+APEVLA+K Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
K D WS GV Y++L G PF + + + F K I+ Y F + +S +
Sbjct: 185 -SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAK 239
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
+ + DP++R + HPW N
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 17 HHC----FYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPA 70
C + HRDLK N LDG +K+ DFG ++ L H K+ VGTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARI-LNHDTSFAKTFVGTPY 181
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL 129
Y++PE + R Y+ K SD+WS G LY + PF + ++ +IR ++ +
Sbjct: 182 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRI 236
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
P R S + +++++ R + EI ++P L++
Sbjct: 237 PY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 8/159 (5%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI- 210
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
+D+W+ G+ Y++L PF ++ + I V + + VS
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQLATD 266
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT 180
+ + V +P KR H W + + + E+T
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 25 ICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++ +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
G +D+WS GV Y++L GA PF ++T+ I V Y F ++ + S +
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTSELAK 250
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
+ ++ V + KR+ I E +HPW ++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 25 ICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++ +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
G +D+WS GV Y++L GA PF ++T+ I +V Y F ++ S +
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTSELAK 250
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166
+ ++ V + KR+ I E +HPW
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 40/157 (25%), Positives = 61/157 (38%), Gaps = 17/157 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----------VGTPAYIAP 74
HRDLK N LL QP + D G +H + T +Y AP
Sbjct: 155 YAHRDLKPTNILLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 75 EVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
E+ + + + + +DVWS G LY M+ G P++ + Q +P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQNQLSIPQS 269
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
R S+ LL+ + DP +R IP + L+
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-36
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 25 ICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++ +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
G +D+WS GV Y++L GA PF ++T+ I V Y F +Y S +
Sbjct: 189 -GLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
+ ++ V DP +R+ I + +H W + +
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 11/156 (7%)
Query: 25 ICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKE 81
I H DLK EN +L P+PR+KI DFG + + K+ GTP ++APE++ +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 139
G +D+WS GV Y++L GA PF ++T+ + V Y F +Y SA
Sbjct: 194 L-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTSALA 248
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
+ + ++ V DP KR+ I + +HPW ++ +
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 44/193 (22%), Positives = 71/193 (36%), Gaps = 26/193 (13%)
Query: 17 HHCFYLQE-ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---------- 65
H + I HRDLK+EN LL K+CDFG + + + +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTI--KLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 66 ---VGTPAYIAPEV--LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 120
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AKL 259
Query: 121 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT 180
RI N +Y +P + L+ + +P +R+ I E+ + + T
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 181 NYKEAGRDQPTQS 193
E + +
Sbjct: 320 ELLEQNGGYGSAT 332
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 25 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
K D+W+CGV LY++LVG PF D + R + + I+ Y + V+ + +
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 263
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169
L+ + +P KRI + K PW
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I H DLK EN L ++KI DFG ++ + K GTP ++APEV+ +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-FVS 266
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 142
+D+WS GV Y++L G PF D +T++ I ++ + +S + +
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAKEF 322
Query: 143 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 179
+S++ + + S RI E KHPW + + +K
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-36
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YLQ I HRD+K +N LLD + I DF + +Q + GT Y+APE+ +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 79 RKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
++ G D WS GVT Y +L G P+ + ++ + P S
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPSA--WS 244
Query: 137 ADCRHLLSQIFVADPSKRI-PIPEIKKHPWF 166
+ LL ++ +P +R + +++ P+
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-36
Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 27/166 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
CFYL EI +RDLK EN +L+ Q +K+ DFG K + T
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 67 -GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GT Y+APE+L R + + D WS G +Y ML GA PF N +KTID+I
Sbjct: 182 CGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKC 236
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ LP Y ++ + R LL ++ + + R+ E++ HP+F
Sbjct: 237 KLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 56/154 (36%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 141
G D+WS G+ Y++L G PF D R + RI N +Y F+ + VS + +
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPF---YDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
L+ ++ V DP KR+ + +HPW +
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-36
Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 8/166 (4%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
+ I H D++ EN + +KI +FG ++ + P Y APEV
Sbjct: 116 QFL-HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VR 134
+D+WS G +YV+L G PF + ++ I+ I N +Y F +
Sbjct: 175 HQHDVV-STATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKE 229
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT 180
+S + + ++ V + R+ E +HPW + + + ++ +T
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 17 HHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAP 74
+C + I HRD+K LL +K+ FG + VGTP ++AP
Sbjct: 144 RYC-HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 75 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 132
EV+ R+ Y GK DVW CGV L+++L G PF ++ + + I +Y P
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
+S + L+ ++ + DP++RI + E HPW +
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 55/173 (31%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 13 IFTSHH-CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
F H FY EI +RDLKL+N +LD + +KI DFG K +
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWD 174
Query: 60 SQPKSTV-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
T GTP YIAPE++A + Y GK D W+ GV LY ML G PFE + +
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDEL 229
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
I P +S + + + P KR+ +IK+H +F
Sbjct: 230 FQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 60/172 (34%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 13 IFTSHH-CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
F FY EI +RDLK EN LLD Q + + DFG K + H
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEH 192
Query: 60 SQPKSTV-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
+ ST GTP Y+APEVL ++ Y + D W G LY ML G PF RN +
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEM 247
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP----EIKKHPWF 166
D I N L ++ RHLL + D +KR+ EIK H +F
Sbjct: 248 YDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-35
Identities = 58/162 (35%), Positives = 81/162 (50%), Gaps = 23/162 (14%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FY EI +RDLKL+N LLD +KI DFG K +L +T
Sbjct: 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTF 178
Query: 67 -GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GTP YIAPE+L ++Y D WS GV LY ML+G PF ++ + IR
Sbjct: 179 CGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMD 233
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-PIPEIKKHPWF 166
F P + + + + LL ++FV +P KR+ +I++HP F
Sbjct: 234 NPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-35
Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD- 83
I HRDLK EN LLD + Q +++ DFG+S + + GTP Y+APE+L +
Sbjct: 221 IVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 84 ----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSA 137
GK D+W+CGV L+ +L G+ PF R I QY F S+
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRSS 334
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
+ L+S++ DP R+ + +HP+F +
Sbjct: 335 TVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
Y+ EI +RD+KLEN LLD + + DFG SK + ++
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYD 219
Query: 66 -VGTPAYIAPEVLARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
GT Y+AP+++ + K D WS GV +Y +L GA PF + + + RI
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ P +SA + L+ ++ + DP KR+ EIK+H +F
Sbjct: 280 KSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-35
Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 13/151 (8%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+++ +RDLK N L + Q +KI DFG S + + GT Y++PE ++ ++Y
Sbjct: 141 KKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY 198
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
+ D+++ G+ L +L + K +R+ + D + L
Sbjct: 199 GKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLRDGI--ISD--IFDKKEKTL 247
Query: 143 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
L ++ P R EI + K P++
Sbjct: 248 LQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 53/149 (35%), Positives = 78/149 (52%), Gaps = 9/149 (6%)
Query: 25 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 82
+ HR+LK EN LL +K+ DFG + Q GTP Y++PEVL + Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 140
GK D+W+CGV LY++LVG PF D + R +++ I+ Y F V+ + +
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAK 245
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
L++++ +PSKRI E KHPW
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHR 274
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FY EI +RD+KLEN +LD +KI DFG K G+ T
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTF 165
Query: 67 -GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GTP Y+APEVL +Y G+ D W GV +Y M+ G PF + ++ + + I
Sbjct: 166 CGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILME 220
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ P +S + + LL+ + DP +R+ E+ +H +F
Sbjct: 221 EIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 55/179 (30%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 13 IFTSHH-CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
H FY EI +RDLKL+N LLD + +K+ D+G K GL
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRP 163
Query: 60 SQPKSTV-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF-----EDPEDPR 113
ST GTP YIAPE+L ++Y G D W+ GV ++ M+ G PF D D
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 114 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI------PIPEIKKHPWF 166
I Q +P +S +L DP +R+ +I+ HP+F
Sbjct: 223 TEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 55/167 (32%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FY EI +RDLKL+N LLD + K+ DFG K G+ + +T
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTATF 184
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GTP YIAPE+L Y G D W+ GV LY ML G PFE N + I N
Sbjct: 185 CGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEA----ENEDDLFEAILND 239
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI------PIPEIKKHPWF 166
+ P + + D +L +P+ R+ I +HP+F
Sbjct: 240 EVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-34
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 9/170 (5%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
H + H DLK EN + LK+ DFG + K T GT + APEV
Sbjct: 269 CHM-HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 134
K G +D+WS GV Y++L G PF D +T+ +++ + + D +
Sbjct: 328 AEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSG 382
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYK 183
+S D + + ++ +ADP+ R+ I + +HPW N P +I + Y
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 432
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-34
Identities = 29/208 (13%), Positives = 58/208 (27%), Gaps = 42/208 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
+ H L+ + +LD + + + F + + P A +L ++
Sbjct: 232 LVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQH 289
Query: 83 DGKI----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 138
+ D W+ G+ +Y + P D + +
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK----------NIPQP 339
Query: 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIM 198
R LL R+ + + P + Q E+
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEY------------------------EQLRTELS 375
Query: 199 RIIQEAKMPGEATKVAGQGAAGASDPDD 226
+ + GE T+ G +G S PD+
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTSQPDE 403
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 55/179 (30%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 13 IFTSHH-CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
H FY EI +RDLKL+N LLD + +K+ D+G K GL
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRP 206
Query: 60 SQPKSTV-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF-----EDPEDPR 113
ST GTP YIAPE+L ++Y G D W+ GV ++ M+ G PF D D
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 114 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI------PIPEIKKHPWF 166
I Q +P +S +L DP +R+ +I+ HP+F
Sbjct: 266 TEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 81
++I HRD+K +N L +++ DFG ++ ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCR 140
Y+ K SD+W+ G LY + + FE + + + +I + + + S D R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
L+SQ+F +P R + I + + K + K
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 60/165 (36%), Positives = 83/165 (50%), Gaps = 28/165 (16%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FY E+C +RDLK EN LLD +KI DFG++K + +
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAK--YVPDVTYTLC 164
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
GTP YIAPEV++ K Y K D WS G+ +Y ML G PF D N KT ++I N +
Sbjct: 165 GTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAE 219
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
P + + D + LLS++ D S+R+ ++K HPWF
Sbjct: 220 LRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FY EI +RDLK N LLD ++I D G + +P ++V
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFS-KKKPHASV 351
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
GT Y+APEVL + +D +S G L+ +L G PF ++ + +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMA 410
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
LPD S + R LL + D ++R+ E+K+ P+F
Sbjct: 411 VELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 54/167 (32%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 19 CFYLQEIC-------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 65
FY EI +RDLKLEN +LD +KI DFG K G+ T
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKT 308
Query: 66 V-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN 124
GTP Y+APEVL +Y G+ D W GV +Y M+ G PF + ++ K + I
Sbjct: 309 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILM 363
Query: 125 VQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ P + + + LLS + DP +R+ EI +H +F
Sbjct: 364 EEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 55/173 (31%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 13 IFTSHH-CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
F H FY EI +RDLKL+N +LD + +KI DFG K +
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWD 495
Query: 60 SQPKSTV-GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
T GTP YIAPE++A + Y GK D W+ GV LY ML G PFE + +
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDEL 550
Query: 119 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
I P +S + + + P KR+ +IK+H +F
Sbjct: 551 FQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 31/172 (18%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FYL E+ HRD+K +N L+D +++ DFG + +S+
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 66 -VGTPAYIAPEVLARKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 120
VGTP YI+PE+L E G D WS GV +Y ML G PF + +T
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYG 291
Query: 121 RIRNVQYFLP---DYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
+I N + VS + + L+ + + R+ I + KKHP+F
Sbjct: 292 KIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFF 342
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 18/153 (11%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL ++ +RDLK EN L+D Q +++ DFG++K + + + GTP +APE++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIIL 211
Query: 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 138
K Y K D W+ GV +Y M G PF + P + ++I + + P + S+D
Sbjct: 212 SKGY-NKAVDWWALGVLIYEMAAGYPPFFA-DQP---IQIYEKIVSGKVRFPSH--FSSD 264
Query: 139 CRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ LL + D +KR + +IK H WF
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 44/166 (26%), Positives = 65/166 (39%), Gaps = 23/166 (13%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FY +I +RDLK EN LLD ++I D G +
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD--DGNVRISDLGLAVELKAGQTKTKGY 349
Query: 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 125
GTP ++APE+L +EY D ++ GVTLY M+ PF + ++ R+
Sbjct: 350 AGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
PD S + + DP KR+ ++ HP F
Sbjct: 409 AVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 57/170 (33%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FY E+ HRD+K +N LLD LK+ DFG +
Sbjct: 171 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 66 -VGTPAYIAPEVLARKEYD---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 121
VGTP YI+PEVL + D G+ D WS GV LY MLVG PF + T +
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSK 284
Query: 122 IRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWF 166
I N + L PD +S + ++L+ F+ D R+ + EIK+H +F
Sbjct: 285 IMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 38/205 (18%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQP-----------RLKICDFGYSK-----SGLLHSQP 62
+L +I HRDLK +N L+ S + R+ I DFG K +
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 63 KSTVGTPAYIAPEVL-------ARKEYDGKISDVWSCGVTLYVMLVGAY-PFEDPEDPRN 114
+ GT + APE+L ++ I D++S G Y +L PF D
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKYS--- 245
Query: 115 FRKTIDRIRNVQYFLPDYVR-----VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169
I + L + + A+ L+SQ+ DP KR ++ +HP F
Sbjct: 246 ---RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
Query: 170 LPKEIIEIEKTNYKEAGRDQPTQSV 194
K ++ ++ E P ++
Sbjct: 303 SKKLEFLLKVSDRLEIENRDPPSAL 327
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 50/165 (30%), Positives = 71/165 (43%), Gaps = 22/165 (13%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
FY EIC +RDLK EN LLD ++I D G + K V
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
GT Y+APEV+ + Y D W+ G LY M+ G PF+ + + ++ V
Sbjct: 347 GTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 166
+ S R L SQ+ DP++R+ E+K+HP F
Sbjct: 406 EEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 75
I HRDLK EN L + +KICDF S + + + G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 76 VL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI----------- 119
V+ YD K D+WS GV LY++L G PF
Sbjct: 192 VVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 120 DRIRNVQY-FLPDY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+ I+ +Y F +S + L+S++ V D +R+ ++ +HPW P+
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 39/158 (24%), Positives = 60/158 (37%), Gaps = 15/158 (9%)
Query: 21 YL--QEICHRDLKLENTLL---DGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAY 71
+L I HRDLK N L+ + + + I DFG K S+ GT +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 72 IAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F 128
IAPE+L+ + D++S G Y ++ P R+ +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGKSLQRQANILLGACSLDC 249
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
L R L+ ++ DP KR + KHP+F
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 33/174 (18%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST- 65
FYL EI HRD+K +N LLD +++ DFG +S
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLV 222
Query: 66 -VGTPAYIAPEVLARKEYD------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 118
VGTP Y++PE+L G D W+ GV Y M G PF + +T
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAET 278
Query: 119 IDRIRNVQYFLP---DYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 166
+I + + L V + R + + + P R+ + + HP+F
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 35/160 (21%), Positives = 57/160 (35%), Gaps = 23/160 (14%)
Query: 19 CFYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 66
YL++ H D+K N L P+ R K+ DFG +
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
G P Y+APE+L + Y +DV+S G+T+ + E + R+
Sbjct: 218 GDPRYMAPELL-QGSYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE--- 272
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+S++ R +L + DP R + P
Sbjct: 273 --FTAG--LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 24/172 (13%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------------SGLLHSQPKSTVGTP 69
+ + HRDLK N +K+ DFG +++ VGT
Sbjct: 137 KGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
Y++PE + Y K D++S G+ L+ +L YPF + +T+ +RN F
Sbjct: 195 LYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMER---VRTLTDVRN-LKFP 246
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKT 180
P + + ++ + P +R I ++ F + P + + +++
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 45/148 (30%), Positives = 63/148 (42%), Gaps = 25/148 (16%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83
I HRD+K EN L P LK+ DFG A E K YD
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTGEK-YD 176
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVSADCRH 141
D+WS GV +Y++L G PF RIR QY P+ VS + +
Sbjct: 177 KSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235
Query: 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169
L+ + +P++R+ I E HPW +++
Sbjct: 236 LIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 8/154 (5%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 83
+ HRD+K N + + +K+ D G + + S VGTP Y++PE + Y+
Sbjct: 157 VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHL 142
K SD+WS G LY M PF D N +I Y LP S + R L
Sbjct: 215 FK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSEELRQL 270
Query: 143 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176
++ DP KR + + + +E
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-28
Identities = 33/157 (21%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-------------VGTP 69
+ + HRDLK N +K+ DFG + + ++ VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
Y++PE + Y K D++S G+ L+ +L Y F + I +RN++ F
Sbjct: 241 LYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQM---ERVRIITDVRNLK-FP 292
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ + ++ + P++R +I ++ F
Sbjct: 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 32/172 (18%), Positives = 59/172 (34%), Gaps = 30/172 (17%)
Query: 23 QEICHRDLKLENTLLDGSPQPR---------LKICDFGYSKSGLLHSQPKSTV-----GT 68
EI H D+K +N +L + L + D G S + PK T+ T
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTIFTAKCET 248
Query: 69 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
+ E+L+ K ++ +I D + T+Y ML G Y E + + R +
Sbjct: 249 SGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR----RLP 303
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP---WFLKNLPKEIIEI 177
D + +P ++ + F ++ +I +
Sbjct: 304 HLDM------WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 28/166 (16%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
H + + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIRNVQYF 128
Y K DV+S G+ L+ ++ PF++ P R +
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------- 225
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
+ L+++ + DPS+R + EI K + +L +
Sbjct: 226 -IKN--LPKPIESLMTRCWSKDPSQRPSMEEIVKI---MTHLMRYF 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-22
Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ K YD
Sbjct: 152 IIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEEK-YDE 208
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
DV++ G+ + M YP+ + ++ +R+ ++ + + ++
Sbjct: 209 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDK--VAIPEVKEII 263
Query: 144 SQIFVADPSKRIPIPEIKKHPWF 166
+ +R I ++ H +F
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 45/195 (23%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
YL+E I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL 202
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
Y + SD+WS G++L M VG YP P+ ++ P R
Sbjct: 203 QGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 138 DCRH--------------LLSQI-------------------FVA-----DPSKRIPIPE 159
+ LL I FV +P++R + +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 160 IKKHPWFLKNLPKEI 174
+ H + ++ +E+
Sbjct: 322 LMVHAFIKRSDAEEV 336
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-21
Identities = 33/173 (19%), Positives = 58/173 (33%), Gaps = 34/173 (19%)
Query: 21 YL--QEICHRDLKLENTLLD-----------------GSPQPRLKICDFGYSKSGLLHSQ 61
Y+ + H D+K N + S + KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 62 PKSTVGTPAYIAPEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 120
P+ G ++A EVL + K +D+++ +T+ + +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------WH 238
Query: 121 RIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
IR + +P +S + LL + DP +R + KH L K
Sbjct: 239 EIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-21
Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 13/172 (7%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYI 72
YL + I H D+K +N LL R +CDFG++ G GT ++
Sbjct: 165 YLHTRRILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
APEV+ K D K D+WS + ML G +P+ K I +P
Sbjct: 224 APEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP- 280
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 184
+ + + +P R E+++ + K YKE
Sbjct: 281 -SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 14/152 (9%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVL 77
YL +I HRD+K +N L++ + LKI DFG SK ++ ++ GT Y+APE++
Sbjct: 137 YLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 78 --ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYV 133
+ Y +D+WS G T+ M G PF + +P+ + ++ + +P+
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFKVHPEIPE-- 249
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+SA+ + + + F DP KR ++ +
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-21
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
YL+E + HRD+K N LLD Q +K+CDFG S L+ + K G AY+APE
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGR-LVDDKAKDRSAGCAAYMAPER 195
Query: 77 LARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
+ + YD + +DVWS G++L + G +P+++ + + ++ LP
Sbjct: 196 IDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPG 252
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
++ S D + + D KR ++ +H + + E+
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-21
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
+L + HRD+K N L++ Q K+CDFG S L+ K G Y+APE
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQV--KMCDFGISGY-LVDDVAKDIDAGCKPYMAPER 180
Query: 77 LA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
+ +K Y K SD+WS G+T+ + + +P++ P F++ + LP
Sbjct: 181 INPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLPA- 236
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
+ SA+ SQ + +R PE+ +HP+F
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-20
Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 18 HCFYLQEICHRDLKLENTLLDGS------PQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 71
H + I HRDLK N L+ LKI DFG ++ + S G A+
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAW 180
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED 108
+APEV+ + SDVWS GV L+ +L G PF
Sbjct: 181 MAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-20
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPE 75
YL + I HRDLK N L +KI DFG + Q + G+ ++APE
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 76 VLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
V+ ++ Y + SDV++ G+ LY ++ G P+ + + + + R PD
Sbjct: 193 VIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDL 247
Query: 133 VRVSADC----RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
+V ++C + L+++ +R P I ++ L +E
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKE 81
I HR+LK N L+D +K+CDFG S+ L S KS GTP ++APEVL +
Sbjct: 160 IVHRNLKSPNLLVDKKY--TVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFED 108
+ K SDV+S GV L+ + P+ +
Sbjct: 216 SNEK-SDVYSFGVILWELATLQQPWGN 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 21 YLQE---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEV 76
+L+E I HRD+K N LLD S +K+CDFG S L+ S K+ G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG-QLVDSIAKTRDAGCRPYMAPER 196
Query: 77 LA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
+ R+ YD + SDVWS G+TLY + G +P+ + + ++ L +
Sbjct: 197 IDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNS 253
Query: 133 VRV--SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 174
S + ++ D SKR E+ KHP+ L + +
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 8/89 (8%)
Query: 25 ICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA--R 79
I HRDL+ N L + K+ DFG S+ +G ++APE +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEE 202
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFED 108
+ Y K +D +S + LY +L G PF++
Sbjct: 203 ESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-18
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I L + ++D +I S Q + PA++APE L +K D
Sbjct: 134 IPRHALNSRSVMIDEDM--TARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 85 KI--SDVWSCGVTLYVMLVGAYPFED 108
+D+WS V L+ ++ PF D
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-18
Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
YL Q + HRD+K ++ LL + R+K+ DFG+ + PK S VGTP ++APEV
Sbjct: 156 YLHAQGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEV 212
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRV 135
++R Y ++ D+WS G+ + M+ G P+ + P + + R+R + L + +V
Sbjct: 213 ISRSLYATEV-DIWSLGIMVIEMVDGEPPYFS-DSP---VQAMKRLRDSPPPKLKNSHKV 267
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
S R L ++ V DP +R E+ HP+ L+ E +
Sbjct: 268 SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECL 307
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-18
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
+L ++ HRD+K +N LL +K+ DFG+ + Q K + VGTP ++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEV 187
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRV 135
+ RK Y K+ D+WS G+ M+ G P+ + E+P + + I N L + ++
Sbjct: 188 VTRKAYGPKV-DIWSLGIMAIEMIEGEPPYLN-ENP---LRALYLIATNGTPELQNPEKL 242
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 175
SA R L++ D KR E+ +H + P +
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-18
Identities = 41/172 (23%), Positives = 62/172 (36%), Gaps = 44/172 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLAR 79
I HRDLK +N L+ + + I D G + + L VGT Y+APEVL
Sbjct: 134 IAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 80 K------EYDGKISDVWSCGVTLYVMLVGAY----------PFED--PEDP--------- 112
+ ++ D+W+ G+ L+ + PF D P DP
Sbjct: 192 TIQVDCFDSYKRV-DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 113 --RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162
R I L ++ +C + +PS R+ IKK
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIKK 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-17
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 15/157 (9%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
YL ++ HRD+K N LL + +K+ DFG + L +Q K + VGTP ++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEV 190
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRV 135
+ + YD K +D+WS G+T + G P + P K + I +N L
Sbjct: 191 IKQSAYDSK-ADIWSLGITAIELARGEPPHSE-LHP---MKVLFLIPKNNPPTLEG--NY 243
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
S + + +PS R E+ KH + L+N K
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-17
Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 15/182 (8%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
YL HRD+K N LL + + K+ DFG + L + K + +GTP ++APEV
Sbjct: 140 YLHFMRKIHRDIKAGNILL--NTEGHAKLADFGVAGQ-LTDTMAKRNTVIGTPFWMAPEV 196
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRV 135
+ Y+ +D+WS G+T M G P+ D P + I I N
Sbjct: 197 IQEIGYNCV-ADIWSLGITAIEMAEGKPPYAD-IHP---MRAIFMIPTNPPPTFRKPELW 251
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE--IEKTNYKEAGRDQPTQS 193
S + + Q V P +R ++ +HP+ I+ I + + R + Q
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQR 311
Query: 194 VE 195
E
Sbjct: 312 EE 313
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-17
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYS------KSGLLHSQPKSTVGTPAYIAPEVLAR- 79
HRD+K N LL ++I DFG S + K+ VGTP ++APEV+ +
Sbjct: 144 HRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTID----RIRNVQYFLPDYVR 134
+ YD K +D+WS G+T + GA P+ P + T+ + +
Sbjct: 202 RGYDFK-ADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 179
R ++S DP KR E+ +H +F K KE + EK
Sbjct: 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL-QEK 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 14/98 (14%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
+ + DLK EN +L +LK+ D G + GTP + APE+ R
Sbjct: 203 LVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI-VRTGPTV 255
Query: 85 KISDVWSCGVTLYVMLVGAYPFED------PEDPRNFR 116
+D+++ G TL + + PED +
Sbjct: 256 A-TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 47/183 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLA- 78
I HRDLK +N L+ + I D G + + + P + VGT Y+ PEVL
Sbjct: 163 IAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 79 -----RKEYDGKISDVWSCGVTLYVMLVG----------AYPFED--PEDP--------- 112
+ D++S G+ L+ + P+ D P DP
Sbjct: 221 SLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 113 --RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170
+ R + + L ++ +C +P+ R+ +KK L +
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWA-------HNPASRLTALRVKKT---LAKM 329
Query: 171 PKE 173
+
Sbjct: 330 SES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 40/183 (21%), Positives = 65/183 (35%), Gaps = 47/183 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVL-- 77
I HRDLK +N L+ + I D G + + + P VGT Y+APEVL
Sbjct: 168 IAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 78 ----ARKEYDGKISDVWSCGVTLYVMLVG----------AYPFED--PEDP--------- 112
E + D+++ G+ + + P+ D P DP
Sbjct: 226 SINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284
Query: 113 --RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170
+ R I L ++ +C + A+ + R+ IKK L L
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWY-------ANGAARLTALRIKKT---LSQL 334
Query: 171 PKE 173
++
Sbjct: 335 SQQ 337
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 33/177 (18%), Positives = 64/177 (36%), Gaps = 42/177 (23%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYI 72
YL + I H+DLK +N D ++ I DFG +G + + G ++
Sbjct: 145 YLHAKGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 73 APEVL---------ARKEYDGKISDVWSCGVTLYVMLVGAYPFED--PED-----PRNFR 116
APE++ + + SDV++ G Y + +PF+ E +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 117 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
+ +I + + +L + + +R ++ L+ LPK
Sbjct: 261 PNLSQI-----------GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLPKR 303
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 44/218 (20%), Positives = 74/218 (33%), Gaps = 51/218 (23%)
Query: 25 ICHRDLKLENTLLDGSPQPR----LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
I H D+K EN L++ P +KI D G + +++ T Y +PEVL
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRSPEVLLGA 210
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF------------------RKTIDRI 122
+ D+WS ++ ++ G + F +P++ ++ +
Sbjct: 211 PWGCGA-DIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268
Query: 123 RNVQYF---------------------LPDYVRVSADCR----HLLSQIFVADPSKRIPI 157
+ + F L + + S D LS + DP KR
Sbjct: 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328
Query: 158 PEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVE 195
+ HPW L E I + +G D P E
Sbjct: 329 GGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 366
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 30/112 (26%), Positives = 46/112 (41%), Gaps = 22/112 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
HRD+K EN L+ S + DFG + L +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSES 210
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPF-------------EDPEDPRNFRKTI 119
+ +D+++ LY L G+ P+ + P R I
Sbjct: 211 HATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 36/171 (21%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR-KE 81
ICHRD+K +N LLD LK+ DFG +K L + + + + Y APE++
Sbjct: 162 ICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRAPELIFGATN 218
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED---------------------PRNFRKT 118
Y I D+WS G + ++ G +P E D P
Sbjct: 219 YTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 119 IDRIRNV---QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+IR + F P R D L+S++ PS R+ E HP+F
Sbjct: 278 FPQIRPHPFSKVFRP---RTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 31/155 (20%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------SGLLHSQPK 63
YL I HRDL N L+ + + + DFG ++ +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 123
+ VG P ++APE++ + YD K DV+S G+ L ++ D PR ++
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRG 238
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFV----ADPSKR 154
+ + P +C I V DP KR
Sbjct: 239 FLDRYCPP------NCPPSFFPITVRCCDLDPEKR 267
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 49/196 (25%), Positives = 77/196 (39%), Gaps = 36/196 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKE 81
ICHRD+K +N L++ LK+CDFG +K L S + + Y APE+ L E
Sbjct: 162 ICHRDIKPQNLLVNSKDN-TLKLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLGATE 218
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTIDRIRN--VQ 126
Y I D+WS G +++G + E D P ++ + R+ +
Sbjct: 219 YTPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTE 275
Query: 127 YFLPDYVRVS----------ADCRHLLSQIFVADPSKRIPIPEIKKHPWF--LKNLPKEI 174
P + LL QI +P RI E HP+F L+N +
Sbjct: 276 VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESE 335
Query: 175 IEIEKTNYKEAGRDQP 190
++ ++ P
Sbjct: 336 VKNNSNFPHGVNQNIP 351
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLAR-KEY 82
ICHRD+K +N LLD LK+CDFG +K L+ +P S + + Y APE++ +Y
Sbjct: 177 ICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTIDRI--RNVQY 127
I DVWS G L +L+G +P + D P R+ I + ++
Sbjct: 235 TSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIREMNPNYTEF 291
Query: 128 FLPDYV----------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
P R + L S++ P+ R+ E H +F
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 11/96 (11%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVL---- 77
I HRD+K +N LL + I DFG + +G VGT Y+APEVL
Sbjct: 152 ISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 78 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 112
+++ + D+++ G+ L+ + + P D
Sbjct: 210 NFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-15
Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
+L ++ HRD+K +N LL + +K+ DFG S L + + + +GTP ++APEV
Sbjct: 144 HLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPEV 200
Query: 77 LARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--F---RKTIDRIRNVQ 126
+A E YD K SD+WS G+T M GA P D P F R R+++ +
Sbjct: 201 IACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKK 258
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK------EIIE-IEK 179
+ S + + V + S+R ++ KHP F+++ P ++ + I++
Sbjct: 259 W--------SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNERQVRIQLKDHIDR 309
Query: 180 TNYKEAGRDQP 190
T K +D+
Sbjct: 310 TKKKRGEKDET 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-15
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 21/113 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
I HRD+K N ++ S +K+ DFG + SG +Q + +GT Y++PE AR
Sbjct: 137 IIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARG 193
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPF--------------EDPEDPRNFRKTI 119
+ SDV+S G LY +L G PF EDP P + +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-15
Identities = 37/171 (21%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKE 81
+CHRD+K N L++ + LK+CDFG +K L + + + Y APE+ +
Sbjct: 152 VCHRDIKPHNVLVNEADG-TLKLCDFGSAKK--LSPSEPNVAYICSRYYRAPELIFGNQH 208
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED---------------------PRNFRKT 118
Y + D+WS G M++G + ++ P +
Sbjct: 209 YTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD 267
Query: 119 IDRIRNV---QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ + + F ++ + + LLS + P +R+ E HP+F
Sbjct: 268 LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-14
Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARK 80
I HRD+K +N L+D LKI DFG S++ L +Q +GT Y +PE A+
Sbjct: 132 IVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYFSPE-QAKG 186
Query: 81 EYDGKISDVWSCGVTLYVMLVGAYPFE 107
E + +D++S G+ LY MLVG PF
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-14
Identities = 36/230 (15%), Positives = 67/230 (29%), Gaps = 63/230 (27%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYS--------KSGLLHSQPKSTVGTPAYIAPEVLA 78
HR +K + L+ + + + + + ++H PK +V +++PEVL
Sbjct: 151 HRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 79 R--KEYDGKISDVWSCGVTLYVMLVGAYPFED---------------------------- 108
+ + YD K SD++S G+T + G PF+D
Sbjct: 209 QNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 109 ------------PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156
T P + S H + Q +P R
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
Query: 157 IPEIKKHPWF----------LKNLPKEIIEIEKTNYKEAGRDQPTQSVEE 196
+ H +F L L + + I ++ +
Sbjct: 328 ASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVT 377
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-14
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEV 76
+L + I HRDLK N L+ + + +++ DFG S + L + K S +GTP ++APEV
Sbjct: 132 FLHSKRIIHRDLKAGNVLM--TLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 77 LARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLP 130
+ + YD K +D+WS G+TL M P + +P + + +I ++ L
Sbjct: 189 VMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP---MRVLLKIAKSDPPTLL 243
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQ 189
+ S + R L +P R ++ +HP+ + + K ++
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-14
Identities = 45/214 (21%), Positives = 61/214 (28%), Gaps = 58/214 (27%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAY 71
I + I H DLK EN LL + +K+ DFG S Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF------------------------- 106
APEV+ Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 107 --------------------EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR------ 140
D R P+ +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 141 --HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
L Q DP+ R+ + +HPW + LPK
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 41/202 (20%), Positives = 70/202 (34%), Gaps = 52/202 (25%)
Query: 13 IFTSHHC-FYLQEIC------------HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 59
T + FY+ EI HRD+K N ++D +L++ D+G ++ H
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE-HRKLRLIDWGLAEFY--H 182
Query: 60 SQPKST--VGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPF---------- 106
+ V + + PE+L + YD + D+WS G L M+ PF
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 107 --------EDPEDPRNFRKTIDRIRNVQYFLPDYVR--------------VSADCRHLLS 144
+ + I+ L + R VS + L
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 301
Query: 145 QIFVADPSKRIPIPEIKKHPWF 166
++ D R+ E +HP+F
Sbjct: 302 KLLRYDHQSRLTAREAMEHPYF 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 42/171 (24%), Positives = 62/171 (36%), Gaps = 37/171 (21%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---------SGLLHSQPKSTVGTPAYIAPE 75
I HRDL N L+ I DFG S G + S VGT Y+APE
Sbjct: 141 ISHRDLNSRNVLVKN--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 76 VL------ARKEYDGKISDVWSCGVTLYVML---VGAYPFEDPEDPRNFRKTIDRIRNVQ 126
VL E K D+++ G+ + + +P E +
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE--------------- 243
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE-IKKHPWFLKNLPKEIIE 176
Y + V Q+ V+ +R PE K++ +++L KE IE
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KETIE 293
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 34/171 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKEYD 83
+ HRDL N LL + + ICDF ++ + V Y APE+ + K +
Sbjct: 155 VVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFT 212
Query: 84 GKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTIDRIRN------ 124
+ D+WS G + M + + P+ + + +
Sbjct: 213 KLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK--IEDVVMFSSPSARDY 269
Query: 125 VQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
++ L + L++++ +P +RI + +HP+F
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 35/170 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKE 81
+ HRDLK N ++ + LKI DFG ++ + + T V T Y APEV L+
Sbjct: 147 VVHRDLKPGNLAVNEDCE--LKILDFGLARH----ADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI--DRIRNV 125
Y+ + D+WS G + ML G + +D D F + + ++
Sbjct: 201 YNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259
Query: 126 QYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP R S LL ++ D KR+ + HP+F
Sbjct: 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-13
Identities = 39/171 (22%), Positives = 56/171 (32%), Gaps = 31/171 (18%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV-LAR 79
+ HRDLK N ++ + LKI DFG ++ H K + T Y +P + L+
Sbjct: 141 VLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFE------------------DPED----PRNFRK 117
Y I D+W+ G ML G F ED
Sbjct: 200 NNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPV 258
Query: 118 TIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
I + +S + L QI P R+ E HP+
Sbjct: 259 YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-13
Identities = 49/190 (25%), Positives = 74/190 (38%), Gaps = 58/190 (30%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 79
I HRDLK +N L++ LK+ DFG +++ P + V T Y AP+VL
Sbjct: 140 ILHRDLKPQNLLINSDGA--LKLADFGLARA---FGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 80 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF--------- 128
K+Y + D+WS G M+ G +P +D + +I F
Sbjct: 195 KKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDD------QLPKI-----FSILGTPNPR 242
Query: 129 -------LPDYV-----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
LP + + LLS + DP+KRI + HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 165 WFLKNLPKEI 174
+F K+L +I
Sbjct: 303 YF-KDLDPQI 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 45/170 (26%), Positives = 67/170 (39%), Gaps = 35/170 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKE 81
I HRDLK N ++ + LKI DFG ++ + + T V T Y APE+ L
Sbjct: 153 IIHRDLKPSNLAVNEDCE--LKILDFGLARH----TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI--DRIRNV 125
Y+ + D+WS G + +L G +P D D K I + RN
Sbjct: 207 YNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 126 QYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
L ++ + LL ++ V D KRI + H +F
Sbjct: 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 50/180 (27%), Positives = 70/180 (38%), Gaps = 43/180 (23%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
I HRDLK N ++ LKI DFG +++ + T V T Y APEV+ Y
Sbjct: 148 IIHRDLKPSNIVVKS--DCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-DRIRNVQY 127
+ D+WS G + M+ G +P D D F K + +R
Sbjct: 204 KENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 128 FLPDYVRVS---------------------ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
P Y S + R LLS++ V D SKRI + E +HP+
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 8e-13
Identities = 49/254 (19%), Positives = 76/254 (29%), Gaps = 51/254 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPR--LKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVL- 77
+ HRDLK N L+ G R +KI D G ++ + V T Y APE+L
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 78 ARKEYDGKISDVWSCGVTLYVML------------------------------------- 100
+ Y I D+W+ G +L
Sbjct: 209 GARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267
Query: 101 ----VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP 156
+ P R T ++Y V+ + HLL ++ DP KRI
Sbjct: 268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
Query: 157 IPEIKKHPWFLKNLPKEII-EIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAG 215
+ + P+F P R+ T+ + + + G
Sbjct: 328 SEQAMQDPYF-LEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNG 386
Query: 216 QGAAGASDPDDMEG 229
G G D +G
Sbjct: 387 TGHPGNQDSSHTQG 400
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-12
Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 58/188 (30%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 79
+ HRDLK +N L++ + + LK+ +FG +++ P V T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGE--LKLANFGLARA---FGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNFRKTIDRIRNVQYF-------- 128
K Y I D+WS G + P D +D + RI F
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDD------QLKRI-----FRLLGTPTE 224
Query: 129 --------LPDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
LPDY +++A R LL + +P +RI E +HP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 165 WFLKNLPK 172
+F +
Sbjct: 285 YF-SDFCP 291
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 35/170 (20%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKE 81
I HRDLK N ++ + LKI DFG ++ + + T V T Y APEV L
Sbjct: 149 IIHRDLKPGNLAVNEDCE--LKILDFGLARQ----ADSEMTGYVVTRWYRAPEVILNWMR 202
Query: 82 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI--DRIRNV 125
Y + D+WS G + M+ G + D D P F + + D +N
Sbjct: 203 YTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 126 QYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP+ + S +LL ++ V D +R+ E HP+F
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 44/206 (21%), Positives = 62/206 (30%), Gaps = 63/206 (30%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I H DLK EN LL + +KI DFG S Q + + Y +PEVL YD
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLGMPYD 236
Query: 84 GKISDVWSCGVTLYVMLVG----------------------------------------- 102
I D+WS G L M G
Sbjct: 237 LAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295
Query: 103 ---AYPFEDPEDPRN-----FRKTIDRIRNVQYFLPDYVRVSADCR---------HLLSQ 145
+ + +D + + + I V+ P R L+ +
Sbjct: 296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355
Query: 146 IFVADPSKRIPIPEIKKHPWFLKNLP 171
+ DP RI +H +F K
Sbjct: 356 MLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-12
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 58/196 (29%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 79
+ HRDLK +N L++ + LK+ DFG +++ S P T V T Y P++L
Sbjct: 121 VLHRDLKPQNLLINERGE--LKLADFGLARA---KSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 80 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF--------- 128
+Y +I D+W G Y M G +P E+ + I F
Sbjct: 176 TDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEE------QLHFI-----FRILGTPTEE 223
Query: 129 -------LPDYV-----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164
++ R+ +D LL+++ + RI + KHP
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 165 WFLKNLPKEIIEIEKT 180
+F +L + I ++ T
Sbjct: 284 FF-LSLGERIHKLPDT 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL + HRD+K N LL S +K+ DFG + ++ + S VGTP ++APEV+
Sbjct: 169 YLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSA--SIM-APANSFVGTPYWMAPEVIL 223
Query: 79 ---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--F---RKTIDRIRNVQYFLP 130
+YDGK DVWS G+T + P + + + + + +++ +
Sbjct: 224 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHW--- 278
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE--IEKTNYKEAGRD 188
S R+ + P R + KH + L+ P +I I++ K+A R+
Sbjct: 279 -----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR--TKDAVRE 331
Query: 189 QPTQSVEEIMRI-IQEA 204
++ +I QEA
Sbjct: 332 LDNLQYRKMKKILFQEA 348
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 44/192 (22%), Positives = 67/192 (34%), Gaps = 59/192 (30%)
Query: 25 ICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL 77
HRDLK +N LL S LKI DFG +++ P + T Y PE+L
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEIL 209
Query: 78 -ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF------ 128
+ Y + D+WS ML+ +P + D + +I F
Sbjct: 210 LGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEID------QLFKI-----FEVLGLP 257
Query: 129 ----------LPDYV-----------------RVSADCRHLLSQIFVADPSKRIPIPEIK 161
LPD+ + + LL+ + DP KRI
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 162 KHPWFLKNLPKE 173
+HP+F + +
Sbjct: 318 EHPYF-SHNDFD 328
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 46/177 (25%), Positives = 63/177 (35%), Gaps = 40/177 (22%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKE 81
I HRDLK EN L+ +K+ DFG ++ +S V T Y APEVL +
Sbjct: 141 IVHRDLKPENILVTSGGT--VKLADFGLARI---YSYQMALTPVVVTLWYRAPEVLLQST 195
Query: 82 YDGKISDVWSCGVTLYVMLVGA--------------------YPFED--PEDPR----NF 115
Y + D+WS G M P ED P D F
Sbjct: 196 YATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254
Query: 116 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
R VQ +P + LL ++ +P KRI +H + K+
Sbjct: 255 PPR--GPRPVQSVVP---EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 40/190 (21%), Positives = 64/190 (33%), Gaps = 61/190 (32%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-T--VGTPAYIAPEVLAR-K 80
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L
Sbjct: 123 CIHRDVKPENILITKHSV--IKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 81 EYDGKISDVWSCGVTLYVMLVG-------------------------------------- 102
+Y + DVW+ G +L G
Sbjct: 179 QYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 103 AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162
DPED + +S LL DP++R+ ++
Sbjct: 238 GVKIPDPEDMEPLELK-------------FPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 163 HPWFLKNLPK 172
HP+F +N+ +
Sbjct: 285 HPYF-ENIRE 293
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-12
Identities = 43/182 (23%), Positives = 65/182 (35%), Gaps = 51/182 (28%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
+ HRDLK +N L+ S Q +K+ DFG ++ Q T V T Y APEVL + Y
Sbjct: 141 VVHRDLKPQNILVTSSGQ--IKLADFGLARI--YSFQMALTSVVVTLWYRAPEVLLQSSY 196
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF------------ 128
+ D+WS G M + D + +I
Sbjct: 197 ATPV-DLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKI-----LDVIGLPGEEDWP 244
Query: 129 ----LPDYV--------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170
LP + + LL + +P+KRI HP+F ++L
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDL 303
Query: 171 PK 172
+
Sbjct: 304 ER 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 49/174 (28%), Positives = 70/174 (40%), Gaps = 37/174 (21%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV-LAR 79
+ HRDLK N LL+ + LKICDFG ++ V T Y APE+ L
Sbjct: 149 VLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 80 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTIDRIRN-- 124
K Y I D+WS G L ML +P + D P ++ ++ I N
Sbjct: 207 KGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS--QEDLNCIINLK 263
Query: 125 -VQYF--LPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
Y LP +V + LL ++ +P KRI + + HP+
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-11
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 46/177 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYIAPEVLAR-K 80
I HRD+K EN L+ S +K+CDFG++++ L + + V T Y APE+L
Sbjct: 145 IIHRDIKPENILVSQSGV--VKLCDFGFART--LAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 81 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQ-----------Y 127
+Y + DVW+ G + M +G +P + D + I
Sbjct: 201 KYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDID------QLYHIMMCLGNLIPRHQELFN 253
Query: 128 FLPDYV------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
P + ++S L + DP KR E+ H +F
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-11
Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 50/178 (28%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARKEY 82
+ HRDLK +N L++ + LKI DFG +++ + + + + T Y AP+VL K+Y
Sbjct: 121 VLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF------------ 128
I D+WS G M+ G +P D + RI F
Sbjct: 179 STTI-DIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRI-----FRILGTPNSKNWP 226
Query: 129 ----LPDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
LP Y + LLS++ DP++RI + +H +F
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-11
Identities = 58/228 (25%), Positives = 82/228 (35%), Gaps = 58/228 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 79
I HRDLK N LLD + LK+ DFG +KS P V T Y APE+L
Sbjct: 133 ILHRDLKPNNLLLDENGV--LKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNFRKTIDRIRNVQYF-------- 128
+ Y + D+W+ G L +L+ PF + D + RI F
Sbjct: 188 RMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLD------QLTRI-----FETLGTPTE 234
Query: 129 --------LPDYV---------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
LPDYV D L+ +F+ +P RI + K +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 166 FL-KNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATK 212
F + P ++ + N + + I R EA G K
Sbjct: 295 FSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 43/180 (23%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
I HRDLK N ++ LKI DFG +++ + T V T Y APEV+ Y
Sbjct: 185 IIHRDLKPSNIVVKSDCT--LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 83 DGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-DRIRNVQY 127
+ D+WS G + M+ +P D D F K + +RN
Sbjct: 241 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 128 FLPDYVRVS---------------------ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
P Y ++ + R LLS++ V DP+KRI + + +HP+
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 43/181 (23%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKST-------VGTPAYIA 73
+ HRDLK N L++ + LK+CDFG +S +S+P V T Y A
Sbjct: 133 VIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 74 PEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTI 119
PEV L +Y + DVWSCG L + + +P D P + +
Sbjct: 191 PEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS-DNDL 248
Query: 120 DRIRN---VQYF--LPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
I + +Y LP Y + LL ++ V DP+KRI E +HP+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 166 F 166
Sbjct: 309 L 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 40/146 (27%), Positives = 56/146 (38%), Gaps = 43/146 (29%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK------ST--VGTPA 70
+L E HRD+K N LLD + KI DFG +++ K ++ VGT A
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTA--KISDFGLARAS-----EKFAQTVMTSRIVGTTA 200
Query: 71 YIAPEVLARKEY-DGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
Y+AP E G+I SD++S GV L ++ G +D R Q
Sbjct: 201 YMAP------EALRGEITPKSDIYSFGVVLLEIITG-------------LPAVDEHREPQ 241
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPS 152
L D D + D
Sbjct: 242 L-LLDIKEEIEDEEKTIEDY--IDKK 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 39/205 (19%), Positives = 66/205 (32%), Gaps = 60/205 (29%)
Query: 25 ICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHSQPKST-V 66
+ H DLK EN L S +++ DFG S + +T V
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIV 200
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFED---------------- 108
T Y PEV+ + DVWS G L+ G + +
Sbjct: 201 ATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIP 259
Query: 109 --------------------PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 148
E+ + R + + ++ ++ L+ ++
Sbjct: 260 SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319
Query: 149 ADPSKRIPIPEIKKHPWFLKNLPKE 173
DP++RI + E HP+F P+E
Sbjct: 320 FDPAQRITLAEALLHPFFAGLTPEE 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 48/185 (25%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 79
I HRDLK +N L++ + +LK+ DFG +++ P +T V T Y AP+VL
Sbjct: 129 ILHRDLKPQNLLIN--KRGQLKLGDFGLARA---FGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 80 KEYDGKISDVWSCGVTLYVML--------------------------------VGAYPFE 107
+ Y I D+WSCG L M+ V P
Sbjct: 184 RTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 108 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 167
+P + + + ++ + + L + +P R+ + HPWF
Sbjct: 243 NPNIQQRPPRDLRQV----LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF- 297
Query: 168 KNLPK 172
Sbjct: 298 AEYYH 302
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 49/206 (23%), Positives = 67/206 (32%), Gaps = 61/206 (29%)
Query: 25 ICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHSQPKST-V 66
+ H DLK EN L S P +K+ DFG S + ST V
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEHHSTLV 195
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLY---------------------VMLVGAYP 105
T Y APEV+ + DVWS G L ++G P
Sbjct: 196 STRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254
Query: 106 ------------FED-----PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 148
F E R + ++ F+ L+ ++
Sbjct: 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314
Query: 149 ADPSKRIPIPEIKKHPWFLKNLPKEI 174
DP+KRI + E KHP+F L K I
Sbjct: 315 YDPAKRITLREALKHPFF-DLLKKSI 339
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 43/194 (22%), Positives = 72/194 (37%), Gaps = 38/194 (19%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQP-KSTVGTPAYIAPEVL-A 78
I HRD+K N L+ LK+ DFG +S + + V T Y PE+L
Sbjct: 145 ILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202
Query: 79 RKEYDGKISDVWSCGVTLYVMLVG--------------------------AYP-FEDPED 111
++Y I D+W G + M +P ++ E
Sbjct: 203 ERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 261
Query: 112 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-L 170
+ R V+ L YVR L+ ++ V DP++RI + H +F + +
Sbjct: 262 YEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320
Query: 171 PKEIIEIEKTNYKE 184
P ++ + T+
Sbjct: 321 PSDLKGMLSTHLTS 334
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 41/207 (19%), Positives = 68/207 (32%), Gaps = 67/207 (32%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------------------ 65
+ HRD+K N LL+ +K+ DFG S+S + + +
Sbjct: 129 GLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 66 ----VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG------------------ 102
V T Y APE+ L +Y I D+WS G L +L G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 103 -----------------------AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
+ + N R + +N+ + + +
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWF 166
LL ++ +P+KRI + KHP+
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 41/102 (40%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STV--GTPAYIAPE 75
YL I HRD+K N LLD + P KI DFG SK G Q STV GT YI PE
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
Query: 76 VLARKEYDGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRN 114
+ G++ SDV+S GV L+ +L PR
Sbjct: 212 YFIK----GRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 39/206 (18%), Positives = 62/206 (30%), Gaps = 68/206 (33%)
Query: 25 ICHRDLKLENTLLDGSP-----------------------QPRLKICDFGYSKSGLLHSQ 61
+ H DLK EN LLD +K+ DFG S
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKSD 214
Query: 62 PKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------- 111
+ + T Y APEV+ +D D+WS G L + G+ + + +
Sbjct: 215 YHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES 273
Query: 112 -----PRNFRKTIDRIRNVQYFLPDYVRVS--------------------------ADCR 140
P+N + +Y D ++++
Sbjct: 274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333
Query: 141 HLLSQIFVADPSKRIPIPEIKKHPWF 166
L I DP+ R E+ KH +
Sbjct: 334 DFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 31/89 (34%), Positives = 41/89 (46%), Gaps = 22/89 (24%)
Query: 21 YLQEIC-----HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 70
YL + C HRD+K N LLD + + DFG +K L + V GT
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTIG 200
Query: 71 YIAPEVLARKEYDGKI---SDVWSCGVTL 96
+IAPE L+ GK +DV+ GV L
Sbjct: 201 HIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 45/220 (20%), Positives = 69/220 (31%), Gaps = 80/220 (36%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFG---------------------YSKSGLLHSQP 62
I HRDLK N LL+ +K+CDFG + +
Sbjct: 149 GIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 63 KST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG----------------- 102
+ T V T Y APE+ L ++ Y I D+WS G +L
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 103 -------AYPFEDPEDPRNFRKTIDRIRNV------------------QYF--LPDYVRV 135
++ R ++ I N+ +Y P +
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 136 ---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
S D +LL + +P+KRI I + HP+
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL++ HRDL N L+ +PQ +KI DFG +K LL ++ K + A
Sbjct: 132 YLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMA 187
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E + + Y + SDVWS GVT++ +M G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 28/97 (28%), Positives = 37/97 (38%), Gaps = 14/97 (14%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI--- 72
YL+ HRDL N LL + +KI DFG + L
Sbjct: 136 YLESKRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWC 191
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
APE L + + SD W GVTL+ + G P+
Sbjct: 192 APESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL+E HR+L N LL SP ++++ DFG + LL K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E + +Y + SDVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 31/168 (18%), Positives = 51/168 (30%), Gaps = 47/168 (27%)
Query: 42 QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV 101
+ ++KI D G + H + T Y + EVL Y+ D+WS + +
Sbjct: 232 KLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGSGYNTPA-DIWSTACMAFELAT 288
Query: 102 GAYPFEDPEDPRNFRKTIDRI-------------------RNVQYF-------------- 128
G Y F +P + + D I + ++F
Sbjct: 289 GDYLF-EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347
Query: 129 ------LPDYVRVSAD----CRHLLSQIFVADPSKRIPIPEIKKHPWF 166
L + S + L + P KR E +HPW
Sbjct: 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL++ HRDL N L+ +PQ +KI DFG +K LL ++ K + A
Sbjct: 132 YLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMA 187
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E + + Y + SDVWS GVT++ +M G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 31/84 (36%), Positives = 38/84 (45%), Gaps = 11/84 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL HRDL N L+ + R+KI DFG +K L + V P A
Sbjct: 129 YLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYA 185
Query: 74 PEVLARKEYDGKISDVWSCGVTLY 97
PE L ++ SDVWS GV LY
Sbjct: 186 PESLTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 31/84 (36%), Positives = 38/84 (45%), Gaps = 11/84 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL HRDL N L+ + R+KI DFG +K L + V P A
Sbjct: 160 YLGTKRYIHRDLATRNILV--ENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYA 216
Query: 74 PEVLARKEYDGKISDVWSCGVTLY 97
PE L ++ SDVWS GV LY
Sbjct: 217 PESLTESKFSVA-SDVWSFGVVLY 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 8/93 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEV 76
Y++ HRDL+ N L+ K+ DFG ++ + APE
Sbjct: 295 YVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 77 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ K SDVWS G+ L + G P+
Sbjct: 353 ALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 33/97 (34%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGT--P-AYI 72
YL+E HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
APE + ++ K SDVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEV 76
YL++ HR+L N L+ +K+ DFG S+ + APE
Sbjct: 333 YLEKKNFIHRNLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 77 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
LA ++ K SDVW+ GV L+ + G P+
Sbjct: 391 LAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL+E HRDL N LL + KI DFG SK+ L T + A
Sbjct: 125 YLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYA 181
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
PE + +++ + SDVWS GVT++ + G P++
Sbjct: 182 PECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 8/93 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEV 76
Y++ HRDL+ N L+ K+ DFG ++ + APE
Sbjct: 378 YVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 77 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ K SDVWS G+ L + G P+
Sbjct: 436 ALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 42/163 (25%), Positives = 63/163 (38%), Gaps = 25/163 (15%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL+ C HRDL N L+ + + LKI DFG S+ + G + A
Sbjct: 228 YLESKCCIHRDLAARNCLV--TEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTA 283
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLP 130
PE L Y + SDVWS G+ L+ +GA P+ + V+ LP
Sbjct: 284 PEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPN-------LSNQQTREFVEKGGRLP 335
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
L+ Q + +P +R I L+++ K
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIY---QELQSIRKR 375
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 10/88 (11%), Positives = 20/88 (22%), Gaps = 29/88 (32%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
+ + S + + PA +
Sbjct: 150 VALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDANPQ------ 182
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDP 112
D+ G +LY +LV +P +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 31/99 (31%), Positives = 40/99 (40%), Gaps = 12/99 (12%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL HRDL N L+ S +KI DFG +K L + V P A
Sbjct: 142 YLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAKL-LPLDKDYYVVREPGQSPIFWYA 198
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 111
PE L+ + + SDVWS GV LY + +
Sbjct: 199 PESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 14/97 (14%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI--- 72
YL+E HR+L N LL + KI DFG SK L + + +
Sbjct: 451 YLEEKNFVHRNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWY 506
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
APE + +++ + SDVWS GVT++ + G P++
Sbjct: 507 APECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 48/230 (20%), Positives = 69/230 (30%), Gaps = 92/230 (40%)
Query: 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------------- 70
I HRDLK N L++ +K+CDFG +++ S +
Sbjct: 176 GILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 71 ---------------YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 114
Y APE+ L ++ Y I DVWS G +L R
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 115 --F----------------------------------------RKTIDRIRNVQYFLPDY 132
F + I+ + Y
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK--EDAKRY 350
Query: 133 VR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+R SAD HLL ++ V +P+KRI I E HP+F
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 14/94 (14%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
YL+ HRDL N L+ S K+ DFG +K + + APE
Sbjct: 304 YLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 356
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
L K++ K SDVWS G+ L+ + G P+
Sbjct: 357 ALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---AP 74
YL ++ HRDL N L+ K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 75 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E +A + + SDVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 30/84 (35%), Positives = 38/84 (45%), Gaps = 11/84 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL HRDL N LL + + +KI DFG +K+ + V A
Sbjct: 149 YLHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYA 205
Query: 74 PEVLARKEYDGKISDVWSCGVTLY 97
PE L ++ SDVWS GVTLY
Sbjct: 206 PECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 19 CFYLQE--ICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 72
C YL+E HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAMLPVK 251
Query: 73 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE + K +D WS GV L+ + +G P+
Sbjct: 252 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-06
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARKE 81
HRDL N LL +KICDFG ++ ++ P A + APE + +
Sbjct: 216 HRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPETIFDRV 271
Query: 82 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI 119
Y + SDVWS GV L+ + +GA P+ + F + +
Sbjct: 272 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 19 CFYLQE--ICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 72
C YL+E HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVK 210
Query: 73 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE + K +D WS GV L+ + +G P+
Sbjct: 211 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-06
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
YL+E C HRDL N L+ +K+ DFG ++ +L Q S+ GT + +PE
Sbjct: 119 YLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPE 175
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
V + Y K SDVWS GV ++ V G P+E+
Sbjct: 176 VFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 13/85 (15%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYI----- 72
YL HRDL N L++ + ++KI DFG +K + + + TV
Sbjct: 141 YLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWY 196
Query: 73 APEVLARKEYDGKISDVWSCGVTLY 97
APE L + ++ SDVWS GVTL+
Sbjct: 197 APECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 10/95 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---AP 74
YL + HRDL N L+ + K+ DFG S+ + +T G I AP
Sbjct: 162 YLANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 75 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E ++ +++ SDVWS G+ ++ VM G P+ +
Sbjct: 220 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 7e-06
Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYD 83
HRDL N L+ +K+ DFG ++ +L Q S+VGT + APEV +Y
Sbjct: 127 HRDLAARNCLV--DRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SDVW+ G+ ++ V +G P++
Sbjct: 184 SK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
++++ HRDL+ N L+ S KI DFG ++ + ++ + G I APE
Sbjct: 299 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ + K SDVWS G+ L ++ G P+
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-06
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 14/97 (14%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI--- 72
YL ++ HRDL N L+ + K+ DFG + +L P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILI--NSNLVCKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 73 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+PE +A +++ SDVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYD 83
HRDL N L+ S K+ DFG +K + + APE L K++
Sbjct: 140 HRDLAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SDVWS G+ L+ + G P+
Sbjct: 193 TK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPEVLARKEYD 83
HRDL N L+ +K+ DFG S+ + + G P + APE LA ++
Sbjct: 134 HRDLAARNCLV--GENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SDVW+ GV L+ + G P+
Sbjct: 191 IK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYD 83
HRDL+ N L+ S KI DFG ++ + ++ + G I APE + +
Sbjct: 132 HRDLRAANILV--SDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SDVWS G+ L ++ G P+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 27 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYD 83
HRDL N L+ + Q +K+ DFG S+ +L + S+VG+ + PEVL ++
Sbjct: 143 HRDLAARNCLV--NDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 84 GKISDVWSCGVTLY-VMLVGAYPFED 108
K SD+W+ GV ++ + +G P+E
Sbjct: 200 SK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPE 75
YL+ HRD+ N L+ S +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ + + SDVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 12/84 (14%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
+L HRD+ N LL + KI DFG ++ + + V A + A
Sbjct: 179 FLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMA 234
Query: 74 PEVLARKEYDGKISDVWSCGVTLY 97
PE + Y + SDVWS G+ L+
Sbjct: 235 PESIFDCVYTVQ-SDVWSYGILLW 257
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL Q+ HRDL N L+ + +KI DFG ++ +++ T + A
Sbjct: 172 YLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMA 227
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 105
PE L + Y + SDVWS GV ++ + +G P
Sbjct: 228 PEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-05
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APE 75
YL+ I HRD+ + N L+ +K+ DFG S+ + T I +PE
Sbjct: 128 YLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPE 184
Query: 76 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
+ + + SDVW V ++ ++ G PF
Sbjct: 185 SINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 13/94 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL HRDL N L+ + +KI DFG ++ +++ T + A
Sbjct: 218 YLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMA 273
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE L + Y + SDVWS GV ++ + +G P+
Sbjct: 274 PEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 28/84 (33%), Positives = 40/84 (47%), Gaps = 12/84 (14%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL ++ HRDL N L+ + +KI DFG ++ +H T + A
Sbjct: 206 YLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMA 261
Query: 74 PEVLARKEYDGKISDVWSCGVTLY 97
PE L + Y + SDVWS GV L+
Sbjct: 262 PEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-05
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 12/86 (13%)
Query: 19 CFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL Q HRDL N L+ +KI DFG S+ ++S VG +
Sbjct: 146 MVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRW 201
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY 97
PE + +++ + SDVWS GV L+
Sbjct: 202 MPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-05
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
+L ++ HRDL N LL S + +KICDFG ++ ++ P A + A
Sbjct: 163 FLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMA 218
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE + + Y + SDVWS GV L+ + +GA P+
Sbjct: 219 PETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 9e-05
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 21 YLQEIC--HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVG-TPA-YIAP 74
YL+ HRD+ N L+ S +K+ DFG S+ + K++ G P ++AP
Sbjct: 506 YLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAP 561
Query: 75 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
E + + + SDVW GV ++ +++ G PF+
Sbjct: 562 ESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 13/96 (13%)
Query: 19 CFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL + HRDL N +L + + DFG S+ ++S G + +
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLPVKW 205
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
A E LA Y SDVW+ GVT++ +M G P+
Sbjct: 206 LALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 13/94 (13%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL ++ HRDL N L+ + ++KI DFG S+ ++ + + I A
Sbjct: 165 YLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSR--DVYEEDSYVKRSQGRIPVKWMA 220
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
E L Y + SDVWS GV L+ ++ +G P+
Sbjct: 221 IESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 13/93 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
+L HRDL N LL + KICDFG ++ + + V A + A
Sbjct: 160 FLASKNCIHRDLAARNILL--THGRITKICDFGLAR--DIKNDSNYVVKGNARLPVKWMA 215
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 105
PE + Y + SDVWS G+ L+ + +G+ P
Sbjct: 216 PESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 13/96 (13%)
Query: 19 CFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL E HRDL N L+ +KI DFG S++ ++S I
Sbjct: 187 MAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYSADYYKADGNDAIPIRW 242
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE + Y + SDVW+ GV L+ + G P+
Sbjct: 243 MPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 13/96 (13%)
Query: 19 CFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL + HRDL N ++ + +KI DFG ++ ++ G +
Sbjct: 151 MAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 206
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
+PE L + SDVWS GV L+ + + P+
Sbjct: 207 MSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 13/96 (13%)
Query: 19 CFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL + HRDL N +L + + DFG SK ++S G A +
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKMPVKW 215
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
A E LA + Y K SDVW+ GVT++ + G P+
Sbjct: 216 IAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 13/96 (13%)
Query: 19 CFYL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL HRDL N L+ +KI DFG S+ ++S VG +
Sbjct: 171 MVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRTMLPIRW 226
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
PE + +++ + SDVWS GV L+ + G P+
Sbjct: 227 MPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 14/100 (14%)
Query: 19 CFYLQEIC--HRDLKLENTLLDGSPQPRL------KICDFGYSKSGLLHSQPKSTVGTPA 70
+L+E H ++ +N LL + K+ D G S + L + +
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---P 182
Query: 71 YIAPEVLA-RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 108
++ PE + K + +D WS G TL+ + G P
Sbjct: 183 WVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 2e-04
Identities = 34/208 (16%), Positives = 62/208 (29%), Gaps = 59/208 (28%)
Query: 22 LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81
LQ++ ++ + D S +L+I LL S+P + VL
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----CLL---VL---- 250
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPE--DPRNFR-KTI--DRIRNVQYFLPDYVRV- 135
+V + + + N K + R + V FL
Sbjct: 251 -L----NVQ-----------------NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 136 -----------SADCRHLLSQIFVADPSKRIPIPEIKK-HPWFLKNLPKEIIEIEKT--N 181
+ + LL + P +P E+ +P L + + I + T N
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQD-LP-REVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 182 YKEAGRDQPTQSVEEIMRIIQEAKMPGE 209
+K D+ + I+ P E
Sbjct: 347 WKHVNCDK----LTTIIESSLNVLEPAE 370
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 29/93 (31%), Positives = 40/93 (43%), Gaps = 16/93 (17%)
Query: 21 YL--QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
YL ++ HRDL N L+ KI DFG S+ ++ T + A
Sbjct: 157 YLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRWMA 209
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 105
E L Y SDVWS GV L+ ++ +G P
Sbjct: 210 IESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 13/93 (13%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----A 73
+L+ HRDL N L+ + +KICDFG ++ + S V A + A
Sbjct: 187 FLEFKSCVHRDLAARNVLV--THGKVVKICDFGLARD--IMSDSNYVVRGNARLPVKWMA 242
Query: 74 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 105
PE L Y K SDVWS G+ L+ + +G P
Sbjct: 243 PESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 6e-04
Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 11/96 (11%)
Query: 19 CFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
+L HRDL N +LD +K+ DFG ++ T A +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
A E L +++ K SDVWS GV L+ +M GA P+
Sbjct: 263 MALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 8e-04
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 13/96 (13%)
Query: 19 CFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---- 72
YL + H+DL N L+ + +KI D G + +++ + + +
Sbjct: 141 MEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLGNSLLPIRW 196
Query: 73 -APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 106
APE + ++ SD+WS GV L+ V G P+
Sbjct: 197 MAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.68 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.46 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.18 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.73 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.47 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 93.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 92.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 92.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.59 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 88.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 81.51 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=313.62 Aligned_cols=158 Identities=39% Similarity=0.603 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.........+.+||+.|||||++.+..|++.+
T Consensus 115 ~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~ 192 (275)
T 3hyh_A 115 RRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192 (275)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------------CTTSCHHHHSSSSCCCTH
T ss_pred HHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCCh
Confidence 456778889999999999999999999999988776 999999999865545555677999999999999998887666
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 166 (246)
+||||+||++|+|++|+.||.+.+. ..++..+.+..+.+|. .+|+++++||.+||++||++|||++|+++||||
T Consensus 193 ~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 193 VDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred hhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 9999999999999999999987543 3344445555555554 689999999999999999999999999999999
Q ss_pred ccCCCh
Q 025933 167 LKNLPK 172 (246)
Q Consensus 167 ~~~~~~ 172 (246)
+...++
T Consensus 267 k~~~p~ 272 (275)
T 3hyh_A 267 KVDLPE 272 (275)
T ss_dssp HTTCCG
T ss_pred ccCCCh
Confidence 876553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=313.96 Aligned_cols=159 Identities=28% Similarity=0.514 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||+|||++|||||||||+|||++.++. |||+|||+|+..... ....+.+||+.|||||++.+..|+.+
T Consensus 173 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~ 250 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcH
Confidence 456778899999999999999999999999988876 999999999854332 33456799999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|||||||++|+|++|++||.+.+..+.+..+.. ......+.+..+|+++++||.+||++||++|||++|+|+|||
T Consensus 251 -~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 251 -VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 9999999999999999999987655444333221 222334455679999999999999999999999999999999
Q ss_pred cccCCC
Q 025933 166 FLKNLP 171 (246)
Q Consensus 166 ~~~~~~ 171 (246)
|.+..+
T Consensus 327 ~~~~~~ 332 (346)
T 4fih_A 327 LAKAGP 332 (346)
T ss_dssp GGGCCC
T ss_pred hcCCCC
Confidence 987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=308.63 Aligned_cols=153 Identities=31% Similarity=0.528 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhccccccCC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
.++.||+.||+|||+++||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|||||++.+..|+.
T Consensus 136 ~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~ 213 (311)
T 4aw0_A 136 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 213 (311)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc
Confidence 45678889999999999999999999999988876 99999999985432 22345678999999999999888865
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH-----
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE----- 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e----- 159 (246)
++||||+||++|+|++|++||.+.+.. .++.++.+..+.+|. .+|+++++||.+||++||.+|+|++|
T Consensus 214 -~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~ 286 (311)
T 4aw0_A 214 -SSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYG 286 (311)
T ss_dssp -HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred -HHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCH
Confidence 499999999999999999999875543 344455555555554 68999999999999999999999987
Q ss_pred -HhcCcccccC
Q 025933 160 -IKKHPWFLKN 169 (246)
Q Consensus 160 -~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 287 ~i~~Hp~F~~i 297 (311)
T 4aw0_A 287 PLKAHPFFESV 297 (311)
T ss_dssp HHHTSGGGTTC
T ss_pred HHHCCCCcCCC
Confidence 6899999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.05 Aligned_cols=159 Identities=28% Similarity=0.514 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||+|||++|||||||||+||||+.++. |||+|||+|+..... ....+.+||+.|||||++.+..|+.+
T Consensus 250 ~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~ 327 (423)
T 4fie_A 250 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 327 (423)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcH
Confidence 456778899999999999999999999999988876 999999999854332 33456789999999999998888755
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|||||||++|+|++|++||.+....+.+..+.. ......+.+..+|+++++||.+||++||.+|||+.|+|+|||
T Consensus 328 -~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 328 -VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred -HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 9999999999999999999987655444333221 222334455679999999999999999999999999999999
Q ss_pred cccCCC
Q 025933 166 FLKNLP 171 (246)
Q Consensus 166 ~~~~~~ 171 (246)
|.+..+
T Consensus 404 ~~~~~~ 409 (423)
T 4fie_A 404 LAKAGP 409 (423)
T ss_dssp GGGCCC
T ss_pred hcCCCC
Confidence 987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=301.33 Aligned_cols=155 Identities=23% Similarity=0.401 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.||+.||+|||+++ ||||||||+|||+++ ++. +||+|||+|+.. ......+.+||+.|||||++.+ .|
T Consensus 131 ~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~-~y 206 (290)
T 3fpq_A 131 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KY 206 (290)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT-CC
T ss_pred HHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC-CC
Confidence 3456788999999999999 999999999999975 455 999999999843 2333456789999999999865 57
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|++||.+......+. ..+.............++++++||.+||.+||.+|||++|+|+
T Consensus 207 ~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 207 DES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHH---HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 655 999999999999999999998765544333 3333322222223457899999999999999999999999999
Q ss_pred Cccccc
Q 025933 163 HPWFLK 168 (246)
Q Consensus 163 hp~~~~ 168 (246)
||||++
T Consensus 283 Hp~~~~ 288 (290)
T 3fpq_A 283 HAFFQE 288 (290)
T ss_dssp SGGGC-
T ss_pred CccccC
Confidence 999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=303.61 Aligned_cols=154 Identities=31% Similarity=0.500 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|||||++.+..|+.+
T Consensus 129 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~ 206 (304)
T 3ubd_A 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206 (304)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTH
T ss_pred HHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCccccccccCcccCCHHHhccCCCCCC
Confidence 345678889999999999999999999999988876 99999999985432 234456789999999999999888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
+||||+||++|+|++|++||.+.+..+. +..+.+....+|. .+|+++++||++||++||++||| ++|+
T Consensus 207 -~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~ei 279 (304)
T 3ubd_A 207 -ADWWSFGVLMFEMLTGTLPFQGKDRKET----MTMILKAKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279 (304)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHH
T ss_pred -CcccchHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHH
Confidence 9999999999999999999987654433 3444444544444 68999999999999999999998 5899
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 280 l~Hp~f~~i 288 (304)
T 3ubd_A 280 KRHSFFSTI 288 (304)
T ss_dssp HTSGGGTTC
T ss_pred HcCccccCC
Confidence 999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=310.61 Aligned_cols=157 Identities=27% Similarity=0.421 Sum_probs=129.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.||+.||.|||++|||||||||+|||++.++. |||+|||+|+...... ...+.+||+.|||||++.+..|+.
T Consensus 127 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~ 204 (350)
T 4b9d_A 127 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCc
Confidence 3456788999999999999999999999999988776 9999999998543221 123457999999999999988875
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|||||||++|+|++|++||.+.+..+.+. ++....+ .+....+|+++++||.+||++||.+|||++|+|+||
T Consensus 205 ~-~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 205 K-SDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred H-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 5 999999999999999999998765544333 3333332 233457899999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||.+..
T Consensus 279 ~~~~~~ 284 (350)
T 4b9d_A 279 FIAKRI 284 (350)
T ss_dssp HHHTTG
T ss_pred HhhcCC
Confidence 997654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.64 Aligned_cols=163 Identities=23% Similarity=0.290 Sum_probs=131.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-----CCCCCCCCCCCCCCcchhccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-----HSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|||||++.+..
T Consensus 161 ~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 161 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC
Confidence 456778889999999999999999999999998876 99999999985422 22345678999999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------------CCCC---------CCcCC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY----------------FLPD---------YVRVS 136 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------~~~~---------~~~~~ 136 (246)
+.+.++||||+||++|+|++|++||.+.+....+..++........ .++. ++.++
T Consensus 239 ~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 318 (398)
T 4b99_A 239 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGAD 318 (398)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCC
T ss_pred CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCC
Confidence 6666699999999999999999999987776666665543321110 0010 23578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+++++||.+||++||.+|||++|+|+||||.+...
T Consensus 319 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 319 RQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.43 Aligned_cols=207 Identities=63% Similarity=1.061 Sum_probs=147.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++.++..++||+|||+++...........+||+.|+|||++.+..+++
T Consensus 117 ~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 196 (361)
T 3uc3_A 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCH
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCC
Confidence 34567889999999999999999999999999987776679999999998544444455678999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+++|||||||++|+|++|+.||.+......+.+.+..+....+..|....+++.+++||.+||..||.+|||+.++++||
T Consensus 197 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 66899999999999999999998877666677777777777777777778999999999999999999999999999999
Q ss_pred ccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHhcCCCccc
Q 025933 165 WFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEAT 211 (246)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (246)
||.+..+.................+..++++++.+.+.+...+....
T Consensus 277 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
T 3uc3_A 277 WFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323 (361)
T ss_dssp HHHTTCCCC------------------CCHHHHHHHHHHHTCC----
T ss_pred chhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCccccc
Confidence 99887665544332222222334456678889999888887766543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=302.44 Aligned_cols=160 Identities=27% Similarity=0.450 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----------------------------
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---------------------------- 59 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---------------------------- 59 (246)
..+.|++.||+|||++|||||||||+|||++.+. +.+||+|||+|+.....
T Consensus 121 ~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (361)
T 4f9c_A 121 EYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSR 199 (361)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGGGGGC--------------------
T ss_pred HHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccccccccccccccccccccccccccc
Confidence 4567888999999999999999999999998652 24999999999732211
Q ss_pred -CCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHH---------------
Q 025933 60 -SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRI--------------- 122 (246)
Q Consensus 60 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~--------------- 122 (246)
....+.+||+.|||||++.+..+++.++||||+||++|+|++|+.||....+. ..+..+....
T Consensus 200 ~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~ 279 (361)
T 4f9c_A 200 RQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKS 279 (361)
T ss_dssp ------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEE
T ss_pred cccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccc
Confidence 11234589999999999988765556699999999999999999999765543 2232222110
Q ss_pred -------------------hccc--------------cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 123 -------------------RNVQ--------------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 123 -------------------~~~~--------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
.... ...+.+..+|++++|||++||++||++|+|++|+|+||||+.
T Consensus 280 ~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 280 ILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp EEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 011234568999999999999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=297.35 Aligned_cols=158 Identities=22% Similarity=0.258 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC------CCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS------QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~------~~~~~~gt~~y~aPE~~~~ 79 (246)
...++.|++.||+|||+++||||||||+|||++.++. ++||+|||+|+...... ...+.+||+.|||||++.+
T Consensus 152 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 152 ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC
Confidence 3456788899999999999999999999999987652 49999999998543221 1233579999999999999
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC-CCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..|+.+ +|||||||++|+|++|++||.+......+.++.. ..... ..++.+++.+++||.+||++||.+|||+.
T Consensus 231 ~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~ 305 (336)
T 4g3f_A 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAM 305 (336)
T ss_dssp CCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 888765 9999999999999999999987665544444432 22111 22347899999999999999999999999
Q ss_pred HH-------------hcCcccccC
Q 025933 159 EI-------------KKHPWFLKN 169 (246)
Q Consensus 159 e~-------------l~hp~~~~~ 169 (246)
|+ ++|||+.+.
T Consensus 306 el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 306 ELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHHhhhhhccCCCcCCC
Confidence 97 578988653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.27 Aligned_cols=154 Identities=29% Similarity=0.443 Sum_probs=127.1
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-ccCCcch
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDGKIS 87 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~ 87 (246)
.+.||+.||.|||++|||||||||+||||+.++. |||+|||+|+... .....+.+||+.|||||++.++ .|+ .++
T Consensus 297 y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~-~~~~~t~~GTp~YmAPEvl~~~~~y~-~~v 372 (689)
T 3v5w_A 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYD-SSA 372 (689)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS-SCCCCSCCSCGGGCCHHHHSTTCCCC-THH
T ss_pred HHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecC-CCCCCCccCCcCccCHHHHhCCCCCC-cHH
Confidence 4567789999999999999999999999998877 9999999998543 3345677999999999999754 565 559
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKK 162 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~ 162 (246)
|||||||++|+|++|.+||.+..... ...+...+......+|. .+|+++++||.+||++||.+|++ ++|+++
T Consensus 373 DiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 373 DWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 99999999999999999997644322 23445555555554454 69999999999999999999998 799999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 450 HpfF~~i 456 (689)
T 3v5w_A 450 SPFFRSL 456 (689)
T ss_dssp SGGGTTC
T ss_pred CccccCC
Confidence 9999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=283.97 Aligned_cols=154 Identities=22% Similarity=0.358 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-------------CCCCCCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------QPKSTVGTPAYI 72 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-------------~~~~~~gt~~y~ 72 (246)
...++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.||
T Consensus 120 ~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Ym 197 (299)
T 4g31_A 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM 197 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC--------------------------CCCTTS
T ss_pred HHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCCccccccccccccccccCCcccCcccc
Confidence 3456789999999999999999999999999988876 9999999998532211 123457999999
Q ss_pred cchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 73 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
|||++.+..|+.+ +|||||||++|+|++ ||.+. ......+..+....+ .+.+...++.+++||++||++||.
T Consensus 198 APE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~---~~~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~ 269 (299)
T 4g31_A 198 SPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQ---MERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPM 269 (299)
T ss_dssp CHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSH---HHHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGG
T ss_pred CHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCc---cHHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChh
Confidence 9999999888765 999999999999995 88542 122233333333322 123345678899999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 025933 153 KRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 153 ~R~t~~e~l~hp~~~~~ 169 (246)
+|||+.|+++||||...
T Consensus 270 ~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 270 ERPEAINIIENAVFEDL 286 (299)
T ss_dssp GSCCHHHHHTSGGGCCC
T ss_pred HCcCHHHHhcCHhhCCC
Confidence 99999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=280.02 Aligned_cols=156 Identities=21% Similarity=0.318 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhcccc-
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARK- 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~- 80 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|||||++.+.
T Consensus 133 ~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~ 210 (307)
T 3omv_A 133 QLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------------CCCCTTSCCHHHHHCCS
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcceeecccccCCCccCHHHhhccC
Confidence 45678899999999999999999999999999998776 99999999985322 1223456899999999999643
Q ss_pred --ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 81 --EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 81 --~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
.|+.+ +|||||||++|||++|+.||.+......+...+...............+++.+.+|+.+||+.||.+|||+.
T Consensus 211 ~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 289 (307)
T 3omv_A 211 NNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFP 289 (307)
T ss_dssp SCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHH
T ss_pred CCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 45544 999999999999999999998776655444333221111111122346899999999999999999999999
Q ss_pred HHhcC
Q 025933 159 EIKKH 163 (246)
Q Consensus 159 e~l~h 163 (246)
+++++
T Consensus 290 ei~~~ 294 (307)
T 3omv_A 290 QILSS 294 (307)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.11 Aligned_cols=159 Identities=26% Similarity=0.461 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
...+.||+.||+|||+++|+||||||+|||++.+..+.+||+|||+|+.........+.+||+.|||||++.+..|+.+
T Consensus 258 ~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~- 336 (573)
T 3uto_A 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY- 336 (573)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHH-
T ss_pred HHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcH-
Confidence 3456788899999999999999999999999876445699999999986555544556789999999999999888644
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+|||||||++|+|++|.+||.+....+.+ ..+....+.++ .+..+|+++++||++||++||.+|||+.|+|+||
T Consensus 337 ~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 337 TDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99999999999999999999876654443 34444444333 3457999999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||....
T Consensus 413 w~~~~~ 418 (573)
T 3uto_A 413 WLTPGN 418 (573)
T ss_dssp TTSCCC
T ss_pred CcCCCC
Confidence 998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.81 Aligned_cols=198 Identities=25% Similarity=0.342 Sum_probs=137.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..|+.+
T Consensus 166 ~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 243 (464)
T 3ttj_A 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243 (464)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHH
Confidence 3456889999999999999999999999999998776 99999999986544444556789999999999999888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------cCCCCCCc----------------
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------YFLPDYVR---------------- 134 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~---------------- 134 (246)
+||||+||++|+|++|+.||.+.+....+.+++....... ...+....
T Consensus 244 -~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (464)
T 3ttj_A 244 -VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 322 (464)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred -HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccc
Confidence 9999999999999999999998776666665554321110 00000000
Q ss_pred -----CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHhcC
Q 025933 135 -----VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKM 206 (246)
Q Consensus 135 -----~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (246)
.++++++||.+||..||.+|||++|+|+||||.....................+....+.+++.+.+.+..+
T Consensus 323 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 399 (464)
T 3ttj_A 323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 399 (464)
T ss_dssp HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHH
Confidence 156799999999999999999999999999998766544332211111222233345567777766655433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.51 Aligned_cols=152 Identities=22% Similarity=0.367 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.||+.||+|||+++||||||||+|||++.++. +||+|||+|+....... ..+.+||+.|||||++.+..
T Consensus 186 ~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 263 (353)
T 4ase_A 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 263 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC
Confidence 34567889999999999999999999999999988876 99999999985432221 23457999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|||++ |+.||.+......+.+.+... ...+.+..+++++.+|+.+||+.||.+|||+.++
T Consensus 264 y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g----~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 264 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp CCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC----CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 8755 999999999999998 999998866555444443321 2233344689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 339 l~~ 341 (353)
T 4ase_A 339 VEH 341 (353)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=273.36 Aligned_cols=151 Identities=20% Similarity=0.317 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+...... .....+||+.|||||++.+..
T Consensus 159 ~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC----------------CCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EEEcccccceeccCCCcceecCcccccccccChhhhcCCC
Confidence 45678899999999999999999999999999998776 9999999998542221 223457999999999999988
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|||++ |+.||.+....+.+. .+.... ..+.+..+++++.+|+.+||+.||++|||+.|+
T Consensus 237 ~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~----~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 237 FTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----CITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH----HHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred CCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 8755 999999999999998 899998766543332 332222 233345789999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 311 ~~~ 313 (329)
T 4aoj_A 311 HAR 313 (329)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=270.81 Aligned_cols=151 Identities=23% Similarity=0.336 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.||+.||+|||+++||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..
T Consensus 146 ~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 223 (308)
T 4gt4_A 146 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 223 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC
Confidence 35678899999999999999999999999999998876 999999999853222 2234457999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|||++ |..||.+....+ ++..+.... ..|.+..++..+.+|+.+||..||.+|||+.++
T Consensus 224 ~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~----~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 224 FSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD----VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHH----HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8765 999999999999998 899998765533 333333322 334555799999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 298 ~~~ 300 (308)
T 4gt4_A 298 HSR 300 (308)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.83 Aligned_cols=157 Identities=35% Similarity=0.585 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..+.+.
T Consensus 116 ~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (328)
T 3fe3_A 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred HHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCc
Confidence 3466788999999999999999999999999988776 99999999975544444556789999999999998888766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
++||||+||++|+|++|..||.+.... .....+....+..|. .+++++.+||++||..||.+|||++++++|||
T Consensus 194 ~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 194 EVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIPF--YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 799999999999999999999875433 333444455555554 58999999999999999999999999999999
Q ss_pred cccCC
Q 025933 166 FLKNL 170 (246)
Q Consensus 166 ~~~~~ 170 (246)
|....
T Consensus 268 ~~~~~ 272 (328)
T 3fe3_A 268 INAGH 272 (328)
T ss_dssp TTTTC
T ss_pred hcCCC
Confidence 97643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=270.33 Aligned_cols=149 Identities=23% Similarity=0.336 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+...... .....+||+.|||||++.+..
T Consensus 129 ~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 129 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC
Confidence 45678899999999999999999999999999988876 9999999997432221 122346999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|||++ |+.||.+.+..+. +..+.... ..+.+..+|+++.+|+.+||+.||++|||+.++
T Consensus 207 ~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 207 FTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8765 999999999999998 8999987665433 33333322 223345789999999999999999999999998
Q ss_pred h
Q 025933 161 K 161 (246)
Q Consensus 161 l 161 (246)
.
T Consensus 281 ~ 281 (299)
T 4asz_A 281 H 281 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.73 Aligned_cols=164 Identities=24% Similarity=0.292 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC----------------------CCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL----------------------HSQPK 63 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~----------------------~~~~~ 63 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .....
T Consensus 111 ~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (388)
T 3oz6_A 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188 (388)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred HHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccccccccccccccccccccccccccccc
Confidence 3456789999999999999999999999999988776 99999999974321 11123
Q ss_pred CCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------------
Q 025933 64 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------- 127 (246)
Q Consensus 64 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------- 127 (246)
..+||++|+|||++.+....+.++||||+||++|+|++|++||.+.+....+..++..+.....
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp -CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 4579999999999987443345599999999999999999999987766665555432211000
Q ss_pred -------------------------CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 128 -------------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 128 -------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.......+++++++||++||..||.+|||++++++||||.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred hCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 00011257899999999999999999999999999999976544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=260.83 Aligned_cols=162 Identities=25% Similarity=0.301 Sum_probs=130.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..++.
T Consensus 121 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 198 (308)
T 3g33_A 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT 198 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCS
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCc
Confidence 34567889999999999999999999999999988776 9999999998654444445568999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCC--------------------CCCcCCHHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP--------------------DYVRVSADCRHLL 143 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~li 143 (246)
+ +|||||||++|+|++|..||.+......+.++......... .++ ..+.++..+.+||
T Consensus 199 ~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (308)
T 3g33_A 199 P-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLL 277 (308)
T ss_dssp T-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHH
T ss_pred h-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHH
Confidence 5 89999999999999999999887766666555544321110 000 0135789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccccC
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.+||..||.+|||+.++++||||.+.
T Consensus 278 ~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 278 LEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHhcCCCccCCCHHHHhcCccccCC
Confidence 99999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=260.96 Aligned_cols=155 Identities=32% Similarity=0.560 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...+.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.+
T Consensus 108 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 185 (337)
T 1o6l_A 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT
T ss_pred HHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCch
Confidence 445778899999999999999999999999988776 99999999985322 233455689999999999988888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|+|||||++|+|++|..||.+...... ...+......+|. .+++++++||.+||..||.+|| +++++
T Consensus 186 -~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei 258 (337)
T 1o6l_A 186 -VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258 (337)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred -hhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 9999999999999999999987554333 3333334444443 6899999999999999999999 89999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 259 ~~h~~f~~~~ 268 (337)
T 1o6l_A 259 MEHRFFLSIN 268 (337)
T ss_dssp HTSGGGTTCC
T ss_pred HcCCCcCCCC
Confidence 9999997643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=267.42 Aligned_cols=158 Identities=30% Similarity=0.488 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||.|||++|||||||||+|||++.++. +||+|||+++... ......+.+||+.|+|||++.+..++.+
T Consensus 156 ~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~ 233 (396)
T 4dc2_A 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233 (396)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChH
Confidence 345778899999999999999999999999988876 9999999998532 2334456789999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH---
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPR-----NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI--- 157 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--- 157 (246)
+|||||||++|+|++|+.||....... ........+......+|. .++.++++||++||++||.+|+++
T Consensus 234 -~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~ 310 (396)
T 4dc2_A 234 -VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQ 310 (396)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTT
T ss_pred -HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCC
Confidence 999999999999999999996533211 112233444444444454 689999999999999999999985
Q ss_pred ---HHHhcCcccccC
Q 025933 158 ---PEIKKHPWFLKN 169 (246)
Q Consensus 158 ---~e~l~hp~~~~~ 169 (246)
+++++||||...
T Consensus 311 ~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 311 TGFADIQGHPFFRNV 325 (396)
T ss_dssp THHHHHHHSTTTTTC
T ss_pred CCHHHHhcCccccCC
Confidence 799999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.18 Aligned_cols=154 Identities=32% Similarity=0.520 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.|++.||.|||++|||||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.+
T Consensus 127 ~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 204 (353)
T 3txo_A 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPA 204 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTH
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCc
Confidence 456788899999999999999999999999988876 99999999985332 223345689999999999988888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH------HH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI------PE 159 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e 159 (246)
+|||||||++|+|++|..||.+.+.... ...+......+|. .++..+++||++||.+||.+||++ ++
T Consensus 205 -~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~ 277 (353)
T 3txo_A 205 -VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHA 277 (353)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHH
T ss_pred -cCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHH
Confidence 9999999999999999999987654333 3444444544454 589999999999999999999998 89
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 278 il~hp~f~~~ 287 (353)
T 3txo_A 278 ILRHPFFKEI 287 (353)
T ss_dssp HHTSGGGTTC
T ss_pred HhhCCcccCC
Confidence 9999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=270.90 Aligned_cols=196 Identities=23% Similarity=0.300 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--------------------------
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-------------------------- 59 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-------------------------- 59 (246)
...++.||+.||+|||++|||||||||+|||++.++. +||+|||+++.....
T Consensus 158 ~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (458)
T 3rp9_A 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235 (458)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCCCCCC------------------
T ss_pred HHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCccccccccccCcccccccccccccccc
Confidence 4556789999999999999999999999999988876 999999999853211
Q ss_pred --CCCCCCCCCCCCCcchhccc-cccCCcchhHHhHHHHHHHHHh-----------CCCCCCCCCC--------------
Q 025933 60 --SQPKSTVGTPAYIAPEVLAR-KEYDGKISDVWSCGVTLYVMLV-----------GAYPFEDPED-------------- 111 (246)
Q Consensus 60 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~-----------g~~Pf~~~~~-------------- 111 (246)
......+||++|+|||++.. ..|+ .++|||||||++|+|++ |.++|.+...
T Consensus 236 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~ 314 (458)
T 3rp9_A 236 LKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFK 314 (458)
T ss_dssp ---------CCCTTCCHHHHTTCCCCC-THHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------------
T ss_pred ccccccCCcccccccChHHhhCCCCCC-cHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccc
Confidence 12234578999999998754 4555 45999999999999998 6777765431
Q ss_pred ------hHHHHHHHHHHhcc-------------------------ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 112 ------PRNFRKTIDRIRNV-------------------------QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 112 ------~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
...+..++..+... ......++..++++++||++||.+||.+|||++|+
T Consensus 315 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~ 394 (458)
T 3rp9_A 315 FHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC 394 (458)
T ss_dssp --CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 11111121111000 00011234579999999999999999999999999
Q ss_pred hcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 161 KKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 161 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
|+||||.....................+....+.+++.+.+.+.
T Consensus 395 L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 438 (458)
T 3rp9_A 395 LAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKE 438 (458)
T ss_dssp HHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHH
T ss_pred hcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHH
Confidence 99999987654332211111111111122345666676665543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=265.73 Aligned_cols=158 Identities=41% Similarity=0.672 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||++..........+.+||+.|+|||++.+..+.+.
T Consensus 110 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 187 (336)
T 3h4j_B 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCH
T ss_pred HHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCC
Confidence 4566788999999999999999999999999988776 99999999986555555566789999999999998887666
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
++|||||||++|+|++|..||.+...... ...+....+..| ..+++.+++||++||..||.+|||++++++|||
T Consensus 188 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKVNSCVYVMP--DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BCCCCSSCCCCC--TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ccchhHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCCCCc--ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 69999999999999999999976543221 111222222333 358999999999999999999999999999999
Q ss_pred cccCCC
Q 025933 166 FLKNLP 171 (246)
Q Consensus 166 ~~~~~~ 171 (246)
|....+
T Consensus 262 ~~~~~~ 267 (336)
T 3h4j_B 262 FNVNLP 267 (336)
T ss_dssp HHTTCC
T ss_pred hccCCc
Confidence 987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.87 Aligned_cols=195 Identities=26% Similarity=0.349 Sum_probs=133.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..++.+
T Consensus 129 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 206 (371)
T 2xrw_A 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----------------CTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccccccCCceecCCccCHHHhcCCCCCch
Confidence 4567889999999999999999999999999988776 99999999985443333455689999999999998888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------cCCCCC------------------
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------YFLPDY------------------ 132 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~------------------ 132 (246)
+|||||||++|+|++|..||.+.+....+..++....... ...+.+
T Consensus 207 -~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (371)
T 2xrw_A 207 -VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS 285 (371)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSS
T ss_pred -HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccc
Confidence 8999999999999999999988665544444432210000 000000
Q ss_pred ---CcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHH
Q 025933 133 ---VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203 (246)
Q Consensus 133 ---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (246)
...+..+++||++||..||.+|||++++++||||.............+.......+....+.+++.+++..
T Consensus 286 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (371)
T 2xrw_A 286 EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYK 359 (371)
T ss_dssp HHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHH
T ss_pred cccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHH
Confidence 01257899999999999999999999999999998776654333222222233334455677777776554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.90 Aligned_cols=160 Identities=28% Similarity=0.468 Sum_probs=131.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC--CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++...........+||+.|+|||++.+..++
T Consensus 117 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCC
Confidence 4567888999999999999999999999999976652 25999999999865544445667899999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+...... +..+....+.++ .+..++..+++||.+||..||.+|||+.+++
T Consensus 197 ~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 197 LE-ADMWSIGVITYILLSGASPFLGDTKQET----LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp TH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 9999999999999999999987654333 333444443333 2356899999999999999999999999999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||....
T Consensus 272 ~hp~~~~~~ 280 (361)
T 2yab_A 272 RHPWITPVD 280 (361)
T ss_dssp TSTTTSCSS
T ss_pred cCcCcCCCc
Confidence 999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=272.86 Aligned_cols=164 Identities=32% Similarity=0.542 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++|||||||||+|||++... .+.+||+|||+++.........+.+||+.|+|||++.+..++
T Consensus 162 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 241 (400)
T 1nxk_A 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241 (400)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSS
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCC
Confidence 3456788999999999999999999999999998732 245999999999865444445567899999999999888887
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+.............+....+.+ +.+..++.++++||++||..||.+|||+.+++
T Consensus 242 ~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 242 KS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp SH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred Cc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 9999999999999999999976543221111122233333333 34467899999999999999999999999999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 321 ~hp~~~~~ 328 (400)
T 1nxk_A 321 NHPWIMQS 328 (400)
T ss_dssp HSHHHHTT
T ss_pred cCccccCC
Confidence 99999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=255.80 Aligned_cols=162 Identities=25% Similarity=0.325 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+....+
T Consensus 121 ~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (311)
T 3niz_A 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCC
Confidence 3456788999999999999999999999999988776 999999999754322 2334457999999999997744334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-CC-----------------------CCCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LP-----------------------DYVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~ 140 (246)
.++||||+||++|+|++|+.||.+......+..+.......... .+ ....++++++
T Consensus 199 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (311)
T 3niz_A 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278 (311)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHH
T ss_pred chHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHH
Confidence 55999999999999999999998877766666555433211100 00 0134788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+||.+||..||.+|||++++++||||...
T Consensus 279 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 279 DLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 99999999999999999999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.82 Aligned_cols=193 Identities=23% Similarity=0.325 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 84 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++... ......+||+.|+|||++.+ ..++
T Consensus 130 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~- 204 (367)
T 1cm8_A 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYT- 204 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccc--cccCcCcCCCCcCCHHHHhCCCCCC-
Confidence 4556789999999999999999999999999988776 9999999998532 23455689999999999987 4555
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------------------cCCCCCCcCCHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-------------------------YFLPDYVRVSADC 139 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~ 139 (246)
.++||||+||++|+|++|+.||.+......+..++....... .....+...++.+
T Consensus 205 ~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (367)
T 1cm8_A 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 284 (367)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHH
T ss_pred hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 449999999999999999999988776555555443221100 0001124579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHhc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 205 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (246)
++||.+||..||.+|||++++++||||............. .+ ....+....+.+++.+.+.+..
T Consensus 285 ~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 348 (367)
T 1cm8_A 285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KY-DDSFDDVDRTLDEWKRVTYKEV 348 (367)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CC-CCC-----CCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CC-CCChhhhcCCHHHHHHHHHHHH
Confidence 9999999999999999999999999998755433221111 11 1112223456777777765543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.38 Aligned_cols=160 Identities=27% Similarity=0.397 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+..++.
T Consensus 118 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 195 (297)
T 3fxz_A 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195 (297)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCc
Confidence 4567888999999999999999999999999988776 9999999987543222 234457999999999999888865
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|||||||++|+|++|..||.+.........+.. ...........++..+++||.+||..||.+|||+.++++||
T Consensus 196 ~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred H-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 5 9999999999999999999987655444333222 22223334457899999999999999999999999999999
Q ss_pred ccccCCC
Q 025933 165 WFLKNLP 171 (246)
Q Consensus 165 ~~~~~~~ 171 (246)
||....+
T Consensus 272 ~~~~~~~ 278 (297)
T 3fxz_A 272 FLKIAKP 278 (297)
T ss_dssp GGGGCCC
T ss_pred hhcccCc
Confidence 9976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=266.57 Aligned_cols=162 Identities=26% Similarity=0.331 Sum_probs=129.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEec-CCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~-~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||++||+||||||+|||++ .++. +||+|||+++...........+||+.|+|||++.+....+
T Consensus 143 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (394)
T 4e7w_A 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220 (394)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCC
Confidence 345678899999999999999999999999998 4554 9999999998654455556678999999999997765334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------c---cCCCC----------CCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------Q---YFLPD----------YVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~----------~---~~~~~----------~~~~~~~~~~ 141 (246)
.++||||+||++|+|++|+.||.+......+.+++...... . ..++. ...+++++++
T Consensus 221 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (394)
T 4e7w_A 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300 (394)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHH
Confidence 55999999999999999999999877666666655432110 0 01111 1247899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
||.+||..||.+|||+.++++||||...
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 301 LISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 9999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=262.74 Aligned_cols=159 Identities=31% Similarity=0.547 Sum_probs=129.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+|||++.++. ..+||+|||++............+||+.|+|||++.+..++
T Consensus 129 ~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (362)
T 2bdw_A 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCC
Confidence 34567889999999999999999999999999976532 45999999999865544444566899999999999888886
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+...... ...+....+. .+.+..+++++++||.+||..||.+|||+.+++
T Consensus 209 ~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 209 KP-VDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ch-hhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 55 9999999999999999999987554333 3333333333 334567899999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 284 ~hp~~~~ 290 (362)
T 2bdw_A 284 KVPWICN 290 (362)
T ss_dssp TSHHHHT
T ss_pred cCcccCC
Confidence 9999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.44 Aligned_cols=155 Identities=32% Similarity=0.512 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.
T Consensus 123 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (353)
T 2i0e_A 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCC
Confidence 3456788999999999999999999999999988776 99999999985322 22345568999999999999888865
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e 159 (246)
+ +|||||||++|+|++|..||.+.+.... ...+......+|. .++.++++||++||.+||.+||+ +++
T Consensus 201 ~-~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 273 (353)
T 2i0e_A 201 S-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273 (353)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHH
T ss_pred c-ccccchHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 5 9999999999999999999987554333 3344444444444 68999999999999999999995 699
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 274 i~~h~~f~~~ 283 (353)
T 2i0e_A 274 IKEHAFFRYI 283 (353)
T ss_dssp HHTSGGGTTC
T ss_pred HhcCccccCC
Confidence 9999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.59 Aligned_cols=161 Identities=27% Similarity=0.408 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-ccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 84 (246)
...++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++...........+||+.|+|||++.+. .++
T Consensus 158 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~- 235 (420)
T 1j1b_A 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT- 235 (420)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCC-
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCC-
Confidence 3456789999999999999999999999999986532 4899999999865444445567899999999999765 454
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------c---ccCCCC----------CCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------V---QYFLPD----------YVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~----------~---~~~~~~----------~~~~~~~~~~ 141 (246)
.++|||||||++|+|++|+.||.+....+.+.+++..+.. . .+.+|. ...+++++++
T Consensus 236 ~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 315 (420)
T 1j1b_A 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315 (420)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHH
Confidence 4599999999999999999999987766666666543211 0 111111 1246899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
||.+||.+||.+|||+.|+++||||..
T Consensus 316 Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 316 LCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 999999999999999999999999965
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=261.42 Aligned_cols=155 Identities=35% Similarity=0.631 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...+.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.+
T Consensus 121 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 198 (345)
T 1xjd_A 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 198 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCCh
Confidence 345788999999999999999999999999988776 99999999985332 223455689999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH-HHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP-EIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp 164 (246)
+|+|||||++|+|++|..||.+.+... +...+......+|. .++.++++||.+||..||.+||++. ++++||
T Consensus 199 -~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 199 -VDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred -hhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCCCCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 999999999999999999998755433 33334444444443 5899999999999999999999998 999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||....
T Consensus 272 ~f~~~~ 277 (345)
T 1xjd_A 272 LFREIN 277 (345)
T ss_dssp GGTTCC
T ss_pred cccCCC
Confidence 997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=258.52 Aligned_cols=159 Identities=30% Similarity=0.482 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....+.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++.
T Consensus 112 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 189 (345)
T 3a8x_A 112 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCcccccCCCccccCccccCCCCCCh
Confidence 3456778899999999999999999999999988776 99999999985322 23345568999999999999888865
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH--
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-- 157 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-- 157 (246)
+ +|+|||||++|+|++|..||...... .........+......+|. .++..+++||++||.+||.+||++
T Consensus 190 ~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~ 266 (345)
T 3a8x_A 190 S-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHP 266 (345)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCT
T ss_pred H-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCC
Confidence 5 99999999999999999999753221 1122233344444444444 689999999999999999999995
Q ss_pred ----HHHhcCcccccC
Q 025933 158 ----PEIKKHPWFLKN 169 (246)
Q Consensus 158 ----~e~l~hp~~~~~ 169 (246)
+++++||||...
T Consensus 267 ~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 267 QTGFADIQGHPFFRNV 282 (345)
T ss_dssp TTHHHHHHTSGGGTTC
T ss_pred cCCHHHHhcCCccCCC
Confidence 799999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=252.17 Aligned_cols=161 Identities=22% Similarity=0.309 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+....+
T Consensus 102 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (288)
T 1ob3_A 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccccccccccccccCchheeCCCCCC
Confidence 4567889999999999999999999999999988776 99999999874321 12233457999999999997654334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C-------------C---------CCCCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F-------------L---------PDYVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~-------------~---------~~~~~~~~~~~~ 141 (246)
.++|||||||++|+|++|..||.+......+..+......... . . .....+++++++
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T 1ob3_A 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (288)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence 5599999999999999999999887665555555443211100 0 0 011357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
||.+||..||.+|||+.++++||||.+
T Consensus 260 li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 260 LLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.87 Aligned_cols=153 Identities=35% Similarity=0.592 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++... ....+.+||+.|+|||++.+..++.+
T Consensus 109 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~- 183 (318)
T 1fot_A 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKS- 183 (318)
T ss_dssp HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--SCBCCCCSCTTTCCHHHHTTCCBCTT-
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecC--CccccccCCccccCHhHhcCCCCCcc-
Confidence 446788999999999999999999999999988776 9999999998532 23345689999999999998888755
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHHh
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIK 161 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l 161 (246)
+|+|||||++|+|++|..||.+.+....+. .+......+|. .++.++++||++||..||.+|+ ++++++
T Consensus 184 ~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 899999999999999999998765443333 33344444443 6899999999999999999999 899999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||....
T Consensus 258 ~hp~f~~~~ 266 (318)
T 1fot_A 258 NHPWFKEVV 266 (318)
T ss_dssp TSGGGSSCC
T ss_pred cCccccCCC
Confidence 999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.42 Aligned_cols=165 Identities=25% Similarity=0.354 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+....+
T Consensus 110 ~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 187 (317)
T 2pmi_A 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCC
Confidence 3445679999999999999999999999999988776 999999999754322 2334557999999999997654334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-------C---------------------CCCCcCC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------L---------------------PDYVRVS 136 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~---------------------~~~~~~~ 136 (246)
.++|||||||++|+|++|+.||.+......+..+.......... . .....++
T Consensus 188 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (317)
T 2pmi_A 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD 267 (317)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCC
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCC
Confidence 45999999999999999999998877655555544432111000 0 0112478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
.++++||.+||..||.+|||+.++++||||.+....
T Consensus 268 ~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 268 GNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 999999999999999999999999999999876554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.64 Aligned_cols=164 Identities=26% Similarity=0.338 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++||||||||+|||++.++...+||+|||++... .....+.+||+.|+|||++.+..++.+
T Consensus 202 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~ 279 (429)
T 3kvw_A 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMP 279 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET--TCCCCSSCSCGGGCCHHHHHTBCCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec--CCcccccCCCCCccChHHHhCCCCCch
Confidence 456788999999999999999999999999998876555999999999742 333456789999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------------CCC-------------------
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY----------------FLP------------------- 130 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------~~~------------------- 130 (246)
+|||||||++|+|++|.+||.+......+..++........ ..|
T Consensus 280 -~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (429)
T 3kvw_A 280 -IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358 (429)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE
T ss_pred -HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc
Confidence 99999999999999999999887766555554433210000 000
Q ss_pred ----------C--------CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 131 ----------D--------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 131 ----------~--------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
. ....++.+++||++||+.||.+|||+.|+|+||||++..+.
T Consensus 359 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp CTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred cchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 0 01237889999999999999999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=264.20 Aligned_cols=197 Identities=24% Similarity=0.301 Sum_probs=130.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----------------------C
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----------------------Q 61 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----------------------~ 61 (246)
....++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 130 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (432)
T 3n9x_A 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCcccccccccccccccccccccccccccchhcc
Confidence 34567889999999999999999999999999988776 9999999997532211 2
Q ss_pred CCCCCCCCCCCcchhccc-cccCCcchhHHhHHHHHHHHHhC-----------CCCCCCCCC-----------------h
Q 025933 62 PKSTVGTPAYIAPEVLAR-KEYDGKISDVWSCGVTLYVMLVG-----------AYPFEDPED-----------------P 112 (246)
Q Consensus 62 ~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g-----------~~Pf~~~~~-----------------~ 112 (246)
....+||++|+|||++.. ..++ .++||||+||++|+|++| .++|.+... .
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~-~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~ 286 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR 286 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCC-THHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCC-cccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchH
Confidence 355689999999999754 4454 559999999999999984 444433221 1
Q ss_pred HHHHHHHHHH--------------------hccccCCC-----CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 113 RNFRKTIDRI--------------------RNVQYFLP-----DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 113 ~~~~~~~~~~--------------------~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
..+..++..+ .......+ .++.+++++++||++||..||.+|||++|+|+||||.
T Consensus 287 ~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 287 DQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 1121111111 11111111 1245899999999999999999999999999999998
Q ss_pred cCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 168 KNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
....................+....+.+++.+.+.+.
T Consensus 367 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 403 (432)
T 3n9x_A 367 DVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKE 403 (432)
T ss_dssp TTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHH
T ss_pred hccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHH
Confidence 7654433222111111111122345666776665543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.06 Aligned_cols=160 Identities=23% Similarity=0.424 Sum_probs=129.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++....+.+||+|||+++............||+.|+|||++.+..++.
T Consensus 103 ~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (321)
T 1tki_A 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECH
T ss_pred HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCc
Confidence 34567889999999999999999999999999987434559999999998654433334557999999999998877754
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++|..||.+......+ ..+....+.++ .+..++.++++||.+||..||.+|||+.++++
T Consensus 183 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 183 A-TDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-hhHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4 99999999999999999999876544333 33333333332 23468999999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 258 hp~~~~~ 264 (321)
T 1tki_A 258 HPWLKQK 264 (321)
T ss_dssp SHHHHSC
T ss_pred ChhhccC
Confidence 9999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=252.97 Aligned_cols=157 Identities=34% Similarity=0.533 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcccccc-
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEY- 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~- 82 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+...
T Consensus 138 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 215 (298)
T 2zv2_A 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKI 215 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCC
Confidence 34567889999999999999999999999999988776 9999999997543222 2234579999999999976542
Q ss_pred -CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 -DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 -~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+.++|||||||++|+|++|..||.+.... .....+.......+....+++.+++||.+||..||.+|||+.+++
T Consensus 216 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIM----CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp EESHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCchhhhHhHHHHHHHHHHCCCCCCCccHH----HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 345589999999999999999999765432 223333444444555567999999999999999999999999999
Q ss_pred cCcccc
Q 025933 162 KHPWFL 167 (246)
Q Consensus 162 ~hp~~~ 167 (246)
+||||.
T Consensus 292 ~hp~~~ 297 (298)
T 2zv2_A 292 LHPWVT 297 (298)
T ss_dssp TCHHHH
T ss_pred cCcccc
Confidence 999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=265.24 Aligned_cols=158 Identities=32% Similarity=0.573 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||++||+||||||+|||++.. ..+.+||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 112 ~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCC
Confidence 34567889999999999999999999999999853 22459999999997543322 23456899999999999888886
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +||||+||++|+|++|.+||.+......+ ..+....+ ..+.+..+++++++||.+||..||.+|||+.++|
T Consensus 192 ~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L 266 (444)
T 3soa_A 192 KP-VDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266 (444)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred Cc-cccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 55 99999999999999999999875543333 33333333 3344567999999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 267 ~hp~~~~ 273 (444)
T 3soa_A 267 KHPWISH 273 (444)
T ss_dssp HSCTTHH
T ss_pred cCccccC
Confidence 9999954
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=250.01 Aligned_cols=163 Identities=21% Similarity=0.311 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+....+
T Consensus 103 ~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (292)
T 3o0g_A 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccccCCccccCCcChHHHcCCCCcC
Confidence 3456789999999999999999999999999988776 99999999975432 22334557999999999998766434
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHHhcccc-----------------------CCCCCCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRIRNVQY-----------------------FLPDYVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~ 140 (246)
.++||||+||++|+|++|..||....+.. .+..+......... .......++..++
T Consensus 181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (292)
T 3o0g_A 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260 (292)
T ss_dssp THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred chHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHH
Confidence 55999999999999999888865444433 33333332211100 0011235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+||++||..||.+|||++|+++||||....
T Consensus 261 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.11 Aligned_cols=158 Identities=32% Similarity=0.495 Sum_probs=128.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc---
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE--- 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--- 81 (246)
..++.|++.||.|||++|||||||||+|||++.++. +||+|||+++...... ...+.+||+.|+|||++.+..
T Consensus 171 ~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~ 248 (410)
T 3v8s_A 171 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248 (410)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred HHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCc
Confidence 345678899999999999999999999999988876 9999999997543222 234668999999999997654
Q ss_pred -cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC--CCCHH
Q 025933 82 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIPIP 158 (246)
Q Consensus 82 -~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ 158 (246)
++ .++|||||||++|+|++|+.||.+.+....+.+++.... ...+|....++.++++||++||..+|.+ |++++
T Consensus 249 ~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ 325 (410)
T 3v8s_A 249 YYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVE 325 (410)
T ss_dssp EEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHH
T ss_pred CCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCcccccHHHHHHHHHHccChhhhCCCCCHH
Confidence 44 449999999999999999999988666555555544322 2334555679999999999999999988 99999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 326 ei~~Hp~f~~~ 336 (410)
T 3v8s_A 326 EIKRHLFFKND 336 (410)
T ss_dssp HHHTSGGGCCS
T ss_pred HHhcCccccCC
Confidence 99999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.06 Aligned_cols=192 Identities=21% Similarity=0.333 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++... ......+||+.|+|||++.+ ..++
T Consensus 133 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 208 (367)
T 2fst_X 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYN 208 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC-----------------CCCTTCCHHHHTTCCSCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc--ccCCCcCcCcCccChHHHcCCcCCC
Confidence 34567889999999999999999999999999988776 9999999997532 23445689999999999987 4454
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------------cCCC------CCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-------------------YFLP------DYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~------~~~~~~~~ 138 (246)
.++||||+||++|+|++|+.||.+.+....+..++..+.... ...+ .+...++.
T Consensus 209 -~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (367)
T 2fst_X 209 -QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 287 (367)
T ss_dssp -TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHH
T ss_pred -chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHH
Confidence 459999999999999999999988776555555544321100 0001 12356899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHH
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (246)
+++||.+||..||.+|||+.++|+||||............. .+. ...+......+++.+.+.+
T Consensus 288 ~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 350 (367)
T 2fst_X 288 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYD-QSLESRDLLIDEWKSLTYD 350 (367)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CCC-GGGSSCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CCC-cchhhccCCHHHHHHHHHH
Confidence 99999999999999999999999999998765443211111 011 1112234456677666554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=256.04 Aligned_cols=161 Identities=29% Similarity=0.494 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC--CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+|||++.++ ...+||+|||+++...........+||+.|+|||++.+..+
T Consensus 115 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (326)
T 2y0a_A 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCC
Confidence 3456788999999999999999999999999998765 12499999999986544444556789999999999988887
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+ +|||||||++|+|++|..||.+......+. .+....+..+ .+..++..+++||++||..||.+|||+.++
T Consensus 195 ~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 269 (326)
T 2y0a_A 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269 (326)
T ss_dssp CTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 655 899999999999999999998755433332 2222222222 234689999999999999999999999999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 270 l~hp~~~~~~ 279 (326)
T 2y0a_A 270 LQHPWIKPKD 279 (326)
T ss_dssp HHSTTTSCCS
T ss_pred hcCCCccCCc
Confidence 9999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=266.57 Aligned_cols=157 Identities=34% Similarity=0.602 Sum_probs=131.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.........+.+||+.|+|||++.+..+.+.
T Consensus 118 ~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (476)
T 2y94_A 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 195 (476)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSH
T ss_pred HHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCC
Confidence 4566788999999999999999999999999988776 99999999986544444556789999999999998877666
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
++||||+||++|+|++|..||.+......+ ..+....+..|. .+++++++||++||..||.+|||+.++++|||
T Consensus 196 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKICDGIFYTPQ--YLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----HHHHTTCCCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred cceehhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCcCCCc--cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 699999999999999999999876654333 333444444443 58999999999999999999999999999999
Q ss_pred cccCC
Q 025933 166 FLKNL 170 (246)
Q Consensus 166 ~~~~~ 170 (246)
|....
T Consensus 270 ~~~~~ 274 (476)
T 2y94_A 270 FKQDL 274 (476)
T ss_dssp HHTTC
T ss_pred hhhcC
Confidence 97654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.07 Aligned_cols=161 Identities=23% Similarity=0.422 Sum_probs=130.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++.+..+.+||+|||+++...........+||+.|+|||++.+..++.
T Consensus 150 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 229 (387)
T 1kob_A 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229 (387)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCC
Confidence 34567889999999999999999999999999986554569999999998644333334457999999999998877764
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++|..||.+......+ ..+....+. .+.+..+++++++||.+||..||.+|||+.++++
T Consensus 230 ~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 230 Y-TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp H-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c-ccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 4 99999999999999999999876543333 233333322 2334578999999999999999999999999999
Q ss_pred CcccccCC
Q 025933 163 HPWFLKNL 170 (246)
Q Consensus 163 hp~~~~~~ 170 (246)
||||....
T Consensus 305 hp~~~~~~ 312 (387)
T 1kob_A 305 HPWLKGDH 312 (387)
T ss_dssp STTTSSCC
T ss_pred CccccCCc
Confidence 99997643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.50 Aligned_cols=153 Identities=29% Similarity=0.483 Sum_probs=127.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++... ....+.+||+.|+|||++.+..++.+
T Consensus 143 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 218 (350)
T 1rdq_E 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKA 218 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBCCCEECGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceecc--CCcccccCCccccCHHHhcCCCCCCc
Confidence 3456788999999999999999999999999988776 9999999998532 23345689999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
+|||||||++|+|++|..||.+...... ...+......+|. .++.++++||.+||..||.+||+ ++++
T Consensus 219 -~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei 291 (350)
T 1rdq_E 219 -VDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred -CCEecccHhHhHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHH
Confidence 9999999999999999999987554333 3334444444443 68999999999999999999998 9999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 292 ~~h~~f~~~ 300 (350)
T 1rdq_E 292 KNHKWFATT 300 (350)
T ss_dssp HTSGGGTTC
T ss_pred HhCcCcCCC
Confidence 999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=259.10 Aligned_cols=158 Identities=24% Similarity=0.395 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---ccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---KEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~ 82 (246)
...++.|++.||.|||++|||||||||+|||++.++. +||+|||+++.........+.+||+.|+|||++.+ ..+
T Consensus 117 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 194 (384)
T 4fr4_A 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194 (384)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCB
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCC
Confidence 3456778999999999999999999999999988876 99999999986544455566789999999999964 345
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-HHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-IPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l 161 (246)
+.+ +|||||||++|+|++|..||...... ........+.......| ..++..+.+||.+||..||.+||+ +++++
T Consensus 195 ~~~-~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 195 SFA-VDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CTT-HHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred Ccc-ceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 544 89999999999999999999754432 22333344444443334 368999999999999999999998 89999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 271 ~hp~f~~~ 278 (384)
T 4fr4_A 271 NFPYMNDI 278 (384)
T ss_dssp TSGGGTTC
T ss_pred cChhhhcC
Confidence 99999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.54 Aligned_cols=158 Identities=28% Similarity=0.462 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+|||+..+...++||+|||+++...........+||+.|+|||++.+..++.+
T Consensus 189 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 268 (373)
T 2x4f_A 189 TILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHH
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcH
Confidence 45567899999999999999999999999999544444699999999986544444455679999999999987777544
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|||||||++|+|++|..||.+......+..+. ...+.. ..+..+++++++||.+||..||.+|||+.++++|
T Consensus 269 -~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 269 -TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL----ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 899999999999999999998766554444333 222222 2345689999999999999999999999999999
Q ss_pred ccccc
Q 025933 164 PWFLK 168 (246)
Q Consensus 164 p~~~~ 168 (246)
|||..
T Consensus 344 p~~~~ 348 (373)
T 2x4f_A 344 PWLSD 348 (373)
T ss_dssp HHHHC
T ss_pred cCcCC
Confidence 99975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=262.86 Aligned_cols=155 Identities=32% Similarity=0.543 Sum_probs=126.6
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+ +|||||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..++
T Consensus 250 ~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC
T ss_pred HHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCC
Confidence 34567889999999998 99999999999999988776 99999999985322 2334556899999999999888886
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIP 158 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ 158 (246)
.+ +|||||||++|+|++|+.||.+...... ...+......+|. .+++++++||.+||.+||.+|| |++
T Consensus 328 ~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ 400 (446)
T 4ejn_A 328 RA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400 (446)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred Cc-cchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHH
Confidence 55 9999999999999999999987554333 3333333443443 6899999999999999999999 999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 401 ell~hp~f~~~ 411 (446)
T 4ejn_A 401 EIMQHRFFAGI 411 (446)
T ss_dssp HHHTSGGGTTC
T ss_pred HHHhCccccCC
Confidence 99999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=263.02 Aligned_cols=164 Identities=25% Similarity=0.336 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC--CCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~ 79 (246)
...++.||+.||.|||+++|+||||||+|||+... ..+.+||+|||+++..... ......+||+.|+|||++.+
T Consensus 130 ~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 45678899999999999999999999999999321 2234999999999753321 22344679999999999987
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHhccccC-C--------------------
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIRNVQYF-L-------------------- 129 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------~~~~~~~~~~~~~~~~-~-------------------- 129 (246)
....+.++|||||||++|+|++|.+||.+.... ..+..++..+...... +
T Consensus 210 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (405)
T 3rgf_A 210 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT 289 (405)
T ss_dssp CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGG
T ss_pred CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccC
Confidence 554455699999999999999999999765431 3333333222110000 0
Q ss_pred -----------CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 130 -----------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 130 -----------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
......+..+.+||.+||..||.+|||++|+|+||||...
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 290 YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp GTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred CCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 0001237789999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=252.87 Aligned_cols=153 Identities=20% Similarity=0.240 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++............||+.|+|||++.+ .++.
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 234 (311)
T 3p1a_A 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGT 234 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCST
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCc
Confidence 44567889999999999999999999999999988776 99999999876544444455679999999999876 5655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|||||||++|+|++|..||.+. ... ..+............++..+.+||.+||..||.+|||+.++++||
T Consensus 235 ~-~DiwslG~il~el~~g~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 235 A-ADVFSLGLTILEVACNMELPHGG---EGW----QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp H-HHHHHHHHHHHHHHHTCCCCSSH---HHH----HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCc---cHH----HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 4 99999999999999997766542 111 122221111112346899999999999999999999999999999
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
||++
T Consensus 307 ~~~~ 310 (311)
T 3p1a_A 307 VLRQ 310 (311)
T ss_dssp GGSC
T ss_pred cccC
Confidence 9974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=257.75 Aligned_cols=155 Identities=34% Similarity=0.492 Sum_probs=127.1
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...+.|++.||.|||++||+||||||+|||++.++. +||+|||+++... ......+.+||+.|+|||++.+..++.+
T Consensus 142 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (373)
T 2r5t_A 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT 219 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCch
Confidence 345778999999999999999999999999988776 9999999998532 2233456689999999999998887655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH----HHHh
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEIK 161 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l 161 (246)
+|+|||||++|+|++|..||.+.+....+. .+......++ ..++..+++||++||.+||.+|+++ .+++
T Consensus 220 -~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 220 -VDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSBHHHHHH----HHHHSCCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred -hhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 999999999999999999998755443333 3333333333 3689999999999999999999986 6999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||....
T Consensus 293 ~h~~f~~~~ 301 (373)
T 2r5t_A 293 SHVFFSLIN 301 (373)
T ss_dssp TSGGGTTCC
T ss_pred CCccccCCC
Confidence 999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=272.32 Aligned_cols=159 Identities=31% Similarity=0.445 Sum_probs=130.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||.|||++|||||||||+|||++.++. +||+|||+++.........+.+||+.|+|||++.+..++.+
T Consensus 288 ~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~ 365 (576)
T 2acx_A 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365 (576)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSH
T ss_pred HHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCccccccCCCccccCHHHHcCCCCCcc
Confidence 3456788999999999999999999999999988776 99999999986544434455689999999999998888755
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~ 160 (246)
+|||||||++|+|++|..||.+.........+...+......++ ..+++++++||++||..||.+|| +++++
T Consensus 366 -~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei 442 (576)
T 2acx_A 366 -PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442 (576)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH
T ss_pred -chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH
Confidence 89999999999999999999876543233334444444443344 36899999999999999999999 78999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 443 l~HpfF~~i 451 (576)
T 2acx_A 443 KEHPLFKKL 451 (576)
T ss_dssp HTSGGGTTC
T ss_pred HhChhhccC
Confidence 999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=253.36 Aligned_cols=161 Identities=34% Similarity=0.556 Sum_probs=129.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..
T Consensus 106 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 183 (323)
T 3tki_A 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC
Confidence 34567889999999999999999999999999988776 99999999974321 12233567999999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+.++|||||||++|+|++|..||.+......... .........+.+..++..+.+||.+||..||.+|||+.|++
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 655569999999999999999999987655322221 12222333444567999999999999999999999999999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||.+..
T Consensus 261 ~h~~~~~~~ 269 (323)
T 3tki_A 261 KDRWYNKPL 269 (323)
T ss_dssp TCTTTTCCC
T ss_pred hChhhcccc
Confidence 999997654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.57 Aligned_cols=162 Identities=26% Similarity=0.333 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+....+
T Consensus 114 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 191 (346)
T 1ua2_A 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 191 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred HHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCcccCCcccccccccCchHhhCCCCCC
Confidence 4567888999999999999999999999999988776 999999999854322 2334567999999999997655444
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCC---------------------CCcCCHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD---------------------YVRVSADCRHL 142 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------~~~~~~~~~~l 142 (246)
.++|||||||++|+|++|.+||.+......+..++........ .++. +..++.++++|
T Consensus 192 ~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (346)
T 1ua2_A 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271 (346)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred chhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHH
Confidence 5599999999999999999999887766666665554321110 0010 13567999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 143 LSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
|.+||..||.+|||+.|+++||||...
T Consensus 272 i~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 272 IQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHHhccChhhCCCHHHHhcChhhhcC
Confidence 999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=257.32 Aligned_cols=162 Identities=23% Similarity=0.318 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 83 (246)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.. .......+||+.|+|||++.+ ..++
T Consensus 145 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (371)
T 4exu_A 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYN 220 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccc--ccCcCCcccCccccCHHHhcCCCCCC
Confidence 34567889999999999999999999999999988776 999999999743 233455679999999999987 4555
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------------cCC------CCCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-------------------YFL------PDYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~~~~~~~~ 138 (246)
. ++|||||||++|+|++|..||.+......+..++....... ... ..+..+++.
T Consensus 221 ~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (371)
T 4exu_A 221 Q-TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 299 (371)
T ss_dssp T-THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHH
T ss_pred c-HHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChH
Confidence 4 49999999999999999999988766555554443221100 000 012357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
+++||.+||+.||.+|||+.++++||||.....
T Consensus 300 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 300 AADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 999999999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=254.38 Aligned_cols=164 Identities=21% Similarity=0.283 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-----CCCCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-----HSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-----~~~~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+
T Consensus 125 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccccccccCCcccccCccCchhhcC
Confidence 34567889999999999999999999999999988776 99999999874321 122344579999999999976
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-CCCCC-------------------------
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYV------------------------- 133 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------------- 133 (246)
....+.++|||||||++|+|++|..||.+.........+.......... .+...
T Consensus 203 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (351)
T 3mi9_A 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 282 (351)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHH
T ss_pred CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhc
Confidence 5433455999999999999999999998866554444443322211110 11110
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 134 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
..++.+++||.+||..||.+|||+.++++||||....
T Consensus 283 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 283 VRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 0278899999999999999999999999999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=274.85 Aligned_cols=154 Identities=32% Similarity=0.520 Sum_probs=129.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC-CCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||.|||+++||||||||+|||++.++. +||+|||+++... ......+.+||+.|+|||++.+..|+.+
T Consensus 445 ~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 522 (674)
T 3pfq_A 445 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 522 (674)
T ss_dssp HHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTH
T ss_pred HHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCcc
Confidence 456788999999999999999999999999998876 9999999998532 2233456689999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH-----HHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-----PEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~ 160 (246)
+|||||||++|+|++|..||.+.+..+ ++..+......+|. .++.++++||++||.+||.+|+++ +++
T Consensus 523 -~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei 595 (674)
T 3pfq_A 523 -VDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595 (674)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHH
T ss_pred -ceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHH
Confidence 999999999999999999998755433 34444555554554 689999999999999999999997 999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||...
T Consensus 596 ~~h~ff~~i 604 (674)
T 3pfq_A 596 KEHAFFRYI 604 (674)
T ss_dssp HSSGGGSSC
T ss_pred hcCccccCC
Confidence 999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.89 Aligned_cols=162 Identities=22% Similarity=0.321 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+....+
T Consensus 102 ~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC------------CGGGCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccccccCcccccChhhhcCCCCCC
Confidence 4456789999999999999999999999999988776 999999998743322 2233457899999999998744334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC-----------------------CCCCcCCHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL-----------------------PDYVRVSADCR 140 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~~ 140 (246)
.++||||+||++|+|++|..||.+.........+......... .+ .....++++++
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (324)
T 3mtl_A 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259 (324)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHH
Confidence 5599999999999999999999887665555444433221100 00 01235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+||.+||+.||.+|||++|+++||||...
T Consensus 260 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=256.49 Aligned_cols=166 Identities=25% Similarity=0.344 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+.
T Consensus 129 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCC
Confidence 34567889999999999999999999999999988776 9999999997433221 12445899999999987655
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------cCCC---------CCCcC
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------------YFLP---------DYVRV 135 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------~~~~---------~~~~~ 135 (246)
...+.++|||||||++|+|++|+.||.+......+..+........ ...+ ....+
T Consensus 207 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (364)
T 3qyz_A 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286 (364)
T ss_dssp CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS
T ss_pred CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC
Confidence 5334559999999999999999999988776666555543221100 0000 12357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 136 ~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
+.++++||.+||..||.+|||+.++++||||......
T Consensus 287 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 8999999999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=250.18 Aligned_cols=155 Identities=29% Similarity=0.474 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|||++.+..++.
T Consensus 123 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (327)
T 3a62_A 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCC
Confidence 4456789999999999999999999999999988776 99999999874322 22234567999999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPE 159 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e 159 (246)
+ +|||||||++|+|++|..||.+......+ ..+......+| ..++..+++||.+||..||.+|| ++.+
T Consensus 201 ~-~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e 273 (327)
T 3a62_A 201 A-VDWWSLGALMYDMLTGAPPFTGENRKKTI----DKILKCKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273 (327)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHH
T ss_pred c-ccchhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHH
Confidence 5 99999999999999999999876543333 33333343344 36899999999999999999999 8899
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 274 ~l~hp~f~~~ 283 (327)
T 3a62_A 274 VQAHPFFRHI 283 (327)
T ss_dssp HHHSGGGSSC
T ss_pred HHcCCcccCC
Confidence 9999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.22 Aligned_cols=157 Identities=13% Similarity=0.171 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc--cccCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDG 84 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ 84 (246)
+.++.|++.||+|||++|||||||||+|||++.++. +||+|||+++... .......||+.|+|||++.+ ..++
T Consensus 197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~- 271 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFT- 271 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECC-
T ss_pred HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcC-
Confidence 455689999999999999999999999999988776 9999999998432 12224567799999999986 5665
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHH--HHHH-HHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRN--FRKT-IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.++|||||||++|+|++|+.||.+...... +... ...........+....+++.+++||.+||..||.+|||+.+++
T Consensus 272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 449999999999999999999976532110 0000 0000112233444557899999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 352 ~hp~f~~ 358 (371)
T 3q60_A 352 ETPEFLQ 358 (371)
T ss_dssp TSHHHHH
T ss_pred cCHHHHH
Confidence 9999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.98 Aligned_cols=161 Identities=24% Similarity=0.341 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++. ++ .+||+|||+++............||+.|+|||++.+....+
T Consensus 143 ~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 143 ISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCC
Confidence 3456789999999999999999999999999974 44 49999999998655555556678999999999988765334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------ccCCC----------CCCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------QYFLP----------DYVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~ 141 (246)
.++||||+||++|+|++|+.||.+....+.+.+++...... ...+| ....++.++++
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 45999999999999999999999877766666655432110 00011 12247899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
||.+||..||.+|||+.|+++||||..
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=262.95 Aligned_cols=159 Identities=26% Similarity=0.463 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcc-----c
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLA-----R 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~-----~ 79 (246)
..++.|++.||.|||+++||||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++. .
T Consensus 178 ~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 255 (437)
T 4aw2_A 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255 (437)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSC
T ss_pred HHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCC
Confidence 346778899999999999999999999999988876 99999999975432222 23468999999999997 3
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCC--CCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSK--RIP 156 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~--R~t 156 (246)
..++. ++|||||||++|+|++|+.||.+.+..+.+.+++..... ..+|. ...+++++++||++||..+|++ |++
T Consensus 256 ~~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~ 332 (437)
T 4aw2_A 256 GRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--FQFPTQVTDVSENAKDLIRRLICSREHRLGQNG 332 (437)
T ss_dssp CEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT
T ss_pred CCCCC-cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--ccCCcccccCCHHHHHHHHHHhcccccccCCCC
Confidence 45654 499999999999999999999887665555555443222 22333 2468999999999999998888 999
Q ss_pred HHHHhcCcccccCC
Q 025933 157 IPEIKKHPWFLKNL 170 (246)
Q Consensus 157 ~~e~l~hp~~~~~~ 170 (246)
++++++||||....
T Consensus 333 ~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 333 IEDFKKHPFFSGID 346 (437)
T ss_dssp THHHHTSGGGTTCC
T ss_pred HHHHhCCCccCCCC
Confidence 99999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=253.91 Aligned_cols=162 Identities=34% Similarity=0.551 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+|||++. +..+.+||+|||+++...........+||+.|+|||++.+..++
T Consensus 149 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 228 (349)
T 2w4o_A 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228 (349)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCC
Confidence 34567889999999999999999999999999975 22345999999999854433334556799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+....... ...+...... .+.+..++.++++||++||..||.+|||+.+++
T Consensus 229 ~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 229 PE-VDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 55 99999999999999999999876554322 2233333322 233457899999999999999999999999999
Q ss_pred cCcccccCC
Q 025933 162 KHPWFLKNL 170 (246)
Q Consensus 162 ~hp~~~~~~ 170 (246)
+||||....
T Consensus 305 ~hp~~~~~~ 313 (349)
T 2w4o_A 305 QHPWVTGKA 313 (349)
T ss_dssp HSTTTTSTT
T ss_pred cCcccCCCc
Confidence 999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.22 Aligned_cols=161 Identities=31% Similarity=0.550 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC--CcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.|||++||+||||||+|||+..... ..+||+|||+++..... ....+.+||+.|+|||++.+..+
T Consensus 118 ~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 197 (342)
T 2qr7_A 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCC
Confidence 4567788999999999999999999999999854321 35999999999754322 23345689999999999988777
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+ +|||||||++|+|++|..||.+... .....++..+....+..+ .+..++.++++||++||..||.+|||+.++
T Consensus 198 ~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 198 DAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp HHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 655 8999999999999999999976432 223344455554444433 345789999999999999999999999999
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
++||||..
T Consensus 276 l~hp~~~~ 283 (342)
T 2qr7_A 276 LRHPWIVH 283 (342)
T ss_dssp TTSHHHHT
T ss_pred hcCCeecC
Confidence 99999954
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=267.76 Aligned_cols=159 Identities=28% Similarity=0.430 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-CCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... ..+.+||+.|+|||++.+..++.+
T Consensus 292 ~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 369 (543)
T 3c4z_A 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369 (543)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChH
Confidence 445778999999999999999999999999988876 99999999975433322 234589999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
+|||||||++|+|++|..||.+.........+...+.......| ..++..+++||++||.+||.+||+ ++++
T Consensus 370 -~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei 446 (543)
T 3c4z_A 370 -VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446 (543)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHH
T ss_pred -HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHH
Confidence 99999999999999999999876543333344444444444444 368999999999999999999996 5899
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 447 ~~Hpff~~i~ 456 (543)
T 3c4z_A 447 RTHPLFRDIS 456 (543)
T ss_dssp HTSGGGTTCC
T ss_pred HcCccccCCC
Confidence 9999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=243.99 Aligned_cols=162 Identities=30% Similarity=0.535 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. ..+||+|||++.............||+.|+|||++.+..++
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (284)
T 3kk8_A 106 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCC
Confidence 34567789999999999999999999999999976543 45999999999755444444556899999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||.+.........+.. ....+..+.+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 186 ~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 186 KP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh--ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 55 8999999999999999999987554333322221 11222334445789999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 263 ~~~~~~ 268 (284)
T 3kk8_A 263 PWICNR 268 (284)
T ss_dssp HHHHSC
T ss_pred ccccCC
Confidence 999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=248.49 Aligned_cols=160 Identities=28% Similarity=0.473 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 142 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2c30_A 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCC
Confidence 34567889999999999999999999999999987776 9999999987543222 23455799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|||||||++|+|++|..||.+........ .+... .........+++.+++||.+||..||.+|||+.++++
T Consensus 220 ~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 220 TE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 55 899999999999999999998755433322 22222 1122334468999999999999999999999999999
Q ss_pred CcccccCCC
Q 025933 163 HPWFLKNLP 171 (246)
Q Consensus 163 hp~~~~~~~ 171 (246)
||||.....
T Consensus 295 hp~~~~~~~ 303 (321)
T 2c30_A 295 HPFLLQTGL 303 (321)
T ss_dssp SGGGGGCCC
T ss_pred ChhhccCCC
Confidence 999976543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=250.46 Aligned_cols=194 Identities=22% Similarity=0.308 Sum_probs=136.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++... .......||+.|+|||++.+ ..++
T Consensus 127 ~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 202 (353)
T 3coi_A 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYN 202 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC----------CCSBCCSCHHHHSCCSCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC--CCccccccCcCcCCHHHHhCcCCCC
Confidence 34567889999999999999999999999999988776 9999999997532 22345679999999999977 4454
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------------------c-cCCCCCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------------------Q-YFLPDYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------~-~~~~~~~~~~~~ 138 (246)
.++|||||||++|+|++|..||.+......+..+....... . ........+++.
T Consensus 203 -~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T 3coi_A 203 -QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 281 (353)
T ss_dssp -TTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHH
T ss_pred -chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHH
Confidence 44999999999999999999998766554444443321100 0 001123467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
+++||.+||..||.+|||+.++++||||...............+ .........+.+++.+.+.+.
T Consensus 282 ~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 346 (353)
T 3coi_A 282 AADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPF-DDSLEHEKLTVDEWKQHIYKE 346 (353)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCC-CCTTTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCC-ccchhhccCCHHHHHHHHHHH
Confidence 99999999999999999999999999998654432111111111 111223345677777766543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=253.51 Aligned_cols=162 Identities=23% Similarity=0.362 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHHhH--hCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFY--LQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH--~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||.||| ++||+||||||+|||++. ++. +||+|||+++............||+.|+|||++.+...
T Consensus 131 ~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 208 (360)
T 3e3p_A 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQH 208 (360)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCC
Confidence 3456789999999999 999999999999999986 554 99999999986555545556689999999999976653
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------c------------------CCCCCCcCC
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------Y------------------FLPDYVRVS 136 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~------------------~~~~~~~~~ 136 (246)
.+.++|||||||++|+|++|..||.+......+..+........ . ........+
T Consensus 209 ~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3e3p_A 209 YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDA 288 (360)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhcccc
Confidence 34559999999999999999999988776555555544321100 0 001112257
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.++++||.+||+.||.+|||+.++++||||...
T Consensus 289 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 289 KEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 899999999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.84 Aligned_cols=164 Identities=20% Similarity=0.279 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++............||+.|+|||++.+....+.
T Consensus 132 ~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (330)
T 3nsz_A 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210 (330)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCc
Confidence 4557889999999999999999999999999986652 499999999986544445556689999999999987443345
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHH---------hccccC----------------------CCCCC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRI---------RNVQYF----------------------LPDYV 133 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~~~~~~---------~~~~~~----------------------~~~~~ 133 (246)
++|||||||++|+|++|..||....... .+..+.... ...... .....
T Consensus 211 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (330)
T 3nsz_A 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 290 (330)
T ss_dssp HHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG
T ss_pred hhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccc
Confidence 5999999999999999999996544432 222221111 000000 01112
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 134 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
.+++++++||.+||..||.+|||++++++||||....
T Consensus 291 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 291 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp GCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 3799999999999999999999999999999997654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=253.76 Aligned_cols=152 Identities=26% Similarity=0.396 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.........+.+||+.|+|||++.+..+.+.
T Consensus 132 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 209 (335)
T 3dls_A 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSH
T ss_pred HHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCC
Confidence 4567889999999999999999999999999988766 99999999986544444455679999999999988887566
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
++|||||||++|+|++|..||..... ..... ......++.++++||.+||..||.+|||+.++++|||
T Consensus 210 ~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 210 ELEMWSLGVTLYTLVFEENPFCELEE----------TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred cccchhHHHHHHHHHhCCCchhhHHH----------HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 68999999999999999999975221 11111 2223358999999999999999999999999999999
Q ss_pred cccCCC
Q 025933 166 FLKNLP 171 (246)
Q Consensus 166 ~~~~~~ 171 (246)
|.....
T Consensus 278 ~~~~~~ 283 (335)
T 3dls_A 278 VTQPVN 283 (335)
T ss_dssp TTCCCC
T ss_pred ccCCcc
Confidence 976543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.42 Aligned_cols=162 Identities=25% Similarity=0.415 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++... .+.+||+|||+++...........+||+.|+|||++.+..++
T Consensus 132 ~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 211 (327)
T 3lm5_A 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT 211 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCC
Confidence 3556788999999999999999999999999998621 234999999999865444444556899999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||.+......+..+... ...+..+.+..++..+++||.+||..||.+|||++++++|
T Consensus 212 ~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 212 TA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 55 89999999999999999999876654443332221 2223334445789999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 289 ~~~~~~ 294 (327)
T 3lm5_A 289 SWLQQW 294 (327)
T ss_dssp GGGCCC
T ss_pred Hhhccc
Confidence 999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.47 Aligned_cols=161 Identities=26% Similarity=0.291 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHHhH--hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFY--LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH--~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.||| +++||||||||+|||++.+..+.+||+|||+++.. .......+||+.|+|||++.+..++
T Consensus 159 ~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~--~~~~~~~~~t~~y~aPE~~~~~~~~ 236 (382)
T 2vx3_A 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYD 236 (382)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET--TCCCCSSCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec--ccccccccCCccccChHHHcCCCCC
Confidence 4567888999999999 57899999999999996544455999999999753 2334566899999999999988887
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------------CCC-------------------
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--------------FLP------------------- 130 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------~~~------------------- 130 (246)
.+ +|||||||++|+|++|+.||.+......+..+......... ..+
T Consensus 237 ~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (382)
T 2vx3_A 237 LA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315 (382)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCT
T ss_pred cH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCc
Confidence 55 99999999999999999999987766555555443211000 000
Q ss_pred CCC-------------------------cCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 131 DYV-------------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 131 ~~~-------------------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
... ..++.+++||.+||+.||.+|||+.++|+||||.+.
T Consensus 316 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 000 001478999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=264.77 Aligned_cols=158 Identities=35% Similarity=0.588 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++..+ ...+||+|||+++...........+||+.|+|||++.+ .++
T Consensus 123 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~- 200 (486)
T 3mwu_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYD- 200 (486)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCC-
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCC-
Confidence 456788899999999999999999999999996532 24599999999986544444556789999999999975 465
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.++||||+||++|+|++|.+||.+......+ ..+.... +..+.+..+|+++++||++||..||.+|||+.++++
T Consensus 201 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4499999999999999999999876554333 3333333 334556679999999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||.+.
T Consensus 277 hp~~~~~ 283 (486)
T 3mwu_A 277 HPWIQKY 283 (486)
T ss_dssp CHHHHHT
T ss_pred CHhhccC
Confidence 9999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=251.03 Aligned_cols=165 Identities=25% Similarity=0.299 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC---CCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP---QPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~---~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+|||++.++ ...+||+|||+++.... .......+||+.|+|||++.+.
T Consensus 133 ~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 212 (329)
T 3gbz_A 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCC
Confidence 3456788999999999999999999999999995422 23499999999874321 2233445789999999999875
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C-------------CCC----------CCcCC
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F-------------LPD----------YVRVS 136 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~-------------~~~----------~~~~~ 136 (246)
...+.++|||||||++|+|++|..||.+......+..+......... . .+. ...++
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
T 3gbz_A 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD 292 (329)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccC
Confidence 53345599999999999999999999887766665555544321110 0 000 01168
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.++++||.+||..||.+|||+.++++||||...
T Consensus 293 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 293 DEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 999999999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=252.51 Aligned_cols=157 Identities=28% Similarity=0.531 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||+|||+++|+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 132 ~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 211 (351)
T 3c0i_A 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211 (351)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCC
Confidence 3456789999999999999999999999999976432 459999999997543322 23456799999999999888886
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+.. . .....+....+..+ .+..++..+++||.+||..||.+|||+.+++
T Consensus 212 ~~-~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 212 KP-VDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ch-HhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 999999999999999999998632 1 22333333333222 2346899999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 286 ~hp~~~~ 292 (351)
T 3c0i_A 286 NHPWLKE 292 (351)
T ss_dssp TSHHHHT
T ss_pred cChhhcC
Confidence 9999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.47 Aligned_cols=160 Identities=26% Similarity=0.347 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-----------------------CCCcEEEeccCCccCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-----------------------PQPRLKICDFGYSKSGLLHSQ 61 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-----------------------~~~~vkl~Dfg~s~~~~~~~~ 61 (246)
....++.|++.||.|||++|||||||||+|||++.. ....+||+|||+++.. ...
T Consensus 138 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~--~~~ 215 (360)
T 3llt_A 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDY 215 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET--TSC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceec--CCC
Confidence 345678899999999999999999999999999751 1345999999999742 223
Q ss_pred CCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------
Q 025933 62 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------- 126 (246)
Q Consensus 62 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 126 (246)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+..+........
T Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 294 (360)
T 3llt_A 216 HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKY 294 (360)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGG
T ss_pred CcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccc
Confidence 455689999999999998888766 8999999999999999999987665444333222110000
Q ss_pred -------cCCCCC------------------CcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 025933 127 -------YFLPDY------------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 167 (246)
Q Consensus 127 -------~~~~~~------------------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 167 (246)
..+|.. ...++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 295 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 295 VNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp EETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000100 01247788999999999999999999999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=251.62 Aligned_cols=159 Identities=28% Similarity=0.374 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccc---
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLAR--- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~--- 79 (246)
...++.|++.||+|||+++|+||||||+|||++. + .+||+|||+++...... .....+||+.|+|||++.+
T Consensus 110 ~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 186 (343)
T 3dbq_A 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccc
Confidence 3466788999999999999999999999999973 3 49999999998543222 1234579999999999864
Q ss_pred --------cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCC
Q 025933 80 --------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 80 --------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 151 (246)
..++ .++|||||||++|+|++|+.||.+...... .+..+.............+..+.+||.+||..||
T Consensus 187 ~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 187 SRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp ----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCCh
Confidence 4444 448999999999999999999976544211 1222222222223334578899999999999999
Q ss_pred CCCCCHHHHhcCcccccCCC
Q 025933 152 SKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 152 ~~R~t~~e~l~hp~~~~~~~ 171 (246)
.+|||+.++++||||.....
T Consensus 263 ~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 263 KQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp TTSCCHHHHHTSHHHHSCCC
T ss_pred hHCCCHHHHHhCccccccCC
Confidence 99999999999999976443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=252.75 Aligned_cols=155 Identities=21% Similarity=0.284 Sum_probs=109.3
Q ss_pred HHHHHHHHHHHHHHHhHhC--------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQ--------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~--------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y 71 (246)
..+.++.|++.||+|||++ +||||||||+|||++.++. +||+|||+|+...... ...+.+||+.|
T Consensus 101 ~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~y 178 (303)
T 3hmm_A 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178 (303)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEESCC-----CCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCccccCCCCceeeecccccccccc
Confidence 3457788999999999987 8999999999999998876 9999999997432211 22345799999
Q ss_pred Ccchhcccc------ccCCcchhHHhHHHHHHHHHhCCCCCCCCCC----------hH-HHHHHHHHHhcccc--CCCCC
Q 025933 72 IAPEVLARK------EYDGKISDVWSCGVTLYVMLVGAYPFEDPED----------PR-NFRKTIDRIRNVQY--FLPDY 132 (246)
Q Consensus 72 ~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----------~~-~~~~~~~~~~~~~~--~~~~~ 132 (246)
||||++.+. .|+ .++|||||||++|||++|.+||..... .. ........+..... .+|..
T Consensus 179 mAPE~l~~~~~~~~~~~~-~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~ 257 (303)
T 3hmm_A 179 MAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp CCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred cCHHHhcccccccCCccC-hhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCcc
Confidence 999999754 243 348999999999999999876643211 11 11222222222211 12221
Q ss_pred ---CcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 133 ---VRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 133 ---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
...+..+.+|+.+||..||.+|||+.++++
T Consensus 258 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 113357889999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=252.40 Aligned_cols=165 Identities=21% Similarity=0.356 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-cccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+ ..++
T Consensus 135 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 212 (362)
T 3pg1_A 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFT 212 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC---------------CGGGCCHHHHTTCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCcccccccccccceecccceecCcHHhcCCCCCC
Confidence 34567889999999999999999999999999987776 99999999975444444455679999999999987 4454
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------------cCCC------CCCcCCH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------------YFLP------DYVRVSA 137 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------~~~~------~~~~~~~ 137 (246)
.++|||||||++|+|++|+.||.+......+..+........ ...+ .....++
T Consensus 213 -~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (362)
T 3pg1_A 213 -KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291 (362)
T ss_dssp -THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCH
T ss_pred -cHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCH
Confidence 559999999999999999999988765555544443221100 0000 1235689
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
.+.+||.+||..||.+|||+.++++||||.....+
T Consensus 292 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 292 VALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 99999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.69 Aligned_cols=157 Identities=34% Similarity=0.579 Sum_probs=128.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++..+ ...+||+|||+++...........+||+.|+|||++. ..++.
T Consensus 138 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~ 216 (494)
T 3lij_A 138 AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDE 216 (494)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCC
Confidence 456788999999999999999999999999997643 2459999999998655444556678999999999986 45655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +||||+||++|+|++|.+||.+...... +..+....+. .+.+..+++.+++||++||..||.+|||+.++++
T Consensus 217 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 217 K-CDVWSIGVILFILLAGYPPFGGQTDQEI----LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 4 9999999999999999999987655433 3333333332 3445679999999999999999999999999999
Q ss_pred Cccccc
Q 025933 163 HPWFLK 168 (246)
Q Consensus 163 hp~~~~ 168 (246)
||||..
T Consensus 292 hp~~~~ 297 (494)
T 3lij_A 292 HPWIKE 297 (494)
T ss_dssp CHHHHH
T ss_pred Cccccc
Confidence 999965
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=255.34 Aligned_cols=158 Identities=28% Similarity=0.373 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccc---
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLAR--- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~--- 79 (246)
...++.||+.||+|||+++|+||||||+|||++. + .+||+|||+++...... .....+||+.|+|||++.+
T Consensus 157 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (390)
T 2zmd_A 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233 (390)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccc
Confidence 4456788999999999999999999999999954 3 49999999998543222 2245679999999999865
Q ss_pred --------cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCC
Q 025933 80 --------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 80 --------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 151 (246)
..++ .++|||||||++|+|++|+.||.+..... ..+..+.......+.....+..+++||.+||..||
T Consensus 234 ~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 309 (390)
T 2zmd_A 234 SRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 309 (390)
T ss_dssp ----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccCCCCccchHHHHHHHHHHcccCh
Confidence 2344 45999999999999999999997654321 12223333333333333568999999999999999
Q ss_pred CCCCCHHHHhcCcccccCC
Q 025933 152 SKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 152 ~~R~t~~e~l~hp~~~~~~ 170 (246)
.+|||+.++++||||....
T Consensus 310 ~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 310 KQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TTSCCHHHHHTSHHHHSCC
T ss_pred hhCCCHHHHhhCcCccccC
Confidence 9999999999999997544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.02 Aligned_cols=160 Identities=25% Similarity=0.320 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---ccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++... .....+||+.|+|||++. +..
T Consensus 155 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ 229 (348)
T 1u5q_A 155 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQ 229 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBCCCCSCGGGCCHHHHHTTSSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecC---CCCcccCCcceeCHhhhccccCCC
Confidence 34567889999999999999999999999999988765 9999999997532 224567999999999985 455
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|||||||++|+|++|..||.+.........+ ............++..+++||.+||..||.+|||+++++
T Consensus 230 ~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 230 YDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp BCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 6554 89999999999999999999876544333322 222222222346899999999999999999999999999
Q ss_pred cCcccccCCChHH
Q 025933 162 KHPWFLKNLPKEI 174 (246)
Q Consensus 162 ~hp~~~~~~~~~~ 174 (246)
+||||....+...
T Consensus 305 ~h~~~~~~~~~~~ 317 (348)
T 1u5q_A 305 KHRFVLRERPPTV 317 (348)
T ss_dssp TCHHHHSCCCTTH
T ss_pred hChhhhccCCcch
Confidence 9999977655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=258.13 Aligned_cols=157 Identities=25% Similarity=0.425 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccc-----
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLAR----- 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~----- 79 (246)
..++.|++.||.|||+++||||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++.+
T Consensus 165 ~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ 242 (412)
T 2vd5_A 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242 (412)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred HHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCc
Confidence 345778899999999999999999999999998876 99999999975433222 234589999999999973
Q ss_pred --cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCcCCHHHHHHHHHhcccCCCCC--
Q 025933 80 --KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKR-- 154 (246)
Q Consensus 80 --~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R-- 154 (246)
..|+. ++|||||||++|+|++|+.||.+.+....+.++...... ..+|. ...+++++++||++||. +|.+|
T Consensus 243 ~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlg 318 (412)
T 2vd5_A 243 GTGSYGP-ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--LSLPLVDEGVPEEARDFIQRLLC-PPETRLG 318 (412)
T ss_dssp TCSEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCC----CCCHHHHHHHHTTSS-CGGGCTT
T ss_pred CCCCCCh-HHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--cCCCccccCCCHHHHHHHHHHcC-ChhhcCC
Confidence 45554 499999999999999999999886665555554432222 22232 24689999999999999 99998
Q ss_pred -CCHHHHhcCcccccC
Q 025933 155 -IPIPEIKKHPWFLKN 169 (246)
Q Consensus 155 -~t~~e~l~hp~~~~~ 169 (246)
++++++++||||...
T Consensus 319 r~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 319 RGGAGDFRTHPFFFGL 334 (412)
T ss_dssp TTTHHHHHTSGGGTTC
T ss_pred CCCHHHHhcCCCcCCC
Confidence 589999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=251.95 Aligned_cols=161 Identities=32% Similarity=0.537 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccc-
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~- 79 (246)
...++.|++.||.|||+++|+||||||+|||++.++...+||+|||+++...... ......||+.|+|||++.+
T Consensus 170 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 4457889999999999999999999999999987664469999999987432111 1234579999999999975
Q ss_pred -cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 -KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 -~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++. ++|||||||++|+|++|..||.+.........+... ......+....+++.+++||.+||..||.+|||+.
T Consensus 250 ~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 250 NESYGP-KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp SSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 45544 499999999999999999999876665444433322 11222334446899999999999999999999999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 327 ~~l~hp~~~~~ 337 (345)
T 3hko_A 327 RALQHPWISQF 337 (345)
T ss_dssp HHHHSHHHHTT
T ss_pred HHhcChhhccC
Confidence 99999999654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=254.89 Aligned_cols=161 Identities=20% Similarity=0.307 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCC--------CCCCCCCCCCCCCCCcchhc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL--------LHSQPKSTVGTPAYIAPEVL 77 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~--------~~~~~~~~~gt~~y~aPE~~ 77 (246)
...++.|++.||+|||+++|+||||||+|||++.++. +||+|||++.... ........+||+.|+|||++
T Consensus 130 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence 4567888999999999999999999999999987776 9999999875321 11122334799999999999
Q ss_pred cc--cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-------------------------------
Q 025933 78 AR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------------------------- 124 (246)
Q Consensus 78 ~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------------------------- 124 (246)
.+ ..++.+ +|||||||++|+|++|+.||.+......+...+.....
T Consensus 208 ~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (389)
T 3gni_B 208 QQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 286 (389)
T ss_dssp STTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------
T ss_pred hccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccc
Confidence 87 456554 99999999999999999999876655444332221100
Q ss_pred ---------cccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 125 ---------VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 125 ---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.....+....+++.+++||++||+.||.+|||+.++++||||...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 287 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000112234578999999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=253.35 Aligned_cols=157 Identities=32% Similarity=0.553 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc----
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK---- 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~---- 80 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||++............+||+.|+|||++.+.
T Consensus 201 ~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 278 (365)
T 2y7j_A 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTT
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCcccccCCCCCCccChhhcccccccc
Confidence 34567788999999999999999999999999988776 999999998765444444567899999999998632
Q ss_pred --ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 81 --EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 81 --~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
.++.+ +|||||||++|+|++|..||.+......+. .+....+. .+.+..++..+.+||.+||..||.+|||
T Consensus 279 ~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 353 (365)
T 2y7j_A 279 HPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILMLR----MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353 (365)
T ss_dssp SCCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CcCCCch-hhHHhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC
Confidence 35444 899999999999999999998755433322 22222222 2334568999999999999999999999
Q ss_pred HHHHhcCccccc
Q 025933 157 IPEIKKHPWFLK 168 (246)
Q Consensus 157 ~~e~l~hp~~~~ 168 (246)
+.++++||||.+
T Consensus 354 ~~ell~hp~f~r 365 (365)
T 2y7j_A 354 AEQALQHPFFER 365 (365)
T ss_dssp HHHHHHSGGGCC
T ss_pred HHHHhcCcccCC
Confidence 999999999963
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=245.74 Aligned_cols=162 Identities=26% Similarity=0.327 Sum_probs=130.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.
T Consensus 121 ~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 198 (326)
T 1blx_A 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCCCCccccccccceeCHHHHhcCCCCc
Confidence 34567889999999999999999999999999988776 9999999998544333345567999999999998888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCC--------------------CCCCcCCHHHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFL--------------------PDYVRVSADCRHLL 143 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~~li 143 (246)
+ +|||||||++|+|++|..||.+......+..++....... ... .....++..+++||
T Consensus 199 ~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (326)
T 1blx_A 199 P-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277 (326)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred c-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHH
Confidence 5 8999999999999999999988776655555554321100 000 01235889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccccC
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
.+||..||.+|||+.++++||||...
T Consensus 278 ~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 278 LKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHcCCCcccCCCHHHHhcCcccccc
Confidence 99999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=245.10 Aligned_cols=163 Identities=24% Similarity=0.358 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+....+
T Consensus 104 ~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (311)
T 4agu_A 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------------GGGCCHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCC
Confidence 4566788999999999999999999999999988776 999999999754322 2234457999999999997644334
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCCCC----------CCcCCHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFLPD----------YVRVSADC 139 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~----------~~~~~~~~ 139 (246)
.++||||+||++|+|++|..||.+.........+....... ....+. .+.++..+
T Consensus 182 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 4agu_A 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPA 261 (311)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHH
T ss_pred cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHH
Confidence 55999999999999999999998876655544433321110 000111 24588999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
.+||.+||..||.+|||++++++||||.+..
T Consensus 262 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 262 LGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 9999999999999999999999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.69 Aligned_cols=161 Identities=28% Similarity=0.474 Sum_probs=129.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC--CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++............||+.|+|||++.+..+
T Consensus 116 ~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 195 (321)
T 2a2a_A 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCC
Confidence 34567889999999999999999999999999987652 1499999999986544444456679999999999988887
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+ +|||||||++|+|++|..||.+...... +..+.......+. +..++..+++||.+||..||.+|||+.++
T Consensus 196 ~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 270 (321)
T 2a2a_A 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270 (321)
T ss_dssp CTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH
T ss_pred CCc-cccHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 655 8999999999999999999987554333 2333333332221 24689999999999999999999999999
Q ss_pred hcCcccccCC
Q 025933 161 KKHPWFLKNL 170 (246)
Q Consensus 161 l~hp~~~~~~ 170 (246)
++||||....
T Consensus 271 l~hp~~~~~~ 280 (321)
T 2a2a_A 271 LRHPWITPVD 280 (321)
T ss_dssp HHSTTTSCSS
T ss_pred hcCccccCCC
Confidence 9999997654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=266.64 Aligned_cols=158 Identities=32% Similarity=0.556 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.. ..+.+||+|||+++...........+||+.|+|||++.+ .++.
T Consensus 128 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 206 (484)
T 3nyv_A 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 206 (484)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCT
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCC
Confidence 45678899999999999999999999999999532 224599999999975433333344579999999999976 5654
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +||||+||++|+|++|.+||.+......+ ..+.... +..+.+..+++.+++||++||..||.+|||+.++++
T Consensus 207 ~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 207 K-CDVWSTGVILYILLSGCPPFNGANEYDIL----KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-ceeHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 4 99999999999999999999876554333 3333333 334555679999999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 282 h~~~~~~ 288 (484)
T 3nyv_A 282 HEWIQTY 288 (484)
T ss_dssp SHHHHHH
T ss_pred Chhhccc
Confidence 9999653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=258.25 Aligned_cols=148 Identities=15% Similarity=0.219 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc----
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK---- 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~---- 80 (246)
..+.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.. .......+| +.|+|||++.+.
T Consensus 207 ~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~ 281 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATIS 281 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTH
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheec--CCcccCCCC-cCccChhhhccccccc
Confidence 34567899999999999999999999999999998775 999999999842 223345578 999999999877
Q ss_pred -------ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCC
Q 025933 81 -------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 153 (246)
Q Consensus 81 -------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 153 (246)
.++ .++|||||||++|+|++|+.||.+....... .........+++++++||.+||..||.+
T Consensus 282 ~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 282 YHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC------CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred ccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccch----------hhhhhhccCCCHHHHHHHHHHcCCCchh
Confidence 665 4499999999999999999999764332111 1112233478999999999999999999
Q ss_pred CCCHHHHhcCccccc
Q 025933 154 RIPIPEIKKHPWFLK 168 (246)
Q Consensus 154 R~t~~e~l~hp~~~~ 168 (246)
|||+.++++||||..
T Consensus 351 Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 351 RLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHTSHHHHH
T ss_pred CCCHHHHhhChHHHH
Confidence 999999999999954
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=243.82 Aligned_cols=158 Identities=25% Similarity=0.402 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhc----cc
Q 025933 5 CYFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL----AR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~----~~ 79 (246)
....++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++............||+.|+|||++ .+
T Consensus 110 ~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 187 (290)
T 3fme_A 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC---------------CCCCCCSCHHHHSCCTTC
T ss_pred HHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccccccccccCCCccccChhhcChhhcC
Confidence 3456788999999999998 9999999999999988766 999999999754444444445799999999997 34
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++ .++||||+||++|+|++|..||........ ............ .....++..+.+||.+||..||.+|||+.+
T Consensus 188 ~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 188 KGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQVVEEPSPQ-LPADKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp --CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHHHHHSCCCC-CCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCC-cHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHHHhccCCCC-cccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 4454 459999999999999999999976444322 112222222222 223468999999999999999999999999
Q ss_pred HhcCccccc
Q 025933 160 IKKHPWFLK 168 (246)
Q Consensus 160 ~l~hp~~~~ 168 (246)
+++||||..
T Consensus 264 ~l~hp~f~~ 272 (290)
T 3fme_A 264 LMQHPFFTL 272 (290)
T ss_dssp HTTSHHHHH
T ss_pred HHhCccccc
Confidence 999999953
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=248.26 Aligned_cols=163 Identities=22% Similarity=0.348 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-----------------CCCcEEEeccCCccCCCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHSQPKSTVG 67 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-----------------~~~~vkl~Dfg~s~~~~~~~~~~~~~g 67 (246)
....++.|++.||.|||+++|+||||||+|||+... ....+||+|||+++.. .......+|
T Consensus 124 ~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~--~~~~~~~~g 201 (355)
T 2eu9_A 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVA 201 (355)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEET--TSCCCSSCS
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccc--cccccCCcC
Confidence 345678899999999999999999999999999432 1234999999999742 233455689
Q ss_pred CCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------------
Q 025933 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------------- 126 (246)
Q Consensus 68 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 126 (246)
|+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.........+........
T Consensus 202 t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T 2eu9_A 202 TRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280 (355)
T ss_dssp CGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCC
T ss_pred CCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccc
Confidence 999999999988888655 9999999999999999999987665443332222110000
Q ss_pred -----------------cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 127 -----------------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 127 -----------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
.........+..+.+||++||..||.+|||+.++++||||....
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 281 ENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 00001112356889999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=247.15 Aligned_cols=160 Identities=28% Similarity=0.373 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-----------------CCcEEEeccCCccCCCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHSQPKSTVG 67 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-----------------~~~vkl~Dfg~s~~~~~~~~~~~~~g 67 (246)
....++.|++.||+|||++||+||||||+|||++... ...+||+|||+++.. .......+|
T Consensus 119 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~--~~~~~~~~g 196 (339)
T 1z57_A 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD--DEHHSTLVS 196 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEET--TSCCCSSCS
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccC--ccccccccC
Confidence 3556788999999999999999999999999998643 345999999999743 233455689
Q ss_pred CCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------------
Q 025933 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------------- 126 (246)
Q Consensus 68 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 126 (246)
|+.|+|||++.+..++.+ +|||||||++|+|++|..||...........+. .+....
T Consensus 197 t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~ 274 (339)
T 1z57_A 197 TRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME-RILGPLPKHMIQKTRKRKYFHHDRLDW 274 (339)
T ss_dssp CGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH-HHHCSCCHHHHHHCSCGGGEETTEECC
T ss_pred CccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCCHHHHhhccchhHHhhccccc
Confidence 999999999988887655 999999999999999999998765544332222 211100
Q ss_pred ------------------cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 127 ------------------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 127 ------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
.........++.+.+||.+||..||.+|||+.|+++||||..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 275 DEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 000011124578999999999999999999999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.01 Aligned_cols=163 Identities=26% Similarity=0.485 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||.|||+++|+||||||+|||++.++ ...+||+|||+++..... ....+.+||+.|+|||++.+..++
T Consensus 108 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 108 ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCC
Confidence 456788999999999999999999999999997654 235999999999743322 233456799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
.+ +|||||||++|+|++|..||.+.... ......+..+....+..+. +..+++++++||.+||..||.+|||+.
T Consensus 188 ~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 266 (325)
T 3kn6_A 188 ES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266 (325)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTT
T ss_pred Cc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHH
Confidence 55 89999999999999999999764431 1223444555544443332 246899999999999999999999999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++||||...
T Consensus 267 ell~h~w~~~~ 277 (325)
T 3kn6_A 267 GLRYNEWLQDG 277 (325)
T ss_dssp TSTTCGGGCTT
T ss_pred HHhcChhhccC
Confidence 99999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=257.62 Aligned_cols=160 Identities=32% Similarity=0.510 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---c
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---K 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~ 80 (246)
....++.|++.||.|||+++|+||||||+|||++..+ ...+||+|||+++.........+.+||+.|+|||++.+ .
T Consensus 240 ~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 319 (419)
T 3i6u_A 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 319 (419)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----C
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCC
Confidence 3456778999999999999999999999999997543 23599999999986544444456789999999999864 3
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
.++ .++|||||||++|+|++|..||.+......+...+ ....+.. ..+..++..+++||.+||..||.+|||+.
T Consensus 320 ~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 395 (419)
T 3i6u_A 320 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395 (419)
T ss_dssp TTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHH
Confidence 444 44899999999999999999998755443333322 2222221 12346899999999999999999999999
Q ss_pred HHhcCccccc
Q 025933 159 EIKKHPWFLK 168 (246)
Q Consensus 159 e~l~hp~~~~ 168 (246)
++++||||..
T Consensus 396 e~l~hp~~~~ 405 (419)
T 3i6u_A 396 EALRHPWLQD 405 (419)
T ss_dssp HHHHSGGGCC
T ss_pred HHhCCcccCC
Confidence 9999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=248.05 Aligned_cols=165 Identities=26% Similarity=0.362 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----------CCCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----------QPKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----------~~~~~~gt~~y~a 73 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|
T Consensus 113 ~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 190 (353)
T 2b9h_A 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC----------------CCCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccccccCccccccchhhccccccccC
Confidence 34567889999999999999999999999999988776 9999999987432111 1223478999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------------cCCC---
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------------YFLP--- 130 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------~~~~--- 130 (246)
||++.+....+.++|||||||++|+|++|..||.+......+..+........ ...+
T Consensus 191 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T 2b9h_A 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270 (353)
T ss_dssp HHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCC
T ss_pred CeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcc
Confidence 99986533334559999999999999999999987665444433332211100 0000
Q ss_pred ---CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 025933 131 ---DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 131 ---~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 171 (246)
.+..+++.+++||.+||..||.+|||+.++++||||.....
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 12368999999999999999999999999999999976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=245.28 Aligned_cols=164 Identities=29% Similarity=0.524 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchh
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~ 76 (246)
...++.|++.||+|||+++|+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|||+
T Consensus 113 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 192 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHH
Confidence 4556889999999999999999999999999986543 348999999987432111 1223469999999999
Q ss_pred ccc-----cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhccccCCCC--CCcCCHH
Q 025933 77 LAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRKTIDRIRNVQYFLPD--YVRVSAD 138 (246)
Q Consensus 77 ~~~-----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~--~~~~~~~ 138 (246)
+.+ ..++.+ +|||||||++|+|++|..||.+..... ........+......++. +..++..
T Consensus 193 ~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (316)
T 2ac3_A 193 VEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCA 271 (316)
T ss_dssp HHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred hhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHH
Confidence 875 445555 899999999999999999997654211 112233444444444332 2468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+++||.+||..||.+|||+.++++||||....
T Consensus 272 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 99999999999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=242.05 Aligned_cols=157 Identities=27% Similarity=0.498 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.+ ..+.+||+|||+++............||+.|+|||++.+ .++
T Consensus 126 ~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~- 203 (285)
T 3is5_A 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVT- 203 (285)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCC-
T ss_pred HHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCC-
Confidence 45678899999999999999999999999999542 234599999999975444444455679999999999864 454
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.++|||||||++|+|++|+.||.+....... ........ .......+++.+.+||.+||..||.+|||+.++++|
T Consensus 204 ~~~Di~slG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 204 FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ----QKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccCeehHHHHHHHHHhCCCCCCCCCHHHHH----hhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4499999999999999999999875533222 22221111 122233579999999999999999999999999999
Q ss_pred ccccc
Q 025933 164 PWFLK 168 (246)
Q Consensus 164 p~~~~ 168 (246)
|||++
T Consensus 280 p~f~~ 284 (285)
T 3is5_A 280 EWFKQ 284 (285)
T ss_dssp GGGGC
T ss_pred HHhhc
Confidence 99974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=241.54 Aligned_cols=154 Identities=33% Similarity=0.553 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||++.... ........||+.|+|||++.+..++.
T Consensus 110 ~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (279)
T 3fdn_A 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDE 186 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC---------CCCCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCC-cccccccCCCCCccCHhHhccCCCCc
Confidence 34567889999999999999999999999999988776 9999999986432 22334567999999999998877765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +||||||+++|+|++|..||........ ...+.......|. .++..+++||.+||..||.+|||+.++++||
T Consensus 187 ~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 187 K-VDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp T-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCT--TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred c-chhHhHHHHHHHHHHCCCCCCCCcHHHH----HHHHHhCCCCCCC--cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 5 8999999999999999999986543322 2333333433443 5899999999999999999999999999999
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
||..
T Consensus 260 ~~~~ 263 (279)
T 3fdn_A 260 WITA 263 (279)
T ss_dssp HHHH
T ss_pred cccC
Confidence 9964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=240.81 Aligned_cols=156 Identities=31% Similarity=0.544 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe---cCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill---~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||+ +.++ .+||+|||++.............||+.|+|||++.+.
T Consensus 107 ~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 183 (277)
T 3f3z_A 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL- 183 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccchhccCCCCCccChHHhccc-
Confidence 345678899999999999999999999999999 4444 4999999999765444445566899999999998754
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|||||||++|+|++|..||.+........ .+.......+. +..+++.+.+||.+||..||.+|||+.+
T Consensus 184 ~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~ 258 (277)
T 3f3z_A 184 YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVML----KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258 (277)
T ss_dssp BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 5544 899999999999999999998765443332 33333333332 2368999999999999999999999999
Q ss_pred HhcCccccc
Q 025933 160 IKKHPWFLK 168 (246)
Q Consensus 160 ~l~hp~~~~ 168 (246)
+++||||.+
T Consensus 259 ~l~h~~~~~ 267 (277)
T 3f3z_A 259 ALEHEWFEK 267 (277)
T ss_dssp HTTSHHHHH
T ss_pred HhcCHHHhc
Confidence 999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=249.39 Aligned_cols=160 Identities=31% Similarity=0.434 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc-c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE-Y 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~ 82 (246)
...++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+.. .
T Consensus 161 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (355)
T 1vzo_A 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238 (355)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCC
Confidence 4556778999999999999999999999999988776 9999999987432211 223457999999999998532 2
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PI 157 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~ 157 (246)
...++|||||||++|+|++|..||...........+...+.......+ ..++..+++||.+||..||.+|| |+
T Consensus 239 ~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~ 316 (355)
T 1vzo_A 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316 (355)
T ss_dssp -CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence 234589999999999999999999765443334444444444333333 46899999999999999999999 99
Q ss_pred HHHhcCcccccC
Q 025933 158 PEIKKHPWFLKN 169 (246)
Q Consensus 158 ~e~l~hp~~~~~ 169 (246)
+++++||||...
T Consensus 317 ~ell~h~~f~~~ 328 (355)
T 1vzo_A 317 DEIKEHLFFQKI 328 (355)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHHcCcchhcC
Confidence 999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=254.86 Aligned_cols=163 Identities=32% Similarity=0.531 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++... .......+||+.|+|||++.+..++
T Consensus 129 ~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~ 207 (336)
T 3fhr_A 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPEKYD 207 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc-ccccccCCCCcCccChhhhCCCCCC
Confidence 3466788999999999999999999999999997633 3459999999997532 2233456799999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|..||.+.............+.... ...+.+..++..+++||.+||..||.+|||+.+++
T Consensus 208 ~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 208 KS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55 8999999999999999999976554332222222222222 22344457899999999999999999999999999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 287 ~hp~~~~~ 294 (336)
T 3fhr_A 287 NHPWINQS 294 (336)
T ss_dssp HSHHHHTG
T ss_pred cCcccccc
Confidence 99999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=238.47 Aligned_cols=162 Identities=34% Similarity=0.553 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.+..
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC
Confidence 45667889999999999999999999999999988776 999999998743211 1234457999999999998777
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+.++|||||||++|+|++|..||.+......... .........+....++..+++||.+||..||.+|||+.+++
T Consensus 184 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 655559999999999999999999987654322221 12222223344557899999999999999999999999999
Q ss_pred cCcccccCCC
Q 025933 162 KHPWFLKNLP 171 (246)
Q Consensus 162 ~hp~~~~~~~ 171 (246)
+||||.+...
T Consensus 261 ~~~~~~~~~~ 270 (276)
T 2yex_A 261 KDRWYNKPLK 270 (276)
T ss_dssp TCTTTTCCCC
T ss_pred cCccccChhh
Confidence 9999987544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=262.15 Aligned_cols=159 Identities=32% Similarity=0.562 Sum_probs=129.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++...........+||+.|+|||++.+ .++.
T Consensus 148 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 226 (504)
T 3q5i_A 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE 226 (504)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred HHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCc
Confidence 4567889999999999999999999999999987653 3599999999986554445566789999999999874 5655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +||||+||++|+|++|..||.+..... ++..+....+.. +.+..+++++++||++||..||.+|||++++++
T Consensus 227 ~-~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 227 K-CDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred h-HHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 4 999999999999999999998765433 333344433332 234578999999999999999999999999999
Q ss_pred CcccccCC
Q 025933 163 HPWFLKNL 170 (246)
Q Consensus 163 hp~~~~~~ 170 (246)
||||.+..
T Consensus 302 h~~~~~~~ 309 (504)
T 3q5i_A 302 SRWIKKYA 309 (504)
T ss_dssp SHHHHHTC
T ss_pred CHhhhhch
Confidence 99997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=255.10 Aligned_cols=160 Identities=23% Similarity=0.349 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCC------------------------------------------
Q 025933 5 CYFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSP------------------------------------------ 41 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~------------------------------------------ 41 (246)
....++.|++.||+|||++ |||||||||+|||++.++
T Consensus 147 ~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (397)
T 1wak_A 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTS
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccc
Confidence 3456788999999999999 999999999999998653
Q ss_pred -----CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh----
Q 025933 42 -----QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---- 112 (246)
Q Consensus 42 -----~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---- 112 (246)
...+||+|||+++... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....
T Consensus 227 ~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~ 303 (397)
T 1wak_A 227 PKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTR 303 (397)
T ss_dssp GGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCH
T ss_pred cccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCc
Confidence 0249999999997432 23455689999999999998888755 89999999999999999999765431
Q ss_pred --HHHHHHHHHHhc--------cccC----------------------------CCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 113 --RNFRKTIDRIRN--------VQYF----------------------------LPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 113 --~~~~~~~~~~~~--------~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
..+..+...... ..+. .......+..+++||.+||..||.+|
T Consensus 304 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 383 (397)
T 1wak_A 304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383 (397)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGS
T ss_pred hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhc
Confidence 112222211100 0000 00112235678999999999999999
Q ss_pred CCHHHHhcCcccc
Q 025933 155 IPIPEIKKHPWFL 167 (246)
Q Consensus 155 ~t~~e~l~hp~~~ 167 (246)
||+.++++||||.
T Consensus 384 pt~~e~l~hp~~~ 396 (397)
T 1wak_A 384 ATAAECLRHPWLN 396 (397)
T ss_dssp CCHHHHHTSGGGG
T ss_pred CCHHHHhhCcccc
Confidence 9999999999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=240.67 Aligned_cols=159 Identities=35% Similarity=0.641 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++.............||+.|+|||++.+..+.+
T Consensus 112 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (276)
T 2h6d_A 112 EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC-------------CCTGGGTTSCCCH
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcceecccCCccccCHHHHcCCCCCC
Confidence 34567889999999999999999999999999988776 9999999998654433344567999999999998776654
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
.++|+||||+++|+|++|..||....... ....+.......|. .++..+.+||.+||..||.+|||+.++++||
T Consensus 190 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 190 PEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKIRGGVFYIPE--YLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCcccCch--hcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 56999999999999999999997654322 23333333333343 5799999999999999999999999999999
Q ss_pred ccccCCC
Q 025933 165 WFLKNLP 171 (246)
Q Consensus 165 ~~~~~~~ 171 (246)
||.+..+
T Consensus 264 ~~~~~~~ 270 (276)
T 2h6d_A 264 WFKQDLP 270 (276)
T ss_dssp HHHTTCC
T ss_pred hhccCch
Confidence 9987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=239.40 Aligned_cols=162 Identities=31% Similarity=0.496 Sum_probs=128.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc------
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA------ 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~------ 78 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++.............||+.|+|||++.
T Consensus 125 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 202 (298)
T 1phk_A 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCcccccccCCccccCHHHhccccccc
Confidence 44567889999999999999999999999999988776 9999999997554444445567999999999985
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
...++ .++|||||||++|+|++|..||.+.........+... ......+.+..++..+.+||.+||..||.+|||+.
T Consensus 203 ~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 203 HPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp SCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred cccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC--CcccCcccccccCHHHHHHHHHHccCCcccCCCHH
Confidence 23444 4489999999999999999999875543332222211 12222344457899999999999999999999999
Q ss_pred HHhcCcccccCCC
Q 025933 159 EIKKHPWFLKNLP 171 (246)
Q Consensus 159 e~l~hp~~~~~~~ 171 (246)
++++||||.+...
T Consensus 280 ~ll~h~~~~~~~~ 292 (298)
T 1phk_A 280 EALAHPFFQQYVV 292 (298)
T ss_dssp HHTTSGGGCTTC-
T ss_pred HHHhChHhhhccc
Confidence 9999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=256.53 Aligned_cols=148 Identities=14% Similarity=0.197 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhc-------
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL------- 77 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~------- 77 (246)
..+.++.|++.||.|||+++||||||||+|||++.++. +||+|||+++.... ...+.+| +.|+|||++
T Consensus 212 ~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~ 286 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPF 286 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTT
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeecCC--ccccCCC-CceeCchhhhcccccc
Confidence 34566789999999999999999999999999998877 99999999874322 2445678 999999999
Q ss_pred ---cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 78 ---ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 78 ---~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
.+..++. ++|||||||++|+|++|+.||.+....... ...+.....++..+++||.+||..||.+|
T Consensus 287 ~~~~~~~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 287 GQHHPTLMTF-AFDTWTLGLAIYWIWCADLPNTDDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp GGGCCEEECH-HHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred ccccCcCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------HHHHhhcccCCHHHHHHHHHHccCChhhC
Confidence 4444544 499999999999999999999764432211 11223334689999999999999999999
Q ss_pred CCHHHHhcCccccc
Q 025933 155 IPIPEIKKHPWFLK 168 (246)
Q Consensus 155 ~t~~e~l~hp~~~~ 168 (246)
||+.++++||||..
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=251.28 Aligned_cols=163 Identities=21% Similarity=0.344 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCC----CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSP----QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~----~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||.|||++ ||+||||||+|||++..+ ...+||+|||+++... ......+||+.|+|||++.+
T Consensus 132 ~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccC--CCCCCCCCCccccCcHHHhC
Confidence 3456788999999999998 999999999999995322 2359999999997432 23445689999999999998
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHHHhccc---------------------------
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPED------PRNFRKTIDRIRNVQ--------------------------- 126 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~~~~~~~~~~--------------------------- 126 (246)
..++.+ +|||||||++|+|++|..||.+... ...+..+........
T Consensus 210 ~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (373)
T 1q8y_A 210 APWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288 (373)
T ss_dssp CCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccc
Confidence 887655 9999999999999999999976442 112222222111000
Q ss_pred ---------cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 127 ---------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 127 ---------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
.........+..+.+||.+||..||.+|||+.++++||||....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 00011123567899999999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=238.12 Aligned_cols=154 Identities=31% Similarity=0.549 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++..... .......||+.|+|||++.+..++.
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (284)
T 2vgo_A 115 RSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDE 191 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cccccccCCCCcCCHHHhccCCCCc
Confidence 34567889999999999999999999999999987776 99999999864322 2234567999999999999888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +||||||+++|+|++|..||......... ..+.......| ..++..+++||.+||..||.+|||+.++++||
T Consensus 192 ~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 192 K-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp T-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred c-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 5 89999999999999999999875543332 23333333333 36899999999999999999999999999999
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
||..
T Consensus 265 ~~~~ 268 (284)
T 2vgo_A 265 WVKA 268 (284)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=237.37 Aligned_cols=156 Identities=22% Similarity=0.387 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEec-CCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~-~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++ |+||||||+|||++ .++. +||+|||++.... ........||+.|+|||++.+ .
T Consensus 130 ~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~ 205 (290)
T 1t4h_A 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-K 205 (290)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-C
T ss_pred HHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCccccc-ccccccccCCcCcCCHHHHhc-c
Confidence 34567889999999999999 99999999999997 4554 9999999997432 222344579999999999874 4
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|||||||++|+|++|..||.+......... .+.............++.+.+||.+||..||.+|||+.+++
T Consensus 206 ~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 206 YDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp CCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCc-chHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 5544 9999999999999999999987665444332 22222222222335789999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||..
T Consensus 282 ~h~~f~~ 288 (290)
T 1t4h_A 282 NHAFFQE 288 (290)
T ss_dssp TSGGGC-
T ss_pred hCccccc
Confidence 9999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=245.04 Aligned_cols=163 Identities=28% Similarity=0.381 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+....
T Consensus 125 ~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 202 (331)
T 4aaa_A 125 VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC------------CCCCCTTCCHHHHTTCTTC
T ss_pred HHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCc
Confidence 34567889999999999999999999999999988776 99999999974332 2223445799999999999876433
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCCC----------CCCcCCHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYFLP----------DYVRVSAD 138 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------~~~~~----------~~~~~~~~ 138 (246)
+.++|||||||++|+|++|..||.+.........+....... ....+ ..+.++..
T Consensus 203 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
T 4aaa_A 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV 282 (331)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHH
T ss_pred chHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHH
Confidence 455999999999999999999998877655554444321110 00111 12357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 139 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 139 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+.+||.+||..||.+|||+.++++||||...
T Consensus 283 l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 283 VIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 9999999999999999999999999999653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=246.49 Aligned_cols=153 Identities=20% Similarity=0.333 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-------------CCCCCCCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-------------SQPKSTVGTPAYI 72 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-------------~~~~~~~gt~~y~ 72 (246)
.+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 4567889999999999999999999999999987776 999999998754322 1223457999999
Q ss_pred cchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 73 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
|||++.+..++.+ +|||||||++|+|++|..|+. .............. .......++.+++||.+||..||.
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCC-CcccccCChhHHHHHHHHccCCCC
Confidence 9999988888655 899999999999999877652 22222333332221 112235678899999999999999
Q ss_pred CCCCHHHHhcCccccc
Q 025933 153 KRIPIPEIKKHPWFLK 168 (246)
Q Consensus 153 ~R~t~~e~l~hp~~~~ 168 (246)
+|||+.++++||||.+
T Consensus 316 ~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEATDIIENAIFEN 331 (332)
T ss_dssp GSCCHHHHHHSTTCCC
T ss_pred cCCCHHHHhhchhhhc
Confidence 9999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=242.15 Aligned_cols=166 Identities=27% Similarity=0.439 Sum_probs=131.0
Q ss_pred HHHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc-cc
Q 025933 5 CYFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 82 (246)
....++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+. .+
T Consensus 152 ~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 228 (348)
T 2pml_X 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSY 228 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCE
T ss_pred HHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCC
Confidence 455678899999999999 99999999999999988776 999999999753222 33456799999999999877 55
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC-----------------CcCCHHHHHHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-----------------VRVSADCRHLLSQ 145 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~ 145 (246)
+..++|||||||++|+|++|..||.+...... ....+.......|.. ..++..+.+||.+
T Consensus 229 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 305 (348)
T 2pml_X 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL 305 (348)
T ss_dssp EHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH
Confidence 55359999999999999999999987665322 233333333333321 4689999999999
Q ss_pred hcccCCCCCCCHHHHhcCcccccCCChHHHH
Q 025933 146 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176 (246)
Q Consensus 146 ~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~ 176 (246)
||..||.+|||+.++++||||..........
T Consensus 306 ~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 306 FLRKNPAERITSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HCCSSGGGSCCHHHHHTSGGGTTCCHHHHHH
T ss_pred HccCChhhCCCHHHHhcCccccCCCHHHHHH
Confidence 9999999999999999999998765544443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.65 Aligned_cols=157 Identities=29% Similarity=0.508 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.+..++
T Consensus 113 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (278)
T 3cok_A 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC---------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCC
Confidence 34567889999999999999999999999999988776 999999998753322 222345799999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||......... ..+....+..| ..++.++++||.+||..||.+|||+.++++|
T Consensus 191 ~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 191 LE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYEMP--SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccCCc--cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 55 89999999999999999999865543222 22222222223 3589999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|||....
T Consensus 264 ~~~~~~~ 270 (278)
T 3cok_A 264 PFMSRNS 270 (278)
T ss_dssp TTTC---
T ss_pred ccccCCC
Confidence 9997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=240.99 Aligned_cols=160 Identities=28% Similarity=0.363 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcc-----c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLA-----R 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~-----~ 79 (246)
...++.|++.||.|||++||+||||||+|||++.++. +||+|||++...... .......||+.|+|||++. +
T Consensus 131 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 208 (326)
T 2x7f_A 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-------------CCGGGCCHHHHC------
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCccccccccCCccccChhhhccccccC
Confidence 4567789999999999999999999999999987776 999999998753322 1233457999999999986 3
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|||||||++|+|++|..||.+......... +............++..+++||.+||..||.+|||+.+
T Consensus 209 ~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 209 ATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp --CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 455544 8999999999999999999977554333222 22222222223468999999999999999999999999
Q ss_pred HhcCcccccCCCh
Q 025933 160 IKKHPWFLKNLPK 172 (246)
Q Consensus 160 ~l~hp~~~~~~~~ 172 (246)
+++||||......
T Consensus 284 ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 284 LMKHPFIRDQPNE 296 (326)
T ss_dssp HHTSHHHHCCTTH
T ss_pred HhhChHHhhCccc
Confidence 9999999875543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=240.60 Aligned_cols=157 Identities=31% Similarity=0.552 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe---cCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill---~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||++||+||||||+||++ +.++ .+||+|||+++... ........||+.|+|||++.+..
T Consensus 107 ~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 183 (304)
T 2jam_A 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKP 183 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCC-CBTTHHHHSCCCBCCTTTBSSCS
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecC-CCccccccCCCCccChHHhccCC
Confidence 345678899999999999999999999999999 4444 49999999987432 22223346999999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|||||||++|+|++|..||.+....... ..+....+. .+.+..++..+++||.+||..||.+|||+.+
T Consensus 184 ~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 184 YSKA-VDCWSIGVITYILLCGYPPFYEETESKLF----EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp CCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 7644 99999999999999999999875543332 233333222 2334578999999999999999999999999
Q ss_pred HhcCcccccC
Q 025933 160 IKKHPWFLKN 169 (246)
Q Consensus 160 ~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 259 ~l~h~~~~~~ 268 (304)
T 2jam_A 259 ALSHPWIDGN 268 (304)
T ss_dssp HHTSHHHHSS
T ss_pred HhcCccccCC
Confidence 9999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=240.91 Aligned_cols=153 Identities=33% Similarity=0.512 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEec-CCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~-~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||+++|+||||||+|||++ .++. +||+|||+++... ........||+.|+|||++.+..+.+
T Consensus 151 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (320)
T 3a99_A 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 227 (320)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCccccccc-cccccCCCCCccCCChHHhccCCCCC
Confidence 456778999999999999999999999999998 4444 9999999987533 22334557999999999998777655
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
.++|||||||++|+|++|..||.... . +....... ...+++.+.+||.+||..||.+|||+.++++||
T Consensus 228 ~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 228 RSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVFF--RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccccc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 66899999999999999999996521 1 11222222 236899999999999999999999999999999
Q ss_pred ccccCCChH
Q 025933 165 WFLKNLPKE 173 (246)
Q Consensus 165 ~~~~~~~~~ 173 (246)
||.......
T Consensus 296 ~~~~~~~~~ 304 (320)
T 3a99_A 296 WMQDVLLPQ 304 (320)
T ss_dssp GGSSCCCHH
T ss_pred hhcCccCcc
Confidence 998766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=237.99 Aligned_cols=159 Identities=30% Similarity=0.510 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||++..... ........||+.|+|||++.+..
T Consensus 110 ~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (305)
T 2wtk_C 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCS
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCccccccccccCCCCCCCcChhhccCcc
Confidence 34567889999999999999999999999999988776 99999999874322 11223456999999999997643
Q ss_pred -cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 -~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+.++|||||||++|+|++|..||.+.... .....+.......+ ..+++.+.+||.+||..||.+|||+.++
T Consensus 188 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 188 TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFENIGKGSYAIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHHHhcCCCCCC--CccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 2344599999999999999999999875432 23333444444333 3689999999999999999999999999
Q ss_pred hcCcccccCCC
Q 025933 161 KKHPWFLKNLP 171 (246)
Q Consensus 161 l~hp~~~~~~~ 171 (246)
++||||.+...
T Consensus 262 l~~~~~~~~~~ 272 (305)
T 2wtk_C 262 RQHSWFRKKHP 272 (305)
T ss_dssp HHSHHHHSCCC
T ss_pred hcCcccccCCC
Confidence 99999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=245.82 Aligned_cols=159 Identities=26% Similarity=0.451 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++.... ........||+.|+|||++.+..++.
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 209 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHC----CCCCTTCCHHHHTTCCCSH
T ss_pred HHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccc-cccccCCCCCCCeECHHHHcCCCCCc
Confidence 456788899999999996 9999999999999988776 9999999986321 12234457999999999998888765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHH--------------------------------------HHHHHHHhccc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNF--------------------------------------RKTIDRIRNVQ 126 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------------------------------~~~~~~~~~~~ 126 (246)
+ +|||||||++|+|++|..||......... ......+....
T Consensus 210 ~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3eqc_A 210 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288 (360)
T ss_dssp H-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC
T ss_pred h-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC
Confidence 5 89999999999999999999765432211 11112222222
Q ss_pred cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 127 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
........++.++++||.+||..||.+|||+.++++||||..
T Consensus 289 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 111122347899999999999999999999999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=241.18 Aligned_cols=157 Identities=31% Similarity=0.500 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++
T Consensus 142 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (335)
T 2owb_A 142 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcccccccCCCccccCHHHhccCCCC
Confidence 34567889999999999999999999999999988776 999999999754322 223445799999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||........+ ..+.......+. .++..+.+||.+||..||.+|||+.++++|
T Consensus 220 ~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 220 FE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIPK--HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCCCCCc--cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 55 89999999999999999999875543332 223333333343 689999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|||....
T Consensus 293 ~~~~~~~ 299 (335)
T 2owb_A 293 EFFTSGY 299 (335)
T ss_dssp HHHHTSC
T ss_pred ccccCCC
Confidence 9997654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=237.43 Aligned_cols=159 Identities=26% Similarity=0.453 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc-----
Q 025933 5 CYFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA----- 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~----- 78 (246)
....++.|++.||.|||++ ||+||||||+|||++.++. +||+|||++.............||+.|+|||++.
T Consensus 125 ~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (318)
T 2dyl_A 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------------CCTTCCHHHHC-----
T ss_pred HHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCccccccCCCccccChhhccccccc
Confidence 3456788999999999995 9999999999999988776 9999999997544333344557999999999995
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
...++ .++|||||||++|+|++|..||............ .........+....++.++.+||.+||..||.+|||+.
T Consensus 203 ~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (318)
T 2dyl_A 203 KPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTK--VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN 279 (318)
T ss_dssp ---CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH--HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred ccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH--HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 34454 4489999999999999999999865443222211 12222333444456899999999999999999999999
Q ss_pred HHhcCccccc
Q 025933 159 EIKKHPWFLK 168 (246)
Q Consensus 159 e~l~hp~~~~ 168 (246)
++++||||..
T Consensus 280 ~ll~h~~~~~ 289 (318)
T 2dyl_A 280 KLLEHSFIKR 289 (318)
T ss_dssp HHTTSHHHHH
T ss_pred HHhhCHHHHh
Confidence 9999999953
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=240.07 Aligned_cols=164 Identities=22% Similarity=0.286 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.|++.||+|||++||+||||||+|||++..+ ..+||+|||+++..... .......||+.|+|||++.+..
T Consensus 122 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (320)
T 2i6l_A 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN 200 (320)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc
Confidence 456788999999999999999999999999997433 24999999999753221 1223346899999999987633
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------------cccCCC------CCCcCCH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------------VQYFLP------DYVRVSA 137 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------------~~~~~~------~~~~~~~ 137 (246)
..+.++|||||||++|+|++|+.||.+.........+...... .....+ ....++.
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (320)
T 2i6l_A 201 NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280 (320)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCH
T ss_pred cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhH
Confidence 3345599999999999999999999887655444444332100 000000 1235899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
.+++||++||..||.+|||+.++++||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 281 EAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 999999999999999999999999999997543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=238.48 Aligned_cols=159 Identities=28% Similarity=0.498 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC--CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+||+++.++ ..++||+|||++.............||+.|+|||++.+..+
T Consensus 109 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (283)
T 3bhy_A 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCC
Confidence 3456788999999999999999999999999997765 22599999999975444334445679999999999988877
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
+.+ +||||||+++|+|++|..||.+...... ...+.......+ .+..++..+.+||.+||..||.+|||+.++
T Consensus 189 ~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 263 (283)
T 3bhy_A 189 GLE-ADMWSIGVITYILLSGASPFLGETKQET----LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263 (283)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred Ccc-hhhhhHHHHHHHHHHCCCCCCCcchHHH----HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 655 8999999999999999999987554332 222333222222 124689999999999999999999999999
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
++||||..
T Consensus 264 l~h~~~~~ 271 (283)
T 3bhy_A 264 LEHSWIKA 271 (283)
T ss_dssp HHCHHHHH
T ss_pred HhCHHHHH
Confidence 99999953
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=249.97 Aligned_cols=157 Identities=25% Similarity=0.384 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC---CCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~---~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~ 79 (246)
..++.|++.||+|||+++||||||||+|||++. ++..++||+|||+++..... ......+||+.|+|||++.+
T Consensus 121 ~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSC
T ss_pred HHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 456788999999999999999999999999953 34445889999999754322 22334579999999999974
Q ss_pred ---cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc-CCCCCCcCCHHHHHHHHHhcccCCCCC
Q 025933 80 ---KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKR 154 (246)
Q Consensus 80 ---~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R 154 (246)
..++ .++|||||||++|+|++ |..||...... ... .. ...... ........+..+++||.+||..||.+|
T Consensus 201 ~~~~~~t-~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~-~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 201 DCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQR-QAN-IL--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp C---CCC-THHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHH-HH--TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred ccccCCC-cHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHH-HH--hccCCccccCccccccHHHHHHHHHHHhCCHhhC
Confidence 3343 34899999999999999 99999654332 111 11 111111 111122346678999999999999999
Q ss_pred CCHHHHhcCccccc
Q 025933 155 IPIPEIKKHPWFLK 168 (246)
Q Consensus 155 ~t~~e~l~hp~~~~ 168 (246)
||+.++++||||..
T Consensus 276 ps~~evl~hp~f~~ 289 (432)
T 3p23_A 276 PSAKHVLKHPFFWS 289 (432)
T ss_dssp CCHHHHHTSTTTCC
T ss_pred CCHHHHHhCccccC
Confidence 99999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.36 Aligned_cols=157 Identities=31% Similarity=0.495 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||++...... .......||+.|+|||++.+..++
T Consensus 116 ~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 193 (294)
T 2rku_A 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccccccccCCCCcCCcchhccCCCC
Confidence 35667889999999999999999999999999988776 999999998754322 223345799999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +||||||+++|+|++|..||.+....+.. ..+.......| ..++..+.+||.+||..||.+|||+.++++|
T Consensus 194 ~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 194 FE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhhccCCCc--cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 55 89999999999999999999875543332 23333333333 3689999999999999999999999999999
Q ss_pred cccccCC
Q 025933 164 PWFLKNL 170 (246)
Q Consensus 164 p~~~~~~ 170 (246)
|||....
T Consensus 267 ~~~~~~~ 273 (294)
T 2rku_A 267 EFFTSGY 273 (294)
T ss_dssp HHHHTSC
T ss_pred hheecCC
Confidence 9997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=242.31 Aligned_cols=160 Identities=33% Similarity=0.527 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc---cc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---RK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 80 (246)
....++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++............||+.|+|||++. ..
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 194 (322)
T 2ycf_A 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCC
Confidence 3456678999999999999999999999999997654 2359999999997543222223346999999999974 34
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC-C-CCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-P-DYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
.++ .++|||||||++|+|++|..||........+...+. ...... + .+..++..+.+||.+||..||.+|||+.
T Consensus 195 ~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 270 (322)
T 2ycf_A 195 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270 (322)
T ss_dssp TCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHH
Confidence 454 449999999999999999999976554333333222 222211 1 1246899999999999999999999999
Q ss_pred HHhcCccccc
Q 025933 159 EIKKHPWFLK 168 (246)
Q Consensus 159 e~l~hp~~~~ 168 (246)
++++||||..
T Consensus 271 ~~l~h~~~~~ 280 (322)
T 2ycf_A 271 EALRHPWLQD 280 (322)
T ss_dssp HHHTSGGGCC
T ss_pred HHhhCcCcCC
Confidence 9999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=235.06 Aligned_cols=161 Identities=23% Similarity=0.332 Sum_probs=128.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.+..++
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (314)
T 3com_A 126 EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred HHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCC
Confidence 34567889999999999999999999999999988776 999999998743322 223345799999999999888877
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||............ .............++..+.+||.+||..||.+|||+.++++|
T Consensus 204 ~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 204 CV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp TT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 66 89999999999999999999865543332211 112222223344679999999999999999999999999999
Q ss_pred cccccCCC
Q 025933 164 PWFLKNLP 171 (246)
Q Consensus 164 p~~~~~~~ 171 (246)
|||.....
T Consensus 280 ~~~~~~~~ 287 (314)
T 3com_A 280 PFVRSAKG 287 (314)
T ss_dssp HHHHTCCC
T ss_pred HHHhcCCc
Confidence 99976543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=240.37 Aligned_cols=157 Identities=25% Similarity=0.356 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe----cCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc--
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL----DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA-- 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill----~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~-- 78 (246)
....++.|++.||.|||+++|+||||||+|||+ +..+ .+||+|||+++............||+.|+|||++.
T Consensus 113 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (319)
T 4euu_A 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCceecCCCCceeecccCCCccCHHHhhhc
Confidence 456678899999999999999999999999998 4443 49999999998654444445667999999999986
Q ss_pred ------ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------------------CCCC--
Q 025933 79 ------RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------------------FLPD-- 131 (246)
Q Consensus 79 ------~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~-- 131 (246)
+..++.+ +|||||||++|+|++|..||............+..+..... ..+.
T Consensus 191 ~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (319)
T 4euu_A 191 VLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (319)
T ss_dssp TSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred cccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCccc
Confidence 3555544 99999999999999999999765554444444444432221 1111
Q ss_pred --CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 132 --YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 132 --~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
...++..+.+||++||+.||.+|||++|+++||
T Consensus 270 ~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred ccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 123456789999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=237.69 Aligned_cols=158 Identities=35% Similarity=0.588 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+||+++.++ ...+||+|||++.............||+.|+|||++.+. ++
T Consensus 122 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~ 200 (287)
T 2wei_A 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YD 200 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-CC
Confidence 3456788999999999999999999999999997643 245999999998754433333445689999999998754 55
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
. ++||||||+++|+|++|..||.+...... ...+..... ..+.+..++.++.+||.+||..||.+|||+.+++
T Consensus 201 ~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 275 (287)
T 2wei_A 201 E-KCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (287)
T ss_dssp T-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred C-chhhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 4 48999999999999999999987554332 233333332 2344457899999999999999999999999999
Q ss_pred cCccccc
Q 025933 162 KHPWFLK 168 (246)
Q Consensus 162 ~hp~~~~ 168 (246)
+||||.+
T Consensus 276 ~hp~~~~ 282 (287)
T 2wei_A 276 EHPWIQK 282 (287)
T ss_dssp HSHHHHH
T ss_pred cCHHHhc
Confidence 9999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=238.26 Aligned_cols=164 Identities=26% Similarity=0.352 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC------CCCCCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH------SQPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~------~~~~~~~gt~~y~aPE~~~ 78 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.
T Consensus 122 ~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 122 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC---------------CCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhc
Confidence 35567889999999999999999999999999988776 999999998643221 1123457999999999987
Q ss_pred c-cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----cCCCCCCcCCHHHHHHHHHhcccCCCC
Q 025933 79 R-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----YFLPDYVRVSADCRHLLSQIFVADPSK 153 (246)
Q Consensus 79 ~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~ 153 (246)
+ ..++ .++|||||||++|+|++|..||.+.................. ........++..+++||.+||..||.+
T Consensus 200 ~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 278 (303)
T 2vwi_A 200 QVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278 (303)
T ss_dssp HHHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGG
T ss_pred cccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhh
Confidence 6 3454 459999999999999999999987665444332221110000 001122467899999999999999999
Q ss_pred CCCHHHHhcCcccccCCC
Q 025933 154 RIPIPEIKKHPWFLKNLP 171 (246)
Q Consensus 154 R~t~~e~l~hp~~~~~~~ 171 (246)
|||+.++++||||.+...
T Consensus 279 Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 279 RPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp SCCHHHHHTSTTC-----
T ss_pred CcCHHHHhhChhhhcCCC
Confidence 999999999999976443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=244.55 Aligned_cols=156 Identities=29% Similarity=0.406 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-----------CCcEEEeccCCccCCCCCC-----CCCCCCCCCC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-----------QPRLKICDFGYSKSGLLHS-----QPKSTVGTPA 70 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-----------~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~ 70 (246)
+.++.|++.||.|||+++||||||||+|||++.++ ...+||+|||+++...... .....+||+.
T Consensus 118 ~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~ 197 (434)
T 2rio_A 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197 (434)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCT
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCC
Confidence 45788999999999999999999999999997542 3469999999997543221 1234579999
Q ss_pred CCcchhccc-------cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC-----CCcCCH
Q 025933 71 YIAPEVLAR-------KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-----YVRVSA 137 (246)
Q Consensus 71 y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 137 (246)
|+|||++.+ ..++ .++|||||||++|+|++ |..||.+..... ..++ ......+. ...++.
T Consensus 198 y~aPE~~~~~~~~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~----~~~~~~~~~~~~~~~~~~~ 270 (434)
T 2rio_A 198 WRAPELLEESNNLQTKRRLT-RSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII----RGIFSLDEMKCLHDRSLIA 270 (434)
T ss_dssp TSCHHHHSCCCTTSCCCCCC-THHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHH----HTCCCCCCCTTCCCHHHHH
T ss_pred ccCHHHhccccccccccCcc-hhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHh----cCCCCcccccccccccchH
Confidence 999999975 3454 45999999999999998 999997654322 1222 22222221 123568
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 138 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
++++||.+||..||.+|||+.++++||||...
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 271 EATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 89999999999999999999999999999643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.03 Aligned_cols=154 Identities=18% Similarity=0.193 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-----------------CCcEEEeccCCccCCCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHSQPKSTVG 67 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-----------------~~~vkl~Dfg~s~~~~~~~~~~~~~g 67 (246)
....++.|++.||.|||+++|+||||||+|||++.++ ...+||+|||++..... .....|
T Consensus 116 ~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~g 192 (289)
T 1x8b_A 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEG 192 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC---SCCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC---ccccCC
Confidence 3456788999999999999999999999999997442 23599999999875332 234569
Q ss_pred CCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhc
Q 025933 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 147 (246)
Q Consensus 68 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 147 (246)
|+.|+|||++.+....+.++|||||||++|+|++|.+|+.... .... +..... ......++..+.+||.+||
T Consensus 193 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l 264 (289)
T 1x8b_A 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE----IRQGRL-PRIPQVLSQEFTELLKVMI 264 (289)
T ss_dssp CGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH----HHTTCC-CCCSSCCCHHHHHHHHHHT
T ss_pred CccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH----HHcCCC-CCCCcccCHHHHHHHHHHh
Confidence 9999999999866444445999999999999999998775422 2221 222211 1223468999999999999
Q ss_pred ccCCCCCCCHHHHhcCcccccC
Q 025933 148 VADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 148 ~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
..||.+|||+.++++||||...
T Consensus 265 ~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 265 HPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CSSGGGSCCHHHHHTCTTC---
T ss_pred CCCcccCCCHHHHhhChHhhhh
Confidence 9999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=242.40 Aligned_cols=158 Identities=30% Similarity=0.462 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHHHHHhHhC-CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhc----cc
Q 025933 5 CYFSSTVMIFTSHHCFYLQ-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL----AR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~-~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~----~~ 79 (246)
....++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++............||+.|+|||++ .+
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 203 (327)
T 3aln_A 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC----------------------------
T ss_pred HHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecccccccccCCCCccccCceeeccccCc
Confidence 3456788999999999999 9999999999999987766 999999999754433333445799999999998 34
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCC--CCCCcCCHHHHHHHHHhcccCCCCCCC
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFL--PDYVRVSADCRHLLSQIFVADPSKRIP 156 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t 156 (246)
..++.+ +|||||||++|+|++|..||.+..... ..+..+.... ..+ .....++..+.+||.+||..||.+|||
T Consensus 204 ~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 279 (327)
T 3aln_A 204 QGYDVR-SDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279 (327)
T ss_dssp --CCSH-HHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC
Confidence 455544 899999999999999999997643211 1111111111 111 112358999999999999999999999
Q ss_pred HHHHhcCccccc
Q 025933 157 IPEIKKHPWFLK 168 (246)
Q Consensus 157 ~~e~l~hp~~~~ 168 (246)
+.++++||||..
T Consensus 280 ~~ell~hp~~~~ 291 (327)
T 3aln_A 280 YKELLKHPFILM 291 (327)
T ss_dssp HHHHTTSHHHHH
T ss_pred HHHHHhChHHHH
Confidence 999999999953
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=234.81 Aligned_cols=157 Identities=29% Similarity=0.384 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccc---
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLAR--- 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~--- 79 (246)
...++.|++.||.|||+++|+||||||+|||++. + .+||+|||+++...... ......||+.|+|||++.+
T Consensus 129 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (313)
T 3cek_A 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC--------------CCGGGCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccc
Confidence 4567789999999999999999999999999964 3 49999999997543221 1234579999999999875
Q ss_pred --------cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCC
Q 025933 80 --------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 80 --------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 151 (246)
..++ .++|||||||++|+|++|..||........ .+..........+.....+..+.+||.+||..||
T Consensus 206 ~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 206 SRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp ---------CCC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccCC-chHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccccCCcccchHHHHHHHHHHccCCc
Confidence 2343 459999999999999999999976544321 1222222222223334568999999999999999
Q ss_pred CCCCCHHHHhcCcccccC
Q 025933 152 SKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 152 ~~R~t~~e~l~hp~~~~~ 169 (246)
.+|||+.++++||||...
T Consensus 282 ~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 282 KQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCHHHHHTSHHHHCC
T ss_pred ccCcCHHHHhcCccccCC
Confidence 999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=232.24 Aligned_cols=158 Identities=28% Similarity=0.372 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccc--
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE-- 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-- 81 (246)
...++.|++.||.|||+++|+||||||+||+++. ++. +||+|||+++..... .......||+.|+|||++.+..
T Consensus 124 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 201 (295)
T 2clq_A 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGG
T ss_pred HHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCCcccccCCCccccChhhhcCCCCC
Confidence 3456789999999999999999999999999986 554 999999998743321 2233457999999999997643
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++ .++|||||||++|+|++|..||............ ........ .....++..+.+||.+||..||.+|||+.+++
T Consensus 202 ~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 202 YG-KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHP--EIPESMSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp CS-HHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCC--CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CC-cHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccc--cccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 44 4599999999999999999999765443221111 11112222 22346899999999999999999999999999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 278 ~~~~~~~~ 285 (295)
T 2clq_A 278 VDEFLKVS 285 (295)
T ss_dssp TSGGGCC-
T ss_pred cChhhhhc
Confidence 99999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=234.36 Aligned_cols=162 Identities=25% Similarity=0.358 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhcc-----
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLA----- 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~----- 78 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||++..... ........||+.|+|||++.
T Consensus 118 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (302)
T 2j7t_A 118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccccccCChhhcCCeeeccccCC
Confidence 34567889999999999999999999999999987776 99999998752111 11223457999999999984
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+..++. ++|||||||++|+|++|..||............. ............++..+.+||.+||..||.+|||+.
T Consensus 196 ~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 196 DTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp STTTTT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh---ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHH
Confidence 445544 4999999999999999999998765433332221 112222233456899999999999999999999999
Q ss_pred HHhcCcccccCCCh
Q 025933 159 EIKKHPWFLKNLPK 172 (246)
Q Consensus 159 e~l~hp~~~~~~~~ 172 (246)
++++||||......
T Consensus 272 ~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 272 QLLEHPFVSSITSN 285 (302)
T ss_dssp HHTTSTTTTTCCCC
T ss_pred HHhcChHHhhhccc
Confidence 99999999875543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=239.05 Aligned_cols=155 Identities=21% Similarity=0.304 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------------------CCTTCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC
Confidence 4567889999999999999999999999999988776 999999999743222 1223356999999999998887
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
++.+ +|||||||++|+|++|+.||.+............ ..... .....++.++.+||.+||..||.+||++.+
T Consensus 196 ~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 196 VDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp CCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 7655 8999999999999999999987654333322221 11111 113458999999999999999999999999
Q ss_pred HhcCcccc
Q 025933 160 IKKHPWFL 167 (246)
Q Consensus 160 ~l~hp~~~ 167 (246)
++.|+|+.
T Consensus 271 ~l~~~l~~ 278 (311)
T 3ork_A 271 EMRADLVR 278 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=231.75 Aligned_cols=157 Identities=25% Similarity=0.355 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..++
T Consensus 120 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 197 (303)
T 3a7i_A 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccCccCCCcCccCHHHHhcCCCC
Confidence 44567889999999999999999999999999987776 9999999987533222 22345799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||.......... .+.... .......++..+.+||.+||..||.+|||+.++++|
T Consensus 198 ~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLF----LIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSC-CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHH----HhhcCC-CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 55 899999999999999999997654432222 222111 112234689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 272 ~~~~~~ 277 (303)
T 3a7i_A 272 KFILRN 277 (303)
T ss_dssp HHHHHH
T ss_pred hhhhcC
Confidence 999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=233.14 Aligned_cols=150 Identities=29% Similarity=0.455 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEec-CCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~-~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++ .++. +||+|||+++.... .......||+.|+|||++.+..+.
T Consensus 140 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 216 (312)
T 2iwi_A 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYH 216 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcchhhhccc-CcccccCCcccccCceeeecCCCC
Confidence 3456788999999999999999999999999998 5554 99999999875432 233456799999999999877776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
..++|||||||++|+|++|+.||.... . +.......+ ..++..+++||.+||..||.+|||+.++++|
T Consensus 217 ~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 217 ALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 545999999999999999999996421 1 112222223 3689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 285 ~~~~~~ 290 (312)
T 2iwi_A 285 PWMQTP 290 (312)
T ss_dssp TTTCC-
T ss_pred hhhcCc
Confidence 999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=230.63 Aligned_cols=160 Identities=25% Similarity=0.348 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---------------CCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---------------SQPKSTVGTP 69 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---------------~~~~~~~gt~ 69 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......||+
T Consensus 117 ~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (303)
T 1zy4_A 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC-------------------------C
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchhccccccccccccccccCCCcc
Confidence 34567889999999999999999999999999988776 999999998743211 1223456999
Q ss_pred CCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhc
Q 025933 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIF 147 (246)
Q Consensus 70 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L 147 (246)
.|+|||++.+....+.++|||||||++|+|++ ||... .........+.......| .....+..+++||++||
T Consensus 195 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 268 (303)
T 1zy4_A 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268 (303)
T ss_dssp TTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHT
T ss_pred cccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHHHHHhccccccccCccccccchHHHHHHHHHHH
Confidence 99999999865333455999999999999998 55432 222233344433333222 22456788999999999
Q ss_pred ccCCCCCCCHHHHhcCcccccCCCh
Q 025933 148 VADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 148 ~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
..||.+|||+.++++||||......
T Consensus 269 ~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 269 DHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp CSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred hcCcccCcCHHHHhCCCCcCCCChH
Confidence 9999999999999999999765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=234.87 Aligned_cols=158 Identities=24% Similarity=0.316 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..
T Consensus 138 ~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (323)
T 3qup_A 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL 215 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------------CCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeeccccccccccccccccccccCcccccCchhhcCCC
Confidence 45677889999999999999999999999999988766 99999999975332221 12335778899999998887
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC----
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---- 156 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---- 156 (246)
++.+ +|||||||++|+|++ |..||.+.........+. ... ..+....++..+.+||.+||..||.+|||
T Consensus 216 ~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 289 (323)
T 3qup_A 216 YTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----GGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289 (323)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----TTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----cCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7644 999999999999999 999998766554433322 211 22334478999999999999999999999
Q ss_pred ---HHHHhcCcccccCC
Q 025933 157 ---IPEIKKHPWFLKNL 170 (246)
Q Consensus 157 ---~~e~l~hp~~~~~~ 170 (246)
+++++.|||+....
T Consensus 290 ~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 290 RMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHHHHHC-------
T ss_pred HHHHHHHHHHhhhcCCC
Confidence 67889999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=231.53 Aligned_cols=151 Identities=26% Similarity=0.354 Sum_probs=113.3
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||++| |+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..
T Consensus 138 ~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 138 RRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----------------CCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccccccccccCCCCccccChhhhcCCC
Confidence 35667889999999999999 999999999999988776 999999999743222 1234457999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|||||||++|+|++|..||.+........ .+.......+....+++.+.+||.+||..||.+|||+.+++
T Consensus 216 ~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 290 (309)
T 3p86_A 216 SNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVA----AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290 (309)
T ss_dssp CCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7655 899999999999999999998765433322 22222222333447899999999999999999999999998
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 291 ~ 291 (309)
T 3p86_A 291 D 291 (309)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=227.93 Aligned_cols=155 Identities=21% Similarity=0.326 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhcc---
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLA--- 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~--- 78 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.
T Consensus 121 ~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 198 (289)
T 3og7_A 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC------------------CCCTTCCHHHHC---
T ss_pred HHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceeccccccccccccccccCCCccccCchhhcccC
Confidence 45677889999999999999999999999999988765 99999999874322 12223457999999999986
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+..++ .++|||||||++|+|++|..||.+........+.+...............+++.+.+||.+||..||.+|||+.
T Consensus 199 ~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 277 (289)
T 3og7_A 199 SNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277 (289)
T ss_dssp -CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 34444 34899999999999999999998877665554444332211111112346889999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++++
T Consensus 278 ell~ 281 (289)
T 3og7_A 278 RILA 281 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=235.58 Aligned_cols=151 Identities=22% Similarity=0.332 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 204 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 281 (370)
T 2psq_A 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281 (370)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCC
Confidence 34567889999999999999999999999999988776 9999999997432221 122345788999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+. .+... ...+....++..+.+||.+||..||.+|||+.++
T Consensus 282 ~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 282 YTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----HHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 999999999999999 999998765433322 22222 1223334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 356 l~~ 358 (370)
T 2psq_A 356 VED 358 (370)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=235.29 Aligned_cols=156 Identities=14% Similarity=0.202 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchh
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~ 76 (246)
..+.++.|++.||.|||+++|+||||||+|||++.+..+.+||+|||+++...... .....+||+.|+|||+
T Consensus 153 ~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 232 (364)
T 3op5_A 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH
Confidence 45677889999999999999999999999999983333459999999996432211 1133469999999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-hcc-----ccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNV-----QYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
+.+..++.+ +|||||||++|+|++|+.||.+.............. ... ...++ ...++.++.+|+..||..|
T Consensus 233 ~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 233 HNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp HTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCC
T ss_pred hCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCC
Confidence 988887654 999999999999999999998644333222211111 000 00011 1367999999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+||++.++++
T Consensus 311 p~~RP~~~~l~~ 322 (364)
T 3op5_A 311 YTEKPLYENLRD 322 (364)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=226.51 Aligned_cols=156 Identities=12% Similarity=0.145 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC---CcEEEeccCCccCCCCCC--------CCCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~---~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~a 73 (246)
....++.|++.||+|||+++|+||||||+|||++.++. ..+||+|||+++...... ......||+.|+|
T Consensus 107 ~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 186 (298)
T 1csn_A 107 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCC
Confidence 45677889999999999999999999999999975432 349999999987432221 1244579999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH---HHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
||++.+..++.+ +|||||||++|+|++|+.||.+..... .+..+....... ........+++++.+||.+||..|
T Consensus 187 PE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 187 INTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLRELCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHHCC
T ss_pred chhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cHHHHHhhCcHHHHHHHHHHhcCC
Confidence 999988887644 999999999999999999998754322 222222211111 101112368999999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+|||+.++++
T Consensus 265 p~~RP~~~~l~~ 276 (298)
T 1csn_A 265 FDATPDYDYLQG 276 (298)
T ss_dssp TTCCCCHHHHHH
T ss_pred cccCCCHHHHHH
Confidence 999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=234.03 Aligned_cols=157 Identities=17% Similarity=0.168 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchh
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~ 76 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++...+||+|||+++...... ......||+.|+|||+
T Consensus 152 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 231 (345)
T 2v62_A 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA 231 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHH
Confidence 45677889999999999999999999999999988764459999999997432211 1134579999999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhccccC----CCCCCcCCHHHHHHHHHhcccCC
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-DPRNFRKTIDRIRNVQYF----LPDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp 151 (246)
+.+..++.+ +|||||||++|+|++|+.||.+.. .................. ......++.++++||.+||..||
T Consensus 232 ~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 310 (345)
T 2v62_A 232 HKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAY 310 (345)
T ss_dssp HHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCT
T ss_pred hcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCc
Confidence 988777654 999999999999999999996432 222222222221111000 00112689999999999999999
Q ss_pred CCCCCHHHHhc
Q 025933 152 SKRIPIPEIKK 162 (246)
Q Consensus 152 ~~R~t~~e~l~ 162 (246)
.+|||++++++
T Consensus 311 ~~Rps~~~l~~ 321 (345)
T 2v62_A 311 DEKPNYQALKK 321 (345)
T ss_dssp TCCCCHHHHHH
T ss_pred ccCCCHHHHHH
Confidence 99999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=235.23 Aligned_cols=152 Identities=22% Similarity=0.368 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 194 ~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 271 (359)
T 3vhe_A 194 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 271 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCceeEChhhhcCCC
Confidence 35667889999999999999999999999999987776 9999999997532222 123346889999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+..........+... ...+....+++++.+||.+||..||.+|||+.++
T Consensus 272 ~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 346 (359)
T 3vhe_A 272 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346 (359)
T ss_dssp CCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 7655 999999999999998 999998776555444433321 1223334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 347 l~~ 349 (359)
T 3vhe_A 347 VEH 349 (359)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=228.56 Aligned_cols=154 Identities=15% Similarity=0.176 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe---cCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill---~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~a 73 (246)
....++.|++.||+|||+++|+||||||+|||+ +.++. +||+|||+++...... ......||+.|+|
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 4hgt_A 106 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcccCccCCCCcccccCCCccccc
Confidence 456678899999999999999999999999999 55554 9999999997433221 1234579999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..+........ .......+++.+.+||.+||..|
T Consensus 184 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 184 INTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSC
T ss_pred hHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-hhhhhccCCHHHHHHHHHHHhcC
Confidence 999988887644 89999999999999999999765432 22222222211110 00112357999999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+|||+.++++
T Consensus 262 p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 262 FDDKPDYSYLRQ 273 (296)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=230.75 Aligned_cols=151 Identities=21% Similarity=0.281 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 116 ~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (325)
T 3kex_A 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcccccccccCCCCcccccChHHhccCC
Confidence 34567889999999999999999999999999988776 9999999998543222 123346888999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+....... . .+.... ..+....++.++.+||.+||..||.+|||+.++
T Consensus 194 ~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 194 YTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVP-D---LLEKGE-RLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-H---HHHTTC-BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred CChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHH-H---HHHcCC-CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7654 999999999999999 99999876553332 2 222221 223334578899999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 268 ~~~ 270 (325)
T 3kex_A 268 ANE 270 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=226.42 Aligned_cols=154 Identities=15% Similarity=0.171 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEec---CCCCCcEEEeccCCccCCCCCCC--------CCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLD---GSPQPRLKICDFGYSKSGLLHSQ--------PKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~---~~~~~~vkl~Dfg~s~~~~~~~~--------~~~~~gt~~y~a 73 (246)
....++.|++.||+|||+++|+||||||+|||++ .++. +||+|||+++....... .....||+.|+|
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 3uzp_A 106 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccccccccccccccccccccccCC
Confidence 3456788999999999999999999999999994 4444 99999999874332211 234579999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..+........ .......+++.+.+||.+||..|
T Consensus 184 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 184 INTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSC
T ss_pred hhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hHHHHhhCCHHHHHHHHHHHhcC
Confidence 999988887644 99999999999999999999864322 22333222211111 00012368999999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+|||+.++++
T Consensus 262 p~~Rps~~~l~~ 273 (296)
T 3uzp_A 262 FDDKPDYSYLRQ 273 (296)
T ss_dssp TTCCCCHHHHHH
T ss_pred cCcCCCHHHHHH
Confidence 999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=231.03 Aligned_cols=157 Identities=13% Similarity=0.223 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcchh
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEV 76 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~ 76 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++...+||+|||+++...... ......||+.|+|||+
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 239 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence 45677899999999999999999999999999988763359999999997433211 1133479999999999
Q ss_pred ccccccCCcchhHHhHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhccccCC----CCCCcCCHHHHHHHHHhcccCC
Q 025933 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-DPRNFRKTIDRIRNVQYFL----PDYVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 77 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp 151 (246)
+.+..++.+ +|||||||++|+|++|+.||.+.. ..................+ ..+..++..+.+||.+||..||
T Consensus 240 ~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 240 HKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp HTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred HccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 988777654 999999999999999999998754 3333333333322221111 1123579999999999999999
Q ss_pred CCCCCHHHHhc
Q 025933 152 SKRIPIPEIKK 162 (246)
Q Consensus 152 ~~R~t~~e~l~ 162 (246)
.+|||+.++++
T Consensus 319 ~~Rps~~~l~~ 329 (352)
T 2jii_A 319 EEKPPYAMLRN 329 (352)
T ss_dssp TCCCCHHHHHH
T ss_pred hhCCCHHHHHH
Confidence 99999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=232.00 Aligned_cols=151 Identities=22% Similarity=0.341 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 118 ~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 195 (327)
T 3poz_A 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCcccccccCCCccccccChHHhccCC
Confidence 34667889999999999999999999999999988776 9999999987432221 112335788999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... ...+. . ....+....++..+.+|+.+||..||.+|||+.++
T Consensus 196 ~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE---K-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHH---T-TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred CCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHH---c-CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7655 999999999999999 9999987654332 22222 1 22234445689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 270 l~~ 272 (327)
T 3poz_A 270 IIE 272 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=236.82 Aligned_cols=157 Identities=17% Similarity=0.262 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCC---CCCCCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL---LHSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~---~~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++... .........||+.|+|||++.+.
T Consensus 182 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 261 (367)
T 3l9p_A 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence 4566788999999999999999999999999998543 2349999999986321 11223345689999999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+...... ...+.... ..+....++..+.+||.+||..||.+|||+.+
T Consensus 262 ~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~----~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 262 IFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 87655 999999999999998 9999987554332 22333222 22333468999999999999999999999999
Q ss_pred HhcCcccc
Q 025933 160 IKKHPWFL 167 (246)
Q Consensus 160 ~l~hp~~~ 167 (246)
+++|.++.
T Consensus 336 il~~l~~~ 343 (367)
T 3l9p_A 336 ILERIEYC 343 (367)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=229.08 Aligned_cols=155 Identities=25% Similarity=0.343 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHhH--------hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFY--------LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH--------~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y 71 (246)
..+.++.|++.||+||| +++|+||||||+|||++.++. +||+|||+++...... .....+||+.|
T Consensus 106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 183 (301)
T 3q4u_A 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183 (301)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEEECCCCCCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeecccccccccccccccccccce
Confidence 34677889999999999 999999999999999988776 9999999986322111 12344799999
Q ss_pred Ccchhcccc------ccCCcchhHHhHHHHHHHHHhC----------CCCCCCCCChHHHHHHHHHHhccccCCCCC---
Q 025933 72 IAPEVLARK------EYDGKISDVWSCGVTLYVMLVG----------AYPFEDPEDPRNFRKTIDRIRNVQYFLPDY--- 132 (246)
Q Consensus 72 ~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 132 (246)
+|||++.+. .++ .++|||||||++|+|++| ..||............+..........+..
T Consensus 184 ~aPE~~~~~~~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (301)
T 3q4u_A 184 MAPEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR 262 (301)
T ss_dssp CCHHHHTTCCCTTCHHHH-HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred eChhhhcCcCCCCcccCC-chhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChh
Confidence 999999876 333 348999999999999999 889865433222122222222111111211
Q ss_pred ---CcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 133 ---VRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 133 ---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
...+..+.+||.+||..||.+|||+.++++
T Consensus 263 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 125578999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=226.99 Aligned_cols=157 Identities=27% Similarity=0.422 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHhHhCC-----cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQE-----ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~-----ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~ 78 (246)
....++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.
T Consensus 112 ~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (279)
T 2w5a_A 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccccccccCCCccccChHHhc
Confidence 35677889999999999999 999999999999987776 9999999987432211 112346899999999998
Q ss_pred ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
+..++.+ +|||||||++|+|++|..||........ ...+..... .+....++.++.+||.+||..||.+|||+.
T Consensus 190 ~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 263 (279)
T 2w5a_A 190 RMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVE 263 (279)
T ss_dssp CC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHH----HHHHhhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHH
Confidence 8777644 8999999999999999999987543222 222322222 122336899999999999999999999999
Q ss_pred HHhcCcccccC
Q 025933 159 EIKKHPWFLKN 169 (246)
Q Consensus 159 e~l~hp~~~~~ 169 (246)
++++|+|+...
T Consensus 264 ~ll~~~~~~~~ 274 (279)
T 2w5a_A 264 EILENPLILEH 274 (279)
T ss_dssp HHHTSTTCCGG
T ss_pred HHHhChhhhhh
Confidence 99999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=221.29 Aligned_cols=153 Identities=24% Similarity=0.342 Sum_probs=118.0
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCC---CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc-
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA- 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~---~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~- 78 (246)
....++.|++.||+|||+++ |+||||||+|||++.++. ..+||+|||+++... .......||+.|+|||++.
T Consensus 123 ~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSC
T ss_pred HHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc--ccccccCCCccccCchhhcc
Confidence 34567889999999999999 999999999999976442 248999999997432 2334567999999999984
Q ss_pred -ccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 -RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 -~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
...++ .++|||||||++|+|++|..||......... ....+............+++.+.+||.+||..||.+|||+
T Consensus 201 ~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 277 (287)
T 4f0f_A 201 EEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277 (287)
T ss_dssp SSCEEC-HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCcC-chhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH
Confidence 33444 4489999999999999999999865543321 1222222222233344789999999999999999999999
Q ss_pred HHHhc
Q 025933 158 PEIKK 162 (246)
Q Consensus 158 ~e~l~ 162 (246)
.++++
T Consensus 278 ~~ll~ 282 (287)
T 4f0f_A 278 SYIVK 282 (287)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=231.51 Aligned_cols=151 Identities=21% Similarity=0.322 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..
T Consensus 192 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC
Confidence 45677889999999999999999999999999988776 999999999754322 1223345788999999998887
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+..... ....+.... .......++.++.+||.+||..||.+|||+.++
T Consensus 270 ~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 270 YTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 899999999999999 999998755332 222222221 223334789999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 344 l~~ 346 (382)
T 3tt0_A 344 VED 346 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=222.13 Aligned_cols=153 Identities=27% Similarity=0.377 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHhHhCC---cccCCCCCCCEEecCC------CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcch
Q 025933 5 CYFSSTVMIFTSHHCFYLQE---ICHRDLKLENTLLDGS------PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 75 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~---ivHrDlkp~Nill~~~------~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE 75 (246)
....++.|++.||.|||+++ |+||||||+|||++.. ..+.+||+|||+++.... .......||+.|+|||
T Consensus 106 ~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE 184 (271)
T 3dtc_A 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPE 184 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc-ccccCCCCccceeCHH
Confidence 34567889999999999999 8999999999999752 124599999999975332 2223457999999999
Q ss_pred hccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC
Q 025933 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI 155 (246)
Q Consensus 76 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 155 (246)
++.+..++.+ +|||||||++|+|++|..||.+........ .........+....+++.+.+||.+||..||.+||
T Consensus 185 ~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 185 VIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp HHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence 9988777654 899999999999999999998755433222 22233333344457899999999999999999999
Q ss_pred CHHHHhcC
Q 025933 156 PIPEIKKH 163 (246)
Q Consensus 156 t~~e~l~h 163 (246)
|+.++++|
T Consensus 260 s~~e~l~~ 267 (271)
T 3dtc_A 260 SFTNILDQ 267 (271)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=229.51 Aligned_cols=150 Identities=22% Similarity=0.344 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..
T Consensus 118 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 195 (327)
T 3lzb_A 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC----------------CCCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCccccccccCCCccccccCHHHHcCCC
Confidence 34567889999999999999999999999999988776 99999999975322221 12335788999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... ...+. . ....+....++.++.+||.+||..||.+|||+.++
T Consensus 196 ~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE---K-GERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHH---T-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHH---c-CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7655 999999999999999 9999987655332 22221 1 22334445789999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 270 l~ 271 (327)
T 3lzb_A 270 II 271 (327)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=224.35 Aligned_cols=151 Identities=23% Similarity=0.369 Sum_probs=111.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..+
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccccccccCCCcccccChhhcccCCC
Confidence 34567889999999999999999999999999987765 99999999975432221 123357789999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+......... +.... ..+....+++.+.+||.+||..||.+|||+.+++
T Consensus 195 ~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~----i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 268 (281)
T 1mp8_A 195 TSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268 (281)
T ss_dssp SHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----HHcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 654 899999999999996 9999987665443322 22221 2234457899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 269 ~~ 270 (281)
T 1mp8_A 269 AQ 270 (281)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=229.15 Aligned_cols=157 Identities=21% Similarity=0.351 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHhHhC--------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-----CCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQ--------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----PKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~--------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-----~~~~~gt~~y 71 (246)
....++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++....... ....+||+.|
T Consensus 135 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 212 (337)
T 3mdy_A 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212 (337)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC---------CCSSCSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccccCCCCCCccCcce
Confidence 3456788999999999999 9999999999999988776 99999999964322211 2345799999
Q ss_pred CcchhccccccCCc-----chhHHhHHHHHHHHHhC----------CCCCCCCCChHHHHHHHHHHhcccc---CCCC--
Q 025933 72 IAPEVLARKEYDGK-----ISDVWSCGVTLYVMLVG----------AYPFEDPEDPRNFRKTIDRIRNVQY---FLPD-- 131 (246)
Q Consensus 72 ~aPE~~~~~~~~~~-----~~DiwslG~il~~ll~g----------~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~-- 131 (246)
+|||++.+..+... ++|||||||++|+|++| ..||..................... ..+.
T Consensus 213 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (337)
T 3mdy_A 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292 (337)
T ss_dssp CCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred eChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccc
Confidence 99999987665443 37999999999999999 7777653322221122222221111 1111
Q ss_pred -CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 132 -YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 132 -~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
...++..+.+||.+||..||.+|||+.++++|
T Consensus 293 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 12456789999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=224.87 Aligned_cols=152 Identities=25% Similarity=0.345 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..
T Consensus 146 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 223 (313)
T 1t46_A 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCC
Confidence 45667889999999999999999999999999987765 99999999975433221 22345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+..........+... ...+....++..+.+||.+||..||.+|||+.++
T Consensus 224 ~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 224 YTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 7644 999999999999998 999998776555544443322 2223334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 299 l~~ 301 (313)
T 1t46_A 299 VQL 301 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=231.22 Aligned_cols=153 Identities=24% Similarity=0.381 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||++||+||||||+|||++.++. +||+|||++........ .....||+.|+|||++.+..
T Consensus 173 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence 34668889999999999999999999999999987765 99999999974322221 12335788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+...+.. ....+....+++.+.+||.+||..||.+|||+.++
T Consensus 251 ~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 251 YTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp CCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChh-HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 7654 999999999999998 99999887655554443332 22233344689999999999999999999999999
Q ss_pred hcCc
Q 025933 161 KKHP 164 (246)
Q Consensus 161 l~hp 164 (246)
++|.
T Consensus 326 ~~~l 329 (344)
T 1rjb_A 326 TSFL 329 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=227.92 Aligned_cols=156 Identities=17% Similarity=0.229 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC---CcEEEeccCCccCCCCCC--------CCCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~---~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~a 73 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 185 (330)
T 2izr_A 106 TVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccC
Confidence 45667889999999999999999999999999976543 239999999997432221 1245679999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCC
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADP 151 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp 151 (246)
||++.+..++.+ +|||||||++|+|++|..||.+..... ..+.+..+.......+. .....+++.+||.+||..||
T Consensus 186 PE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p 263 (330)
T 2izr_A 186 INTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDF 263 (330)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCT
T ss_pred hHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCC
Confidence 999998887644 999999999999999999998754322 22222222222211111 11123399999999999999
Q ss_pred CCCCCHHHHhc
Q 025933 152 SKRIPIPEIKK 162 (246)
Q Consensus 152 ~~R~t~~e~l~ 162 (246)
.+||++.++++
T Consensus 264 ~~RP~~~~l~~ 274 (330)
T 2izr_A 264 FEKPDYDYLRK 274 (330)
T ss_dssp TCCCCHHHHHH
T ss_pred CCCCCHHHHHH
Confidence 99999998876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=228.39 Aligned_cols=150 Identities=22% Similarity=0.309 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+.
T Consensus 152 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 229 (325)
T 3kul_A 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC
Confidence 45677889999999999999999999999999988776 99999999975332211 1223467889999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+....... ..+... ...+....++..+.+||.+||..||.+|||+.+
T Consensus 230 ~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 303 (325)
T 3kul_A 230 TFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVI----SSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303 (325)
T ss_dssp EECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHcC-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence 87655 899999999999999 99999876543332 222222 233444578999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 304 il~ 306 (325)
T 3kul_A 304 IVS 306 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=226.19 Aligned_cols=154 Identities=27% Similarity=0.309 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 113 ~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-------------CCSSCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC
Confidence 4567889999999999999999999999999988776 9999999997543222 22345799999999999888876
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +|||||||++|+|++|+.||.+........+.+ ...... ......++..+.++|.+||..||.+||+..+.+
T Consensus 191 ~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l 266 (294)
T 4eqm_A 191 EC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI---QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266 (294)
T ss_dssp TT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH---SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred ch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence 55 899999999999999999998765433322221 111111 012246899999999999999999999555555
Q ss_pred cCcc
Q 025933 162 KHPW 165 (246)
Q Consensus 162 ~hp~ 165 (246)
.+.|
T Consensus 267 ~~~l 270 (294)
T 4eqm_A 267 KDDL 270 (294)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=227.04 Aligned_cols=151 Identities=22% Similarity=0.307 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++............+++.|+|||++.+..++.
T Consensus 143 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 220 (327)
T 1fvr_A 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 220 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCc
Confidence 34667889999999999999999999999999987766 9999999997433333334446788999999998777765
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|||||||++|+|++ |..||.+..... ....+... ...+....+++.+.+||.+||..||.+|||+.+++++
T Consensus 221 ~-~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 221 N-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-hcchHHHHHHHHHHcCCCCCCCCCcHHH----HHHHhhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4 999999999999998 999998755432 22232222 2223344789999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=224.70 Aligned_cols=151 Identities=25% Similarity=0.346 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..
T Consensus 151 ~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 45677889999999999999999999999999987765 9999999987432221 123345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+....... .. +... ...+....+++.+.+||.+||..||.+|||+.++
T Consensus 229 ~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~---~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 229 YTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF-NL---LKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp ECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HH---HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---hhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7655 899999999999999 99999876553332 22 2221 1223344789999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=221.75 Aligned_cols=151 Identities=21% Similarity=0.369 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++..... .......||+.|+|||++.+..+
T Consensus 107 ~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (269)
T 4hcu_A 107 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 184 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccccccCcccccccCCHHHhcCCCC
Confidence 34567889999999999999999999999999987765 999999998743221 12234457888999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +||||+||++|+|++ |..||.+....... ..+... .........+..+.+|+.+||..||.+|||+.+++
T Consensus 185 ~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 258 (269)
T 4hcu_A 185 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLL 258 (269)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHhcC-ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 655 899999999999999 99999875543332 222222 12223346799999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 259 ~~ 260 (269)
T 4hcu_A 259 RQ 260 (269)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=221.29 Aligned_cols=151 Identities=22% Similarity=0.270 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++............||+.|+|||++.+..++.
T Consensus 123 ~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 200 (284)
T 2a19_B 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK 200 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCT
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccccccccCCcccccChhhhccCCCcc
Confidence 34567889999999999999999999999999988765 9999999987554444445567999999999998887765
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +|||||||++|+|++|..||.. .......+.... .+ ..++..+++||.+||..||.+|||+.++++|.
T Consensus 201 ~-~Di~slG~il~~l~~~~~~~~~------~~~~~~~~~~~~--~~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 201 E-VDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGI--IS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp H-HHHHHHHHHHHHHHSCCSSHHH------HHHHHHHHHTTC--CC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred h-hhhHHHHHHHHHHHhcCCcchh------HHHHHHHhhccc--cc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 5 8999999999999999988742 112222222211 22 35899999999999999999999999999998
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
+..+
T Consensus 270 ~~~~ 273 (284)
T 2a19_B 270 TVWK 273 (284)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 7654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=225.21 Aligned_cols=152 Identities=22% Similarity=0.367 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..
T Consensus 149 ~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 226 (316)
T 2xir_A 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 226 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhcccc
Confidence 34567889999999999999999999999999987766 99999999975432221 12345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+...+... ...+....+++.+.++|.+||..||.+|||+.++
T Consensus 227 ~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 301 (316)
T 2xir_A 227 YTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301 (316)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC----ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7654 999999999999998 999998766544443333221 1122334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 302 l~~ 304 (316)
T 2xir_A 302 VEH 304 (316)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=222.27 Aligned_cols=153 Identities=27% Similarity=0.394 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHHhHh---CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYL---QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~---~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
...+.++.|++.||.|||+ ++|+||||||+|||++.++. .+||+|||++.... .......||+.|+|||++.+.
T Consensus 102 ~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 178 (307)
T 2eva_A 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGS 178 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC--------------CCTTSSCHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc--cccccCCCCCceEChhhhCCC
Confidence 3456778899999999999 89999999999999987653 37999999987432 223345699999999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
.++.+ +|||||||++|+|++|+.||........ ......... ...+....++..+.+||.+||..||.+|||+.++
T Consensus 179 ~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 254 (307)
T 2eva_A 179 NYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG-TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254 (307)
T ss_dssp CCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTT-CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcC-CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 87655 8999999999999999999976443221 122222221 2223345789999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 255 l~~ 257 (307)
T 2eva_A 255 VKI 257 (307)
T ss_dssp HHH
T ss_pred HHH
Confidence 873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=219.69 Aligned_cols=151 Identities=21% Similarity=0.295 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 105 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (268)
T 3sxs_A 105 QLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEE
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCC
Confidence 34567889999999999999999999999999988776 9999999987432221 1223456778999999988888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +||||+||++|+|++ |..||........... +.... ........++.+.+||.+||..||.+|||+.+++
T Consensus 183 ~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 256 (268)
T 3sxs_A 183 SSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQGH-RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLL 256 (268)
T ss_dssp ETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred chh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcCC-CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 766 899999999999998 9999987554333222 22222 1222335799999999999999999999999999
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 257 ~~ 258 (268)
T 3sxs_A 257 SS 258 (268)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=221.30 Aligned_cols=154 Identities=21% Similarity=0.276 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+.
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 192 (295)
T 3ugc_A 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------------CTTCGGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC
Confidence 34567889999999999999999999999999988765 9999999997533221 12233577889999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCC------------hHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED------------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 148 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 148 (246)
.++.+ +|||||||++|+|++|..||..... ..........+. .....+....+++++.+||.+||.
T Consensus 193 ~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~ 270 (295)
T 3ugc_A 193 KFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWN 270 (295)
T ss_dssp CCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred CCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh-ccCcCCCCcCcCHHHHHHHHHHcC
Confidence 87655 9999999999999999999864211 011112222222 222334455789999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 025933 149 ADPSKRIPIPEIKK 162 (246)
Q Consensus 149 ~dp~~R~t~~e~l~ 162 (246)
.||.+|||+.++++
T Consensus 271 ~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 271 NNVNQRPSFRDLAL 284 (295)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=226.30 Aligned_cols=147 Identities=24% Similarity=0.300 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---------------CCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---------------PKSTVGTP 69 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---------------~~~~~gt~ 69 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... ..+.+||+
T Consensus 109 ~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 186 (310)
T 3s95_A 109 QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------------------CCCCSCG
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccccccccccccccccccCCCc
Confidence 34567889999999999999999999999999988776 99999999874322111 11457999
Q ss_pred CCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhccccCCCCCCcCCHHHHHHHH
Q 025933 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----NFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144 (246)
Q Consensus 70 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 144 (246)
.|+|||++.+..++.+ +|||||||++|+|++|..||....... ........ .....+++.+.+||.
T Consensus 187 ~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~ 257 (310)
T 3s95_A 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--------YCPPNCPPSFFPITV 257 (310)
T ss_dssp GGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--------TCCTTCCTTHHHHHH
T ss_pred ceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--------cCCCCCCHHHHHHHH
Confidence 9999999998888765 899999999999999999986533211 11111111 112367889999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 025933 145 QIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 145 ~~L~~dp~~R~t~~e~l~ 162 (246)
+||..||.+|||+.++++
T Consensus 258 ~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 258 RCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.00 Aligned_cols=151 Identities=21% Similarity=0.275 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 114 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccccccccccCCCCcceeCchhhccCCC
Confidence 34566789999999999999999999999999988765 9999999987543222 1223457889999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.......... .+. .. ...+....+++.+.+||.+||..||.+|||+.+++
T Consensus 192 ~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 265 (281)
T 3cc6_A 192 TTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLE---KG-DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265 (281)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHH---HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHh---cC-CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 644 899999999999998 999998655543322 221 11 12333446899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 266 ~~ 267 (281)
T 3cc6_A 266 CS 267 (281)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=235.73 Aligned_cols=154 Identities=18% Similarity=0.185 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe---cCCCCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIA 73 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill---~~~~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~a 73 (246)
..+.++.||+.||.|||+++||||||||+|||+ +.++. +||+|||+++...... .....+||+.|+|
T Consensus 104 ~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 181 (483)
T 3sv0_A 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181 (483)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence 456778899999999999999999999999999 44554 9999999997533221 1225679999999
Q ss_pred chhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH---HHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 74 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
||++.+..++.+ +|||||||++|+|++|+.||.+..... .+.++....... ........++.++.+||.+||..|
T Consensus 182 PE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 182 VNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-SIEALCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-CHHHHHTTSCHHHHHHHHHHHTCC
T ss_pred HHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-cHHHHhcCCcHHHHHHHHHHhcCC
Confidence 999998887655 899999999999999999998755422 222222211110 000111367999999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+||++.++++
T Consensus 260 P~~RPs~~el~~ 271 (483)
T 3sv0_A 260 FDDKPDYSYLKR 271 (483)
T ss_dssp TTCCCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=235.48 Aligned_cols=150 Identities=22% Similarity=0.345 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..... .......+|+.|+|||++.+..+
T Consensus 285 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 362 (454)
T 1qcf_A 285 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362 (454)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCC
Confidence 34567889999999999999999999999999988776 999999999753221 11223457788999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+.... +.. ....+....+++.+.+||.+||..||.+|||+++++
T Consensus 363 ~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 363 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 655 999999999999999 9999987655433322 222 233445557899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 437 ~ 437 (454)
T 1qcf_A 437 S 437 (454)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=222.29 Aligned_cols=152 Identities=23% Similarity=0.335 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+.
T Consensus 122 ~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (291)
T 1u46_A 122 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccccccccchhhhccCCCCceeeCchhhcCC
Confidence 34567889999999999999999999999999987765 99999999875432221 2234578899999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+..... ....+.......+....++..+.++|.+||..||.+|||+.+
T Consensus 200 ~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 274 (291)
T 1u46_A 200 TFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 274 (291)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence 77644 899999999999999 999998765432 333333333444555678999999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
++++
T Consensus 275 l~~~ 278 (291)
T 1u46_A 275 LRDF 278 (291)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=222.85 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC----------------CCGGGSCHHHHHSSC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceecccccccCcccccCCCccccCchhhcCCC
Confidence 45677889999999999999999999999999988776 9999999997533221 122345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+.........+ .... ..+....++..+.+||.+||..||.+|||+.++
T Consensus 226 ~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 226 YTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----LHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----HcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7655 899999999999999 99999876654333222 2211 223344689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 300 ~~~ 302 (313)
T 3brb_A 300 RLQ 302 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=233.80 Aligned_cols=148 Identities=20% Similarity=0.359 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.... ......+++.|+|||++.+..++.
T Consensus 290 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 365 (450)
T 1k9a_A 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFST 365 (450)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCcccccc--cccCCCCCcceeCHHHhcCCCCCc
Confidence 45677889999999999999999999999999988776 99999999984322 223346788999999998888865
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++ |..||.+....+.... +.. ....+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 366 ~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 366 K-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEK-GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp H-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH----HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5 999999999999998 9999987665443322 222 2233444578999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=226.61 Aligned_cols=152 Identities=20% Similarity=0.316 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..
T Consensus 165 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 242 (333)
T 2i1m_A 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--EEECccccccccccccceeecCCCCCCccccCHHHhccCC
Confidence 45667889999999999999999999999999987765 99999999974322211 22345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+......+...... ....+.....+..+.+||.+||..||.+|||+.++
T Consensus 243 ~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 317 (333)
T 2i1m_A 243 YTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317 (333)
T ss_dssp CCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 7644 999999999999998 99999876655544443332 22233344679999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 318 ~~~ 320 (333)
T 2i1m_A 318 CSF 320 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=220.38 Aligned_cols=153 Identities=22% Similarity=0.278 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||+++...... ......||+.|+|||++.+.
T Consensus 111 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 111 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCcceeeccccccccccccCHHHhccC
Confidence 45667889999999999999999999999999987765 9999999987432221 12233578999999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+....... ..+.... ..+....+++.+.+||.+||..||.+|||+.+
T Consensus 189 ~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 262 (287)
T 1u59_A 189 KFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLT 262 (287)
T ss_dssp EECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHhcCC-cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHH
Confidence 77655 999999999999998 99999876654332 2222221 12333478999999999999999999999999
Q ss_pred HhcCcc
Q 025933 160 IKKHPW 165 (246)
Q Consensus 160 ~l~hp~ 165 (246)
+++|.+
T Consensus 263 l~~~l~ 268 (287)
T 1u59_A 263 VEQRMR 268 (287)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=228.63 Aligned_cols=157 Identities=23% Similarity=0.223 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 217 (321)
T 2qkw_B 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR 217 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB
T ss_pred HHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccccccccccccCCCccccCHHHhcCCC
Confidence 45677889999999999999999999999999987776 9999999987432211 122345899999999998888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHH--HHHH-HHHHhcccc--------CCCCCCcCCHHHHHHHHHhcccC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--FRKT-IDRIRNVQY--------FLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~d 150 (246)
++.+ +|||||||++|+|++|+.||.+...... .... ......... ........+..+.+++.+||..|
T Consensus 218 ~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 296 (321)
T 2qkw_B 218 LTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296 (321)
T ss_dssp CCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSS
T ss_pred CCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCC
Confidence 7655 8999999999999999999976443211 1111 111111100 00111234677899999999999
Q ss_pred CCCCCCHHHHhcCc
Q 025933 151 PSKRIPIPEIKKHP 164 (246)
Q Consensus 151 p~~R~t~~e~l~hp 164 (246)
|.+|||+.++++|.
T Consensus 297 P~~Rps~~ell~~L 310 (321)
T 2qkw_B 297 SEDRPSMGDVLWKL 310 (321)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred cccCcCHHHHHHHH
Confidence 99999999999764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=218.29 Aligned_cols=151 Identities=26% Similarity=0.319 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-----CCCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||.+.+
T Consensus 125 ~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 125 DLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc
Confidence 34567889999999999999999999999999988776 999999999743221 12233468899999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|||||||++|+|++|..||............+.. . ...+....++..+.+||.+||..||.+|||+.+
T Consensus 203 ~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 203 YRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---G-RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---C-CCCCCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence 877655 89999999999999965554444443333332221 1 123334468999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 278 ll~ 280 (298)
T 3pls_A 278 LVG 280 (298)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=224.37 Aligned_cols=151 Identities=19% Similarity=0.259 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 139 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcCccccccccccccccccCCCCCCCccChhhhccCC
Confidence 45667889999999999999999999999999988766 9999999987432211 112345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... ...+.... ..+....++..+.+||.+||..||.+|||+.++
T Consensus 217 ~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 217 FTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp CCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhHHHHHHHHHHHHhcCCCccccCCHHHH----HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 7654 899999999999999 8999987554322 22222222 123344789999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 291 l~~ 293 (322)
T 1p4o_A 291 ISS 293 (322)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=214.19 Aligned_cols=148 Identities=21% Similarity=0.202 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++ |+||||||+|||++.++. ++|+|||++... ......||+.|+|||++.+..+
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~ 185 (271)
T 3kmu_A 112 QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPE 185 (271)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT----SCTTCBSCGGGSCHHHHHSCGG
T ss_pred HHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee----cccCccCCccccChhhhccCCC
Confidence 45677889999999999999 999999999999988776 888888876532 2234578999999999987665
Q ss_pred CCc--chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 83 DGK--ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 83 ~~~--~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
... ++|||||||++|+|++|..||.+.......... .......+....++..+.+||.+||..||.+|||+.++
T Consensus 186 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV----ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH----HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 442 489999999999999999999876544333222 22222223344789999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 262 l~ 263 (271)
T 3kmu_A 262 VP 263 (271)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=226.80 Aligned_cols=154 Identities=19% Similarity=0.219 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHHHHHhHhC----------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQ----------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~----------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y 71 (246)
....++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++...... .....+||+.|
T Consensus 122 ~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y 199 (322)
T 3soc_A 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAGDTHGQVGTRRY 199 (322)
T ss_dssp HHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCEEECTTSCCCCCTTCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcccccccccCccccccCccCccc
Confidence 3466788999999999999 9999999999999988766 9999999996432221 22345799999
Q ss_pred Ccchhcccc-----ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChH------------HHHHHHHHHhccccCCCCC--
Q 025933 72 IAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------------NFRKTIDRIRNVQYFLPDY-- 132 (246)
Q Consensus 72 ~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~-- 132 (246)
+|||++.+. .++ .++|||||||++|+|++|+.||.+..... ............. ..|..
T Consensus 200 ~aPE~~~~~~~~~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 277 (322)
T 3soc_A 200 MAPEVLEGAINFQRDAF-LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRD 277 (322)
T ss_dssp CCHHHHTTCCCCCHHHH-HHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCG
T ss_pred cCHhhcccccccCcCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccc
Confidence 999999763 333 34799999999999999999997643211 1111111111111 11111
Q ss_pred ----CcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 133 ----VRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 133 ----~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
...+..+.+||.+||..||.+|||+.++++
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 123456999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=220.31 Aligned_cols=151 Identities=19% Similarity=0.287 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......+|+.|+|||++.+..+
T Consensus 121 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (283)
T 3gen_A 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccCCccCcccCCHHHhccCCC
Confidence 35667889999999999999999999999999988776 999999998743221 11223457888999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +||||+||++|+|++ |..||........... +.... ........++.+.+||.+||..||.+|||+.+++
T Consensus 199 ~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 272 (283)
T 3gen_A 199 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPTFKILL 272 (283)
T ss_dssp SHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhccc-CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 654 899999999999998 9999987654433322 22221 1222335799999999999999999999999999
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 273 ~~ 274 (283)
T 3gen_A 273 SN 274 (283)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=226.63 Aligned_cols=150 Identities=21% Similarity=0.304 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..+
T Consensus 176 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 176 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 4567889999999999999999999999999987776 999999998632211 12234568999999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+...... ...+..... .+....++..+.+||++||..||.+|||+.+++
T Consensus 254 ~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~ 327 (343)
T 1luf_A 254 TTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEV----IYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327 (343)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-cccHHHHHHHHHHHhcCCCcCCCCChHHH----HHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 654 999999999999998 9999987554322 223332222 223346899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 328 ~~ 329 (343)
T 1luf_A 328 RI 329 (343)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=229.02 Aligned_cols=150 Identities=23% Similarity=0.304 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..
T Consensus 214 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 214 TLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 45677889999999999999999999999999988776 9999999997432211 111223567899999998888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... ...+.. ....+....++..+.+||.+||..||.+|||+.++
T Consensus 292 ~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 365 (377)
T 3cbl_A 292 YSSE-SDVWSFGILLWETFSLGASPYPNLSNQQT----REFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365 (377)
T ss_dssp EEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHH----HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 7655 899999999999998 9999987554322 222222 22334445689999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 366 ~~ 367 (377)
T 3cbl_A 366 YQ 367 (377)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=217.01 Aligned_cols=148 Identities=21% Similarity=0.356 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++..... ......+++.|+|||++.+..++.
T Consensus 118 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 193 (278)
T 1byg_A 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFST 193 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeeccccccccc--cccCCCccccccCHHHhCCCCCCc
Confidence 34667889999999999999999999999999987776 99999999874322 223446889999999998777765
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++ |..||......... ..+... ...+....+++.+.++|++||..||.+|||+.++++
T Consensus 194 ~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 194 K-SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----HHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhcC-CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 4 899999999999998 99999875543322 222221 222334578999999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=225.05 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC-------------CCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-------------PKSTVGTP 69 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~-------------~~~~~gt~ 69 (246)
....++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++....... .....||+
T Consensus 137 ~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~ 214 (337)
T 3ll6_A 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC----------------------
T ss_pred HHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccccccccccchhhccccCCC
Confidence 35667889999999999999 999999999999988776 99999999975432211 11446999
Q ss_pred CCCcchhc---cccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHh
Q 025933 70 AYIAPEVL---ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 146 (246)
Q Consensus 70 ~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 146 (246)
.|+|||++ .+..++ .++|||||||++|+|++|..||....... . .......+.....+..+.+||.+|
T Consensus 215 ~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~----~----~~~~~~~~~~~~~~~~~~~li~~~ 285 (337)
T 3ll6_A 215 MYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLR----I----VNGKYSIPPHDTQYTVFHSLIRAM 285 (337)
T ss_dssp ---------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC--------------------CCCCTTCCSSGGGHHHHHHH
T ss_pred CcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHH----h----hcCcccCCcccccchHHHHHHHHH
Confidence 99999998 444554 44999999999999999999997543321 1 122223344456788899999999
Q ss_pred cccCCCCCCCHHHHhcCc
Q 025933 147 FVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 147 L~~dp~~R~t~~e~l~hp 164 (246)
|..||.+|||+.++++|.
T Consensus 286 l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 286 LQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp SCSSGGGSCCHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHH
Confidence 999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=227.84 Aligned_cols=151 Identities=20% Similarity=0.263 Sum_probs=110.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 79 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+
T Consensus 193 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 270 (373)
T 3c1x_A 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------------------CCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccccccccccccccCCCCCcccccChHHhcC
Confidence 45667889999999999999999999999999988776 9999999997432211 1123457889999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|||||||++|+|++ |.+||.+....+....+ .... ..+....++..+.++|.+||..||.+|||+.
T Consensus 271 ~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~-~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ 344 (373)
T 3c1x_A 271 QKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 344 (373)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 877654 999999999999999 78888765554332222 2222 1223346899999999999999999999999
Q ss_pred HHhcC
Q 025933 159 EIKKH 163 (246)
Q Consensus 159 e~l~h 163 (246)
+++++
T Consensus 345 ell~~ 349 (373)
T 3c1x_A 345 ELVSR 349 (373)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=219.74 Aligned_cols=154 Identities=23% Similarity=0.312 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+.
T Consensus 127 ~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 204 (302)
T 4e5w_A 127 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccccCCCcceeccCCCCCCccccCCeeecCC
Confidence 34567889999999999999999999999999988765 9999999997543222 22345688899999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCC-----------ChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPE-----------DPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.++.+ +|||||||++|+|++|..|+.... ...........+. .....+....+++.+.+||.+||..
T Consensus 205 ~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 282 (302)
T 4e5w_A 205 KFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEF 282 (302)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHcCC
Confidence 87655 899999999999999999864311 1112222222222 2223344557899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
||.+|||+.++++
T Consensus 283 dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 283 QPSNRTSFQNLIE 295 (302)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=232.82 Aligned_cols=156 Identities=26% Similarity=0.362 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEe----cCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc-
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLL----DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR- 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill----~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~- 79 (246)
....++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||+++...........+||+.|+|||++.+
T Consensus 113 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (396)
T 4eut_A 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceEccCCCccccccCCccccCHHHhhcc
Confidence 456778899999999999999999999999998 4433 499999999986544444456689999999999865
Q ss_pred -------cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------------------CCCCC-
Q 025933 80 -------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------------------FLPDY- 132 (246)
Q Consensus 80 -------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~- 132 (246)
..++ .++|||||||++|+|++|+.||............+..+..... ..+..
T Consensus 191 ~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (396)
T 4eut_A 191 VLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (396)
T ss_dssp CC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred ccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCccc
Confidence 3444 3489999999999999999999754443333333333332221 11111
Q ss_pred ---CcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 133 ---VRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 133 ---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
..++..+.+||++||..||.+|||+.+++++
T Consensus 270 ~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2245678999999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=219.74 Aligned_cols=154 Identities=25% Similarity=0.367 Sum_probs=110.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..++
T Consensus 137 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (310)
T 2wqm_A 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------------------CCSSCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCC
Confidence 34567889999999999999999999999999987776 9999999987533222 22345799999999999887776
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
.+ +|||||||++|+|++|..||.+.... .......+....+.......++.++.+||.+||..||.+|||+.+++++
T Consensus 215 ~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 215 FK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HH-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ch-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 55 89999999999999999999764321 1223333333333222234689999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=215.90 Aligned_cols=150 Identities=20% Similarity=0.302 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||++||+||||||+|||++.++. +||+|||++....... ......+|+.|+|||++.+..+
T Consensus 110 ~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 187 (279)
T 1qpc_A 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccccccCCCCccCccChhhhccCCC
Confidence 45677889999999999999999999999999987766 9999999997543221 1223457889999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....... ..+... ........++..+.+||.+||..||.+|||+.+++
T Consensus 188 ~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 261 (279)
T 1qpc_A 188 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261 (279)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHH----HHHhcc-cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHH
Confidence 654 899999999999999 99999875543322 222222 22233447899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 262 ~ 262 (279)
T 1qpc_A 262 S 262 (279)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=221.82 Aligned_cols=151 Identities=22% Similarity=0.318 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCC
Confidence 35667889999999999999999999999999987776 9999999987433221 123345788999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |..||.+...... .. .+.... ..+....++..+.+||.+||..||.+|||+.++
T Consensus 236 ~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~~---~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 236 YTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FK---LLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp ECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HH---HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHH-HH---HHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7655 899999999999999 9999987544322 22 222221 223334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
+++
T Consensus 310 l~~ 312 (334)
T 2pvf_A 310 VED 312 (334)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=221.76 Aligned_cols=151 Identities=20% Similarity=0.324 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+.
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (333)
T 1mqb_A 148 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccccccccccCCCCccccccCchhcccC
Confidence 45677889999999999999999999999999987766 99999999975332211 1123467889999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+...... ...+... ...+....++..+.+||.+||..||.+||++.+
T Consensus 226 ~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 299 (333)
T 1mqb_A 226 KFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 299 (333)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 77654 899999999999998 9999977554322 2222222 223444578999999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
++++
T Consensus 300 l~~~ 303 (333)
T 1mqb_A 300 IVSI 303 (333)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=224.39 Aligned_cols=155 Identities=22% Similarity=0.330 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+.
T Consensus 128 ~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (327)
T 3lxl_A 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCccceeeccCCccccccCHHHhccC
Confidence 35667889999999999999999999999999988776 9999999997432221 22334688899999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.++.+ +|||||||++|+|++|..||...... .........+. .....+....+++.+.+||.+||..
T Consensus 206 ~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 283 (327)
T 3lxl_A 206 IFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-EGQRLPAPPACPAEVHELMKLCWAP 283 (327)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh-cccCCCCCCcccHHHHHHHHHHcCC
Confidence 77654 89999999999999999998643211 01122222222 2223344557899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 025933 150 DPSKRIPIPEIKKH 163 (246)
Q Consensus 150 dp~~R~t~~e~l~h 163 (246)
||.+|||+.+++++
T Consensus 284 dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 284 SPQDRPSFSALGPQ 297 (327)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=222.57 Aligned_cols=157 Identities=17% Similarity=0.262 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCC---CCCCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++.... ........||+.|+|||++.+.
T Consensus 141 ~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 220 (327)
T 2yfx_A 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG 220 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC
Confidence 4567788999999999999999999999999998433 23599999999863211 1222344689999999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+..... ....+.... ..+....++..+.+||.+||..||.+|||+.+
T Consensus 221 ~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 221 IFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294 (327)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHHhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 77654 999999999999998 999998754432 222222222 22233468999999999999999999999999
Q ss_pred HhcCcccc
Q 025933 160 IKKHPWFL 167 (246)
Q Consensus 160 ~l~hp~~~ 167 (246)
+++|.|+.
T Consensus 295 ll~~l~~~ 302 (327)
T 2yfx_A 295 ILERIEYC 302 (327)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=226.45 Aligned_cols=150 Identities=21% Similarity=0.325 Sum_probs=109.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+.
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 148 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----------------------CTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCccceeccCCCcCCCccChhhhccC
Confidence 45677889999999999999999999999999988776 99999999975432211 1122357789999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+....... ..+.. ....+....++..+.+||.+||..||.+||++.+
T Consensus 226 ~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 299 (373)
T 2qol_A 226 KFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KAVDE-GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299 (373)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HHHHT-TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence 87655 899999999999997 99999876543322 22222 2223444578999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 300 i~~ 302 (373)
T 2qol_A 300 IVS 302 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=218.93 Aligned_cols=155 Identities=24% Similarity=0.306 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+.
T Consensus 134 ~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 210 (307)
T 2nru_A 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE- 210 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-
T ss_pred HHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccccccccccccCCCcCcCChHHhcCC-
Confidence 34567889999999999999999999999999987766 9999999987432211 12345799999999998754
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------CCCCCCcCCHHHHHHHHHhcccCCC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------FLPDYVRVSADCRHLLSQIFVADPS 152 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dp~ 152 (246)
++.+ +|||||||++|+|++|..||...........+...+..... ..+.....+..+.+++.+||..||.
T Consensus 211 ~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 211 ITPK-SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp ECTH-HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred CCcc-chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcc
Confidence 5544 89999999999999999999875544333333322221111 0111223557889999999999999
Q ss_pred CCCCHHHHhcC
Q 025933 153 KRIPIPEIKKH 163 (246)
Q Consensus 153 ~R~t~~e~l~h 163 (246)
+|||+.+++++
T Consensus 290 ~Rps~~~l~~~ 300 (307)
T 2nru_A 290 KRPDIKKVQQL 300 (307)
T ss_dssp TSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=231.54 Aligned_cols=150 Identities=21% Similarity=0.299 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..+
T Consensus 281 ~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceecccCCcccccccCHhHHhcCCC
Confidence 45677889999999999999999999999999987766 9999999997533211 1123357788999999988887
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+.. ..+.. ....+....++..+.+||.+||..||.+|||+++++
T Consensus 359 ~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 359 TIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 655 999999999999999 99999876543332 22222 223344557899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 433 ~ 433 (452)
T 1fmk_A 433 A 433 (452)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=216.23 Aligned_cols=150 Identities=20% Similarity=0.259 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+.
T Consensus 118 ~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 118 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC
Confidence 35667889999999999999999999999999988765 99999999874322211 1223467889999999877
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+...... ...+.... ..+....++..+.++|.+||..||.+|||+.+
T Consensus 196 ~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 269 (291)
T 1xbb_A 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 269 (291)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 77654 899999999999999 9999987554322 22222221 22333468999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 270 l~~ 272 (291)
T 1xbb_A 270 VEL 272 (291)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=216.40 Aligned_cols=150 Identities=20% Similarity=0.264 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+
T Consensus 129 ~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (298)
T 3f66_A 129 DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccchhccccccCCCCCccccChHHhcC
Confidence 45567889999999999999999999999999987766 9999999997543221 1233467889999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|||||||++|+|++ |.+||.+.......... .... .......++..+.++|.+||..||.+|||+.
T Consensus 207 ~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 280 (298)
T 3f66_A 207 QKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 280 (298)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 777655 899999999999999 66677665543332222 2211 1222346899999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++++
T Consensus 281 ell~ 284 (298)
T 3f66_A 281 ELVS 284 (298)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=242.42 Aligned_cols=162 Identities=27% Similarity=0.331 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC-CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~-~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||.|||++||+||||||+|||++.++. ..+||+|||++.............||+.|+|||++.+..++.
T Consensus 123 i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ 202 (676)
T 3qa8_A 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV 202 (676)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCST
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCc
Confidence 4567889999999999999999999999999986543 348999999998655444455668999999999998888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HHH-----hcccc----CCCC----CCcCCHHHHHHHHHh
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-----DRI-----RNVQY----FLPD----YVRVSADCRHLLSQI 146 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~-----~~~~~----~~~~----~~~~~~~~~~li~~~ 146 (246)
+ +||||+||++|+|++|..||.+......+...+ ... ..... ..+. ...++..+.+||.+|
T Consensus 203 k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~m 281 (676)
T 3qa8_A 203 T-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281 (676)
T ss_dssp T-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHH
T ss_pred h-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHH
Confidence 6 899999999999999999997643221110000 000 00000 0111 123678999999999
Q ss_pred cccCCCCCCCHHHHhcCccccc
Q 025933 147 FVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 147 L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
|..||.+|||+.++++||||..
T Consensus 282 L~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 282 LMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCSSCC---CCTTCCCCTTHHH
T ss_pred ccCCHhhCcCHHHHhcCHHHHH
Confidence 9999999999999999999954
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=223.62 Aligned_cols=154 Identities=19% Similarity=0.242 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHHHHhHhC---------CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---------CCCCCCCC
Q 025933 6 YFSSTVMIFTSHHCFYLQ---------EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---------SQPKSTVG 67 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~---------~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---------~~~~~~~g 67 (246)
...++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++..... ......+|
T Consensus 113 ~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~g 190 (336)
T 3g2f_A 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190 (336)
T ss_dssp HHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCEECSSSSCC---------CCTTS
T ss_pred HHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeeccceeecccccccCccccccccccCCC
Confidence 456788999999999999 9999999999999988766 999999999743221 11224579
Q ss_pred CCCCCcchhccc-------cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHH--------------HHHHHHHHhcc-
Q 025933 68 TPAYIAPEVLAR-------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--------------FRKTIDRIRNV- 125 (246)
Q Consensus 68 t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------~~~~~~~~~~~- 125 (246)
|+.|+|||++.+ ..++ .++|||||||++|+|++|..||........ ...........
T Consensus 191 t~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (336)
T 3g2f_A 191 TIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK 269 (336)
T ss_dssp CGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC
T ss_pred ccceeCchhhcCCcccccccccc-cccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc
Confidence 999999999976 2333 348999999999999999777643222100 01111111111
Q ss_pred -ccCCCC----CCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 126 -QYFLPD----YVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 126 -~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
...+|. ...+++.+.+||.+||..||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 270 QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111 1124568999999999999999999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=214.94 Aligned_cols=151 Identities=21% Similarity=0.347 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||.|||+++|+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.+..+
T Consensus 105 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (267)
T 3t9t_A 105 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 182 (267)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccccccccccccccChhhhcCCCc
Confidence 34667889999999999999999999999999987766 999999998743221 12233467889999999987777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+. ++||||||+++|+|++ |..||.+...... ...+.... ........+..+.+|+.+||..||.+|||+.+++
T Consensus 183 ~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 256 (267)
T 3t9t_A 183 SS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTGF-RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLL 256 (267)
T ss_dssp CH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cc-hhchhhhHHHHHHHhccCCCCCCCCCHHHH----HHHHhcCC-cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHH
Confidence 64 4999999999999999 8999987554332 22222221 2222346799999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
++
T Consensus 257 ~~ 258 (267)
T 3t9t_A 257 RQ 258 (267)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=233.34 Aligned_cols=150 Identities=22% Similarity=0.339 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..+
T Consensus 319 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 44567889999999999999999999999999987766 9999999998532211 1223356788999999988887
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....... +.+ . .....+....++..+.+||.+||..||.+|||+.+++
T Consensus 397 ~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~ 470 (495)
T 1opk_A 397 SIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELL---E-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470 (495)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHH---H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHH---H-cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 655 999999999999998 99999876544332 222 2 2223344457899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 471 ~ 471 (495)
T 1opk_A 471 Q 471 (495)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=218.97 Aligned_cols=149 Identities=18% Similarity=0.216 Sum_probs=112.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCC------cEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQP------RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~------~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~ 79 (246)
...++.|++.||.|||+++|+||||||+|||++.++.. .+||+|||++..... .....||+.|+|||++.+
T Consensus 115 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIEN 191 (289)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHC
T ss_pred HHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCC
Confidence 45678899999999999999999999999999776531 289999999864321 123458899999999987
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
....+.++|||||||++|+|++|..|+............. ......+ ...+.++.+||.+||..||.+|||+.+
T Consensus 192 ~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ 265 (289)
T 4fvq_A 192 PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLP--APKAAELANLINNCMDYEPDHRPSFRA 265 (289)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 3433455999999999999999655544433333222221 1122222 246888999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
+++|
T Consensus 266 ll~~ 269 (289)
T 4fvq_A 266 IIRD 269 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=216.65 Aligned_cols=150 Identities=23% Similarity=0.352 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+||+++.++. +||+|||++........ .....+|+.|+|||++.+..+
T Consensus 112 ~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccccccCCccccCcCChhhhccCCC
Confidence 34567789999999999999999999999999987766 99999999975432221 122357889999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....... ..+. . ....+....+++.+.+||.+||..||.+|||+.+++
T Consensus 190 ~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~~~---~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~ 263 (288)
T 3kfa_A 190 SIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLE---K-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263 (288)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHH---T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHh---c-cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHH
Confidence 644 899999999999999 99999876543332 2221 1 222333457899999999999999999999999997
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 264 ~ 264 (288)
T 3kfa_A 264 Q 264 (288)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=216.42 Aligned_cols=150 Identities=17% Similarity=0.232 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC------CCCCCCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL------HSQPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~------~~~~~~~~gt~~y~aPE~~~ 78 (246)
....++.|++.||.|||++||+||||||+|||++ ++ .+||+|||+++.... ........||+.|+|||++.
T Consensus 131 ~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 207 (319)
T 2y4i_B 131 KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCccccccccccccccccccCCCcccccChHHhh
Confidence 3456788999999999999999999999999997 33 499999999764211 11223346899999999987
Q ss_pred cc---------ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 79 RK---------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 79 ~~---------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
+. .+ +.++|||||||++|+|++|..||.+....... ..+............++..+.+||.+||..
T Consensus 208 ~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 282 (319)
T 2y4i_B 208 QLSPDTEEDKLPF-SKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTGMKPNLSQIGMGKEISDILLFCWAF 282 (319)
T ss_dssp CBSCC--CCCSCC-CHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HHHHTTCCCCCCCSSCCTTHHHHHHHHHCS
T ss_pred hccccccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccCCCCCCCcCCCCHHHHHHHHHHhcC
Confidence 52 23 34589999999999999999999875543322 222222222222235789999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
||.+|||+.++++
T Consensus 283 ~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 283 EQEERPTFTKLMD 295 (319)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=218.83 Aligned_cols=154 Identities=25% Similarity=0.293 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+.
T Consensus 135 ~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 212 (318)
T 3lxp_A 135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccccccccccccccCCCCCceeeChHHhcCC
Confidence 45667889999999999999999999999999988776 9999999997543221 12334688899999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.++.+ +|||||||++|+|++|..||...... ......... .......+....++..+.+||++||..
T Consensus 213 ~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 213 KFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGERLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH-HhcccCCCCCccccHHHHHHHHHHcCC
Confidence 77644 89999999999999999999653211 111111222 222223344557899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
||.+|||+.++++
T Consensus 291 dP~~Rps~~ell~ 303 (318)
T 3lxp_A 291 EASFRPTFENLIP 303 (318)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=223.27 Aligned_cols=143 Identities=30% Similarity=0.522 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||+|||+++|+||||||+|||++... .+.+||+|||+++... +..++
T Consensus 118 ~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~ 176 (299)
T 3m2w_A 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYD 176 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCC
Confidence 4567788999999999999999999999999998732 2359999999986321 13344
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
. ++|||||||++|+|++|..||.+.............+.......+ .+..++.++++||.+||..||.+|||+.+++
T Consensus 177 ~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l 255 (299)
T 3m2w_A 177 K-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255 (299)
T ss_dssp G-HHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred c-hhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 3 489999999999999999999764432111100011111111111 1146899999999999999999999999999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 256 ~hp~~~~~ 263 (299)
T 3m2w_A 256 NHPWIMQS 263 (299)
T ss_dssp TSHHHHTG
T ss_pred cChhhccc
Confidence 99999653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=218.13 Aligned_cols=151 Identities=19% Similarity=0.242 Sum_probs=108.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||++....... ......||+.|+|||++.+..+
T Consensus 135 ~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 212 (309)
T 2h34_A 135 RAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC----------------CCGGGCCGGGTCC---
T ss_pred HHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccccccccccccCCCcCccCHHHHcCCCC
Confidence 34567889999999999999999999999999988776 9999999987533221 2234579999999999988877
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCCCCcCCHHHHHHHHHhcccCCCCCC-CHHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKRI-PIPEI 160 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~-t~~e~ 160 (246)
+.+ +|||||||++|+|++|+.||.+.... ... ..+..... .......++..+.+||.+||..||.+|| +++++
T Consensus 213 ~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l 287 (309)
T 2h34_A 213 TYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMG---AHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL 287 (309)
T ss_dssp -CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHH---HHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred Cch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHH---HHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH
Confidence 655 89999999999999999999764322 111 11211111 1122346899999999999999999999 88887
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 288 ~~ 289 (309)
T 2h34_A 288 SA 289 (309)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=222.36 Aligned_cols=158 Identities=20% Similarity=0.173 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHhHhC---CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQ---EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~---~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~ 79 (246)
....++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+
T Consensus 132 ~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCcccccccccccCCcCccCHHHhcc
Confidence 4467788999999999999 9999999999999988766 99999999974332221 233469999999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCC----CCChHHHHHHHHHHhcccc---------CCCCCCcCCHHHHHHHHHh
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFED----PEDPRNFRKTIDRIRNVQY---------FLPDYVRVSADCRHLLSQI 146 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~----~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~ 146 (246)
..++.+ +|||||||++|+|++|..||.. ................... ........+..+.+|+.+|
T Consensus 210 ~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 288 (326)
T 3uim_A 210 GKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288 (326)
T ss_dssp SEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHH
Confidence 777655 9999999999999999999952 1111111111111110000 0011122347899999999
Q ss_pred cccCCCCCCCHHHHhcCcc
Q 025933 147 FVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 147 L~~dp~~R~t~~e~l~hp~ 165 (246)
|..||.+|||+.++++|..
T Consensus 289 l~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 289 TQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TCSCGGGSCCHHHHHHHHH
T ss_pred hCcCCccCCCHHHHHHHhc
Confidence 9999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=235.01 Aligned_cols=150 Identities=21% Similarity=0.281 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----CCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~~~~~ 80 (246)
....++.|++.||.|||+++||||||||+|||++.++. +||+|||+++........ ....+|+.|+|||++.+.
T Consensus 437 ~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--------------CCTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC
Confidence 45667889999999999999999999999999988775 999999999854322111 122466899999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |..||.+....+.. ..+.... ..+....+++++.+||.+||..||.+|||+.+
T Consensus 515 ~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 588 (613)
T 2ozo_A 515 KFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLT 588 (613)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 87655 999999999999998 99999887664433 2232222 23334478999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 589 l~~ 591 (613)
T 2ozo_A 589 VEQ 591 (613)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=221.16 Aligned_cols=157 Identities=20% Similarity=0.288 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHhH--------hCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFY--------LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH--------~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y 71 (246)
..+.++.|++.||.||| +++|+||||||+|||++.++. +||+|||++....... ......||+.|
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y 217 (342)
T 1b6c_B 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217 (342)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceeccccccccccccccCCcCccc
Confidence 35667889999999999 899999999999999988776 9999999986432222 23445799999
Q ss_pred CcchhccccccCC-----cchhHHhHHHHHHHHHhC----------CCCCCCCCChH-HHHHHHHHHhcccc--CCCC--
Q 025933 72 IAPEVLARKEYDG-----KISDVWSCGVTLYVMLVG----------AYPFEDPEDPR-NFRKTIDRIRNVQY--FLPD-- 131 (246)
Q Consensus 72 ~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g----------~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~-- 131 (246)
+|||++.+..... .++|||||||++|+|++| ..||....... ........+..... ..+.
T Consensus 218 ~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (342)
T 1b6c_B 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297 (342)
T ss_dssp CCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred CCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc
Confidence 9999997653211 348999999999999999 78987643221 11222222222111 1111
Q ss_pred -CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 132 -YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 132 -~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
....+..+.+||.+||..||.+|||+.++++|
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 298 QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 11344689999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=223.31 Aligned_cols=145 Identities=18% Similarity=0.204 Sum_probs=111.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecC-----------CCCCcEEEeccCCccCC---CCCCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDG-----------SPQPRLKICDFGYSKSG---LLHSQPKSTVGTPA 70 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~-----------~~~~~vkl~Dfg~s~~~---~~~~~~~~~~gt~~ 70 (246)
....++.|++.||+|||+++||||||||+|||++. ++. +||+|||+++.. .........+||+.
T Consensus 173 ~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 250 (365)
T 3e7e_A 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG--LALIDLGQSIDMKLFPKGTIFTAKCETSG 250 (365)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT--EEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred HHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC--EEEeeCchhhhhhccCCCceeeeecCCCC
Confidence 35667889999999999999999999999999977 444 999999999632 12223345689999
Q ss_pred CCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 71 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
|+|||++.+..++.+ +|||||||++|+|++|+.||....... ......++.. ..++.+.+++.+||..+
T Consensus 251 y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~l~~~ 319 (365)
T 3e7e_A 251 FQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE---------CKPEGLFRRL-PHLDMWNEFFHVMLNIP 319 (365)
T ss_dssp CCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE---------EEECSCCTTC-SSHHHHHHHHHHHHCCC
T ss_pred CCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc---------eeechhcccc-CcHHHHHHHHHHHcCCC
Confidence 999999998888755 999999999999999999996433210 0111111221 24778999999999999
Q ss_pred CCCCCCHHHHhc
Q 025933 151 PSKRIPIPEIKK 162 (246)
Q Consensus 151 p~~R~t~~e~l~ 162 (246)
|.+|++..+.+.
T Consensus 320 p~~r~~~~~~l~ 331 (365)
T 3e7e_A 320 DCHHLPSLDLLR 331 (365)
T ss_dssp CTTCCCCHHHHH
T ss_pred CCCcchHHHHHH
Confidence 999976544444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=236.82 Aligned_cols=150 Identities=20% Similarity=0.257 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+.
T Consensus 470 ~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~ 547 (635)
T 4fl3_A 470 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC-------------CGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC
Confidence 34567889999999999999999999999999988776 9999999987432221 11223577889999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |+.||.+...... ...+.... ..+....++.++.+||.+||..||.+|||+.+
T Consensus 548 ~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~----~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 548 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 87655 999999999999998 9999987655332 22222221 23334478999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 622 l~~ 624 (635)
T 4fl3_A 622 VEL 624 (635)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=216.59 Aligned_cols=154 Identities=21% Similarity=0.288 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+.
T Consensus 146 ~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccccccccccccCCCCceeEECchhhcCC
Confidence 35667889999999999999999999999999987765 99999999975432221 2234578889999999887
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCC-----------hHH-HHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcc
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 148 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 148 (246)
.++.+ +|||||||++|+|++|..||..... ... ...+...+. .....+....++..+.+||.+||.
T Consensus 224 ~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 301 (326)
T 2w1i_A 224 KFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWN 301 (326)
T ss_dssp EEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred CCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh-cCCCCCCCCcccHHHHHHHHHHcC
Confidence 77654 8999999999999999999864210 011 111222222 222334455789999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 025933 149 ADPSKRIPIPEIKK 162 (246)
Q Consensus 149 ~dp~~R~t~~e~l~ 162 (246)
.||.+|||+.++++
T Consensus 302 ~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 302 NNVNQRPSFRDLAL 315 (326)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=232.09 Aligned_cols=150 Identities=21% Similarity=0.300 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++...... ......++..|+|||++.+..+
T Consensus 364 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceecccCCcCcccccCHHHhccCCC
Confidence 45677889999999999999999999999999987765 9999999997543211 1223457789999999988877
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+....+. +..+.. .+..+....++..+.+||.+||..||.+|||+++++
T Consensus 442 ~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~----~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 515 (535)
T 2h8h_A 442 TIK-SDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 515 (535)
T ss_dssp CHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHH----HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 999999999999999 9999987654333 222222 223344457899999999999999999999999987
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 516 ~ 516 (535)
T 2h8h_A 516 A 516 (535)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=219.38 Aligned_cols=152 Identities=26% Similarity=0.380 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC----------CCCCCCCCCCcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----------KSTVGTPAYIAP 74 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~----------~~~~gt~~y~aP 74 (246)
....++.|++.||.|||+++|+||||||+|||++.++. +||+|||++......... ....||+.|+||
T Consensus 135 ~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccccccccccccccccccccCCcccCCH
Confidence 34567889999999999999999999999999987776 999999988643211110 123579999999
Q ss_pred hhccccc---cCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccC
Q 025933 75 EVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 150 (246)
Q Consensus 75 E~~~~~~---~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 150 (246)
|++.+.. ++ .++|||||||++|+|++|..||...... ..... .. ......+....++..+.+||.+||..|
T Consensus 213 E~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~l~~li~~~l~~d 287 (317)
T 2buj_A 213 ELFSVQSHCVID-ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---AV-QNQLSIPQSPRHSSALWQLLNSMMTVD 287 (317)
T ss_dssp GGSSCCSEEEEC-THHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---HH-HCC--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred hHhccCCCcCCC-chhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---Hh-hccCCCCccccCCHHHHHHHHHHhhcC
Confidence 9987543 44 4499999999999999999999531100 01111 11 123334555678999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 025933 151 PSKRIPIPEIKKH 163 (246)
Q Consensus 151 p~~R~t~~e~l~h 163 (246)
|.+|||+.+++++
T Consensus 288 p~~Rps~~~ll~~ 300 (317)
T 2buj_A 288 PHQRPHIPLLLSQ 300 (317)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-30 Score=234.09 Aligned_cols=150 Identities=24% Similarity=0.373 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..+
T Consensus 492 ~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC----------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCC
Confidence 34567889999999999999999999999999988765 99999999985432221 122357789999999988777
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |..||.+........ .+.... ..+....+++.+.+||.+||..||.+|||+.+++
T Consensus 570 ~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~----~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~ 643 (656)
T 2j0j_A 570 TSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 643 (656)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHcCC-CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 654 999999999999997 999998765433322 222221 2233457899999999999999999999999998
Q ss_pred c
Q 025933 162 K 162 (246)
Q Consensus 162 ~ 162 (246)
+
T Consensus 644 ~ 644 (656)
T 2j0j_A 644 A 644 (656)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=220.47 Aligned_cols=149 Identities=13% Similarity=0.107 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHHHHhH-hCCcccCCCCCCCEEecCCCC------------------CcEEEeccCCccCCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFY-LQEICHRDLKLENTLLDGSPQ------------------PRLKICDFGYSKSGLLHSQPKST 65 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH-~~~ivHrDlkp~Nill~~~~~------------------~~vkl~Dfg~s~~~~~~~~~~~~ 65 (246)
....++.||+.||.||| +++||||||||+|||++.++. ..+||+|||+|+.... ...
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~ 237 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEE
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcE
Confidence 45667889999999999 999999999999999987751 1599999999984321 245
Q ss_pred CCCCCCCcchhccccccCCcchhHHhHHHH-HHHHHhCCCCCCCCCChHHHHHHHHHHhc-cccC----CCCCCcCCHHH
Q 025933 66 VGTPAYIAPEVLARKEYDGKISDVWSCGVT-LYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYF----LPDYVRVSADC 139 (246)
Q Consensus 66 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~ 139 (246)
+||+.|+|||++.+.. + .++||||+|++ .++++.|..||.+.. ........+.. .... .+.+..+++++
T Consensus 238 ~gt~~y~aPE~~~g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-D-YQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp ECCCCTTCSGGGCCCS-S-HHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred EEeecccChhhhcCCC-c-cceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHH
Confidence 7999999999998765 3 45999998777 678888999984310 00112222221 1111 11123578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHh-cCcccc
Q 025933 140 RHLLSQIFVADPSKRIPIPEIK-KHPWFL 167 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l-~hp~~~ 167 (246)
++||++||++| |+.|+| +||||+
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 99999999987 999999 999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=226.23 Aligned_cols=142 Identities=19% Similarity=0.172 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..+.++.|++.||.|||++|||||||||+|||++.+ .+||+|||+++.... ....+||+.|+|||++.+.. +
T Consensus 183 ~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~--~ 254 (681)
T 2pzi_A 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGP--T 254 (681)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC---CSCCCCCTTTSCTTHHHHCS--C
T ss_pred HHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc---CCccCCCccccCHHHHcCCC--C
Confidence 456778899999999999999999999999999874 399999999975332 24567999999999987543 3
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
.++|||||||++|+|++|..||.+..... ..........++.+.+||.+||..||.+||+..+.+.|+
T Consensus 255 ~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 255 VATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp HHHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred CceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 45999999999999999999886421100 000001113468899999999999999999999999988
Q ss_pred cc
Q 025933 165 WF 166 (246)
Q Consensus 165 ~~ 166 (246)
|+
T Consensus 323 l~ 324 (681)
T 2pzi_A 323 LT 324 (681)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=186.58 Aligned_cols=126 Identities=8% Similarity=0.030 Sum_probs=93.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
.+.++.|++.||.|||++||+||||||+|||++.++. +||+++| |++| + +.
T Consensus 131 ~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~-------------------~~~~-------~-~~ 181 (286)
T 3uqc_A 131 AIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA-------------------TMPD-------A-NP 181 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC-------------------CCTT-------C-CH
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc-------------------ccCC-------C-Cc
Confidence 4567889999999999999999999999999998776 8888543 2332 3 34
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
++|||||||++|+|++|+.||.+......+...... ....... .....++..+.+||.+||..||.+| |+.++++
T Consensus 182 ~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 489999999999999999999875542211000000 0000000 1123689999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-24 Score=196.26 Aligned_cols=92 Identities=17% Similarity=0.121 Sum_probs=61.5
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
.++.||+.||+|+|++|||||||||+|||++.++. |||+|||+|+..... ....+.+||+.|||||++.+... ..
T Consensus 343 ~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~-~~- 418 (569)
T 4azs_A 343 KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKS-WN- 418 (569)
T ss_dssp HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---------
T ss_pred HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccccCceechhhccHHHhCCCCC-Cc-
Confidence 35789999999999999999999999999988776 999999999854332 23345589999999999986543 33
Q ss_pred hhHHhHHHHHHHHHhCC
Q 025933 87 SDVWSCGVTLYVMLVGA 103 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~ 103 (246)
+|+||+|++++.+.++.
T Consensus 419 ~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 419 GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----------CCCCTTH
T ss_pred ccccccccchhhhcccc
Confidence 89999999988765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-18 Score=155.14 Aligned_cols=95 Identities=22% Similarity=0.239 Sum_probs=77.0
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--------CCCCCCCCCCCcchhccc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--------PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 79 (246)
.++.|++.+|.|||+++|+||||||+|||++. ++||+|||+++....... ..+.+||+.|||||++..
T Consensus 435 ~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 435 DIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 56788999999999999999999999999987 399999999985432211 124579999999999976
Q ss_pred --cccCCcchhHHhHHHHHHHHHhCCCCCC
Q 025933 80 --KEYDGKISDVWSCGVTLYVMLVGAYPFE 107 (246)
Q Consensus 80 --~~~~~~~~DiwslG~il~~ll~g~~Pf~ 107 (246)
..|+.. +|+||..+-..+.+.++.+|.
T Consensus 511 ~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 511 FLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 566544 799999988888777776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-14 Score=117.76 Aligned_cols=56 Identities=29% Similarity=0.260 Sum_probs=48.7
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcc
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~ 78 (246)
.++.|++.||.|||++||+||||||+|||++ ++. +||+|||+++ .+..++|||++.
T Consensus 197 ~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DFG~a~------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 197 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDFPQSV------------EVGEEGWREILE 252 (282)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCCTTCE------------ETTSTTHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEECCCCe------------ECCCCCHHHHHH
Confidence 4678899999999999999999999999999 554 9999999986 345678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.7e-11 Score=99.89 Aligned_cols=46 Identities=17% Similarity=0.176 Sum_probs=40.7
Q ss_pred HHHHHHHHHHHHHHhH-hCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 6 YFSSTVMIFTSHHCFY-LQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH-~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
...++.|++.+|.||| ++|||||||||+|||++. . ++|+|||+|..
T Consensus 172 ~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~--~~liDFG~a~~ 218 (258)
T 1zth_A 172 VEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--K--VYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--S--EEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--c--EEEEECccccc
Confidence 3456778899999999 999999999999999986 3 99999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.73 E-value=6.4e-09 Score=89.22 Aligned_cols=46 Identities=13% Similarity=0.030 Sum_probs=38.4
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCC--------cEEEeccCCcc
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQP--------RLKICDFGYSK 54 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~--------~vkl~Dfg~s~ 54 (246)
...|++.+|.+||.+|||||||||.|||++.++.+ .+.|+||+-+.
T Consensus 210 l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 210 LYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 34678899999999999999999999999876532 27899998665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=6.9e-05 Score=59.86 Aligned_cols=28 Identities=21% Similarity=0.261 Sum_probs=23.4
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
++|+|++|.|||++.+.. ++|+|||.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999976532 5699999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00014 Score=58.37 Aligned_cols=30 Identities=23% Similarity=0.242 Sum_probs=23.8
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|++|.|||++.+.. +.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 45899999999999976432 5699998664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.30 E-value=3.3e-05 Score=63.81 Aligned_cols=83 Identities=19% Similarity=0.247 Sum_probs=47.6
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc--cccCCc-----------chhHH
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGK-----------ISDVW 90 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~-----------~~Diw 90 (246)
.++|+|++|.||+++.+....+.|+||+.+..+..............-..|+.... ..|... ..+.|
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~ 271 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW 271 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence 58999999999999874222378999998764321110000000000012222110 011100 15889
Q ss_pred hHHHHHHHHHhCCCCC
Q 025933 91 SCGVTLYVMLVGAYPF 106 (246)
Q Consensus 91 slG~il~~ll~g~~Pf 106 (246)
++|.++|.+.+|..+|
T Consensus 272 ~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 272 SFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCHHH
Confidence 9999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0003 Score=59.34 Aligned_cols=33 Identities=24% Similarity=0.407 Sum_probs=26.6
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++|+|+++.|||++.++...+.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 468999999999999876532358999998863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0071 Score=50.06 Aligned_cols=30 Identities=30% Similarity=0.512 Sum_probs=25.4
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+++.|||++.++. +.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 57999999999999975554 8999998664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.18 E-value=0.015 Score=49.99 Aligned_cols=32 Identities=19% Similarity=0.245 Sum_probs=27.0
Q ss_pred HhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 21 YLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 21 H~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
+...++|+|+++.|||++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 456799999999999997653 89999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.21 E-value=0.91 Score=35.46 Aligned_cols=83 Identities=12% Similarity=0.085 Sum_probs=46.6
Q ss_pred CCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcchhHHhHHHHHHHHHhCCCCCC
Q 025933 28 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 107 (246)
Q Consensus 28 rDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 107 (246)
+=+-|..|++..+|. |.+.+ +.+. .....+.|||... ...+ .+.-|+|||+++|..+-=..|=
T Consensus 74 ~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~~~~~~~~pe~~~-~~~t-e~~~IysLG~tLY~ALDygL~e- 136 (229)
T 2yle_A 74 RVRSAAQIRVWRDGA--VTLAP-AADD-----------AGEPPPVAGKLGY-SQCM-ETEVIESLGIIIYKALDYGLKE- 136 (229)
T ss_dssp CCCSGGGEEEETTSC--EEECC-C-----------------------CCSS-SSSC-HHHHHHHHHHHHHHHHTTTCCT-
T ss_pred eecCCcceEEecCCc--eeccc-cccc-----------ccccCCCChhhcc-ccch-HHHHHHHHHHHHHHHhhcCCCc-
Confidence 334578899988887 55442 1111 1123456788763 1222 3368999999999876422211
Q ss_pred CCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 108 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
.....+|+++..||..|..-
T Consensus 137 ----------------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 137 ----------------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----------------------TEEECCCHHHHHHHHHHTTC
T ss_pred ----------------------ccchhhCHHHHHHHHHHHhc
Confidence 11236899999999999765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.04 E-value=0.047 Score=44.96 Aligned_cols=28 Identities=18% Similarity=0.114 Sum_probs=23.9
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+++.|||++ + . +.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~--~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-G--PMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-S--EEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-C--CEEEECCCCC
Confidence 4589999999999998 3 3 8999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.80 E-value=0.017 Score=47.47 Aligned_cols=30 Identities=23% Similarity=0.349 Sum_probs=24.1
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.+++|+|+++.|||++.+.. +.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 46899999999999986532 4799998654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.63 E-value=0.027 Score=45.00 Aligned_cols=28 Identities=25% Similarity=0.448 Sum_probs=23.3
Q ss_pred cccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 25 ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
++|+|+.+.|||++..+. +-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 799999999999986543 5699998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.52 E-value=0.037 Score=45.81 Aligned_cols=34 Identities=26% Similarity=0.279 Sum_probs=26.4
Q ss_pred hCCcccCCCCCCCEEecCCC--CCcEEEeccCCccC
Q 025933 22 LQEICHRDLKLENTLLDGSP--QPRLKICDFGYSKS 55 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~~--~~~vkl~Dfg~s~~ 55 (246)
...++|+|+.+.|||++.+. ...+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 35699999999999997631 12489999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=92.81 E-value=0.042 Score=45.09 Aligned_cols=32 Identities=25% Similarity=0.297 Sum_probs=24.8
Q ss_pred CCcccCCCCCCCEEecC---CCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDG---SPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~---~~~~~vkl~Dfg~s~~ 55 (246)
..++|+|+++.|||++. ++. .+.|+||+.+..
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~ 224 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAI 224 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEE
T ss_pred CeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCC
Confidence 36899999999999986 222 247999997763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=92.41 E-value=0.035 Score=46.41 Aligned_cols=31 Identities=13% Similarity=0.157 Sum_probs=24.7
Q ss_pred hCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 22 LQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
...++|+|+.+.|||++.+. .+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~--~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQ--PVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTE--EEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCc--EEEEEcccccc
Confidence 35699999999999998432 26899998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.12 Score=43.85 Aligned_cols=30 Identities=17% Similarity=0.238 Sum_probs=25.0
Q ss_pred hCCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 22 LQEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 22 ~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
...++|+|+.+.|||++.+. ++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~---~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE---TKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC---EEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCC---eEEEeCcccc
Confidence 45799999999999997643 8999998665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.59 E-value=0.07 Score=44.86 Aligned_cols=28 Identities=36% Similarity=0.641 Sum_probs=23.1
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+++.|||++.+. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~---~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC---LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C---EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc---EEEEEecCCC
Confidence 589999999999997532 8999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.13 E-value=0.11 Score=44.88 Aligned_cols=17 Identities=41% Similarity=0.702 Sum_probs=14.7
Q ss_pred CcccCCCCCCCEEecCC
Q 025933 24 EICHRDLKLENTLLDGS 40 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~ 40 (246)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.39 E-value=0.13 Score=42.82 Aligned_cols=31 Identities=23% Similarity=0.418 Sum_probs=25.7
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..++|+|+.+.||+++.++. +.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCee
Confidence 46899999999999976554 89999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.29 E-value=0.16 Score=41.26 Aligned_cols=28 Identities=36% Similarity=0.459 Sum_probs=22.7
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.+.||+. .++. +.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil~-~~~~--~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TGER--MWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEE-CSSC--EEECCCTTCE
T ss_pred eeeccCCCcCCEEE-CCCC--EEEEeccccc
Confidence 48999999999994 3343 8999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.28 E-value=0.18 Score=44.02 Aligned_cols=15 Identities=33% Similarity=0.532 Sum_probs=14.0
Q ss_pred CcccCCCCCCCEEec
Q 025933 24 EICHRDLKLENTLLD 38 (246)
Q Consensus 24 ~ivHrDlkp~Nill~ 38 (246)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999997
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=88.46 E-value=0.22 Score=42.25 Aligned_cols=31 Identities=35% Similarity=0.587 Sum_probs=24.6
Q ss_pred CcccCCCCCCCEEecCC--CCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGS--PQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~--~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.+.|||++.+ ....+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999875 11248999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.68 E-value=0.46 Score=40.46 Aligned_cols=30 Identities=40% Similarity=0.637 Sum_probs=23.3
Q ss_pred cccCCCCCCCEEecC----CCCCcEEEeccCCcc
Q 025933 25 ICHRDLKLENTLLDG----SPQPRLKICDFGYSK 54 (246)
Q Consensus 25 ivHrDlkp~Nill~~----~~~~~vkl~Dfg~s~ 54 (246)
++|.|+.+.|||+.. +....++++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999943 122359999998775
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=81.51 E-value=0.66 Score=39.99 Aligned_cols=28 Identities=29% Similarity=0.548 Sum_probs=23.1
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.+.||+ +.++. +.|+||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~--~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNN--IRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSC--EEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCc--EEEEecccCC
Confidence 4899999999999 44444 8999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 246 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-24 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-23 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-22 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-21 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-21 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-21 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-20 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-17 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-15 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-41
Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 8/153 (5%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLAR 79
I HRD+K EN LLD + LKI DFG + +++ + GT Y+APE+L R
Sbjct: 122 IGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
+E+ + DVWSCG+ L ML G P++ P D + + +L + ++ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAP 236
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
LL +I V +PS RI IP+IKK W+ K L K
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-40
Identities = 53/147 (36%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ + HRD+K EN LL LKI DFG+S S+ + GT Y+ PE++ + +
Sbjct: 125 KRVIHRDIKPENLLLG--SAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
D K D+WS GV Y LVG PFE +++T RI V++ PD+V + R L
Sbjct: 182 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDFV--TEGARDL 234
Query: 143 LSQIFVADPSKRIPIPEIKKHPWFLKN 169
+S++ +PS+R + E+ +HPW N
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-37
Identities = 43/217 (19%), Positives = 88/217 (40%), Gaps = 11/217 (5%)
Query: 10 TVMIFTSHHCFYLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 67
+ + +L I H D++ EN + +KI +FG ++ +
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 68 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 127
P Y APEV +D+WS G +YV+L G PF ++ I+ I N +Y
Sbjct: 166 APEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEY 220
Query: 128 FLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEA 185
+ + +S + + ++ V + R+ E +HPW + + + ++ +T
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR- 279
Query: 186 GRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGAS 222
R T +++ ++ A++ + +G + A
Sbjct: 280 -RYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAK 315
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ ++YD
Sbjct: 135 IIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EEKYDE 191
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144
DV++ G+ + M YP+ + ++ + R+ + + + ++
Sbjct: 192 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIE 247
Query: 145 QIFVADPSKRIPIPEIKKHPWF 166
+ +R I ++ H +F
Sbjct: 248 GCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 4e-35
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 4/194 (2%)
Query: 23 QEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 81
I HRD+K EN L P LK+ DFG++K H+ + TP Y+APEVL ++
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADC 139
YD D+WS GV +Y++L G PF RIR QY P+ + VS +
Sbjct: 190 YDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMR 199
+ L+ + +P++R+ I E HPW +++ + + + +++ EE+
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
Query: 200 IIQEAKMPGEATKV 213
+ ++ E K+
Sbjct: 309 ALATMRVDYEQIKI 322
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 125 bits (315), Expect = 7e-35
Identities = 40/185 (21%), Positives = 78/185 (42%), Gaps = 7/185 (3%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
I H D+K EN + + +KI DFG + K T T + APE++ R+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG- 206
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 142
+D+W+ GV YV+L G PF +D +T+ ++ + + + VS + +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 143 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQ 202
+ + +P KR+ + + +HPW + I + Y + + + +
Sbjct: 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 322
Query: 203 EAKMP 207
++
Sbjct: 323 IGRIA 327
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-35
Identities = 55/166 (33%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 72
+ + + + HRD+K EN L+D + + LK+ DFG L + GT Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGAL-LKDTVYTDFDGTRVYS 176
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
PE + Y G+ + VWS G+ LY M+ G PFE E+ I Q F
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ- 225
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 177
RVS++C+HL+ PS R EI+ HPW LP+E EI
Sbjct: 226 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (314), Expect = 1e-34
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+ H DLK EN + LK+ DFG + K T GT + APEV
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 135
K +D+WS GV Y++L G PF N +T+ +++ + + D + +
Sbjct: 198 EGKPVGYY-TDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWNMDDSAFSGI 252
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYKE 184
S D + + ++ +ADP+ R+ I + +HPW N P +I + Y +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (311), Expect = 1e-34
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 16/190 (8%)
Query: 21 YLQE--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 78
YL + HRD+K N LL +K+ DFG + + + S VGTP ++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVIL 184
Query: 79 ---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 135
+YDGK DVWS G+T + P + N + I +
Sbjct: 185 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHW 239
Query: 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVE 195
S R+ + P R + KH + L+ P +I K+A R+
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYR 299
Query: 196 EIMRII-QEA 204
++ +I+ QEA
Sbjct: 300 KMKKILFQEA 309
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-34
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 10/158 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
I HRDLK N L +K+ DFG S Q + + +GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 84 GKI----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
+ +DVWS G+TL M P + R K ++ L R S++
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA---KSEPPTLAQPSRWSSNF 245
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
+ L + + R ++ +HP+ + K I E+
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-34
Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 42/196 (21%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
+ +I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVN--SRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPER 174
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED------------------------- 111
L Y + SD+WS G++L M VG YP P+
Sbjct: 175 LQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 112 -------------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158
P + +D I N S + + +++ + +P++R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 159 EIKKHPWFLKNLPKEI 174
++ H + ++ +E+
Sbjct: 294 QLMVHAFIKRSDAEEV 309
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-33
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 83
+ HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ RK Y
Sbjct: 137 VIHRDIKSDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K D+WS G+ M+ G P+ + R N L + ++SA R L
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFL 250
Query: 144 SQIFVADPSKRIPIPEIKKHPWFLKNLP 171
++ D KR E+ +H + P
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (301), Expect = 2e-33
Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD- 83
I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++ D
Sbjct: 131 IVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 188
Query: 84 ----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
GK D+WS GV +Y +L G+ PF + R + N Q+ P++ S
Sbjct: 189 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTV 246
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ L+S+ V P KR E HP+F
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-33
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 69
I + + +I H DLK EN +L P+PR+KI DFG + ++ K+ GTP
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
++APE++ + +D+WS GV Y++L GA PF ++T+ + V Y
Sbjct: 181 EFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEF 235
Query: 130 PD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
D + SA + + ++ V DP KR+ I + +HPW
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-33
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 9/142 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG-TPAYIAPEVLARKEYD 83
+ HRDLK N LDG +K+ DFG ++ + TP Y++PE + R Y+
Sbjct: 135 VLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192
Query: 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 143
K SD+WS G LY + PF + ++ +IR ++ Y R S + ++
Sbjct: 193 EK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY-RYSDELNEII 246
Query: 144 SQIFVADPSKRIPIPEIKKHPW 165
+++ R + EI ++P
Sbjct: 247 TRMLNLKDYHRPSVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 3e-32
Identities = 57/174 (32%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
+ I HRDLK EN L + ++ I DFG SK S + GTP Y+APEV
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVR 134
LA+K Y D WS GV Y++L G PF D N K ++I +Y P +
Sbjct: 181 LAQKPYSKA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDD 235
Query: 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL------KNLPKEIIEIEKTNY 182
+S + + + DP KR + +HPW KN+ + + E K N+
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 3e-32
Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 16/159 (10%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 72
+ + + ++I +RDLK EN LLD + +KI DFG++K + + GTP YI
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKY--VPDVTYTLCGTPDYI 168
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
APEV++ K Y+ D WS G+ +Y ML G PF D N KT ++I N + P +
Sbjct: 169 APEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPF 223
Query: 133 VRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 166
+ D + LLS++ D S+R+ ++K HPWF
Sbjct: 224 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 8e-32
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 18/166 (10%)
Query: 10 TVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---V 66
T I ++ + + I HRDLK EN LL+ ++I DFG +K S+ V
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 126
GT Y++PE+L K SD+W+ G +Y ++ G PF N +I ++
Sbjct: 172 GTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLE 226
Query: 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPI------PEIKKHPWF 166
Y P+ + R L+ ++ V D +KR+ +K HP+F
Sbjct: 227 YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-29
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 8/161 (4%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAP 74
+ + I HRDLK N L KI DFG + Q + G+ ++AP
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 75 EVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
EV+ ++ + SDV++ G+ LY ++ G P+ + + + R
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 133 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 172
+ L+++ +R P+I L ++LPK
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-29
Identities = 56/156 (35%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAY 71
I + + I +RDLKL+N LLD +KI DFG K +L +T GTP Y
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
IAPE+L ++Y+ D WS GV LY ML+G PF ++ + IR F P
Sbjct: 170 IAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR 224
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIP-EIKKHPWF 166
+ + + + LL ++FV +P KR+ + +I++HP F
Sbjct: 225 W--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (273), Expect = 1e-28
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
+ + +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 126 RFVVYRDLKPANILLD--EHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKGVA 182
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
+D +S G L+ +L G PF ++ + + LPD S + R L
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 239
Query: 143 LSQIFVADPSKRIPIP-----EIKKHPWFLKNLPKEIIEIEK 179
L + D ++R+ E+K+ P+F ++L +++ ++K
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-28
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV 76
+ +++ +RD+KLEN +LD +KI DFG K G+ K+ GTP Y+APEV
Sbjct: 119 EYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
L +Y D W GV +Y M+ G PF + ++ + + I + P +S
Sbjct: 177 LEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LS 229
Query: 137 ADCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 166
+ + LL+ + DP +R+ E+ +H +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-28
Identities = 44/169 (26%), Positives = 64/169 (37%), Gaps = 25/169 (14%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
+ HRDLK +N L+ S Q K+ DFG ++ S V T Y APEVL + Y
Sbjct: 137 VVHRDLKPQNILVTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---------------------R 123
D+WS G M F D K +D I +
Sbjct: 195 P-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 253
Query: 124 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172
+ Q + + LL + +P+KRI HP+F ++L +
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-26
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 27/181 (14%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 76
+ + HRDLK +N L++ + +K+ DFG +++ + + + V T Y APE+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLIN--TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-------DRIRNVQYFL 129
L +Y D+WS G M+ F + + + + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 130 PDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
PDY + D R LLSQ+ DP+KRI HP+F +++ K
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKP 292
Query: 174 I 174
+
Sbjct: 293 V 293
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-26
Identities = 43/215 (20%), Positives = 70/215 (32%), Gaps = 32/215 (14%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 73
+ + HRDLK N LL+ LKICDFG ++ V T Y A
Sbjct: 123 KYIHSANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 74 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI----------- 122
PE++ + K D+WS G L ML F + +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 123 --------------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
+N + + + LL ++ +P KRI + + HP+ +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL-E 299
Query: 169 NLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
E + + E++ +I E
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-26
Identities = 48/184 (26%), Positives = 66/184 (35%), Gaps = 26/184 (14%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPA 70
M + I HRDLK N LLD LK+ DFG +KS G + V T
Sbjct: 108 MTLQGLEYLHQHWILHRDLKPNNLLLD--ENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 165
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----- 125
Y APE+L G D+W+ G L +L+ D + + +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225
Query: 126 --QYFLPDYV---------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168
LPDYV D L+ +F+ +P RI + K +F
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-S 284
Query: 169 NLPK 172
N P
Sbjct: 285 NRPG 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (251), Expect = 9e-26
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 72
I + + ++ +RDLK EN L+D Q +++ DFG++K + + GTP +
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLID--QQGYIQVTDFGFAKRV--KGRTWTLCGTPEAL 205
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 132
APE++ K Y+ D W+ GV +Y M G PF + ++I + + P +
Sbjct: 206 APEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPSH 260
Query: 133 VRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPWFLKNLPKEIIEIEKT 180
S+D + LL + D +KR + +IK H WF I K
Sbjct: 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF-ATTDWIAIYQRKV 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 3e-25
Identities = 40/196 (20%), Positives = 72/196 (36%), Gaps = 36/196 (18%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTV 66
M+ + + +I HRD+K N L+ LK+ DFG ++ ++ + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF-------------------- 106
T Y PE+L + G D+W G + M +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 107 -------EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159
++ E + R V+ L YVR L+ ++ V DP++RI +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPAQRIDSDD 301
Query: 160 IKKHPWFLKN-LPKEI 174
H +F + +P ++
Sbjct: 302 ALNHDFFWSDPMPSDL 317
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 3e-25
Identities = 32/164 (19%), Positives = 57/164 (34%), Gaps = 11/164 (6%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPA 70
I + HRDL+ N L+ + K+ DFG ++ ++ +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIK 179
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
+ APE + K SDVWS G+ L + R ++R Y +P
Sbjct: 180 WTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMP 234
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKK--HPWFLKNLPK 172
L+ Q + +P +R ++ +F P+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 4e-25
Identities = 42/178 (23%), Positives = 67/178 (37%), Gaps = 25/178 (14%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
ICHRD+K +N LLD K+CDFG +K + S + + Y APE++
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-----RNVQYFLPDYV---- 133
DVWS G L +L+G F + I + ++ P+Y
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 134 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
R + L S++ P+ R+ E H +F L +++
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDPNVKL 316
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 96.7 bits (240), Expect = 1e-24
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 5/155 (3%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFG--YSKSGLLHSQPKSTVGTPA 70
+ + + I HRD+K N ++ + ++ + SG +Q + +GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
Y++PE D + SDV+S G LY +L G PF + + +
Sbjct: 180 YLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSA 236
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165
+ +SAD ++ + +P R +
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-24
Identities = 33/169 (19%), Positives = 63/169 (37%), Gaps = 10/169 (5%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTP 69
I + + + HRDL N L+ +KI DFG +K +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
++A E + + Y + SDVWS GVT++ ++ D +++ L
Sbjct: 178 KWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERL 232
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 178
P + D ++ + ++ D R E+ + P+ + I+
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-24
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 72
I + + I +RD+KLEN LLD + L + GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 73 APEVLARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
AP+++ + K D WS GV +Y +L GA PF + + + RI + P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 132 YVRVSADCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 166
+SA + L+ ++ + DP KR+ EIK+H +F
Sbjct: 258 --EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 2e-24
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEV 76
+ + + HRDLK +N L++ LK+ +FG +++ + + S V T Y P+V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLIN--RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-------------- 122
L + D+WS G + P D + K I R+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 123 ----------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 171
+ +++A R LL + +P +RI E +HP+F P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 95.7 bits (237), Expect = 6e-24
Identities = 34/183 (18%), Positives = 63/183 (34%), Gaps = 34/183 (18%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I HRD+K N ++D +L++ D+G ++ + V + + PE+L +
Sbjct: 148 MGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------------- 128
D+WS G L M+ PF D + I ++ +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 129 ------------------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170
+ VS + L ++ D R+ E +HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-YTV 325
Query: 171 PKE 173
K+
Sbjct: 326 VKD 328
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 1e-23
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 10/168 (5%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
++ HRDL N L+ KI DFG S+ ++ + ++A E L
Sbjct: 141 DYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
Y SDVWS GV L+ ++ P + +++ Y L +
Sbjct: 199 NYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ-GYRLEKPLNCDD 253
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE---IEKTNY 182
+ L+ Q + P +R +I + K + EK Y
Sbjct: 254 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 301
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 93.4 bits (231), Expect = 3e-23
Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEV 76
+ + + HRDLK +N L++ + LKI DFG +++ G+ + + T Y AP+V
Sbjct: 114 AYCHDRRVLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----------TIDRIRNV 125
L + D+WS G M+ G F + + + +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 126 QYFLPDYVR------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
+ P++ + LLS++ DP++RI + +H +F
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 4e-23
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 31/206 (15%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82
I HRDLK N ++ LKI DFG ++ S+ V T Y APEV+
Sbjct: 140 AGIIHRDLKPGNLAVN--EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI----------------DRIRNVQ 126
+ D+WS G + M+ G F+ + ++ + D +N
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 127 YFLPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 177
LP+ + S +LL ++ V D +R+ E HP+F ++L E
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLHDTEDEP 314
Query: 178 EKTNYKEAGRDQPTQSVEEIMRIIQE 203
+ Y ++ D ++++E R+ +
Sbjct: 315 QVQKYDDS-FDDVDRTLDEWKRVTYK 339
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 5e-23
Identities = 28/152 (18%), Positives = 54/152 (35%), Gaps = 12/152 (7%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAY 71
++ HRDL N +LD K+ DFG ++ +
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
+A E L +++ K SDVWS GV L+ ++ P + + + ++ + P+
Sbjct: 201 MALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGRRLLQPE 257
Query: 132 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
Y ++ + + R E+
Sbjct: 258 Y--CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 7e-23
Identities = 30/139 (21%), Positives = 52/139 (37%), Gaps = 9/139 (6%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84
HRDL N L+ K+ DFG +K S + + APE L K++
Sbjct: 124 FVHRDLAARNVLVSE--DNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 144
K SDVWS G+ L+ + P + + R+ Y + ++
Sbjct: 180 K-SDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMK 234
Query: 145 QIFVADPSKRIPIPEIKKH 163
+ D + R ++++
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.4 bits (228), Expect = 2e-22
Identities = 43/225 (19%), Positives = 75/225 (33%), Gaps = 46/225 (20%)
Query: 17 HHCFYLQEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 74
+ I H D+K EN L++ SP+ ++I + +++ T Y +P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 75 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDY 132
EVL + +D+WS ++ ++ G + F ++ I +I + LP Y
Sbjct: 199 EVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 133 V----------------------------------------RVSADCRHLLSQIFVADPS 152
+ + + LS + DP
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317
Query: 153 KRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEI 197
KR + HPW L E I + +G D P EE+
Sbjct: 318 KRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF-EEV 361
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 4e-22
Identities = 30/154 (19%), Positives = 57/154 (37%), Gaps = 9/154 (5%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTP 69
+ + HRDL N L+ + K+ DFG ++ ++ T
Sbjct: 109 DVCEGMAYLEEACVIHRDLAARNCLVGENQVI--KVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 70 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 129
+ +PEV + Y K SDVWS GV ++ + P + R+ + ++ I + L
Sbjct: 167 KWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRL 221
Query: 130 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
S +++ + P R + +
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 4e-22
Identities = 35/145 (24%), Positives = 57/145 (39%), Gaps = 11/145 (7%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 79
+ HRDL N L+ + ICDFG ++ S + + ++APE L
Sbjct: 183 KSCVHRDLAARNVLVTHGKVVK--ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
Query: 80 KEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 138
Y K SDVWS G+ L+ + +G P+ NF K I + + + +
Sbjct: 241 GIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN----GFKMDQPFYATEE 295
Query: 139 CRHLLSQIFVADPSKRIPIPEIKKH 163
++ + D KR P +
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 1e-21
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 12/146 (8%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLA 78
+ HRDL N LL + +KI DFG + + + + A+ APE L
Sbjct: 130 KRFIHRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 79 RKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 137
+ + SD W GVTL+ M G P+ N + + +I LP
Sbjct: 188 TRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 138 DCRHLLSQIFVADPSKRIPIPEIKKH 163
D +++ Q + P R ++
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 1e-21
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 9/153 (5%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPA 70
+ T+ + HRD+ N L+ +K+ DFG S+ + K++
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
++APE + + + SDVW GV ++ +L+ P I RI N + LP
Sbjct: 175 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LP 229
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
L+++ + DPS+R E+K
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 2e-21
Identities = 29/152 (19%), Positives = 55/152 (36%), Gaps = 11/152 (7%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGT 68
I HRDL N L++ + K+ DFG S+
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 69 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
+ APE ++ +++ SDVWS G+ ++ ++ K I+ +
Sbjct: 177 IRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFR 231
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160
LP + + L+ Q + + ++R +I
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.0 bits (217), Expect = 3e-21
Identities = 31/141 (21%), Positives = 52/141 (36%), Gaps = 10/141 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE 81
HRDL N L+ + KI DFG S+ S + + ++ PE +
Sbjct: 161 FVHRDLATRNCLVGENMVV--KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218
Query: 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 141
Y + SDVW+ GV L+ + P + I +R+ L + +
Sbjct: 219 YTTE-SDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYYVRD-GNILACPENCPLELYN 273
Query: 142 LLSQIFVADPSKRIPIPEIKK 162
L+ + P+ R I +
Sbjct: 274 LMRLCWSKLPADRPSFCSIHR 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 3e-21
Identities = 31/162 (19%), Positives = 55/162 (33%), Gaps = 16/162 (9%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGT 68
+ HRDL N LL Q KI DFG SK+ +
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 69 PAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQY 127
+ APE + ++ K SDVWS GV ++ G P+ + + +
Sbjct: 174 VKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGER 228
Query: 128 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK---KHPWF 166
+ + L++ + D R ++ ++ ++
Sbjct: 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.5 bits (216), Expect = 4e-21
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 22/170 (12%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTV 66
I HRDL N L++ + K+ DFG S+ S ++
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVC--KVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 67 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNV 125
+ APE + +++ SDVWS G+ ++ ++ G P+ D + I+ I
Sbjct: 195 IPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ- 248
Query: 126 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI-------KKHPWFLK 168
Y LP + + L+ + D + R +I ++P LK
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 5e-21
Identities = 31/150 (20%), Positives = 56/150 (37%), Gaps = 11/150 (7%)
Query: 17 HHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 74
++ HRDL N L++ Q +K+ DFG S+ L S + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 75 EVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 133
EVL ++ K SD+W+ GV ++ + +G P+E + +R L
Sbjct: 171 EVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----LYRPH 224
Query: 134 RVSADCRHLLSQIFVADPSKRIPIPEIKKH 163
S ++ + +R + +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 7e-21
Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 16/150 (10%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLARK 80
HRDL N LL + I DFG SK ++ + + APE + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 81 EYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
++ + SDVWS GVT++ L G P++ + + I + +
Sbjct: 188 KFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQ-GKRMECPPECPPEL 241
Query: 140 RHLLSQIFVADPSKRIPIPEIK---KHPWF 166
L+S ++ R ++ + ++
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.3 bits (213), Expect = 1e-20
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 12/163 (7%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPA 70
I ++ + HRDL N L+ + K+ DFG S+ +G ++
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLV--KVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 71 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 130
+ APE LA ++ K SDVW+ GV L+ + D + +++ Y +
Sbjct: 182 WTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRME 236
Query: 131 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 173
L+ + +PS R EI + + + +E
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ---AFETMFQE 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 85.2 bits (210), Expect = 3e-20
Identities = 22/154 (14%), Positives = 50/154 (32%), Gaps = 16/154 (10%)
Query: 23 QEICHRDLKLENTLLDGSPQPR---LKICDFGYSK--------SGLLHSQPKSTVGTPAY 71
+ + +RD+K +N L+ + + DFG K + + + K+ GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 72 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 131
++ +E + D+ + G L G+ P+ ++ +RI + P
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPL 237
Query: 132 YVR---VSADCRHLLSQIFVADPSKRIPIPEIKK 162
+ + ++
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 5e-20
Identities = 40/180 (22%), Positives = 68/180 (37%), Gaps = 31/180 (17%)
Query: 13 IFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 72
I + +I HRDLK N ++ LKI DFG ++ + V T Y
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYR 185
Query: 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED------------------------ 108
APE++ + + D+WS G + +L G F
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 109 --PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 166
E RN+ +++ ++ + F ++ + LL ++ V D KRI + H +F
Sbjct: 246 ISSESARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 5e-20
Identities = 49/222 (22%), Positives = 79/222 (35%), Gaps = 39/222 (17%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 77
+ I HRDLK N ++ KI DFG +++ V T Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 78 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------------PRNFRKTIDRI 122
Y + D+WS G + M+ F + P +K +
Sbjct: 191 LGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 123 RNVQYFLPDYVR---------------------VSADCRHLLSQIFVADPSKRIPIPEIK 161
RN P Y ++ R LLS++ V DP+KRI + +
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 162 KHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203
+HP+ +E + D+ ++EE +I +
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYK 351
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 1e-19
Identities = 28/146 (19%), Positives = 49/146 (33%), Gaps = 11/146 (7%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 82
HRDL+ N L+ KI DFG ++ + + APE + +
Sbjct: 130 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 142
K SDVWS G+ L ++ + ++R Y + + L
Sbjct: 188 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQL 242
Query: 143 LSQIFVADPSKRIPIPEIKK--HPWF 166
+ + P R ++ +F
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.2 bits (202), Expect = 4e-19
Identities = 25/163 (15%), Positives = 56/163 (34%), Gaps = 15/163 (9%)
Query: 25 ICHRDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 75
HRD+K +N L+ G + I DFG +K + + + K+ GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR- 134
E + D+ S G L +G+ P++ + +K + +
Sbjct: 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 135 -VSADCRHLLSQIFVADPSKRIPIPEIK---KHPWFLKNLPKE 173
++ L+ + ++ ++ + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 4e-18
Identities = 32/144 (22%), Positives = 57/144 (39%), Gaps = 9/144 (6%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 79
++ HRDL N LL + +KICDFG ++ + + ++APE +
Sbjct: 153 RKCIHRDLAARNILLS--EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
+ Y + SDVWS GV L+ + P + R + + +
Sbjct: 211 RVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 266
Query: 140 RHLLSQIFVADPSKRIPIPEIKKH 163
+ + +PS+R E+ +H
Sbjct: 267 YQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 4e-17
Identities = 34/164 (20%), Positives = 59/164 (35%), Gaps = 28/164 (17%)
Query: 25 ICHRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 79
I HRDLK +N L+ I D G S + + P VGT Y+APEVL
Sbjct: 129 IAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 80 KEYDGKI-----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFR----------KTIDRIRN 124
+D+++ G+ + + ED + + + ++
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 125 VQYFLPDYVRVSADC------RHLLSQIFVADPSKRIPIPEIKK 162
Q P+ C ++ + + A+ + R+ IKK
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 7e-17
Identities = 24/147 (16%), Positives = 52/147 (35%), Gaps = 6/147 (4%)
Query: 18 HCFYLQEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 76
++ HRDL N L+ ++ + + + ++APE
Sbjct: 149 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208
Query: 77 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 136
L + Y + SDVWS GV L+ + P + ++ + + +
Sbjct: 209 LFDRIYTHQ-SDVWSFGVLLWEIFTLGGS---PYPGVPVEELFKLLKE-GHRMDKPSNCT 263
Query: 137 ADCRHLLSQIFVADPSKRIPIPEIKKH 163
+ ++ + A PS+R ++ +
Sbjct: 264 NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 8e-17
Identities = 31/164 (18%), Positives = 54/164 (32%), Gaps = 16/164 (9%)
Query: 12 MIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGT 68
I + HRDL N ++ +KI DFG ++ + + +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVA--EDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 69 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 128
+++PE L + DVWS GV L+ + A P + + + +
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVME-GGL 253
Query: 129 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEI------KKHPWF 166
L L+ + +P R EI + P F
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 4e-15
Identities = 35/157 (22%), Positives = 58/157 (36%), Gaps = 15/157 (9%)
Query: 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLAR 79
+ HRDL N LL KICDFG ++ S ++APE +
Sbjct: 164 KNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 139
Y + SDVWS G+ L+ + ++ + + A+
Sbjct: 222 CVYTFE-SDVWSYGIFLWELFSLGSSP---YPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277
Query: 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 176
++ + ADP KR +I ++ + K+I E
Sbjct: 278 YDIMKTCWDADPLKRPTFKQI------VQLIEKQISE 308
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 246 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.97 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 81.95 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=297.74 Aligned_cols=161 Identities=34% Similarity=0.563 Sum_probs=130.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..+
T Consensus 105 ~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred HHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC
Confidence 3456788899999999999999999999999988776 999999999853221 22345689999999999998887
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
++.++||||+||++|+|++|++||.+.......... ........+.+..+|+++++||.+||..||++|||++|+++
T Consensus 183 ~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 666689999999999999999999765543332222 22333334445678999999999999999999999999999
Q ss_pred CcccccCCC
Q 025933 163 HPWFLKNLP 171 (246)
Q Consensus 163 hp~~~~~~~ 171 (246)
||||++...
T Consensus 260 hpwf~~~l~ 268 (271)
T d1nvra_ 260 DRWYNKPLK 268 (271)
T ss_dssp CTTTTCCCC
T ss_pred CHhhCcCCC
Confidence 999987554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=294.95 Aligned_cols=153 Identities=34% Similarity=0.570 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+... .......+||+.|||||++.+..|+.+
T Consensus 108 ~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~~~~~Gt~~Y~APE~~~~~~~~~~ 184 (263)
T d2j4za1 108 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 184 (263)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCCEETTEEGGGCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCcccccCCCCcccCHHHHcCCCCCch
Confidence 3456788999999999999999999999999988776 9999999998543 233455689999999999999888755
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
+|||||||++|+|++|+.||.+.+.. ..+..+....+.+|. .+|+++++||.+||++||.+|||++|+|+|||
T Consensus 185 -~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 185 -VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred -hhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 89999999999999999999875443 334445555555554 68999999999999999999999999999999
Q ss_pred ccc
Q 025933 166 FLK 168 (246)
Q Consensus 166 ~~~ 168 (246)
|..
T Consensus 258 ~~~ 260 (263)
T d2j4za1 258 ITA 260 (263)
T ss_dssp HHH
T ss_pred cCC
Confidence 964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=293.50 Aligned_cols=159 Identities=27% Similarity=0.385 Sum_probs=130.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+..... ......+||+.|||||++.+..|+.
T Consensus 118 ~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 195 (293)
T d1yhwa1 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred HHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--EeeccchhheeeccccccccccccCCCccChhhhcCCCCCc
Confidence 3456788999999999999999999999999988776 999999999854332 2334567999999999999988875
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 164 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 164 (246)
+ +||||+||++|+|++|..||.+......+..+. ....+..+.+..+|+++++||.+||.+||.+|||++|+|+||
T Consensus 196 ~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp H-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred h-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 5 999999999999999999998766544443332 222333444567999999999999999999999999999999
Q ss_pred ccccCC
Q 025933 165 WFLKNL 170 (246)
Q Consensus 165 ~~~~~~ 170 (246)
||+...
T Consensus 272 ~~~~~~ 277 (293)
T d1yhwa1 272 FLKIAK 277 (293)
T ss_dssp GGGGCC
T ss_pred hhCCCC
Confidence 997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-43 Score=292.52 Aligned_cols=158 Identities=33% Similarity=0.547 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||+++||||||||+|||+... ..+.+||+|||+|+.........+.+||+.|||||++.+..|+.
T Consensus 109 ~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~ 188 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCc
Confidence 34567889999999999999999999999999642 23459999999998655455556678999999999999888876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++|++||.+....... ..+..... ..+....+|+++++||.+||.+||.+|||++|+++
T Consensus 189 ~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 189 A-VDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 5 99999999999999999999875543333 33333333 23445679999999999999999999999999999
Q ss_pred Cccccc
Q 025933 163 HPWFLK 168 (246)
Q Consensus 163 hp~~~~ 168 (246)
||||..
T Consensus 264 hp~~~~ 269 (307)
T d1a06a_ 264 HPWIAG 269 (307)
T ss_dssp STTTTS
T ss_pred CHhhCC
Confidence 999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=288.59 Aligned_cols=162 Identities=27% Similarity=0.365 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhcc-----c
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLA-----R 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~-----~ 79 (246)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++. +
T Consensus 112 ~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 189 (288)
T d2jfla1 112 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred HHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccccccccccCCHHHHhhcccCC
Confidence 3456788999999999999999999999999998776 999999998743221 1234568999999999984 3
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..|+.+ +|||||||++|+|++|+.||.+.+..+.+.++.. ......+....+|+++++||++||++||.+|||++|
T Consensus 190 ~~y~~k-~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 190 RPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp SSTTTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCChh-hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 445544 9999999999999999999988766555443332 122233445578999999999999999999999999
Q ss_pred HhcCcccccCCChH
Q 025933 160 IKKHPWFLKNLPKE 173 (246)
Q Consensus 160 ~l~hp~~~~~~~~~ 173 (246)
+++||||.....+.
T Consensus 266 ll~hp~~~~~~~~p 279 (288)
T d2jfla1 266 LLQHPFVTVDSNKP 279 (288)
T ss_dssp HTTSGGGCCCCCHH
T ss_pred HhcCcccCCCCCCC
Confidence 99999997655543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=283.83 Aligned_cols=154 Identities=23% Similarity=0.401 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHhHhCC--cccCCCCCCCEEecC-CCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQE--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~--ivHrDlkp~Nill~~-~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.||+.||+|||+++ ||||||||+|||+++ ++. +||+|||+|+... .....+.+||+.|||||++.+ .|
T Consensus 114 ~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~ 189 (270)
T d1t4ha_ 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KY 189 (270)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CC
T ss_pred HHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceecc-CCccCCcccCccccCHHHhCC-CC
Confidence 3456789999999999999 999999999999964 444 9999999997432 223345689999999999875 56
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|+.||.+......+. ..+.............++++++||.+||.+||++|||++|+++
T Consensus 190 ~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 190 DES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc-CchhhHHHHHHHHHHCCCCCCCcccHHHHH---HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 655 999999999999999999998766544433 3333322222223457899999999999999999999999999
Q ss_pred Ccccc
Q 025933 163 HPWFL 167 (246)
Q Consensus 163 hp~~~ 167 (246)
||||+
T Consensus 266 Hp~fk 270 (270)
T d1t4ha_ 266 HAFFQ 270 (270)
T ss_dssp SGGGC
T ss_pred CcccC
Confidence 99995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-43 Score=293.27 Aligned_cols=157 Identities=26% Similarity=0.333 Sum_probs=127.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccc---ccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR---KEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~ 82 (246)
...++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+... .....+||+.|||||++.+ ..|
T Consensus 117 ~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~---~~~~~~GT~~Y~APE~~~~~~~~~y 191 (309)
T d1u5ra_ 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQY 191 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBCCCCSCGGGCCHHHHTTTTSCCB
T ss_pred HHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccC---CCCccccCccccCHHHHhccCCCCc
Confidence 3456788899999999999999999999999998776 9999999998532 2345689999999999864 346
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|..||.+......+.. +............+|+++++||.+||++||.+|||++++|+
T Consensus 192 ~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 192 DGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 555 8999999999999999999987655443333 23333333334468999999999999999999999999999
Q ss_pred CcccccCCCh
Q 025933 163 HPWFLKNLPK 172 (246)
Q Consensus 163 hp~~~~~~~~ 172 (246)
||||.+..+.
T Consensus 267 Hp~~~~~~~~ 276 (309)
T d1u5ra_ 267 HRFVLRERPP 276 (309)
T ss_dssp CHHHHSCCCT
T ss_pred CHHhcCCCCc
Confidence 9999876544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=286.81 Aligned_cols=160 Identities=26% Similarity=0.334 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||+++||||||||+|||++..+. +||+|||+++.........+.+||+.|+|||++.+..|+.+
T Consensus 118 ~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~ 195 (305)
T d1blxa_ 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195 (305)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChh
Confidence 3457889999999999999999999999999988776 99999999986555555567789999999999999888765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C--------------------CCCCCcCCHHHHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F--------------------LPDYVRVSADCRHLLS 144 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~--------------------~~~~~~~~~~~~~li~ 144 (246)
+||||+||++|+|++|++||.+.+..+.+..++........ . ......+++.+++||+
T Consensus 196 -~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 196 -VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp -HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred -ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHH
Confidence 99999999999999999999987766666655543211100 0 0112357899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccc
Q 025933 145 QIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 145 ~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
+||++||++|||++|+|+||||+.
T Consensus 275 ~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 275 KCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHCcCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=290.06 Aligned_cols=152 Identities=32% Similarity=0.592 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhccccccCCcch
Q 025933 9 STVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 9 ~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
.+.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.... .....+.+||+.|||||++.+..|+.+ +
T Consensus 110 ~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~-~ 186 (337)
T d1o6la_ 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 186 (337)
T ss_dssp HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT-H
T ss_pred HHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChh-h
Confidence 4567889999999999999999999999988876 99999999985433 333455789999999999999998765 9
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHHhc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEIKK 162 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~ 162 (246)
|||||||++|+|++|++||.+.+... +...+......+|. .+|+++++||++||++||.+|++ ++++++
T Consensus 187 DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 187 DWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cccchhhHHHHHHHCCCCCCCcCHHH----HHHHHhcCCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 99999999999999999998765433 33444444544444 69999999999999999999994 899999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||...
T Consensus 261 Hp~f~~i 267 (337)
T d1o6la_ 261 HRFFLSI 267 (337)
T ss_dssp SGGGTTC
T ss_pred CcccccC
Confidence 9999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-42 Score=295.39 Aligned_cols=159 Identities=26% Similarity=0.473 Sum_probs=130.9
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++|||||||||+|||++.+..+.+||+|||+|+.........+.+||+.|||||++.+..|+.+
T Consensus 126 ~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~ 205 (350)
T d1koaa2 126 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHH
T ss_pred HHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChh
Confidence 45568889999999999999999999999999765445699999999986544444456789999999999998888644
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|||||||++|+|++|+.||.+.+..+.+. .+....+..+ .+..+|+++++||++||..||.+|||++|+|+|
T Consensus 206 -~DiwSlGvilyell~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 206 -TDMWSVGVLSYILLSGLSPFGGENDDETLR----NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -HhhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999998765543333 3333333332 335689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||...
T Consensus 281 p~~~~~ 286 (350)
T d1koaa2 281 PWLTPG 286 (350)
T ss_dssp TTTSCT
T ss_pred cccCCC
Confidence 999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=291.74 Aligned_cols=159 Identities=26% Similarity=0.447 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
....+.|++.||.|||+ ++||||||||+|||++.++. +||+|||+|+... .....+.+||+.|||||++.+..|+.
T Consensus 106 ~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~-~~~~~~~~GT~~Y~APEvl~~~~y~~ 182 (322)
T d1s9ja_ 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHTC---CCSSCCCCHHHHHCSCCCT
T ss_pred HHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccC-CCccccccCCccccCchHHcCCCCCc
Confidence 34567788999999997 59999999999999988776 9999999998432 23345678999999999999988876
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH--------------------------------------HHHHHhccc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK--------------------------------------TIDRIRNVQ 126 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------------------------------------~~~~~~~~~ 126 (246)
+ +||||+||++|+|++|+.||.+.+....... ....+....
T Consensus 183 ~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T d1s9ja_ 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261 (322)
T ss_dssp T-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSC
T ss_pred H-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC
Confidence 6 8999999999999999999976553221100 011111111
Q ss_pred cCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 127 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 127 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
...-....+|.++++||.+||+.||.+|||++|+|+||||++
T Consensus 262 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 262 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000011236899999999999999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-42 Score=294.95 Aligned_cols=159 Identities=23% Similarity=0.447 Sum_probs=131.8
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++|||||||||+|||++....+++||+|||+|+.........+..||+.|||||++.+..|+.+
T Consensus 129 ~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (352)
T d1koba_ 129 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208 (352)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCc
Confidence 35578889999999999999999999999999855455699999999986554444556689999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+|||||||++|+|++|..||.+......+ ..+....+.++ .+..+|+++++||++||++||.+|||+.|+|+|
T Consensus 209 -~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 209 -TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876554433 33333333332 345799999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||+..
T Consensus 284 p~~~~~ 289 (352)
T d1koba_ 284 PWLKGD 289 (352)
T ss_dssp TTTSSC
T ss_pred HhhCCC
Confidence 999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=296.95 Aligned_cols=163 Identities=32% Similarity=0.550 Sum_probs=130.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCC-CCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||++||+||||||+|||++... .+.+||+|||+|+.........+.+||+.|||||++.+..|+.
T Consensus 113 ~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~ 192 (335)
T d2ozaa1 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 192 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSH
T ss_pred HHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCH
Confidence 345678888999999999999999999999997643 3459999999998655555556778999999999999888875
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+ +|||||||++|+|++|++||.+.........+...+....+.+|. +..+|+++++||++||++||.+|||+.|+++
T Consensus 193 ~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 193 S-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp H-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 5 999999999999999999998766554444444444444444433 3468999999999999999999999999999
Q ss_pred CcccccC
Q 025933 163 HPWFLKN 169 (246)
Q Consensus 163 hp~~~~~ 169 (246)
||||.+.
T Consensus 272 hp~~~~~ 278 (335)
T d2ozaa1 272 HPWIMQS 278 (335)
T ss_dssp SHHHHTT
T ss_pred CHHhhCC
Confidence 9999654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-42 Score=286.94 Aligned_cols=152 Identities=35% Similarity=0.596 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcch
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 87 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 87 (246)
.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.. .....+.+||+.|||||++.+..|+.+ +
T Consensus 108 ~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~--~~~~~~~~Gt~~Y~APE~l~~~~y~~~-~ 182 (316)
T d1fota_ 108 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKS-I 182 (316)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEEC--SSCBCCCCSCTTTCCHHHHTTCCBCTT-H
T ss_pred HHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEe--ccccccccCcccccCHHHHcCCCCCch-h
Confidence 45678889999999999999999999999988776 999999999853 233456789999999999998888765 8
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHHhc
Q 025933 88 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIKK 162 (246)
Q Consensus 88 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~ 162 (246)
|||||||++|+|++|+.||.+.+..+. ..++.......| ..++++++++|.+||.+||.+|+ |++++++
T Consensus 183 DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 183 DWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hccccchhHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 999999999999999999987554333 334444444444 36899999999999999999996 8999999
Q ss_pred CcccccCC
Q 025933 163 HPWFLKNL 170 (246)
Q Consensus 163 hp~~~~~~ 170 (246)
||||++..
T Consensus 257 Hp~f~~i~ 264 (316)
T d1fota_ 257 HPWFKEVV 264 (316)
T ss_dssp SGGGSSCC
T ss_pred CcccccCC
Confidence 99997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=286.48 Aligned_cols=155 Identities=31% Similarity=0.512 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
...++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..|
T Consensus 110 ~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 187 (288)
T d1uu3a_ 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcccccccccCCccccCceeeccCCC
Confidence 3456778899999999999999999999999988876 999999999854322 22345689999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH---
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE--- 159 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e--- 159 (246)
+.+ +||||+||++|+|++|..||.+.+... +..++.+..+.+|. .+++++++||++||++||.+|||++|
T Consensus 188 ~~~-~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 188 CKS-SDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CHH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred Ccc-cceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 654 999999999999999999998755433 34445555555554 68999999999999999999999987
Q ss_pred ---HhcCcccccC
Q 025933 160 ---IKKHPWFLKN 169 (246)
Q Consensus 160 ---~l~hp~~~~~ 169 (246)
+++||||...
T Consensus 261 ~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 261 YGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHTSGGGTTC
T ss_pred CHHHHcCCccCCC
Confidence 6889999653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=282.65 Aligned_cols=160 Identities=26% Similarity=0.323 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
..++.||+.||+|||++|||||||||+|||++.++. +||+|||+++..... ....+.+||+.|+|||++.+....+.
T Consensus 103 ~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 180 (299)
T d1ua2a_ 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCH
T ss_pred HHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccceecChhhccHHHHccCCCCCh
Confidence 455778889999999999999999999999988776 999999999754332 23345689999999999976655456
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC----------------CC------CCCcCCHHHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF----------------LP------DYVRVSADCRHLL 143 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li 143 (246)
++||||+||++|+|++|.+||.+..+.+.+..+.......... .+ ....+++++++||
T Consensus 181 ~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 260 (299)
T d1ua2a_ 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI 260 (299)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHH
T ss_pred hhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHH
Confidence 6999999999999999999998877766666655443211000 00 0135689999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccc
Q 025933 144 SQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 144 ~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
++||+.||++|||++|+|+||||+.
T Consensus 261 ~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 261 QGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp HHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HHHccCChhhCcCHHHHhCCHhhCC
Confidence 9999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-42 Score=291.33 Aligned_cols=152 Identities=29% Similarity=0.492 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
..++.||+.||.|||+++||||||||+|||++.++. +||+|||+|+... ....+.+||+.|||||++.+..|+.+
T Consensus 144 ~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~- 218 (350)
T d1rdqe_ 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKA- 218 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBCCCEECGGGCCHHHHTTCCBCTH-
T ss_pred HHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecc--cccccccCccccCCHHHHcCCCCCcc-
Confidence 456788899999999999999999999999988776 9999999998542 33456789999999999999888755
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHHHHh
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEIK 161 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l 161 (246)
+|||||||++|+|++|+.||.+.+... .+..+.......| ..+++++.+||++||.+||.+|+ |+++++
T Consensus 219 ~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell 292 (350)
T d1rdqe_ 219 VDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred ccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHhcCCCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHHH
Confidence 999999999999999999998755433 3334444444444 37899999999999999999995 899999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||...
T Consensus 293 ~Hp~f~~~ 300 (350)
T d1rdqe_ 293 NHKWFATT 300 (350)
T ss_dssp TSGGGTTC
T ss_pred cCccccCC
Confidence 99999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-42 Score=291.04 Aligned_cols=158 Identities=25% Similarity=0.323 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+... .......+||+.|||||++......+.
T Consensus 109 ~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~-~~~~~~~~GT~~y~APE~~~~~~~~~~ 185 (364)
T d1omwa3 109 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDS 185 (364)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECS-SSCCCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecC-CCcccccccccccchhHHhhcCCCCCc
Confidence 3456778899999999999999999999999988776 9999999998543 234456689999999999975443344
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-----IPEI 160 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~ 160 (246)
++|||||||++|+|++|+.||.+..... ...+...+...... .+..+|+++++||.+||++||.+||| ++++
T Consensus 186 ~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei 262 (364)
T d1omwa3 186 SADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262 (364)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred ccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence 5999999999999999999998755432 22333333333332 33479999999999999999999999 7999
Q ss_pred hcCcccccC
Q 025933 161 KKHPWFLKN 169 (246)
Q Consensus 161 l~hp~~~~~ 169 (246)
++||||+..
T Consensus 263 l~Hp~f~~i 271 (364)
T d1omwa3 263 KESPFFRSL 271 (364)
T ss_dssp HTSGGGTTC
T ss_pred HcCccccCC
Confidence 999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=281.33 Aligned_cols=152 Identities=34% Similarity=0.501 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++|||||||||+|||++.+. +.+||+|||+|+... .....+.+||+.|+|||++.+..+++.
T Consensus 112 ~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~ 189 (273)
T d1xwsa_ 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGR 189 (273)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHH
T ss_pred HHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc-cccccccccCCCcCCHHHHcCCCCCCc
Confidence 345678889999999999999999999999998543 249999999997532 333456789999999999988877666
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 165 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 165 (246)
++||||+||++|+|++|+.||.+.. .+......++ ..+|+++++||++||.+||++|||++|+++|||
T Consensus 190 ~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 190 SAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 6899999999999999999997521 1223333333 368999999999999999999999999999999
Q ss_pred cccCCC
Q 025933 166 FLKNLP 171 (246)
Q Consensus 166 ~~~~~~ 171 (246)
|++...
T Consensus 258 ~~~~~~ 263 (273)
T d1xwsa_ 258 MQDVLL 263 (273)
T ss_dssp GSSCCC
T ss_pred hCCCCC
Confidence 987554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=280.59 Aligned_cols=153 Identities=27% Similarity=0.423 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHhHhCC-----cccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccc
Q 025933 6 YFSSTVMIFTSHHCFYLQE-----ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~-----ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~ 79 (246)
...++.|++.||+|||+++ ||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+
T Consensus 111 ~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHHHHC-----------CCCSCCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCCCccccCCCCcccCCHHHHcC
Confidence 4567889999999999976 999999999999998876 999999999854332 22345689999999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..|+.+ +|||||||++|+|++|+.||.+.+..+ +...+...... +.+..+|+++++||.+||+.||.+|||+.|
T Consensus 189 ~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 189 MSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 888655 999999999999999999998755433 33333333322 223478999999999999999999999999
Q ss_pred HhcCccc
Q 025933 160 IKKHPWF 166 (246)
Q Consensus 160 ~l~hp~~ 166 (246)
+++|||+
T Consensus 263 ll~hp~i 269 (269)
T d2java1 263 ILENPLI 269 (269)
T ss_dssp HHTSTTC
T ss_pred HHhCCcC
Confidence 9999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=281.93 Aligned_cols=159 Identities=30% Similarity=0.510 Sum_probs=130.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCC--CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~--~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...++.|++.||+|||+++||||||||+|||++.++. ..+||+|||+++.........+..||+.|+|||++.+..++
T Consensus 115 ~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCC
Confidence 3456788899999999999999999999999976653 35999999999865555555667899999999999988886
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
.+ +||||+||++|+|++|+.||.+.+..+. +..+.......+ .+..+|..+++||++||..||.+|||++|++
T Consensus 195 ~~-~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 195 LE-ADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp TH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred Cc-ccchhhhHHHHHHHcCCCCCCCCCHHHH----HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 55 9999999999999999999987654433 333444333332 2356899999999999999999999999999
Q ss_pred cCcccccC
Q 025933 162 KHPWFLKN 169 (246)
Q Consensus 162 ~hp~~~~~ 169 (246)
+||||+..
T Consensus 270 ~hp~~~~~ 277 (293)
T d1jksa_ 270 QHPWIKPK 277 (293)
T ss_dssp HSTTTCC-
T ss_pred cCcccCCC
Confidence 99999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.5e-41 Score=275.27 Aligned_cols=159 Identities=31% Similarity=0.491 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccc----
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE---- 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~---- 81 (246)
...++.||+.||+|||++|||||||||+|||++.++. +||+|||+++...........+||+.|+|||++.+..
T Consensus 112 ~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~ 189 (277)
T d1phka_ 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred HHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccC
Confidence 3456778889999999999999999999999988776 9999999998655444455678999999999986422
Q ss_pred -cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 -~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
..+.++||||+||++|+|++|+.||.+.........+... ...+..+...++|+++++||++||+.||.+|||++|+
T Consensus 190 ~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 190 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1234599999999999999999999876654433333221 2233345556899999999999999999999999999
Q ss_pred hcCccccc
Q 025933 161 KKHPWFLK 168 (246)
Q Consensus 161 l~hp~~~~ 168 (246)
++||||++
T Consensus 268 l~h~~~~~ 275 (277)
T d1phka_ 268 LAHPFFQQ 275 (277)
T ss_dssp TTSGGGCT
T ss_pred HcCHHHHH
Confidence 99999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=274.85 Aligned_cols=164 Identities=25% Similarity=0.329 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-CCCCCCCCCCCCCCcchhcccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.....++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.... .......+||+.|+|||++....+
T Consensus 102 ~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccceeecccceeeehhhhccccC
Confidence 345567888999999999999999999999999987776 99999999974322 233445689999999999988887
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------------CCC---------CCCcCCHHH
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--------------FLP---------DYVRVSADC 139 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------~~~---------~~~~~~~~~ 139 (246)
.+.++||||+||++|+|++|+.||.+.+....+.++......... ..+ ....++.++
T Consensus 180 ~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 259 (298)
T d1gz8a_ 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259 (298)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHH
T ss_pred CCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHH
Confidence 667799999999999999999999887665555555443211110 000 023578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
++||++||++||++|||++|+++||||+..
T Consensus 260 ~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 260 RSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 999999999999999999999999999653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=278.94 Aligned_cols=153 Identities=36% Similarity=0.648 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCCc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...+.||+.||+|||+++||||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..|+.+
T Consensus 106 ~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (320)
T d1xjda_ 106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183 (320)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCch
Confidence 345678889999999999999999999999998776 999999999854332 23344689999999999999998765
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH-HHhcCc
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP-EIKKHP 164 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp 164 (246)
+||||+||++|+|++|+.||.+.+... +..++....+..|. .+|+++++||.+||.+||.+|||+. ++++||
T Consensus 184 -~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 184 -VDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred -hhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCc--cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 999999999999999999998765433 33344444444443 6899999999999999999999996 899999
Q ss_pred cccc
Q 025933 165 WFLK 168 (246)
Q Consensus 165 ~~~~ 168 (246)
||.+
T Consensus 257 ff~~ 260 (320)
T d1xjda_ 257 LFRE 260 (320)
T ss_dssp GGTT
T ss_pred hhcc
Confidence 9975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=276.59 Aligned_cols=193 Identities=22% Similarity=0.298 Sum_probs=138.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.. .......+||+.|+|||++.+..+.+.
T Consensus 123 ~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~ 198 (346)
T d1cm8a_ 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQ 198 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC--CSSCCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc--CCccccccccccccCHHHHcCCCCCCc
Confidence 4456788999999999999999999999999988876 999999999853 334566789999999999987665555
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------------cc----CCCCCCcCCHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------------QY----FLPDYVRVSADCR 140 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------~~----~~~~~~~~~~~~~ 140 (246)
++||||+||++|+|++|++||.+.+....+.......... .. .......+++.++
T Consensus 199 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 278 (346)
T d1cm8a_ 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278 (346)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHH
T ss_pred cchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHH
Confidence 6999999999999999999998876554444333221000 00 0011245789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHHh
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 204 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (246)
+||.+||..||.+|||++|+|+||||.......... .........+....+++++.+++.+.
T Consensus 279 dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~e~k~~~~~e 340 (346)
T d1cm8a_ 279 NLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP--QVQKYDDSFDDVDRTLDEWKRVTYKE 340 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--------CCCCCCCC-----CCHHHHHHHHHHH
T ss_pred HHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc--cCCCCCCchhhhhcCHHHHHHHHHHH
Confidence 999999999999999999999999997644322111 11111112233456677877776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=283.33 Aligned_cols=159 Identities=23% Similarity=0.440 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++||+||||||+|||++.++..++||+|||+++.........+.+||+.|+|||.+.+..|+.+
T Consensus 104 ~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~ 183 (321)
T d1tkia_ 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHH
T ss_pred HHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCch
Confidence 45567888999999999999999999999999876666799999999986544444455679999999999998888655
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+||||+||++|+|++|..||.+......+ ..+....+.++. +..+|+++++||++||.+||.+|||++|+++|
T Consensus 184 -~DiWSlGvily~ll~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 184 -TDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhcccHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876554333 334444443332 34689999999999999999999999999999
Q ss_pred cccccC
Q 025933 164 PWFLKN 169 (246)
Q Consensus 164 p~~~~~ 169 (246)
|||.+.
T Consensus 259 p~~~~~ 264 (321)
T d1tkia_ 259 PWLKQK 264 (321)
T ss_dssp HHHHSC
T ss_pred HhhccC
Confidence 999653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-40 Score=277.71 Aligned_cols=162 Identities=27% Similarity=0.363 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++|||||||||+|||++.++. .+||+|||+++.........+.+||+.|+|||.+.+....+.
T Consensus 124 ~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCCcccccccccccccChHHhhcccCCCc
Confidence 3456888999999999999999999999999987652 399999999986555555667789999999999876554445
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-------------cccCCC----------CCCcCCHHHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-------------VQYFLP----------DYVRVSADCRHL 142 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~~l 142 (246)
++||||+||++|+|++|.+||......+.+.+++..... ....++ .....++++++|
T Consensus 203 ~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred ceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHH
Confidence 599999999999999999999887766555554432110 000011 123578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccc
Q 025933 143 LSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 143 i~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
|.+||.+||.+|||+.|+|+||||..
T Consensus 283 l~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 283 CSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999964
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-39 Score=268.68 Aligned_cols=161 Identities=22% Similarity=0.301 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC-CCCCCCCCCCCCCcchhccccccCC
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
...++.|++.||+|||+++||||||||+|||++.++. +||+|||++...... .......|++.|+|||.+.+..+.+
T Consensus 102 ~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (286)
T d1ob3a_ 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred hHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccceecccchhhhHHHHhCCCCCC
Confidence 4456888999999999999999999999999988876 999999998743222 2234457999999999998766656
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C----------------------CCCCCcCCHHHHH
Q 025933 85 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F----------------------LPDYVRVSADCRH 141 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~----------------------~~~~~~~~~~~~~ 141 (246)
.++||||+||++|+|++|+.||.+....+.+.++......... . ......+++.+++
T Consensus 180 ~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 259 (286)
T d1ob3a_ 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (286)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence 6699999999999999999999887665555554433211000 0 0012357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 025933 142 LLSQIFVADPSKRIPIPEIKKHPWFLK 168 (246)
Q Consensus 142 li~~~L~~dp~~R~t~~e~l~hp~~~~ 168 (246)
||++||++||++|||++|+|+||||++
T Consensus 260 li~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 260 LLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999999999999999999963
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=268.94 Aligned_cols=157 Identities=21% Similarity=0.304 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 80 (246)
...+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+..... ....+..||+.|||||++.+.
T Consensus 104 ~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------------CCCCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcccccccccCcccCCHHHHhcc
Confidence 345678899999999999999999999999999998876 999999999753321 223456799999999999653
Q ss_pred ---ccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 81 ---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 81 ---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
.|+ .++|||||||++|+|++|+.||.+..........+...............+++++++||.+||..||.+|||+
T Consensus 182 ~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 182 DKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp SSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 354 4589999999999999999999887765555444433211111112234689999999999999999999999
Q ss_pred HHHhcC
Q 025933 158 PEIKKH 163 (246)
Q Consensus 158 ~e~l~h 163 (246)
.+++++
T Consensus 261 ~~il~~ 266 (276)
T d1uwha_ 261 PQILAS 266 (276)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=278.57 Aligned_cols=195 Identities=24% Similarity=0.331 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.|++.||+|||++||+||||||+|||++.++. +|++|||+++...........+||+.|+|||++.+..++.+
T Consensus 121 i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~ 198 (355)
T d2b1pa1 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198 (355)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---------------CCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccccccccccccccccccChhhhcCCCCCCC
Confidence 3456788899999999999999999999999998776 99999999886555555566789999999999998888766
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------------cccCC--------------C---
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------------VQYFL--------------P--- 130 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------------------~~~~~--------------~--- 130 (246)
+||||+||++|+|++|++||.+.+......+++..... ..... +
T Consensus 199 -~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (355)
T d2b1pa1 199 -VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 277 (355)
T ss_dssp -HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred -cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccc
Confidence 89999999999999999999877655554444432211 00000 0
Q ss_pred -CCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCChHHHHHHhhhhhhcCCCCCCccHHHHHHHHHH
Q 025933 131 -DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 203 (246)
Q Consensus 131 -~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (246)
.....++++++||++||..||++||||+|+|+||||.............+...+...++...+.+++.+.+..
T Consensus 278 ~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (355)
T d2b1pa1 278 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYK 351 (355)
T ss_dssp HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHH
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHH
Confidence 0012467899999999999999999999999999999876655544444444444556667788888776654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=275.68 Aligned_cols=165 Identities=25% Similarity=0.347 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.|++.||+|||++|||||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++....
T Consensus 111 i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 188 (345)
T d1pmea_ 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccceeeccccccceechHHHhhcCC
Confidence 4567888999999999999999999999999988776 999999998743222 1234567999999999986665
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------------ccCCC---------CCCcCC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------------QYFLP---------DYVRVS 136 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~----------------~~~~~---------~~~~~~ 136 (246)
..+.++||||+||++|+|++|+.||.+................. ....+ ..+.++
T Consensus 189 ~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 268 (345)
T d1pmea_ 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268 (345)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC
T ss_pred CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCC
Confidence 55566999999999999999999998766544433332211000 00000 124578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCh
Q 025933 137 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 172 (246)
Q Consensus 137 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 172 (246)
+++++||.+||+.||.+|||++++|+||||......
T Consensus 269 ~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 269 SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 999999999999999999999999999999866544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=269.75 Aligned_cols=161 Identities=21% Similarity=0.309 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCC-----CCCCCCCCCCCCCCcchhccccc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-----HSQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..++.|++.||+|||++|||||||||+|||++.++. +||+|||+++.... .....+.+||+.|+|||++.+..
T Consensus 120 ~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 197 (318)
T d3blha1 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197 (318)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCC
Confidence 456788999999999999999999999999988876 99999999964321 22234457999999999998764
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC-CCC-------------------------CcC
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDY-------------------------VRV 135 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~ 135 (246)
..+.++||||+||++|+|++|+.||.+..+......+........... ... ...
T Consensus 198 ~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T d3blha1 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277 (318)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHC
T ss_pred CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccC
Confidence 444559999999999999999999987665544444333321111000 000 013
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 136 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 136 ~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
++.+++||.+||+.||++|||++|+|+||||+..
T Consensus 278 ~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 278 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 7788999999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-39 Score=270.35 Aligned_cols=162 Identities=21% Similarity=0.286 Sum_probs=126.4
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCcc
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 86 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 86 (246)
...+.||+.||.|||++|||||||||+|||++.++. .+||+|||+|+...........+||+.|+|||.+.+....+.+
T Consensus 132 ~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 210 (328)
T d3bqca1 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 210 (328)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccccccCccccCcccccCCCCCCcc
Confidence 456788899999999999999999999999986543 4899999999865555556677899999999998876644556
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------cc----------------------cCCCCCCc
Q 025933 87 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------VQ----------------------YFLPDYVR 134 (246)
Q Consensus 87 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~----------~~----------------------~~~~~~~~ 134 (246)
+||||+||++|+|++|..||....+.......+..... .. ...+....
T Consensus 211 ~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T d3bqca1 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290 (328)
T ss_dssp HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGG
T ss_pred cchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccccccccc
Confidence 99999999999999999999876654332222211100 00 00112234
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 025933 135 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 169 (246)
Q Consensus 135 ~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 169 (246)
+++++++||++||++||.+|||++|+|+||||...
T Consensus 291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 78999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=271.91 Aligned_cols=151 Identities=24% Similarity=0.393 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+....... ..+..||+.|||||++.+..|
T Consensus 166 ~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 4567889999999999999999999999999988776 99999999985333222 124468999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |.+||.+......+.+++. ....++.+..+|+++++||.+||+.||++|||++|++
T Consensus 244 ~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 244 TIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp CHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 755 999999999999997 8999988766555554433 2333444557899999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=264.76 Aligned_cols=151 Identities=22% Similarity=0.349 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhcccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
.+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+...... ...+.+||+.|||||++.+..+
T Consensus 136 ~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 4567889999999999999999999999999988776 9999999997433222 2234579999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++| .+||.+......+...+... ...+.+..+++++++||.+||..||.+|||+.+++
T Consensus 214 ~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil 288 (299)
T d1ywna1 214 TIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288 (299)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Ccc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 655 9999999999999986 56887766555544443321 22233446899999999999999999999999999
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 289 ~~ 290 (299)
T d1ywna1 289 EH 290 (299)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-38 Score=259.18 Aligned_cols=164 Identities=23% Similarity=0.307 Sum_probs=126.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-CCCCCCCCCCCCcchhccccccC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
....++.|++.||+|||+++||||||||+|||++.++. +||+|||.++...... ......+++.|+|||++.+..+.
T Consensus 102 ~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 179 (292)
T d1unla_ 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCC
T ss_pred HHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccceeeccccchhhhhHhccCCCC
Confidence 34567888999999999999999999999999988776 9999999998543332 23344688999999999877765
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------------------cCCCCCCcCCHHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------------------YFLPDYVRVSADC 139 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~ 139 (246)
+.++||||+||++|+|++|+.||....+.......+....... ........+++.+
T Consensus 180 ~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 259 (292)
T d1unla_ 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259 (292)
T ss_dssp CTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHH
T ss_pred CchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHH
Confidence 5669999999999999999999766555444333332221110 0001123578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 140 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 140 ~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
++||++||+.||.+|||++|+|+||||.+..
T Consensus 260 ~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 260 RDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred HHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 9999999999999999999999999997643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=265.34 Aligned_cols=158 Identities=31% Similarity=0.447 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC--CCCCCCCCCCCCCcchhccccc-cC
Q 025933 7 FSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKE-YD 83 (246)
Q Consensus 7 ~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~ 83 (246)
...+.|++.||+|||+++||||||||+|||++.++. +||+|||+++..... ....+..|++.|+|||.+.+.. +.
T Consensus 132 ~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~ 209 (322)
T d1vzoa_ 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---
T ss_pred HHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcccccccccccccccccchhHHhhcCCcCC
Confidence 445678899999999999999999999999998776 999999999753322 2234557999999999997654 23
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCC-----CHH
Q 025933 84 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIP 158 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ 158 (246)
..++|||||||++|+|++|+.||.+.........+...........| ..+|+++++||++||.+||.+|| |++
T Consensus 210 ~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ 287 (322)
T d1vzoa_ 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287 (322)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHH
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHH
Confidence 44589999999999999999999887766666666555444443333 46999999999999999999999 589
Q ss_pred HHhcCccccc
Q 025933 159 EIKKHPWFLK 168 (246)
Q Consensus 159 e~l~hp~~~~ 168 (246)
|+++||||+.
T Consensus 288 eil~Hpff~~ 297 (322)
T d1vzoa_ 288 EIKEHLFFQK 297 (322)
T ss_dssp HHHTSGGGTT
T ss_pred HHHcCHhhcC
Confidence 9999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=270.00 Aligned_cols=161 Identities=23% Similarity=0.341 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCCc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 85 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 85 (246)
...++.||+.||+|||++|||||||||+|||++.++. +|++|||++... .....+..||+.|+|||++.+..+.+.
T Consensus 123 ~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~--~~~~~~~~g~~~y~apE~~~~~~~~~~ 198 (348)
T d2gfsa1 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQ 198 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC--TGGGSSSCHHHHTSCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc--CcccccccccccccCchhhcCCccCCc
Confidence 4566888999999999999999999999999988876 999999998743 334456789999999999887766566
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------------cCCC------CCCcCCHHHH
Q 025933 86 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-------------------YFLP------DYVRVSADCR 140 (246)
Q Consensus 86 ~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~------~~~~~~~~~~ 140 (246)
++||||+||++|+|++|.+||.+.+.......+........ ...+ ....++++++
T Consensus 199 ~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 278 (348)
T d2gfsa1 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278 (348)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred ccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHH
Confidence 69999999999999999999988766555444443321100 0000 1235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 141 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 141 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
+||++||..||.+|||++|+|+||||.+..
T Consensus 279 dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 279 DLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=258.67 Aligned_cols=156 Identities=19% Similarity=0.231 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+...... ......||+.|||||++.+..+
T Consensus 110 ~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccccccccCCcccccChHHHhCCCC
Confidence 45678899999999999999999999999999998776 9999999998543222 2334579999999999988888
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|..|+........ ++..+... ...+.+..+++++.+||.+||..||++|||++++++
T Consensus 188 ~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 188 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp CHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch-hhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhc-CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 655 9999999999999996555443333322 23333332 223334578999999999999999999999999988
Q ss_pred --Ccccc
Q 025933 163 --HPWFL 167 (246)
Q Consensus 163 --hp~~~ 167 (246)
|+||.
T Consensus 263 ~L~~~ft 269 (272)
T d1qpca_ 263 VLEDFFT 269 (272)
T ss_dssp HHHHHHH
T ss_pred Hhhhhhh
Confidence 77774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=260.05 Aligned_cols=154 Identities=19% Similarity=0.281 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.||+.||+|||+++||||||||+|||++.++. +||+|||+++...... ......||+.|||||++.+.
T Consensus 108 ~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccccCCCceecCchhhcCC
Confidence 45678889999999999999999999999999998776 9999999997432221 12234689999999999988
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|+|++ |+.||.+....+ +...+.... ..+.+..+|+++++||.+||..||.+|||+.+
T Consensus 186 ~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 186 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp EEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCch-hhhccchhhhhHHhhCCCCCCCCCCHHH----HHHHHHcCC-CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 88755 999999999999997 899998765432 223333322 23344578999999999999999999999999
Q ss_pred Hh---cCccc
Q 025933 160 IK---KHPWF 166 (246)
Q Consensus 160 ~l---~hp~~ 166 (246)
++ +|+|+
T Consensus 260 i~~~L~~~~~ 269 (277)
T d1xbba_ 260 VELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHhhCHHh
Confidence 84 55554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-37 Score=257.68 Aligned_cols=151 Identities=22% Similarity=0.276 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+....... .....||+.|+|||++.+..|
T Consensus 116 ~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 116 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeeccccccccccChHHHcCCCC
Confidence 45667889999999999999999999999999988776 99999999985432221 122358899999999998888
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 83 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
+.+ +|||||||++|+|++|..||....+.....+.+. .....+.+..+++++++||.+||..||.+|||+.++++
T Consensus 194 ~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 194 SIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp SHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 755 9999999999999997777655555444433332 22333444578999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-38 Score=258.10 Aligned_cols=154 Identities=21% Similarity=0.292 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC----CCCCCCCCCCCCcchhcccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 80 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++...... ......||+.|||||++.+.
T Consensus 110 ~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 110 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccccccccccccccccCccccChHHHhCC
Confidence 34667899999999999999999999999999988776 9999999997532221 22344689999999999888
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.++.+ +|||||||++|||++ |+.||.+....+.. ..+.... ..+.+..+|+++.+||.+||..||++|||+.+
T Consensus 188 ~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~----~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~ 261 (285)
T d1u59a_ 188 KFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLT 261 (285)
T ss_dssp EECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 88755 999999999999998 99999887654332 3333322 22334579999999999999999999999988
Q ss_pred H---hcCccc
Q 025933 160 I---KKHPWF 166 (246)
Q Consensus 160 ~---l~hp~~ 166 (246)
+ |+|+|+
T Consensus 262 i~~~L~~~~~ 271 (285)
T d1u59a_ 262 VEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7 456664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-37 Score=257.25 Aligned_cols=151 Identities=22% Similarity=0.322 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCC------CCCCCCCCCCcchhcc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP------KSTVGTPAYIAPEVLA 78 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~------~~~~gt~~y~aPE~~~ 78 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++........ ....||+.|||||++.
T Consensus 129 ~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (299)
T d1jpaa_ 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------------------CGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCCcceeeecccccCCccccCHHHHh
Confidence 45678889999999999999999999999999998776 999999999853322111 1235789999999999
Q ss_pred ccccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCH
Q 025933 79 RKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 157 (246)
Q Consensus 79 ~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 157 (246)
+..++.+ +|||||||++|||++ |..||.+....+ ++..+... ...+....++..+.+||.+||..||.+|||+
T Consensus 207 ~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 280 (299)
T d1jpaa_ 207 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQD----VINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280 (299)
T ss_dssp SCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred cCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHH----HHHHHHcC-CCCCCCccchHHHHHHHHHHcCCCHhHCcCH
Confidence 8888755 999999999999998 899998765433 23333322 2344455789999999999999999999999
Q ss_pred HHHhcC
Q 025933 158 PEIKKH 163 (246)
Q Consensus 158 ~e~l~h 163 (246)
.+++++
T Consensus 281 ~ei~~~ 286 (299)
T d1jpaa_ 281 GQIVNT 286 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=252.39 Aligned_cols=152 Identities=20% Similarity=0.351 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 81 (246)
...+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..
T Consensus 101 ~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 178 (263)
T d1sm2a_ 101 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------------CTTSCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecceecCcccCChHHhcCCC
Confidence 345678999999999999999999999999999998876 99999999985432222 22356899999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|+|+++ .+||..... ..+ +..+... ...+.+..+++++.+||.+||+.||++|||++++
T Consensus 179 ~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~~---~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~i 252 (263)
T d1sm2a_ 179 YSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SEV---VEDISTG-FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252 (263)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HHH---HHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HHH---HHHHHhc-CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 8755 9999999999999995 555654333 222 2222222 1223334689999999999999999999999999
Q ss_pred hcC
Q 025933 161 KKH 163 (246)
Q Consensus 161 l~h 163 (246)
++|
T Consensus 253 l~~ 255 (263)
T d1sm2a_ 253 LRQ 255 (263)
T ss_dssp HHH
T ss_pred HHH
Confidence 885
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-37 Score=252.65 Aligned_cols=152 Identities=18% Similarity=0.257 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~ 79 (246)
...+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++....... .....||+.|||||++.+
T Consensus 110 ~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 110 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHS
T ss_pred HHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc
Confidence 345678899999999999999999999999999998876 99999999985332211 122468999999999998
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|||||||++|+|++|..||......... +..+... ...+....++..+.+||.+||..||++|||+.+
T Consensus 188 ~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 262 (283)
T d1mqba_ 188 RKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262 (283)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhcc-CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence 888765 99999999999999966555444433332 2233222 233444578999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 263 il~ 265 (283)
T d1mqba_ 263 IVS 265 (283)
T ss_dssp HHH
T ss_pred HHH
Confidence 976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=249.77 Aligned_cols=151 Identities=19% Similarity=0.285 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC--CCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..++++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..+
T Consensus 101 ~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 178 (258)
T d1k2pa_ 101 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCC
Confidence 45677899999999999999999999999999998776 99999999975433222 223568999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |+.||.+....+.. .++.... ..+.+...++.+++||++||+.||++|||+++++
T Consensus 179 ~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil 252 (258)
T d1k2pa_ 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETA----EHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPTFKILL 252 (258)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred Ccc-eeecccchhhHhHHhcCCCCCCCCCHHHHH----HHHHhCC-CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 755 999999999999998 89999876654333 3333322 2344457899999999999999999999999999
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 253 ~~ 254 (258)
T d1k2pa_ 253 SN 254 (258)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=254.41 Aligned_cols=151 Identities=23% Similarity=0.376 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhcccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEY 82 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 82 (246)
..+..+.|++.||+|||+++||||||||+||+++.++. +||+|||+|+...... ......||+.|+|||++.+..+
T Consensus 109 ~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 109 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcceeccceecCcccchhhHhccCCC
Confidence 34567889999999999999999999999999998776 9999999998543222 2233468999999999998888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 83 DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 83 ~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
+.+ +|||||||++|+|++ |.+||.+....+.+.. +.... ..+.+..+|+++.+||.+||..||.+|||+.+++
T Consensus 187 ~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----i~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~ 260 (273)
T d1mp8a_ 187 TSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260 (273)
T ss_dssp SHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCC-CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 755 999999999999998 8999987666444333 23322 2345567999999999999999999999999998
Q ss_pred cC
Q 025933 162 KH 163 (246)
Q Consensus 162 ~h 163 (246)
+|
T Consensus 261 ~~ 262 (273)
T d1mp8a_ 261 AQ 262 (273)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-37 Score=254.72 Aligned_cols=153 Identities=22% Similarity=0.336 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC----CCCCCCCCCCCCCcchhccccc
Q 025933 6 YFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
...++.||+.||+|||++|||||||||+|||++.++. ++|+|||+++..... ....+.+||+.|||||++.+..
T Consensus 113 ~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 190 (277)
T d1o6ya_ 113 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC
Confidence 4567889999999999999999999999999998877 999999988643221 2234557999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCcCCHHHHHHHHHhcccCCCCCC-CHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRI-PIP 158 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~-t~~ 158 (246)
++.+ +||||+||++|+|++|++||.+.+..+.+.+.+ ...... .....+|+++++||.+||++||.+|| |++
T Consensus 191 ~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 191 VDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 265 (277)
T ss_dssp CCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----hcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHH
Confidence 8655 999999999999999999998765544433332 222221 23457899999999999999999999 555
Q ss_pred HHhcCccc
Q 025933 159 EIKKHPWF 166 (246)
Q Consensus 159 e~l~hp~~ 166 (246)
++ .|+|.
T Consensus 266 ~l-~~~l~ 272 (277)
T d1o6ya_ 266 EM-RADLV 272 (277)
T ss_dssp HH-HHHHH
T ss_pred HH-HHHHH
Confidence 54 45554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=252.30 Aligned_cols=159 Identities=19% Similarity=0.243 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC--CCCCCCCCCCCCcchhccccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 81 (246)
...+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..
T Consensus 113 ~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 190 (285)
T d1fmka3 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeeccccccccccChHHHhCCC
Confidence 355778899999999999999999999999999988776 9999999997532222 223356999999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 025933 82 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 161 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 161 (246)
++.+ +|||||||++|+|++|..||......... +..+... ...+....+++++++||.+||+.||++|||+++++
T Consensus 191 ~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~---~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHhc-CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 8755 99999999999999976665544443332 3333322 23344557899999999999999999999999998
Q ss_pred c--CcccccC
Q 025933 162 K--HPWFLKN 169 (246)
Q Consensus 162 ~--hp~~~~~ 169 (246)
+ |+||...
T Consensus 266 ~~L~~~~~~~ 275 (285)
T d1fmka3 266 AFLEDYFTST 275 (285)
T ss_dssp HHHHTTTSCS
T ss_pred HHHhhhhcCC
Confidence 7 7888653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=257.73 Aligned_cols=152 Identities=22% Similarity=0.335 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+....... .....||+.|||||++.+..
T Consensus 112 ~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 189 (317)
T d1xkka_ 112 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccccccccccccccCccccChHHHhcCC
Confidence 34567889999999999999999999999999998776 99999999975332221 22346899999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|+|++ |.+||.+....+. ...+.. ....+.+..+++++.+||.+||..||.+|||+.++
T Consensus 190 ~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 190 YTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHH----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHc----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 8655 999999999999998 8899977654332 333222 12234445789999999999999999999999999
Q ss_pred hcCc
Q 025933 161 KKHP 164 (246)
Q Consensus 161 l~hp 164 (246)
+.|.
T Consensus 264 l~~l 267 (317)
T d1xkka_ 264 IIEF 267 (317)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=250.20 Aligned_cols=152 Identities=23% Similarity=0.323 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC----CCCCCCCCCCCcchhccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~~~~ 79 (246)
...+.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++....... .....|+..|+|||++.+
T Consensus 111 ~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC
Confidence 345677899999999999999999999999999998775 99999999985322211 123357889999999998
Q ss_pred cccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 158 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 158 (246)
..++.+ +|||||||++|+|++ |..||.+.+..+. +.++.......+....+|+.+++||.+||..||++|||+.
T Consensus 189 ~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 263 (273)
T d1u46a_ 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263 (273)
T ss_dssp CEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHH----HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence 888655 899999999999998 8999987655433 3444444445555667999999999999999999999999
Q ss_pred HHhc
Q 025933 159 EIKK 162 (246)
Q Consensus 159 e~l~ 162 (246)
++++
T Consensus 264 ei~~ 267 (273)
T d1u46a_ 264 ALRD 267 (273)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-36 Score=250.53 Aligned_cols=150 Identities=20% Similarity=0.286 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+..... ....+..||+.|+|||++.+..
T Consensus 141 ~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 45677889999999999999999999999999998776 999999998743221 2223457899999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
|+.+ +|||||||++|+|++|. +||.+....+. ...+.... ..+.+..+++++.+||.+||..||++|||+.|+
T Consensus 219 ~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~~e~----~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 219 YTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEV----IYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CChh-hhhccchhhHHHHHccCCCCCCCCCHHHH----HHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8755 99999999999999985 67776554333 33333333 233345789999999999999999999999998
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-36 Score=248.55 Aligned_cols=162 Identities=15% Similarity=0.117 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC-CCCcEEEeccCCccCCCCCC--------CCCCCCCCCCCCcch
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPE 75 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~-~~~~vkl~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE 75 (246)
..+.++.|++.||+|||++|||||||||+|||++.. ....+||+|||+|+...... ...+.+||+.|||||
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHH
Confidence 346678899999999999999999999999998543 22459999999998533211 223457999999999
Q ss_pred hccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-cccCCC-CCCcCCHHHHHHHHHhcccCCCC
Q 025933 76 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLP-DYVRVSADCRHLLSQIFVADPSK 153 (246)
Q Consensus 76 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~L~~dp~~ 153 (246)
++.+..++.+ +|||||||++|+|++|..||.................. .....+ ....+|+++.+||.+||..||.+
T Consensus 184 ~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~ 262 (299)
T d1ckia_ 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 262 (299)
T ss_dssp HHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTC
T ss_pred HHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhH
Confidence 9998888655 99999999999999999999876554333222211111 011111 12368999999999999999999
Q ss_pred CCCHHHH---hcCcccc
Q 025933 154 RIPIPEI---KKHPWFL 167 (246)
Q Consensus 154 R~t~~e~---l~hp~~~ 167 (246)
||++.++ |+|+|.+
T Consensus 263 RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 263 KPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHH
Confidence 9998754 5666543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=245.66 Aligned_cols=151 Identities=21% Similarity=0.315 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCC---CCCCCCCCCCCCCcchhcccc
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 80 (246)
...+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+.
T Consensus 135 ~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~ 212 (299)
T d1fgka_ 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCC
Confidence 345678889999999999999999999999999998876 999999999843222 223345789999999999988
Q ss_pred ccCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 81 EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
.|+.+ +|||||||++|+|++ |.+||.+..... +...+.. ....+.+..+++.+++||.+||+.||.+|||+.|
T Consensus 213 ~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~----~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 213 IYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp CCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHH----HHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHH
Confidence 88755 899999999999998 788887655432 2233333 2233444578999999999999999999999999
Q ss_pred Hhc
Q 025933 160 IKK 162 (246)
Q Consensus 160 ~l~ 162 (246)
+++
T Consensus 287 il~ 289 (299)
T d1fgka_ 287 LVE 289 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=246.51 Aligned_cols=151 Identities=21% Similarity=0.285 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccCC
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 84 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 84 (246)
..+..+.||+.||+|+|+++||||||||+|||++.++. +||+|||+++............||+.|+|||.+.+..++.
T Consensus 128 ~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 205 (309)
T d1fvra_ 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 205 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eEEccccccccccccccccceecCCcccchHHhccCCCCc
Confidence 45667899999999999999999999999999988776 9999999998654444444557999999999999888875
Q ss_pred cchhHHhHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 85 KISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 85 ~~~DiwslG~il~~ll~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
+ +|||||||++|+|++|. +||.+.+.. ++...+... ...+.+..+++++++||.+||..||++|||++++++|
T Consensus 206 ~-sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 206 N-SDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp H-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-ceeehhHHHHHHHHhcCCCCCCCCCHH----HHHHHHHhc-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 89999999999999965 567654432 233333332 2334445789999999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-35 Score=239.51 Aligned_cols=150 Identities=21% Similarity=0.356 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhccccccC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 83 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 83 (246)
...+.++.||+.||+|||+++||||||||+|||++.++. +||+|||+++... .......+|+.|+|||++.+..++
T Consensus 103 ~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~~~~~~~~~~~y~aPE~l~~~~~t 178 (262)
T d1byga_ 103 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFS 178 (262)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--CCCccccccccCCChHHHhCCCCC
Confidence 345678999999999999999999999999999998876 9999999998532 223445789999999999888886
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 025933 84 GKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 162 (246)
Q Consensus 84 ~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 162 (246)
.+ +|||||||++|+|++ |.+||......+... .+.+. ...+....+++.+++||++||..||.+|||+.++++
T Consensus 179 ~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~----~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 179 TK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----HHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcC-CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 55 999999999999998 788887655433322 22221 223334468999999999999999999999999987
Q ss_pred C
Q 025933 163 H 163 (246)
Q Consensus 163 h 163 (246)
+
T Consensus 253 ~ 253 (262)
T d1byga_ 253 Q 253 (262)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-35 Score=253.04 Aligned_cols=162 Identities=22% Similarity=0.346 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHhHh-CCcccCCCCCCCEEecCCCC----CcEEEeccCCccCCCCCCCCCCCCCCCCCCcchhcccc
Q 025933 6 YFSSTVMIFTSHHCFYL-QEICHRDLKLENTLLDGSPQ----PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 80 (246)
Q Consensus 6 ~~~~~~qil~~l~~lH~-~~ivHrDlkp~Nill~~~~~----~~vkl~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~~~~~ 80 (246)
.-.++.|++.||.|||+ +||+||||||+|||++..+. ..+|++|||.+... .......+||+.|+|||++.+.
T Consensus 127 i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccc--ccccccccccccccChhhcccc
Confidence 34567889999999998 88999999999999975543 24899999998743 3344567899999999999988
Q ss_pred ccCCcchhHHhHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHHHhc--------cc-------------c------
Q 025933 81 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------RNFRKTIDRIRN--------VQ-------------Y------ 127 (246)
Q Consensus 81 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~~~~~~~~--------~~-------------~------ 127 (246)
.++.+ +|+||+||++++|++|+.||...... ......+..... .. .
T Consensus 205 ~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
T d1q8ya_ 205 PWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283 (362)
T ss_dssp CCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred CCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC
Confidence 88765 89999999999999999999653321 111111111000 00 0
Q ss_pred ---------CCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 025933 128 ---------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 170 (246)
Q Consensus 128 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 170 (246)
........++.+++||.+||.+||.+|||++|+|+||||+...
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred CchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0001123467899999999999999999999999999998543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-35 Score=243.57 Aligned_cols=150 Identities=19% Similarity=0.249 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC---CCCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||.|||+++||||||||+|||++.++. +||+|||+++...... .....+||+.|+|||.+.+..
T Consensus 134 ~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~ 211 (308)
T d1p4oa_ 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeecccceeccCCcceeeccceecccccCCHHHHccCC
Confidence 35667889999999999999999999999999988776 9999999997432221 123346899999999999888
Q ss_pred cCCcchhHHhHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++| .+||.+....+.+ ..+.+.. ..+....+++.+.+||.+||+.||.+|||++++
T Consensus 212 ~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 212 FTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp CCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8655 8999999999999998 5778765543333 3333322 233445789999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 286 l~ 287 (308)
T d1p4oa_ 286 IS 287 (308)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=241.89 Aligned_cols=151 Identities=25% Similarity=0.359 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCCC---CCCCCCCCCCCcchhccccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKE 81 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 81 (246)
..+.++.|++.||+|||+++||||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++.+..
T Consensus 146 ~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 45667899999999999999999999999999988776 99999999985432221 23357899999999998877
Q ss_pred cCCcchhHHhHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHHH
Q 025933 82 YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 160 (246)
Q Consensus 82 ~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 160 (246)
++.+ +|||||||++|+|++ |.+||.+......+.+++.. ..........++.+.+||.+||..||.+|||++++
T Consensus 224 ~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 224 YTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp CCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7655 999999999999998 66667665555555544433 22233334689999999999999999999999999
Q ss_pred hc
Q 025933 161 KK 162 (246)
Q Consensus 161 l~ 162 (246)
++
T Consensus 299 l~ 300 (311)
T d1t46a_ 299 VQ 300 (311)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=241.60 Aligned_cols=152 Identities=18% Similarity=0.230 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCCCcchhccc
Q 025933 5 CYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR 79 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 79 (246)
..+.++.|++.||.|+|+++|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||.+.+
T Consensus 131 ~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccceecccccccccccChHHHhc
Confidence 34678889999999999999999999999999988776 9999999998533221 1223468999999999988
Q ss_pred cccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCcCCHHHHHHHHHhcccCCCCCCCHHH
Q 025933 80 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE 159 (246)
Q Consensus 80 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 159 (246)
..++.+ +|||||||++|+|++|..||........ +...+.... ..+.+..+++++.+||.+||..||++|||+.|
T Consensus 209 ~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~i~~g~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 209 QKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 888655 8999999999999998777765433322 222233322 22333468999999999999999999999999
Q ss_pred HhcC
Q 025933 160 IKKH 163 (246)
Q Consensus 160 ~l~h 163 (246)
+++|
T Consensus 284 i~~~ 287 (311)
T d1r0pa_ 284 LVSR 287 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-33 Score=233.75 Aligned_cols=157 Identities=13% Similarity=0.148 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHHhHhCCcccCCCCCCCEEecCC---CCCcEEEeccCCccCCCCC--------CCCCCCCCCCCCC
Q 025933 4 VCYFSSTVMIFTSHHCFYLQEICHRDLKLENTLLDGS---PQPRLKICDFGYSKSGLLH--------SQPKSTVGTPAYI 72 (246)
Q Consensus 4 ~~~~~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~---~~~~vkl~Dfg~s~~~~~~--------~~~~~~~gt~~y~ 72 (246)
...+.++.|++.||+|||++|||||||||+|||++.. ..+.+||+|||+|+..... ....+.+||+.||
T Consensus 101 ~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~ 180 (293)
T d1csna_ 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhc
Confidence 3456778899999999999999999999999999652 2245999999999743211 1233457999999
Q ss_pred cchhccccccCCcchhHHhHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhccccCCCCCCcCCHHHHHHHHHhccc
Q 025933 73 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN---FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 149 (246)
Q Consensus 73 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 149 (246)
|||++.+..++.+ +|||||||++|+|++|..||.+...... +.++....... .......++|+++.+++..|+..
T Consensus 181 aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l~~~~p~~l~~ii~~~~~~ 258 (293)
T d1csna_ 181 SINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLRELCAGFPEEFYKYMHYARNL 258 (293)
T ss_dssp CHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHHC
T ss_pred CHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-ChHHhcCCCCHHHHHHHHHHhcC
Confidence 9999998888655 9999999999999999999976544322 22222211111 00011235889999999999999
Q ss_pred CCCCCCCHHHHhc
Q 025933 150 DPSKRIPIPEIKK 162 (246)
Q Consensus 150 dp~~R~t~~e~l~ 162 (246)
+|.+||+++.+.+
T Consensus 259 ~~~~rP~y~~l~~ 271 (293)
T d1csna_ 259 AFDATPDYDYLQG 271 (293)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.2e-33 Score=230.48 Aligned_cols=156 Identities=21% Similarity=0.256 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHHHHHhHh--------CCcccCCCCCCCEEecCCCCCcEEEeccCCccCCCCCC-----CCCCCCCCCCC
Q 025933 5 CYFSSTVMIFTSHHCFYL--------QEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAY 71 (246)
Q Consensus 5 ~~~~~~~qil~~l~~lH~--------~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~~~~~~-----~~~~~~gt~~y 71 (246)
..+.++.|++.||+|+|+ ++||||||||+|||++.++. +||+|||+++...... .....+||+.|
T Consensus 101 ~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y 178 (303)
T d1vjya_ 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178 (303)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEECC----CCSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccccccCCCcceeccccceecccCc
Confidence 346788899999999996 59999999999999988776 9999999987432221 22345799999
Q ss_pred Ccchhccccc------cCCcchhHHhHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhcccc--CCCCC
Q 025933 72 IAPEVLARKE------YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIRNVQY--FLPDY 132 (246)
Q Consensus 72 ~aPE~~~~~~------~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~ 132 (246)
||||++.+.. ++ .++|||||||++|+|++|..||...... ............... .++..
T Consensus 179 ~aPE~~~~~~~~~~~~~~-~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 257 (303)
T d1vjya_ 179 MAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp CCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred CChhhccccccccCCCcC-cchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc
Confidence 9999987543 33 3489999999999999998887432211 111112222211111 11111
Q ss_pred ---CcCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 025933 133 ---VRVSADCRHLLSQIFVADPSKRIPIPEIKKH 163 (246)
Q Consensus 133 ---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 163 (246)
......+.+|+.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1123468999999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.49 E-value=7.9e-15 Score=112.56 Aligned_cols=45 Identities=31% Similarity=0.343 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHhHhCCcccCCCCCCCEEecCCCCCcEEEeccCCccC
Q 025933 8 SSTVMIFTSHHCFYLQEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 55 (246)
Q Consensus 8 ~~~~qil~~l~~lH~~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~~ 55 (246)
..+.|++.+++|||++||+||||||+|||++.++ ++|+|||+|+.
T Consensus 107 ~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~ 151 (191)
T d1zara2 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVE 151 (191)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCccc
Confidence 4567888999999999999999999999998643 89999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.97 E-value=0.0032 Score=49.98 Aligned_cols=30 Identities=23% Similarity=0.349 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.|+||+|+.+.||+++.+.. +-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcchhhhhcccccc--eeEecccccc
Confidence 47999999999999987653 5799999764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.15 E-value=0.017 Score=44.01 Aligned_cols=29 Identities=24% Similarity=0.268 Sum_probs=23.4
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.|.|||++.++. +-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred EEEEeeccCcceeecCCce--EEEeechhcc
Confidence 4899999999999986543 4699998664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.70 E-value=0.017 Score=43.80 Aligned_cols=29 Identities=21% Similarity=0.231 Sum_probs=23.6
Q ss_pred CcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 24 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 24 ~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++|+|+.|.|||++.+.. +-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~--~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRF--SGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCce--EEEEEchhcc
Confidence 3799999999999986543 5699998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.49 E-value=0.039 Score=45.04 Aligned_cols=29 Identities=17% Similarity=0.260 Sum_probs=24.6
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
..++|+|+.+.|||++.+. ++|+||.++.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 3589999999999998653 8999998765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.19 E-value=0.11 Score=41.02 Aligned_cols=28 Identities=18% Similarity=0.126 Sum_probs=22.8
Q ss_pred CCcccCCCCCCCEEecCCCCCcEEEeccCCcc
Q 025933 23 QEICHRDLKLENTLLDGSPQPRLKICDFGYSK 54 (246)
Q Consensus 23 ~~ivHrDlkp~Nill~~~~~~~vkl~Dfg~s~ 54 (246)
.++||+|+.+.|||++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC----ceEEechhcc
Confidence 368999999999999642 4589999765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=81.95 E-value=0.25 Score=39.89 Aligned_cols=16 Identities=44% Similarity=0.748 Sum_probs=13.4
Q ss_pred cccCCCCCCCEEecCC
Q 025933 25 ICHRDLKLENTLLDGS 40 (246)
Q Consensus 25 ivHrDlkp~Nill~~~ 40 (246)
++|.|+.+.||++...
T Consensus 220 ~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKA 235 (395)
T ss_dssp EECSCCCGGGEEEEC-
T ss_pred EEecCCCcccEeeccc
Confidence 5799999999999653
|